1 1976 01 16 2019 02 08 0006-2944 13 2 1975 Jun Biochemical medicine Biochem Med Formate assay in body fluids: application in methanol poisoning. 117-26 Makar A B AB McMartin K E KE Palese M M Tephly T R TR eng MC_UU_12013/5 MRC United Kingdom Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochem Med 0151424 0006-2944 0 Formates 142M471B3J Carbon Dioxide EC 1.2.- Aldehyde Oxidoreductases Y4S76JWI15 Methanol IM Aldehyde Oxidoreductases metabolism Animals Body Fluids analysis Carbon Dioxide blood Formates blood poisoning Haplorhini Humans Hydrogen-Ion Concentration Kinetics Methanol blood Methods Pseudomonas enzymology 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 1 10.1016/0006-2944(75)90147-7 2 1976 01 10 2019 06 12 1090-2104 66 4 1975 Oct 27 Biochemical and biophysical research communications Biochem Biophys Res Commun Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution. 1173-9 Bose K S KS Sarma R H RH eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochem Biophys Res Commun 0372516 0006-291X 0U46U6E8UK NAD 53-59-8 NADP IM Biochem Pharmacol. 1975 Aug 15;24(16):1517-21 8 Fourier Analysis Magnetic Resonance Spectroscopy Models, Molecular Molecular Conformation NAD analogs & derivatives NADP Structure-Activity Relationship Temperature 1975 10 27 1975 10 27 0 1 1975 10 27 0 0 ppublish 2 0006-291X(75)90482-9 10.1016/0006-291x(75)90482-9 3 1976 01 10 2019 06 12 0006-291X 66 4 1975 Oct 27 Biochemical and biophysical research communications Biochem Biophys Res Commun Metal substitutions incarbonic anhydrase: a halide ion probe study. 1281-6 Smith R J RJ Bryant R G RG eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochem Biophys Res Commun 0372516 0006-291X 00BH33GNGH Cadmium EC 4.2.1.1 Carbonic Anhydrases FXS1BY2PGL Mercury J41CSQ7QDS Zinc IM Animals Binding Sites Cadmium Carbonic Anhydrases metabolism Cattle Humans Hydrogen-Ion Concentration Magnetic Resonance Spectroscopy Mercury Protein Binding Protein Conformation Zinc pharmacology 1975 10 27 1975 10 27 0 1 1975 10 27 0 0 ppublish 3 0006-291X(75)90498-2 10.1016/0006-291x(75)90498-2 4 1976 01 10 2019 06 12 1090-2104 66 4 1975 Oct 27 Biochemical and biophysical research communications Biochem Biophys Res Commun Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake. 1338-43 Wiesmann U N UN DiDonato S S Herschkowitz N N NN eng BB/C008219/1 Biotechnology and Biological Sciences Research Council United Kingdom G1100377 Medical Research Council United Kingdom G1100377 MRC United Kingdom Journal Article United States Biochem Biophys Res Commun 0372516 0006-291X 0 Dextrans 886U3H6UFF Chloroquine EC 3.1.6.- Sulfatases EC 3.1.6.8 Cerebroside-Sulfatase EC 3.2.1.31 Glucuronidase IM Biological Transport Cells, Cultured Cerebroside-Sulfatase metabolism Chloroquine pharmacology Dextrans metabolism Fibroblasts enzymology metabolism Glucuronidase metabolism Humans Leukodystrophy, Metachromatic enzymology Lysosomes drug effects enzymology Pinocytosis drug effects Skin enzymology Sulfatases metabolism 1975 10 27 1975 10 27 0 1 1975 10 27 0 0 ppublish 4 0006-291X(75)90506-9 10.1016/0006-291x(75)90506-9 5 1976 01 10 2019 06 12 1090-2104 66 4 1975 Oct 27 Biochemical and biophysical research communications Biochem Biophys Res Commun Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin. 1349-56 Hendrickson W A WA Ward K B KB eng Journal Article United States Biochem Biophys Res Commun 0372516 0006-291X 0 Hemerythrin 0 Metalloproteins 0 Muscle Proteins IM Animals Cnidaria Computers Hemerythrin Metalloproteins Models, Molecular Muscle Proteins Protein Conformation Species Specificity 1975 10 27 1975 10 27 0 1 1975 10 27 0 0 ppublish 5 0006-291X(75)90508-2 10.1016/0006-291x(75)90508-2 6 1976 01 10 2019 06 12 0006-291X 66 4 1975 Oct 27 Biochemical and biophysical research communications Biochem Biophys Res Commun Studies of oxygen binding energy to hemoglobin molecule. 1424-31 Chow Y W YW Pietranico R R Mukerji A A eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States Biochem Biophys Res Commun 0372516 0006-291X 0 Hemoglobins 0 Ligands 0 Oxyhemoglobins 3G0H8C9362 Cobalt E1UOL152H7 Iron S88TT14065 Oxygen IM Binding Sites Cobalt blood Hemoglobins Humans Hydrogen-Ion Concentration Iron blood Ligands Mathematics Oxygen blood Oxyhemoglobins Protein Binding Spectrum Analysis 1975 10 27 1975 10 27 0 1 1975 10 27 0 0 ppublish 6 0006-291X(75)90518-5 10.1016/0006-291x(75)90518-5 7 1976 01 26 2020 02 25 1873-2968 24 16 1975 Aug 15 Biochemical pharmacology Biochem Pharmacol Maturation of the adrenal medulla--IV. Effects of morphine. 1469-74 Anderson T R TR Slotkin T A TA eng MC_U147585819 MRC United Kingdom MC_UU_12011/1 MRC United Kingdom MC_UP_A620_1014 MRC United Kingdom Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Biochem Pharmacol 0101032 0006-2952 0 Catecholamines 76I7G6D29C Morphine 818U2PZ2EH Metaraminol EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.14.17.1 Dopamine beta-Hydroxylase YKH834O4BH Epinephrine IM Adrenal Medulla enzymology growth & development metabolism Aging Animals Animals, Newborn Body Weight drug effects Catecholamines metabolism Dopamine beta-Hydroxylase metabolism Epinephrine metabolism Female Humans In Vitro Techniques Maternal-Fetal Exchange Metaraminol metabolism Morphine pharmacology Morphine Dependence metabolism Pregnancy Rats Tyrosine 3-Monooxygenase metabolism 1975 8 15 1975 8 15 0 1 1975 8 15 0 0 ppublish 7 0006-2952(75)90020-9 10.1016/0006-2952(75)90020-9 Br J Gen Pract. 1999 Oct;49(447):823-8 10885091 J Gastroenterol Hepatol. 2000 Oct;15(10):1093-9 11106086 Ann Intern Med. 2001 Jul 3;135(1):68-9 11434754 J Viral Hepat. 2001 Sep;8(5):358-66 11555193 BJOG. 2002 Mar;109(3):227-35 11950176 Drug Saf. 2002;25(5):323-44 12020172 Am J Med. 2002 Oct 15;113(6):506-15 12427501 J Altern Complement Med. 2003 Feb;9(1):161-8 12676044 Psychosomatics. 2003 Jul-Aug;44(4):271-82 12832592 Aliment Pharmacol Ther. 2003 Sep 1;18(5):451-71 12950418 Dig Dis Sci. 2003 Oct;48(10):1925-8 14627335 Cochrane Database Syst Rev. 2004;(1):CD002286 14973986 Mycoses. 2004 Apr;47(3-4):87-92 15078424 Planta Med. 2004 Apr;70(4):293-8 15095142 J Herb Pharmacother. 2004;4(1):49-67 15273078 J Herb Pharmacother. 2003;3(2):69-90 15277068 J Herb Pharmacother. 2003;3(1):121-33 15277076 J Herb Pharmacother. 2002;2(3):49-72 15277090 J Herb Pharmacother. 2002;2(1):71-85 15277109 J Herb Pharmacother. 2004;4(2):63-78 15364646 Expert Opin Pharmacother. 2004 Dec;5(12):2485-501 15571467 Drug Saf. 2005;28(4):319-32 15783241 Obstet Gynecol. 2005 Apr;105(4):849-56 15802416 J Herb Pharmacother. 2004;4(3):63-83 15829470 Obes Rev. 2005 May;6(2):93-111 15836459 Drug Saf. 2005;28(5):387-400 15853441 J Herb Pharmacother. 2004;4(4):61-90 15927926 Semin Arthritis Rheum. 2005 Jun;34(6):773-84 15942912 Expert Opin Drug Saf. 2005 Jul;4(4):779-94 16011454 J Herb Pharmacother. 2005;5(1):79-93 16093238 Complement Ther Med. 2005 Dec;13(4):279-90 16338199 Phytomedicine. 2006 May;13(5):371-7 16487688 J Herb Pharmacother. 2005;5(3):119-43 16520304 J Herb Pharmacother. 2005;5(4):71-114 16635970 Drug Saf. 2006;29(6):523-35 16752934 Mov Disord. 2006 Oct;21(10):1709-15 16830309 Eur Respir J. 2006 Aug;28(2):330-8 16880367 J Herb Pharmacother. 2006;6(1):89-126 17135164 J Herb Pharmacother. 2006;6(2):101-22 17182489 J Herb Pharmacother. 2006;6(3-4):135-59 17317655 Int J Toxicol. 2007;26 Suppl 1:3-106 17365137 Br J Psychiatry. 2007 May;190:379-84 17470951 Sleep Med Rev. 2007 Jun;11(3):209-30 17517355 J Herb Pharmacother. 2007;7(1):99-113 17594991 Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004559 17943819 Can J Physiol Pharmacol. 2007 Sep;85(9):837-47 18066129 World J Gastroenterol. 2008 Jan 21;14(3):454-62 18200670 Can J Clin Pharmacol. 2008 Winter;15(1):e66-73 18204101 J Herb Pharmacother. 2007;7(2):91-143 18285310 J Clin Epidemiol. 1991;44(11):1271-8 1834807 Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005288 18425916 Drug Saf. 2008;31(6):469-84 18484782 Cell Mol Neurobiol. 2009 Feb;29(1):17-25 18584321 J Herb Pharmacother. 2007;7(3-4):143-77 18928139 J Herb Pharmacother. 2007;7(3-4):279-323 18928148 Evid Based Complement Alternat Med. 2009 Mar;6(1):99-105 18955223 Am J Obstet Gynecol. 2008 Nov;199(5):455-66 18984078 Phytother Res. 2009 Apr;23(4):447-59 19086008 J Soc Integr Oncol. 2009 Spring;7(2):73-80 19476742 Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006568 19588398 Drug Saf. 2009;32(8):637-47 19591529 Curr Gastroenterol Rep. 2009 Aug;11(4):317-24 19615308 World J Gastroenterol. 2009 Oct 21;15(39):4886-95 19842218 Rev Recent Clin Trials. 2009 Sep;4(3):168-74 20028328 Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006556 20091597 Cardiovasc Hematol Agents Med Chem. 2010 Apr;8(2):113-27 20370653 Menopause. 2011 Apr;18(4):366-75 21228727 Planta Med. 2011 Jul;77(11):1149-60 21259185 Cochrane Database Syst Rev. 2011 Feb 16;(2):CD002948 21328257 Maturitas. 2011 Sep;70(1):37-41 21782365 J Psychiatr Res. 2011 Nov;45(11):1518-24 21820672 BMC Complement Altern Med. 2011 Aug 28;11:72 21871125 J Diet Suppl. 2010 Sep;7(3):283-302 22432518 J Diet Suppl. 2010 Dec;7(4):351-413 22432564 J Diet Suppl. 2011 Mar;8(1):58-114 22432635 J Diet Suppl. 2011 Jun;8(2):189-238 22432689 J Diet Suppl. 2011 Sep;8(3):311-30 22432729 J Diet Suppl. 2009;6(1):54-90 22435354 J Diet Suppl. 2009;6(2):162-200 22435415 J Diet Suppl. 2010 Jun;7(2):179-215 22435615 8 1976 01 26 2020 02 25 1873-2968 24 16 1975 Aug 15 Biochemical pharmacology Biochem Pharmacol Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase. 1517-21 Moroi K K Sato T T eng SF19107 Biotechnology and Biological Sciences Research Council United Kingdom Comparative Study Journal Article Published Erratum England Biochem Pharmacol 0101032 0006-2952 0 Metals 0 Phospholipids 0 Proteins 34237V843T Isocarboxazid 4Z8Y51M438 Procaine EC 3.1.- Esterases EC 3.5.- Amidohydrolases IM Biochem Biophys Res Commun. 1975 Oct 27;66(4):1173-9 2 Amidohydrolases metabolism Animals Esterases metabolism Hydrogen-Ion Concentration In Vitro Techniques Isocarboxazid metabolism Kinetics Male Metals pharmacology Microsomes, Liver enzymology Phospholipids metabolism Procaine metabolism Proteins metabolism Rats Subcellular Fractions enzymology Temperature 1975 8 15 1975 8 15 0 1 1975 8 15 0 0 ppublish 8 0006-2952(75)90029-5 10.1016/0006-2952(75)90029-5 Nature. 2001 May 31;411(6837):599-603 11385576 Gastroenterology. 2003 Jul;125(1):47-57 12851870 Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):525-39 15157825 Gastroenterology. 2004 Oct;127(4):1051-7 15480983 N Engl J Med. 2004 Nov 11;351(20):2069-79 15537905 Nat Med. 2005 Apr;11(4):383-4 15812518 Int J Colorectal Dis. 2006 Dec;21(8):747-53 16228179 World J Gastroenterol. 2006 Apr 7;12(13):1991-9 16610046 Am J Gastroenterol. 2006 Jul;101(7):1559-68 16863561 Science. 2006 Dec 1;314(5804):1461-3 17068223 Int J Immunogenet. 2007 Jun;34(3):181-91 17504508 Nat Rev Genet. 2008 Jan;9(1):9-14 17968351 Nat Genet. 2008 Aug;40(8):955-62 18587394 Inflamm Bowel Dis. 2008 Nov;14(11):1469-82 18618634 Gut. 2008 Sep;57(9):1294-6 18719139 Nature. 2008 Nov 13;456(7219):259-63 18849966 Annu Rev Genomics Hum Genet. 2009;10:89-116 19453248 Inflamm Bowel Dis. 2009 Nov;15(11):1643-55 19462429 Nat Immunol. 2009 Oct;10(10):1073-80 19701189 Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15813-8 19805227 Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):513-34 19817673 Nat Immunol. 2010 Jan;11(1):55-62 19898471 Curr Gastroenterol Rep. 2009 Dec;11(6):481-7 19903424 Nat Med. 2010 Jan;16(1):90-7 19966812 Inflamm Bowel Dis. 2010 Jul;16(7):1108-17 20024904 Am J Gastroenterol. 2010 Aug;105(8):1811-9 20197757 Curr Opin Gastroenterol. 2010 Jul;26(4):327-31 20445446 J Immunol. 2010 Jun 15;184(12):7247-56 20483763 Inflamm Bowel Dis. 2011 Jan;17(1):346-61 20839313 Nat Genet. 2010 Dec;42(12):1118-25 21102463 Gastroenterology. 1989 Apr;96(4):1016-20 2925048 Gut. 1988 Jul;29(7):990-6 3396969 Nature. 1996 Feb 29;379(6568):821-3 8587604 Gastroenterology. 1996 Sep;111(3):597-603 8780562 Gut. 1996 Nov;39(5):690-7 9014768 9 1976 01 23 2019 06 23 0006-2952 24 17 1975 Sep 01 Biochemical pharmacology Biochem Pharmacol Radiochemical assay of glutathione S-epoxide transferase and its enhancement by phenobarbital in rat liver in vivo. 1569-72 Marniemi J J Parkki M G MG eng Journal Article Research Support, U.S. Gov't, P.H.S. England Biochem Pharmacol 0101032 0006-2952 0 Carrier Proteins 0 Epoxy Compounds 0 Styrenes 56-49-5 Methylcholanthrene EC 2.5.1.18 Glutathione Transferase GAN16C9B8O Glutathione YQE403BP4D Phenobarbital IM Animals Carrier Proteins metabolism Epoxy Compounds metabolism pharmacology Glutathione pharmacology Glutathione Transferase metabolism Hydrogen-Ion Concentration Liver enzymology Male Methylcholanthrene pharmacology Phenobarbital pharmacology Rats Stimulation, Chemical Styrenes pharmacology 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 9 0006-2952(75)90080-5 10.1016/0006-2952(75)90080-5 10 1976 01 23 2020 03 03 1873-2968 24 17 1975 Sep 01 Biochemical pharmacology Biochem Pharmacol Digitoxin metabolism by rat liver microsomes. 1639-41 Schmoldt A A Benthe H F HF Haberland G G eng K01 AG044439 AG NIA NIH HHS United States Journal Article England Biochem Pharmacol 0101032 0006-2952 143-62-4 Digitoxigenin 53-59-8 NADP E90NZP2L9U Digitoxin IM Animals Chromatography, Thin Layer Digitoxigenin metabolism Digitoxin metabolism Hydroxylation In Vitro Techniques Male Microsomes, Liver metabolism NADP metabolism Rats Time Factors 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 10 0006-2952(75)90094-5 11 1976 01 23 2020 02 25 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists. 1651-8 Lefkowitz R J RJ eng Journal Article Research Support, U.S. Gov't, P.H.S. England Biochem Pharmacol 0101032 0006-2952 0 Adrenergic beta-Antagonists 0 Catecholamines 0 Receptors, Adrenergic 10028-17-8 Tritium 877K5MQ27W Alprenolol 9Y8NXQ24VQ Propranolol EC 4.6.1.1 Adenylyl Cyclases L628TT009W Isoproterenol IM Adenylyl Cyclases blood metabolism Adrenergic beta-Antagonists pharmacology Alprenolol blood Animals Anura Binding Sites Catecholamines pharmacology Cattle Cell Membrane enzymology Eels Erythrocytes enzymology Guinea Pigs In Vitro Techniques Isoproterenol pharmacology Kinetics Propranolol pharmacology Receptors, Adrenergic drug effects Stereoisomerism Tritium 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 11 0006-2952(75)90001-5 10.1016/0006-2952(75)90001-5 J Am Coll Cardiol. 2002 Jul 3;40(1):142-8 12103268 Postgrad Med J. 2005 Jul;81(957):442-7 15998820 Eur Heart J. 2006 Feb;27(3):344-50 16223744 Heart. 2006 Apr;92(4):559-68 16537784 Europace. 2006 Sep;8(9):746-837 16935866 Eur Heart J. 2007 Sep;28(18):2256-95 17726042 J Cardiovasc Electrophysiol. 2008 Jan;19(1):48-55 17916139 QJM. 2009 Jul;102(7):485-90 19474111 Eur Heart J. 2009 Nov;30(21):2631-71 19713422 Ann Intern Med. 1997 Jun 15;126(12):989-96 9182479 12 1976 01 23 2020 02 25 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells. 1659-62 Stein J M JM eng G1002528 Medical Research Council United Kingdom Journal Article England Biochem Pharmacol 0101032 0006-2952 0 Adrenergic alpha-Antagonists 0 Adrenergic beta-Antagonists 0 Phosphorus Radioisotopes 0TTZ664R7Z Phenoxybenzamine 27YLU75U4W Phosphorus 8L70Q75FXE Adenosine Triphosphate 9Y8NXQ24VQ Propranolol EC 1.13.12.- Luciferases EC 2.7.1.1 Hexokinase YKH834O4BH Epinephrine IM Adenosine Triphosphate biosynthesis metabolism Adipose Tissue drug effects metabolism Adrenergic alpha-Antagonists pharmacology Adrenergic beta-Antagonists pharmacology Animals Epinephrine pharmacology Hexokinase pharmacology In Vitro Techniques Luciferases pharmacology Male Oxygen Consumption drug effects Phenoxybenzamine pharmacology Phosphorus metabolism Phosphorus Radioisotopes Propranolol pharmacology Rats Time Factors 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 12 0006-2952(75)90002-7 10.1016/0006-2952(75)90002-7 Int J Qual Health Care. 2007 Feb;19(1):50-5 17172600 Nurse Educ Pract. 2008 Sep;8(5):299-301 18692016 BMJ. 2009 Apr 21;338:b1555 19383750 BMJ. 2009 May 12;338:b1900 19435768 BMJ. 2011 Feb 03;342:c6646 21292716 BMJ. 2011 Sep 13;343:d5672 21914758 BMJ Qual Saf. 2012 Mar;21(3):234-8 22282817 Clin Med (Lond). 2012 Dec;12(6):520-5 23342404 BMJ Qual Saf. 2013 Aug;22(8):613-7 23661281 13 1976 01 23 2019 06 23 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Action of propranolol on mitochondrial functions--effects on energized ion fluxes in the presence of valinomycin. 1701-5 Järvisalo J J Saris N E NE eng G9901400 Medical Research Council United Kingdom Journal Article England Biochem Pharmacol 0101032 0006-2952 2001-95-8 Valinomycin 8L70Q75FXE Adenosine Triphosphate 9Y8NXQ24VQ Propranolol EC 3.6.1.- Adenosine Triphosphatases RRU6GY95IS Nigericin RWP5GA015D Potassium IM Adenosine Triphosphatases metabolism Adenosine Triphosphate pharmacology Animals Hydrogen-Ion Concentration In Vitro Techniques Mitochondria drug effects Mitochondria, Liver enzymology metabolism Mitochondrial Swelling drug effects Nigericin pharmacology Oxidative Phosphorylation drug effects Oxygen Consumption drug effects Potassium pharmacology Propranolol pharmacology Rats Time Factors Valinomycin pharmacology 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 13 0006-2952(75)90009-X 10.1016/0006-2952(75)90009-x 14 1976 01 23 2020 02 25 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Malathion A and B esterases of mouse liver-I. 1713-7 Bhagwat V M VM Ramachandran B V BV eng G0100165 Medical Research Council United Kingdom Journal Article England Biochem Pharmacol 0101032 0006-2952 0 Metals 0 Sulfhydryl Compounds EC 3.1.- Esterases U5N7SU872W Malathion IM Animals Drug Stability Esterases analysis antagonists & inhibitors isolation & purification Female Hydrogen-Ion Concentration Liver enzymology ultrastructure Malathion metabolism Male Metals pharmacology Mice Sex Factors Sulfhydryl Compounds pharmacology 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 14 0006-2952(75)90011-8 10.1016/0006-2952(75)90011-8 Nature. 2003 Jan 2;421(6918):37-42 12511946 Proc Biol Sci. 2003 Sep 22;270(1527):1887-92 14561301 Nature. 2004 Jan 8;427(6970):145-8 14712274 Nature. 2006 Jan 12;439(7073):161-7 16407945 15 1976 01 23 2020 02 25 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Increase in acetyl CoA synthetase activity after phenobarbital treatment. 1725-7 Akamatsu N N Nakajima H H Ono M M Miura Y Y eng Journal Article England Biochem Pharmacol 0101032 0006-2952 0 Proteins 98600C0908 Cycloheximide EC 2.6.1.16 Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) EC 2.7.- Phosphotransferases EC 3.1.1.6 Acetylesterase EC 6.2.1.- Coenzyme A Ligases EC 6.2.1.1 Acetate-CoA Ligase N08U5BOQ1K Glucosamine V956696549 Acetylglucosamine YQE403BP4D Phenobarbital IM Acetate-CoA Ligase metabolism Acetylesterase metabolism Acetylglucosamine Animals Coenzyme A Ligases metabolism Cycloheximide pharmacology Glucosamine Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) metabolism Liver drug effects enzymology Male Phenobarbital pharmacology Phosphotransferases metabolism Proteins metabolism Rats Stimulation, Chemical 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 15 0006-2952(75)90013-1 10.1016/0006-2952(75)90013-1 Clin Med (Lond). 2005 Jul-Aug;5(4):344-8 16138488 Arch Dis Child. 2007 Jul;92(7):573-5 17588971 Arch Dis Child. 2007 Dec;92(12):1143 18032643 Pediatrics. 2010 Nov;126(5):851-5 20956413 J Health Serv Res Policy. 2011 Apr;16(2):75-80 21389060 BMJ. 2011 Apr 18;342:d2421 21502273 Clin Med (Lond). 2011 Oct;11(5):420-1 22034695 Bull Hist Med. 1998 Summer;72(2):246-78 9628051 16 1976 01 23 2020 02 25 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines. 1731-3 Turner A J AJ Hick P E PE eng Journal Article England Biochem Pharmacol 0101032 0006-2952 0 Biogenic Amines 0 Pyrimidines 53-59-8 NADP EC 1.2.- Aldehyde Oxidoreductases X77S6GMS36 Homovanillic Acid IM Aldehyde Oxidoreductases antagonists & inhibitors Animals Biogenic Amines metabolism pharmacology Brain enzymology Homovanillic Acid pharmacology In Vitro Techniques Kinetics NADP Pyrimidines pharmacology Sheep 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 16 0006-2952(75)90016-7 10.1016/0006-2952(75)90016-7 J Clin Endocrinol Metab. 2000 Feb;85(2):637-44 10690869 NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25 14768652 Endocr Rev. 2004 Apr;25(2):309-40 15082524 J Endocrinol Invest. 2006 Apr;29(4):298-302 16699294 N Engl J Med. 2007 Feb 8;356(6):601-10 17287480 Endocr Pract. 2008 Apr;14(3):279-84 18463033 Endocr Pract. 2009 Jul-Aug;15 Suppl 1:1-20 19632967 Endocrine. 2010 Feb;37(1):40-6 19882253 J Clin Endocrinol Metab. 2010 Sep;95(9):4106-13 20823463 Endocrine. 2011 Aug;40(1):80-3 21547511 Endocrine. 2011 Aug;40(1):134-6 21562920 Br J Surg. 2011 Oct;98(10):1383-91 21618498 Horm Metab Res. 2011 Dec;43(13):962-9 22048862 BMJ. 2012 May 28;344:e3502 22645185 17 1976 01 23 2020 03 04 0006-2952 24 18 1975 Sep 15 Biochemical pharmacology Biochem Pharmacol Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat. 1739-42 Renaud B B Buda M M Lewis B D BD Pujol J F JF eng HERU1 CSO_ Chief Scientist Office United Kingdom Journal Article England Biochem Pharmacol 0101032 0006-2952 0 Catecholamines 0 Tryptamines EC 1.14.16.2 Tyrosine 3-Monooxygenase W2QY253O8S 5,6-Dihydroxytryptamine IM 5,6-Dihydroxytryptamine administration & dosage pharmacology Animals Brain enzymology Catecholamines physiology Cerebral Cortex enzymology Cisterna Magna Corpus Striatum enzymology In Vitro Techniques Injections Male Neurons enzymology Rats Rats, Inbred Strains Stimulation, Chemical Substantia Nigra enzymology Time Factors Tryptamines pharmacology Tyrosine 3-Monooxygenase metabolism 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 17 0006-2952(75)90018-0 10.1016/0006-2952(75)90018-0 BMJ. 2010 Apr 20;340:c2016 20406861 18 1976 01 29 2019 06 23 0006-2952 24 20 1975 Oct 15 Biochemical pharmacology Biochem Pharmacol Inhibition of aldehyde reductase isoenzymes in human and rat brain. 1865-9 Ris M M MM Deitrich R A RA Von Wartburg J P JP eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England Biochem Pharmacol 0101032 0006-2952 0 Anticonvulsants 0 Barbiturates 0 Hydantoins 0 Isoenzymes 0 Succinimides 0U46U6E8UK NAD 53-59-8 NADP C8I4BVN78E Glutethimide EC 1.2.- Aldehyde Oxidoreductases IM Aldehyde Oxidoreductases antagonists & inhibitors Animals Anticonvulsants pharmacology Barbiturates pharmacology Brain enzymology Glutethimide pharmacology Humans Hydantoins pharmacology In Vitro Techniques Isoenzymes antagonists & inhibitors Kinetics NAD metabolism NADP pharmacology Rats Succinimides pharmacology 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 18 0006-2952(75)90405-0 10.1016/0006-2952(75)90405-0 19 1976 01 29 2020 02 25 0006-2952 24 20 1975 Oct 15 Biochemical pharmacology Biochem Pharmacol Antidepressant drugs affect dopamine uptake. 1896-7 Halaris A E AE Belendiuk K T KT Freedman D X DX eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Biochem Pharmacol 0101032 0006-2952 0 Antidepressive Agents 0 Central Nervous System Stimulants VTD58H1Z2X Dopamine IM Animals Antidepressive Agents pharmacology Brain drug effects metabolism Central Nervous System Stimulants pharmacology Depression, Chemical Dopamine metabolism In Vitro Techniques Male Rats 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 19 0006-2952(75)90412-8 10.1016/0006-2952(75)90412-8 JAMA. 2001 Jun 13;285(22):2871-9 11401608 Med Care. 2001 Aug;39(8 Suppl 2):II2-45 11583120 Health Serv Manage Res. 2002 May;15(2):126-37 12028801 Qual Saf Health Care. 2003 Dec;12(6):458-64 14645763 J Am Soc Nephrol. 2004 Mar;15(3):754-60 14978178 Lancet. 2004 Apr 3;363(9415):1147-54 15064036 BMJ. 2005 Apr 2;330(7494):781-3 15802723 J Am Coll Cardiol. 2005 Oct 4;46(7):1236-41 16198837 Milbank Q. 2005;83(4):691-729 16279964 JAMA. 2006 Jan 18;295(3):324-7 16418469 N Engl J Med. 2006 Nov 30;355(22):2308-20 17101617 J Eval Clin Pract. 2007 Apr;13(2):161-8 17378860 N Engl J Med. 2007 Aug 9;357(6):608-13 17687138 Qual Saf Health Care. 2007 Oct;16(5):387-99 17913782 BMJ. 2008 Jun 28;336(7659):1491-4 18577559 BMJ. 2008 Aug 13;337:a957 18703659 JAMA. 2008 Dec 24;300(24):2913-5 19109120 Clin Med (Lond). 2009 Apr;9(2):140-4 19435119 BMJ. 2009 Nov 19;339:b4809 19926689 BMJ. 2009 Nov 19;339:b4811 19926690 BMJ. 2010 Mar 31;340:c1234 20360220 BMJ. 2010 Apr 20;340:c2016 20406861 BMJ. 2010 Apr 23;340:c2153 20418546 N Engl J Med. 2010 Jul 1;363(1):45-53 20463332 BMJ. 2010 Aug 13;341:c4078 20709715 N Engl J Med. 2010 Dec 23;363(26):2477-81 21142528 J Am Soc Nephrol. 2011 Feb;22(2):225-34 21289212 BMJ. 2011 Feb 03;342:d199 21292720 Clin Med (Lond). 2010 Dec;10(6):537-9 21413472 Nephron Clin Pract. 2011;119(1):c10-7; discussion c17 21659780 Kidney Int. 2011 Nov;80(10):1021-34 21775971 Implement Sci. 2011 Oct 24;6:119 22024188 BMJ. 2012 Mar 01;344:e1001 22381521 Methods Inf Med. 2012;51(3):189-98 22476327 Ann Intern Med. 1998 Feb 15;128(4):289-92 9471932 Int J Qual Health Care. 1998 Oct;10(5):443-7 9828034 20 1976 01 29 2020 02 25 0006-2952 24 20 1975 Oct 15 Biochemical pharmacology Biochem Pharmacol Aggregation of blood platelets by adrenaline and its uptake. 1903-4 Barthel W W Markwardt F F eng Journal Article England Biochem Pharmacol 0101032 0006-2952 436O5HM03C Dihydroergotamine 8NA5SWF92O Lysergic Acid Diethylamide YKH834O4BH Epinephrine IM Animals Blood Platelets metabolism Dihydroergotamine pharmacology Drug Interactions Epinephrine blood pharmacology In Vitro Techniques Lysergic Acid Diethylamide pharmacology Platelet Aggregation drug effects Rabbits 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 20 0006-2952(75)90415-3 10.1016/0006-2952(75)90415-3 Int J Qual Health Care. 2008 Feb;20(1):22-30 18073269 Qual Health Res. 2008 Mar;18(3):380-90 18235161 N Engl J Med. 2009 Jan 29;360(5):491-9 19144931 Med Educ. 1998 May;32(3):239-43 9743776 21 1976 01 26 2017 03 22 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung [Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--)-alpha-bisabolol (author's transl)]. 1352-4 (--)-alpha-Bisabolol has a primary antipeptic action depending on dosage, which is not caused by an alteration of the pH-value. The proteolytic activity of pepsin is reduced by 50 percent through addition of bisabolol in the ratio of 1/0.5. The antipeptic action of bisabolol only occurs in case of direct contact. In case of a previous contact with the substrate, the inhibiting effect is lost. Isaac O O Thiemer K K ger English Abstract Journal Article Biochemische Untersuchungen von Kamilleninhaltsstoffen. III. In-vitro-Versuche über die antipeptische Wirkung des (-)-alpha-Bisabolols Germany Arzneimittelforschung 0372660 0004-4172 0 Hemoglobins 0 Sesquiterpenes 42HK56048U Tyrosine 5V2JDO056X Trichloroacetic Acid EC 3.4.23.1 Pepsin A IM Dose-Response Relationship, Drug Hemoglobins metabolism Hydrogen-Ion Concentration In Vitro Techniques Methods Pepsin A antagonists & inhibitors metabolism Plants, Medicinal Sesquiterpenes pharmacology Spectrophotometry, Ultraviolet Trichloroacetic Acid Tyrosine metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 21 22 1976 01 26 2020 02 25 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities]. 1369-79 A report is given on the recent discovery of outstanding immunological properties in BA 1 [N-(2-cyanoethylene)-urea] having a (low) molecular mass M = 111.104. Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 mg kg) and negligible lethality (1.7 percent), results in a recovery rate of 40 percent without hyperglycemia and, in one test, of 80 percent with hyperglycemia. Under otherwise unchanged conditions the reference substance ifosfamide (IF) -- a further development of cyclophosphamide -- applied without hyperglycemia in its most efficient dosage of 47 percent LD50 (150 mg kg) brought about a recovery rate of 25 percent at a lethality of 18 percent. (Contrary to BA 1, 250-min hyperglycemia caused no further improvement of the recovery rate.) However this comparison is characterized by the fact that both substances exhibit two quite different (complementary) mechanisms of action. Leucocyte counts made after application of the said cancerostatics and dosages have shown a pronounced stimulation with BA 1 and with ifosfamide, the known suppression in the post-therapeutic interval usually found with standard cancerostatics. In combination with the cited plaque test for BA 1, blood pictures then allow conclusions on the immunity status. Since IF can be taken as one of the most efficient cancerostatics--there is no other chemotherapeutic known up to now that has a more significant effect on the DS carcinosarcoma in rats -- these findings are of special importance. Finally, the total amount of leucocytes and lymphocytes as well as their time behaviour was determined from the blood picture of tumour-free rats after i.v. application of BA 1. The thus obtained numerical values clearly show that further research work on the prophylactic use of this substance seems to be necessary and very promising. Ardenne M M Reitnauer P G PG ger Comparative Study English Abstract Journal Article Nachweis krebshemmender Eigenschaften einer stark immunstimulierenden Verbindung kleiner Molekülmasse. Versuche am immunlabilen DS-Karzinosarkom im Vergleich mit Ifosfamid. Stimulierung der körpereigenen Abwehr über etwa 20 Tage durch BA 1, einen N-(2-Cyanthylen)-harnstoff. Neue prophylaktische Möglichkeiten Germany Arzneimittelforschung 0372660 0004-4172 0 Antineoplastic Agents 8N3DW7272P Cyclophosphamide 8W8T17847W Urea UM20QQM95Y Ifosfamide IM Animals Antineoplastic Agents pharmacology therapeutic use Carcinosarcoma drug therapy Cyclophosphamide analogs & derivatives Drug Evaluation, Preclinical Drug Tolerance Erythrocyte Count Hydrogen-Ion Concentration Hyperglycemia Ifosfamide pharmacology therapeutic use Immunity drug effects Immunosuppression Lethal Dose 50 Leukocyte Count Male Mice Neoplasms, Experimental drug therapy Rats Stimulation, Chemical Time Factors Urea analogs & derivatives pharmacology therapeutic use 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 22 Crit Care Med. 2006 Jul;34(7):1913-7 16715038 Crit Care. 2007;11(2):R31 17331245 J Am Soc Nephrol. 2010 Feb;21(2):345-52 20019168 Am J Kidney Dis. 2010 Oct;56(4):651-60 20673605 Blood Purif. 2010;30(2):120-6 20714143 Nephrol Dial Transplant. 2011 Jul;26(7):2161-8 21148028 Am J Kidney Dis. 2011 Feb;57(2):228-34 21195518 Clin J Am Soc Nephrol. 2012 Apr;7(4):533-40 22362062 QJM. 2012 Aug;105(8):729-40 22408153 Clin J Am Soc Nephrol. 2012 May;7(5):712-9 22422536 QJM. 2013 Apr;106(4):323-32 23345468 J R Coll Physicians Edinb. 2013;43(1):37-8 23516690 23 1976 01 26 2020 02 25 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung Effect of etafenone on total and regional myocardial blood flow. 1400-3 The distribution of blood flow to the subendocardial, medium and subepicardial layers of the left ventricular free wall was studied in anaesthetized dogs under normoxic (A), hypoxic (B) conditions and under pharmacologically induced (etafenone) coronary vasodilation (C). Regional myocardial blood flow was determined by means of the particle distribution method. In normoxia a transmural gradient of flow was observed, with the subendocardial layers receiving a significantly higher flow rate compared with the subepicardial layers. In hypoxia induced vasodilation this transmural gradient of flow was persistent. In contrast a marked redistribution of regional flow was observed under pharmacologically induced vasodilation. The transmural gradient decreased. In contrast to some findings these experiments demonstrate that a considerable vasodilatory capacity exists in all layers of the myocardium and can be utilized by drugs. The differences observed for the intramural distribution pattern of flow under hypoxia and drug induced vasodilation support the hypothesis that this pattern reflects corresponding gradients of regional myocardial metabolism. Flohr H H Breull W W eng G0700399 Medical Research Council United Kingdom Journal Article Germany Arzneimittelforschung 0372660 0004-4172 0 Propiophenones 0 Vasodilator Agents 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Animals Blood Pressure drug effects Carbon Dioxide blood Cardiac Output drug effects Coronary Circulation drug effects Coronary Vessels drug effects Dogs Heart Rate drug effects Heart Septum Heart Ventricles Hydrogen-Ion Concentration Hypoxia physiopathology Oxygen blood Propiophenones pharmacology Vasodilator Agents pharmacology 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 23 J Appl Psychol. 2001 Aug;86(4):730-40 11519656 South Med J. 2005 May;98(5):528-32 15954509 J Crit Care. 2008 Jun;23(2):167-72 18538207 Med Educ. 2009 Jan;43(1):50-7 19140997 Clin Med (Lond). 2009 Oct;9(5):417-20 19886098 24 1976 01 26 2020 02 25 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung Influence of a new virostatic compound on the induction of enzymes in rat liver. 1426-9 The virostatic compound N,N-diethyl-4-[2-(2-oxo-3-tetradecyl-1-imidazolidinyl)-ethyl]-1-piperazinecarboxamide-hydrochloride (5531) was analyzed as to its effect on the induction of tryptophan-pyrrolase and tyrosineaminotransferase in rat liver. 1. The basic activity of the enzymes was not influenced by the substance either in normal or in adrenalectomized animals. 2. The induction of the enzymes by cortisone increased in the presence of the compound whereas the substrate induction remained unchanged. 3. The induction of tyrosine-aminotransferase by dexamethasonephosphate in tissue culture is inhibited if the dose of compound 5531 is higher than 5 mug/ml. Kröger H H Donner I I Skiello G G eng Journal Article Germany Arzneimittelforschung 0372660 0004-4172 0 Antiviral Agents 0 Imidazoles 0 Piperazines 42HK56048U Tyrosine EC 1.13.11.11 Tryptophan Oxygenase EC 2.6.1.5 Tyrosine Transaminase V27W9254FZ Cortisone IM Adrenalectomy Animals Antiviral Agents pharmacology Cortisone pharmacology Culture Techniques Dose-Response Relationship, Drug Enzyme Induction drug effects Female Imidazoles pharmacology Liver enzymology metabolism Piperazines pharmacology Rats Time Factors Tryptophan Oxygenase metabolism Tyrosine pharmacology Tyrosine Transaminase metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 24 Clin Med (Lond). 2008 Feb;8(1):61-4 18335672 25 1976 01 26 2017 03 22 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung Pharmacological properties of new neuroleptic compounds. 1436-42 RMI 61 140, RMI 61 144 and RMI 61 280 are newly synthetized N-[8-R-dibenzo(b,f)oxepin-10-yl]-N'-methyl-piperazine-maleates which show interesting psychopharmacologic effects. This work contains the results of a study performed with these three compounds, in order to demonstrate their neuropsycholeptic activity in comparison with chloropromazine (CPZ) and chlordiazepoxide (CPD). The inhibition of motility observed in mice shows that the compounds reduce the normal spontaneous motility as well as the muscle tone. The central-depressant activity is evidenced by increased barbiturate-induced sleep and a remarkable eyelid ptosis can also be observed. Our compounds do not show any activity on electroshock just as do CPZ and CPD. As to the antipsychotic outline, our compounds show strong reduction of lethality due to amphetamine in grouped mice and a strong antiapomorphine activity. They show also an antiaggressive effect and an inhibitory activity on avoidance behaviour much stronger than CPZ. We have also found extrapyramidal effects, as catalepsy, common to many tranquillizers of the kind of the standards used by us. As for vegetative phenomena, the compounds show hypotensive dose related action ranging from moderate to strong, probably due to an a-receptor inhibition. Adrenolytic activity against lethal doses of adrenaline, antiserotonin and antihistaminic effects, as well as other actions (hypothermia, analgesia, etc.) confirm that RMI 61 140, RMI 61 144 and RMI 61 280 are endowed with pharmacologic properties similar and more potent than those of CPZ. Studies on the metabolism of brain catecholamines show that they are similar to CPZ, although with less effect on dopamine level. Coscia L L Causa P P Giuliani E E Nunziata A A eng Comparative Study Journal Article Germany Arzneimittelforschung 0372660 0004-4172 0 Dibenzoxepins 0 Histamine H1 Antagonists 0 Piperazines 0 Tranquilizing Agents 6RZ6XEZ3CR Chlordiazepoxide CK833KGX7E Amphetamine N21FAR7B4S Apomorphine U42B7VYA4P Chlorpromazine YKH834O4BH Epinephrine IM Aggression drug effects Amphetamine antagonists & inhibitors Animals Apomorphine antagonists & inhibitors Avoidance Learning drug effects Behavior, Animal drug effects Blood Pressure drug effects Chlordiazepoxide pharmacology Chlorpromazine pharmacology Dibenzoxepins pharmacology Drug Evaluation, Preclinical Epinephrine antagonists & inhibitors Guinea Pigs Histamine H1 Antagonists Humans Lethal Dose 50 Male Mice Motor Activity drug effects Muscle Contraction drug effects Piperazines pharmacology Rats Sleep drug effects Time Factors Tranquilizing Agents pharmacology 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 25 26 1976 01 26 2018 12 03 0004-4172 25 9 1975 Sep Arzneimittel-Forschung Arzneimittelforschung [Studies on the action of an anticholinergic agent in combination with a tranquilizer on gastric juice secretion in man]. 1460-3 A double-blind study with intra-individual comparisons was carried out to investigate the effects of 15 mg of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH-tropanium bromide(+/-)-tropate (Sch 1000), 15 mg Sch 1000 + 10 mg oxazepam, 10 mg oxazepam and placebo with oral administration in randomized sequence on gastric juice volume, amount of acid, concentration and pH values in 12 healthy volunteers. The secretion parameters were measured during a 1-h basal period and a 2-h stimulation period. The gastric juice was obtained in 15 min portions via stomach tube. Stimulation was effected by 1 mug/kg/h pentagastrin via drip infusion. The Friedman test was used for the comparative statistical evaluation, and individual comparisons were carried out by means of the Wilcoxon test (pair-differences rank). The results show that Sch 1000 and Sch 1000 + oxazepam were equal in effect on basal and stimulated secretion volume. As compared with placebo, it was not possible to establish an effect on secretion volume for oxazepam alone. Sch 1000 and Sch 1000 + oxazepam were found to be equipotent in reducing the amount of basal acid, while oxazepam reduced this quantity only during the first 30 min of basal secretion. None of the three active preparations was capable of inhibiting the stimulated acid, although both Sch 1000 preparations produced a clear trend towards lowered mean values. During the basal secretion period, all three test preparations had an inhibiting action on acid concentration, but none of them had a significant effect during the stimulation period. The pH value was savely increased only by Sch 1000 and Sch 1000 + oxazepam, and this even only during the basal period. The results are discussed. Scherberger R R RR Kaess H H Brückner S S ger Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Untersuchunger über die Wirkung eines Anticholinergikums in Verbindung mit einem Tranquilizer aud die Magensaftsekretion beim Menschen Germany Arzneimittelforschung 0372660 0004-4172 0 Atropine Derivatives 0 Drug Combinations 6GOW6DWN2A Oxazepam EF0NX91490 Pentagastrin GR88G0I6UL Ipratropium IM Adult Atropine Derivatives Clinical Trials as Topic Depression, Chemical Drug Combinations Female Gastric Juice metabolism Humans Hydrogen-Ion Concentration Ipratropium pharmacology Male Middle Aged Oxazepam pharmacology Pentagastrin antagonists & inhibitors Time Factors 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 26 27 1976 03 01 2020 02 25 0007-0912 47 8 1975 Aug British journal of anaesthesia Br J Anaesth Editorial: "Old lamps for new". 811-2 Conway C M CM eng Journal Article England Br J Anaesth 0372541 0007-0912 0 Ethers 290YE8AR51 Trichloroethylene 30905R8O7B Methoxyflurane 75-89-8 Trifluoroethanol 91I69L5AY5 Enflurane CYS9AKD70P Isoflurane UQT9G45D1P Halothane IM Anesthesia, Inhalation Arrhythmias, Cardiac chemically induced Enflurane Ethers Halothane Humans Isoflurane Kidney Diseases chemically induced Methoxyflurane adverse effects Trichloroethylene Trifluoroethanol 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 27 S0007-0912(17)47631-8 J Diabetes Complications. 2000 Mar-Apr;14(2):84-9 10959070 Diabetes Care. 2004 May;27(5):1047-53 15111519 Diabetes Care. 2005 Sep;28(9):2136-40 16123479 East Afr Med J. 2005 Dec;82(12 Suppl):S197-203 16619733 Lancet. 2006 May 27;367(9524):1747-57 16731270 Aust Fam Physician. 2006 Jun;35(6):386-90 16751852 Med Eng Phys. 2007 Sep;29(7):824-7 17052939 Postgrad Med J. 2007 Apr;83(978):224-9 17403947 Clin Chem. 2007 Nov;53(11):1954-9 17954497 Heart. 2008 Nov;94(11):1376-82 18519551 PLoS Med. 2008 Jun 10;5(6):e124 18547138 Lancet. 2009 May 23;373(9677):1735 19465209 Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-65-7 19484879 Global Health. 2009 Sep 14;5:9 19751503 Prim Care Diabetes. 2010 Jul;4(2):69-72 20211589 Diab Vasc Dis Res. 2010 Jan;7(1):28-39 20368230 Am J Trop Med Hyg. 2010 Sep;83(3):575-81 20810823 Trop Med Int Health. 2010 Nov;15(11):1289-99 20955495 Trop Med Int Health. 2010 Nov;15(11):1300-14 20958887 Drug Des Devel Ther. 2010 Oct 22;4:279-90 21116334 Trop Med Int Health. 2011 Sep;16(9):1077-84 21702868 Clin Med (Lond). 2011 Aug;11(4):344-7 21853830 Ethn Dis. 2011 Summer;21(3):288-93 21942160 28 1976 02 19 2020 02 25 0007-0912 47 9 1975 Sep British journal of anaesthesia Br J Anaesth Letter: Duration of action of AH8165. 1033 Thornton J A JA Harrison M J MJ eng Journal Article England Br J Anaesth 0372541 0007-0912 0 Pyridinium Compounds IM Dose-Response Relationship, Drug Hemodynamics drug effects Humans Pyridinium Compounds administration & dosage pharmacology Time Factors 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 28 10.1093/bja/47.9.1033 J Gen Intern Med. 2002 Aug;17(8):579-87 12213138 Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):365-71 18302300 29 1976 02 09 2017 03 22 0007-0947 29 7 1975 Jul The British journal of clinical practice Br J Clin Pract Lorazepam in sexual disorders. 175-6 Maneksha S S Harry T V TV eng Clinical Trial Journal Article Randomized Controlled Trial England Br J Clin Pract 0372546 0007-0947 0 Anti-Anxiety Agents 0 Placebos O26FZP769L Lorazepam IM Adult Anti-Anxiety Agents therapeutic use Anxiety drug therapy Clinical Trials as Topic Female Humans Lorazepam therapeutic use Male Placebos Psychotherapy Sexual Dysfunction, Physiological drug therapy 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 29 30 1976 02 13 2020 02 25 0007-0963 93 1 1975 Jul The British journal of dermatology Br J Dermatol Lysosomal hydrolases of the epidermis. I. Glycosidases. 1-10 Seven distinct glycosidases (EC 3.2) have been characterized in guinea-pig epidermis. Their properties indicate them to be of lysosomal origin. The 'profile' of the epidermal glycosidases is significantly different from that reported for whole skin, the activities of beta-galactosidase and beta-acetylglucosaminidase being very high and those of the remaining enzymes relatively low in epidermis. Mier P D PD van den Hurk J J JJ eng MC_UP_A620_1017 Medical Research Council United Kingdom Journal Article England Br J Dermatol 0004041 0007-0963 EC 3.2.1.- Galactosidases EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.52 Acetylglucosaminidase IM Acetylglucosaminidase metabolism Animals Galactosidases metabolism Glycoside Hydrolases metabolism Guinea Pigs Hydrogen-Ion Concentration Kinetics Lysosomes enzymology Skin enzymology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 30 10.1111/j.1365-2133.1975.tb06468.x JAMA. 2004 Oct 13;292(14):1724-37 15479938 Obes Surg. 2005 Feb;15(2):266-72 15802072 Obes Rev. 2007 Mar;8 Suppl 1:vi-ix 17316292 Obes Rev. 2007 Mar;8 Suppl 1:161-4 17316321 Public Health. 2007 Jul;121(7):492-6 17399752 Clin Obes. 2011 Apr;1(2-3):77-84 25585572 31 1976 03 01 2020 02 25 0007-0963 93 4 1975 Oct The British journal of dermatology Br J Dermatol Lysosomal hydrolases of the epidermis. 2. Ester hydrolases. 391-8 Five distinct ester hydrolases (EC 3-1) have been characterized in guinea-pig epidermis. These are carboxylic esterase, acid phosphatase, pyrophosphatase, and arylsulphatase A and B. Their properties are consistent with those of lysosomal enzymes. Mier P D PD van den Hurk J J JJ eng Journal Article England Br J Dermatol 0004041 0007-0963 EC 3.- Hydrolases EC 3.1.1.- Carboxylic Ester Hydrolases EC 3.1.3.2 Acid Phosphatase EC 3.1.6.8 Cerebroside-Sulfatase EC 3.1.6.9 Chondro-4-Sulfatase EC 3.6.1.- Pyrophosphatases IM Acid Phosphatase metabolism Animals Carboxylic Ester Hydrolases metabolism Cerebroside-Sulfatase metabolism Chondro-4-Sulfatase metabolism Guinea Pigs Hydrogen-Ion Concentration Hydrolases metabolism Kinetics Lysosomes enzymology Pyrophosphatases metabolism Skin enzymology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 31 10.1111/j.1365-2133.1975.tb06512.x J Healthc Manag. 2006 Sep-Oct;51(5):309-20; discussion 320-2 17039690 Clin Med (Lond). 2010 Feb;10(1):13-5 20408298 Clin Med (Lond). 2010 Oct;10(5):441-4 21117373 32 1976 03 01 2020 02 25 0007-1048 29 1 1975 Jan British journal of haematology Br J Haematol A serum haemagglutinating property dependent upon polycarboxyl groups. 149-56 A serum agglutinin reactive with red cells in the presence of polycarboxyl groups is reported. It is likely that this represents an additional example of the type of agglutinin previously described as agglutinating red cells in the absence of ionized calcium. Experimental evidence is presented indicating that it is free polycarboxyl groups that potentiate agglutination and that any metal ion, such as calcium, capable of chelating with these groups will prove to be inhibitory. Beck M L ML Freihaut B B Henry R R Pierce S S Bayer W L WL eng Journal Article England Br J Haematol 0372544 0007-1048 0 ABO Blood-Group System 0 Agglutinins 0 Carboxylic Acids 0 Cations, Divalent 0 Citrates 9G34HU7RV0 Edetic Acid EC 3.2.1.18 Neuraminidase EC 3.4.22.2 Papain EC 3.4.22.3 Ficain IM ABO Blood-Group System Aged Agglutinins analysis Antibody Specificity Carboxylic Acids pharmacology Cations, Divalent Citrates pharmacology Edetic Acid pharmacology Ficain pharmacology Hemagglutination drug effects Humans Hydrogen-Ion Concentration Neuraminidase pharmacology Papain pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 32 10.1111/j.1365-2141.1975.tb01808.x Reg Anesth Pain Med. 2000 Jul-Aug;25(4):393-402 10925937 Anesth Analg. 2000 Oct;91(4):916-20 11004048 Neurology. 2005 Aug 23;65(4):510-2 16116106 Neurologist. 2006 Jul;12(4):224-8 16832241 JAMA. 2006 Oct 25;296(16):2012-22 17062865 Postgrad Med J. 2006 Nov;82(973):713-6 17099089 Intern Med J. 2008 Jul;38(7):587-91 18422562 Headache. 2010 Oct;50(9):1482-98 20807248 Anesthesiol Res Pract. 2010;2010:null 20814596 Anaesth Intensive Care. 2011 Mar;39(2):247-51 21485674 Neurology. 2011 Jul 5;77(1):71-4 21593442 CMAJ. 1993 Oct 15;149(8):1087-93 8221447 BMJ. 1993 Apr 3;306(6882):883-5 8490410 Reg Anesth. 1997 Jan-Feb;22(1):66-72 9010949 J Neurol. 1998 Sep;245(9):589-92 9758296 33 1976 02 27 2019 07 04 0007-1048 29 2 1975 Feb British journal of haematology Br J Haematol Effect of human erythrocyte stromata on complement activation. 235-41 Stroma from either normal or PNH-like red cells is capable of inhibiting, to some extent, lysis in the sucrose test and enhancing lysis in the acidified-serum test. The same opposing effects are displayed by the exclusion peaks from Sephadex G-200 obtained from each stroma preparation, suggesting that the same factor could be responsible for both activities. Stromata and peaks also induce lysis of PNH-like cells in unacidified serum, indicating activation of complement through the alternate pathway. This is confirmed by immunoelectrophoretic observation. When serum previously activated through the alternate pathway is used in the sucrose test the amount of lysis is markedly reduced. This would indicate that the classical pathway activation can be controlled by the alternate pathway. The possible clinical significance of these factors in determining the haemolytic crisis in PNH patients is discussed. Corrocher R R Tedesco F F Rabusin P P De Sandre G G eng Journal Article England Br J Haematol 0372544 0007-1048 57-50-1 Sucrose 9007-36-7 Complement System Proteins IM Complement System Proteins metabolism Erythrocytes metabolism Hemoglobinuria, Paroxysmal immunology Hemolysis Humans Hydrogen-Ion Concentration Sucrose metabolism 1975 2 1 1975 2 1 0 1 1975 2 1 0 0 ppublish 33 10.1111/j.1365-2141.1975.tb01817.x 34 1976 02 27 2020 02 25 0007-1048 29 3 1975 Mar British journal of haematology Br J Haematol Determinants of intracellular pH in the erythrocyte. 369-72 Warth J J Desforges J F JF eng Journal Article Research Support, U.S. Gov't, P.H.S. Review England Br J Haematol 0372544 0007-1048 0 Diphosphoglyceric Acids IM Cell Membrane Permeability Diphosphoglyceric Acids metabolism Erythrocytes metabolism Humans Hydrogen-Ion Concentration Membrane Potentials 18 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 34 10.1111/j.1365-2141.1975.tb01833.x Pacing Clin Electrophysiol. 1999 May;22(5):711-20 10353129 Am J Cardiol. 2003 Sep 15;92(6):740-1 12972124 World J Surg. 2004 Mar;28(3):321-6 14961191 Heart. 2005 Apr;91(4):500-6 15772212 Circulation. 2007 Sep 18;116(12):1349-55 17724263 Eur Heart J. 2011 Apr;32(8):991-8 21252172 J Am Coll Cardiol. 2012 Oct 16;60(16):1540-5 22999727 Br Heart J. 1987 Nov;58(5):537-46 3676046 Br Heart J. 1995 Jun;73(6):571-5 7626359 Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):2012-5 7845809 Br Heart J. 1994 Sep;72(3):303-8 7946793 J Interv Card Electrophysiol. 1998 Jun;2(2):175-9 9870010 35 1976 03 01 2019 07 04 0007-1048 30 2 1975 Jun British journal of haematology Br J Haematol The effect of o-salicylate upon pentose phosphate pathway activity in normal and G6PD-deficient red cells. 225-31 The effect of the major metabolite of aspirin, namely salicylic acid, upon the pentose phosphate pathway (PPP) of normal and G6PD-deficient red cells has been studied. Salicylic acid was shown to inhibit this pathway in proportion to the amount present. At any concentration of this substance there was greater inhibition of the PPP in G6PD-deficient than in normal red cells. Worathumrong N N Grimes A J AJ eng Journal Article England Br J Haematol 0372544 0007-1048 0 Blood Glucose 0 Pentosephosphates T42P99266K Methylene Blue WIQ1H85SYP Sodium Salicylate IM Blood Glucose metabolism Erythrocytes metabolism Glucosephosphate Dehydrogenase Deficiency blood Humans Hydrogen-Ion Concentration Methylene Blue Pentosephosphates antagonists & inhibitors blood metabolism Sodium Salicylate metabolism pharmacology 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 35 10.1111/j.1365-2141.1975.tb00536.x 36 1976 03 01 2019 07 19 0007-1145 34 3 1975 Nov The British journal of nutrition Br J Nutr The effects of processing of barley-based supplements on rumen pH, rate of digestion of voluntary intake of dried grass in sheep. 493-500 1. In one experiment the effect on rumen pH of feeding with restricted amounts of whole or pelleted barley was studied. With whole barley there was little variation in rumen pH associated with feeding time, but with pelleted barley the pH decreased from about 7-0 before feeding to about 5-3, 2--3 h after feeding. 2. The rate of disappearance of dried grass during incubation in the rumens of sheep receiving either whole or pelleted barley was studied in a second experiment. After 24 h incubation only 423 mg/g incubated had disappeared in the rumen of sheep receiving pelleted barley while 625 mg/g incubated had disappeared when it was incubated in the rumen of sheep receiving whole barley. 3. The voluntary intake of dried grass of lambs was studied in a third experiment when they received supplements of either 25 or 50 g whole or pelleted barley/kg live weight 0-75. At the high level, pelleted barley reduced intake of dried grass by 534 g/kg but whole barley reduced it by only 352 g/kg. The digestibility of acid-detergent fibre was reduced more by pelleted barley than by whole barley but there was a tendency for a small increase in digestibility of the barley due to processing. 4. The implications of these findings on supplementation of roughages with cereals are discussed. Orskov E R ER Fraser C C eng Journal Article England Br J Nutr 0372547 0007-1145 IM Animal Feed standards Animals Digestion Edible Grain Gastric Juice metabolism Hordeum Hydrogen-Ion Concentration Rumen metabolism Sheep 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 36 10.1017/s0007114575000530 37 1976 02 19 2020 02 25 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Poly(8-aminoguanylic acid): formation of ordered self-structures and interaction with poly(cytidylic acid). 5033-45 Poly(8-aminoguanylic acid) has in neutral solution a novel ordered structure of high stability. The 8-amino group permits formation of three hydrogen bonds between two residues along the "top", or long axis, of the purines. The usual hydrogen bonding protons and Watson-Crick pairing sites are not involved in the association. The bonding scheme has a twofold rotation axis and is hemiprotonated at N(7). Poly(8NH2G) is converted by alkaline titration (pK = 9.7) to a quite different ordered structure, which is the favored form over the range approximately pH 10-11. The bonding scheme appears to be composed of a planar, tetrameric array of guanine residues, in which the 8-amino group does not participate in interbase hydrogen bonding. Poly (8NH2G) does not interact with poly(C) in neutral solution because of the high stability of the hemiprotonated G-G self-structure. Titration to the alkaline plateau, however, permits ready formation of a two-stranded Watson-Crick helix. In contrast to the monomer 8NH2GMP, poly(8NH2G) does not form a triple helix with poly(C) under any conditions. The properties of the ordered structures are interpreted in terms of a strong tendency of the 8-amino group to form a third interbase hydrogen bond, when this possibility is not prevented by high pH. Hattori M M Frazier J J Miles H T HT eng Journal Article United States Biochemistry 0370623 0006-2960 0 Polyribonucleotides 25191-14-4 Poly G 30811-80-4 Poly C EC 2.7.7.8 Polyribonucleotide Nucleotidyltransferase IM Binding Sites Circular Dichroism Drug Stability Escherichia coli enzymology Hydrogen Bonding Hydrogen-Ion Concentration Micrococcus enzymology Models, Molecular Nucleic Acid Conformation Poly C Poly G analogs & derivatives Polyribonucleotide Nucleotidyltransferase metabolism Polyribonucleotides analogs & derivatives Spectrophotometry, Infrared Spectrophotometry, Ultraviolet Temperature 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 37 10.1021/bi00694a002 Arch Intern Med. 2003 Apr 14;163(7):803-8 12695271 Postgrad Med J. 2004 Feb;80(940):104-6 14970300 Surg Endosc. 2005 Oct;19(10):1349-52 16021375 Clin Radiol. 2006 Feb;61(2):127-39 16439217 Surg Endosc. 2006 Jul;20(7):1147-60 16763922 Age Ageing. 2007 Jan;36(1):48-52 17114203 J Clin Gastroenterol. 2009 May-Jun;43(5):448-52 18978506 Ann Intern Med. 2009 Jun 16;150(12):849-57, W152 19528563 AJR Am J Roentgenol. 2010 May;194(5):1279-87 20410415 Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):271-80 20510828 Clin Radiol. 1993 Jul;48(1):48-51 8370220 38 1976 02 19 2020 02 25 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Effect of pH on substrate and inhibitor kinetic constants of human liver alanine aminopeptidase. Evidence for two ionizable active center groups. 5084-8 The presence of at least two ionizable active center groups has been detected by a study of the effect of pH upon catalysis of hydrolysis of L-alanyl-beta-naphthylamide by human liver alanine aminopeptidase and upon the inhibition of hydrolysis by inhibitors and substrate analogs. Octanoic acid, octylamine, and peptide inhibitors have been found to be competitive inhibitors and are therefore thought to bind the active center. L-Phe was previously shown to bind the active center since it was found to be a competitive inhibitor of the hydrolysis of tripeptide substrates (Garner, C. W., and Behal, F. J. (1975), Biochemistry 14, 3208). A plot of pKm vs. pH for the substrate L-Ala-beta-naphthylamide showed that binding decreased below pH 5.9 and above 7.5, the points at which the theoretical curve undergoes an integral change in slope. These points are interpreted as the pKa either of substrate ionizable groups or binding-dependent enzyme active center groups. Similar plots of pKm vs. pH for L-alanyl-p-nitroanilide (as substrate) and pKi vs. pH for L-Leu-L-Leu-L-Leu and D-Leu-L-Tyr (as inhibitors) gave pairs fo pKa values of 5.8 and 7.4, 6.0 and 7.5, and 5.7 and 7.5, respectively. All the above substrates (and D-Leu-L-Tyr) have pKa values near 7.5; therefore, the binding-dependent group with a pKa value near 7.5 is possibly this substrate group. Similar plots of pKi vs. pH for the inhibitors L-Phe, L-Met, L-Leu, octylamine, and octanoic acid had only one bending point at 7.7, 7.6, 7.4, 6.3, and 5.9, respectively. Amino acid inhibitors, octylamine, and octanoic acid have no groups with pKa values between 5 and 9. These data indicate that there are two active center ionizable groups with pKa values of approximately 6.0 and 7.5 which are involved in substrate binding or inhibitory amino acid binding but not in catalysis since Vmax was constant at all pH values tested. Garner C W CW Behal F J FJ eng Journal Article United States Biochemistry 0370623 0006-2960 EC 3.4.11.- Aminopeptidases OF5P57N2ZX Alanine IM Alanine Aminopeptidases metabolism Binding Sites Humans Hydrogen-Ion Concentration Kinetics Liver enzymology Mathematics Protein Binding Structure-Activity Relationship Thermodynamics 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 38 10.1021/bi00694a009 Postgrad Med J. 1994 Oct;70(828):728-31 7831169 39 1976 02 19 2020 02 25 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Formation of transient complexes in the glutamate dehydrogenase catalyzed reaction. 5094-8 The reaction of glutamate dehydrogenase and glutamate (gl) with NAD+ and NADP+ has been studied with stopped-flow techniques. The enzyme was in all experiments present in excess of the coenzyme. The results indicate that the ternary complex (E-NAD(P)H-kg) is present as an intermediate in the formation of the stable complex (E-NAD(P)H-gl). The identification of the complexes is based on their absorption spectra. The binding of the coenzyme to (E-gl) is the rate-limiting step in the formation of (E-NAD(P)H-kg) while the dissociation of alpha-ketoglutarate (kg) from this complex is the rate-limiting step in the formation of (E-NAD(P)H-gl). The Km for glutamate was 20-25 mM in the first reaction and 3 mM in the formation of the stable complex. The Km values were independent of the coenzyme. The reaction rates with NAD+ were approximately 50% greater than those with NADP+. Furthermore, high glutamate concentration inhibited the formation of (E-NADH-kg) while no substrate inhibition was found with NADP+ as coenzyme. ADP enhanced while GTP reduced the rate of (E-NAD(P)H-gl) formation. The rate of formation of (E-NAD(P)H-kg) was inhibited by ADP, while it increased at high glutamate concentration when small amounts of GTP were added. The results show that the higher activity found with NAD+ compared to NADP+ under steady-state assay conditions do not necessarily involve binding of NAD+ to the ADP activating site of the enzyme. Moreover, the substrate inhibition found at high glutamate concentration under steady-state assay condition is not due to the formation of (E-NAD(P)H-gl) as this complex is formed with Km of 3 mM glutamate, and the substrate inhibition is only significant at 20-30 times this concentration. Sanner T T eng Journal Article United States Biochemistry 0370623 0006-2960 0 Glutamates 0U46U6E8UK NAD 53-59-8 NADP 61D2G4IYVH Adenosine Diphosphate 86-01-1 Guanosine Triphosphate EC 1.4.1.2 Glutamate Dehydrogenase IM Adenosine Diphosphate pharmacology Animals Binding Sites Cattle Glutamate Dehydrogenase metabolism Glutamates Guanosine Triphosphate pharmacology Kinetics Liver enzymology NAD NADP Protein Binding Spectrophotometry, Ultraviolet Time Factors 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 39 10.1021/bi00694a011 Nature. 2000 May 25;405(6785):417 10839527 Gastroenterology. 2000 Aug;119(2):300-4 10930364 Gut. 2003 Jun;52 Suppl 4:iv17-22 12746264 Gut. 2004 Feb;53(2):277-83 14724164 Gastrointest Endosc Clin N Am. 2004 Jan;14(1):1-9 15062374 Gastrointest Endosc Clin N Am. 2004 Jan;14(1):43-50 15062379 JAMA. 2004 Apr 14;291(14):1713-9 15082698 Endoscopy. 2004 Jul;36(7):656-8 15243892 Gut. 2004 Dec;53(12):1866-75 15542530 Aliment Pharmacol Ther. 2004 Nov 15;20(10):1083-9 15569110 Ann Intern Med. 2005 Apr 19;142(8):635-50 15838071 Aliment Pharmacol Ther. 2005 Oct 1;22(7):595-604 16181299 Endoscopy. 2005 Oct;37(10):960-5 16189768 Gastrointest Endosc. 2005 Nov;62(5):785-90 16246700 Am J Gastroenterol. 2005 Nov;100(11):2407-18 16279893 Endoscopy. 2006 Jan;38(1):31-5 16429352 Endoscopy. 2006 Jan;38(1):59-66 16429356 Gastrointest Endosc. 2006 Apr;63(4):539-45 16564850 Endoscopy. 2006 Oct;38(10):963-70 17058158 Endoscopy. 2006 Oct;38(10):971-7 17058159 Endoscopy. 2006 Oct;38(10):1047-53 17058174 Gastrointest Endosc. 2007 Apr;65(4):577-83 17324414 Dig Dis Sci. 2007 May;52(5):1382-6 17357836 Dig Liver Dis. 2007 Oct;39(10):895-9 17720639 Trials. 2007 Oct 27;8:32 17963520 N Engl J Med. 2007 Nov 29;357(22):2277-84 18046031 BMJ. 2007 Dec 8;335(7631):1182-4 18063642 Gut. 2008 Jan;57(1):125-36 18094205 Radiology. 1981 Jul;140(1):47-50 7244242 AJR Am J Roentgenol. 1994 Dec;163(6):1381-4 7992733 Gastrointest Endosc Clin N Am. 1999 Jan;9(1):13-27 9834314 40 1976 02 19 2020 02 25 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Human brain and placental choline acetyltransferase: purification and properties. 5105-10 Choline acetyltransferase (EC 2.3.1.6) catalyzes the biosynthesis of acetylcholine according to the following chemical equation: acetyl-CoA + choline in equilibrium to acetylcholine + CoA. In addition to nervous tissue, primate placenta is the only other animal source which contains appreciable acetylcholine and its biosynthetic enzyme. Human brain caudate nucleus and human placental choline acetyltransferase were purified to electrophoretic homogeneity using ion-exchange and blue dextran-Sepharose affinity chromatography. The molecular weights determined by Sephadex G-150 gel filtration and sodium dodecyl sulfate gel electrophoresis are 67000 plus or minus 3000. N-Ethylmaleimide, p-chloromercuribenzoate, and dithiobis(2-nitrobenzoic acid) inhibit the enzyme. Dithiothreitol reverses the inhibition produced by the latter two reagents. The pKa of the group associated with N-ethylmaleimide inhibition is 8.6 plus or minus 0.3. A chemically competent acetyl-thioenzyme is isolable by Sephadex gel filtration. The enzymes from the brain and placenta are thus far physically and biochemically indistinguishable. Roskoski R R Jr Lim C T CT Roskoski L M LM eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Sulfhydryl Reagents EC 2.3.1.- Acetyltransferases EC 2.3.1.6 Choline O-Acetyltransferase O3C74ACM9V Ethylmaleimide IM Acetyltransferases metabolism Caudate Nucleus enzymology Choline O-Acetyltransferase isolation & purification metabolism Ethylmaleimide pharmacology Female Humans Hydrogen-Ion Concentration Kinetics Molecular Weight Organ Specificity Placenta enzymology Pregnancy Sulfhydryl Reagents pharmacology 1975 11 18 2001 3 28 10 1 1975 11 18 0 0 ppublish 40 10.1021/bi00694a013 Lancet. 1999 Jul 17;354(9174):191-6 10421300 J Rehabil Med. 2001 Jan;33(1):47-8 11480471 Disabil Rehabil. 2001 Oct 15;23(15):670-6 11720117 Clin Rehabil. 2002 Mar;16(2):182-9 11926176 Clin Rehabil. 2002 May;16(3):231-47 12017511 J Psychiatr Res. 1975 Nov;12(3):189-98 1202204 Lancet. 2002 Jun 22;359(9324):2205 12091014 J Clin Epidemiol. 2002 Sep;55(9):922-8 12393081 J Rehabil Med. 2002 Nov;34(6):260-6 12440799 Md State Med J. 1965 Feb;14:61-5 14258950 Disabil Rehabil. 2004 Jan 21;26(2):71-7 14668142 Neurology. 2004 May 25;62(10):1842-4 15159490 J Neurol Neurosurg Psychiatry. 2006 May;77(5):634-9 16614023 Neuroepidemiology. 2009;33(3):254-60 19641331 J Clin Epidemiol. 1989;42(8):703-9 2760661 Int Disabil Stud. 1988;10(2):61-3 3403500 Stroke. 1998 Apr;29(4):779-84 9550511 Clin Rehabil. 1998 Aug;12(4):304-18 9744666 41 1976 02 19 2019 06 12 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Stabilization of the globular structure of ferricytochrome c by chloride in acidic solvents. 5135-40 Increasing concentrations of chloride were found to increase the resolution between two visible absorbance spectral transitions associated with acidification of ferricytochrome c. Analysis of a variety of spectral and viscosity measurements indicates that protonation of a single group having an apparent pK of 2.1 +/- 0.2 and an intrinsic pK of about 5.3 displaces the methionine ligand without significantly perturbing the native globular conformation. Analysis of methylated ferricytochrome c suggests that protonation of a carboxylate ion, most likely a heme propionate residue, is responsible for displacement of the methionine ligand. Addition of a proton to a second group having an apparent pK of 1.2 +/- 0.1 displaces the histidine ligand and unfolds the protein from a globular conformation into a random coil. It is most likely that the second protonation occurs on the imidazole ring of the histidine ligand itself. Chloride is proposed to perturb these transitions by ligation in the fifth coordination position of the heme ion. Such ligation stabilizes a globular conformation of ferricytochrome c at pH 0.0 and 25 degrees. Stellwagen E E Babul J J eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Chlorides 0 Cytochrome c Group 0 Solvents IM Animals Binding Sites Chlorides Cytochrome c Group Horses Hydrogen-Ion Concentration Kinetics Mathematics Myocardium enzymology Protein Binding Protein Conformation Solvents Spectrophotometry Viscosity 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 41 10.1021/bi00694a018 42 1976 02 19 2019 06 12 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry A competitive labeling method for the determination of the chemical properties of solitary functional groups in proteins. 5168-75 The properties of the functional groups in a protein can be used as built-in-probes of the structure of the protein. We have developed a general procedure whereby the ionization constant and chemical reactivity of solitary functional groups in proteins may be determined. The method may be applied to the side chain of histidine, tyrosine, lysine, and cysteine, as well as to the amino terminus of the protein. The method, which is an extension of the competitive labeling technique using [3H]- and [14C]1-fluoro-2,4-dinitrobenzene (N2ph-F) in a double-labeling procedure, is rapid and sensitive. Advantage is taken of the fact that after acid hydrolysis of a dinitrophenylated protein, a derivative is obtained which must be derived from a unique position in the protein. The method has been applied to the solitary histidine residue of lysozyme, alpha-lytic protease, and Streptomyces griseus (S.G.) trypsin, as well as to the amino terminus of the latter protein. The following parameters were obtained for reaction with N2ph-F at 20 degrees C in 0.1 N KCl: the histidine of hen egg-white lysozyme, pKa of 6.4 and second-order velocity constant of 0.188 M-1 min-1; the histidine of alpha-lytic protease, pKa of 6.5 and second-order velocity constant of 0.0235 M-1 min-1; the histidine of S.G. trypsin, pKa of 6.5 and second-order velocity constant of 0.0328 M-1 min-1; the valyl amino terminus of S.G. trypsin, pKa of 8.1 and second-order velocity constant of 0.403 M-1 min-1. In addition, the results obtained provide clues as to the microenvironments of these functional groups, and indicate that the proteins studied undergo pH-dependent conformational changes which affect the microenvironment, and hence the chemical reactivity of these groups. Duggleby R G RG Kaplan H H eng Journal Article United States Biochemistry 0370623 0006-2960 4QD397987E Histidine D241E059U6 Dinitrofluorobenzene EC 3.2.1.17 Muramidase EC 3.4.- Peptide Hydrolases EC 3.4.21.4 Trypsin HG18B9YRS7 Valine IM Binding Sites Binding, Competitive Dinitrofluorobenzene Histidine analysis Hydrogen-Ion Concentration Kinetics Muramidase analysis Peptide Hydrolases analysis Protein Binding Streptomyces griseus enzymology Trypsin analysis Valine analysis 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 42 10.1021/bi00694a023 43 1976 02 19 2019 06 12 0006-2960 14 23 1975 Nov 18 Biochemistry Biochemistry Modification of arginine and lysine in proteins with 2,4-pentanedione. 5194-9 Primary amines react with 2,4-pentanedione at pH 6-9 to form enamines, N-alkyl-4-amino-3-penten-2-ones. The latter compounds readily regenerate the primary amine at low pH or on treatment with hydroxylamine. Guanidine and substituted guanidines react with 2,4-pentanedione to form N-substituted 2-amino-4,6-dimethylpyrimidines at a rate which is lower by at least a factor of 20 than the rate of reaction of 2,4-pentanedione with primary amines. Selective modification of lysine and arginine side chains in proteins can readily be achieved with 2,4-pentanedione. Modification of lysine is favored by reaction at pH 7 or for short reaction times at pH 9. Selective modification of arginine is achieved by reaction with 2,4-pentanedione for long times at pH 9, followed by treatment of the protein with hydroxylamine. The extent of modification of lysine and arginine side chains can readily be measured spectrophotometrically. Modification of lysozyme with 2,4-pentanedione at pH 7 results in modification of 3.8 lysine residues and less than 0.4 arginine residue in 24 hr. Modification of lysozyme with 2,4-pentanedione at pH 9 results in modification of 4 lysine residues and 4.5 arginine residues in 100 hr. Treatment of this modified protein with hydroxylamine regenerated the modified lysine residues but caused no change in the modified arginine residues. One arginine residue seems to be essential for the catalytic activity of the enzyme. Gilbert H F HF 3rd O'Leary M H MH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Ketones 0 Pentanones 0 Proteins 94ZLA3W45F Arginine EC 3.2.1.17 Muramidase K3Z4F929H6 Lysine IM Arginine Binding Sites Hydrogen-Ion Concentration Ketones Kinetics Lysine Micrococcus enzymology Muramidase analysis Pentanones Protein Binding Protein Conformation Proteins Spectrophotometry, Ultraviolet 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 43 10.1021/bi00694a027 44 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry The origin of the alkaline inactivation of pepsinogen. 5253-6 Above pH 8.5, pepsinogen is converted into a form which cannot be activated to pepsin on exposure to low pH. Intermediate exposure to neutral pH, however, returns the protein to a form which can be activated. Evidence is presented for a reversible, small conformational change in the molecule, distinct from the unfolding of the protein. At the same time, the molecule is converted to a form of limited solubility, which is precipitated at low pH, where activation is normally seen. The results are interpreted in terms of the peculiar structure of the pepsinogen molecule. Titration of the basic NH2-terminal region produced an open form, which can return to the native form at neutral pH, but which is maintained at low pH by neutralization of carboxylate groups in the pepsin portion. McPhie P P eng Journal Article United States Biochemistry 0370623 0006-2960 0 Hemoglobins 0 Pepsinogens EC 3.4.23.1 Pepsin A IM Hemoglobins Hydrogen-Ion Concentration Kinetics Pepsin A metabolism Pepsinogens antagonists & inhibitors Protein Conformation Spectrophotometry, Ultraviolet 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 44 10.1021/bi00695a003 45 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Bovine liver dihydrofolate reductase: purification and properties of the enzyme. 5261-7 A purification procedure is reported for obtaining bovine liver dihydrofolate reductase in high yield and amounts of 100-200 mg. A key step in the procedure is the use of an affinity gel prepared by coupling pteroyl-L-lysine to Sepharose. The purified reductase has a specific activity of about 100 units/mg and is homogeneous as judged by analytical ultracentrifugation, polyacrylamide gel electrophoresis, and titration with methotrexate. The products of the first step of Edman degradation indicated a minimum purity of 79%. The reductase has a molecular weight of about 21500 on the basis of amino acid composition and 22100 +/- 300 from equilibrium sedimentation. It is not inhibited by antiserum to the Streptococcus faecium reductase (isoenzyme 2). Unlike the reductase of many other vertebrate tissues, the bovine enzyme is inhibited by mercurials rather than activated and it has a single pH optimum at both low and high ionic strength. However, the position of the pH optimum is shifted and the activity increased by increasing ionic strength. Automatic Edman degradation has been used to determine 34 of the amino-terminal 37 amino acid residues. Considerable homology exists between this region and the corresponding regions of the reductase from S. faecium and from Escherichia coli. This strengthens the idea that this region contributes to the structure of the binding site for dihydrofolate. Peterson D L DL Gleisner J M JM Blakley R L RL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Amino Acids 0 Isoenzymes EC 1.5.1.3 Tetrahydrofolate Dehydrogenase YL5FZ2Y5U1 Methotrexate IM Amino Acid Sequence Amino Acids analysis Animals Antigen-Antibody Reactions Cattle Chromatography, Affinity Hydrogen-Ion Concentration Isoenzymes immunology isolation & purification metabolism Kinetics Liver enzymology Methotrexate pharmacology Tetrahydrofolate Dehydrogenase immunology isolation & purification metabolism 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 45 10.1021/bi00695a005 46 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Purification and properties of Escherichia coli dihydrofolate reductase. 5267-73 Dihydrofolate reductase has been purified 40-fold to apparent homogeneity from a trimethoprim-resistant strain of Escherichia coli (RT 500) using a procedure that includes methotrexate affinity column chromatography. Determinations of the molecular weight of the enzyme based on its amino acid composition, sedimentation velocity, and sodium dodecyl sulfate gel electrophoresis gave values of 17680, 17470 and 18300, respectively. An aggregated form of the enzyme with a low specific activity can be separated from the monomer by gel filtration; treatment of the aggregate with mercaptoethanol or dithiothreitol results in an increase in enzymic activity and a regeneration of the monomer. Also, multiple molecular forms of the monomer have been detected by polyacrylamide gel electrophoresis. The unresolved enzyme exhibits two pH optima (pH 4.5 and pH 7.0) with dihydrofolate as a substrate. Highest activities are observed in buffers containing large organic cations. In 100 mM imidazolium chloride (pH 7), the specific activity is 47 mumol of dihydrofolate reduced per min per mg at 30 degrees. Folic acid also serves as a substrate with a single pH optimum of pH 4.5. At this pH the Km for folate is 16 muM, and the Vmax is 1/1000 of the rate observed with dihydrofolate as the substrate. Monovalent cations (Na+, K+, Rb+, and Cs+) inhibit dihydrofolate reductase; at a given ionic strength the degree of inhibition is a function of the ionic radius of the cation. Divalent cations are more potent inhibitors; the I50 of BaCl2 is 250 muM, as compared to 125 mM for KCl. Anions neither inhibit nor activate the enzyme. Baccanari D D Phillips A A Smith S S Sinski D D Burchall J J eng Journal Article United States Biochemistry 0370623 0006-2960 0 Amino Acids 0 Isoenzymes 0 Macromolecular Substances 451W47IQ8X Sodium Chloride 660YQ98I10 Potassium Chloride EC 1.5.1.3 Tetrahydrofolate Dehydrogenase YL5FZ2Y5U1 Methotrexate IM Amino Acids analysis Chromatography, Affinity Escherichia coli enzymology Hydrogen-Ion Concentration Isoenzymes isolation & purification metabolism Kinetics Macromolecular Substances Methotrexate Molecular Weight Osmolar Concentration Potassium Chloride pharmacology Protein Conformation Sodium Chloride pharmacology Tetrahydrofolate Dehydrogenase isolation & purification metabolism 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 46 10.1021/bi00695a006 47 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry The influence of pH on the interaction of inhibitors with triosephosphate isomerase and determination of the pKa of the active-site carboxyl group. 5274-9 Ionization effects on the binding of the potential transition state analogues 2-phosphoglycolate and 2-phosphoglycolohydroxamate appear to be attributable to the changing state of ionization of the ligands themselves, therefore it is unnecessary to postulate the additional involvement of an ionizing residue at the active site of triosephosphate isomerase to explain the influence of changing pH on Ki in the neutral range. The binding of the competitive inhibitor inorganic sulfate is insensitive to changing pH in the neutral range. 3-Chloroacetol sulfate, synthesized as an active-site-specific reagent for triosephosphate isomerase, is used to provide an indication of the pKa of the essential carboxyl group of this enzyme. Previously described active-site-specific reagents for the isomerase were phosphate esters, and their changing state of ionization (accompanied by possible changes in their affinity for the active site) may have complicated earlier attempts to determine the pKa of the essential carboxyl group from the pH dependence of the rate of inactivation. Being a strong monoprotic acid, chloroacetol sulfate is better suited to the determination of the pKa of the carboxyl group. Chloroacetol sulfate inactivates triosephosphate isomerase by the selective esterification of the same carboxyl group as that which is esterified by the phosphate esters described earlier. From the pH dependence of the rate of inactivation of yeast triosephosphate isomerase, the apparent pKa of the active-site carboxyl group is estimated as 3.9 +/- 0.1. Hartman F C FC LaMuraglia G M GM Tomozawa Y Y Wolfenden R R eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Hydroxymercuribenzoates 9BZQ3U62JX Dithionitrobenzoic Acid EC 5.1.3.- Carbohydrate Epimerases EC 5.3.1.1 Triose-Phosphate Isomerase IM Animals Binding Sites Carbohydrate Epimerases metabolism Dithionitrobenzoic Acid pharmacology Hydrogen-Ion Concentration Hydroxymercuribenzoates pharmacology Kinetics Muscles enzymology Protein Binding Rabbits Saccharomyces cerevisiae enzymology Triose-Phosphate Isomerase metabolism 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 47 10.1021/bi00695a007 48 1976 02 09 2020 02 25 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Monoanion inhibition and 35Cl nuclear magnetic resonance studies of renal dipeptidase. 5280-5 Kinetic analyses of monoanion inhibition and 15Cl nuclear magnetic resonance at 5.88 MHz were employed to study monoanion interactions with the zinc metalloenzyme, renal dipeptidase. The enzyme-catalyzed hydrolysis of glycyldehydrophenylalanine exhibited competitive inhibition when the reaction rate was determined in the presence of the monovalent anions fluoride, chloride, bromide, iodide, azide, nitrate, or thiocyanate or upon the addition of the divalent anion, sulfate. Competitive inhibition was produced by these anions. One anion was bound per enzyme molecule, and except in the case of fluoride all of the anions appeared to bind at the same site. Cyanide ion produced a much more effective inhibition of renal dipeptidase than the other monoanions, and it was shown that two cyanide ions were bound per enzyme molecule. An investigation of the effect of pH upon monoanion inhibition suggested that the anion inhibitors bind to the group with a pK of approximately 7.8. Complete dissociation of this group (approximately pH 8.4) eliminates the inhibitory effect of anions. The 35Cl line broadening produced by renal dipeptidase in 0.5 M NaCl solutions was 100 times more effective than that produced by equivalent concentrations of aquozinc(II). The line broadening was dependent upon the concentration of the metalloenzyme and independent of the frequency of the exciting radiation. When zinc ion was removed from the metalloenzyme by dialysis or when chloride was titrated from the metalloenzyme by cyanide, line broadening was decreased. Treatment of renal dipeptidase with saturating concentrations of the competitive inhibitor, guanosine triphosphate, in the presence of 0.5 M NaCl also produced a significant decrease in the 35Cl line width. The 35Cl line broadening produced by renal dipeptidase was shown to decrease with increasing pH through the range pH 5.8-10.8. This line-width variation with pH appeared to result from the titration of a site on the metalloprotein with an approximate pK of 7.4. Temperature studies of 35Cl line broadening by the metalloenzyme in the presence of chloride and cyanide inhibitors suggest that the fast exchange process pertains and that the dominant relaxation mechanism is quadrupolar in nature. Ferren L G LG Ward R L RL Campbell B J BJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Anions 0 Azides 0 Bromides 0 Chlorides 0 Cyanides 0 Iodides 0 Nitrates 0 Sulfates 0 Thiocyanates EC 3.4.13.- Dipeptidases Q80VPU408O Fluorides IM Animals Anions Azides pharmacology Bromides pharmacology Chlorides pharmacology Cyanides pharmacology Dipeptidases antagonists & inhibitors Fluorides pharmacology Hydrogen-Ion Concentration Iodides pharmacology Kidney Cortex enzymology Kinetics Magnetic Resonance Spectroscopy Mathematics Nitrates pharmacology Protein Conformation Sulfates pharmacology Swine Temperature Thiocyanates pharmacology 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 48 10.1021/bi00695a008 Med Educ. 2002 Oct;36(10):972-8 12390466 Med Care. 2004 Mar;42(3):259-66 15076825 Med Educ. 2004 Sep;38(9):1006-12 15327684 Fam Pract. 2005 Jun;22(3):328-34 15772120 Med Educ. 2005 Aug;39(8):820-8 16048624 Br J Gen Pract. 2006 Apr;56(525):262-8 16611514 Med Educ. 2008 Apr;42(4):364-73 18338989 Nurse Educ Pract. 2008 Sep;8(5):299-301 18692016 Ann Intern Med. 1995 Nov 15;123(10):795-9 7574198 BMJ. 1995 Aug 5;311(7001):376-80 7640549 49 1976 02 09 2020 02 25 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. 5294-9 Bovine erythrocyte superoxide dismutase was slowly and irreversibly inactivated by hydrogen peroxide. The rate of this inactivation was directly dependent upon the concentrations of both H2O2 and of enzyme, and its second-order rate constant at pH 10.0 and 25 degrees was 6.7 M-1 sec-1. Inactivation was preceded by a bleaching due to rapid reduction of Cu2+ on the enzyme, and following this there was a gradual reappearance of a new absorption in the visible region, which was coincident with the loss of catalytic activity. Inactivation of the enzyme was pH-dependent and indicated an essential ionization whose pKa was approximately 10.2. Replacement of H2O by D2O raised this pKa but did not diminish the catalytic activity of superoxide dismutase, measured at pH 10.0. Several compounds, including xanthine, urate, formate, and azide, protected the enzyme against inactivation by H2O2. Alcohols and benzoate, which scavenge hydroxyl radical, did not protect. Compounds with special affinity for singlet oxygen were similarly ineffective. The data were interpreted in terms of the reduction of the enzyme-bound Cu2+ to Cu+, by H2O2, followed by a Fenton's type reaction of the Cu+ with additional H2O2. This would generate Cu2+-OH- or its ionized equivalent, Cu2+-O--, which could then oxidatively attack an adjacent histidine and thus inactivate the enzyme. Compounds which protected the enzyme could have done so by reacting with the bound oxidant, in competition with the adjacent histidine. Hodgson E K EK Fridovich I I eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 BBX060AN9V Hydrogen Peroxide EC 1.15.1.1 Superoxide Dismutase IM Animals Binding Sites Cattle Erythrocytes enzymology Hydrogen Peroxide pharmacology Hydrogen-Ion Concentration Kinetics Protein Binding Spectrophotometry Spectrophotometry, Ultraviolet Superoxide Dismutase antagonists & inhibitors blood 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 49 10.1021/bi00695a010 JAMA. 2001 Nov 14;286(18):2322-4 11710899 Nature. 2002 Jan 31;415(6871):530-6 11823860 Genet Med. 2002 Mar-Apr;4(2):43-4 11882780 Eur Heart J. 2003 Mar;24(6):560-6 12643889 Nat Rev Cancer. 2004 May;4(5):361-70 15122207 Nat Genet. 2006 Mar;38(3):337-42 16444271 Genet Med. 2006 Feb;8(2):109-15 16481894 Nat Genet. 2006 Apr;38(4):441-6 16550169 Nature. 2007 Jun 7;447(7145):661-78 17554300 Med Educ. 2007 Jul;41(7):698-702 17614891 Am Heart J. 2007 Oct;154(4):624-31 17892982 50 1976 02 09 2020 02 25 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Circular dichroism and fluorescence studies of homogeneous antibodies to type III pneumococcal polysaccharide. 5308-11 The near-ultraviolet circular dichroism (CD) of three homogeneous anti-type III pneumococcal antibodies in the absence and the presence of the specific hexasaccharide ligand was studied. In addition recombinations and hybridizations of H and L chains derived from two of these antibodies were carried out and the CD spectra of bound and free reconstituted IgG molecules were measured. The results indicate that the CD spectra of the native antibodies in the 260-310-nm range are very similar in shape and sign and exhibit a positive band at 285 nm. The homologous reconstituted antibody molecules exhibited CD spectra very similar in shape and sign to those of the native antibody molecules although recombinant molecules are no longer stabilized by interchain disulfide bonds. Upon addition of the hexasaccharide ligand, a significant decrease in amplitude of the CD spectra (18-21%) occurred in all three native antibodies and their Fab fragments as well as in the homologous recombinant molecules. No CD spectral changes could be detected upon interaction of the hapten ligand with the heterologous recombinants. All homogeneous antibodies studied exhibited fluorescence quenching upon oligosaccharide binding and a blue shift of the emission maximum. This property allowed the determination of the binding constant of one selected antibody to be made. Taken together, CD and fluorescence spectroscopic data suggest that oligosaccharide ligands induced detectable conformational changes in the Fab fragment of the antibody. Jaton J C JC Huser H H Blatt Y Y Pecht I I eng Journal Article United States Biochemistry 0370623 0006-2960 0 Antibodies, Bacterial 0 Haptens 0 Immunoglobulin Fab Fragments 0 Immunoglobulin G 0 Polysaccharides, Bacterial IM Antibodies, Bacterial analysis Antigen-Antibody Reactions Circular Dichroism Haptens Immunoglobulin Fab Fragments Immunoglobulin G Kinetics Polysaccharides, Bacterial immunology Protein Conformation Spectrometry, Fluorescence Streptococcus pneumoniae immunology 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 50 10.1021/bi00695a013 J Clin Oncol. 2006 Apr 20;24(12):1932-9 16622269 Br J Cancer. 2007 Aug 20;97(4):472-8 17667931 Br J Hosp Med (Lond). 2011 Apr;72(4):184-5 21537231 Can Fam Physician. 2011 Jun;57(6):e216-27 21673198 Acad Med. 1995 May;70(5):388-97 7748384 J Gen Intern Med. 1997 Jan;12(1):53-6 9034946 51 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size. 5312-5 The circular polarization of luminescence (CPL) emitted by tryptophan residues was used as a sensitive probe for measuring ligand-induced structural changes in a homogeneous type III pneumococcal antibody. A series of oligosaccharide ligands of increasing size derived from type III polysaccharide by partial acid hydrolysis was assayed. Ligand-induced changes in the circular polarization of fluorescence of the antibody were observed for all antigens tested, including tetra-, hexa-, and octasaccharides and a 16-residue oligomer, the largest changes being recorded upon interaction with the intact soluble type III pneumococcal (SIII) polysaccharide. When Fab' or F(ab')2 fragments were used instead of the antibody IgG for binding of SIII polysaccharide, the extent of conformational changes was decreased. This suggests interactions between Fab and Fc portions in the IgG molecule and subsequent conformational changes in Fc part upon antigen binding. Reduction of interchain disulfide bonds abolished the additional spectral changes attributed to the Fc part but not the changes observed in the Fab part, thus suggesting that the presence of the interchain disulfide bond in the hinge region is required for maximal CPL changes to occur. Small monovalent ligands, i.e., the tetra-, hexa-, and octasaccharides, were capable of inducing CPL changes in the Fab part of the antibody molecule as well as CPL changes attributed to the Fc portion. A multivalent ligand containing about 16 sugar residues appears to be the minimal antigenic size required for triggering conformational changes attributed to the Fc part, similar to those seen in the interaction with the whole polysaccharide antigen. Jaton J C JC Huser H H Braun D G DG Givol D D Pecht I I Schlessinger J J eng Journal Article United States Biochemistry 0370623 0006-2960 0 Antibodies, Bacterial 0 Haptens 0 Immunoglobulin Fab Fragments 0 Oligosaccharides 0 Polysaccharides, Bacterial IM Antibodies, Bacterial analysis Haptens Immunoglobulin Fab Fragments Luminescent Measurements Molecular Weight Oligosaccharides immunology Polysaccharides, Bacterial immunology Protein Conformation Streptococcus pneumoniae immunology Structure-Activity Relationship 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 51 10.1021/bi00695a014 52 1976 02 09 2019 06 12 0006-2960 14 24 1975 Dec 02 Biochemistry Biochemistry Evidence of the involvement of a 50S ribosomal protein in several active sites. 5321-7 The functional role of the Bacillus stearothermophilus 50S ribosomal protein B-L3 (probably homologous to the Escherichia coli protein L2) was examined by chemical modification. The complex [B-L3-23S RNA] was photooxidized in the presence of rose bengal and the modified protein incorporated by reconstitution into 50S ribosomal subunits containing all other unmodified components. Particles containing photooxidized B-L3 are defective in several functional assays, including (1) poly(U)-directed poly(Phe) synthesis, (2) peptidyltransferase activity, (3) ability to associate with a [30S-poly(U)-Phe-tRNA] complex, and (4) binding of elongation factor G and GTP. The rates of loss of the partial functional activities during photooxidation of B-L3 indicate that at least two independent inactivating events are occurring, a faster one, involving oxidation of one or more histidine residues, affecting peptidyltransferase and subunit association activities and a slower one affecting EF-G binding. Therefore the protein B-L3 has one or more histidine residues which are essential for peptidyltransferase and subunit association, and another residue which is essential for EF-G-GTP binding. B-L3 may be the ribosomal peptidyltransferase protein, or a part of the active site, and may contribute functional groups to the other active sites as well. Fahnestock S R SR eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Macromolecular Substances 0 Ribosomal Proteins IM Binding Sites Geobacillus stearothermophilus metabolism Hydrogen-Ion Concentration Kinetics Macromolecular Substances Oxidation-Reduction Photochemistry Protein Binding Ribosomal Proteins metabolism Ribosomes metabolism 1975 12 2 1975 12 2 0 1 1975 12 2 0 0 ppublish 52 10.1021/bi00695a016 53 1976 03 01 2020 02 25 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry The interaction of phospholipase A2 with micellar interfaces. The role of the N-terminal region. 5387-94 The localization of the previously postulated interface recognition site (IRS) in porcine pancreatic phospholipase A2, required for a specific interaction between the enzyme and organized lipid-water interfaces, was investigated by ultraviolet difference spectroscopy, by measurements of the intrinsic fluorescence of the unique Trp residue, and by protection experiments against specific tryptic hydrolysis. Using the enzymically nondegradable substrate analogues: CnH(2n+1)(0-)OOCH2CH2N+(CH3)3-(H,OH), it is shown that the rather hydrophobic N-terminal sequence of the enzyme, viz., Ala-Leu-Trp-Gln-Phe-Arg, is directly involved in the interaction with the lipid-water interface. Besides hydrophobic probably also polar interactions contribute to the binding process. At neutral or acidic pH the presence of a salt bridge between the N-terminal alpha-NH3+ group and a negatively charged side chain stablizes the interface recognition site and allows the enzyme to penetrate micellar surfaces, even in the absence of metal ion. At alkaline pH, interaction of the enzyme with micellar interfaces requires the presence of Ca2+ (Ba2+) ions. van Dam-Mieras M C MC Slotboom A J AJ Pieterson W A WA de Haas G H GH eng Journal Article United States Biochemistry 0370623 0006-2960 0 Amines 0 Lysophosphatidylcholines 0 Micelles 0 Phosphatidylcholines 24GP945V5T Barium EC 3.1.- Phospholipases EC 3.4.21.4 Trypsin SY7Q814VUP Calcium IM Amines Barium pharmacology Binding Sites Calcium pharmacology Hydrogen-Ion Concentration Kinetics Lysophosphatidylcholines metabolism Micelles metabolism Pancreas enzymology Phosphatidylcholines metabolism Phospholipases metabolism Protein Conformation Trypsin pharmacology 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 53 10.1021/bi00696a001 Med Care Rev. 1993 Spring;50(1):49-79 10125117 J Health Care Chaplain. 1997;6(2):1-61 10174489 Eval Program Plann. 1983;6(3-4):185-210 10299618 J Pastoral Care Counsel. 2004 Winter;58(4):335-42 15739871 54 1976 03 01 2019 06 12 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry Phospholipase A2 as a probe of phospholipid distribution in erythrocyte membranes. Factors influencing the apparent specificity of the reaction. 5400-8 The action of snake venom phospholipases A2 in intact human erythrocytes was investigated in detail. The basis phospholipase from Agkistrodon halys blomhifii was found to induce both hydrolysis of membrane phospholipids and total cell hemolysis under certain experimental conditions. The hydrolytic action of the basic enzyme was found to consist of two sequential events: (a) hydrolysis of 70% of the total cell ph osphatidylcholine without any evident hemolysis; and (b) complete hydrolysis of the remaining phosphatidylcholine, followed closely by extensive phosphatidylethanolamine hydrolysis and finally with onset of hemolysis, attack on the phosphatidylserine. At pH 7.4 and 10 mM Ca2+ only stage (a) occurred. However, a slight elevation of the pH of incubation to pH 8.0 and/or inclusion of 40 mM Ca2+ in the reaction mixture caused both events (a) and (b) to occur. The addition of glucose limited the action of the enzyme to stage (a) under any reaction conditions. An investigation showed that enzymically induced hemolysis occurred under conditions where the intracellular ATP levels were lowered. Data are presented which suggest that stage (b) is mediated by in influx of Ca2+ into the cell when the levels of ATP are low. Interestingly the phosphllipase from Naja naja venom (Pakistan) yielded results similar to those observed with the basic enzyme from Agkistrodon venom. However, the enzyme from Crotalus adamanteus and the acidic enzyme also present in the Agkistrodon venom produced only slight hydrolysis or hemolysis under any of the conditions studied. Other species of erythrocytes, e.g., guinea pig, monkey, pig, and rat, were tested but only those from guinea pig behaved similarly to the human cells. Pig, monkey, and rat erythrocytes underwent very limited hydrolysis and hemolysis. It is evident that the use of these phospholipases to probe the localization of phospholipds in erythrocyte membranes must be approached with caution. Certain facets of this problem are discussed. Martin J K JK Luthra M G MG Wells M A MA Watts R P RP Hanahan D J DJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Citrates 0 Phosphatidylcholines 0 Phospholipids 0 Snake Venoms 8L70Q75FXE Adenosine Triphosphate EC 3.1.- Phospholipases I38ZP9992A Magnesium IY9XDZ35W2 Glucose RWP5GA015D Potassium SY7Q814VUP Calcium IM Adenosine Triphosphate metabolism Animals Calcium metabolism Cell Membrane metabolism Citrates pharmacology Erythrocyte Aging Erythrocytes metabolism Glucose pharmacology Guinea Pigs Haplorhini Hemolysis drug effects Humans Hydrogen-Ion Concentration Magnesium metabolism Phosphatidylcholines metabolism Phospholipases isolation & purification pharmacology Phospholipids metabolism Potassium metabolism Rats Snake Venoms Swine Time Factors 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 54 10.1021/bi00696a003 55 1976 03 01 2019 06 12 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry Subunit interactions in yeast glyceraldehyde-3-phosphate dehydrogenase. 5428-37 The spontaneous inactivation of yeast glyceraldehyde-3-phosphate dehydrogenase was found to fit a simple two-state model at pH 8.5 and 25 degrees. The first step is a relatively rapid dissociation of the tetramer to dimers with the equilibrium largely in favor of the tetramer. In the absence of NAD+ the dimer inactivates irreversibly. The apoenzyme is quite stable with a half-life for complete activity loss proportional to the square root of the enzyme concentration. Perturbances of the protein structure (by pH, ionic strength, and specific salts), which have no effect on the tetrameric state of the molecule, result in an alteration of the cooperativity of NAD+ binding, the reactivity of the active-site sulfhydryl group, and the catalytic activity of the enzyme. Covalent modification of two of the four active-site sulfhydryl groups has profound effects on the enzymic activity which are mediated by changes in the subunit interactions. Sedimentation analysis and hybridization studies indicate that the interaction between subunits remains strong after covalent modification. Under normal physiological and equilibrium dialysis conditions the protein is a tetramer. Equilibrium dialysis studies of NAD+ binding to the enzyme at pH 8.5 and 25 degrees reveal a mixed cooperativity pattern. A model consistent with these observations and the observed half-of-the-sites reactivity is that of ligand induced sequential conformational changes which are transferred across strongly interacting subunit domains. Methods for distinguishing negatively cooperative binding patterns from mixtures of denatured enzyme and multiple species are discussed. Mockrin S C SC Byers L D LD Koshland D E DE Jr eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Cyanates 0 Macromolecular Substances 0 Sulfhydryl Compounds 0U46U6E8UK NAD 451W47IQ8X Sodium Chloride 8L70Q75FXE Adenosine Triphosphate EC 1.2.1.- Glyceraldehyde-3-Phosphate Dehydrogenases IM Adenosine Triphosphate metabolism Binding Sites Cyanates Glyceraldehyde-3-Phosphate Dehydrogenases metabolism Hydrogen-Ion Concentration Kinetics Macromolecular Substances Models, Chemical NAD metabolism Protein Binding Protein Conformation Protein Denaturation Saccharomyces cerevisiae enzymology Sodium Chloride pharmacology Sulfhydryl Compounds metabolism 1975 12 16 2001 3 28 10 1 1975 12 16 0 0 ppublish 55 10.1021/bi00696a008 56 1976 03 01 2019 06 12 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry Kinetic light scattering studies on the dissociation of hemoglobin from Lumbricus terrestris. 5461-4 The kinetics of the pH-induced dissociation of the 3 X 10(6) mol wt hemoglobin from Lumbricus terrestris (the earthworm) have been studied in a light-scattering stopped-flow apparatus. The ligand dependent dissociation data were fit well by a simple sequential model. The data for CO and oxyhemoglobin are consistent with Hb12 leads to 2Hb6 leads to 12Hb. Methemoglobin at pH 7 appears to be hexameric and the dissociation is consistent with the model: Hb6 leads to 6Hb. In a sequential decay scheme for which light-scattering changes are monitored, the relative amounts of rapid and slow phase are determined by the rate constants as well as the molecular weights of intermediate species. Assignment of the hexameric intermediate is supported by an investigation of the sensitivity of the theoretical kinetic curves to the molecular weights of the intermediates. This assignment is further supported by the following: (1) the same model will fit the data for oxy- and CO-hemoglobin at all three temperatures (a 24-29-fold variation in rate constants), (2) evidence from electron microscopy shows hexameric forms, and (3) methemoglobin is apparently stable as a hexamer at pH 7. When CO replaces O2 as the ligand, the dissociation rate increases by a factor of four. The met is about 20 times faster than the initial oxyhemoglobin dissociation rate, but perhaps more relevant for comparing dissociation of the hexamer, the met rate was respectively 100 times and 500 times faster than that for the assumed hexameric forms of CO- and oxy-hemoglobin. The activation energies for the dodecamer to hexamer dissociation and for the dissociation of the hexamer to smaller forms were about 30 kcal/mol for oxy-, CO-, and methemoglobin. Goss D J DJ Parkhurst L J LJ Görisch H H eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Biochemistry 0370623 0006-2960 0 Hemoglobins 0 Macromolecular Substances 0 Oxyhemoglobins 7U1EE4V452 Carbon Monoxide 9061-29-4 Carboxyhemoglobin S88TT14065 Oxygen IM Carbon Monoxide Carboxyhemoglobin Hemoglobins Hydrogen-Ion Concentration Kinetics Macromolecular Substances Molecular Weight Oligochaeta Oxygen Oxyhemoglobins Protein Binding Scattering, Radiation Temperature 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 56 10.1021/bi00696a012 57 1976 03 01 2019 12 10 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry The reversible reduction of horse metmyoglobin by the iron(II) complex of trans-1,2-diaminocyclohexane-N,N,N,n-tetraacetate. 5470-5 The reduction of metmyoglobin by the iron(II) complex of trans-1,2-diaminocyclohexane-N,N,N'N'-tetraacetate (FeCDTA2-) has been investigated. The equilibrium constant, measured spectrophotometrically, is 0.21 with a resulting reduction potential of 0.050 V for Mb0. The rate constant for the reduction is 28 M-1 sec-1 with a deltaH ++ of 13 kcal M-1 and deltaS ++ of -11 eu. Both CN- and OH- inhibit the reduction because of the relatively low reactivity of cyanometmyoglobin (Mb+CN-) and ionized metmyglobin (Mb+OH-). The rate constant for the reduction of Mb+CN- by FeCDTA2- is 4.0 X 10(-2) M-1 sec-1 and that for reduction of Mb+OH- is 4.8 M-1 sec-1. The nitric oxide complex of metmyoglobin is reduced with a rate constant of 10 M-1 sec-1. The kinetics of oxidation of oxymyoglobin by FeCDTA- were studied. The data are consistent with a mechanism where oxidation takes place entirely through the deoxy form. A rate constant of 1.45 X 10(2) M-1 sec-1 was calculated for the oxidation of deoxymyoglobin by FeCDTA-, in equilibrium constant and rate constant for reduction. The above data are discussed in terms of a simple outer-sphere reduction reaction. Cassatt J C JC Marini C P CP Bender J W JW eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States Biochemistry 0370623 0006-2960 0 Acetates 0 Chelating Agents 0 Cyanides 0 Cyclohexylamines 0 Ferrous Compounds 0 Myoglobin 31C4KY9ESH Nitric Oxide 482-54-2 CDTA 9G34HU7RV0 Edetic Acid E1UOL152H7 Iron S88TT14065 Oxygen IM Acetates Animals Chelating Agents Cyanides Cyclohexylamines Edetic Acid analogs & derivatives Ferrous Compounds Horses Hydrogen-Ion Concentration Iron Kinetics Myoglobin Nitric Oxide Oxidation-Reduction Oxygen Protein Binding 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 57 10.1021/bi00696a014 58 1976 03 01 2020 02 25 0006-2960 14 25 1975 Dec 16 Biochemistry Biochemistry Constitution and properties of axonal membranes of crustacean nerves. 5500-11 The purification of axonal membranes of crustaceans was followed by measuring enrichment in [3H]tetrodotoxin binding capacity and in Na+, K+-ATPase activity. A characteristic of these membranes is their high content of lipids and their low content of protein as compared to other types of plasmatic membranes. The axonal membrane contains myosin-like, actin-like, tropomyosin-like, and tubulin-like proteins. It also contains Na+, K+-ATPase and acetylcholinesterase. The molecular weights of these two enzymes after solubilization are 280,000 and 270,000, respectively. The molecular weights of the catalytic subunits are 96,000 for ATPase and 71,000 for acetylcholinesterase. We confirmed the presence of a nicotine binding component in the axonal membrane of the lobster but we have been unable to find [3H]nicotine binding to crab axonal membranes. The binding to axonal membranes og of the sodium channel, has been studied in detail. The dissociation constant for the binding of [3H]tetrodotoxin to the axonal membrane receptor is 2.9 nM at pH 7.4. The concentration of the tetrodotoxin receptor in crustacean membranes is about 10 pmol/mg of membrane protein, 7 times less than the acetylcholinesterase, 30 times less than the Na+, K+-ATPase, and 30 times less than the nicotine binding component in the lobster membrane. A reasonable estimate indicates that approximately only one peptide chain in 1000 constitutes the tetrodotoxin binding part of the sodium channel in the axonal membrane. Veratridine, which acts selectively on the resting sodium permeability, binds to the phospholipid part of the axonal membrane. [3H]Veratridine binding to membranes parallels the electrophysiological effect. Veratridine and tetrodotoxin have different receptor sites. Although tetrodotoxin can repolarize the excitable membrane of a giant axon depolarized by veratridine, veratridine does not affect the binding of [3H]tetrodotoxin to purified axonal membranes. Similarly, tetrodotoxin does not affect the binding of [3H]veratridine to axonal membranes. Scorpion neurotoxin I, a presynaptic toxin which affects both the Na+ and the K+ channels, does not interfere with the binding of [3H]tetrodotoxin or [3H]veratridine to axonal membranes. Tetrodotoxin, veratridine, and scorpion neurotoxin I, which have in common the perturbation of the normal functioning of the sodium channel, act upon three different types of receptor sites. Balerna M M Fosset M M Chicheportiche R R Romey G G Lazdunski M M eng Journal Article United States Biochemistry 0370623 0006-2960 0 Carbohydrates 0 Lipids 0 Proteins 0 Toxins, Biological 4368-28-9 Tetrodotoxin 6M3C89ZY6R Nicotine 71-62-5 Veratridine EC 3.1.1.7 Acetylcholinesterase EC 3.6.1.- Adenosine Triphosphatases IM Acetylcholinesterase metabolism Adenosine Triphosphatases metabolism Axons analysis metabolism Binding Sites Carbohydrates analysis Crustacea metabolism Hydrogen-Ion Concentration Kinetics Lipids analysis Membranes analysis metabolism Molecular Weight Nicotine metabolism Proteins analysis Scorpions Tetrodotoxin metabolism Toxins, Biological metabolism Veratridine metabolism 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 58 10.1021/bi00696a019 JAMA. 2000 Feb 16;283(7):897-903 10685714 Anesth Analg. 2005 Jul;101(1):233-4, table of contents 15976237 Lancet. 2008 Jul 5;372(9632):55-66 18603160 Cases J. 2008 Dec 02;1(1):369 19055707 Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):141-3 19386660 59 1976 02 09 2019 06 09 0006-3002 408 2 1975 Nov 11 Biochimica et biophysica acta Biochim Biophys Acta Regulation of nitrogen fixation. Nitrogenase-derepressed mutants of Klebsiella pneumoniae. 101-11 1. A new procedure is described for selecting nitrogenase-derepressed mutants based on the method of Brenchley et al. (Brenchley, J.E., Prival, M.J. and Magasanik, B. (1973) J. Biol. Chem. 248, 6122-6128) for isolating histidase-constitutive mutants of a non-N2-fixing bacterium. 2. Nitrogenase levels of the new mutants in the presence of NH4+ were as high as 100% of the nitrogenase activity detected in the absence of NH4+. 3. Biochemical characterization of these nitrogen fixation (nif) derepressed mutants reveals that they fall into three classes. Three mutants (strains SK-24, 28 and 29), requiring glutamate for growth, synthesize nitrogenase and glutamine synthetase constitutively (in the presence of NH4+). A second class of mutants (strains SK-27 and 37) requiring glutamine for growth produces derepressed levels of nitrogenase activity and synthesized catalytically inactive glutamine synthetase protein, as determined immunologically. A third class of glutamine-requiring, nitrogenase-derepressed mutants (strain SK-25 and 26) synthesizes neither a catalytically active glutamine synthetase enzyme nor an immunologically cross-reactive glutamine synthetase protein. 4. F-prime complementation analysis reveals that the mutant strains SK-25, 26, 27, 37 map in a segment of the Klebsiella chromosome corresponding to the region coding for glutamine synthetase. Since the mutant strains SK-27 and SK-37 produce inactive glutamine synthetase protein, it is concluded that these mutations map within the glutamine synthetase structural gene. Shanmugam K T KT Chan I I Morandi C C eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 7664-41-7 Ammonia EC 1.18.6.1 Nitrogenase EC 1.4.1.2 Glutamate Dehydrogenase EC 6.3.1.2 Glutamate-Ammonia Ligase IM Ammonia pharmacology Chromosome Mapping Glutamate Dehydrogenase metabolism Glutamate-Ammonia Ligase immunology metabolism Hybridization, Genetic Immunodiffusion Klebsiella pneumoniae drug effects metabolism Mutation Nitrogen Fixation drug effects Nitrogenase metabolism Phenotype Species Specificity 1975 11 11 1975 11 11 0 1 1975 11 11 0 0 ppublish 59 0005-2728(75)90002-X 10.1016/0005-2728(75)90002-x 60 1976 02 13 2019 06 09 0006-3002 408 3 1975 Dec 11 Biochimica et biophysica acta Biochim Biophys Acta The reaction between the superoxide anion radical and cytochrome c. 215-22 1. The superoxide anion radical (O2-) reacts with ferricytochrome c to form ferrocytochrome c. No intermediate complexes are observable. No reaction could be detected between O2- and ferrocytochrome c. 2. At 20 degrees C the rate constant for the reaction at pH 4.7 to 6.7 is 1.4-10(6) M-1. S -1 and as the pH increases above 6.7 the rate constant steadily decreases. The dependence on pH is the same for tuna heart and horse heart cytochrome c. No reaction could be demonstrated between O2- and the form of cytochrome c which exists above pH approximately 9.2. The dependence of the rate constant on pH can be explained if cytochrome c has pKs of 7.45 and 9.2, and O2- reacts with the form present below pH 7.45 with k = 1.4-10(6) M-1 - S-1, the form above pH 7.45 with k = 3.0- 10(5) M-1 - S-1, and the form present above pH 9.2 with k = 0. 3. The reaction has an activation energy of 20 kJ mol-1 and an enthalpy of activation at 25 degrees C of 18 kJ mol-1 both above and below pH 7.45. It is suggested that O2- may reduce cytochrome c through a track composed of aromatic amino acids, and that little protein rearrangement is required for the formation of the activated complex. 4. No reduction of ferricytochrome c by HO2 radicals could be demonstrated at pH 1.2-6.2 but at pH 5.3, HO2 radicals oxidize ferrocytochrome c with a rate constant of about 5-10(5)-5-10(6) M-1 - S-1. Butler J J Jayson G G GG Swallow A J AJ eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Cytochrome c Group 0 Free Radicals 11062-77-4 Superoxides S88TT14065 Oxygen IM Animals Binding Sites Calorimetry Cytochrome c Group Free Radicals Horses Hydrogen-Ion Concentration Kinetics Myocardium enzymology Oxygen Protein Binding Spectrophotometry Spectrophotometry, Ultraviolet Superoxides Temperature Thermodynamics 1975 12 11 1975 12 11 0 1 1975 12 11 0 0 ppublish 60 0005-2728(75)90124-3 10.1016/0005-2728(75)90124-3 61 1976 02 13 2019 06 09 0006-3002 408 3 1975 Dec 11 Biochimica et biophysica acta Biochim Biophys Acta Identification of the 120 mus phase in the decay of delayed fluorescence in spinach chloroplasts and subchloroplast particles as the intrinsic back reaction. The dependence of the level of this phase on the thylakoids internal pH. 269-38 After a 500 mus laser flash a 120 mus phase in the decay of delayed fluorescence is visible under a variety of circumstances in spinach chloroplasts and subchloroplast particles enriched in Photosystem II prepared by means of digitonin. The level of this phase is high in the case of inhibition of oxygen evolution at the donor side of Photosystem II. Comparison with the results of Babcock and Sauer (1975) Biochim. Bio-phys. Acta 376, 329-344, indicates that their EPR signal IIf which they suppose to be due to Z+, the oxidized first secondary donor of Photosystem II, is well correlated with a large amplitude of our 120 mus phase. We explain our 120 mus phase by the intrinsic back reaction of the excited reaction center in the presence of Z+, as predicted by Van Gorkom and Donze (1973) Photochem. Photobiol. 17, 333-342. The redox state of Z+ is dependent on the internal pH of the thylakoids. The results on the effect of pH in the mus region are compared with those obtained in the ms region. Haveman J J Lavorel J J eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Hydroxylamines 0 Semicarbazides 2001-95-8 Valinomycin 555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone 9I3SDS92WY Diuron KOO5CM684H Digitonin RRU6GY95IS Nigericin IM Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology Chloroplasts drug effects metabolism ultrastructure Digitonin Diuron pharmacology Electron Spin Resonance Spectroscopy Hydrogen-Ion Concentration Hydroxylamines pharmacology Kinetics Lasers Luminescent Measurements Nigericin pharmacology Photosynthesis drug effects Plants Semicarbazides pharmacology Spectrometry, Fluorescence Valinomycin pharmacology 1975 12 11 1975 12 11 0 1 1975 12 11 0 0 ppublish 61 0005-2728(75)90129-2 10.1016/0005-2728(75)90129-2 62 1976 02 13 2019 06 09 0006-3002 408 3 1975 Dec 11 Biochimica et biophysica acta Biochim Biophys Acta Light-induced changes of absorbance and electron spin resonance in small photosystem II particles. 331-9 Photosystem II reaction center components have been studied in small system II particles prepared with digitonin. Upon illumination the reduction of the primary acceptor was indicated by absorbance changes due to the reduction of a plastoquinone to the semiquinone anion and by a small blue shifts of absorption bands near 545 nm (C550) and 685 nm. The semiquinone to chlorophyll ratio was between 1/20 and 1/70 in various preparations. The terminal electron donor in this reaction did not cause large absorbance changes but its oxidized form was revealed by a hitherto unknown electron spin resonance (ESR) signal, which had some properties of the well-known signal II but a linewidth and g-value much nearer to those of signal I. Upon darkening absorbance and ESR changes decayed together in a cyclic or back reaction which was stimulated by 3-(3,4 dichlorophenyl)-1,1-dimethylurea. The donor could be oxidized by ferricyanide in the dark. Illumination in the presence of ferricyanide induced absorbance and ESR changes, rapidly reversed upon darkening, which may be ascribed to the oxidation of a chlorophyll a dimer, possibly the primary electron donor of photosystem II. In addition an ESR signal with 15 to 20 gauss linewidth and a slower dark decay was observed, which may have been caused by a secondary donor. Van Gorkom H J HJ Pulles M P MP Wessels J S JS eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Ferricyanides 1406-65-1 Chlorophyll 9I3SDS92WY Diuron IM Binding Sites Chlorophyll metabolism Chloroplasts drug effects metabolism ultrastructure Darkness Diuron pharmacology Electron Spin Resonance Spectroscopy Ferricyanides Hydrogen-Ion Concentration Light Photophosphorylation drug effects Plants Spectrophotometry Spectrophotometry, Ultraviolet 1975 12 11 1975 12 11 0 1 1975 12 11 0 0 ppublish 62 0005-2728(75)90134-6 10.1016/0005-2728(75)90134-6 63 1976 02 19 2019 06 09 0006-3002 409 2 1975 Nov 21 Biochimica et biophysica acta Biochim Biophys Acta Enzymic reactions of fatty acid hydroperoxides in extracts of potato tuber. II. Conversion of 9- and 13-hydroperoxy-octadecadienoic acids to monohydroxydienoic acid, epoxyhydroxy- and trihydroxymonoenoic acid derivatives. 157-71 1. Crude extracts and partially purified enzyme preparations from potato tubers catalyse, at pH 5-7, the conversion of linoleic acid hydroperoxides to a range of oxygenated fatty acid derivatives. 2. 9-D- and 13-L-hydroperoxide isomers are converted at similar rates to equivalent (isomeric) products. 3. The major products from the 13-hydroperoxide isomer were identified as the corresponding monohydroxydienoic acid derivative, threo-11-hydroxy-trans12,13-epoxy-octadec-cis9-enoic acid and 9,12,13-trihydroxy-octadec-trans10-enoic acid. The corresponding products from the 9-hydroperoxide were the monohydroxydienoic acid, 9,10-epoxy-11-hydroxy-octadec-12-enoic acid and 9,10,13-trihydroxy-octadec-11-enoic acid. 4. No separation of activities forming the different products was achieved by partial purification of enzyme extracts. 5. Product formation was unaffected by EDTA, CN-, sulphydryl reagents or glutathione but was reduced by boiling the extracts. 6. This system is compared with the 9-hydroperoxide-specific enzymic formation of divinyl ether derivatives by potato extracts. Galliard T T Phillips D R DR Matthew J A JA eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Fatty Acids, Unsaturated 0 Linoleic Acids EC 1.11.1.- Peroxidases IM Fatty Acids, Unsaturated Hydrogen-Ion Concentration Linoleic Acids Magnetic Resonance Spectroscopy Peroxidases metabolism Plants enzymology Structure-Activity Relationship 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 63 0005-2760(75)90151-4 10.1016/0005-2760(75)90151-4 64 1976 02 19 2019 06 09 0006-3002 409 2 1975 Nov 21 Biochimica et biophysica acta Biochim Biophys Acta Partial purification and properties of microsomal phosphatidate phosphohydrolase from rat liver. 201-11 Microsomal phosphatidate phosphohydrolase (phosphatidate phosphatase EC 3.1.3.4) was solubilized and fractionated to yield at least two distinct enzymatically active fractions. One, denoted FA, was non-specific, had a relatively high Km for phosphatidic acid and was insensitive to inhibition by diacylglycerol. The second fraction, FB, was specific for phosphatidates, had a low Km, and was inhibited, non-competitively, by diacylglycerol. FA exhibited a sigmoid substrate-activity curve. The isolated FB aggregated to particles of about 10(6) in the absence of salts and could be dissociated by the addition of monovalent cations at ionic strength 0.4-0.6 to about 2-10(5) daltons and thereby doubled its activity. Dissociation was time- and temperature-dependent. F- was inhibitory. Divalent ions were not required for the activity of FA or FB and inhibited at concentrations exceeding 1 mM. Caras I I Shapiro B B eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Diglycerides 0 Phospholipids 005990WHZZ Deoxycholic Acid 42Z2K6ZL8P Manganese 451W47IQ8X Sodium Chloride EC 3.1.3.2 Phosphoric Monoester Hydrolases I38ZP9992A Magnesium SY7Q814VUP Calcium IM Animals Calcium pharmacology Deoxycholic Acid Diglycerides pharmacology Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Manganese pharmacology Microsomes, Liver enzymology Osmolar Concentration Phospholipids metabolism Phosphoric Monoester Hydrolases isolation & purification metabolism Rats Sodium Chloride pharmacology Structure-Activity Relationship Temperature 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 64 0005-2760(75)90154-X 10.1016/0005-2760(75)90154-x 65 1976 02 19 2020 02 25 0006-3002 409 2 1975 Nov 21 Biochimica et biophysica acta Biochim Biophys Acta Bile acids. XLVII. 12alpha-Hydroxylation of precursors of allo bile acids by rabbit liver microsomes. 249-57 Rabbit liver microsomal preparations fortified with 0.1 mM NADPH effectively promote hydroxylation of [3beta-3H]- or [24-14C]allochenodeoxycholic acid or [5alpha,6alpha-3H2]5alpha-cholestane-3alpha,7alpha-diol to their respective 12alpha-hydroxyl derivatives in yields of about 25 or 65% in 60 min. Minor amounts of other products are formed from the diol. The requirements for activity of rabbit liver microsomal 12alpha-hydroxylase resemble those of rat liver microsomes. Of a number of enzyme inhibitors studied only p-chloromercuribenzoate demonstrated a marked ability to inhibit the reaction with either tritiated substrate. There was no difference in the quantity of product produced from the tritiated acid or the 14C-labeled acid. No clear sex difference was found in activity of the enzyme, nor was an appreciable difference noted in activity of the enzyme between mature and immature animals. Ali S S SS Elliott W H WH eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Bile Acids and Salts 53-59-8 NADP EC 1.- Mixed Function Oxygenases IM Aging Animals Bile Acids and Salts metabolism Female Kinetics Male Microsomes, Liver metabolism Mixed Function Oxygenases metabolism NADP Oxidation-Reduction Rabbits Sex Factors 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 65 0005-2760(75)90159-9 10.1016/0005-2760(75)90159-9 Ann Rheum Dis. 1999 Apr;58(4):230-6 10364902 JAMA. 1985 Nov 15;254(19):2763-7 4057484 Ann Rheum Dis. 1995 Aug;54(8):681-4 7677447 J Rheumatol. 1999 Jan;26(1):115-20 9918251 66 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Partial purification and properties of a phenobarbital-induced aldehyde dehydrogenase of rat liver. 1-11 Properties of the phenobarbital induced cytoplasmic aldehyde dehydrogenase (EC 1.2.1.3) have been studied in rat liver. 7-12-Fold higher levels were seen in the cytoplasmic activities after phenobarbital treatment in reactor compared to non-reactor animals with high concentrations of acetaldehyde (18 mM) and propionaldehyde (9 mM). No difference was found with 0.12 mM acetaldehyde, 2 mM glycolaldehyde, 6 mM formaldehyde or 0.5 mM betaine aldehyde. The reactor group also had slightly higher activity in the mitochondrial fraction with the high acetaldehyde and propionaldehyde concentrations. In the microsomal fraction, the activities showed no differences at any substrate concentration. An induced aldehyde dehydrogenase was purified 70-fold by chromatographic techniques. It had different molecular and enzymic properties than the main high-Km enzyme normally present in rat liver cytoplasm. The pI of the induced enzyme was about 7.0 as measured by isoelectric focusing. It was active with several aliphatic and aromatic aldehydes but not with formaldehyde, glycolaldehyde or D-glyceraldehyde. The Km-values for propionaldehyde and acetaldehyde were in the millimolar range. Millimolar concentrations of aromatic aldehydes caused a strong substrate inhibition. The enzyme was inhibited by submicromolar concentrations of disulfiram. Estrone, deoxycorticosterone, progesterone and diethylstilbestrol also affected the enzyme activity. Koivula T T Koivusalo M M eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 EC 1.2.- Aldehyde Oxidoreductases YQE403BP4D Phenobarbital IM Aldehyde Oxidoreductases isolation & purification metabolism Animals Enzyme Activation drug effects Enzyme Induction drug effects Hydrogen-Ion Concentration Kinetics Liver drug effects enzymology Male Phenobarbital pharmacology Rats Structure-Activity Relationship Subcellular Fractions enzymology 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 66 0005-2744(75)90202-8 10.1016/0005-2744(75)90202-8 67 1976 02 13 2020 02 25 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Cholinesterases from plant tissues. VI. Preliminary characterization of enzymes from Solanum melongena L. and Zea mays L. 130-4 Enzymes capable of hydrolyzing esters of thiocholine have been assayed in extracts of Solanum melongena L. (eggplant) and Zea Mays L. (corn). The enzymes from both species are inhibited by the anti-cholinesterases neostigmine, physostigmine, and 284c51 and by AMO-1618, a plant growth retardant and they both have pH optima near pH 8.0. The enzyme from eggplant is maximally active at a substrate concentration of 0.15 mM acetylthiocholine and is inhibited at higher substrate concentrations. On the basis of this last property, the magnitude of inhibition by the various inhibitors, and the substrate specificity, we conclude that the enzyme from eggplant, but not that from corn, is a cholinesterase. Fluck R A RA Jaffe M J MJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Cholinesterase Inhibitors 4468-05-7 Acetylthiocholine EC 3.1.1.8 Cholinesterases IM Acetylthiocholine Cholinesterase Inhibitors pharmacology Cholinesterases metabolism Hydrogen-Ion Concentration Kinetics Plants enzymology Species Specificity Structure-Activity Relationship Subcellular Fractions enzymology Zea mays enzymology 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 67 0005-2744(75)90213-2 10.1016/0005-2744(75)90213-2 J Am Geriatr Soc. 1999 Jul;47(7):824-9 10404926 J Psychiatr Res. 1975 Nov;12(3):189-98 1202204 Dement Geriatr Cogn Disord. 2002;14(1):33-40 12053130 Lancet Neurol. 2003 Feb;2(2):89-98 12849265 BMJ. 1992 Sep 19;305(6855):673-8 1356550 Neurotox Res. 2000;2(2-3):85-97 16787834 Am J Geriatr Psychiatry. 2007 Jan;15(1):84-7 17194818 Eur J Neurol. 2007 Jan;14(1):e1-26 17222085 Dement Geriatr Cogn Disord. 2007;24(2):138-45 17622761 Lancet Neurol. 2007 Sep;6(9):782-92 17689146 Neurology. 2008 Oct 14;71(16):1227-34 18633132 Mov Disord. 2008 Nov 15;23(15):2248-50 18823039 Lancet Neurol. 2009 Jul;8(7):613-8 19520613 Dement Geriatr Cogn Disord. 2009;28(3):244-51 19786776 Clin Med (Lond). 2010 Aug;10(4):391-4 20849018 J Psychopharmacol. 2011 Aug;25(8):997-1019 21088041 68 1976 02 13 2020 02 25 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Behavior of soluble and immobilized acid phosphatase in hydro-organic media. 135-44 The hydrolysis of p-nitrophenyl phosphate by wheat germ acid phosphatase (orthophosphoric monoester phosphohydrolase, EC 3.1.3.2) has been investigated in mixtures of aqueous buffers with acetone, dioxane and acetonitrile. The enzyme was either in free solution or immobilized on a pellicular support which consisted of a porous carbonaceous layer on solid glass beads. The highest enzyme activity was obtained in acetone and acetonitrile mixed with citrate buffer over a wide range of organic solvent concentration. In 50% (v/v) acetone both V and Km of the immobilized enzyme were about half of the values in the neat aqueous buffer, but the Ki for inorganic phosphate was unchanged. In 50% (v/v) mixtures of various solvents and citrate buffers of different pH, the enzymic activity was found to depend on the pH of the aqueous buffer component rather than the pH of the hydro-organic mixture as measured with the glass-calomel electrode. The relatively high rates of p-nitrophenol liberation in the presence of glucose even at high organic solvent concentrations suggest that transphosphorylation is facilitated at low water activity. Wan H H Horvath C C eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 EC 3.1.3.2 Acid Phosphatase IM Acid Phosphatase metabolism Hydrogen-Ion Concentration Kinetics Protein Binding Seeds enzymology Solubility Triticum enzymology 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 68 0005-2744(75)90214-4 10.1016/0005-2744(75)90214-4 Am J Respir Crit Care Med. 2000 Nov;162(5):1807-11 11069817 Radiology. 2003 Dec;229(3):731-6 14576443 Chest. 2004 Mar;125(3):1103-17 15006974 69 1976 02 13 2019 12 10 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Purification and some enzymatic properties of the chitosanase from Bacillus R-4 which lyses Rhizopus cell walls. 145-55 A strain of Bacillus sp (Bacillus R-4) produces a protease and a carbohydrolase both of which have the ability to lyse Rhizopus cell walls. Of the enzymes, the carbohydrolase has been purified to an ultracentrifugally and electrophoretically homogeneous state, and identified as a chitosanase. The enzyme was active on glycol chitosan as well as chitosan. Molecular weight of the purified enzyme was estimated as 31 000 and isoelectric point as pH 8.30. The enzyme was most active at pH 5.6 and at 40 degrees C with either Rhizopus cell wall or glycol chitosan as substrate, and was stable over a range of pH 4.5 to 7.5 at 40 degrees C for 3 h. The activity was lost by sulfhydryl reagents and restored by either reduced glutathione of L-cysteine. An abrupt decrease in viscosity of the reaction mixture suggested an endowise cleavage of chitosan by this enzyme. Tominaga Y Y Tsujisaka Y Y eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Cations, Divalent 0 Citrates 0 Polysaccharides 0 Sulfhydryl Reagents 9G34HU7RV0 Edetic Acid EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.132 chitosanase IM Bacillus enzymology Cations, Divalent Cell Wall ultrastructure Citrates pharmacology Drug Stability Edetic Acid pharmacology Glycoside Hydrolases isolation & purification metabolism Hydrogen-Ion Concentration Kinetics Molecular Weight Polysaccharides metabolism Rhizopus ultrastructure Sulfhydryl Reagents pharmacology Temperature 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 69 0005-2744(75)90215-6 10.1016/0005-2744(75)90215-6 70 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Specificity studies on alpha-mannosidases using oligosaccharides from mannosidosis urine as substrates. 156-63 Oligosaccharides containing terminal non-reducing alpha(1 leads to 2)-, alpha(1 leads to 3)-, and alpha(1 leads to 6)-linked mannose residues, isolated from human and bovine mannosidosis urines were used as substrates to test the specificities of acidic alpha-mannosidases isolated from human and bovine liver. The enzymes released all the alpha-linked mannose residues from each oligosaccharide and were most effective on the smallest substrate. Enzyme A in each case was less active on the oligosaccharides than alpha-mannosidase B2, even though the apparent Km value for the substrates was the same with each enzyme. The human acidic alpha-mannosidases were also found to be more active on substrates isolated from human rather than bovine mannosidosis urine. Human alpha-mannosidase C, which has a neutral pH optimum when assayed with a synthetic substrate, did not hydrolyse any of the oligosaccharides at neutral pH, but was found to be active at an acidic pH. Hultberg B B Lundblad A A Masson P K PK Ockerman P A PA eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Oligosaccharides EC 3.2.1.- Disaccharidases EC 3.2.1.- Mannosidases PHA4727WTP Mannose IM Animals Carbohydrate Metabolism, Inborn Errors urine Cattle Disaccharidases metabolism Humans Hydrogen-Ion Concentration Kinetics Liver enzymology Mannose metabolism Mannosidases isolation & purification metabolism Oligosaccharides urine Species Specificity 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 70 0005-2744(75)90216-8 10.1016/0005-2744(75)90216-8 71 1976 02 13 2020 02 25 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Calcium-stimulated adenosine triphosphatase in the microsomal fraction of tooth germ from porcine fetus. 167-77 The characterization and localization of a Ca(2+)-ATPase (ATP phosphohydrolase, EC 3.6.1.3) in the tooth germ of the porcine fetus are reported. This enzyme, a microsome fraction, is preferentially activated by Ca(2+). In the presence of 0.5 mM ATP, maximal enzyme activity is obtained at 0.5--1.0 mM CaCl2. The maximal rate of ATP hydrolysis is approx. 20 mumol per h per mg of protein as the enzyme preparation is used here. At optimal Ca(2+) concentration, the Mg(2+) has an inhibitory effect. The enzyme does not require Na+ or/and K+ for activation by Ca(2+). Other nucleotide triphosphates may serve as the substrate, but V for ATP is the highest. The Km for ATP is 8.85 - 10(-5) M. The optimal pH for Ca(2+) activation of the enzyme lies around 9.2. Well known inhibitors of (Na+ + K+)-ATPase, mitochondria ATPase and Ca(2+)-ATPase in the erthrocyte do not inhibit the enzyme. In the subcellular order the enzyme may be assumed to be localized in the smooth endoplasmic reticulum fraction containing cell and Golgi body membrane fragments and in the tissue order in the enamel organ containing an ameloblast layer, stratum intermedium and stellate reticulum. Yoshimura F F Suzuki T T eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Cations, Divalent 9G34HU7RV0 Edetic Acid EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium SY7Q814VUP Calcium IM Adenosine Triphosphatases metabolism Animals Calcium pharmacology Cations, Divalent Edetic Acid pharmacology Enzyme Activation drug effects Female Fetus Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Microsomes enzymology Pregnancy Swine Tooth Germ embryology enzymology 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 71 0005-2744(75)90218-1 10.1016/0005-2744(75)90218-1 Lancet. 2006 Jan 21;367(9506):241-51 16427494 Clin Radiol. 2006 Jul;61(7):593-9 16784945 BMC Med. 2006 Oct 06;4:23 17026742 Curr Opin Rheumatol. 2011 Jan;23(1):88-94 21037477 N Engl J Med. 2012 Feb 9;366(6):539-51 22316447 72 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Preparation and characterization of an enzymatically active immobilized derivative of myosin. 178-92 Purified skeletal muscle myosin (EC 3.6.1.3) has been covalently bound to Sepharose 4B by the cyanogen bromide procedure. The resulting complex, Sepharose-Myosin, possesses adenosine triphosphatase activity and is relatively stable for long periods of time. Under optimal binding conditions, approximately 33% of the specific ATPase activity of the bound myosin is retained. Polyacrylamide gel electrophoresis of polypeptides released from denatured Sepharose-Myosin indicates that 85% of the myosin is attached to the agarose beads through the heavy chains and the remainder through the light chains, in agreement with predictions of binding and release based upon either the lysine contents or molecular weights of themyosin subunits. The adenosine triphosphatase of the immobilized myosin has been investigated under conditions of varying pH, ionic strength, and cation concentration. The ATPase profiles of immobilized myosin are quite similar to those for free myosin, however subtle differences are found. The Sepharose-Myosin ATPase is not as sensitive as myosin to alterations in salt concentration and the apparent KM is approximately two-fold higher than that of myosin. These differences are probably due to chemical modification in the region of the attachment site(s) to the agarose beads and hydration and diffusion limitations imposed by the polymeric agarose matrix. Elgart E S ES Gusovsky T T Rosenberg M D MD eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Actins 660YQ98I10 Potassium Chloride 9012-36-6 Sepharose 9G34HU7RV0 Edetic Acid EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins SY7Q814VUP Calcium IM S Actins metabolism Adenosine Triphosphatases metabolism Animals Calcium pharmacology Chickens Chromatography, Affinity Edetic Acid pharmacology Enzyme Activation drug effects Female Hydrogen-Ion Concentration Molecular Weight Muscles enzymology Myosins isolation & purification metabolism Osmolar Concentration Potassium Chloride pharmacology Protein Binding Sepharose 76062498 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 72 0005-2744(75)90219-3 10.1016/0005-2744(75)90219-3 73 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Radioactive labeling and location of specific thiol groups in myosin from fast, slow and cardiac muscles. 193-209 1. Based on incorporation of radioactively labeled N-ethylmaleimide, the readily reactive thiol groups of isolated myosin (EC 3.6.1.3) from fast, slow and cardiac muscles could be classified into 3 types. All 3 myosins contain 2 thiol-1, 2 thiol-2 and a variable number of thiol-3 groups per molecule. Both thiol-1 and thiol-2 groups which are essential for functioning of the K+-stimulated ATPase, are located in the heavy chains in all 3 myosin types. 2. The variation in the incorporation pattern of N-ethylmaleimide over the 3 thiol group classes under steady-state conditions of Mg(2+) - ATP hydrolysis allowed different conformations of some reaction intermediates to be characterized. In all 3 types of myosin the hydrolytic cycle of Mg(2+) - ATP was found to be controlled by the same step at 25 degrees C. In all three cases, this rate-limiting step is changed in the same way by lowereing temperature. 3. Using the chemically determined molecular weights for myosin light chains, their stoichiometry was found on the basis of sodium dodecyl sulfate electrophoresis to be 1.2 : 2.1 : 0.8 for light chain-1: light chain-2:light chain-3 per molecule of fast myosin, 2.0 : 1.9 for light chain-1:light chain-2 per molecule of slow myosin and 1.9 : 1.9 for light chain-1:light chain-2 per molecule of cardiac myosin. This qualitative difference in light subunit composition between the fast and the two types of slow myosin is not reflected in the small variations of the characteristics exhibited by the isolated myosins, but rather seems to be connected with their respective myofibrillar ATPase activities. Pfister M M Schaub M C MC Watterson J G JG Knecht M M Waser P G PG eng SF19107 Biotechnology and Biological Sciences Research Council United Kingdom Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Sulfhydryl Compounds EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins I38ZP9992A Magnesium O3C74ACM9V Ethylmaleimide RWP5GA015D Potassium IM Adenosine Triphosphatases analysis Animals Binding Sites Enzyme Activation drug effects Ethylmaleimide pharmacology Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Molecular Weight Muscle, Smooth enzymology Muscles enzymology Myocardium enzymology Myosins analysis metabolism Potassium pharmacology Protein Binding Protein Conformation Rabbits Sulfhydryl Compounds analysis Swine Temperature 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 73 0005-2744(75)90220-X 10.1016/0005-2744(75)90220-x 74 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Yeast glutathione reductase. Studies of the kinetics and stability of the enzyme as a function of pH and salt concentration. 21-31 1. The pH dependencies of the apparent Michaelis constant for oxidized glutathione and the apparent turnover number of yeast glutathione reductase (EC 1.6.4.2) have been determined at a fixed concentration of 0.1 mM NADPH in the range pH 4.5--8.0. Between pH 5.5 and 7.6, both of these parameters are relatively constant. The principal effect of low pH on the kinetics of the enzyme-catalyzed reaction is the observation of a pH-dependent substrate inhibition by oxidized glutathione at pH less than or equal 7, which is shown to correlate with the binding of oxidized glutathione to the oxidized form of the enzyme. 2. The catalytic activity of yeast glutathione reductase at pH 5.5 is affected by the sodium acetate buffer concentration. The stability of the oxidized and reduced forms of the enzyme at pH 5.5 and 25 degrees C in the absence of bovine serum albumin was studied as a function of sodium acetate concentration. The results show that activation of the catalytic activity of the enzyme at low sodium acetate concentration correlates with an effect of sodium acetate on a reduced form of the enzyme. In contrast, inhibition of the catalytic activity of the enzyme at high sodium acetate concentration correlates with an effect of sodium acetate on the oxidized form of the enzyme. Moroff G G Brandt K G KG eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Acetates EC 1.8.1.7 Glutathione Reductase GAN16C9B8O Glutathione IM Acetates pharmacology Drug Stability Enzyme Activation drug effects Glutathione pharmacology Glutathione Reductase metabolism Hydrogen-Ion Concentration Kinetics Osmolar Concentration Oxidation-Reduction Saccharomyces cerevisiae enzymology Temperature 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 74 0005-2744(75)90204-1 10.1016/0005-2744(75)90204-1 75 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Characteristics of the dephosphorylated form of phosphorylase purified from rat liver and measurement of its activity in crude liver preparations. 45-60 The phosphorylated form of liver glycogen phosphorylase (alpha-1,4-glucan : orthophosphate alpha-glucosyl-transferase, EC 2.4.1.1) (phosphorylase a) is active and easily measured while the dephosphorylated form (phosphorylase b), in contrast to the muscle enzyme, has been reported to be essentially inactive even in the presence of AMP. We have purified both forms of phosphorylase from rat liver and studied the characteristics of each. Phosphorylase b activity can be measured with our assay conditions. The phosphorylase b we obtained was stimulated by high concentrations of sulfate, and was a substrate for muscle phosphorylase kinase whereas phosphorylase a was inhibited by sulfate, and was a substrate for liver phosphorylase phosphatase. Substrate binding to phosphorylase b was poor (KM glycogen = 2.5 mM, glucose-1-P = 250 mM) compared to phosphorylase a (KM glycogen = 1.8 mM, KM glucose-1-P = 0.7 mM). Liver phosphorylase b was active in the absence of AMP. However, AMP lowered the KM for glucose-1-P to 80 mM for purified phosphorylase b and to 60 mM for the enzyme in crude extract (Ka = 0.5 mM). Using appropriate substrate, buffer and AMP concentrations, assay conditions have been developed which allow determination of phosphorylase a and 90% of the phosphorylase b activity in liver extracts. Interconversion of the two forms can be demonstrated in vivo (under acute stimulation) and in vitro with little change in total activity. A decrease in total phosphorylase activity has been observed after prolonged starvation and in diabetes. Tan A W AW Nuttall F Q FQ eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Buffers 0 Salts 415SHH325A Adenosine Monophosphate EC 2.4.1.- Phosphorylases EC 2.7.1.19 Phosphorylase Kinase EC 3.1.3.17 Phosphorylase Phosphatase IM Adenosine Monophosphate pharmacology Adrenal Glands physiology Adrenalectomy Animals Buffers Chickens Diabetes Mellitus metabolism Fasting Hydrogen-Ion Concentration Kinetics Liver metabolism Muscles enzymology Phosphorylase Kinase metabolism Phosphorylase Phosphatase metabolism Phosphorylases isolation & purification metabolism Rabbits Rats Salts 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 75 0005-2744(75)90206-5 10.1016/0005-2744(75)90206-5 76 1976 02 13 2020 02 25 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Multiple forms of casein kinase from rabbit erythrocytes. 87-98 Two rabbit erythrocyte casein kinases, GTP:casein kinase I and GTP:casein kinase II, have been purified 29 000- and 47 000-fold, respectively. Studies employing sucrose density gradient centrifugation indicate that kinase I has a molecular weight of about 9.5 - 10(5) (25 S) and kinase II about 1.4 - 10(6) (32 S). These enzymes can utilize either ATP or GTP as the phosphoryl donor. Among various protein substrates examined, these kinases catalyze the phosphorylation of casein greater than 50% dephosphorylated phosvitin congruent to 50% dephosphorylated casein greater than phosvitin. Histones, protamine and bovine serum albumin are poor phosphoryl acceptors. Kinetic data indicate that both enzymes are inhibited by high casein substrate concentrations which may be partially relieved by NaCl. Both phosphotransferases require Mg(2+) for activity and are optimally active at pH 9.0. The enzymes have apparent Km values of 2.5 - 10(-5) M for GTP, 2 - 10(-5) M for ATP, and 0.4--0.6 mg/ml for casein. The incorporation of the terminal phosphate of GTP into casein as catalyzed by these enzymes is inhibited to varying degrees by ATP, ITP, ADP, and GDP but not by UTP, CTP, GMP, adenosine 3':5'-cyclic monophosphate, and guanosine 3':5'-cyclic monophosphate. In addition, NaF and 2,3-diphosphoglyceric acid are also found to inhibit the activity of both kinases. The effect of 2,3-diphosphoglycerate is interesting and suggests that this metabolite may regulate the activity of the casein kinases in the red blood cells. Kumar R R Tao M M eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Caseins 0 Isoenzymes 0 Ribonucleotides EC 2.7.- Protein Kinases I38ZP9992A Magnesium Q80VPU408O Fluorides IM Animals Caseins Enzyme Activation drug effects Erythrocytes enzymology Fluorides pharmacology Hydrogen-Ion Concentration Isoenzymes blood isolation & purification Kinetics Magnesium pharmacology Protein Kinases blood isolation & purification Rabbits Ribonucleotides pharmacology 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 76 0005-2744(75)90209-0 10.1016/0005-2744(75)90209-0 Genet Test. 1997;1(1):35-9 10464623 Respiration. 2000;67(2):117-33 10773783 Cell. 1992 Feb 21;68(4):809-18 1371239 Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30 19846789 N Engl J Med. 2011 Nov 3;365(18):1663-72 22047557 Thorax. 2013 Nov;68(11):1075-7 23525080 Science. 1989 Sep 8;245(4922):1073-80 2570460 J Pediatr. 1995 Nov;127(5):705-10 7472820 Hum Mutat. 1994;4(3):167-77 7530552 77 1976 02 13 2019 06 09 0006-3002 410 1 1975 Nov 20 Biochimica et biophysica acta Biochim Biophys Acta Kinetic studies and effects of anions on creatine phosphokinase from skeletal muscle of rhesus monkey (Macaca mulatta). 99-114 A purification procedure for creatine kinase (EC 2.7.3.2) from muscle of the monke35--170 muequiv H+/mg protein per min at 30 degrees C and a yield of approx. 0.5 g/kg muscle. Assuming equilibrium kinetics, synergistic binding of substrates at one catalytic site is found for both the forward and back reactions. Kinetic constants for the binding of each substrate to the free enzyme and the enzyme-second substrate complex are determined and are compared with those for the enzyme from other species. Inhibition by small anions is determined in the presence of different combinations of substrates and products. SO4(2-) inhibits by simple competitive inhibition and probably binds at the site of the transferrable phosphoryl group. Inhibition by NO3-, NO2-, SCN- and Cl- is more complex and these ions are suggested to mimic the transferrable phosphoryl group in a planar transition-state complex. These anions stabilize the dead-end complex, enzyme-creatine-MgADP, which lacks the transferable phosphoryl group. The effects of these anions on the dissociation constants of the enzyme-substrate complexes is reported and is in accord with the above hypothesis. The dead-end complex in the absence of anion does not protect the essential thiol group against inhibition by iodoacetamide. Addition of NO3- or Cl- to the dead-end complex or a substrate equilibrium mixture without anion confers protection. The essential thiol group is inhibited by iodoacetamide at a rate which is essentially independent of pH over the normal stability range of the enzyme. Contrary to our previous report this pH independence is not altered by the presence of dead-end complex, creatine plus MgADP, in the presence or absence of anion or in the presence of a substrate equilibrium mixture. It is inferred that the 'essential' thiol group of the monkey enzyme has essentially the same properties as that of the rabbit enzyme. In consequence, the inferences made about the role of this group based on our previous work on the monkey enzyme are no longer valid. The present findings are compatible with the essential thiol group playing a conformational role in the catalytic process. Chegwidden W R WR Watts D C DC eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Acetates 0 Anions 8L70Q75FXE Adenosine Triphosphate EC 2.7.3.2 Creatine Kinase I38ZP9992A Magnesium ZRH8M27S79 Iodoacetamide IM Acetates pharmacology Adenosine Triphosphate pharmacology Animals Anions Creatine Kinase isolation & purification metabolism Enzyme Activation drug effects Haplorhini Hydrogen-Ion Concentration Iodoacetamide pharmacology Kinetics Macaca mulatta Magnesium pharmacology Muscles enzymology Organ Specificity Rabbits Species Specificity 1975 11 20 1975 11 20 0 1 1975 11 20 0 0 ppublish 77 0005-2744(75)90210-7 10.1016/0005-2744(75)90210-7 78 1976 03 01 2019 06 09 0006-3002 411 2 1975 Dec 05 Biochimica et biophysica acta Biochim Biophys Acta Studies on rat renal cortical cell kallikrein. I. Separation and measurement. 305-15 A technique has been developed to separate and measure kallikrein in a heterogeneous population of rat renal cortical cells in suspension. After rat kidneys were perfused in situ in anaesthetized rats, viable, counted cortical cell suspensions were obtained. Cells were suspended in a sucrose/Tris buffer containing 0.5% deoxycholate, homogenized, centrifuged, dialyzed, and gel filtered on Sephadex G-25. Column chromatography on DEAE-cellulose resulted in a single peak of esterase activity between 0.20 to 0.25 M NaCl/sodium phosphate buffer. Subsequent elution yielded an alkaline esterase which was identical to kallikrein isolated from rat urine, insofar as pH optimum, effects of inhibitors, bioassay activity and immunological properties were concerned. Calculated yields were about 70% of the total esterase activity present in the parent cell homogenates. Recoveries of a purified rat urinary kallikrein added to the cell homogenates, the DEAE-cellulose columns, or the eluates from the columns ranged from 83-108% (mean 96%). Using this technique, it was found that the amount of kallikrein activity present in non-incubated renal cortical cells ranged from 0.6-10(-2) to 4.6 - 10(-2) alpha-N-tosyl-L-arginine methyl ester (Tos-Arg-OMe) esterase units per 10(8) cells. However, cells incubated in a nutrient medium at 37 degrees C for 3-8 h contained no measurable kallikrein activity, whereas the surrounding medium had kallikrein activity which could be significantly increased by aldosterone and decreased by spironolactone. Kaizu T T Margolius H S HS eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 27O7W4T232 Spironolactone 4964P6T9RB Aldosterone EC 3.4.21.- Kallikreins IM Aldosterone pharmacology Animals Biological Assay Hydrogen-Ion Concentration Immunodiffusion Kallikreins immunology isolation & purification metabolism Kidney enzymology Kidney Cortex enzymology Kinetics Male Organ Specificity Rats Spironolactone pharmacology 1975 12 5 1975 12 5 0 1 1975 12 5 0 0 ppublish 78 0304-4165(75)90310-4 10.1016/0304-4165(75)90310-4 79 1976 02 20 2020 02 25 0006-3002 412 1 1975 Nov 18 Biochimica et biophysica acta Biochim Biophys Acta Studies on electron transfer between mercury electrode and hemoprotein. 157-67 The electrochemical behaviour of ferricytochrome c, metmyoglobin and methemoglobin was studied using d.c., a.c. and differential pulse polarography, and controlled potential electrolysis. 1. The three hemoproteins yield d.c. polarographic steps, and peaks in differential pulse polarograms, the height of which is proportional to concentration. The charge transfer is influenced by strong adsorption. 2. The concentration dependence of the a.c. polarograms indicates structural changes in the adsorbed molecules. 3. The reduction products of controlled potential electrolysis of metmyoglobin and methemoglobin have absorption spectra identical with the native control samples. The affinity for oxygen and the cooperativity in hemoglobin are not affected by the reaction at the electrode. 4. The charge transfer proceeds via adsorbed, already reduced, molecules to freely diffusible proteins. Scheller F F Jänchen M M Lampe J J Prümke H J HJ Blanck J J Palecek E E eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Cytochrome c Group 0 Myoglobin 9008-37-1 Methemoglobin FXS1BY2PGL Mercury S88TT14065 Oxygen IM Binding Sites Cytochrome c Group Electrodes Electron Transport Hydrogen-Ion Concentration Mercury Methemoglobin Myoglobin Oxygen blood Polarography Potentiometry Protein Binding Spectrophotometry 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 79 0005-2795(75)90348-7 10.1016/0005-2795(75)90348-7 Thorax. 2000 Dec;55(12):1000-6 11083884 Thorax. 2002 Nov;57(11):939-44 12403875 Palliat Med. 2005 Mar;19(2):128-30 15810751 J R Soc Med. 2006;99 Suppl 46:27-9 16927954 Am J Respir Crit Care Med. 2007 Feb 15;175(4):312-5 17122382 Am J Respir Crit Care Med. 2008 Apr 15;177(8):912-27 18390964 Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005623 18425927 Chron Respir Dis. 2009;6(1):13-7 19176708 Palliat Med. 2009 Apr;23(3):213-27 19251835 Palliat Med. 2009 Sep;23(6):512-7 19460834 Lancet. 2010 Sep 4;376(9743):784-93 20816546 N Engl J Med. 2010 Aug 19;363(8):733-42 20818875 Palliat Med. 2012 Sep;26(6):780-7 21993808 Thorax. 2013 Sep;68(9):867-79 23204065 BMJ. 2013 Apr 17;346:f2174 23596214 Palliat Med. 2013 Oct;27(9):811-6 23838376 Am Rev Respir Dis. 1987 Jul;136(1):58-61 3605841 80 1976 02 20 2019 06 09 0006-3002 412 1 1975 Nov 18 Biochimica et biophysica acta Biochim Biophys Acta The binding of organic phosphates to human methaemoglobin A. Perturbation of the polymerization of proteins by effectors. 168-80 Theory is presented relating to the binding of an effector to two states of a protein acceptor coexisting in equilibrium. The problem is treated in terms of the four possible cases which specify relations between numbers of binding sites and intrinsic binding constants relevant to the acceptor states. It is shown that a distinction between these cases may be possible on the basis of the form of a plot of unbound effector concentration versus the constituent equilibrium coefficient which may be calculated from the sedimentation coefficient of the protein constituent. Particularly noteworthy in this respect is the finding that a turning point may exist in this plot for defined conditions with systems in which binding sites are not conserved (and binding affinities are altered) on polymer formation. The latter type of system is exemplified by studies on methaemoglobin A in 0.25 M sodium acetate, pH 5.4. In the absence of added organic phosphate effectors, a dimer-tetramer equilibrium operates governed by an association constant of 4.15 +/- 0.06 X 10(3) 1/mol, determined from sedimentation equilibrium results. Correlation of sedimentation velocity and equilibrium results shows that addition of adenosine 5'-triphosphate (ATP) results in its binding to one site on each of the dimeric (alpha beta) and tetrameric (alpha beta)2 species with intrinsic binding constants 1.03-10(3)-1.20-10(3) and 1.1-10(4)-2.1-10(4) 1/mol, respectively. It is also shown that 2,3-diphosphoglycerate perturbs the dimer-tetramer equilibrium in a similar way to ATP. Baghurst P A PA Nichol L W LW eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Diphosphoglyceric Acids 0 Macromolecular Substances 8L70Q75FXE Adenosine Triphosphate 9008-37-1 Methemoglobin IM Adenosine Triphosphate blood Binding Sites Diphosphoglyceric Acids blood Humans Hydrogen-Ion Concentration Kinetics Macromolecular Substances Mathematics Methemoglobin Protein Binding Protein Conformation 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 80 0005-2795(75)90349-9 10.1016/0005-2795(75)90349-9 81 1976 02 20 2019 06 09 0006-3002 412 1 1975 Nov 18 Biochimica et biophysica acta Biochim Biophys Acta N-terminal spin label studies of hemoglobin, Ligand and pH dependence. 187-93 Human hemoglobin was spin labeled with 4-isothiocanato-2,2,6,6-tetramethyl-piperdinooxyl, which is known to bind specifically to the N-terminal alpha-amino groups of proteins and slightly to the reactive sulfhydryl groups. Electron spin resonance (ESR) analysis indicated a partially resolved five-line spectrum, suggesting that the label was attached to at least two different binding sites. Using specific blocking reagents prior to spin labeling, the two binding sites were attributed to the sulfhydryl group of beta-93 (immobile) and the alpha-amino group of the N-terminal valines (mobile). The relative motion of the spin at one set of binding sites was restricted regardless of the state of ligation and pH, while the motion at the other site showed dependence on those parameters, e.g. the spin-labeled N-terminal ends of deoxyhemoglobin have restricted motion at all pH ranges studied, while those of oxyhemoglobin are relatively free to move at the basic pH range, but become more restricted in the acidic pH range. Giangrande M M Kim Y W YW Mizukami H H eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Hemoglobins 0 Ligands 0 Oxyhemoglobins 0 Spin Labels IM Electron Spin Resonance Spectroscopy Hemoglobins Humans Hydrogen-Ion Concentration Ligands Male Oxyhemoglobins Protein Conformation Spectrophotometry Spin Labels 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 81 0005-2795(75)90351-7 10.1016/0005-2795(75)90351-7 82 1976 02 20 2019 06 09 0006-3002 412 1 1975 Nov 18 Biochimica et biophysica acta Biochim Biophys Acta The behavior of holo- and apo-forms of bovine superoxide dismutase at low pH. 26-38 1. Holo-superoxide dismutase from bovine erythrocytes has been shown to undergo a reversible structural modification in the pH 3-5 range. 2. The spectral alterations observed on changing from neutrality to pH 2 were: a slight attenuation of the 680 nm absorbance; the loss of the 450 nm shoulder, apparent in the optical spectrum of the native protein; and a new band appeared at 330 nm. The circular dichroism at 600 nm was essentially lost while a weak negative band appeared at approx. 380 nm and a positive band at 310 nm. 3. The EPR spectrum was also modified on changing from the native to the low pH form: A parallel increased from approximately 130 to approximately 150 G, g parallel remained unchanged at approximately 2.27, and gm decreased from approximately 2.09 to approximately 2.08. The apparent linewidth remained essentially constant. 4. High resolution (220 MHz) PMR spectra of holo- and apoproteins revealed that the metals influence the three-dimensional structure of the protein. 5. PMR studies indicated that at pH 3 the apoprotein existed almost entirely in a random coil form and that it assumed a compact well-ordered structure on returning to neutral pH. The holoprotein maintained a compact, apparently dimeric, structure even at pH 3. Fee J A JA Phillips W D WD eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Apoenzymes 0 Apoproteins EC 1.15.1.1 Superoxide Dismutase IM Animals Apoenzymes blood Apoproteins Binding Sites Cattle Circular Dichroism Electron Spin Resonance Spectroscopy Erythrocytes enzymology Hydrogen-Ion Concentration Magnetic Resonance Spectroscopy Protein Binding Protein Conformation Spectrophotometry Spectrophotometry, Ultraviolet Superoxide Dismutase blood 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 82 0005-2795(75)90336-0 10.1016/0005-2795(75)90336-0 83 1976 02 09 2019 06 09 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta Mechanical precipitation of hemoglobin köln. 197-201 Hb Köln (beta 98 Val leads to Met) was found to precipitate rapidly during mechanical shaking. The rate of precipitation of Hb Köln is 5-6 times faster than that of Hb S. The kinetics of precipitation of the patient's hemolysate, which is a mixture of Hb Köln and Hb A, showed a biphasic curve indicating that Hb Köln precipitates independently from Hb A. The instability of Hb Köln may be attributed to the conformational change in the vicinity of heme. The mechanical shaking may be used as a new method for detection and quantitation of hemoglobin Köln and other unstable hemoglobins. Asakura T T Adachi K K Shapiro M M Friedman S S Schwartz E E eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Hemoglobin, Sickle 0 Hemoglobins, Abnormal AE28F7PNPL Methionine HG18B9YRS7 Valine IM Chemical Precipitation Germany, West Hemoglobin, Sickle isolation & purification Hemoglobins, Abnormal isolation & purification Humans Hydrogen-Ion Concentration Methionine Osmolar Concentration Temperature Valine 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 83 0005-2795(75)90034-3 10.1016/0005-2795(75)90034-3 84 1976 02 09 2019 06 09 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta Physical properties and subunits of Haemopis grandis erythrocruorin. 202-13 The erythrocruorin of the leech Haemopis grandis possessed an S20,w of 57 S at neutral pH, its isoelectric point at pH 6.0 and exhibited a slightly sigmoid oxygenation curve with n approximately 2.1 and P50 = 11.2 mm at pH 7.4. A minimum molecular weight of 24000 +/- 1500 per heme group was determined from the iron and heme contents, 0.22 +/- 0.01 and 2.73 +/- 0.14 weight %, respectively. The subunit composition of the erythrocruorin was investigated using gel filtration in sodium dodecyl sulfate and polyacrylamide gel electrophoresis in sodium dodecyl sulfate at neutral pH. Haemopis erythrocruorin dissociated in the presence of sodium dodecyl sulfate into four subunits (1 through 4) possessing molecular weights of about 27000, 23000, 21000 and 13500, respectively. When the erythrocruorin was reduced with mercaptoethanol prior to sodium dodecyl sulfate electrophoresis, three subunits were observed, possessing molecular weights of about 13000 (I), 16500 (II) and 28000 (III). Sodium dodecyl sulfate electrophoresis of the isolated subunits 1 through 4 showed that subunit I was provided by subunits 1 and 4, subunit II was provided by subunit 1 and subunit III was provided by both subunit 2 and subunit 3. Haemopis erythrocruorin thus appeared to consist of at least five different polypeptide chains. It is likely that not all of the constituent polypeptide chains were associated each with a heme group. The shape of the Haemopis erythrocruorin observed by electron microscopy appeared to be consistent with the two-tiered hexagonal array characteristic of annelid erythrocruorins and chlorocruorins. Andonian M R MR Barrett A S AS Vinogradov S N SN eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Hemeproteins 0 Macromolecular Substances 368GB5141J Sodium Dodecyl Sulfate 42VZT0U6YR Heme 60-24-2 Mercaptoethanol E1UOL152H7 Iron S88TT14065 Oxygen IM Heme analysis Hemeproteins analysis Hydrogen-Ion Concentration Iron analysis Leeches analysis Macromolecular Substances Mercaptoethanol Molecular Weight Oxygen Protein Conformation Sodium Dodecyl Sulfate 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 84 0005-2795(75)90035-5 10.1016/0005-2795(75)90035-5 85 1976 02 09 2019 06 09 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta Myosin from arterial smooth muscle: isolation following actin depolymerization. 241-55 The contractile proteins from arterial smooth muscle are highly soluble, and can be extracted at I = 0.05. However, they can be precipitated by a prolonged dialysis at pH 6 to give an actomyosin with a high, although variable, actin:myosin ratio. The sedimentation behavior of this actomyosin at high ionic strength was examined as a function of pH, protein concentration and composition by preparative ultracentrifugation. Comparisons with synthetic skeletal muscle actomyosins of similar composition demonstrated significant differences in the behaviors of these two systems. It was found that much smooth muscle actomyosin is not dissociated by normally relaxing conditions, and that it sediments at a slower rate than F-actin. The solubility of the supernatant protein (a myosin-enriched actomyosin) in 0.2 M K Cl (pH 7) depended on the pH during centrifugation. A lower solubility was associated only with a higher actin concentration in the supernatant, suggesting a dependence on actin repolymerization. Pure myosin was selectively precipitated from the supernatant by polyethylene glycol-6000, but only when the protein was soluble at low ionic strength. The solubility of purified myosin was similar to that of myosin from striated muscles. A relationship between the presence of depolymerized actin and the high solubility of smooth muscle contractile proteins is suggested. Megerman J J Murphy R A RA eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Actins 3WJQ0SDW1A Polyethylene Glycols 660YQ98I10 Potassium Chloride 8L70Q75FXE Adenosine Triphosphate 9013-26-7 Actomyosin EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins IM Actins isolation & purification Actomyosin isolation & purification Adenosine Triphosphatases analysis Adenosine Triphosphate Animals Carotid Arteries Cats Chemical Precipitation Dialysis Dogs Hydrogen-Ion Concentration Molecular Weight Muscle, Smooth analysis Myosins isolation & purification Osmolar Concentration Polyethylene Glycols Potassium Chloride Solubility Swine 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 85 0005-2795(75)90038-0 10.1016/0005-2795(75)90038-0 86 1976 02 09 2020 02 25 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta Hybrids of chemical derivatives of Escherichia coli alkaline phosphatase. 262-72 The activities of hybrid dimers of alkaline phosphatase containing two chemically modified subunits have been investigated. One hybrid species was prepared by dissociation and reconstitution of a mixture of two variants produced by chemical modification of the native enzyme with succinic anhydride and tetranitromethane, respectively. The succinyl-nitrotyrosyl hybrid was separated from the other members of the hybrid set by DEAE-Sephadex chromatography and then converted to a succinyl-aminotyrosyl hybrid by reduction of the modified tyrosine residues with sodium dithionite. A comparison of the activities of these two hybrids with the activities of the succinyl, nitrotyrosyl and aminotyrosyl derivatives has shown that either the subunits of alkaline phosphatase function independently or if the subunits turnover alternately in a reciprocating mechanism, then the intrinsic activity of each subunit must be strongly dependent on its partner subunit. Meighen E E Yue R R eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Anhydrides 0 Macromolecular Substances 0 Succinates 14844-07-6 Dithionite EC 3.1.3.1 Alkaline Phosphatase K1G7CKU98F Tetranitromethane IM Alkaline Phosphatase Anhydrides Dithionite Escherichia coli enzymology Hydrogen-Ion Concentration Kinetics Macromolecular Substances Protein Conformation Structure-Activity Relationship Succinates Tetranitromethane 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 86 0005-2795(75)90040-9 10.1016/0005-2795(75)90040-9 Clin Pharmacokinet. 2003;42(4):327-60 12648025 Gut. 2004 Nov;53(11):1566-70 15479672 Mayo Clin Proc. 2009;84(1):76-8 19121257 World J Gastroenterol. 2009 Mar 14;15(10):1264-6 19291829 Dig Dis Sci. 2010 Nov;55(11):3113-9 20130993 Can J Gastroenterol. 2010 May;24(5):284-5 20485701 J Am Board Fam Med. 2010 Nov-Dec;23(6):790-3 21057076 Curr Drug Abuse Rev. 2011 Dec;4(4):241-9 22150623 Mayo Clin Proc. 2012 Feb;87(2):114-9 22305024 Case Rep Med. 2012;2012:757696 22685471 BMJ Case Rep. 2010 Sep 07;2010:null 22778182 Biol Pharm Bull. 1995 Aug;18(8):1138-41 8535411 87 1976 02 09 2020 02 25 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2). 283-7 Hb-Manitoba was discovered in 1970 [1] in a Canadian family of British origin. Recently we observed the same variant in a second family, and found that the oxy-derivative of Hb-Manitoba is slightly unstable at 65 degrees C, dissociates less readily at alkaline pH than does Hb-A, and forms asymmetric hybrids with other hemoglobins which are readily detectable by electrophoresis. Wrightstone R N RN Smith L L LL Wilson J B JB Vella F F Huisman T H TH eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Hemoglobins, Abnormal 0 Oxyhemoglobins 452VLY9402 Serine 94ZLA3W45F Arginine IM Adult Arginine Electrophoresis, Starch Gel Female Genetic Variation Hemoglobins, Abnormal Humans Hydrogen-Ion Concentration Male Manitoba Oxyhemoglobins analysis Serine Temperature 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 87 0005-2795(75)90042-2 10.1016/0005-2795(75)90042-2 Nat Rev Genet. 2001 May;2(5):342-52 11331900 Neuromuscul Disord. 2004 Apr;14(4):237-45 15019701 Eye (Lond). 2005 Mar;19(3):258-63 15272295 Biochim Biophys Acta. 2004 Dec 6;1659(2-3):115-20 15576042 Nat Rev Genet. 2005 May;6(5):389-402 15861210 Mitochondrion. 2002 Nov;2(1-2):149-55 16120317 Ann N Y Acad Sci. 2008 Oct;1142:133-58 18990125 Clin Med (Lond). 2008 Dec;8(6):601-6 19149282 Biochim Biophys Acta. 2009 Dec;1792(12):1097-102 19303927 Prog Retin Eye Res. 2011 Mar;30(2):81-114 21112411 Postgrad Med J. 2012 Jun;88(1040):326-34 22328278 Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004426 22513923 Brain. 1986 Oct;109 ( Pt 5):915-38 3779373 88 1976 02 09 2020 02 25 0006-3002 412 2 1975 Dec 15 Biochimica et biophysica acta Biochim Biophys Acta The oxygen affinity of haemoglobin Tak, a variant with an elongated beta chain. 288-94 The oxygen affinity was investigated of purified Hb Tak, a human haemoglobin variant with elongated beta-chains. A very low P50 value was found which was not influenced by the addition of 2,3 diphosphoglycerate. The n value was 1, indicating non-cooperativity. The oxygen equilibrium curve of the whole blood haemolysate containing Hbs A and Tak was close to that of Hb A at the top of the curve, while the bottom of the curve greatly deviated from the latter, indicative of small if any interaction between Hb A and Tak during oxygenation. Imai K K Lehmann H H eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Diphosphoglyceric Acids 0 Hemoglobins, Abnormal 0 Peptide Fragments 7IGF0S7R8I Phytic Acid S88TT14065 Oxygen IM Diphosphoglyceric Acids Genetic Variation Hemoglobins, Abnormal analysis Humans Hydrogen-Ion Concentration Oxygen Peptide Fragments analysis Phytic Acid Protein Binding 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 88 0005-2795(75)90043-4 10.1016/0005-2795(75)90043-4 Eur Heart J. 2004 Apr;25(7):587-610 15120056 Tex Heart Inst J. 2004;31(4):398-403 15745292 Tex Heart Inst J. 2006;33(4):519-22 17215986 Cathet Cardiovasc Diagn. 1991 Dec;24(4):286-7 1756567 Interact Cardiovasc Thorac Surg. 2003 Dec;2(4):626-8 17670141 J Thorac Cardiovasc Surg. 1991 Sep;102(3):413-7 1881180 Intern Med. 2009;48(12):1073-8 19525602 World J Cardiol. 2011 May 26;3(5):135-43 21666814 Postgrad Med J. 1989 Jul;65(765):444-8 2690043 Am J Med. 1981 Feb;70(2):247-51 7468612 JAMA. 1994 Jul 6;272(1):59-64 8007081 Cathet Cardiovasc Diagn. 1993 Aug;29(4):322-4 8221857 J Am Coll Cardiol. 1993 Nov 15;22(6):1661-5 8227835 J Accid Emerg Med. 1997 Jul;14(4):261-3 9248921 89 1976 02 20 2019 06 09 0006-3002 413 1 1975 Nov 17 Biochimica et biophysica acta Biochim Biophys Acta Effects of membrane ribonuclease and 3'-nucleotidase on the digestion of polyuridylic acid by rat liver plasma membrane. 135-42 1. Fragments of isolated rat liver plasma membrane possess a ribonuclease activity which at pH 7.8 in the presence of 10 mM EDTA can digest polyuridylic acid (poly(U)) and polycytidylic acid (poly(C)) but not polyadenylic acid (poly(A)) and polyguanylic acid (poly(G)). Under these conditions, the membrane preparation does not degrade native or denatured DNA. 2. The products of the reaction with poly(U) (10 mM EDTA present) can be separated on DEAE-Sephadex into oligonucleotides of increasing chain length. Most of the products are di- to hexa-nucleotides which contain terminal 3'-phosphate groups. 3. When EDTA is not present (pH 7.8 or 8.8) the plasma membrane preparation degrades both poly(A) and poly(U). With poly(A) the product is all nucleoside while with poly(U) as substrate most of the product is nucleoside, but also some oligonucleotides are produced. 4. The ribonuclease releases acid soluble products very slowly from high concentrations of poly(U) (mg/ml). 5. Uridine trinucleotide with and without a terminal 3'-phosphate group is degraded by rat liver plasma membrane. The trinucleotide diphosphate is rapidly hydrolyzed to nucleoside while the trinucleotide itself is slowly digested and yields intermediate products, including nucleoside. Aronson N N NN Jr Yannarell A A eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Oligoribonucleotides 0 Phosphates 24937-83-5 Poly A 25191-14-4 Poly G 27416-86-0 Poly U 30811-80-4 Poly C 9007-49-2 DNA 9G34HU7RV0 Edetic Acid EC 3.1.- Ribonucleases EC 3.1.3.- Nucleotidases IM Animals Cell Membrane enzymology DNA metabolism Edetic Acid pharmacology Hydrogen-Ion Concentration Nucleotidases metabolism Oligoribonucleotides analysis Phosphates Poly A metabolism Poly C metabolism Poly G metabolism Poly U metabolism Rats Ribonucleases metabolism Structure-Activity Relationship 1975 11 17 2001 3 28 10 1 1975 11 17 0 0 ppublish 89 0005-2736(75)90064-4 10.1016/0005-2736(75)90064-4 90 1976 02 20 2019 06 09 0006-3002 413 1 1975 Nov 17 Biochimica et biophysica acta Biochim Biophys Acta Alterations in phospholipid-dependent (Na+ +K+)-ATPase activity due to lipid fluidity. Effects of cholesterol and Mg2+. 143-56 The (Na+ +K+)-activated, Mg2+-dependent ATPase from rabbit kidney outer medulla was prepared in a partially inactivated, soluble form depleted of endogenous phospholipids, using deoxycholate. This preparation was reactivated 10 to 50-fold by sonicated liposomes of phosphatidylserine, but not by non-sonicated phosphatidylserine liposomes or sonicated phosphatidylcholine liposomes. The reconstituted enzyme resembled native membrane preparations of (Na+ +K+)-ATPase in its pH optimum being around 7.0, showing optimal activity at Mg2+:ATP mol ratios of approximately 1 and a Km value for ATP of 0.4 mM. Arrhenius plots of this reactivated activity at a constant pH of 7.0 and an Mg2+: ATP mol ratio of 1:1 showed a discontinuity (sharp change of slope) at 17 degrees C, with activation energy (Ea) values of 13-15 kcal/mol above this temperature and 30-35 kcal below it. A further discontinuity was also found at 8.0 degrees C and the Ea below this was very high (greater than 100 kcal/mol). Increased Mg2+ concentrations at Mg2+:ATP ratios in excess of 1:1 inhibited the (Na+ +K+)-ATPase activity and also abolished the discontinuities in the Arrhenius plots. The addition of cholesterol to phosphatidylserine at a 1:1 mol ratio partially inhibited (Na+ +K+)-ATPase reactivation. Arrhenius plots under these conditions showed a single discontinuity at 20 degrees C and Ea values of 22 and 68 kcal/mol above and below this temperature respectively. The ouabain-insensitive Mg2+-ATPase normally showed a linear Arrhenius plot with an Ea of 8 kcal/mol. The cholesterol-phosphatidylserine mixed liposomes stimulated the Mg2+-ATPase activity, which now also showed a discontinuity at 20 degrees C with, however, an increased value of 14 kcal/mol above this temperature and 6 kcal/mol below. Kinetic studies showed that cholesterol had no significant effect on the Km values for ATP. Since both cholesterol and Mg2+ are known to alter the effects of temperature on the fluidity of phospholipids, the above results are discussed in this context. Kimelberg H K HK eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Liposomes 0 Phosphatidylethanolamines 0 Phosphatidylserines 8L70Q75FXE Adenosine Triphosphate 97C5T2UQ7J Cholesterol 9NEZ333N27 Sodium EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium RWP5GA015D Potassium IM Adenosine Triphosphatases metabolism Adenosine Triphosphate pharmacology Animals Cholesterol pharmacology Hydrogen-Ion Concentration Kidney Medulla enzymology Kinetics Liposomes metabolism Magnesium pharmacology Microsomes enzymology Phosphatidylethanolamines pharmacology Phosphatidylserines pharmacology Potassium pharmacology Rabbits Sodium pharmacology Sonication Temperature Thermodynamics 1975 11 17 1975 11 17 0 1 1975 11 17 0 0 ppublish 90 0005-2736(75)90065-6 10.1016/0005-2736(75)90065-6 91 1976 02 26 2019 06 09 0006-3002 413 3 1975 Dec 16 Biochimica et biophysica acta Biochim Biophys Acta Conformational and molecular responses to pH variation of the purified membrane adenosine triphosphatase of Micrococcus lysodeikticus. 394-414 A preparation of ATPase from the membranes of Micrococcus lysodeikticus, solubilized and more than 95% pure, showed two main bands in analytical polyacrylamide gel electrophoresis. They did not correspond to isoenzymes because one band could be converted into the other by exposure to a mildly alkaline pH value. The conversion was paralleled by changes in molecular weight, circular dichroism and catalytic properties. Denaturation by pH at 25 degrees C was followed by means of circular dichroism, ultracentrifugation and polyacrylamide gel electrophoresis. A large conformational transition took place in the acid range with midpoints at about pH = 3.6 (I = 10(-4) M), 4.3 (I = 0.03 M) and 5.3 (I = 0.1 M). The transition was irreversible. Strong aggregation of the protein occurred in this range of pH. The final product was largely random coil, but even at pH 1.5 dissociation into individual subunits was not complete. However, partial dissociation took place at pH 5 (I = 0.028 M). At this pH value the enzyme was inactive, but 20-30% of the activity could be recovered when the pH was returned to 7.5. In the alkaline region the midpoint of the transition occurred near pH = 11 (I = 0.028 M). The pK of most of the tyrosine residues of the protein was about 10.9. The unfolding was irreversible and the protein was soon converted into peptide species with molecular weights lower than those determined for the subunits by gel electrophoresis in the presence of sodium dodecyl sulphate. Conventional proteolysis did not account for the transformation. Nieto M M Muñoz E E Carreira J J Andreu J M JM eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 42HK56048U Tyrosine 8DUH1N11BX Tryptophan EC 3.6.1.- Adenosine Triphosphatases IM Adenosine Triphosphatases metabolism Cell Membrane enzymology ultrastructure Circular Dichroism Hydrogen-Ion Concentration Kinetics Micrococcus enzymology ultrastructure Microscopy, Electron Molecular Weight Osmolar Concentration Protein Conformation Spectrophotometry, Ultraviolet Tryptophan analysis Tyrosine analysis 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 91 0005-2736(75)90123-6 10.1016/0005-2736(75)90123-6 92 1976 02 26 2019 06 09 0006-3002 413 3 1975 Dec 16 Biochimica et biophysica acta Biochim Biophys Acta Membrane-bound enzymes. III. Protease activity in leucocytes in relation to erythrocyte membranes. 472-82 Protease activity was detected in membranes of human bovine erythrocytes prepared by the conventional procedures which include washing and removal of the "buffy layer". The enzyme was extracted by 0.75 M KCNS or (NH4)2SO4 and was activated by 0.4 to 0.5 M of the same salts. Colored, particulate hide powder-azure, membrane fractions and soluble proteins such as hemoglobin, casein or albumin were susceptible to hydrolysis by the membraneous protease. Partial purification of the enzyme was accomplished through disc-gel electrophoresis on polyacrylamide in the presence of 0.25% positively charged detergents like cetyltrimethylammonium bromide. An alkaline protease (pH 7.4) with properties similar to those of the erythrocyte enzyme was found in leucocytes. The similarity between the properties of the leucocytic and erythrocytic proteases and the correlation of the activity in erythrocyte membranes with content of white cells in these preparations, suggest that enzymatic activities in the contaminating leucocytes are responsible for the activity of membraneous proteases in erythrocytes. Heller M M Edelstein P P Mayer M M eng Journal Article Netherlands Biochim Biophys Acta 0217513 0006-3002 0 Thiocyanates 3WJQ0SDW1A Polyethylene Glycols EC 3.4.- Peptide Hydrolases IM Animals Cattle Cell Membrane enzymology Erythrocytes enzymology Humans Hydrogen-Ion Concentration Kinetics Leukocytes enzymology Peptide Hydrolases blood isolation & purification Polyethylene Glycols Thiocyanates 1975 12 16 1975 12 16 0 1 1975 12 16 0 0 ppublish 92 0005-2736(75)90130-3 10.1016/0005-2736(75)90130-3 93 1976 03 01 2013 11 21 0006-3029 20 4 1975 Jul-Aug Biofizika Biofizika [Structure formation in interphase adsorption layers of lysozyme at liquid boundaries]. 566-9 In connection with the modelling of biomembranes regularities of the formation and development of interphase adsorption layers of lysozyme at liquid borders under different conditions and depending on the nature of carbohydrate phase were investigated by the determination of mechanical characteristics of such layers. The investigations carried out showed that the most solid layers appeared under the conditions which assured the formation of the maximum number of intermolecular bonds (which in a common case is performed with maximum disorderlinesss of the macromolecules which get at the interphase). Alekseeva I G IG Lapina G P GP Tulovskaia Z D ZD Izmailova V N VN rus English Abstract Journal Article Strukturoobrazovanie v mezhfaznykh adsorbtsionnykh sloiakh lizotsima na zhidkikh granitsakh Russia (Federation) Biofizika 0372666 0006-3029 0 Alkanes 0 Membranes, Artificial 059QF0KO0R Water EC 3.2.1.17 Muramidase J64922108F Benzene IM Adsorption Alkanes Benzene Hydrogen-Ion Concentration Membranes, Artificial Muramidase Temperature Water 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 93 96 1976 02 09 2019 08 27 0301-4622 3 4 1975 Oct Biophysical chemistry Biophys Chem Polymer concentration dependence of the helix to random coil transition of a charged polypeptide in aqueous salt solution. 323-9 The helix to coil transition of poly(L-glutamic acid) was investigated in 0.05 and 0.005 M aqueous potassium chloride solutions by use of potentiometric titration and circular dichroism measurement. Polymer concentration dependence of the transition was observed in the range from 0.006 to 0.04 monomol/e in 0.005 M KG1 solution. The polymer concentration dependence can be interpreted by current theories of the transition of charged polypeptides and of titration curves of linear weak polyelectrolytes taking the effect of polymer concentration into consideration. Nitta K K Yoneyama M M eng Journal Article Netherlands Biophys Chem 0403171 0301-4622 0 Glutamates 0 Peptides 0 Solutions 660YQ98I10 Potassium Chloride IM Glutamates Hydrogen-Ion Concentration Mathematics Osmolar Concentration Peptides Potassium Chloride Potentiometry Protein Conformation Solutions Thermodynamics 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 96 0301-4622(75)80025-1 10.1016/0301-4622(75)80025-1 94 1976 03 01 2016 12 03 0006-3029 20 4 1975 Jul-Aug Biofizika Biofizika [Relation between fluorescence and circular dichroism of the complex of the fluorescence probe 4-dimethylaminochalcone with serum albumin]. 581-5 The fluorescence probe(4-dimethylaminochalcone; DMH) was noncovalently linked to human serum albumin (HSA). The variation of pH was due to serum albumin structural changes, which was determined in terms of DMH and HSA fluorescence and CD spectra. Considerable changes of fluorescence and CD spectra were observed at pH 8 and 10, where there is ionization of two more recently titrated tyrosin residues. It is assumed that these two tyrosine residues are in binding region and quench the fluorescence of DMH between pH 4 to 8. Quenching disappears if these residues are ionized (pH greater than 8) or if the protein undergoes the N -F transition (pH less than 4). Dobretsov G E GE Kharitonenkov I G IG Mishiev V E VE Vladimirov Iu A IuA rus English Abstract Journal Article Sviaz' mezhdu fluorestsentsiei i krugovym dikhroizmom kompleksa fluorestsentnogo zonda 4-dimetilaminokhalkona s syvorotochnym al'buminom Russia (Federation) Biofizika 0372666 0006-3029 0 Propiophenones 0 Serum Albumin 5S5A2Q39HX Chalcone IM Chalcone analogs & derivatives Circular Dichroism Humans Hydrogen-Ion Concentration Propiophenones Serum Albumin Spectrometry, Fluorescence 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 94 97 1976 02 13 2017 03 22 0572-6565 5 1975 Biotechnology and bioengineering symposium Biotechnol Bioeng Symp Hydrogen peroxide and iron: a microbial cellulolytic system? 151-9 Koenigs J W JW eng Journal Article United States Biotechnol Bioeng Symp 1302775 0572-6565 9004-34-6 Cellulose BBX060AN9V Hydrogen Peroxide E1UOL152H7 Iron EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.4 Cellulase IM Cellulase metabolism Cellulose metabolism Glycoside Hydrolases metabolism Hydrogen Peroxide pharmacology Hydrogen-Ion Concentration Iron pharmacology Kinetics Mitosporic Fungi enzymology Structure-Activity Relationship Trichoderma drug effects enzymology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 97 95 1976 03 01 2020 02 25 0006-3029 20 4 1975 Jul-Aug Biofizika Biofizika [Luminescence study of the effect of temperature on the conformational state of fibrinogen]. 586-90 Results are presented of measuring fibrinogen fluorescence parameters in temperature range of 20-80 degrees C at different pH of the solution. It was found that the temperature increase from 20 to 40 degrees C for solutions with pH of 4,5-9,3 were not accompanied by the conformational changes of fibrinogen macromolecules. In the temperature range of 40-50 degrees C for neutral solutions conformational reconstruction of fibrinogen of undenatured character took place. Temperature increase above 50-55 degrees C brings about significant structural changes of fibrinogen molecule which are of denaturation nature. Konev S V SV Katibnikov M A MA Bandarin V A VA Niamaa D D Barkovskii E V EV rus English Abstract Journal Article Liuminestsentnoe issledovanie vliianiia temperatury na konformatsionnoe sostoianie fibrinogena Russia (Federation) Biofizika 0372666 0006-3029 9001-32-5 Fibrinogen IM Hepatology. 2011 May;53(5):1776; author reply 1777 21351112 Fibrinogen Hydrogen-Ion Concentration Molecular Conformation Spectrometry, Fluorescence Temperature 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 95 Ann Rheum Dis. 2012 Jan;71(1):4-12 21953336 Arthritis Rheum. 2013 May;65(5):1213-23 23460467 Rheumatology (Oxford). 2013 Oct;52(10):1754-7 23887065 Arthritis Res Ther. 2013 Jul 26;15(4):R79 23890223 98 1976 02 13 2019 02 06 0572-6565 5 1975 Biotechnology and bioengineering symposium Biotechnol Bioeng Symp Microbial sources of cellulase. 81-105 Mandels M M eng Journal Article United States Biotechnol Bioeng Symp 1302775 0572-6565 EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.4 Cellulase IM Cellulase metabolism Fusarium enzymology Glycoside Hydrolases metabolism Hydrogen-Ion Concentration Kinetics Mutation Paper Penicillium enzymology Species Specificity Trichoderma enzymology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 98 99 1976 03 01 2019 02 06 0547-6844 11 6 1975 Birth defects original article series Birth Defects Orig Artic Ser Mannosidosis: clinical and biochemical findings. 269-72 Gehler J J Cantz M M O'Brien J F JF Tolksdorf M M Spranger J J eng MC_U190081996 Medical Research Council United Kingdom Case Reports Journal Article United States Birth Defects Orig Artic Ser 0003403 0547-6844 EC 3.2.1.- Mannosidases PHA4727WTP Mannose IM Carbohydrate Metabolism, Inborn Errors metabolism Child Fibroblasts enzymology Humans Hydrogen-Ion Concentration Leukocytes enzymology Male Mannose metabolism Mannosidases deficiency 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 99 100 1976 03 01 2020 02 25 0547-6844 11 6 1975 Birth defects original article series Birth Defects Orig Artic Ser Bovine mannosidosis--a model lysosomal storage disease. 273-8 Jolly R D RD Thompson K G KG Winchester B G BG eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Birth Defects Orig Artic Ser 0003403 0547-6844 EC 3.2.1.- Mannosidases PHA4727WTP Mannose IM Animals Blood Carbohydrate Metabolism, Inborn Errors blood enzymology genetics veterinary Cattle Cattle Diseases blood enzymology genetics Disease Models, Animal Heterozygote Hydrogen-Ion Concentration Lymphocytes enzymology Lysosomes enzymology metabolism Mannose metabolism Mannosidases blood deficiency 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 100 Proc Nutr Soc. 2001 Feb;60(1):91-106 11310428 Br J Cancer. 2003 Aug 4;89(3):519-23 12888824 Int J Cancer. 2008 Apr 1;122(7):1604-10 18059032 Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2533-47 18086756 Endocr Rev. 1995 Feb;16(1):3-34 7758431 101 1976 03 01 2016 12 03 0547-6844 11 6 1975 Birth defects original article series Birth Defects Orig Artic Ser Ehlers-Danlos type V (X-linked form): a lysyl oxidase deficiency. 31-7 Di Ferrante N N Leachman R D RD Angelini P P Donnelly P V PV Francis G G Almazan A A Segni G G Franzblau C C Jordan R E RE eng Case Reports Journal Article Research Support, U.S. Gov't, P.H.S. United States Birth Defects Orig Artic Ser 0003403 0547-6844 9007-34-5 Collagen EC 1.4.- Amino Acid Oxidoreductases EC 1.4.3.13 Protein-Lysine 6-Oxidase IM Amino Acid Oxidoreductases deficiency Child Collagen Culture Techniques Ehlers-Danlos Syndrome enzymology genetics metabolism Female Humans Male Pedigree Protein-Lysine 6-Oxidase deficiency Sex Chromosomes Solubility 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 101 102 1976 03 01 2017 11 16 0547-6844 11 6 1975 Birth defects original article series Birth Defects Orig Artic Ser Urinary alpha-L-fucosidase. 335-9 Ng W G WG Donnell G N GN Koch R R Bergren W R WR eng Comparative Study Journal Article United States Birth Defects Orig Artic Ser 0003403 0547-6844 28RYY2IV3F Fucose EC 3.1.6.8 Cerebroside-Sulfatase EC 3.2.1.- Disaccharidases EC 3.2.1.51 alpha-L-Fucosidase IM Carbohydrate Metabolism, Inborn Errors diagnosis urine Cerebroside-Sulfatase urine Child Disaccharidases urine Fucose metabolism Heterozygote Humans alpha-L-Fucosidase urine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 102 103 1976 02 19 2020 02 25 0365-9615 79 4 1975 Apr Biulleten' eksperimental'noi biologii i meditsiny Biull Eksp Biol Med [Combined effects of hypoxia and hypercapnia on the functional state of the respiratory center]. 39-43 Experiments were conducted on cats under nembutal anesthesia; a study was made of pulse activity of bulbar respiratory neurons, electrical activity of the diaphragm and of the intercostal muscles; pO2, pCO2, pH, arterial blood oxygen saturation were determined in combined action of hypoxia and hypercapnia. When hypoxic gaseous mixture was given for respiration the developing hypocapnia disturbed the discharge rhythmic activity of the respiratory neurons, the respiration acquiring a pathological character of the Cheyne--Stokes type. After addition to the hypoxic gaseous mixture of 2% CO2 the gaseous composition of the arterial blood approached the initial values; this addition prevented the development of hypercapnia and disturbances of rhythmic discharge activity of the respiratory neurons. Addition of 5% CO2 to the hypoxic gaseous mixture produced a negative effect: at first it intensified and then depressed the pulse activity of the respiratory neurons, caused metabolic and respiratory acidosis, and promoted asphyxia. Kulik A M AM Kondrat'eva L N LN rus Journal Article Sovmestnoe deistvie gipoksii i giperkapnii na funktsional'noe sostoianie dykhatel'nogo tsentra Russia (Federation) Biull Eksp Biol Med 0370627 0365-9615 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM S Animals Carbon Dioxide blood Cats Cheyne-Stokes Respiration etiology Diaphragm physiopathology Electrophysiology Hydrogen-Ion Concentration Hypercapnia complications physiopathology Hypoxia complications physiopathology Intercostal Muscles physiopathology Neurons Oxygen blood Respiratory Center physiopathology 76062844 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 103 Am J Med. 2003 Sep;115(4):284-90 12967693 Am J Pathol. 1951 Mar-Apr;27(2):277-301 14819261 Ann Intern Med. 2005 Nov 1;143(9):632-8 16263885 Neurologist. 2007 Jan;13(1):12-9 17215723 Curr Rheumatol Rep. 2008 Dec;10(6):453-8 19007535 Arthritis Rheum. 1990 Aug;33(8):1094-100 2202307 Hum Pathol. 1983 Oct;14(10):868-83 6352458 Medicine (Baltimore). 1999 Jan;78(1):26-37 9990352 104 1976 02 19 2017 09 22 0365-9615 79 4 1975 Apr Biulleten' eksperimental'noi biologii i meditsiny Biull Eksp Biol Med [Level of nicotinamide coenzymes in the liver and myocardium of rats poisoned with dichlorethane]. 58-60 Experiments were conducted on male rats. A study was made of the content of nicotinamide coenzymes in the liver and myocardium 24 hours after the administration of 0.5 ml of dichloroethane into the stomach. In parallel with disturbance of the morphological structure of the liver and of the myocardium, increase in the activity of alanine and aspargic aminotranspherases in the blood serum, dichloroethane reduced the content of nicotinamide coenzymes and deranged the ratio of their oxidized and reduced forms in these organs. Natsiuk M V MV Chekman I S IS rus G0502121 Medical Research Council United Kingdom English Abstract Journal Article Soderzhanie nikotinamidnykh kofermentov v pecheni i miokarde krys, otravlennykh dikhlorétanom Russia (Federation) Biull Eksp Biol Med 0370627 0365-9615 0 Ethylene Dichlorides 0 Hydrocarbons, Chlorinated 0U46U6E8UK NAD 53-59-8 NADP EC 2.6.1.1 Aspartate Aminotransferases EC 2.6.1.2 Alanine Transaminase IM Alanine Transaminase blood Animals Aspartate Aminotransferases blood Ethylene Dichlorides poisoning Heart drug effects Hydrocarbons, Chlorinated poisoning Liver drug effects metabolism Male Myocardium metabolism NAD metabolism NADP metabolism Rats 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 104 105 1976 02 19 2008 10 08 0365-9615 79 4 1975 Apr Biulleten' eksperimental'noi biologii i meditsiny Biull Eksp Biol Med [Effect of carbidine on conditioned defense reflexes]. 61-4 Chronic experiments were conducted on rats and rabbits; a study was made of the effect of carbidine on the conditioned defence reflexes in stimulation of the mesencephalic part of the reticular formation. Carbidine prevented the depression of the conditioned defence reflexes caused by stimulation of the mesencephalic portion of the reticular formation. This pointed to its depressive influence on the mentioned structures, and was confirmed by experiments on rabbits in recording changes in biocurrents under conditions of stimulation of the mesencephalic reticular formation. Barkov N K NK Ostrovskaia R U RU rus English Abstract Journal Article Vliianie karbidina na oboronitel'nye uslovnye refleksy Russia (Federation) Biull Eksp Biol Med 0370627 0365-9615 0 Antipsychotic Agents 0 Carbolines 0 Indoles IM Animals Antipsychotic Agents pharmacology Carbolines pharmacology Conditioning, Classical drug effects Defense Mechanisms drug effects Depression, Chemical Electric Stimulation Humans Indoles pharmacology Male Rabbits Rats Reticular Formation drug effects 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 105 106 1976 02 19 2020 02 25 0365-9615 79 4 1975 Apr Biulleten' eksperimental'noi biologii i meditsiny Biull Eksp Biol Med [Level of nicotinamide coenzymes in the myocardium of rats during the effects of methylxanthines (theophylline, theobromine, caffeine) and catecholamines]. 68-71 It was shown in acute experiments on rats that one hour after an intraperitoneal injection of theophylline (50 mg/kg) there was a decrease in the NAD + NADP content by 19.4%, a tendency to a fall of NAD.H2 + NADP.H2 was expressed, and the total nicotinamide coferment level was reduced. A tendency to decrease NAD + NADP and the total pyridine nucleotide level was seen after caffeine administration. The action of catecholamines and methylxanthines was compared. Theobromine produced no significant effect on the indices under study. It was shown that isadrine decreased the NAD + NADP level; adrenaline (25 mkg/kg) increased the content of both the oxidized (by 24%) and of the reduced (by 48%) forms of pyridine nucleotides. An increase of adrenaline dose to 1000 mkg/kg was accompanied by reduction of the oxidized forms (by 22.2%) and of the total nicotinamide coferment level (by 18%). Frantsuzova S B SB rus English Abstract Journal Article Soderzhanie nikotinamidnykh kofermentov v serdechnoi myshtse krys pri deistvii metilksantinov (teofillin, teobromin, kofein) i katekholaminov Russia (Federation) Biull Eksp Biol Med 0370627 0365-9615 0U46U6E8UK NAD 3G6A5W338E Caffeine 53-59-8 NADP C137DTR5RG Theophylline L628TT009W Isoproterenol OBD445WZ5P Theobromine X4W3ENH1CV Norepinephrine YKH834O4BH Epinephrine IM Animals Caffeine pharmacology Epinephrine pharmacology Female Heart drug effects Isoproterenol pharmacology Male Myocardium metabolism NAD metabolism NADP metabolism Norepinephrine pharmacology Rats Stimulation, Chemical Theobromine pharmacology Theophylline pharmacology 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 106 Am J Clin Pathol. 2000 Nov;114(5):754-9 11068550 Arch Neurol. 2007 Aug;64(8):1115-20 17698701 J Thorac Cardiovasc Surg. 1985 Feb;89(2):298-303 3968914 Stroke. 1993 Jan;24(1):35-41 7678184 107 1976 02 09 2019 07 19 0007-4861 14 4 1975 Oct Bulletin of environmental contamination and toxicology Bull Environ Contam Toxicol Potable water quality in rural Georgetown County. 465-72 Drinking water supplies of 161 rural communities, in Georgetown County, South Carolina, were randomly selected for sample collection. The analysis showed that most of the waters were slightly acidic. Low, but acceptable concentrations of chloride, copper, fluoride, sodium, cadmium, nitrate and phosphate were found. A few water samples showed higher then recommended levels of arsenic, mercury, zinc and lead. Although only 2% of the samples exceeded the mandatory limit of 0.05 ppm for arsenic, 72% exceeded the recommended level of 0.01 ppm. The mandatory limit for manganese was exceeded in 37% of the waters while 88% exceeded the limit for iron. The high iron content was generally responsible for the high turbidity found in 45% of the samples. The well depth and the consumer income had some bearing on water quality. Statistical evidence suggested that septic tank seepage was partially responsible for nitrate, phosphate, iron and arsenic contamination of shallow water supplies. Lead concentrations appear to vary according to the plumbing used and the pH of the waters. Sandhu S S SS Nelson P P Warren W J WJ eng Journal Article United States Bull Environ Contam Toxicol 0046021 0007-4861 0 Metals 0 Sewage IM Hydrogen-Ion Concentration Metals analysis Rural Population Sewage analysis South Carolina Water Pollution, Chemical analysis Water Supply analysis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 107 10.1007/BF01705514 Ig Mod. 1961 Jan-Feb;54:3-34 13861580 Environ Health Perspect. 1974 May;7:103-5 4831134 Science. 1970 Apr 17;168(3929):389-90 5467262 J Chronic Dis. 1966 Jan;19(1):85-106 5903856 108 1976 02 21 2020 02 25 0324-8542 26 1 1975 Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia Bull Inst Marit Trop Med Gdynia Symposium on malaria research. 53-8 Lachmajer J J eng Congress Poland Bull Inst Marit Trop Med Gdynia 7603275 0324-8542 IM Congresses as Topic Humans International Cooperation Malaria prevention & control Morocco World Health Organization 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 108 Cochrane Database Syst Rev. 2000;(2):CD000125 10796491 Ann Intern Med. 2002 Feb 5;136(3):243-6 11827500 N Engl J Med. 2003 Jun 26;348(26):2635-45 12826639 Ann Intern Med. 2008 Mar 4;148(5):353-7 18316754 109 1976 02 09 2020 02 25 0324-8542 26 2 1975 Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia Bull Inst Marit Trop Med Gdynia 6th International Symposium on Maritime Medicine 1974. 131-2 Kersten E E eng Congress Poland Bull Inst Marit Trop Med Gdynia 7603275 0324-8542 IM Congresses as Topic International Cooperation Naval Medicine Poland 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 109 Brain. 1948 Sep;71(Pt. 3):229-41 18099548 Clin Med (Lond). 2008 Jun;8(3):338-9 18624052 Clin Med (Lond). 2012 Feb;12(1):92-3 22372235 110 1976 02 09 2020 02 25 0025-9284 39 3 1975 May Bulletin of the Menninger Clinic Bull Menninger Clin Polypsychopharmacy. 274-9 Sturges S S Brown M M eng 098497 Wellcome Trust United Kingdom Journal Article United States Bull Menninger Clin 7507032 0025-9284 0 Antiparkinson Agents 0 Antipsychotic Agents IM Antiparkinson Agents therapeutic use Antipsychotic Agents therapeutic use Drug Therapy, Combination Humans Mental Disorders drug therapy Patient Compliance Psychiatric Department, Hospital Psychopharmacology 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 110 Thorax. 2005 Apr;60(4):314-9 15790987 Thorax. 2006 Mar;61(3):232-9 16284219 Ann Oncol. 2007 Mar;18(3):581-92 17287242 Lancet Oncol. 2007 Sep;8(9):773-83 17714991 Thorax. 2009 Jun;64(6):523-31 19052045 Thorax. 2010 May;65(5):436-41 20435867 112 1976 02 27 2019 08 19 0007-1226 28 3 1975 Jul British journal of plastic surgery Br J Plast Surg PH changes on the surface of burns. 181-4 Kemble J V JV eng Journal Article England Br J Plast Surg 2984714R 0007-1226 0 Bicarbonates 142M471B3J Carbon Dioxide IM Bicarbonates blood Burns metabolism microbiology Carbon Dioxide blood Graft Rejection Humans Hydrogen-Ion Concentration Partial Pressure Proteus isolation & purification Pseudomonas isolation & purification Skin metabolism Skin Transplantation Streptococcus pyogenes isolation & purification 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 112 0007-1226(75)90126-5 10.1016/0007-1226(75)90126-5 113 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: The effects of glucagon on the hepatic arterial vasculature of the dog: an inhibition of the effects of vasoconstrictor agents. 272P-273P Richardson P D PD Withrington P G PG eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Adrenergic alpha-Agonists 0 Vasoconstrictor Agents 11000-17-2 Vasopressins 11128-99-7 Angiotensin II 9007-92-5 Glucagon X4W3ENH1CV Norepinephrine IM Adrenergic alpha-Agonists pharmacology Angiotensin II pharmacology Animals Arteries drug effects Blood Pressure drug effects Dogs Female Glucagon pharmacology Liver blood supply Norepinephrine pharmacology Vasoconstrictor Agents antagonists & inhibitors Vasopressins pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 113 PMC1666769 Pflugers Arch. 1973 Nov 15;344(1):83-92 4797978 J Surg Res. 1971 Jan;11(1):12-7 5542725 111 1976 02 26 2019 02 06 0007-439X 11 1 1975 Jan-Feb Bulletin de physio-pathologie respiratoire Bull Physiopathol Respir (Nancy) [Oxygen affinity of haemoglobin (author's transl)]. 79-170 Robert M M fre Journal Article Review Affinité de l'hémoglobine pour l'oxygène France Bull Physiopathol Respir (Nancy) 7611945 0007-439X 0 Diphosphoglyceric Acids 0 Hemoglobins 0 Oxyhemoglobins 7YNJ3PO35Z Hydrogen S88TT14065 Oxygen IM S Altitude Anemia blood Blood Transfusion Carbon Monoxide Poisoning blood Coronary Disease blood Diphosphoglyceric Acids metabolism Hemoglobins physiology Humans Hydrogen physiology Hydrogen-Ion Concentration Hypoxia blood Lung physiology Models, Theoretical Oxygen blood metabolism Oxygen Consumption Oxyhemoglobins physiology Partial Pressure Respiratory Insufficiency blood 115 76062994 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 111 114 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Central hypertensive action of histamine in rats. 274P-275P Finch L L Hicks P E PE eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Histamine H1 Antagonists 820484N8I3 Histamine IM Animals Blood Pressure drug effects Heart Rate drug effects Histamine administration & dosage pharmacology Histamine H1 Antagonists pharmacology Injections, Intraventricular Rats Stimulation, Chemical 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 114 PMC1666842 Pol J Pharmacol Pharm. 1973 Nov-Dec;25(6):503-10 4799804 Int J Neuropharmacol. 1969 Dec;8(6):593-600 5363032 Experientia. 1965 Mar 15;21(3):132-3 5830042 Circ Res. 1957 Jan;5(1):105-10 13396972 Eur J Pharmacol. 1969 Feb;5(3):235-8 4388969 Neuropharmacology. 1974 Jan;13(1):65-75 4596009 115 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Response of identified ventromedial hypothalamic nucleus neurons to putative neurotransmitters applied by microiontophoresis. 277P-278P Renaud L P LP Kelly J S JS eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Neurotransmitter Agents IM Animals Evoked Potentials drug effects Hypothalamus drug effects Iontophoresis Male Neurons drug effects Neurotransmitter Agents administration & dosage pharmacology Rats 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 115 PMC1666801 Brain Res. 1975 Jul 25;93(1):145-51 1139315 Brain Res. 1974 Aug 16;76(2):363-6 4844460 Brain Res. 1975 Mar 14;86(1):150-4 803854 Nature. 1975 May 15;255(5505):233-5 806808 116 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: The mechanism of "adrenaline reversal" in the anaesthetized cat and rabbit. 282P-283P Grundy H C HC Grundy H F HF eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Adrenergic alpha-Agonists 0 Adrenergic beta-Agonists 0 Vasodilator Agents YKH834O4BH Epinephrine IM Adrenergic alpha-Agonists Adrenergic beta-Agonists Animals Cats Epinephrine pharmacology In Vitro Techniques Rabbits Vasodilator Agents pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 116 PMC1666813 J Pharmacol Exp Ther. 1953 Jul;108(3):281-91 13070147 Br J Pharmacol Chemother. 1964 Dec;23:592-9 14256816 J Physiol. 1906 May 31;34(3):163-206 16992821 117 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Is ATP an inhibitory neurotransmitter in the rat stomach. 285P-286P Heazell M A MA eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Neurotransmitter Agents 8L70Q75FXE Adenosine Triphosphate IM Adenosine Triphosphate pharmacology physiology Animals In Vitro Techniques Muscle Contraction drug effects Neurotransmitter Agents physiology Rats Stomach innervation physiology Synaptic Transmission drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 117 PMC1666776 Eur J Pharmacol. 1972 Sep;19(3):343-50 4344978 Br J Pharmacol Chemother. 1957 Sep;12(3):344-9 13460242 Br J Pharmacol. 1974 Mar;50(3):458P-459P 4853882 Pharmacol Rev. 1972 Sep;24(3):509-81 4404211 118 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Comparison of the effects of selective alpha and beta-receptor agonists on intracellular cyclic AMP levels and glycogen phosphorylase activity in guinea-pig liver. 286P-287P Osborn D D Jenkinson D H DH eng Comparative Study Journal Article England Br J Pharmacol 7502536 0007-1188 0 Adrenergic alpha-Agonists 0 Adrenergic beta-Agonists E0399OZS9N Cyclic AMP EC 2.4.1.- Phosphorylases IY9XDZ35W2 Glucose IM Adrenergic alpha-Agonists pharmacology Adrenergic beta-Agonists pharmacology Animals Cyclic AMP metabolism Glucose metabolism Guinea Pigs In Vitro Techniques Liver enzymology metabolism Phosphorylases metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 118 PMC1666831 J Physiol. 1972 Sep;225(3):721-50 5076396 J Physiol. 1972 Sep;225(3):751-72 4403941 Clin Chim Acta. 1974 Nov 8;56(3):221-34 4371263 Proc Natl Acad Sci U S A. 1962 Jul 15;48:1191-9 13883372 J Biol Chem. 1949 Nov;181(1):149-51 15390401 119 1976 03 01 2017 09 22 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: The role of dopamine in rotational behaviour produced by unilateral lesions of the locus coeruleus. 290P Donaldson I I Dolphin A A Jenner P P Mardsen C K CK Pycock C C eng G0701898 Medical Research Council United Kingdom Journal Article England Br J Pharmacol 7502536 0007-1188 0 Adrenergic alpha-Antagonists 0 Adrenergic beta-Antagonists N21FAR7B4S Apomorphine TZ47U051FI Dextroamphetamine VTD58H1Z2X Dopamine IM Adrenergic alpha-Antagonists pharmacology Adrenergic beta-Antagonists pharmacology Animals Apomorphine pharmacology Behavior Cerebral Ventricles physiology Dextroamphetamine pharmacology Dopamine physiology Humans Rats Stereotyped Behavior drug effects Substantia Nigra physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 119 PMC1666844 120 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Do anti-psychotic drugs act by dopamine receptor blockade in the nucleus accumbens. 295P-296P Crow T J TJ Deakin J F JF Longden A A eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Antipsychotic Agents 0 Receptors, Drug VTD58H1Z2X Dopamine X77S6GMS36 Homovanillic Acid IM Animals Antipsychotic Agents pharmacology Corpus Striatum metabolism Dopamine physiology Homovanillic Acid metabolism Male Olfactory Bulb physiology Rats Receptors, Drug drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 120 PMC1666851 Nature. 1974 Apr 12;248(449):596-7 4150951 121 1976 03 01 2018 11 13 0007-1188 55 2 1975 Oct British journal of pharmacology Br J Pharmacol Proceedings: Evaluation of narcotic and narcotic antagonist analgesic drugs in the dog dental pulp stimulation test. 314P Marriott A S AS Skingle M M Tyers M B MB eng Journal Article England Br J Pharmacol 7502536 0007-1188 0 Analgesics, Opioid 0 Narcotic Antagonists 0 Narcotics IM Analgesics, Opioid pharmacology Animals Dental Pulp physiology Dogs Drug Evaluation, Preclinical Electric Stimulation Male Narcotic Antagonists pharmacology Narcotics pharmacology Reaction Time drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 121 PMC1666858 Br J Pharmacol. 1971 Oct;43(2):476P-477P 5158246 122 1976 02 19 2019 07 19 0007-1331 47 5 1975 Oct British journal of urology Br J Urol Meso-appendicular testis. 579 Zelikovski A A Abu-Dalu J J Urca I I eng Case Reports Journal Article England Br J Urol 15740090R 0007-1331 IM Adult Appendicitis complications Appendix abnormalities Cryptorchidism Humans Male 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 122 10.1111/j.1464-410x.1975.tb06266.x 123 1976 02 09 2019 07 05 0007-1323 62 10 1975 Oct The British journal of surgery Br J Surg The importance of an innervated and intact antrum and pylorus in preventing postoperative duodenogastric reflux and gastritis. 845-9 This study has investigated the relationship between duodenogastric reflux, gastritis and certain symptoms 6-12 months after three operations for uncomplicated duodenal ulcer. The operations studied were proximal gastric vagotomy (PGV, 20 cases), truncal vagotomy and pyloroplasty (TV+P, 22 cases) and truncal vagotomy and antrectomy (TV+A, 21 cases). Duodenogastric reflux was assessed both by a radiological technique and by measuring the concentration of bilirubin in the gastric aspirate before and after operation. Incidence and severity of postoperative gastritis were determined by endoscopic biopsy. Symptoms were assessed by symptomatic score and Visick grading. There was a significant correlation between duodenal reflux and histological evidence of both severe superficial gastritis and glandular atrophy (P less than 0-01). There was also a close association between the degree of reflux and the presence of severe heartburn, epigastric pain and bile vomiting after operation. The amount of reflux did not differ before operation. There was significantly less reflux following PGV than after either TV+P (P less than 0-025) or TV+A (P less than 0-001). The results indicate that an operation which preserves an innervated and intact antrum and pylorus will protect against postoperative duodenogastric reflux, gastritis and symptoms. Keighley M R MR Asquith P P Edwards J A JA Alexander-Williams J J eng Journal Article England Br J Surg 0372553 0007-1323 RFM9X3LJ49 Bilirubin AIM IM Adult Bilirubin analysis Duodenal Diseases diagnostic imaging prevention & control Duodenal Ulcer surgery Endoscopy Female Gastric Juice analysis Gastric Mucosa pathology Gastritis pathology prevention & control Heartburn complications Humans Hydrogen-Ion Concentration Male Middle Aged Postoperative Complications prevention & control Pyloric Antrum innervation Pylorus innervation Radiography Stomach Diseases pathology prevention & control Vagotomy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 123 10.1002/bjs.1800621024 124 1976 02 09 2019 05 01 0007-1447 4 5990 1975 Oct 25 British medical journal Br Med J Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemia. 200-2 A new haemoglobin with increased oxygen affinity, beta82 (EF6) lysine leads to threonine (Hb Rahere), was found during the investigation of a patient who was found to have a raised haemoglobin concentration after a routine blood count. The substitution affects one of the 2, 3-diphosphoglycerate binding sites, resulting in an increased affinity for oxygen, but both the haem-haem interaction and the alkaline Bohr effect are normal in the haemolysate. This variant had the same mobility as haemoglobin A on electrophoresis at alkaline pH but was detected by measuring the whole blood oxygen affinity; it could be separated from haemoglobin A, however, by electrophoresis in agar at acid pH. The raised haemoglobin concentration was mainly due to a reduction in plasma volume (a relative polycythaemia) and was associated with a persistently raised white blood count. This case emphasises the need to measure the oxygen affinity of haemoglobin in all patients with absolute or relative polycythaemia when some obvious cause is not evident. Lorkin P A PA Stephens A D AD Beard M E ME Wrigley P F PF Adams L L Lehmann H H eng Case Reports Journal Article England Br Med J 0372673 0007-1447 0 Amino Acids 0 Diphosphoglyceric Acids 0 Hemoglobins, Abnormal 0 Oxyhemoglobins 0 Peptide Fragments 2ZD004190S Threonine K3Z4F929H6 Lysine S88TT14065 Oxygen AIM IM Adult Amino Acid Sequence Amino Acids analysis Diphosphoglyceric Acids metabolism Hemoglobins, Abnormal analysis Humans Hydrogen-Ion Concentration Leukocyte Count Lysine analysis Male Oxygen blood Oxyhemoglobins analysis Peptide Fragments analysis Plasma Volume Polycythemia blood Threonine analysis 1975 10 25 1975 10 25 0 1 1975 10 25 0 0 ppublish 124 PMC1675002 10.1136/bmj.4.5990.200 J Nucl Med. 1975 Jan;16(1):46-52 1110403 Johns Hopkins Med J. 1975 Mar;136(3):132-6 1117598 Clin Sci (Lond). 1956 Nov;15(4):557-65 13374941 J Biol Chem. 1964 Jan;239:18-30 14114842 J Clin Invest. 1975 Mar;55(3):469-77 234980 Nat New Biol. 1973 Jun 6;243(127):177-9 4514629 Nature. 1972 May 19;237(5351):146-9 4555506 Nature. 1971 Aug 6;232(5310):408-13 4938842 J Clin Invest. 1972 Mar;51(3):666-76 5011106 Clin Biochem. 1972 Mar;5(1):46-50 5022448 Clin Chim Acta. 1972 Apr;38(1):258-62 5031790 Br J Haematol. 1972 May;22(5):599-607 5032098 Blood. 1971 Dec;38(6):730-8 5126162 Mayo Clin Proc. 1971 Nov;46(11):721-7 5128393 J Clin Invest. 1970 Jun;49(6):1088-95 5422014 Biochim Biophys Acta. 1970 Feb 17;200(2):189-96 5461230 Ann Intern Med. 1968 Oct;69(4):769-76 5687529 Nature. 1969 Feb 15;221(5181):618-22 5774935 J Chromatogr. 1965 Jul;19(1):160-9 5857919 J Clin Invest. 1966 Jun;45(6):813-22 5913291 J Mol Biol. 1966 Aug;19(1):91-108 5967288 Nature. 1966 Nov 19;212(5064):792-5 5988206 125 1976 02 26 2019 05 01 0007-1447 4 5993 1975 Nov 15 British medical journal Br Med J Endoscopic papillotomy and removal of gall stones. 371-4 Endoscopic papillotomy was attempted in 59 patients with extrahepatic obstruction of the biliary duct system and was actually performed in 50 patients. A special high-frequency diathermy knife was introduced via a duodenoscope into the terminal common bile duct and the roof of the papilla was incised. In 33 out of 39 patients with choledocholithiasis the stones passed into the duodenum spontaneously or were removed endoscopically. Papillary stenosis without ductal stones was successfully treated with this method in eight out of 11 patients. One perforation of the duodenocholedochal junction occurred and was repaired surgically. Endoscopic papillotomy and stone extraction is a relatively safe and effective method of treating extrahepatic jaundice. Classen M M Safrany L L eng Journal Article England Br Med J 0372673 0007-1447 EC 2.3.2.2 gamma-Glutamyltransferase EC 3.2.1.- Amylases RFM9X3LJ49 Bilirubin AIM IM Aged Ampulla of Vater surgery Amylases blood Bilirubin blood Cholelithiasis blood surgery Diathermy methods Endoscopy methods Female Gallstones blood surgery Humans Male Time Factors gamma-Glutamyltransferase blood 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 125 PMC1675269 10.1136/bmj.4.5993.371 Lancet. 1972 Jan 8;1(7741):53-8 4108942 Dtsch Med Wochenschr. 1974 Nov 8;99(45):2255-7 4448131 Dtsch Med Wochenschr. 1974 Mar 15;99(11):496-7 4835515 Arch Surg. 1971 Mar;102(3):218-20 5101625 126 1976 02 19 2019 05 01 0007-1447 4 5994 1975 Nov 22 British medical journal Br Med J Phobias complicating treatment of uterine carcinoma. 440 Lloyd G G Deakin H G HG eng Case Reports Journal Article England Br Med J 0372673 0007-1447 AIM IM Adenocarcinoma complications surgery Animals Behavior Therapy Desensitization, Psychologic Female Humans Middle Aged Phobic Disorders complications therapy Uterine Neoplasms complications surgery 1975 11 22 1975 11 22 0 1 1975 11 22 0 0 ppublish 126 PMC1675371 10.1136/bmj.4.5994.440 Arch Gen Psychiatry. 1972 Apr;26(4):315-7 5013515 Compr Psychiatry. 1969 Mar;10(2):151-6 5774552 Br J Psychiatry. 1966 Mar;112(484):309-19 5939892 127 1976 02 20 2019 05 01 0007-1447 4 5995 1975 Nov 29 British medical journal Br Med J Editorial: Childhood poisoning: prevention and first-aid management. 483-4 eng Journal Article England Br Med J 0372673 0007-1447 8012-96-2 Ipecac AIM IM Child, Preschool Drug Packaging First Aid Humans Ipecac therapeutic use Legislation, Drug Poisoning prevention & control therapy Vomiting chemically induced 1975 11 29 1975 11 29 0 1 1975 11 29 0 0 ppublish 127 PMC1675615 10.1136/bmj.4.5995.483 Nurs Times. 1975 Jun 19;71(25):977-9 1144087 Pediatrics. 1959 Feb;23(2):286-301 13633344 Acta Paediatr Scand. 1965 Jul;54:331-5 14343442 Am J Dis Child. 1962 Feb;103:136-9 14492839 Med J Aust. 1975 Sep 13;2(11):432, 434, 436-8 241896 J Pediatr. 1966 Jul;69(1):139-41 4379939 J Pediatr. 1966 Jul;69(1):142-6 4379940 Pediatrics. 1968 Jul;42(1):189-93 4385403 J Pediatr. 1969 May;74(5):800-3 4388519 Arch Dis Child. 1970 Jun;45(241):428-33 4393311 Community Health (Bristol). 1974 Sep-Oct;6(2):91-101 4477521 Pediatrics. 1967 Nov;40(5):871-4 6075660 128 1976 02 09 2020 02 25 0006-8993 100 2 1975 Dec 19 Brain research Brain Res Inhibitory postsynaptic actions of taurine, GABA and other amino acids on motoneurons of the isolated frog spinal cord. 327-41 The actions of glycine, GABA, alpha-alanine, beta-alanine and taurine were studied by intracellular recordings from lumbar motoneurons of the isolated spinal cord of the frog. All amino acids tested produced a reduction in the amplitude of postsynaptic potentials, a blockade of the antidromic action potential and an increase of membrane conductance. Furthermore, membrane polarizations occurred, which were always in the same direction as the IPSP. All these effects indicate a postsynaptic inhibitory action of these amino acids. When the relative strength of different amino acids was compared, taurine had the strongest inhibitory potency, followed by beta-alanine, alpha-alanine, GABA and glycine. Topically applied strychnine and picrotoxin induced different changes of post-synaptic potentials, indicating that distinct inhibitory systems might be influenced by these two convulsants. Interactions with amino acids showed that picrotoxin seletively diminished the postsymaptic actions of GABA, while strychnine reduced the effects of taurine, glycine, alpha- and beta-alanine. But differences in the susceptibility of these amino acid actions to strychnine could be detected: the action of taurine was more sensitively blocked by strychnine compared with glycine, alpha- and beta-alanine. With regard to these results the importance of taurine and GABA as transmitters of postsynaptic inhibition on motoneurons in the spinal cord of the frog is discussed. Sonnhof U U Grafe P P Krumnikl J J Linder M M Schindler L L eng Journal Article Netherlands Brain Res 0045503 0006-8993 0 Amino Acids 0 Neurotransmitter Agents 124-87-8 Picrotoxin 1EQV5MLY3D Taurine 56-12-2 gamma-Aminobutyric Acid H9Y79VD43J Strychnine OF5P57N2ZX Alanine TE7660XO1C Glycine IM Alanine pharmacology Amino Acids pharmacology Animals Anura Depression, Chemical Drug Interactions Evoked Potentials Glycine pharmacology Membrane Potentials drug effects Motor Neurons drug effects Neural Inhibition Neurotransmitter Agents pharmacology Picrotoxin pharmacology Rana esculenta Spinal Cord drug effects physiology Spinal Nerve Roots physiology Stereoisomerism Strychnine pharmacology Synaptic Membranes drug effects Taurine pharmacology gamma-Aminobutyric Acid pharmacology 1975 12 19 1975 12 19 0 1 1975 12 19 0 0 ppublish 128 0006-8993(75)90486-2 10.1016/0006-8993(75)90486-2 Qual Health Care. 1993 Jun;2(2):73-4 10131636 Crit Care Nurse. 1999 Apr;19(2):120 10401310 Clin Med (Lond). 2003 Jul-Aug;3(4):329-32 12938746 129 1976 02 20 2019 06 13 0006-8993 100 3 1975 Dec 26 Brain research Brain Res The involvement of lysophosphoglycerides in neurotransmitter release; the composition and turnover of phospholipids of synaptic vesicles of guinea-pig cerebral cortex and Torpedo electric organ and the effect of stimulation. 629-44 (1) Crude synaptosomal fractions (P2) derived from guinea-pig cerebral cortex were incubated in the presence of 50 mM KCl in a Krebs-glucose medium. Torpedo marmorata electric organs were stimulated electrically in vivo at 5 pulses/sec for 30 min by electrodes placed on the electric lobe. Synaptic vesicles were isolated from each source and the phospholipid compositions analysed and compared with vesicles from unstimulated controls. (2) Lysophosphatidylcholine was the only lysophosphoglyceride demonstrable in the synaptic vesicles from either source and its low levels did not increase as a result of chemical or electircal stimulation. In each case there was a close similarity of the phospholipid distributions in the vesicles taken from control and stimulated samples. (3) Control experiments indicated extensive decreases in the acetylcholine content of the vesicles from the stimulated electric organ and smaller decreases in the acetylcholine content of the synaptic vesicles from stimulated crude synaptosomal fractions. These fractions were found to respire linearly in the presence of 10 mM glucose and the vesicle fractions were shown to have low levels of contaiminating membranes as judged by marker enzyme analyses. (4) Crude synaptosomal fractions from guinea-pig cerebral cortex were incubated in a Krebs-glucose medium with labelled fatty acids and [3H]glucose in the presence or absence of 50 mM KCl. Subsynaptosomal fractionation was carried out and specific radioactivities of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol were determined in fractions D (synaptic vesicles), E (microsomes) and H (disrupted synaptosomes). The release of neurotransmitter did not significantly enhance the labelling of phospholipids in any of the fractions studied as compared with phospholipids from unstimulated fractions. This was found after two incubation times and using [14C]oleate, [14C]arachidonate, [3H]palmitate and [3H]glucose. Baker R R RR Dowdall M J MJ Whittaker V P VP eng 100406 Wellcome Trust United Kingdom Journal Article Netherlands Brain Res 0045503 0006-8993 0 Neurotransmitter Agents 0 Phosphatidylcholines 0 Phosphatidylethanolamines 0 Phosphatidylserines 0 Phospholipids EC 3.1.1.8 Cholinesterases N9YNS0M02X Acetylcholine IM Acetylcholine metabolism Animals Cerebral Cortex metabolism Cholinesterases metabolism Electric Organ metabolism Electric Stimulation Guinea Pigs Microsomes metabolism Neurotransmitter Agents metabolism Oxygen Consumption Phosphatidylcholines metabolism Phosphatidylethanolamines metabolism Phosphatidylserines metabolism Phospholipids metabolism Synaptic Vesicles enzymology metabolism Synaptosomes metabolism 1975 12 26 1975 12 26 0 1 1975 12 26 0 0 ppublish 129 0006-8993(75)90162-6 10.1016/0006-8993(75)90162-6 130 1976 02 20 2019 06 13 0006-8993 100 3 1975 Dec 26 Brain research Brain Res Uptake of radiolabeled glucose analogues by organotypic pia arachnoid cultures. 710-5 Spatz M M Renkawek K K Murray M R MR Klatzo I I eng Journal Article Netherlands Brain Res 0045503 0006-8993 IY9XDZ35W2 Glucose IM Animals Biological Transport, Active Blood-Brain Barrier Glucose analogs & derivatives metabolism Hydrogen-Ion Concentration Kinetics Organ Culture Techniques Pia Mater metabolism Rats 1975 12 26 1975 12 26 0 1 1975 12 26 0 0 ppublish 130 0006-8993(75)90174-2 10.1016/0006-8993(75)90174-2 131 1976 02 13 2017 03 22 0068-2799 26 1975 Jul Brookhaven symposia in biology Brookhaven Symp Biol Processing of tRNA precursors in higher organisms. 138-53 Burdon R H RH eng Journal Article United States Brookhaven Symp Biol 2984279R 0068-2799 1CC1JFE158 Dactinomycin 9014-25-9 RNA, Transfer I38ZP9992A Magnesium IM Animals Cell Division Cell Line Cell Nucleus metabolism Cell Transformation, Neoplastic Dactinomycin pharmacology Genetic Linkage Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Microsomes metabolism Molecular Weight Nucleic Acid Hybridization RNA, Transfer biosynthesis Transcription, Genetic drug effects Xenopus 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 131 132 1976 03 01 2019 09 02 0008-2856 22 6 1975 Nov Canadian Anaesthetists' Society journal Can Anaesth Soc J Cardiac output response to altered acid-base status during diethyl ether anaesthesia. 673-9 The effects of acid-base changes on cardiac output during diethyl ether anaesthesia were studied in 25 mongrel dogs prepared by surgically implanting a plastic encased non-ferrous core electromagnetic probe on the ascending aorta. The findings are: (1) Metabolic acidaemia produced only slight decrease in cardiac output but a more marked fall became evident with decreasing pH(2) Respiratory acidaemia led to a slight rise in cardiac output. (3) Respiratory alkalaemia decreased cardiac output. (4) Metabolic alkalaemia also produced a decline in cardiac output. Sodipo J O JO Lee D C DC Morris L E LE eng Journal Article Canada Can Anaesth Soc J 0371163 0008-2856 0 Bicarbonates 0 Ethyl Ethers 0F5N573A2Y Ether 142M471B3J Carbon Dioxide QTT17582CB Hydrochloric Acid S88TT14065 Oxygen IM Acid-Base Equilibrium Acidosis blood chemically induced Acidosis, Respiratory blood chemically induced Alkalosis blood chemically induced Alkalosis, Respiratory blood Anesthesia, Inhalation Animals Bicarbonates Blood Carbon Dioxide blood Cardiac Output Dogs Ether Ethyl Ethers Hydrochloric Acid Hydrogen-Ion Concentration Hypoxia blood Male Oxygen blood 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 132 10.1007/BF03013315 J Biol Chem. 1948 Mar;173(1):25-30 18902367 J Appl Physiol. 1967 Feb;22(2):362-4 5334915 Anesthesiology. 1965 Nov-Dec;26(6):771-7 4378907 J Appl Physiol. 1956 Sep;9(2):201-4 13376428 J Appl Physiol. 1965 Sep;20(5):948-53 5320000 Can Anaesth Soc J. 1972 Mar;19(2):119-28 5029466 133 1976 02 20 2017 03 22 0008-4182 10 4 1975 Oct Canadian journal of ophthalmology. Journal canadien d'ophtalmologie Can J Ophthalmol The prevention of autolysis of stored cornea using steroid as a lysosome membrane stabilizer. 482-6 Many eyes donated for use in corneal grafting are rejected because of signs of autolysis in the donor material. The purpose of this experimental study was to determine whether hydrocortisone acting as a lysosome membrane stabilizer could prevent or retard autolysis of the corneas under storage, and if so, what was the most efficacious concentration. Different groups of rabbit corneas were placed in saline as controls or in varying concentrations of hydrocortisone (10(-10) M to 10(-4) M at pH 7.4) at 37 degrees C and 4 degrees C. Acid phosphatase released after six hours was measured biochemically. This enzyme was used as a marker enzyme reflecting lysosomal labilization. Results showed a significant stabilization of the lysosomal membrane at 4 degrees C as compared to 37 degrees C. A trend towards stabilization of the lysosomal membrane was seen when 10(-8) M concentration of hydrocortisone at 37 degrees C was used, there being no demonstrable stabilization at 4 degrees C. Fook T J TJ Ranadive N S NS Basu P K PK eng Journal Article England Can J Ophthalmol 0045312 0008-4182 EC 3.1.3.2 Acid Phosphatase WI4X0X7BPJ Hydrocortisone IM Acid Phosphatase metabolism Animals Autolysis Cornea Corneal Transplantation Hydrocortisone administration & dosage pharmacology Hydrogen-Ion Concentration Lysosomes drug effects enzymology Membranes drug effects Rabbits Refrigeration Temperature Tissue Preservation Transplantation, Homologous 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 133 134 1976 03 01 2019 07 20 0008-4212 53 5 1975 Oct Canadian journal of physiology and pharmacology Can J Physiol Pharmacol Respiratory effects of H+ and dinitrophenol injections into the brain stem subarachnoid space of fetal lambs. 726-33 Mock cerebrospinal fluid (pH 5.37-8.38) or 2,4-dinitrophenol (DNP) (0.15-1.5 mg) was injected into the subarachnoid space of the ventral brain stem of exteriorized fetal sheep. Changes in pH on the ventral surface of the medulla did not stimulate respiratory efforts or induce significant cardiovascular changes. The respiratory response to DNP injections ranged from no response to prolonged rhythmic ventilation that was independent of the peripheral chemoreceptors or the control arterial pH and blood gas tensions. This inconsistency suggests an effector site somewhat removed from the immediate surface of the medulla. The heart rate and blood pressure were not affected. It is concluded that increased H+ concentration in the extracellular fluid of the fetal ventral medulla does not initiate respiration, and any respiratory response to metabolic inhibitors applied to this area therefore is not attributable to a secondary change in surface pH. Jansen A H AH Russell B J BJ Chernick V V eng Journal Article Canada Can J Physiol Pharmacol 0372712 0008-4212 0 Dinitrophenols IM Animals Blood Pressure drug effects Brain Stem drug effects metabolism Denervation Dinitrophenols pharmacology Female Fetus Heart Rate drug effects Hydrogen-Ion Concentration Male Oxygen Consumption drug effects Pregnancy Sheep Subarachnoid Space drug effects metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 134 10.1139/y75-101 135 1976 03 01 2019 07 20 0008-4166 21 10 1975 Oct Canadian journal of microbiology Can J Microbiol Soil fungistasis: elevation of the exogenous carbon and nitrogen requirements for spore germination by fungistatic volatiles in soils. 1468-75 Axenic, washed conidia of Fusarium solani f. sp. phaseoli, Aspergillus flavus, and Verticillium albo-atrum were placed on washed Difco purified agar discs along with an inorganic salt solution containing various levels of carbon and nitrogen substrates. These discs were exposed to volatiles from six soils (pH 5.1-8.6). Fusarium solani macroconidial germination was inhibited mostly by volatiles from soils of pH 5.1, 6.1, 7.0, and 7.5, but high levels of glucose and NH4Cl reversed this inhibition, raising germination to that of no-soil, no-carbon or nitrogen controls. Conidial germination of A. flavus was inhibited mainly by volatiles from high pH (7.0, 7.8, and 8.6) soils, and increased levels of glucose plus an amino acid mixture nullified this inhibition. Volatiles from soils of pH 5.1, 6.1, and 7.5 stimulated A. flavus conidial germination. Assays after the removal of CO2 from the air above soil of pH 5.1 demonstrated that volatiles inhibitory to A. flavus were produced by this soil. Assays indicated that a KOH-soluble compound was a fungistatic soil volatile to F. solani macroconidial germination. The nullification by carbon and nitrogen substrates of F. solani and A. flavus inhibition caused by soil volatiles parallels that for soil fungistasis. Conidial germination of V. albo-atrum was markedly stimulated by volatiles in all soils tested, and was not affected by removal of CO2. Inhibitory soil volatiles may increase the nutritional requirements for spore germination of certain fungi. Griffin G J GJ Hora T S TS Baker R R eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Canada Can J Microbiol 0372707 0008-4166 0 Amino Acids 0 Antifungal Agents 0 Soil IY9XDZ35W2 Glucose IM Amino Acids metabolism Antifungal Agents pharmacology Aspergillus flavus growth & development metabolism Fusarium growth & development metabolism Glucose metabolism Hydrogen-Ion Concentration Mitosporic Fungi growth & development metabolism Models, Biological Soil Soil Microbiology Spores, Fungal growth & development metabolism Volatilization 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 135 10.1139/m75-218 136 1976 03 01 2019 07 20 0008-4166 21 10 1975 Oct Canadian journal of microbiology Can J Microbiol Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivo. 1484-91 Earlier work showed that Escherichia coli contains at least two enzymes which reduce nitrofurazone and other nitrofuran derivatives. One of these enzymes is lacking in some nitrofurazone-resistant mutant strains. We now report that there are three separable nitrofuran reductases in this organism: reductase I (mol. wt. approximately 50 000, insensitive to O2), reductase IIa (mol. wt. approximately 120 000, inhibited by oxygen), reductase IIb (mol. wt. approximately 700 000, inhibited by O2). Unstable metabolites formed during the reduction of nitrofurazone by preparations containing reductases IIa and IIb produce breaks in DNA in vitro. In vivo experiments with nitrofurazone-resistant strains, which lack reductase II but contain reductases IIa and IIb, demonstrated that lethality, mutation, and DNA breakage are all greatly increased when cultures are incubated under anaerobic conditions, i.e., conditions such that reductase II is active. These results provide further evidence for the importance of reductive activation of nitrofurazone. McCalla D R DR Olive P P Tu Y Y Fan M L ML eng Journal Article Canada Can J Microbiol 0372707 0008-4166 0 DNA, Bacterial 0 Isoenzymes EC 1.- Oxidoreductases X8XI70B5Z6 Nitrofurazone IM Aerobiosis Anaerobiosis Cell-Free System DNA, Bacterial metabolism Escherichia coli enzymology metabolism Hot Temperature Hydrogen-Ion Concentration Isoenzymes metabolism Molecular Weight Mutation Nitrofurazone metabolism pharmacology Nucleic Acid Denaturation Oxidation-Reduction Oxidoreductases metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 136 10.1139/m75-220 137 1976 03 01 2019 07 20 0008-4166 21 10 1975 Oct Canadian journal of microbiology Can J Microbiol Enzymatic hydrolysis of agar: purification and characterization of neoagarobiose hydrolase and p-nitrophenyl alpha-galactoside hydrolase. 1512-8 The mixture of polysaccharides in the gelling component of agar (agarose) is hydrolyzed to D-galactose and 3,6-anhydro-L-galactose by a series of hydrolytic enzymes obtained from Pseudomonas atlantica. The final degradative step in the pathway of agarose decomposition is the hydrolysis of the alpha-linkage in the dissaccharide neoagarobiose yielding D-galactose and 3,6-anhydro-L-galactose. Pseudomonas atlantica when grown on agar produces two specific enzymes, p-nitrophenyl alpha-galactose hydrolase and neoagarobiose hydrolase. The purification and partial characterization of both enzymes are presented. Day D F DF Yaphe W W eng Journal Article Canada Can J Microbiol 0372707 0008-4166 0 Polysaccharides 28347-45-7 Nitrophenylgalactosides 9002-18-0 Agar 9FN79X2M3F Lithium 9NEZ333N27 Sodium EC 3.2.1.- Glycoside Hydrolases RWP5GA015D Potassium SU46BAM238 Ammonium Sulfate IM Agar metabolism Ammonium Sulfate Cell Membrane enzymology Cell-Free System Chemical Precipitation Glycoside Hydrolases isolation & purification metabolism Hydrogen-Ion Concentration Hydrolysis Lithium pharmacology Molecular Weight Nitrophenylgalactosides metabolism Polysaccharides Potassium pharmacology Pseudomonas enzymology metabolism Seawater Sodium pharmacology Water Microbiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 137 10.1139/m75-223 138 1976 03 01 2020 02 25 0008-4166 21 10 1975 Oct Canadian journal of microbiology Can J Microbiol Temperature and pH optima for 21 species of thermophilic and thermotolerant fungi. 1535-40 A glucose-containing mineral medium supplemented with 0.01% yeast extract is described upon which all the species of thermophilic and thermotolerant fungi tested will grow. Thirteen of the 21 species do not require the yeast extract supplement for growth. Using this solid, supplemented mineral medium, the pH and temperature optima for growth of all strains were measured. No correlation was found between temperature optimum and pH optimum among members of the group tested. Rosenberg S L SL eng Journal Article Canada Can J Microbiol 0372707 0008-4166 9002-18-0 Agar IY9XDZ35W2 Glucose IM Agar Fungi growth & development Glucose Hydrogen-Ion Concentration Saccharomyces cerevisiae Species Specificity Temperature 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 138 10.1139/m75-225 Respir Care. 2004 Oct;49(10):1213-6 15447805 Respir Care. 2004 Oct;49(10):1217-21 15447806 Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000005 17443628 Science. 1974 Jun 28;184(4144):1361 17810463 Nutr Clin Pract. 2007 Dec;22(6):641-6 18042952 Nurse Educ Pract. 2008 Jan;8(1):41-5 18086452 Chest. 2008 Aug;134(2):457-459 18682467 J Gen Intern Med. 2009 Mar;24(3):393-7 19089510 Clin Med (Lond). 2009 Feb;9(1):22-5 19271595 Nurs Stand. 2009 Apr 29-May 5;23(34):35-9 19480191 Dtsch Arztebl Int. 2008 Feb;105(5):78-83 19633788 BMC Med Educ. 2009 Dec 08;9:71 19995448 139 1976 03 01 2019 07 20 0008-4166 21 10 1975 Oct Canadian journal of microbiology Can J Microbiol Physiological differences among isolates of Phytophthora cinnamomi. 1548-52 Significant differences in amylase, beta-glucosidase, and phosphatase activities were observed among four Phytophthora cinnamomi isolates grown in nutrient-amended sterilized soil for 20 days. Amylase pH optima for the four isolates were within a relatively narrow range; at pH 5.5 each isolate was within 90% of its peak activity. Isolates SB-216-1, 1-281, and C-39 each exhibited maximal beta-glucosidase activity at pH 5.0 and maximal phosphatase activity at pH 5.0-5.5. Maximal activity for these two enzymes of isolate A-7725 occurred at pH 3.5. In timed experiments, isolates 1-281 and A-7725 exhibited greater amylase activities than did the other two isolates. For beta-glucosidase, greatest activity was observed for SB-216-1; ACTivity of 1-281 was intermediate and least activity was observed for isolates A-7725 and C-39. Isolates SB-216-1 and 1-281 exhibited greatest phosphatase activities; isolate C-39 was intermediate in activity, and A-7725 was least active. Results indicate that significant differences exist among the isolates tested and that these differences can be quantitatively measured by the methods described. Kelley W D WD eng Journal Article Canada Can J Microbiol 0372707 0008-4166 EC 3.1.3.2 Phosphoric Monoester Hydrolases EC 3.2.1.- Amylases EC 3.2.1.- Glucosidases IM Amylases metabolism Fungi enzymology Glucosidases metabolism Hydrogen-Ion Concentration Phosphoric Monoester Hydrolases metabolism Phytophthora enzymology Soil Microbiology Species Specificity Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 139 10.1139/m75-227 140 1976 03 01 2019 07 20 0008-4166 21 11 1975 Nov Canadian journal of microbiology Can J Microbiol Regulation and properties of an invertase from Clostridium pasteurianum. 1711-8 An intracellular invertase was induced in cultures of Clostridium pasteurianum utilizing sucrose as its carbon source for growth. This enzyme synthesis could be repressed by the addition of fructose of a sucrose-growing culture. In contrast, invertase activity was not affected by the addition of glucose to sucrose-growing cells and this enzyme could be induced in a glucose-metabolizing culture by the addition of sucrose. This enzyme was purified 10.5-fold over the induced lese, EC 3.2.1.26) by substrate-specificity studies. Invertase had a pH optimum of 6.5 and an apparent Km of 79.5 mM for sucrose, and required high concentration of potassium phosphate for maximum activity. Invertase was completely inactivated by a 2-min heat treatment at 60 degrees C. This enzyme was strongly inhibited by p-hydroxymercuribenzoate (pCMB) and weakly inhibited by 5,5'-dithiobis(2-nitrobenzoic acid), while cysteine could substantially reverse pCMB) inhibition, suggesting that sulfhydryl group(s) were necessary for invertase activity. Laishley E J EJ eng Journal Article Canada Can J Microbiol 0372707 0008-4166 0 Hydroxymercuribenzoates 0 Phosphates 30237-26-4 Fructose 57-50-1 Sucrose 9BZQ3U62JX Dithionitrobenzoic Acid EC 3.2.1.48 Sucrase IY9XDZ35W2 Glucose K848JZ4886 Cysteine IM Cell-Free System Clostridium enzymology metabolism Cysteine pharmacology Dithionitrobenzoic Acid pharmacology Enzyme Induction Enzyme Repression Fructose metabolism Glucose metabolism Hot Temperature Hydrogen-Ion Concentration Hydroxymercuribenzoates pharmacology Phosphates pharmacology Sucrase biosynthesis metabolism Sucrose metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 140 10.1139/m75-251 141 1976 03 01 2019 07 20 0008-4166 21 11 1975 Nov Canadian journal of microbiology Can J Microbiol Characterization studies on the membrane-bound adenosine triphosphatase (ATPase) of Azotobacter vinelandii. 1807-14 The adenosinetriphosphatase (ATPase) (EC 3.6.1.3) activity in Azotobacter vinelandii concentrates in the membranous R3 fraction that is directly associated with Azotobacter electron transport function. Sonically disrupted Azotobacter cells were examined for distribution of ATPase activity and the highest specific activity (and activity units) was consistently found in the particulate R3 membranous fraction which sediments on ultracentrifugation at 144 000 X g for 2 h. When the sonication time interval was increased, the membrane-bound ATPase activity could neither be solubilized nor released into the supernatant fraction. Optimal ATPase activty occurred at pH 8.0; Mg2+ ion when added to the assay was stimulatory. Maximal activity always occurred when the Mg2+:ATP stoichiometry was 1:1 on a molar ratio at the 5 mM concentration level. Sodium and potassium ions had no stimulatory effect. The reaction kinetics were linear for the time intervals studied (0-60 min). The membrane-bound ATPase in the R3 fraction was stimulated 12-fold by treatment wiTH TRypsin, and fractionation studies showed that trypsin treatment did not solubilize ATPase activity off the membranous R3 electron transport fraction. The ATPase was not cold labile and the temperature during the preparation of the R3 fraction had no effect on activity; overnight refrigeration at 4 degrees C, however, resulted in a 25% loss of activity as compared with a 14% loss when the R3 fraction was stored overnight at 25 degrees C. A marked inactivation (although variable, usually about 60%) did occur by overnight freezing (-20 degrees C), and subsequent sonication failed to restore ATPase activity. This indicates that membrane reaggregation (by freezing) was not responsible for ATPase inactivation. The addition of azide, ouabain, 2,4-dinitrophenol, or oligomycin to the assay system resulted in neither inhibition nor stimulation of the ATPase activity. The property of trypsin activation and that ATPase activity is highest in the R3 electron transport fraction suggests that its probable functional role is in coupling of electron transport to oxidative phosphorylation. Jurtshuk P P McEntire J E JE eng Journal Article Research Support, U.S. Gov't, P.H.S. Canada Can J Microbiol 0372707 0008-4166 EC 3.4.21.4 Trypsin EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium IM Adenosine Triphosphatases metabolism Azotobacter enzymology Cell-Free System Drug Stability Electron Transport Enzyme Activation Freezing Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Sonication Subcellular Fractions enzymology Trypsin pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 141 10.1139/m75-263 142 1976 03 01 2020 02 25 0008-4166 21 11 1975 Nov Canadian journal of microbiology Can J Microbiol Effects of zinc-smelter emissions on forest soil microflora. 1855-65 Within 2 km of a zinc (Zn) smelter in Palmerton, Pennsylvania, near the Lehigh Water Gap, up to 13.5% Zn by weight has been measured in the O2 horizon of the soil, and up to 8% Zn in the A1 horizon. The total numbers of bacteria, actinomycetes, and fungi (measured by dilution plate counts) were greatly reduced in the most severely Zn-contaminated soils compared with control soils. The reduction of microbial populations may be a partial cause of the decreased rate of litter decomposition at Lehigh Gap. Growth of most bacteria from control sites was reduced by 100 to 200 muM Zn, most actinomycetes by 100 muM Zn, and most fungi by 100 to 1000 muM Zn in thin-Pablum extract agar (TPab). All the tested actinomycetes and non-spore-forming bacteria isolated from Zn-contaminated Lehigh Gap soils were Zn-tolerant, growing normally in media containing 600-2000 muM Zn. Most fungi, regardless of source, were capable of at least 50% of normal growth at 700 muM Zn. Zinc-tolerant bacteria, actinomycetes, and fungi were readily isolated from low-Zn soils, suggesting that selection for Zn tolerance may proceed rapidly. Acidophilic Mortierella species have been selectively eliminated near the smelter, apparently because of elevated soil pH. Peryronellaea glomerata (Corda) Goidanich and Coniothyrium spp. were found only in the high-Zn soils. Jordan M J MJ Lechevalier M P MP eng Journal Article Canada Can J Microbiol 0372707 0008-4166 J41CSQ7QDS Zinc IM Actinomycetales drug effects growth & development Bacteria drug effects growth & development Cell Count Environmental Pollution Fungi drug effects growth & development Hydrogen-Ion Concentration Soil Microbiology Species Specificity Trees Zinc pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 142 10.1139/m75-269 Health Aff (Millwood). 2002 Mar-Apr;21(2):78-93 11900188 BMJ. 2005 Mar 5;330(7490):489-90 15746107 Clin Med (Lond). 2010 Jun;10(3):218-9 20726446 Clin Med (Lond). 2011 Feb;11(1):57-60 21404787 143 1976 02 20 2019 12 10 0008-5472 35 12 1975 Dec Cancer research Cancer Res alpha-Naphthoflavone activation of 6-hydroxymethylbenzo(alpha)pyrene synthetase. 3731-4 alpha-Naphthoflavone activates the aryl hydroxymethyl synthetase of both the microsomal membrane-bound and soluble enzymes of rat liver and rat lung. The enzyme catalyzes the hydroxymethylation of benzo(alpha)pyrene to the 6-hydroxymethyl derivative. Sloane N H NH eng Journal Article United States Cancer Res 2984705R 0008-5472 0 Benzoflavones 0 Benzopyrenes 0 Flavonoids 604-59-1 alpha-naphthoflavone EC 2.- Transferases EC 2.1.2.- 6-hydroxymethylbenzo(alpha)pyrene synthetase EC 2.1.2.- Hydroxymethyl and Formyl Transferases IM Animals Benzoflavones Benzopyrenes Enzyme Activation Flavonoids pharmacology Hydrogen-Ion Concentration Hydroxymethyl and Formyl Transferases Lung ultrastructure Membranes metabolism Microsomes drug effects enzymology Microsomes, Liver enzymology Rats Transferases metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 143 144 1976 02 26 2019 08 13 0008-6215 44 1 1975 Oct Carbohydrate research Carbohydr Res Isolation and characterization of an unsubstituted 2,3-unsaturated sugar, trans-2,3-dideoxy-D-glycero-pent-2-enose, produced by thermal dehydration of 2-deoxy-D-erythro-pentose. 126-32 Esterbauer H H Sanders E B EB Schubert J J eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Carbohydr Res 0043535 0008-6215 0 Deoxy Sugars IM Deoxy Sugars chemical synthesis Hydrogen-Ion Concentration Spectrum Analysis Temperature 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 144 S0008-6215(00)84345-1 10.1016/s0008-6215(00)84345-1 145 1976 03 01 2017 03 22 0069-0384 7 2 1975 Cardiovascular clinics Cardiovasc Clin Prophylactic antiarrhythmic drug therapy in acute myocardial infarction. 203-17 Binnion P F PF Das Gupta R R eng Journal Article Review United States Cardiovasc Clin 0213744 0069-0384 0 Adrenergic beta-Antagonists 0 Anti-Arrhythmia Agents 6158TKW0C5 Phenytoin 78ZP3YR353 Bretylium Tosylate 7C0697DR9I Atropine 98PI200987 Lidocaine ITX08688JL Quinidine L39WTC366D Procainamide IM Adrenergic beta-Antagonists therapeutic use Anti-Arrhythmia Agents therapeutic use Arrhythmias, Cardiac etiology prevention & control therapy Atropine therapeutic use Bretylium Tosylate therapeutic use Humans Lidocaine adverse effects therapeutic use Myocardial Infarction complications mortality Phenytoin therapeutic use Procainamide therapeutic use Quinidine therapeutic use 110 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 145 146 1976 02 09 2020 02 25 0008-7335 114 43 1975 Oct 24 Casopis lekaru ceskych Cas Lek Cesk [Influence of beta-blocking agents on experimental atherosclerosis of cocks (author's transl)]. 1320-5 Reinis Z Z Lojda Z Z Heyrovský A A Horáková D D Reisenauer R R cze English Abstract Journal Article Vliv betablokátoru na experimentální aterosklerózu kohoutu Czech Republic Cas Lek Cesk 0004743 0008-7335 0 Adrenergic beta-Antagonists 0 Cholesterol, Dietary IM Adrenergic beta-Antagonists therapeutic use Animals Arteriosclerosis drug therapy Chickens Cholesterol, Dietary administration & dosage Disease Models, Animal Male 1975 10 24 1975 10 24 0 1 1975 10 24 0 0 ppublish 146 BMJ. 2001 Apr 7;322(7290):807-8 11290619 BMJ. 2004 Aug 14;329(7462):360-1 15310588 J Eval Clin Pract. 2008 Dec;14(6):974-8 18462284 147 1976 02 09 2019 07 20 0008-8749 19 2 1975 Oct Cellular immunology Cell Immunol Cytotoxic interaction between gorgonian explants: mode of action. 194-200 Theodor J L JL Senelar R R eng Journal Article Netherlands Cell Immunol 1246405 0008-8749 555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone HG18B9YRS7 Valine IM Animals Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology Cnidaria immunology Culture Techniques Cytotoxicity Tests, Immunologic Models, Biological Oxidative Phosphorylation drug effects Valine metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 147 0008-8749(75)90203-8 10.1016/0008-8749(75)90203-8 148 1976 02 09 2019 08 23 0009-2797 11 5 1975 Nov Chemico-biological interactions Chem Biol Interact The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver. 313-28 (1) The effect of feeding a relatively low-protein diet containing 0.06% DAB for 29 weeks on the activity of DAB-azoreductase, nitroreductase (p-nitrobenzoic acid), N-oxidase (N,N-dimethylaniline), N-demethylase (DAB), cytochrome P-450, NADPH-cytochrome c reductase, beta-glucuronidase and arylsulphatase A were studied. Rapid decreases occurred in the activities of the first six enzymes, reaching minimal values at between 4 and 8 weeks. Activities then increased in all cases to control or nearly control levels. This rate of increase was least for cytochrome P-450. At 4 weeks azoreductase activity with the chemotherapeutic agent CB10-252 (I) as substrate was significantly higher than in control rats. Early increases occurred in the activities of beta-glucuronidase and arylsulphatase A and the activity of the latter never dropped below the control level. (2) An investigation was made of the differential effects of dye feeding on some of the enzyme activities in the two major liver lobes and differences were found. (3) The effect of phenobarbital (PB) pretreatment on the DAB-fed rats was studied at 4-week intervals. The activities of DAB-azoreductase and of nitroreductase increased throughout the whole period, while the activities of the lysosomal enzymes were decreased. (4) After feeding DAB for 4 weeks the effect of PB and 3-methylcholanthrene (MC) on the activities of DAB-azoreductase, CB10-252-azoreductase and components of the azoreductases-cytochrome P-450, NADPH-cytochrome c reductase, the CO-CB10-252-azoreductase was not induced by PB or MC, and CO did not inhibit its reduction. Its reduction depended only slightly on NADH. CO caused a greater relative decrease in the activity of DAB-azoreductase in dye-fed animals and also in animals following PB and MC pretreatment, implying a greater role of cytochrome P-450 in dye-fed animals. Autrup H H Thurlow B J BJ Warwick G P GP eng Journal Article Ireland Chem Biol Interact 0227276 0009-2797 56-49-5 Methylcholanthrene 7U1EE4V452 Carbon Monoxide 9035-51-2 Cytochrome P-450 Enzyme System A49L8E13FD p-Dimethylaminoazobenzene EC 1.- Oxidoreductases EC 1.5.- Oxidoreductases, N-Demethylating EC 1.6.2.4 NADPH-Ferrihemoprotein Reductase EC 1.7.- Nitrate Reductases EC 3.1.6.8 Cerebroside-Sulfatase EC 3.2.1.31 Glucuronidase YQE403BP4D Phenobarbital IM Animals Carbon Monoxide pharmacology Cerebroside-Sulfatase metabolism Cytochrome P-450 Enzyme System metabolism Glucuronidase metabolism Liver drug effects enzymology Lysosomes drug effects enzymology Male Methylcholanthrene pharmacology Microsomes, Liver drug effects enzymology NADPH-Ferrihemoprotein Reductase metabolism Nitrate Reductases metabolism Oxidoreductases metabolism Oxidoreductases, N-Demethylating metabolism Phenobarbital pharmacology Rats p-Dimethylaminoazobenzene pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 148 0009-2797(75)90001-0 10.1016/0009-2797(75)90001-0 149 1976 02 09 2019 08 23 0009-2797 11 5 1975 Nov Chemico-biological interactions Chem Biol Interact Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4'-di(2"-bromopropyl)-aminophenylazo]benzoic acid (CB10-252), a compound possessing latent cytotoxic activity. 329-42 The system involved in the reduction of 2-[4'-di(2''-bromopropyl) aminophenylazolbenzoic acid (CB10-252), an agent designed for treating primary liver cell cancer, has been demonstrated to be localised mainly in the 108 000 X g supernatant fraction of rat liver homogenate. It is also present in other organs particularly in the spleen. DAB-azoreductase as shown previously is present almost entirely in the microsomal fraction and is found in high concentration only in liver. The pH maximum for CB10-252-azoreductase implying the importance of the 2'-carboxyl group in determining substrate specificity. The use of enzyme inhibitors and other additives showed that CB10-252 WAS NOT AXANTHINE OXIDASE OR DIHYDROFOLATE REDUCTASE. Its activity was not affected by carbon monoxide, phenobarbitone (PB), or 3-methylcholanthrene (MC) pretreatment. Enhancement of the activity by ferrous ions and FAD indicated that at least part of the reduction system could involve a flavoprotein with FAD as the prosthetic group. The activity of CB10-252-azoreductase and methylred-azoreductase was reduced by menadione (vitamin K3), cyanide and propylgallate. A diaphorase preparation from pig heart reduced both CB10-252 and methylred with both NADPH- and NADH-generating systems. Autrup H H Warwick G P GP eng Comparative Study Journal Article Ireland Chem Biol Interact 0227276 0009-2797 0 Azo Compounds 146-14-5 Flavin-Adenine Dinucleotide 56-49-5 Methylcholanthrene 7N464URE7E Flavin Mononucleotide EC 1.- Oxidoreductases EC 1.6.- NADH, NADPH Oxidoreductases YQE403BP4D Phenobarbital IM Animals Azo Compounds Cecum enzymology Cell Fractionation Cytosol enzymology Enzyme Induction drug effects Flavin Mononucleotide pharmacology Flavin-Adenine Dinucleotide pharmacology Hydrogen-Ion Concentration Kinetics Liver drug effects enzymology Male Methylcholanthrene pharmacology Microsomes, Liver drug effects enzymology NADH, NADPH Oxidoreductases metabolism Organ Specificity Oxidoreductases metabolism Phenobarbital pharmacology Rats Subcellular Fractions enzymology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 149 0009-2797(75)90002-2 10.1016/0009-2797(75)90002-2 150 1976 02 09 2020 02 25 0009-2797 11 5 1975 Nov Chemico-biological interactions Chem Biol Interact Mercury inhibition of avian fatty acid synthetase complex. 343-50 (1) Subcutaneous or intra-abdominal injections of 8 mg of HgCl2/100 g body weight markedly depressed hepatic fatty acid synthetase activity of chicks at 1 h post-injection. The depression occurred despite the fact that the chicks continued to eat up until the time they were killed. Under these same conditions, the hepatic activity of acetyl-CoA carboxylase (EC 6.4.1.2) was not affected by HgCl2, while the activity of the mitochondrial system of fatty acid elongation was stimulated. (2) When 2-mercaptoethanol was included in the incubation medium for a highly purified preparation of fatty acid synthetase, 500 muM HgCl2 was required to show definite inhibition of the enzyme. When 2-mercaptoethanol was omitted, 50 muM HgCl2 was inhibitory and 100 muM HgCl2 abolished enzyme activity. (3) 2 mM dithiothreitol completely protected the purified fatty acid synthetase preparation from inhibition by 100 muM HgCl2. When dithiothreitol was added after the addition of enzyme to the mercury-containing medium, protection of the enzyme was not complete. (4) Dialysis of cytosol fractions from chicks injected with HgCl2 against 500 vol. of 0.2 M potassium phosphate buffer (pH 7.0) containing 1 mM EDTA and 10 mM dithiothreitol for 4 h at 4 degrees stimulated the fatty acid synthetase activity of the fractions. Dialysis of cytosol fractions from noninjected chicks under the same conditions was without effect on fatty acid synthetase activity. (5) These data support the hypothesis that the inhibitory effect of HgCl2 administered in vivo on hepatic fatty acid synthetase activity in chicks is mediated through the interaction of mercury with the sulfhydryl groups of the enzyme. Donaldson W E WE eng Journal Article Research Support, U.S. Gov't, P.H.S. Ireland Chem Biol Interact 0227276 0009-2797 EC 2.3.1.85 Fatty Acid Synthases EC 6.4.1.2 Acetyl-CoA Carboxylase FXS1BY2PGL Mercury IM Acetyl-CoA Carboxylase metabolism Animals Body Weight Chickens Cytosol enzymology Fatty Acid Synthases antagonists & inhibitors Liver cytology drug effects enzymology Mercury pharmacology Mitochondria, Liver drug effects enzymology Organ Size 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 150 0009-2797(75)90003-4 10.1016/0009-2797(75)90003-4 Thorax. 2000 Jul;55(7):550-4 10856313 Lancet. 2000 Jun 3;355(9219):1931-5 10859037 Thorax. 2000 Dec;55(12):1000-6 11083884 Thorax. 2002 Mar;57(3):192-211 11867822 Intensive Care Med. 2002 Dec;28(12):1701-7 12447511 Eur J Emerg Med. 2002 Dec;9(4):320-4 12501030 Chest. 2003 Jan;123(1):67-79 12527605 BMJ. 2003 Jan 25;326(7382):185 12543832 JAMA. 2003 Dec 10;290(22):2985-91 14665660 Am J Med. 2004 Jan 1;116(1):1-7 14706658 Chest. 2005 Mar;127(3):952-60 15764781 Chest. 2005 Aug;128(2):587-94 16100142 JAMA. 2005 Dec 28;294(24):3124-30 16380593 Lancet. 2006 Apr 8;367(9517):1155-63 16616558 Chest. 2006 Sep;130(3):815-21 16963680 Ann Emerg Med. 2007 Dec;50(6):666-75, 675.e1 17764785 Am J Respir Crit Care Med. 2008 Apr 15;177(8):912-27 18390964 N Engl J Med. 2008 Jul 10;359(2):142-51 18614781 Thorax. 2008 Oct;63 Suppl 6:vi1-68 18838559 Clin Med (Lond). 2008 Oct;8(5):517-21 18975486 Heart Lung. 1988 May;17(3):229-37 3284844 JAMA. 1995 Dec 20;274(23):1852-7 7500534 N Engl J Med. 1995 Sep 28;333(13):817-22 7651472 Eur Respir J. 1996 Apr;9(4):795-807 8726948 Crit Care Med. 1997 Apr;25(4):620-8 9142026 N Engl J Med. 1997 Aug 21;337(8):536-42 9262498 Control Clin Trials. 1997 Dec;18(6):568-79; discussion 661-6 9408719 Chest. 1998 May;113(5):1339-46 9596317 151 1976 02 21 2019 10 21 280 13 1975 Apr 07 Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles C R Acad Hebd Seances Acad Sci D [Basic phospholipase of Naja nigricollis venom]. 1633-5 It is confirmed that N. nigricollis venom contains several phospholipases one of these is a basic phospholipase A. This enzyme is toxic for mice when injected intravenously. In vitro it reacts on egg yolk lecithin producing lysolecithin and prevents the phenomenon of blood clotting. An immunological identity has been established between this basic phospholipase and two acidic phospholipases present in the same venom. Dumarey C C Sket D D Joseph D D Boquet P P fre English Abstract Journal Article Etude d'une phospholipase basique du venin de Naja nigricollis France C R Acad Hebd Seances Acad Sci D 7501107 0 Amino Acids 0 Phosphatidylcholines 0 Snake Venoms EC 3.1.- Phospholipases IM Amino Acids analysis Animals Hydrogen-Ion Concentration Lethal Dose 50 Mice Phosphatidylcholines metabolism Phospholipases analysis metabolism toxicity Rabbits Snake Venoms 1975 4 7 1975 4 7 0 1 1975 4 7 0 0 ppublish 151 152 1976 02 21 2019 10 21 280 13 1975 Apr 07 Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles C R Acad Hebd Seances Acad Sci D [Spontaneous mortality and vascular lesions in 3 rat strains with different blood pressure levels]. 1637-40 We have observed a high and significant mortality in spontaneously hypertensive rats compared to normotensive and hypotensive controls, in the fifth generation. The hypertensive rats exhibited a high frequency of cerebral haemorrhage and periarteritis nodosa. Dupont J J Dupont J C JC Milon H H Froment A A fre English Abstract Journal Article Mortalité spontanée et lesions vasculaires dans 3 souches de rats sélectionnés par leur niveau tensionnel France C R Acad Hebd Seances Acad Sci D 7501107 IM Animals Blood Pressure Cerebral Hemorrhage Female Hypertension mortality pathology Hypotension mortality Longevity Male Meninges pathology Mesenteric Arteries pathology Polyarteritis Nodosa Rats physiology 1975 4 7 1975 4 7 0 1 1975 4 7 0 0 ppublish 152 153 1976 02 09 2019 07 06 0009-7330 37 5 1975 Nov Circulation research Circ Res Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. 550-7 The influence of the sympathetic nervous system on the cerebral circulatory response to graded reductions in mean arterial blood pressure was studied in anesthetized baboons. Cerebral blood flow was measured by the 133Xe clearance method, and arterial blood pressure was decreased by controlled hemorrhage. In normal baboons, the constancy of cerebral blood flow was maintained until mean arterial blood pressure was approximately 65% of the base-line value; thereafter, cerebral blood flow decreased when arterial blood pressure was reduced. Superior cervical sympathectomy of 2-3 weeks duration did not affect the normal response. In contrast, both acute surgical sympathectomy (cervical trunk division) and alpha-receptor blockade (1.5 mg/kg of phenoxybenzamine) enhanced the maintenance of cerebral blood flow in the face of hemorrhagic hypotension in that cerebral blood flow did not decrease until mean arterial blood pressure was approximately 35% of the base-line value. The results indicate that the sympathetic nervous system is not involved in the maintenance of cerebral blood flow in the face of a fall in arterial blood pressure. Indeed, the implication is that the sympathicoadrenal discharge accompanying hemorrhagic hypotension is detrimental to, rather than responsible for, cerebral autoregulation. Fitch W W MacKenzie E T ET Harper A M AM eng Journal Article United States Circ Res 0047103 0009-7330 0 Adrenergic alpha-Antagonists 0TTZ664R7Z Phenoxybenzamine 142M471B3J Carbon Dioxide IM Adrenergic alpha-Antagonists pharmacology Animals Blood Blood Pressure drug effects Blood Transfusion Carbon Dioxide blood Cerebrovascular Circulation drug effects Haplorhini Hemorrhage physiopathology Homeostasis drug effects Hydrogen-Ion Concentration Hypotension physiopathology Papio Phenoxybenzamine pharmacology Sympathectomy Sympathetic Nervous System physiopathology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 153 10.1161/01.res.37.5.550 154 1976 02 09 2020 02 25 0009-7330 37 5 1975 Nov Circulation research Circ Res Influence of hematocrit, blood gas tensions, and pH on pressure-flow relations in the isolated canine lung. 588-96 An isolated perfused canine lung preparation in which determinants of vascular caliber could be individually controlled was developed. The relation of pulmonary arterial (Pa), venous (PV), and alveolar (PA) pressures was such that Pa greater than PA greater than PV throughout the whole lung. The addition of isoprenaline to the perfusate abolished vascular reactivity. Once stability was reached, vascular cross-sectional area remained acceptably constant for 2.25 hours as judged by normalized conductance. The influence of perfusate hematocrit, blood gas tensions, and pH on pressure-flow relations was then studied in 15 isolated canine lungs. The hematocrit-vascular conductance relation was derived at constant perfusion pressure. Conductance varied linearly with hematocrit over a range of 16.5 to 89.5%. Mean pulmonary arterial blood gas tensions were: PO2 = 121 mm Hg, PCO2 = 28 mm Hg, and pH = 7.46. Acute respiratory acidosis (PO2 = 30 mm Hg, PCO2 = 81 mm Hg, pH = 7.17) and lactic acidosis and hypoxemia (PO2 = 32 mm Hg, PCO2 = 21 mm Hg, pH = 6.96) did not significantly alter this relation. Transformation of the conductance-hematocrit data indicated that hematocrit was the most important determinant of relative apparent viscosity of the blood. Both acute respiratory and lactic acidosis failed to significantly increase relative viscosity within the range of hematocrit usually found in secondary polycythemia. Bucens D D Pain M C MC eng Journal Article United States Circ Res 0047103 0009-7330 0 Lactates 142M471B3J Carbon Dioxide L628TT009W Isoproterenol S88TT14065 Oxygen IM Acidosis physiopathology Acidosis, Respiratory physiopathology Animals Blood drug effects Blood Pressure drug effects Blood Viscosity drug effects Carbon Dioxide blood Dogs Hematocrit Hydrogen-Ion Concentration Isoproterenol pharmacology Lactates Lung pathology Lung Volume Measurements Organ Size Oxygen blood Pressure Pulmonary Circulation drug effects Vascular Resistance drug effects 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 154 10.1161/01.res.37.5.588 Diabet Med. 2001 Feb;18(2):162-4 11251683 Diabetes Care. 2004 Feb;27(2):553-91 14747243 Diabet Med. 2004 Jul;21(7):782-5 15209774 Endocr Res. 2004 Aug;30(3):395-402 15554356 QJM. 2004 Dec;97(12):773-80 15569808 Diabetes Care. 2006 Dec;29(12):2739-48 17130218 Diabetes Care. 2008 Apr;31(4):643-7 18184896 Br Med J. 1973 Jun 9;2(5866):578-80 4197425 Acta Diabetol. 1993;30(4):251-3 8180418 Diabetes Care. 1997 Sep;20(9):1347-52 9283776 155 1976 02 09 2019 07 06 0009-7330 37 5 1975 Nov Circulation research Circ Res Interaction of the chemoreflex and the pulmonary inflation reflex in the regulation of coronary circulation in conscious dogs. 664-73 The interaction of chemoreflex and pulmonary inflation reflex control of the coronary circulation was examined in conscious dogs by comparing the responses to chemoreflex stimulation (intracarotid injection of nicotine) when ventilation was allowed to increase with those when ventilation was controlled. The responses were also compared with those elicited by both forced mechanical and spontaneous hyperinflation. When the heart rate was constant, intracarotidly administered nicotine induced an increase in the depth of respiration followed closely by an increase in late diastolic coronary flow from 48 +/- 2 to 106 +/- 8 ml/min and a reduction in late diastolic coronary resistance from 1.62 +/- 0.08 to 0.78 +/- 0.06 mm Hg/ml min-1. After beta-receptor and cholinergic blockade, a similar coronary dilation in response to nicotine occurred only when ventilation was allowed to increase. However, when ventilation was controlled, intracarotidly administered nicotine increased coronary resistance after combined beta-receptor and cholinergic blockade. The reflex coronary dilation was not observed after carotid sinus nerve section or after alpha-receptor blockade. Thus, nicotine stimulation of the carotid chemoreflex results in a striking coronary dilation that has two components. The minor component involves a chemoreflex with its efferent pathway in tthe vagi. The major component of coronary dilation follows an increase in the depth of respiration, and its efferent component appears to involve withdrawal of alpha-adrenergic constrictor tone. An almost identical period of reflex coronary dilation followed either forced mechanical or spontaneous hyperinflation in the conscious dog. Vatner S F SF McRitchie R J RJ eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States Circ Res 0047103 0009-7330 0 Adrenergic alpha-Antagonists 0 Adrenergic beta-Antagonists 0 Parasympatholytics 6M3C89ZY6R Nicotine IM S Adrenergic alpha-Antagonists pharmacology Adrenergic beta-Antagonists pharmacology Animals Autonomic Nerve Block Blood Pressure drug effects Carotid Sinus innervation Chemoreceptor Cells drug effects Coronary Circulation drug effects Dilatation, Pathologic physiopathology Dogs Hyperventilation physiopathology Injections, Intra-Arterial Lung physiology Neurons, Afferent physiopathology Nicotine administration & dosage pharmacology Parasympatholytics pharmacology Pressure Reflex drug effects Respiration drug effects Stimulation, Chemical Vagotomy Vascular Resistance drug effects Vasomotor System drug effects 76064615 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 155 10.1161/01.res.37.5.664 156 1976 02 26 2020 02 25 0009-7330 37 6 1975 Dec Circulation research Circ Res Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts. 733-41 The rate of coronary blood flow was varied in isolated working rat heart preparations to determine its influence on the rate of glocose utilization, tissue high-energy phosphates, and intracellular pH. A 60% reduction in coronary blood flow resulted in a 30% reduction in oxygen consumption, an accelerated rate of glusoe utilization, lower tissue levels of high-energy phosphate, and higher tissue levels of lactate and H+. Ventricular performance deteriorated as reflected by a decrease in heart rate and peak systolic pressure. Further reductions in coronary blood flow resulted in inhibition of glycolysis, a greater decrease in tissue levels of high-energy phosphates, and higher tissue levels of both lactate and H+. These changes in glycolytic flux, tissue metabolites, and ventricular performance were proportional to the degree of restriction in coronary blood flow. The importance of coronary blood flow and washout of the interstitial space in the maintenance of accelerated glycolytic flux in oxygen-deficient hearts is emphasized. It is concluded that acceleration of ATP production from glycolysis can occur only in the marginally ischemic tissue in the peripheral area of tissue supplied by an occluded artery. The central area of tissue which receives a low rate of coronary blood flow will have a reduced rate of ATP production due to both a lack of oxygen and an inhibition of glycolysis. Neely J R JR Whitmer J T JT Rovetto M J MJ eng G1001344 Medical Research Council United Kingdom Journal Article Research Support, U.S. Gov't, P.H.S. United States Circ Res 0047103 0009-7330 0 Lactates 020IUV4N33 Phosphocreatine 8L70Q75FXE Adenosine Triphosphate IM Adenosine Triphosphate analysis Animals Blood Flow Velocity Coronary Circulation Glycolysis Heart physiology Hydrogen-Ion Concentration In Vitro Techniques Lactates analysis Male Myocardium analysis metabolism Oxygen Consumption Phosphocreatine analysis Rats 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 156 10.1161/01.res.37.6.733 J Thromb Thrombolysis. 1995;2(3):227-229 10608028 Thromb Haemost. 2000 Mar;83(3):416-20 10744147 Thromb Haemost. 2000 May;83(5):657-60 10823257 Thorax. 2003 Jun;58(6):470-83 12775856 N Engl J Med. 2004 May 27;350(22):2257-64 15163775 Chest. 2005 Mar;127(3):1051-3 15764793 Circulation. 2008 Apr 1;117(13):1711-6 18347212 Eur Heart J. 2008 Sep;29(18):2276-315 18757870 JAMA. 1990 May 23-30;263(20):2753-9 2332918 157 1976 02 26 2019 07 06 0009-7330 37 6 1975 Dec Circulation research Circ Res Mechanisms of glycolytic inhibition in ischemic rat hearts. 742-51 The mechanisms of glycolytic inhibition in ischemic myocardium were investigated in the isolated, perfused rat heart. Glycolysis was inhibited at the level of glyceraldehyde-3-phosphate dehydrogenase. The major factors that accounted for the glycolytic inhibition in the ischemic heart compared with the anoxic heart appeared to be higher tissue levels of lactate and H+ in the ischemic tissue. Increased extracellular pH inhibited glycolysis in anoxic and hypoxic hearts much more readily than it did in aerobic hearts. However, maintenance of both extracellular and intracellular pH caused only a modest acceleration of glycolysis in ischemic hearts. Accumulation of tissue lactate and inhibition of glycolysis were directly proportional to the reduction in coronary bloow flow in both anoxic and ischemic hearts. At intracellular lactate concentrations between 15 and 20 mM, glycolysis was inhibited under both conditions. Addition of either 10, 20, or 40 mM lactate to the perfusate inhibited glycolysis in aerobic, anoxic, and ischemic hearts. The effect of lactate did not appear to be mediated through changes in intracellular pH. It is concluded that accumulation of lactate represents a major factor in the inhibition of glycolysis that develops in ischemic hearts. Rovetto M J MJ Lamberton W F WF Neely J R JR eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Circ Res 0047103 0009-7330 0 Insulin 0 Lactates IY9XDZ35W2 Glucose IM Animals Blood Flow Velocity Coronary Circulation Coronary Disease metabolism Extracellular Space Glucose administration & dosage Glycolysis Heart Hydrogen-Ion Concentration In Vitro Techniques Insulin administration & dosage Intracellular Fluid Lactates pharmacology Male Myocardium metabolism Perfusion Rats 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 157 10.1161/01.res.37.6.742 158 1976 02 26 2019 07 06 0009-7330 37 6 1975 Dec Circulation research Circ Res Comparison of contractile performance of canine atrial and ventricular muscles. 762-71 This study compared the contractile performance of a canine right atrial trabecula with that of a macroscopically indistinguishable trabecula isolated from the right ventricular apex. The heart was removed from nine mongrel puppies weighing 6-8 kg and placed in Krebs-Ringer's bicarbonate solution. The bathing solution contained only 1.25 mmoles of Ca2+ and was bubbled with a 95% O2-5% CO2 gas mixture. Each atrial trabecula was specially selected from the right atrial appendage. Histologically, these trabeculae showed a remarkable longitudinal orientation of the fibers. At Lmax (the length of the muscle at which developed tension was maximum) under identical conditions of temperature, rate of stimulation, ionic milieu, pH, and O2 and CO2 supply, right atrial trabeculae achieved the same developed and total tensions but in a much shorter time than did ventricular trabeculae. In both muscle groups the maximum developed tension averaged about 2.5 g/mm2. Since Lo (expressed as a fraction of Lmax) was less in atrial muscle than it was in ventribular muscle, we concluded that atrial muscle can be stretched considerably more than can ventricular muscle before optimum length is reached. At any given initial muscle length, the maximum of tension rise for atrial trabeculae amounted to at least twice that for ventricular trabeculae. At any given load up to 1.5 g/mm2, the maximum velocity of shortening of an atrial trabecula was about three to four times that of a ventricular trabecula. These results collectively indicate that the contractile performance of the right atrial muscle is in many respects superior to that of the right ventricle, at least under the conditions of these experiments. Urthaler F F Walker A A AA Hefner L L LL James T N TN eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States Circ Res 0047103 0009-7330 IM Animals Atrial Function Dogs Electric Stimulation Female Humans Hydrogen-Ion Concentration In Vitro Techniques Male Myocardial Contraction Temperature Ventricular Function 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 158 10.1161/01.res.37.6.762 159 1976 03 01 2019 09 02 0009-9120 8 5 1975 Oct Clinical biochemistry Clin Biochem Serum lactate dehydrogenase activity ratios with different substrates. 307-15 1. The lactate dehydrogenase activity of 89 sera from patients suffering myocardial infarction and of 55 sera from patients with hepatocellular damage was assayed under optimal conditions using pyruvate, alpha-oxobutyrate, hydroxypyruvate and glyoxylate as substrates. Activity was also measured with lactate as substrate at different pH values. 2. The ratios of activities under these different assay conditions were calculated for both series of patients. Correct differentiations for single ratios ranged from virtually nil for hydroxypyruvate/alpha-oxobutyrate to is greater than 93 per cent for glyoxylate/hydroxypyruvate and glyoxylate/alpha-oxobutyrate. This was little improved by the use of multiple ratios involving up to seven separate assays. 3. The activity ratio of hydroxypyruvate to pyruvate which is consistently greater than unity was found to be inverted in a case of morphine poisoning. Barlow D D Naghizadeh F F King J J eng Comparative Study Journal Article United States Clin Biochem 0133660 0009-9120 0 Butyrates 0 Glyoxylates 0 Isoenzymes 0 Lactates 0 Pyruvates EC 1.1.1.27 L-Lactate Dehydrogenase IM Butyrates Glyoxylates Humans Hydrogen-Ion Concentration Isoenzymes Kinetics L-Lactate Dehydrogenase blood Lactates Liver enzymology Myocardium enzymology Pyruvates 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 159 S0009-9120(75)93417-7 10.1016/s0009-9120(75)93417-7 160 1976 02 09 2020 02 25 0009-9147 21 13 1975 Dec Clinical chemistry Clin Chem Fluorometric assay for N-acetylprocainamide. 1899-902 We describe a simple, rapid fluorometric assay for separate quantitative analysis of procainamide and N-acetylprocainamide in mixtures. The effective lenear range (fluorescence vs. concentration) in serum is 0.1 to 10.0 mg/liter, regardless of the ratio (by weight) of the two drugs from 1:10 to 10:1. Analytical recoveries by the extraction method used were 100.0 +/- 3.0% and 98.0 +/- 4.0%, respectively. For determination of either compound, the maximum coefficient of variation was 10%. Matusik E E Gibson T P TP eng Journal Article England Clin Chem 9421549 0009-9147 L39WTC366D Procainamide IM Humans Hydrogen-Ion Concentration Procainamide analogs & derivatives blood Spectrometry, Fluorescence 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 160 Age Ageing. 2001 Nov;30 Suppl 4:3-7 11769786 J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):721-5 12023412 Phys Ther. 2003 Mar;83(3):237-52 12620088 J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):678-84 17119004 Clin Rehabil. 2007 Apr;21(4):357-61 17613577 Parkinsonism Relat Disord. 2009 Feb;15(2):110-5 18487069 J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1325-8 19126844 J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1344-9 19126847 Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007146 19370674 Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007830 20091652 161 1976 02 09 2019 07 22 0009-9147 21 13 1975 Dec Clinical chemistry Clin Chem Rapid kinetic measurement of lactate in plasma with a centrifugal analyzer. 1932-4 In this method, blood is collected in ammonium heparinized microhematocrit tubes and lactate is directly determined in the plasma, separated within 15 min from the erythrocytes. Lactate is assayed by mixing 10 mul of sample with NAD+ and lactate dehydrogenase in tris(hydroxymethyl)aminomethane hydrazine buffer. The rate of increase in absorbance of the NADH formed, measured at 340 nm, is proportional to lactate concentration. The assay is complete in 4 min and absorbance is linearly related to concentration from 0.625 to 15 mmol/liter. Analytical recoveries of lactate added to plasma averaged 104% (range, 91-116%). Results compared well for plasma samples analyzed by this method with the CentrifiChem and the Du Pont aca. Pesce M A MA Bodourian S H SH Nicholson J F JF eng Comparative Study Journal Article England Clin Chem 9421549 0009-9147 0 Lactates 0U46U6E8UK NAD EC 1.1.1.27 L-Lactate Dehydrogenase IM Centrifugation Hydrogen-Ion Concentration Kinetics L-Lactate Dehydrogenase metabolism Lactates blood NAD Spectrophotometry 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 161 162 1976 02 09 2020 02 25 0009-9147 21 13 1975 Dec Clinical chemistry Clin Chem Improved high-resolution high-voltage paper electrophoresis system for use in screening for aminoacidopathies. 1981-2 High-voltage paper electrophoresis of small samples of serum and urine at pH 6.0 resolves basic and acidic amino acids and separates them from the neutral amino acids. For separation and identification of the neutral amino acids, the appropriate area of the electrophoretogram is cut out, sewn onto a second sheet of paper, and rerun at pH 1.9. By this method, amino acids are rapidly resolved. It is suited for use with special procedures such as oxidation of biological fluid with performic acid and specific staining for confirmation of amino acid identification. Spiekerman A M AM Hetherly M E ME Hall F F FF eng Comparative Study Journal Article England Clin Chem 9421549 0009-9147 0 Amino Acids IM Amino Acid Metabolism, Inborn Errors diagnosis Amino Acids analysis blood urine Electrophoresis, Paper methods Humans Hydrogen-Ion Concentration 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 162 Acta Neurol Scand. 2000 Nov;102(5):284-91 11083504 Exp Neurol. 2006 Mar;198(1):81-7 16375891 Semin Neurol. 2007 Feb;27(1):58-65 17226742 Neurology. 1992 Jan;42(1):54-9 1734324 Neurosurg Focus. 2007 Apr 15;22(4):E1 17613187 Clin Med (Lond). 2007 Jun;7(3):296-9 17633954 Pract Neurol. 2007 Aug;7(4):252-8 17636141 Acta Neurol Scand. 2008 Jul;118(1):48-53 18205881 Neurol Med Chir (Tokyo). 2008 May;48(5):197-99; discussion 199-200 18497491 Yale J Biol Med. 2008 Mar;81(1):19-29 18604308 J Neurol Sci. 2009 Feb 15;277(1-2):54-7 18990411 Neuroepidemiology. 2009;32(3):171-5 19096225 Arch Neurol. 1989 Jun;46(6):608 2730373 Clin Neurosurg. 1977;24:270-84 583685 Arch Neurol. 1995 Oct;52(10):1017-22 7575219 AJNR Am J Neuroradiol. 1998 Aug;19(7):1277-84 9726467 163 1976 02 09 2019 07 22 0009-9147 21 13 1975 Dec Clinical chemistry Clin Chem Measurement of total alkaline phosphatase activity in human serum. 1988-95 Bowers G N GN Jr McComb R B RB eng Comparative Study Journal Article England Clin Chem 9421549 0009-9147 9G34HU7RV0 Edetic Acid EC 3.1.3.1 Alkaline Phosphatase IM Adult Alkaline Phosphatase blood Blood Specimen Collection Edetic Acid Female Humans Hydrogen-Ion Concentration Male Methods Middle Aged Spectrophotometry Temperature 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 163 164 1976 02 13 2019 07 06 0009-8981 65 1 1975 Nov 15 Clinica chimica acta; international journal of clinical chemistry Clin Chim Acta Problems associated with the determination of arylsulfatase A and B using nitrocatechol sulfate substrate. 1-4 Shapira E E Nadler H L HL eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Clin Chim Acta 1302422 0009-8981 0 Catechols 0 Indicators and Reagents EC 3.1.6.- Sulfatases EC 3.1.6.8 Cerebroside-Sulfatase EC 3.1.6.9 Chondro-4-Sulfatase IM Animals Catechols Cerebroside-Sulfatase analysis metabolism Chondro-4-Sulfatase analysis metabolism Indicators and Reagents Kinetics Spectrophotometry methods Sulfatases analysis 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 164 0009-8981(75)90327-7 10.1016/0009-8981(75)90327-7 165 1976 02 13 2019 07 06 0009-8981 65 1 1975 Nov 15 Clinica chimica acta; international journal of clinical chemistry Clin Chim Acta A clinical method for the determination of serum gamma-glutamyl transpeptidase. 21-7 A simple, highly sensitive and reproducible method for the assay of gamma-glutamyl transpeptidase (EC 2.3.2-) activity is introduced, using gamma-glutamyl-p-nitroanilide as a substrate and glycylglycine as an acceptor in 50 g/l of polyoxyethylene nonylphenol. Serum transpeptidase activity was assayed in 1080 healthy adults, the normal mean value being 14.8 mU/ml. The diagnostic evaluation of the enzyme in various hepatobiliary diseases is also discussed. Tamaoki H H Minato S S Takei S S Fujisawa K K eng Journal Article Netherlands Clin Chim Acta 1302422 0009-8981 0 Detergents EC 2.3.2.2 gamma-Glutamyltransferase IM Adult Biliary Tract Diseases diagnosis Detergents pharmacology Female Humans Liver Diseases diagnosis Male Microchemistry Spectrophotometry methods gamma-Glutamyltransferase blood metabolism 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 165 0009-8981(75)90330-7 10.1016/0009-8981(75)90330-7 166 1976 02 09 2020 02 25 0045-7167 23 9 1975 Sep Horumon to rinsho. Clinical endocrinology Horumon To Rinsho [Inborn error of glycolipid metabolism]. 885-91 Suzuki Y Y jpn Journal Article Review Japan Horumon To Rinsho 0420561 0045-7167 EC 3.1.6.8 Cerebroside-Sulfatase EC 3.2.1.- Galactosidases EC 3.2.1.- Hexosaminidases IM Adolescent Adult Cerebroside-Sulfatase deficiency Child Child, Preschool Female Galactosidases deficiency Gangliosidoses enzymology Hexosaminidases deficiency Humans Infant Leukodystrophy, Globoid Cell enzymology Leukodystrophy, Metachromatic enzymology Lipidoses enzymology Sphingolipidoses classification 27 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 166 Stud Health Technol Inform. 1998;48:74-83 10186577 Drugs Aging. 2000 Oct;17(4):295-302 11087007 Proc Natl Acad Sci U S A. 2001 May 22;98(11):6354-9 11344275 Ageing Soc. 1992;12:269-87 11654434 Clin Rehabil. 2004 Dec;18(8):888-98 15609844 Curr Mol Med. 2005 Mar;5(2):197-203 15974873 Dan Med Bull. 2004 Nov;51(4):315-49 16009060 Br Med J. 1943 Dec 25;2(4329):822-3 20785199 Lancet. 1946 Jun 8;1(6406):841-3 20986120 J Med Ethics. 1987 Sep;13(3):117-23 3669036 Psychol Bull. 1968 Dec;70(6):671-80 5712311 Lancet. 1983 Jun 25;1(8339):1430-3 6134188 J Chronic Dis. 1984;37(5):353-63 6371038 N Engl J Med. 1984 Dec 27;311(26):1664-70 6390207 Lancet. 1993 Oct 23;342(8878):1032-6 8105269 167 1976 02 20 2017 03 22 0301-0430 4 5 1975 Nov Clinical nephrology Clin Nephrol Treatment of renal hypertension. 194-7 There are different types of renal hypertension: hypertension due to parenchymal renal disease, renovascular hypertension, hypertension due to urological disease, hypertension of endstage renal disease. Treatment has to consider-above all-the possibility of specific, medical or surgical procedures that may cause the underlying condition. If the underlying disease is not amenable to specific therapy, symptomatic medical treatment to lower blood pressure is indicated: besides control of sodium-intake and body weight antihypertensive drugs are generally indicated. We use them, alone or in combination, in the following line of order: diuretics, beta-adrenergic blockers, dihydralazine, reserpine, clonidine, alpha-methyldopa, guanethidine. Losse H H eng Journal Article Review Germany Clin Nephrol 0364441 0301-0430 0 Adrenergic beta-Antagonists 0 Antihypertensive Agents 0 Diuretics IM Adrenergic beta-Antagonists therapeutic use Antihypertensive Agents therapeutic use Diuretics therapeutic use Humans Hypertension, Renal drug therapy etiology surgery therapy Kidney Diseases complications Kidney Failure, Chronic complications Middle Aged Nephrectomy Urologic Diseases complications 12 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 167 169 1976 02 13 2020 02 25 0009-9228 14 12 1975 Dec Clinical pediatrics Clin Pediatr (Phila) Some pharmacologic aspects of the antihistamines. A survey of current clinical applications. 1119-24 Zepp E A EA Thomas J A JA Knotts G R GR eng Journal Article United States Clin Pediatr (Phila) 0372606 0009-9228 0 Histamine H1 Antagonists AIM IM Chemical Phenomena Chemistry Histamine H1 Antagonists administration & dosage adverse effects pharmacology therapeutic use Humans Hypersensitivity drug therapy 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 169 10.1177/000992287501401205 Free Radic Biol Med. 1999 Mar;26(5-6):495-500 10218637 J Mol Biol. 1975 Sep 15;97(2):257-65 1177323 J Theor Biol. 1975 Sep;53(2):481-96 1195775 Nature. 2008 Feb 7;451(7179):644-7 18256658 Nature. 2008 Oct 23;455(7216):1057-60 18948946 Lancet. 1969 Dec 27;2(7635):1411-4 4188291 Nature. 1977 Nov 24;270(5635):301-4 593350 Hum Genet. 1982;60(2):101-21 7042533 J Theor Biol. 1994 May 7;168(1):75-94 8022192 Nat Genet. 1994 Jan;6(1):29-32 8136829 Hum Genet. 1993 Jul;91(6):519-26 8340104 Mutat Res. 1996 May;316(5-6):209-36 8649456 Science. 1977 Oct 28;198(4315):366-72 910134 Nature. 1998 Dec 24-31;396(6713):743-6 9874369 170 1976 02 19 2020 02 25 0301-0538 49 5 1975 Nov Clinical science and molecular medicine Clin Sci Mol Med Anaerobic glycolysis in normal human erythrocytes incubated in vitro with sodium salicylate. 375-84 1. Some effects of sodium salicylate upon anaerobic glycolysis have been studied in normal human erythrocytes incubated for up to 6 h at 37 degrees C in autologous sera. 2. Both glucose consumption and lactate production were stimulated by concentrations of salicylate up to 60 mmol/l but at the highest concentration used (90 mmol/l) an initial stimulus was followed by inhibition of glycolysis. 3. Losses occurred of adenosine 5'-triphosphate (ATP), adenosine 5'-diphosphate (ADP) and adenosine 5'-phosphate(AMP)at higher concentrations of salicylate and there was a concomitant increase of inorganic phosphate. 4. Other phosphate esters underwent concentration changes at higher concentrations of salicylate that reflected inadequate concentrations of ATP for glycolysis. 5. The rates of sodium efflux from, and potassium influx into, erythrocytes were unaffected by the presence of salicylate at concentrations sufficient to stimulate glycolysis. Worathumrong N N Grimes A J AJ eng Journal Article England Clin Sci Mol Med 0367540 0301-0538 0 Blood Glucose 0 Lactates 0 Phosphates 0 Pyruvates 415SHH325A Adenosine Monophosphate 61D2G4IYVH Adenosine Diphosphate 8L70Q75FXE Adenosine Triphosphate 9NEZ333N27 Sodium RWP5GA015D Potassium WIQ1H85SYP Sodium Salicylate IM Adenosine Diphosphate blood Adenosine Monophosphate blood Adenosine Triphosphate blood Blood Glucose Dose-Response Relationship, Drug Erythrocytes drug effects metabolism Glycolysis drug effects Hematocrit Humans Hydrogen-Ion Concentration In Vitro Techniques Lactates biosynthesis Phosphates blood Potassium blood Pyruvates blood Sodium blood Sodium Salicylate pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 170 10.1042/cs0490375 Ann Rheum Dis. 2000 May;59(5):331-7 10784513 J Epidemiol Community Health. 2002 Apr;56(4):246-52 11896130 J Am Geriatr Soc. 2003 May;51(5):636-41 12752838 Clin Geriatr Med. 1992 Feb;8(1):35-50 1576579 J Gerontol A Biol Sci Med Sci. 2005 Jun;60(6):768-76 15983181 Br J Sports Med. 2009 Jan;43(1):25-7 19019904 Neuropsychobiology. 2009;59(4):191-8 19521110 Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002759 19588334 Prev Med. 2009 Oct;49(4):283-5 19686772 Diabetes Care. 2009 Nov;32(11):2136-7 19875609 J Am Geriatr Soc. 2010 Jan;58(1):70-5 20002505 Lancet. 2010 Mar 13;375(9718):916-23 20189241 Br Med Bull. 2010;95:139-59 20200012 Rejuvenation Res. 2010 Feb;13(1):3-11 20230273 J Gerontol. 1991 May;46(3):M69-76 2030269 Age Ageing. 2010 Jul;39(4):412-23 20392703 Ageing Res Rev. 2010 Oct;9(4):369-83 20438881 Trials. 2011 Feb 02;12:27 21288340 Acta Med Scand Suppl. 1986;711:227-32 3465207 Age Ageing. 1995 Jul;24(4):308-14 7484488 Age Ageing. 1994 Sep;23(5):371-7 7825481 171 1976 02 19 2019 10 21 0301-0538 49 5 1975 Nov Clinical science and molecular medicine Clin Sci Mol Med Arterial catecholamines in hypoxic exercise in man. 503-6 1. We measured the minute ventilation and arterial blood catecholamine concentrations in four normal men standing and at two levels of moderate treadmill exercise breathing 14% oxygen or air. 2. Minute ventilation was significantly higher during hypoxic exercise than during normoxic exercise at an oxygen uptake of 1500 ml/min. 3. Arterial plasma noradrenaline during hypoxic exercise at an oxygen uptake of 1500 ml/min was significantly greater than at rest. 4. Arterial plasma noradrenaline during normoxic exercise at an oxygen uptake of 1500 ml/min was not elevated above the resting concentration. 5. The results are compatible with the suggestion that increased concentrations of arterial plasma noradrenaline contribute to the hypoxic potentiation of the respiratory response to moderate exercise. Clancy L J LJ Critchley J A JA Leitch A G AG Kirby B J BJ Ungar A A Flenley D C DC eng G0501542 Medical Research Council United Kingdom Journal Article England Clin Sci Mol Med 0367540 0301-0538 S88TT14065 Oxygen X4W3ENH1CV Norepinephrine YKH834O4BH Epinephrine IM S Adult Arteries Epinephrine blood Humans Hydrogen-Ion Concentration Hypoxia blood Male Norepinephrine blood Oxygen Physical Exertion Respiration 76065101 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 171 10.1042/cs0490503 168 1976 02 19 2019 05 16 0009-921X 113 1975 Nov-Dec Clinical orthopaedics and related research Clin Orthop Relat Res Effects of graded infusions of monomethylmethacrylate on coagulation, blood lipids, respiration and circulation. An experimental study in dogs. 187-97 In 4 dogs injected intravenously (i.v.) with 125I labeled fibrinogen, 51Cr labeled platelets and 99mTc labeled albumin, and subjected to successively increasing amounts of i.v. infused monomethylmethacrylate, doses corresponding to the amounts released into the blood stream following implantation of acrylic cement during total hip replacements did not affect the clotting mechanism, did not cause trapping of platelets and fibrin in the lungs, did not generate fat emboli, and did not cause depression of the arterial oxygen tension or blood pressure. Monomethylmethacrylate in whole blood was associated with both blood cells and plasma. Modig J J Busch C C Waernbaum G G eng Journal Article United States Clin Orthop Relat Res 0075674 0009-921X 0 Bone Cements 0 Lipids 0 Methylmethacrylates IM Animals Blood Coagulation drug effects Blood Pressure drug effects Bone Cements pharmacology Collateral Circulation drug effects Dogs Hydrogen-Ion Concentration Infusions, Parenteral Lipids blood Lung drug effects Methylmethacrylates pharmacology Respiration drug effects 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 168 10.1097/00003086-197511000-00030 172 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Meal to pellet intervals in 14 species of captive raptors. 1-6 Duke G E GE Evanson O A OA Jegers A A eng G0502107 Medical Research Council United Kingdom Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Acclimatization Animals Birds physiology Digestion Feces analysis Feeding Behavior Species Specificity Time Factors 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 172 10.1016/s0300-9629(76)80001-1 173 1976 02 26 2020 02 25 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Secretion of sulfuric acid in Cassidaria echinophora Lamarck (Mollusca: Mesogastropoda, marine carnivorous snail). 101-3 Fänge R R Lidman U U eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Chlorides 0 Sulfates 9NEZ333N27 Sodium I38ZP9992A Magnesium RWP5GA015D Potassium SY7Q814VUP Calcium IM Animals Calcium analysis Chlorides analysis Hydrogen-Ion Concentration Magnesium analysis Osmolar Concentration Potassium analysis Snails analysis metabolism Sodium analysis Sulfates metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 173 10.1016/s0300-9629(76)80019-9 Urology. 1999 Dec;54(6A Suppl):22-9 10606281 Acad Emerg Med. 2002 Mar;9(3):179-85 11874772 Ann Emerg Med. 1990 Jan;19(1):38-43 2297154 Ann Emerg Med. 1987 Dec;16(12):1396-7 3688609 Life Sci. 1996;58(10):845-54 8602118 174 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Studies on the lipid content of pigeon breast muscle. 105-7 James N T NT Meek G A GA eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Lipids IM Animals Columbidae Lipids analysis Muscles analysis ultrastructure 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 174 10.1016/s0300-9629(76)80020-5 175 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Seasonal variation in diet, volatile fatty acid production and size of the cecum of roch ptarmigan. 109-14 Gasaway W C WC eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Acetates 0 Butyrates 0 Fatty Acids, Volatile 0 Propionates IM Acclimatization Acetates metabolism Alaska Animals Birds metabolism Butyrates metabolism Cecum anatomy & histology metabolism Diet Fatty Acids, Volatile metabolism Fermentation Propionates metabolism Seasons Species Specificity 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 175 10.1016/s0300-9629(76)80021-7 176 1976 02 26 2020 02 25 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol The auditory system of the goldfish (Carassius auratus): effects of intense acoustic stimulation. 11-8 Popper A N AN Clarke N L NL eng Journal Article Research Support, U.S. Gov't, P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Acoustic Stimulation Animals Avoidance Learning Behavior, Animal Conditioning, Classical Cyprinidae physiology Ear physiology Goldfish physiology Hearing Respiration 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 176 10.1016/s0300-9629(76)80003-5 Liver Transpl. 2001 Apr;7(4):363-73 11303298 Liver Transpl. 2001 Sep;7(9):797-801 11552214 Hepatology. 2004 Nov;40(5):1222-5 15382153 Gastroenterology. 2006 Jan;130(1):207-10 16401483 Hepatology. 2006 Apr;43(4):682-9 16502396 Hepatology. 2006 Aug;44(2):466-71 16871575 J Hepatol. 2006 Oct;45(4):600-6 16899321 Hepatology. 2006 Oct;44(4):865-73 17006923 Clin Gastroenterol Hepatol. 2006 Dec;4(12):1537-43 17162245 Diabetes Care. 2007 May;30(5):1212-8 17277038 Gut. 2008 Jun;57(6):807-13 18270241 J Hepatol. 2009 Aug;51(2):371-9 19501928 Hepatology. 2009 Oct;50(4):1072-8 19585618 Hepatology. 2010 Jan;51(1):121-9 19827166 Curr Pharm Des. 2010 Jun;16(17):1958-62 20370671 N Engl J Med. 2010 May 6;362(18):1675-85 20427778 J Hepatol. 2010 Aug;53(2):372-84 20494470 N Engl J Med. 2010 Sep 30;363(14):1341-50 20879883 177 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Volatile fatty acids and metabolizable energy derived from cecal fermentation in the willow ptarmigan. 115-21 Gasaway W C WC eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Acetates 0 Butyrates 0 Fatty Acids, Volatile 0 Propionates IM Acetates metabolism Animals Birds metabolism Butyrates metabolism Cecum anatomy & histology metabolism Diet Energy Metabolism Fatty Acids, Volatile Female Male Propionates metabolism Sex Factors Species Specificity 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 177 10.1016/s0300-9629(76)80022-9 178 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol A comparison of intestinal amino acid absorption in various avian and mammalian species. 123-7 Lerner J J Kratzer F H FH eng Comparative Study Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Amino Acids IM Amino Acids metabolism Animals Birds metabolism Chickens metabolism Female Ichthyosis metabolism Intestinal Absorption Jejunum metabolism Male Mice Muscular Dystrophy, Animal metabolism Quail metabolism Rats Species Specificity Turkeys metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 178 10.1016/s0300-9629(76)80023-0 179 1976 02 26 2020 02 25 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Holeuryhalinity and its mechanisms in a cirriped crustacean, Balanus improvisus. 19-30 Fyhn H J HJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Amino Acids IM Acclimatization Amino Acids metabolism Animals Fresh Water Hemolymph physiology Muscles metabolism Organ Specificity Osmolar Concentration Seawater Skin Physiological Phenomena Thoracica metabolism physiology 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 179 10.1016/s0300-9629(76)80004-7 Eur J Gastroenterol Hepatol. 2000 Oct;12(10):1121-7 11057458 Arch Pathol Lab Med. 2000 Nov;124(11):1599-607 11079009 Lancet. 2001 Apr 7;357(9262):1069-75 11297957 J Hepatol. 2001 May;34(5):730-9 11434620 J Hepatol. 2004 May;40(5):860-7 15094237 Gastroenterology. 2004 Jun;126(7):1795-808 15188175 J Clin Invest. 2005 Jan;115(1):56-65 15630444 J Hepatol. 2006 Jan;44(1):111-7 16274836 Clin Liver Dis. 2006 Aug;10(3):481-97, viii 17162224 J Clin Invest. 2007 Mar;117(3):539-48 17332881 J Immunol. 2007 Apr 15;178(8):5288-95 17404313 Hepatology. 2008 Feb;47(2):455-60 18038452 Gastroenterology. 2008 May;134(6):1655-69 18471545 Clin Liver Dis. 2008 Nov;12(4):939-62, xi 18984475 J Hepatol. 2009 Mar;50(3):604-20 19157625 Aliment Pharmacol Ther. 2009 Sep 15;30(6):557-76 19519733 Fibrogenesis Tissue Repair. 2009 Dec 04;2(1):6 19961576 Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):59-61 20051972 Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1277-83 20802342 J Clin Invest. 1998 Aug 1;102(3):538-49 9691091 180 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol A comparative study on the regulation of osmotic, ionic and organic-solute concentrations in the blood of aquatic organisms. 31-40 Spaargaren D H DH eng Comparative Study Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Animals Blood Physiological Phenomena Computers Crustacea physiology Fishes physiology Hemolymph physiology Mathematics Osmolar Concentration Osmotic Pressure Regression Analysis Seawater Species Specificity 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 180 10.1016/s0300-9629(76)80005-9 181 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Aestivation and thermoregulation in the Texas tortoise, Gopherus berlandieri. 41-4 Voigt W G WG Johnson C R CR eng 095938 Wellcome Trust United Kingdom Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM S Adaptation, Physiological Animals Body Temperature Body Temperature Regulation Circadian Rhythm Desert Climate Estivation Female Texas Turtles physiology 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 181 10.1016/s0300-9629(76)80006-0 182 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol The respiratory quotient of Gammarus pulex L. 45-6 Wright E A EA Wright A A AA eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Aging Animals Crustacea growth & development physiology Fresh Water Oxygen Consumption 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 182 10.1016/s0300-9629(76)80007-2 183 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Water balance of small lactating rodents--II. Concentration and composition of milk of females on ad libitum and restricted water intakes. 47-52 Baverstock P R PR Spencer L L Pollard C C eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Milk Proteins 50-56-6 Oxytocin IM Adaptation, Physiological Animals Carbohydrate Metabolism Desert Climate Female Lactation drug effects Lipid Metabolism Mice Mice, Inbred BALB C Milk metabolism Milk Proteins metabolism Oxytocin pharmacology Pregnancy Rodentia metabolism Species Specificity Water Deprivation 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 183 10.1016/s0300-9629(76)80008-4 184 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Insect morphogenetic hormones and developmental mechanisms in the nematode, Nematospiroides dubius. 53-6 Dennis R D RD eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Gibberellins 0 Juvenile Hormones 3604-87-3 Ecdysone 3XMK78S47O Testosterone 4TI98Z838E Estradiol 9NEZ333N27 Sodium P39Y9652YJ Kinetin RWP5GA015D Potassium IM Animals Ecdysone pharmacology Estradiol pharmacology Female Gibberellins pharmacology Juvenile Hormones pharmacology Kinetin pharmacology Larva Nematoda drug effects physiology Potassium pharmacology Skin drug effects Skin Physiological Phenomena Sodium pharmacology Testosterone pharmacology 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 184 10.1016/s0300-9629(76)80009-6 Ann Endocrinol (Paris). 2010 Dec;71(6):486-93 20850710 Ann Diagn Pathol. 2003 Aug;7(4):254-8 12913850 J Neurosurg. 1974 Aug;41(2):187-92 4841875 Am J Surg Pathol. 1984 Feb;8(2):129-38 6703189 Cancer. 1988 Jul 1;62(1):174-83 3289725 Rare Tumors. 2012 Jan 2;4(1):e3 22532919 Pathology. 2010 Apr;42(3):287-9 20350225 185 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Osmotic interrelationship between blood and gut fluid in the isopod Porcellio scaber Latr. (Crustacea). 57-9 Lindqvist O V OV Fitzgerald G G eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Animals Body Weight Crustacea physiology Digestive System Physiological Phenomena Hemolymph physiology Osmolar Concentration Osmosis 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 185 10.1016/s0300-9629(76)80010-2 186 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Effects of thermal stimulation to the spinal cord on heart rate in cyprinid fishes. 61-3 Iriki M M Murata S S Nagai M M Tsuchiya K K eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Animals Body Temperature Brain physiology Carps physiology Cyprinidae physiology Heart Rate Species Specificity Spinal Cord physiology Temperature 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 186 10.1016/s0300-9629(76)80011-4 187 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol The long-term monitoring of ventilation rhythms of the polychaetous annelid Nereis virens sars. 65-8 Scott D M DM Mazurkiewicz M M Leeman P P eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Animals Annelida physiology Body Temperature Circadian Rhythm Light Oxygen Consumption 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 187 10.1016/s0300-9629(76)80012-6 188 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Diving bradycardia in four species of North American aquatic snakes. 69-72 Jacob J S JS McDonald H S HS eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 IM Animals Diving Electrocardiography Heart Rate Snakes physiology Species Specificity 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 188 10.1016/s0300-9629(76)80013-8 189 1976 02 26 2020 02 25 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Respiratory responses of Gillichthys mirabilis to changes in temperature, dissolved oxygen and salinity. 7-10 Courtois L A LA eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 S88TT14065 Oxygen IM Acclimatization Animals Fishes physiology Osmolar Concentration Oxygen Partial Pressure Respiration Temperature 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 189 10.1016/s0300-9629(76)80002-3 J Stud Alcohol. 2004 Nov;65(6):782-93 15700517 J Health Serv Res Policy. 2008 Apr;13 Suppl 2:40-4 18416928 Addiction. 1993 Jun;88(6):791-804 8329970 190 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol The pronephroi as the site of presumptive interrenal cells in the hagfish Myxine glutinosa L. 73-7 Idler D R DR Burton M P MP eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Antibodies 0 Isoxazoles 9002-60-2 Adrenocorticotropic Hormone IM Adrenal Glands metabolism Adrenocorticotropic Hormone analysis immunology Animals Antibodies Female Fishes metabolism Fluorescent Antibody Technique Hagfishes metabolism Interrenal Gland cytology metabolism ultrastructure Isoxazoles metabolism Microscopy, Electron Mitosis 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 190 10.1016/s0300-9629(76)80014-x 191 1976 02 26 2019 08 23 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Excreta analysis on additional cockroach species and the house cricket. 79-81 Cochran D G DG eng 098497 Wellcome Trust United Kingdom Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 268B43MJ25 Uric Acid IM Animals Cockroaches metabolism Feces analysis Orthoptera metabolism Species Specificity Uric Acid metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 191 10.1016/s0300-9629(76)80015-1 192 1976 02 26 2019 12 10 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Interrelationships between water and metabolism in Artemia cysts--II. Carbohydrates. 83-7 Clegg J S JS eng 095938 Wellcome Trust United Kingdom Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 059QF0KO0R Water 9005-79-2 Glycogen B8WCK70T7I Trehalose IY9XDZ35W2 Glucose PDC6A3C0OX Glycerol IM Acclimatization Animals Carbohydrate Metabolism Decapoda metabolism Embryo, Nonmammalian Glucose metabolism Glycerol metabolism Glycogen biosynthesis Metamorphosis, Biological Trehalose metabolism Water metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 192 10.1016/s0300-9629(76)80016-3 193 1976 02 26 2019 12 10 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Interrelationships between water and metabolism in Artemia cysts--III. Respiration. 89-93 Clegg J S JS eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 059QF0KO0R Water IM Acclimatization Animals Decapoda metabolism Oxygen Consumption Polarography Pressure Water metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 193 10.1016/s0300-9629(76)80017-5 194 1976 02 26 2020 02 25 0300-9629 53 1 1976 Jan Comparative biochemistry and physiology. A, Comparative physiology Comp Biochem Physiol A Comp Physiol Studies on avian erythrocyte metabolism--I. Procedure for separation and quantitation of the major phosphorylated metabolic intermediates by anion exchange chromatography. 95-9 Isaacks R E RE Harkness D R DR Froeman G A GA Sussman S A SA eng Journal Article England Comp Biochem Physiol A Comp Physiol 1276312 0300-9629 0 Adenine Nucleotides 0 Diphosphoglyceric Acids 415SHH325A Adenosine Monophosphate 4L6452S749 Inositol 61D2G4IYVH Adenosine Diphosphate 7IGF0S7R8I Phytic Acid 8L70Q75FXE Adenosine Triphosphate IM Adenine Nucleotides blood isolation & purification Adenosine Diphosphate blood Adenosine Monophosphate blood Adenosine Triphosphate blood Animals Chromatography, Ion Exchange methods Diphosphoglyceric Acids blood isolation & purification Erythrocytes analysis metabolism Inositol analogs & derivatives Phytic Acid blood isolation & purification 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 194 10.1016/s0300-9629(76)80018-7 Hepatology. 2000 Apr;31(4):864-71 10733541 Ann Surg. 2001 Dec;234(6):723-31 11729378 J Hepatol. 2002 Jan;36(1):93-8 11804670 Lancet. 1992 Sep 19;340(8821):733 1355833 Lancet. 2006 Jan 7;367(9504):52-6 16399153 Liver Transpl. 2006 Jan;12(1):24-30 16498709 Lancet. 2006 Jun 24;367(9528):2045-6 16798373 Gut. 2007 Nov;56(11):1606-13 17356039 Transplantation. 2007 Sep 15;84(5):572-9 17876268 Gut. 2008 Feb;57(2):252-7 17895356 J Hepatol. 2008 Nov;49(5):732-8 18667256 Hepatology. 2009 Aug;50(2):400-6 19472315 BMJ. 2010 Mar 11;340:c1240 20223873 Liver Transpl Surg. 1997 Nov;3(6):628-37 9404965 BMJ. 1998 Jul 18;317(7152):172-5 9665895 195 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Effect of different prostaglandins on the permeability of the toad urinary bladder. 1-4 Urakabe S S Takamitsu Y Y Shirai D D Yuasa S S Kimura G G eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Prostaglandins 0 Prostaglandins A 0 Prostaglandins E 0 Prostaglandins F 11000-17-2 Vasopressins C137DTR5RG Theophylline E0399OZS9N Cyclic AMP IM Animals Body Water metabolism Bufo bufo Cyclic AMP pharmacology Osmosis Permeability Prostaglandins pharmacology Prostaglandins A pharmacology Prostaglandins E pharmacology Prostaglandins F pharmacology Structure-Activity Relationship Theophylline pharmacology Urinary Bladder drug effects physiology Vasopressins pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 195 10.1016/0306-4492(75)90002-7 196 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Evaluation of amplitude and frequency changes of miniature potentials with a poor signal-to-noise ratio. 11-6 Huijbregts L A LA Schreurs M M eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 451W47IQ8X Sodium Chloride 57-50-1 Sucrose H9Y79VD43J Strychnine Q3254X40X2 Gallamine Triethiodide IM Animals Gallamine Triethiodide pharmacology Grasshoppers physiology Muscle Contraction drug effects Potentiometry Sodium Chloride pharmacology Strychnine pharmacology Sucrose pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 196 10.1016/0306-4492(75)90005-2 197 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Practolol, caffeine and calcium in the regulation of mechanical activity of the cardiac ventricle in Myxine glutinosa (L.). 17-22 Storesund A A Helle K B KB eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Hydroxydopamines 0TTZ664R7Z Phenoxybenzamine 3G6A5W338E Caffeine 8B1QWR724A Reserpine 9Y8NXQ24VQ Propranolol C137DTR5RG Theophylline SUG9176GRW Practolol SY7Q814VUP Calcium Z468598HBV Phentolamine IM Animals Caffeine pharmacology Calcium pharmacology Dose-Response Relationship, Drug Fishes physiology Hagfishes physiology Heart Ventricles drug effects Hydroxydopamines pharmacology Myocardial Contraction drug effects Phenoxybenzamine pharmacology Phentolamine pharmacology Practolol pharmacology Propranolol pharmacology Reserpine pharmacology Theophylline pharmacology Ventricular Function 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 197 10.1016/0306-4492(75)90006-4 198 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Asymmetric distribution of aspartate in ganglia and single neurons of Aplysia. 23-6 Zeman G H GH Carpenter D O DO eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Glutamates 0 Neurotransmitter Agents 30KYC7MIAI Aspartic Acid IM Animals Aspartic Acid analysis Ganglia analysis Glutamates analysis Mollusca analysis Muscles analysis Neurons analysis Neurotransmitter Agents Organ Specificity 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 198 10.1016/0306-4492(75)90007-6 199 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Electrophysiological actions of convulsants and anticonvulsants on neurons of the leech subesophageal ganglion. 27-34 Kleinhaus A L AL eng Journal Article Research Support, U.S. Gov't, P.H.S. England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 57DQA39DO2 Bemegride H9Y79VD43J Strychnine I38ZP9992A Magnesium Q42T66VG0C Penicillin G WM5Z385K7T Pentylenetetrazole YQE403BP4D Phenobarbital IM Animals Bemegride pharmacology Ganglia, Autonomic drug effects physiology Leeches physiology Magnesium pharmacology Membrane Potentials drug effects Neurons drug effects physiology Penicillin G pharmacology Pentylenetetrazole pharmacology Phenobarbital pharmacology Strychnine pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 199 10.1016/0306-4492(75)90008-8 J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3:iii9-15 15316039 Neurology. 1990 Mar;40(3 Pt 1):404-7 2107459 Am J Med. 1990 Apr;88(4):325-31 2327419 Epilepsia. 1996 Sep;37(9):875-8 8814101 Heart Lung. 1997 Nov-Dec;26(6):466-83; quiz 484-5 9431493 Neurol Clin. 1998 May;16(2):503-19 9537972 200 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol The relative importance of monoamine oxidase and catechol-O-methyl transferase on the physiologic response to administered norepinephrine in the turkey. 35-9 El Halawani M E ME Waibel P E PE eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 EC 1.4.3.4 Monoamine Oxidase EC 2.1.1.6 Catechol O-Methyltransferase X4W3ENH1CV Norepinephrine YKH834O4BH Epinephrine IM Animals Blood Pressure drug effects Catechol O-Methyltransferase metabolism Chickens Epinephrine metabolism Heart drug effects Kidney drug effects enzymology Kinetics Liver drug effects enzymology Monoamine Oxidase metabolism Myocardium enzymology Norepinephrine pharmacology Organ Specificity Rats Species Specificity Turkeys 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 200 10.1016/0306-4492(75)90009-x 201 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol The cardiac cycle and the effects of neurohumors on myocardial contractility in the Asiatic eel Anguilla japonica, Timm. & Schle. 41-5 Chow P H PH Chan D K DK eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 N9YNS0M02X Acetylcholine X4W3ENH1CV Norepinephrine IM Acetylcholine pharmacology Animals Blood Pressure drug effects Eels physiology Heart drug effects physiology Heart Rate drug effects Heart Ventricles drug effects Myocardial Contraction drug effects Norepinephrine pharmacology Ventricular Function 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 201 10.1016/0306-4492(75)90010-6 Circulation. 2002 Oct 8;106(15):1906-8 12370210 Eur Spine J. 2007 Mar;16(3):307-19 17013656 Surg Neurol. 1998 Feb;49(2):210-4 9457273 202 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Characteristics of the noradrenergic innervation of the left atrium in the chick (Gallus gallus domesticus, L.). 47-9 Bennett T T Malmfors T T eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0TTZ664R7Z Phenoxybenzamine DL48G20X8X Scopolamine I5Y540LHVR Cocaine IM Animals Atrial Function Chickens physiology Cocaine pharmacology Heart innervation Heart Atria drug effects Heart Conduction System drug effects physiology Myocardial Contraction drug effects Phenoxybenzamine pharmacology Scopolamine pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 202 10.1016/0306-4492(75)90011-8 203 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Responsiveness of neurogenic hearts to octopamine. 5-8 Grega D S DS Sherman R G RG eng G1002279 Medical Research Council United Kingdom Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 14O50WS8JD Octopamine IM Animals Arachnida physiology Dose-Response Relationship, Drug Heart drug effects physiology Heart Rate drug effects Nephropidae physiology Octopamine pharmacology Species Specificity Spiders physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 203 10.1016/0306-4492(75)90003-9 204 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Action of kainic acid on a glutamatergic synapse. 51-3 Daoud A A Usherwood P N PN eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Glutamates 0 Pyrrolidines IM Animals Evoked Potentials drug effects Glutamates pharmacology Grasshoppers Muscle Contraction drug effects Neuromuscular Junction drug effects physiology Pyrrolidines pharmacology Synapses drug effects physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 204 10.1016/0306-4492(75)90012-x 205 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol The effects of 5-hydroxytryptamine depletors and monoamine oxidase inhibitors on color changes of the fiddler crab, Uca pugilator: further evidence in support of the hypothesis that 5-hydroxytryptamine controls the release of red pigment-dispersing hormone. 55-9 Fingerman M M Fingerman S W SW eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Hormones 0 Monoamine Oxidase Inhibitors 0 Serotonin Antagonists 8B1QWR724A Reserpine D892HFI3XA Iproniazid R5J7E3L9SP Fenclonine T2Q0RYM725 Nialamide IM Acclimatization Animals Brachyura drug effects physiology Chromatophores drug effects physiology Color Female Fenclonine pharmacology Hormones physiology Iproniazid pharmacology Monoamine Oxidase Inhibitors pharmacology Nialamide pharmacology Reserpine pharmacology Serotonin Antagonists Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 205 10.1016/0306-4492(75)90013-1 Arch Dis Child. 2002 May;86(5):374-5 11970938 Arch Dis Child. 2004 Dec;89(12):1178 15557066 Ann R Coll Surg Engl. 2006 May;88(3):292-6 16786610 BMJ. 1993 Oct 23;307(6911):1044 8251779 BMJ. 1993 Jan 23;306(6872):247 8507242 206 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Evidence of a gastrin-like substance in Rhinobatus productus. 61-3 Hansen D D eng MR/K000608/1 Medical Research Council United Kingdom Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Gastrins EF0NX91490 Pentagastrin IM Animals Biological Assay Dose-Response Relationship, Drug Female Fishes metabolism Gastric Mucosa analysis metabolism Gastrins analysis metabolism Muscles analysis metabolism Organ Specificity Pentagastrin metabolism Rats Species Specificity Stomach analysis Swine 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 206 10.1016/0306-4492(75)90014-3 207 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol 5-hydroxytryptamine as a possible inhibitory neurotransmitter in the central nervous system of the leech, Haemopis sanguisuga. 65-73 Smith P A PA Fitzsimons J T JT Loker J E JE Walker R J RJ eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 333DO1RDJY Serotonin 76I7G6D29C Morphine OGG85SX4E4 Imipramine IM Central Nervous System drug effects physiology Ganglia drug effects physiology ultrastructure Imipramine pharmacology Leeches physiology Microscopy, Electron Microscopy, Fluorescence Morphine pharmacology Neurons drug effects physiology Serotonin pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 207 10.1016/0306-4492(75)90015-5 208 1976 03 01 2020 08 25 0306-4492 52 1 1975 Oct 01 Comparative biochemistry and physiology. C: Comparative pharmacology Comp Biochem Physiol C Comp Pharmacol Gastrin-like activity in an Indian python. 9-10 Olowo-Okorun M O MO eng Journal Article England Comp Biochem Physiol C Comp Pharmacol 7503763 0306-4492 0 Gastrins 820484N8I3 Histamine IM Animals Female Gastrins metabolism Histamine analysis Intestinal Mucosa analysis metabolism Pylorus analysis metabolism Snakes metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 208 10.1016/0306-4492(75)90004-0 209 1976 02 19 2011 11 17 0090-8800 4 1975 Contemporary topics in molecular immunology Contemp Top Mol Immunol Kinetics of antibody--hapten reactions. 23-54 Froese A A Sehon A H AH eng Journal Article Review United States Contemp Top Mol Immunol 0363025 0090-8800 0 Dinitrophenols 0 Haptens 0 Immunoglobulin Fab Fragments IM Antigen-Antibody Reactions Binding Sites, Antibody Dinitrophenols immunology Haptens analysis immunology Hydrogen-Ion Concentration Immunoglobulin Fab Fragments analysis Immunologic Techniques Kinetics Protein Conformation 53 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 209 211 1976 02 09 2020 02 25 0300-1725 4 1975 Current problems in clinical biochemistry Curr Probl Clin Biochem Effects of maleate on renal reabsorption of bicarbonate. 101-5 Gmaj P P Hoppe A A Angielski S S Rogulski J J Metler M M eng Comparative Study Journal Article Switzerland Curr Probl Clin Biochem 0353507 0300-1725 0 Bicarbonates 0 Chlorides 0 Ketoglutaric Acids 0 Maleates 8L70Q75FXE Adenosine Triphosphate 9NEZ333N27 Sodium N712M78A8G Arsenic O3FX965V0I Acetazolamide RWP5GA015D Potassium IM Acetazolamide pharmacology Adenosine Triphosphate metabolism Animals Arsenic pharmacology Bicarbonates metabolism Chlorides urine Glomerular Filtration Rate drug effects Hydrogen-Ion Concentration Ketoglutaric Acids urine Kidney drug effects metabolism Maleates pharmacology Potassium urine Rats Sodium urine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 211 Lancet. 2016 Feb 25;387 Suppl 1:S3-5 26923275 212 1976 02 09 2006 11 15 0300-1725 4 1975 Current problems in clinical biochemistry Curr Probl Clin Biochem Bicarbonate inhibition of rat kidney aconitate hydratase isoenzymes. 65-9 Stepinski J J Angielski S S eng Journal Article Switzerland Curr Probl Clin Biochem 0353507 0300-1725 0 Bicarbonates 0 Citrates 0 Isoenzymes EC 4.2.1.- Hydro-Lyases EC 4.2.1.3 Aconitate Hydratase IM Aconitate Hydratase metabolism Animals Bicarbonates pharmacology Citrates metabolism Cytoplasm enzymology Hydro-Lyases metabolism Hydrogen-Ion Concentration Isoenzymes metabolism Kidney enzymology Kinetics Mitochondria enzymology Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 212 210 1976 02 09 2019 07 06 0090-3493 3 4 1975 Jul-Aug Critical care medicine Crit Care Med Influence of pH and hypoxia on the success of defibrillation. 139-42 Clinical impressions about the problem of defibrillation during states of acid-base imbalance and hypoxia have been influenced by studies involving the effect of these derangements on the ventricular fibrillation threshold. Based on body weight, energy requirements for defibrillation in normal dogs were compared to requirements in dogs subjected to commonly encountered acid-base disturbances and severe hypoxemia. No significant differences were found. Seventy-five percent of all animals in the study were electrically converted with low-to-moderate levels of energy. The incidence of spontaneous resumption of circulation following defibrillation was lowest in animals subjected to metabolic acidosis and hypoxia. The results suggest that pH and blood gas alterations, previously shown to influence the normal ventricular fibrillation threshold, do not significantly affect the normal defibrillation threshold. Yakaitis R W RW Thomas J D JD Mahaffey J E JE eng Journal Article United States Crit Care Med 0355501 0090-3493 IM Acid-Base Imbalance Acidosis Acidosis, Respiratory Alkalosis, Respiratory Animals Dogs Electric Countershock Hydrogen-Ion Concentration Hypoxia 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 210 10.1097/00003246-197507000-00003 213 1976 02 09 2020 02 25 0300-1725 4 1975 Current problems in clinical biochemistry Curr Probl Clin Biochem Metabolic studies in experimental renal dysfunction resulting from maleate administration. 86-100 Angielski S S Rogulski J J eng Journal Article Switzerland Curr Probl Clin Biochem 0353507 0300-1725 0 Acetoacetates 0 Bicarbonates 0 Keto Acids 0 Ketoglutaric Acids 0 Malates 0 Maleates 0 Malonates EC 2.8.1.- Sulfurtransferases J2B2A4N98G Lactose SAA04E81UX Coenzyme A SY7Q814VUP Calcium IM Acetoacetates pharmacology Animals Bicarbonates urine Calcium pharmacology Coenzyme A metabolism Disease Models, Animal Fanconi Syndrome chemically induced Hydrogen-Ion Concentration Keto Acids urine Ketoglutaric Acids metabolism Lactose metabolism Malates blood Maleates metabolism Malonates pharmacology Mitochondria metabolism Mitochondria, Liver metabolism Oxidative Phosphorylation drug effects Permeability Rats Sulfurtransferases metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 213 Clin Med (Lond). 2016 Jun;16(3):254-8 27251915 214 1976 02 09 2019 10 27 0011-3840 1975 Aug Current problems in surgery Curr Probl Surg Multiple endocrine adenomatosis-I and II. 1-51 Harrison T S TS Thompson N W NW eng Journal Article United States Curr Probl Surg 0372617 0011-3840 IM Adolescent Adult Carcinoma genetics Child Child, Preschool Female Humans Male Middle Aged Multiple Endocrine Neoplasia surgery Prognosis Thyroid Neoplasms genetics Zollinger-Ellison Syndrome 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 214 S0011-3840(75)80009-8 10.1016/s0011-3840(75)80009-8 215 1976 02 09 2020 02 25 0011-393X 18 4 1975 Oct Current therapeutic research, clinical and experimental Curr Ther Res Clin Exp A randomized double-blind study of timolol in patients with essential hypertension. 534-8 Guevara J J Sukerman M M Velasco M M eng Clinical Trial Journal Article Randomized Controlled Trial United States Curr Ther Res Clin Exp 0372621 0011-393X 0 Adrenergic beta-Antagonists 0 Placebos 0 Propanolamines 0 Thiadiazoles IM Adrenergic beta-Antagonists therapeutic use Adult Blood Pressure Clinical Trials as Topic Heart Rate Humans Hypertension drug therapy physiopathology Middle Aged Placebos Propanolamines therapeutic use Thiadiazoles therapeutic use 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 215 N Engl J Med. 2002 Jan 31;346(5):368-72 11821517 BMJ. 2003 Nov 1;327(7422):1041-3 14593043 Med J Aust. 2003 Dec 1-15;179(11-12):614-6 14636132 Ann Acad Med Singapore. 2005 Jul;34(6):163C-165C 16010401 JAMA. 2008 Jan 9;299(2):211-3 18182604 JAMA. 2008 Sep 10;300(10):1165-73 18780845 JAMA. 2008 Sep 10;300(10):1208-9 18780852 JAMA. 2009 Feb 11;301(6):597; author reply 597-8 19211462 Swiss Med Wkly. 2009 Sep 19;139(37-38):540-6 19838871 Acad Med. 2010 Apr;85(4):692-701 20186033 Acad Med. 2010 Apr;85(4):687-91 20354390 Acad Med. 2011 Aug;86(8):953-61 21694566 Clin Med (Lond). 2012 Dec;12(6):526-9 23342405 Clin Med (Lond). 2012 Dec;12(6):530-4 23342406 Kaibogaku Zasshi. 2013 Mar;88(1-2):13-6 23600316 Kaibogaku Zasshi. 2013 Mar;88(1-2):17-9 23600317 Clin Med (Lond). 2013 Apr;13(2):214 23681880 Med Educ. 2013 Oct;47(10):1048 24016175 Acad Med. 2014 Jan;89(1):84-93 24280845 S Afr Med J. 2014 Feb;104(2):111-3 24893538 Acad Med. 2014 Oct;89(10):1398-407 25006709 Med Educ Online. 2014 Oct 30;19:26138 25363437 CMAJ. 2015 Sep 8;187(12):E381-2 26261196 Nat Med. 2015 Oct;21(10):1111 26444628 Acad Med. 1994 Aug;69(8):653-5 8054114 J R Coll Physicians Lond. 1993 Apr;27(2):147-50 8501673 216 1976 02 20 2017 03 22 0011-4553 28 11 1975 Nov Czasopismo stomatologiczne Czas Stomatol [Observation of permanent teeth adjacent to teeth damaged by trauma]. 1045-9 Szpringer M M pol English Abstract Journal Article Obserwacja zebów stalych sasiadujacych z zebami uszkodzonymi wskutek urazów Poland Czas Stomatol 2984742R 0011-4553 D IM Adolescent Child Child, Preschool Dental Pulp Necrosis etiology Dentin, Secondary etiology Dentition Dentition, Mixed Follow-Up Studies Humans Periapical Granuloma etiology Tooth Injuries Wounds and Injuries complications 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 216 217 1976 02 09 2019 05 14 0012-3692 68 6 1975 Dec Chest Chest Idiopathic hypertrophic subaortic stenosis (hypertrophic obstructive cardiomyopathy) changing concepts-1975. 814-7 Shah P M PM eng Journal Article Review United States Chest 0231335 0012-3692 0 Adrenergic beta-Antagonists AIM IM Adrenergic beta-Antagonists therapeutic use Arrhythmias, Cardiac etiology Cardiomegaly etiology Cardiomyopathy, Hypertrophic diagnosis drug therapy etiology mortality physiopathology surgery Echocardiography Electrocardiography Follow-Up Studies Heart Murmurs Heart Ventricles physiopathology Hemodynamics Humans Mitral Valve Insufficiency etiology surgery 26 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 217 S0012-3692(16)54842-9 10.1378/chest.68.6.814 218 1976 02 09 2019 05 14 0012-3692 68 6 1975 Dec Chest Chest Pleural effusion associated with aortitis syndrome. 826-8 A patient with aortitis syndrome had a pleural effusion which subsided but reappeared with an exacerbation of aortitis symptoms while under antituberculosis treatment. The character of the fluid was that of an exudate, and the glucose concentration was normal. Clinical and laboratory features of the case suggest that the effusion was part of the aortitis syndrome per se. Kawai T T Yamada Y Y Tsuneda J J Aoyagi T T Mikata A A eng Case Reports Journal Article United States Chest 0231335 0012-3692 AIM IM Adult Aortic Arch Syndromes complications Humans Male Pleural Effusion analysis etiology Takayasu Arteritis complications diagnosis Tuberculosis, Pleural diagnosis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 218 S0012-3692(16)54847-8 10.1378/chest.68.6.826 219 1976 02 20 2019 12 10 0366-6999 1 3 1975 May Chinese medical journal Chin Med J (Engl) The metabolic fate of securinine. 205-15 eng Comparative Study Journal Article China Chin Med J (Engl) 7513795 0366-6999 0 Alkaloids 0 Azepines 0 Heterocyclic Compounds, Bridged-Ring 0 Lactones 0 Piperidines G4VS580P5E securinine S88TT14065 Oxygen IM Alkaloids metabolism Animals Azepines Cats Dogs Erythrocytes metabolism Female Haplorhini Heterocyclic Compounds, Bridged-Ring Hydrogen-Ion Concentration Kidney metabolism Lactones Liver metabolism Male Mice Myocardium metabolism Organ Specificity Oxygen pharmacology Piperidines Rabbits Rats 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 219 220 1976 03 01 2019 02 06 0009-4722 46 7 1975 Jul Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen Chirurg [Transplantation and preservation of tissue-typized skin in burns]. 319-22 At the Department of Plastic Surgery and Burns, Berufsgenossenschaftliche Unfalklinik Ludwigshafen-Oggersheim, a skinbank with typed skin has been established. The storage system consists of deep-freezing at -196 degrees C in liquid nitrogen. The transplantation of HL-A typed skin was evaluated from the clinical and histological point of view. Due to the effort necessary for such an undertaking this method is critically reviewed. Zellner P R PR Taubert I I Wegener K K ger English Abstract Journal Article Transplantation und Konservierung geqebetypisierter Haut bei Brandverletzten Germany Chirurg 16140410R 0009-4722 0 HLA Antigens IM Burns surgery Freezing Graft vs Host Reaction HLA Antigens Histocompatibility Testing Humans Skin Transplantation Tissue Preservation Transplantation, Homologous 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 220 222 1976 03 01 2020 02 25 0002-3264 223 5 1975 Aug 11 Doklady Akademii nauk SSSR Dokl Akad Nauk SSSR [Ability of antilymphocyte sera to counteract the allogeneic inhibition of hematopoietic stem cells]. 1245-7 Golovistikov I N IN rus Journal Article Sposobnost' antilimfotsitarnykh syvorotok syvorotok otmeniat' allogennuiu ingibitsiiu stvolovykh krovetvornykh kletok Russia (Federation) Dokl Akad Nauk SSSR 7505465 0002-3264 0 Antilymphocyte Serum IM Animals Antilymphocyte Serum pharmacology Cell Division Clone Cells Graft Rejection Hematopoietic Stem Cell Transplantation Hybridization, Genetic Mice Mice, Inbred C57BL Radiation Chimera Spleen immunology Transplantation, Homologous 1975 8 11 1975 8 11 0 1 1975 8 11 0 0 ppublish 222 Frontline Gastroenterol. 2012 Jan;3(1):29-33 28839627 223 1976 03 01 2020 02 25 0002-3264 223 5 1975 Aug 11 Doklady Akademii nauk SSSR Dokl Akad Nauk SSSR [Microenvironment of enzymes as 1 of the factors determining enzyme stability. Stabilization of soluble and immobilized horseradish peroxidase]. 1256-9 Berezin I V IV Kershengol'ts B M BM Ugarova N N NN rus Journal Article Mikrookruzhenie fermentov kak odin iz faktorov, opredeliaiushchikh stabil'nost' fermentov. Stabilizatsiia restvorimoi i immobilizovannoi peroksidazy iz khrena Russia (Federation) Dokl Akad Nauk SSSR 7505465 0002-3264 0 Gels 0 Proteins 0 Serum Albumin EC 1.11.1.- Horseradish Peroxidase EC 1.11.1.- Peroxidases IM Drug Stability Gels Horseradish Peroxidase Hydrogen-Ion Concentration Peroxidases Proteins Serum Albumin 1975 8 11 1975 8 11 0 1 1975 8 11 0 0 ppublish 223 Br J Gen Pract. 1999 Oct;49(447):819 10885089 Can J Public Health. 2003 Nov-Dec;94(6):436-40 14700243 Schizophr Bull. 2004;30(4):969-82 15957201 Int J Epidemiol. 2009 Jun;38(3):877-83 19304988 BMJ. 2009 Oct 26;339:b4036 19858533 AIDS Behav. 2010 Jun;14(3):493-503 19949848 Qual Life Res. 2011 Dec;20(10):1727-36 21479777 BMJ. 2012 Sep 28;345:e5999 23045316 Am J Public Health. 2013 Dec;103 Suppl 2:S302-10 24148033 Trials. 2013 Nov 01;14:365 24176253 Lancet. 2014 Oct 25;384(9953):1541-7 25390579 Addiction. 2015 Oct;110(10):1605-14 26052657 224 1976 03 01 2018 12 03 0012-074X 28 9 1975 Sep Deutsche Krankenpflegezeitschrift Dtsch Krankenpflegez [3d regional meeting of the specialty field of supervisory nurses in Baden-Württemberg, Northern Group. June 25, 1975 in district hospital Heidenheim]. 486-7 Stängle H H ger Congress 3. Regionaltagung des Arbeitskreises Leitender Krankenschwestern und -pfleger in Baden-Württemberg, Gruppe Nord. Am 25. Juni 1975 im Kreiskrankenhaus Heidenheim Germany Dtsch Krankenpflegez 0323406 0012-074X N Congresses as Topic Germany, West Nursing, Supervisory 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 224 221 1976 03 01 2003 11 14 0002-3264 223 1 1975 Jul-Aug Doklady Akademii nauk SSSR Dokl Akad Nauk SSSR [Polyploidization and fusion of insect cells exposed to concanavalin A]. 209-12 Kakpakov V T VT Polukarova L G LG rus Journal Article Poliploidizatsiia i sliianie kletok nasekomykh pod vliianiem konkanavalina A Russia (Federation) Dokl Akad Nauk SSSR 7505465 0002-3264 11028-71-0 Concanavalin A IM Animals Cell Fusion drug effects Cell Line Cells, Cultured drug effects Concanavalin A pharmacology Culicidae Drosophila Polyploidy 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 221 2001 225 1976 02 09 2013 11 21 0012-0472 100 38 1975 Sep 19 Deutsche medizinische Wochenschrift (1946) Dtsch Med Wochenschr [Adverse effects of anti-epileptic drugs]. 1904-6 Bohlen N N Hertl M M ger Journal Article Nebenwirkungen antiepileptischer Medikamente Germany Dtsch Med Wochenschr 0006723 0012-0472 0 Anticonvulsants 0 Barbiturates 0 Succinimides 0 Thiazines 13AFD7670Q Primidone 33CM23913M Carbamazepine 5SEH9X1D1D Ethosuximide 614OI1Z5WI Valproic Acid 6158TKW0C5 Phenytoin 9002-60-2 Adrenocorticotropic Hormone 9CLV70W7HS Nitrazepam Q3JTX2Q7TU Diazepam R420KW629U Mephenytoin R7GV3H6FQ4 Trimethadione IM Adrenocorticotropic Hormone adverse effects Anticonvulsants adverse effects Barbiturates adverse effects Carbamazepine adverse effects Diazepam adverse effects Epilepsy drug therapy Ethosuximide adverse effects Humans Mephenytoin adverse effects Nitrazepam adverse effects Phenytoin adverse effects Primidone adverse effects Succinimides adverse effects Thiazines adverse effects Trimethadione adverse effects Valproic Acid adverse effects 1975 9 19 1975 9 19 0 1 1975 9 19 0 0 ppublish 225 10.1055/s-0028-1106478 226 1976 03 01 2019 10 27 0093-6391 2 6-7 1975 Endocrine research communications Endocr Res Commun Charge properties of human pituitary and amniotic fluid prolactins. 379-402 The apparent isoelectric points (pI) in isoelectric focusing (IF) of human pituitary and amniotic fluid prolactin (hPRL), both non-iodinated and iodinated, were determined. Unresolved mixtures of pituitary hPRL isohormones E and F, and of at least five isohormones found in amniotic fluid, and plasma hPRL exhibit an average pI value of 6.5 - 6.7. Transient state pH values observed or previously reported for hPRL components range from pH 5.9 to 6.8 after correction to standard conditions. At pH 8.1, the major isohormone, hPRL-F, carriers a charge of 2.2 net protons per molecule. The net charge differences among isohormones E, F and G are compatible with acquisition or loss of single charged groups per 20,000 molecular weight. This net charge is similar to that of the least prolactin-bioactive major isohormone of human growth hormone (hGH-B), while the hGH with a bioactivity comparable to that of hPRL exhibits a net charge of 3.4 valence units. The "large" isohormones J and H increased net charges, by a factor of 2-3, in direct proportion to their size increments. Rogol A D AD Ben-David M M Sheats R R Rodbard D D Chrambach A A eng Journal Article United States Endocr Res Commun 0426337 0093-6391 9002-62-4 Prolactin IM Amniotic Fluid analysis Female Humans Hydrogen-Ion Concentration Isoelectric Focusing Lactation Pituitary Gland analysis Pregnancy Prolactin blood immunology Radioimmunoassay 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 226 10.1080/07435807509084162 227 1976 02 09 2020 02 25 0013-7227 97 4 1975 Oct Endocrinology Endocrinology Human and monkey prolactin and growth hormone: separation of polymorphic forms by isoelectric focusing. 855-67 The feasibility of using isoelectric focusing for the separation of primate pituitary growth hormone from prolactin and for the characterization of polymorphic forms of these hormones was explored. In a pH 3--10 gradient, extracts of both human and cynomolgus monkey pituitaries were each resolved into 4 growth hormone components and at least 3 prolactin components, as shown by radioimmunoassay. In narrower gradients (of 2--3 pH units) greater resolution was achieved; the principal growth hormone components were well separated from the principal prolactin components but there was overlapping of some minor components. A partially purified human prolactin preparation was found to contain 4 prolactin components, one of which had a prolactin/growth hormone ratio of 760. Clinical grade human growth hormone was also resolved into at least 5 prolactin and 5 growth hormone components, many of which had higher pI values than those found in pituitary extract. Under the conditions used, both growth hormone and prolactin were found to be polymorphic with respect to isoelectric point. Some of the human prolactin components were found to contain less than 0.2% growth hormone by radioimmunoassay. Monkey growth hormone containing 0.01% prolactin was isolated. These findings demonstrate that isoelectric focusing is useful for the preparation of both growth hormone and prolactin which are essentially free of one another. Furthermore, the polymorphic forms were repeatedly found in preparations obtained by several methods and from 2 different species, suggesting that these forms are not artifacts. Hummel B C BC Brown G M GM Hwang P P Friesen H G HG eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Endocrinology 0375040 0013-7227 9002-62-4 Prolactin 9002-72-6 Growth Hormone AIM IM Animals Growth Hormone isolation & purification Haplorhini Humans Hydrogen-Ion Concentration Isoelectric Focusing Macaca fascicularis Pituitary Gland analysis Prolactin isolation & purification Radioimmunoassay 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 227 10.1210/endo-97-4-855 Circulation. 1999 Mar 23;99(11):1452-7 10086969 Circulation. 1999 Oct 26;100(17):1798-801 10534467 J Am Coll Cardiol. 2000 Jul;36(1):174-8 10898430 J Am Coll Cardiol. 2000 Jul;36(1):181-4 10898432 Circulation. 2000 Jul 18;102(3):294-9 10899092 Am Heart J. 2001 Feb;141(2):282-8 11174344 Europace. 2000 Oct;2(4):339-42 11194602 Europace. 2000 Jan;2(1):66-76 11225598 Europace. 1999 Jul;1(3):183-6 11225795 Circulation. 2001 Jul 3;104(1):52-7 11435337 J Cardiovasc Electrophysiol. 2001 Aug;12(8):935-8 11513446 Emerg Med J. 2002 Jan;19(1):23-7 11777866 Age Ageing. 2002 May;31(3):181-6 12006306 Eur Heart J. 2002 May;23(10):815-20 12009722 Age Ageing. 2002 Jul;31(4):272-5 12147565 Ann Neurol. 2002 Sep;52(3):342-5 12205647 Circulation. 2002 Sep 24;106(13):1684-9 12270863 Pacing Clin Electrophysiol. 2002 Oct;25(10):1441-6 12418741 J Am Coll Cardiol. 2002 Dec 4;40(11):2053-9 12475469 Eur Heart J. 2003 Apr;24(7):658-63 12657224 JAMA. 2003 May 7;289(17):2224-9 12734133 Europace. 2003 Jul;5(3):283-91 12842645 Europace. 2003 Jul;5(3):293-8 12842646 Europace. 2004 May;6(3):199-204 15121070 Eur Heart J. 2004 Oct;25(19):1741-8 15451153 Europace. 2004 Nov;6(6):467-537 15519256 Jpn Heart J. 2004 Sep;45(5):833-43 15557724 J Am Geriatr Soc. 2005 Jan;53(1):114-8 15667387 Am J Cardiol. 2005 Mar 1;95(5):668-71 15721118 Europace. 2005 Jul;7(4):400-6 15944102 Eur Heart J. 2006 Jan;27(1):76-82 16272210 Europace. 2006 Aug;8(8):644-50 16864618 J Am Coll Cardiol. 2006 Oct 3;48(7):1425-32 17010806 J Am Coll Cardiol. 2006 Oct 17;48(8):1652-7 17045903 Am J Med. 2007 Jan;120(1):54-62 17208080 Ann Intern Med. 1992 Mar 1;116(5):358-63 1736767 Am J Cardiol. 2007 Aug 15;100(4):672-6 17697827 Age Ageing. 2008 Jul;37(4):411-5 18586835 Am J Cardiol. 1991 Oct 15;68(10):1032-6 1927916 Acta Paediatr. 2009 Jul;98(7):1194-200 19397534 Eur Heart J. 2009 Nov;30(21):2631-71 19713422 J Am Coll Cardiol. 1991 Jan;17(1):125-30 1987214 Pacing Clin Electrophysiol. 2011 Mar;34(3):284-90 21091737 Am J Cardiol. 2011 Jun 1;107(11):1693-7 21420055 Europace. 2011 Nov;13(11):1632-8 21757485 Aging Clin Exp Res. 2011 Aug;23(4):304-8 22067373 Eur J Intern Med. 2012 Mar;23(2):e48-52 22284256 Auton Neurosci. 2012 May 21;168(1-2):1-3 22444321 Circulation. 2012 May 29;125(21):2566-71 22565936 Lancet. 1986 Jun 14;1(8494):1352-5 2872472 N Engl J Med. 1989 Feb 9;320(6):346-51 2913492 Q J Med. 1985 Apr;55(216):45-54 4011842 N Engl J Med. 1983 Jul 28;309(4):197-204 6866032 Yale J Biol Med. 1983 Jan-Feb;56(1):1-8 6880244 JAMA. 1982 Sep 10;248(10):1185-9 7109136 Pacing Clin Electrophysiol. 1995 Apr;18(4 Pt 1):716-24 7596855 Am Heart J. 1995 May;129(5):901-6 7732979 QJM. 1995 Mar;88(3):209-13 7767671 J Am Coll Cardiol. 1995 Jan;25(1):65-9 7798528 Am J Cardiol. 1993 Dec 1;72(17):1286-90 8256705 Am Heart J. 1997 Mar;133(3):346-52 9060805 J Am Coll Cardiol. 1999 Jan;33(1):16-20 9935002 228 1976 02 19 2014 04 08 0013-9300 9 3 1975 Environmental letters Environ Lett The interaction of SO2 with proteins. 265-77 Eickenroht E Y EY Gause E M EM Rowlands J R JR eng Comparative Study Journal Article United States Environ Lett 7610448 0013-9300 0 Blood Proteins 0 Sulfites 0UZA3422Q4 Sulfur Dioxide IM Animals Binding Sites Blood Proteins Hydrogen-Ion Concentration Osmolar Concentration Protein Binding Protein Conformation Rabbits Spectrometry, Fluorescence Spectrophotometry Spectrophotometry, Ultraviolet Sulfites Sulfur Dioxide 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 228 10.1080/00139307509435855 229 1976 02 09 2017 11 16 0300-824X 4 1975 Environmental quality and safety Environ Qual Saf Ecological observation of the 137Cs-contamination in beef of animals from the southern-Bavarian area. 24-36 Certain climatic and edaphic conformations in the Bavarian sub-alpine mountains and in the Alps favor above all the development of a land utilization system and farm structures similar to those in the northern part of Scandinavia. In 1963/64, the years of the highest environmental contamination up to the present, we established in 600 beef samples from the round or shoulder of male and female cattle (mainly Highland cattle) close connections between the 137Cs-contamination of green crop and the long lastnig yearly precipitation quantities, as well as certain relations between the 137Cs-contamination of meat and differences in the feeding and keeping of the animals. During summer-seasons (April-October), beef of cattle from pastures with heavy rainfall (Alps) was contaiminated by 137Cs up to 15 times more than that of confined animals. Hereby the rate of 137Cs-contamination in the meat of grazing cattle was nearly proportional to the quantities of precipitation. When confined cattle were fed on pastures in autumn after harvesting for 2 to 3 weeks, a quick increase of 137Cs-contamination of the meat was caused within this time up to values which in this district were otherwise only observed in grazing cattle. The lower 137Cs-content in meat of cattle housed during the summer season is due to the more varied fodder, which is at that time less contaminated than green crop. During the winter season (November to March), the highest contaminations in the meat of confined (Bohemian Forest) or grazing cattle (Alps) was measured when the animals in these districts were almost exclusively fed with fodder from the own farmground or with leafy silage. The highest contamination was almost regularly noticed in January, February and March, as generally during these months the highly contaminated first cut hay is fed. Here the meat was often even more contaminated than that of grazing cattle. After the quick decrease of 137Cs in fallout noticed in the years 1964 and 1965, in 1965/66 a dependance in the 137Cs-contamination of beef on the methods of keeping and feeding could still be observed in only the extreme cases (Alps, Bavarian- and Bohemian Forest); though in general, meat of animals from districts with heavy rainfall was slightly more contaminated than meat of animals from regions with less precipitation. Kreuzer W W eng Journal Article United States Environ Qual Saf 0332077 0300-824X 0 Cesium Radioisotopes 0 Radioactive Pollutants 0 Soil IM S Animals Cattle Cesium Radioisotopes Ecology Food Contamination, Radioactive Fungi Germany, West Hydrogen-Ion Concentration Meat analysis Plants Radioactive Pollutants Soil analysis Soil Microbiology Time Factors Trees Weather 76066044 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 229 230 1976 02 09 2020 02 25 0013-9432 20 5 1975 Enzyme Enzyme Liver microsomal beta-glucuronidase and UDP-glucuronyltransferase. 269-76 Both UDP-glucuronyltransferase (GT) and beta-glucuronidase (betaG) were assayed in untreated liver microsomes. Optimum assay conditions were established with rat liver microsomes using p-nitrophenol (pNP) and its glucuronide (pNPGA) at the pH optima of GT (7.5) and betaG (4.5). The activities of the two enzymes were compared using microsomes from rats, mice, pigs, cattle and horses, with pNP, pNPGA, and phenolphthalein as substrate, in the presence of various cofactors and inhibitors at pH 7.5 and 4.5. These data disclose pronounced differences with respect to species, substrate and other experimental conditions, thereby precluding the establishment of general optimum conditions. The two enzymes were also assayed under strictly identical conditions using pNP and pNPGA and rat liver microsomes at pH 7.5 in the presence and absence of UDP-glucuronate disodium (UDPGA), activators (ATP;UDP-N-acetylglucosamine) and inhibitors. When provided with a functional level of UDPGA, both enzymes proved active under those conditions, and a conjugation-deconjugation interplay was indicated. The two processes could be selectively and totally inhibited by Zn2+ and saccharolactone. The results suggest that conjugation-deconjugation-reconjugation cycles may be operative in the metabolism of drugs in vivo, taking place already at the level of the liver endoplasmic reticulum. Schöllhammer I I Poll D S DS Bickel M H MH eng Journal Article Switzerland Enzyme 1262265 0013-9432 0 Cations, Divalent 0 Lactones 0 Sugar Alcohols 528-04-1 Uridine Diphosphate N-Acetylglucosamine 8L70Q75FXE Adenosine Triphosphate EC 2.4.1.- Hexosyltransferases EC 2.4.1.17 Glucuronosyltransferase EC 3.2.1.31 Glucuronidase J41CSQ7QDS Zinc IM Adenosine Triphosphate pharmacology Animals Cations, Divalent Cattle Glucuronidase metabolism Glucuronosyltransferase metabolism Hexosyltransferases metabolism Horses Hydrogen-Ion Concentration Kinetics Lactones pharmacology Male Mice Microsomes, Liver enzymology Rats Species Specificity Sugar Alcohols pharmacology Swine Uridine Diphosphate N-Acetylglucosamine pharmacology Zinc pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 230 10.1159/000458949 Haemostasis. 1999 Nov-Dec;29(6):318-25 10844405 Thromb Haemost. 2000 Aug;84(2):210-5 10959691 J Diabetes Complications. 2001 Jan-Feb;15(1):44-54 11259926 Thromb Res. 2001 Dec 1;104(5):353-60 11738078 Intern Med. 2002 Mar;41(3):181-5 11929177 Respir Med. 2002 Jul;96(7):515-8 12194636 Endocr Res. 2003 Feb;29(1):73-82 12665320 J Trauma. 2003 Nov;55(5):886-91 14608161 Thromb Res. 2003;112(4):203-7 14987912 J Trauma. 2005 May;58(5):1002-9; discussion 1009-10 15920416 J Trauma. 2006 Sep;61(3):624-8 16966998 Proc Am Thorac Soc. 2007 Dec;4(8):626-34 18073394 Chest. 2009 Mar;135(3):786-793 18812453 Eur Respir J. 2010 Jun;35(6):1243-8 19926740 Stroke Res Treat. 2011 Feb 22;2011:219706 21423557 J Trauma. 2011 Nov;71(5):1271-7 21502874 Pediatr Hematol Oncol. 2011 Aug;28(5):418-24 21615248 Blood. 2012 Apr 5;119(14):3236-44 22262775 Transfusion. 2013 Jan;53 Suppl 1:23S-27S 23301969 Pediatr Crit Care Med. 2013 Mar;14(3):256-60 23392364 Liver Transpl. 2013 Aug;19(8):852-61 23696318 Clin Chim Acta. 2014 Sep 25;436:143-8 24880040 PLoS One. 2015 Aug 26;10(8):e0136463 26308340 Int J Surg. 2016 Sep;33(Pt B):196-201 26384835 Thromb Haemost. 1994 Sep;72(3):343-6 7855781 231 1976 02 19 2019 09 18 0013-9432 20 6 1975 Enzyme Enzyme Biochemical aspects of renal ammonia formation in metabolic acidosis. 359-80 In omnivorous creatures, the diet is acidogenic, especially as a result of the meat content, which gives rise to phosphoric and sulphuric acids, i.e., to metabolic acidosis. In the short term, metabolic acids are buffered by tissue proteins and bicarbonate (the 'alkali reserve'). In the longer term, acid must be excreted, or neutralized with base which is also generated from the diet, by conversion of dietary amino-nitrogen to ammonia. The final steps of this process occur in the kidney, which converts circulating glutamine to ammonia, and to carbon products such as glucose and carbon dioxide, by metabolic reactions which adapt during acidosis to generate more ammonia and maintain an increased renal ammonia content. The complex mechanisms which govern the formation of ammonia, glucose and carbon dioxide from glutamine, involving the reactions of amino acids, the tricarboxylic acid cycle, and gluconeogenesis, are reviewed. Hems D A DA eng Journal Article Review Switzerland Enzyme 1262265 0013-9432 0 Glutamates 0RH81L854J Glutamine 7664-41-7 Ammonia IY9XDZ35W2 Glucose QTT17582CB Hydrochloric Acid IM Acidosis chemically induced metabolism physiopathology Acute Disease Ammonia metabolism Glucose metabolism Glutamates metabolism Glutamine blood metabolism Hydrochloric Acid pharmacology Hydrogen-Ion Concentration Kidney drug effects metabolism physiopathology Kidney Cortex metabolism Models, Biological Perfusion 117 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 231 10.1159/000458960 232 1976 02 19 2019 09 18 0013-9432 21 1 1976 Enzyme Enzyme Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. I. Experimental extrahepatic cholestasis in rabbits. 1-7 Serum, liver and renal gamma-glutamyl transpeptidase (GGT) activities were studied in four groups of rabbits: controls, rabbits with obstructive extrahepatic cholestasis, rabbits with obstructive anuria, and animals with combined obstructive extrahepatic cholestasis and obstructive anuria. Serum GGT was essentially increased in rabbits with obstructive extrahepatic cholestasis, showing peak values in the combined cholestasis + obstructive anuria group, and practically normal values in animals with anuria. Liver GGT was increased in both cholestasis groups, but the increase was less prominent than the increase in serum GGT and there was no correlation between them. In both anuric groups renal GGT was reduced, probably as a result of inhibited enzyme synthesis secondary to the altered conditions for adequate renal function. The results obtained are suggestive of a probable renal involvement in the formation of the serum GGT activity level. Adjarov D D Popov S S Ivanov E E eng Journal Article Switzerland Enzyme 1262265 0013-9432 EC 2.3.2.2 gamma-Glutamyltransferase IM Animals Bile Ducts physiology Catheterization Cholestasis enzymology Kidney enzymology Ligation Liver enzymology Male Rabbits Ureter physiology gamma-Glutamyltransferase blood metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 232 10.1159/000458836 233 1976 02 19 2020 02 25 0013-9432 21 1 1976 Enzyme Enzyme Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. II. Experimental hexachlorobenzene porphyria in rabbits. 8-20 The mechanism responsible for the changes in serum and liver gamma-glutamyl transpeptidase (gamma-GT) activity was studied in a model of experimental hexachlorobenzene porphyria in rabbits. Porphyria followed the administration of hexachlorobenzene in doses of 280 mumol - kg-1 body weight, which were given daily through a gastric tube over a 20-day period. Serum gamma-GT activity and the activities of the lysosomal enzymes beta-N-acetylglucosaminidase and alpha-mannosidase were increased, whereas L-aspartate: 2-oxoglutarate aminotransferase and L-alanine: 2-oxoglutarate aminotransferase and L-alanine: 2-oxoglutarate aminotransferase remained unaltered. There was a considerable increase in liver microsomal protein, gamma-GT, cytochrome P-450, anilinehydroxylase, aminopyrine-demethylase and delta-aminolevulinic acid synthase. In the liver gamma-GT was detected in the microsomes as well as in the cytoplasm where enzymatic activity was higher. The high correlation coefficient between liver gamma-GT, cytochrome P-450 and delta-aminolevulinic acid synthase witnesses a hexachlorobenzene-induced gamma-GT formation in the liver. A statistically significant correlation between serum and liver gamma-GT activity was also found. These data strongly suggest that the increase in serum gamma-GT activity may result from the induction of the enzyme in the liver. Ivanov E E Krustev L L Adjarov D D Chernev K K Apostolov I I Dimitrov P P Drenska E E Stefanova M M Pramatarova V V eng Journal Article Switzerland Enzyme 1262265 0013-9432 0 Porphyrins 4Z87H0LKUY Hexachlorobenzene EC 2.3.2.2 gamma-Glutamyltransferase EC 3.2.1.- Mannosidases EC 3.2.1.52 Acetylglucosaminidase IM Acetylglucosaminidase metabolism Animals Hexachlorobenzene Liver drug effects enzymology Mannosidases metabolism Porphyrias chemically induced enzymology metabolism Porphyrins metabolism Rabbits gamma-Glutamyltransferase blood metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 233 10.1159/000458837 Intensive Care Med. 2003 Apr;29(4):530-8 12664219 Crit Care. 2004 Aug;8(4):R204-12 15312219 J Am Soc Nephrol. 2005 Nov;16(11):3365-70 16177006 Crit Care. 2006;10(3):R73 16696865 Crit Care. 2007;11(2):R31 17331245 Curr Opin Nephrol Hypertens. 2007 May;16(3):227-36 17420666 Kidney Int. 2011 Jun;79(12):1361-9 21430640 Clin Med (Lond). 2012 Jun;12(3):216-21 22783771 234 1976 03 01 2019 08 27 0301-5548 34 4 1975 Dec 05 European journal of applied physiology and occupational physiology Eur J Appl Physiol Occup Physiol Changes in erythrocyte 2,3 diphosphoglycerate in women following short term maximal exercise. 227-32 15 untrained women were subjected to a walking treadmill test to determine the influence of maximal exercise upon synthesis of erythrocyte 2,3 DPG. Although there was a 9.8% increase in the 2,3 DPG content following exercise, there was a concomitant 9.4% increase in the hemoglobin level; therefore, when 2,3 DPG is expressed as a ratio to hemoglobin (See Article), there was no significant change as a result of exercise stress. It was suggested that three additive factors produced during strenuous exercise; decreased pH; increased hemoglobin concentration; and increased CO2 production result in by-product inhibition of 2,3 DPG synthesis. It is concluded that 2,3 DPG does not provide a physiologic benefit in the adaptation of the oxygen transport system to exercise. Bonner H W HW Tate C A CA Buffington C K CK eng Journal Article Germany Eur J Appl Physiol Occup Physiol 0410266 0301-5548 0 Diphosphoglyceric Acids 0 Hemoglobins 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Adult Carbon Dioxide blood Diphosphoglyceric Acids biosynthesis blood Erythrocytes metabolism Female Hemoglobins metabolism Humans Hydrogen-Ion Concentration Oxygen blood Oxygen Consumption Physical Exertion 1975 12 5 1975 12 5 0 1 1975 12 5 0 0 ppublish 234 10.1007/BF00999936 Annu Rev Med. 1974;25:29-38 4274753 J Biol Chem. 1970 Jun;245(12 ):3232-41 4317427 Int Z Angew Physiol. 1971;30(1):34-9 5136941 Biochemistry. 1969 Jun;8(6):2567-71 5799137 Scand J Clin Lab Invest. 1974 Jun;33(4):347-52 4852400 J Appl Physiol. 1964 Mar;19:243-5 14155288 J Appl Physiol. 1962 Nov;17:967-70 13989261 Scand J Clin Lab Invest. 1965;17(6):515-23 5858746 J Biol Chem. 1971 Feb 10;246(3):547-54 5542668 Science. 1971 Mar 26;171(3977):1205-11 5545197 Nature. 1969 Feb 15;221(5181):618-22 5774935 Adv Exp Med Biol. 1972;28:99-119 5085189 J Pediatr. 1973 Jul;83(1):41-5 4768935 Fed Proc. 1970 May-Jun;29(3):1101-4 5443776 Scand J Clin Lab Invest. 1972 May;29(3):329-33 5037629 J Appl Physiol. 1971 May;30(5):625-31 5572784 J Appl Physiol. 1971 Jun;30(6):827-32 5580800 Proc Soc Exp Biol Med. 1969 Dec;132(3):886-7 5361007 J Clin Invest. 1968 Dec;47(12 ):2652-6 5725278 J Clin Invest. 1971 Mar;50(3):700-6 5545127 Med Sci Sports. 1972 Winter;4(4):182-6 4648576 Med Sci Sports. 1974 Winter;6(4):238-41 4461985 Proc Natl Acad Sci U S A. 1968 Oct;61(2):756-60 5246006 Am J Physiol. 1968 Jul;215(1):23-9 5659338 J Appl Physiol. 1974 Feb;36(2):214-7 4811380 J Appl Physiol. 1972 Jul;33(1):55-61 5037411 J Appl Physiol. 1974 Nov;37(5):658-64 4436190 235 1976 03 01 2020 02 25 0014-2956 55 2 1975 Jul 01 European journal of biochemistry Eur J Biochem Hydroxylation of p-Coumaric acid by illuminated chloroplasts. The role of superoxide. 355-60 1. Chloroplasts isolated from leaves of spinach-beet (Beta vulgaris L. ssp. vulgaris) do not catalyse the hydroxylation of p-coumaric acid in the dark unless a reductant (such as ascorbate, NADH or NADPH) is added. Superoxide dismutase has no effect on this reaction. 2. Illuminated chloroplasts catalyse the hydroxylation in the absence of added reductant. This reaction is completely inhibited by superoxide dismutase, but catalase has little effect. 3. Both hydroxylation in the light and hydroxylation in the dark in the presence of reductants are inhibited by diethyldithiocarbamate, EDTA, cyanide and 2-mercaptoethanol. 4. It is proposed that O-2- generated by illuminated chloroplasts is involved in the provision of a reductant to the enzyme phenolase. Halliwell B B eng Journal Article England Eur J Biochem 0107600 0014-2956 0 Caffeic Acids 0 Cinnamates 0 Coumaric Acids 0 Free Radicals 0U46U6E8UK NAD 1406-65-1 Chlorophyll 53-59-8 NADP EC 1.11.1.6 Catalase EC 1.15.1.1 Superoxide Dismutase PQ6CK8PD0R Ascorbic Acid S88TT14065 Oxygen IM Ascorbic Acid pharmacology Caffeic Acids metabolism Catalase metabolism Chlorophyll metabolism Chloroplasts drug effects metabolism Cinnamates metabolism Coumaric Acids metabolism Free Radicals Kinetics Light NAD pharmacology NADP pharmacology Oxidation-Reduction Oxygen Plants Superoxide Dismutase metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 235 10.1111/j.1432-1033.1975.tb02169.x Am J Surg. 1999 Jan;177(1):28-32 10037304 Heart. 2001 Apr;85(4):454-7 11250976 Clin Oncol (R Coll Radiol). 2001;13(2):138-43 11373878 J Obstet Gynaecol. 2003 May;23(3):294-6 12850865 J Public Health Med. 1992 Jun;14(2):173-6 1515200 J Arthroplasty. 2004 Oct;19(7):853-7 15483800 Surgeon. 2010 Feb;8(1):15-9 20222398 BMJ. 2011 Dec 20;343:d7869 22187189 Anaesthesia. 2012 Sep;67(9):951-6 22804480 Int J Surg. 2013;11(5):378-82 23459186 Aust N Z J Surg. 1989 Mar;59(3):257-60 2930380 Obstet Gynecol. 1995 Dec;86(6):1014-7 7501324 J Bone Joint Surg Br. 1996 Mar;78(2):178-84 8666620 236 1976 03 01 2019 06 20 0014-2956 55 2 1975 Jul 01 European journal of biochemistry Eur J Biochem Identification of chloride-binding sites in hemoglobin by nuclear-magnetic-resonance quadrupole-relaxation studies of hemoglobin digests. 385-90 35Cl minus-nuclear magnetic resonance (NMR) studies indicate that various digests of human hemoglobin with carboxypeptidase A and B, or a combination of the two, may be used for the identification of chloride binding sites. All the digestion products contain, like hemoglobin itself, at least two classes of binding sites, one of high, the others of low affinity. The pH dependence of the excess linewidth of the 35Cl minus NMR signal indicates that in the simple digests with either carboxypeptidase A or B, chloride is bound with high affinity at or near His-beta146-Asp-beta94 and at or near Val-alpha1-Arg-alpha141. The high-affinity sites show, in the case of the simple digests, a strong oxygen linkage which is lost in the forms digested with both carboxypeptidase A and B; this linkage may thus be correlated to the presence of conformational changes. Organic phosphates, like inositol hexaphosphate, show competition for some of the high-affinity chloride binding sites in hemoglobin and in the simple digests. This competition is likewise lost in the doubly digested hemoglobins. Chiancone E E Norne J E JE Forsén S S Bonaventura J J Brunori M M Antonini E E Wyman J J eng Journal Article England Eur J Biochem 0107600 0014-2956 0 Chlorides 0 Hemoglobins 0 Peptide Fragments 451W47IQ8X Sodium Chloride 7IGF0S7R8I Phytic Acid 7U1EE4V452 Carbon Monoxide EC 3.4.- Carboxypeptidases IM Binding Sites Carbon Monoxide blood Carboxypeptidases Chlorides blood Hemoglobins Humans Hydrogen-Ion Concentration Magnetic Resonance Spectroscopy Mathematics Osmolar Concentration Peptide Fragments Phytic Acid blood Protein Binding Protein Conformation Sodium Chloride 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 236 10.1111/j.1432-1033.1975.tb02173.x 237 1976 03 01 2019 06 20 0014-2956 55 2 1975 Jul 01 European journal of biochemistry Eur J Biochem The internal-alkaline pH gradient, sensitive to uncoupler and ATPase inhibitor, in growing Clostridium pasteurianum. 445-53 1. The intracellular pH was measured in growing Clostridium pasteurianum with and acid-base equilibrium distribution method. [14C]Dimethyloxazolidinedione, [14]methylamine and [14C]acetic acid were used as "deltapH-indicators". During growth the extracellular pH decreased from 7.1 to 5.1; simultaneously the intracellular pH changed from 7.5 to 5.9. Thus, the intracellular pH was more alkaline than the extracellular pH by 0.4 to 0.8 pH-units. 2. This pH gradient (interior alkaline) was abolished by the proton conductor carbonylcyanide m-chlorophenylhydrazone and the ATPase inhibitor N,N'-dicyclohexylcarbodiimide. The pH gradient could not be demonstrated in cells depleted of an energy substrate. These results suggest that the pH gradient is formed by an ATPase-driven extrusion of protons from the cells rather than by a Donnan potential. 3. Growth of the organism was inhibited by low concentrations of both carbonylcyanide m-chlorophenylhydrazone (5 muM) and dicyclohexylcarbodiimide (5 muM). This finding suggests that the pH gradient is essential for the growing cell as it may be required for substrate accumulation and other types of transport processes. Riebeling V V Thauer R K RK Jungermann K K eng Journal Article England Eur J Biochem 0107600 0014-2956 0 Carbodiimides 0 Nitriles 538-75-0 Dicyclohexylcarbodiimide 555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone IM Carbodiimides pharmacology Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology Clostridium drug effects metabolism Dicyclohexylcarbodiimide pharmacology Energy Metabolism Hydrogen-Ion Concentration Nitriles pharmacology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 237 10.1111/j.1432-1033.1975.tb02181.x 238 1976 03 01 2019 06 20 0014-2956 55 2 1975 Jul 01 European journal of biochemistry Eur J Biochem D-alanyl-D-alanine carboxypeptidase in the bacterial form and L-form of Proteus mirabilis. 465-73 Membranes of the bacterial form and the stable and unstable L-forms of Proteus mirabilis contain LD and DD-carboxypeptidase. The DD-carboxypeptidase is inhibited non-competitively by penicillin G. The enzyme of the bacterial form is highly penicillin-sensitive (Ki - 4 X 10(-9) M penicillin G). Inhibition is only partly reversible by treatment with penicillinase or by dialysis against buffer. In contrast, the DD-carboxypeptidase of the unstable L-form, grown in the presence of penicillin, is 175-fold less penicillin-sensitive (Ki = 7 X 10(7) M penicillin G). Inhibition is completely reversed by penicillinase or dialysis. After inhibition by penicillin and subsequent reactivation the penicillin sensitivity of the bacterial DD-carboxtpeptidase is similar to the sensitivity of the enzyme of the unstable L-form. The hypothesis is proposed that P. mirabilis contains two DD-carboxypeptidases of different penicillin sensitivity and with different mechanisms of penicillin binding. Peptidoglycan synthesis in the cell walls of the unstable L-form is probably carried out with the help of only one DD-carboxypeptidase, viz. the completely reactivatable enzyme with the lower penicillin sensitivity. Martin H H HH Maskos C C Burger R R eng Journal Article England Eur J Biochem 0107600 0014-2956 0 Detergents EC 1.4.3.3 D-Amino-Acid Oxidase EC 3.4.- Carboxypeptidases OF5P57N2ZX Alanine Q42T66VG0C Penicillin G Z61I075U2W Penicillin V IM Alanine Carboxypeptidases metabolism Cell Membrane drug effects enzymology D-Amino-Acid Oxidase Detergents pharmacology Hydrogen-Ion Concentration Kinetics L Forms enzymology Penicillin G pharmacology Penicillin V pharmacology Proteus mirabilis enzymology Protoplasts enzymology Spheroplasts enzymology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 238 10.1111/j.1432-1033.1975.tb02183.x 239 1976 03 01 2020 02 25 0014-2956 55 2 1975 Jul 01 European journal of biochemistry Eur J Biochem Pigeon-liver NAD kinase. The structural and kinetic basis of regulation of NADPH. 475-83 NAD kinase was purified from pigeon liver by an improved procedure which included chromatography on phosphocellulose. The resultant preparation was homogeneous as judged by gel electrophoresis, but electrofocusing gave indications of heterogeneity. The enzyme appeared to be of molecular weight 270000, and to consist of subunits of molecular weight 34000; it may therefore be an octomer. Kinetic studies over a wide range of substrate concentrations revealed departures from Michaelis-Menten behaviour with the substrate NAD+; these were interpreted tentatively in terms of negative homotropic interactions between identical binding sites, since thermal and chemical inactivation studies revealed no evidence for more than one type of catalytic site. The significance of the kinetics and of the type of inhibition produced by NADPH is discussed in terms of the regulation of NAD kinase activity in vivo. Apps D K DK eng Journal Article England Eur J Biochem 0107600 0014-2956 0 Macromolecular Substances 0U46U6E8UK NAD 53-59-8 NADP EC 2.7.- Phosphotransferases EC 2.7.1.- Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.23 NAD kinase IM Animals Binding Sites Columbidae Isoelectric Focusing Kinetics Liver enzymology Macromolecular Substances Molecular Weight NAD metabolism NADP metabolism Phosphotransferases antagonists & inhibitors metabolism Phosphotransferases (Alcohol Group Acceptor) 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 239 10.1111/j.1432-1033.1975.tb02184.x BMJ Qual Saf. 2012 Mar;21(3):179-83 22198901 Postgrad Med J. 1993 May;69(811):389-91 8346136 240 1976 02 26 2020 02 25 0301-4711 3 4 1975 Dec European journal of cardiology Eur J Cardiol Hydrogen ion changes and contractile behavior in the perfused rat heart. 329-36 The effect of acid-base alterations was analyzed using isolated rat hearts perfused at constant coronary perfusion pressure, and stimulated to contract at constant rat. The amount of shortening in the major axis and its derivative were measured to assess myocardial contractility. Both the 'respiratory' and 'metabolic' alterations affected the contractile behavior to the same extent. In the physiological range studied by us, acidosis depresses and alkalosis increases myocardial contraction. However acidosis seems to depress contractility more than the enhancement produced by the same change in pH towards the alkalotic side. When either amount of shortening or max dl/dt was plotted as a function of hydrogen ion acitvity (aH+) a linear correlation was obtained, either with pure 'metabolic' or 'respiratory' acid-base induced alterations (correlation coefficients higher than -.95; P less than .01). Our findings suggest that in the range studied by us, contraction of the perfused rat heart following acid-base alterations, is a linear function of hydrogen ion activity. Cingolani H E HE Maas A J AJ Zimmerman A N AN Meijler F L FL eng Journal Article Netherlands Eur J Cardiol 0404054 0301-4711 0 Bicarbonates 142M471B3J Carbon Dioxide IM Acid-Base Equilibrium Animals Bicarbonates blood Carbon Dioxide blood Hydrogen-Ion Concentration Myocardial Contraction Myocardium metabolism Perfusion Rats 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 240 Scand J Gastroenterol. 2000 Sep;35(9):947-9 11063154 BMC Fam Pract. 2006 Mar 03;7:12 16512926 Lancet Oncol. 2007 Nov;8(11):1007-17 17976611 Radiother Oncol. 2009 Mar;90(3):400-7 18952309 Scand J Gastroenterol. 2009;44(6):700-7 19308798 HPB (Oxford). 2012 Jan;14(1):9-13 22151445 Lancet. 2013 Dec 21;382(9910):2084-92 24067488 Lancet Oncol. 2014 Sep;15(10):e447-60 25186048 Frontline Gastroenterol. 2015 Jan;6(1):53-72 25580207 Frontline Gastroenterol. 2015 Jul;6(3):169-174 28839807 Dig Dis Sci. 1988 Feb;33(2):129-34 3123181 Scand J Gastroenterol. 1993 Aug;28(8):681-7 8210982 Scand J Gastroenterol. 1997 Sep;32(9):920-4 9299672 Qual Life Res. 1998 Jan;7(1):75-83 9481153 241 1976 03 01 2019 08 23 0014-2972 5 6 1975 Nov 21 European journal of clinical investigation Eur J Clin Invest Changes of EEG and pulmonary venous admixture during a protein load in patients with cirrhosis. 515-20 21 patients with cirrhosis of the liver and 24 control patients were studied before and after a protein load (120 g protein per day during one week). An EEG was recorded and a visual assessment of frequency pattern was performed. Venous admixture was estimated during hyperoxia. According to the EEG frequency pattern the patient group with cirrhosis was subdivided into those with EEG slowing after the protein load (n = 7) and those without (n = 14). The following results were obtained: 1) Resting arterial blood gases did not change in either group. 2) There was a significant increase of the AaD02 (difference between alveolar p02 and peripheral arterial p02) in cirrhotics and controls. 3) The increase in AaD02 was significantly larger in those cirrhotics showing EEG slowing compared to those without EEG - slowing or to the controls. 4) Fractional venous admisture increased significantly in those cirrhotics showing EEG slowing. There was no significant change in those patients who did not show EEG changes or in the controls. Schomerus H H Buchta I I Arndt H H eng Journal Article England Eur J Clin Invest 0245331 0014-2972 0 Dietary Proteins 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Blood Pressure Carbon Dioxide blood Dietary Proteins Electroencephalography Humans Hydrogen-Ion Concentration Liver Cirrhosis physiopathology Oxygen blood Partial Pressure 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 241 10.1111/j.1365-2362.1975.tb00484.x 242 1976 02 19 2019 07 07 0014-4827 94 1 1975 Aug Experimental cell research Exp Cell Res Formation of fertilization acid by sea urchin eggs does not require specific cations. 1-6 Paul M M Epel D D eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States Exp Cell Res 0373226 0014-4827 0 Acids 37H9VM9WZL Calcimycin 451W47IQ8X Sodium Chloride 526U7A2651 Egtazic Acid 660YQ98I10 Potassium Chloride I38ZP9992A Magnesium RWP5GA015D Potassium SY7Q814VUP Calcium IM Acids metabolism Animals Calcimycin pharmacology Calcium metabolism pharmacology Egtazic Acid pharmacology Female Fertilization Hydrogen-Ion Concentration Magnesium pharmacology Ovum drug effects metabolism Potassium pharmacology Potassium Chloride pharmacology Sea Urchins Sodium Chloride pharmacology 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 242 0014-4827(75)90524-8 10.1016/0014-4827(75)90524-8 243 1976 02 19 2019 07 07 0014-4827 94 1 1975 Aug Experimental cell research Exp Cell Res Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. 70-8 Michalopoulos G G Pitot H C HC eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States Exp Cell Res 0373226 0014-4827 0 Insulin 63X7MBT2LQ Bucladesine 9007-34-5 Collagen 9007-92-5 Glucagon EC 2.6.1.5 Tyrosine Transaminase IY9XDZ35W2 Glucose WI4X0X7BPJ Hydrocortisone IM Bucladesine pharmacology Cell Aggregation Cell Nucleus ultrastructure Cell Survival Cells, Cultured enzymology ultrastructure Collagen Cytoplasmic Granules ultrastructure Enzyme Induction drug effects Glucagon pharmacology Glucose pharmacology Hydrocortisone pharmacology Insulin pharmacology Intercellular Junctions ultrastructure Liver cytology Tyrosine Transaminase biosynthesis 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 243 0014-4827(75)90532-7 10.1016/0014-4827(75)90532-7 244 1976 02 20 2020 02 25 0014-4827 94 2 1975 Sep Experimental cell research Exp Cell Res Cell transformation in isolated striated muscle of hydromedusae independent of DNA synthesis. 401-8 Schmid V V eng 090441 Wellcome Trust United Kingdom Journal Article United States Exp Cell Res 0373226 0014-4827 0 Mitomycins 9007-49-2 DNA IM Animals Cell Differentiation Cnidaria DNA biosynthesis Dose-Response Relationship, Drug Flagella ultrastructure Mitomycins pharmacology Muscles cytology metabolism ultrastructure 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 244 10.1016/0014-4827(75)90506-6 Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005542 17636806 Diabet Med. 2008 Jul;25(7):765-74 18644063 Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005103 20091571 J Diabetes Sci Technol. 2012 Jan 01;6(1):184-90 22401338 Br Med J. 1978 Jan 28;1(6107):204-7 340000 245 1976 02 20 2019 07 07 0014-4827 94 2 1975 Sep Experimental cell research Exp Cell Res Induction of DNA synthesis by dichloroisoproterenol without initial rise of the cAMP level in the parotid gland of mouse. 431-4 Furuno I I Matsudaira H H eng Journal Article United States Exp Cell Res 0373226 0014-4827 1CC1JFE158 Dactinomycin 9007-49-2 DNA 98600C0908 Cycloheximide E0399OZS9N Cyclic AMP L628TT009W Isoproterenol IM Animals Cyclic AMP metabolism Cycloheximide pharmacology DNA biosynthesis Dactinomycin pharmacology Dose-Response Relationship, Drug Isoproterenol pharmacology Male Mice Mice, Inbred Strains Parotid Gland metabolism radiation effects Radiation Effects X-Rays 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 245 10.1016/0014-4827(75)90509-1 246 1976 02 20 2019 07 07 0014-4827 94 2 1975 Sep Experimental cell research Exp Cell Res Cell density-dependent stimulation of glutamine synthetase activity in cultured mouse teratoma cells. 459-64 Connolly D T DT Oppenheimer S B SB eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Exp Cell Res 0373226 0014-4827 0 Culture Media 0RH81L854J Glutamine 1CC1JFE158 Dactinomycin 63X7MBT2LQ Bucladesine 98600C0908 Cycloheximide C137DTR5RG Theophylline EC 6.3.1.2 Glutamate-Ammonia Ligase WI4X0X7BPJ Hydrocortisone IM Bucladesine pharmacology Cell Count Cell Division Cells, Cultured Culture Media Cycloheximide pharmacology Dactinomycin pharmacology Glutamate-Ammonia Ligase metabolism Glutamine pharmacology Hydrocortisone pharmacology Theophylline pharmacology 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 246 10.1016/0014-4827(75)90518-2 247 1976 02 20 2020 02 25 0014-4827 95 2 1975 Oct 15 Experimental cell research Exp Cell Res Polyadenylation of nascent RNA during the embryogenesis of Ilyanassa obsoleta. 263-8 Collier J R JR eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States Exp Cell Res 0373226 0014-4827 0 RNA, Ribosomal 1CC1JFE158 Dactinomycin 24937-83-5 Poly A 63231-63-0 RNA IM Animals Cell Division Dactinomycin pharmacology Hydrogen-Ion Concentration Poly A metabolism RNA biosynthesis RNA, Ribosomal biosynthesis Snails embryology metabolism 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 247 10.1016/0014-4827(75)90550-9 Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S115-23 10609690 Neurobiol Aging. 2000 Jan-Feb;21(1):57-62 10794849 Annu Rev Public Health. 2002;23:213-31 11910061 Science. 2002 Jul 19;297(5580):353-6 12130773 Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7 12634421 Neurology. 2003 Apr 22;60(8):1374-7 12707450 Cochrane Database Syst Rev. 2003;(3):CD001190 12917900 Cochrane Database Syst Rev. 2003;(3):CD003154 12917950 Neurobiol Aging. 2004 May-Jun;25(5):609-15 15172738 Neurology. 2004 Oct 12;63(7):1187-92 15477536 Curr Alzheimer Res. 2005 Apr;2(2):155-65 15974913 Drugs. 2006;66(11):1515-34 16906789 Immunol Rev. 2006 Oct;213:48-65 16972896 Expert Rev Neurother. 2008 Nov;8(11):1703-18 18986241 PLoS One. 2009;4(1):e4144 19127292 J Alzheimers Dis. 2009;16(1):15-27 19158417 Expert Opin Pharmacother. 2009 Jul;10(10):1657-64 19527190 J Clin Psychiatry. 2009 Jun;70(6):919-21 19573485 J Clin Psychiatry. 2009 Jun;70(6):922-31 19573486 Neuron. 2009 Aug 13;63(3):287-303 19679070 JAMA. 2009 Dec 16;302(23):2557-64 20009055 J Alzheimers Dis. 2010;19(1):311-23 20061647 J Alzheimers Dis. 2010;20(3):843-54 20182025 J Alzheimers Dis. 2010;21(1):1-14 20182045 Int J Alzheimers Dis. 2010 Jun 23;2010:null 20721349 J Alzheimers Dis. 2010;21(4):1119-28 21504133 Alzheimers Dement. 2011 May;7(3):257-62 21514247 Int J Alzheimers Dis. 2011;2011:280502 21760986 Alzheimers Dement. 2011 Jul;7(4):402-11 21784351 Arch Neurol. 2012 Jan;69(1):29-38 21911655 Dialogues Clin Neurosci. 2003 Mar;5(1):7-15 22033677 Br J Clin Pharmacol. 2012 Apr;73(4):504-17 22035455 Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189 22229116 Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006378 22336816 Rev Neurol (Paris). 2012 Jun;168(6-7):471-82 22579080 Mol Diagn Ther. 2012 Jun 1;16(3):135-41 22646065 J Alzheimers Dis. 2012;32(3):531-40 22842867 Lancet. 2012 Oct 20;380(9851):1441-3 23084456 Nat Rev Neurol. 2013 Feb;9(2):106-18 23296339 Alzheimers Res Ther. 2013 Jan 21;5(1):6 23336974 J Neuroinflammation. 2013 Jun 05;10:70 23735288 N Engl J Med. 2013 Jul 25;369(4):341-50 23883379 Curr Opin Neurol. 2013 Dec;26(6):646-55 24145484 Alzheimers Res Ther. 2013 Nov 11;5(6):56 24216217 Drug Des Devel Ther. 2013 Dec 06;7:1471-8 24353405 Biochem Pharmacol. 2014 Apr 15;88(4):529-39 24361915 N Engl J Med. 2014 Jan 23;370(4):311-21 24450890 N Engl J Med. 2014 Jan 23;370(4):322-33 24450891 JAMA Neurol. 2014 Apr;71(4):505-8 24493463 Curr Pharm Des. 2014;20(38):6007-13 24641219 Front Cell Neurosci. 2014 Apr 22;8:112 24795567 Diabetes. 2014 Jul;63(7):2253-61 24931035 Alzheimers Res Ther. 2014 Jul 03;6(4):37 25024750 BMC Med. 2014 Nov 11;12:160 25385407 J Alzheimers Dis. 2015;44(2):705-20 25550228 Alzheimers Res Ther. 2014 Dec 24;6(9):89 25621019 Lancet. 2015 Jun 6;385(9984):2255-63 25771249 Lancet Neurol. 2015 Apr;14(4):388-405 25792098 BMJ. 2015 Jul 24;351:h4064 26208710 Alzheimers Dement. 2016 Feb;12(2):110-120 26238576 Neurosci Lett. 1995 Feb 15;186(1):17-20 7783942 Am Fam Physician. 1994 Sep 15;50(4):819-26 8079912 Science. 1993 Aug 13;261(5123):921-3 8346443 Neurology. 1996 Aug;47(2):425-32 8757015 Neurobiol Aging. 1997 Jul-Aug;18(4):351-7 9330961 JAMA. 1997 Oct 22-29;278(16):1349-56 9343467 Peptides. 1997;18(9):1423-9 9392846 Neurology. 1998 Jan;50(1):164-8 9443474 J Clin Psychiatry. 1998;59 Suppl 13:19-22 9771826 Trends Cell Biol. 1998 Nov;8(11):425-7 9854307 248 1976 02 21 2020 02 25 0014-4827 96 2 1975 Dec Experimental cell research Exp Cell Res The effect of environmental pH upon acid hydrolase activities of cultured human diploid fibroblasts. 317-20 Wood S S eng Comparative Study Journal Article United States Exp Cell Res 0373226 0014-4827 0 Culture Media EC 3.2.1.- Galactosidases EC 3.2.1.- Glucosidases EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.- Hexosaminidases EC 3.2.1.31 Glucuronidase IM Cells, Cultured Culture Media Galactosidases metabolism Glucosidases metabolism Glucuronidase metabolism Glycoside Hydrolases metabolism Hexosaminidases metabolism Hydrogen-Ion Concentration 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 248 10.1016/0014-4827(75)90263-3 BMJ. 2000 Feb 19;320(7233):469-72 10678857 Nutrition. 2001 Jul-Aug;17(7-8):632-7 11448586 BMJ. 2004 Apr 17;328(7445):908-9 15087326 BMJ. 2008 Jun 28;336(7659):1495-8 18583681 BMJ. 2008 Jul 08;337:a680 18614493 BMJ. 2009 Dec 01;339:b5048 19952043 249 1976 02 21 2019 07 07 0014-4827 96 2 1975 Dec Experimental cell research Exp Cell Res Enucleation of cells by density gradient centrifugation. 360-6 Bossart W W Loeffler H H Bienz K K eng Journal Article United States Exp Cell Res 0373226 0014-4827 3CHI920QS7 Cytochalasin B IM Cell Fractionation methods Cell Line Cell Nucleus Cell Survival Centrifugation, Density Gradient methods Cytochalasin B Hydrogen-Ion Concentration Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 249 10.1016/0014-4827(75)90268-2 250 1976 03 01 2014 11 20 0301-472X 3 6 1975 Nov Experimental hematology Exp Hematol An evaluation of factors affecting the in vitro bioassay for erythropoietin. 362-74 Two main aspects of the in vitro mouse foetal liver cell assay for Erythroid Stimulating Factor (ESF) in human sera have been investigated. The haem extraction process has been shown to give specific and quantitative recovery of 59Fe labelled haem from haemoglobin thus confirming that the material assayed in human sera is stimulating the synthesis of this protein. The extraction procedure can be simplified considerably by prior mixing of the reagents without significantly influencing the results. Several serum constituents (citrate, testosterone, B12, folic acid and iron) have been investigated over a range of concentrations for possible effects on the cultures. Generally only small effects on haem synthesis were observed. It is concluded that variations in the levels of these factors in sera from treated patients will not produce any significant alterations in the estimated ESF concentrations. Dunn C D CD Napier J A JA eng Journal Article Netherlands Exp Hematol 0402313 0301-472X 0 Citrates 0 Culture Media 0 Hemoglobins 11096-26-7 Erythropoietin 3XMK78S47O Testosterone 42VZT0U6YR Heme 935E97BOY8 Folic Acid E1UOL152H7 Iron P6YC3EG204 Vitamin B 12 IM S Animals Biological Assay Cells, Cultured Citrates blood Culture Media Erythropoietin metabolism Evaluation Studies as Topic Fetus Folic Acid blood Heme metabolism Hemoglobins biosynthesis Hemolysis Hydrogen-Ion Concentration In Vitro Techniques Iron blood Liver embryology metabolism Mice Testosterone blood Vitamin B 12 blood 76066375 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 250 251 1976 02 21 2018 04 29 0430-0920 30 11 1975 Nov Il Farmaco; edizione scientifica Farmaco Sci [Synthesis of N-substituted isoindolines]. 884-90 Some derivatives of isoindoline were prepared in order to test their cardiovascular activity. Pharmacological tests showed that some of the compounds had moderate alpha-blocking and coronarodilatory activity whereas others had some local anesthetic activity. Chimenti F F Vomero S S ita 101784 Wellcome Trust United Kingdom English Abstract Journal Article Sintesi di isoindoline N-sostituite Italy Farmaco Sci 0370716 0430-0920 0 Adrenergic beta-Antagonists 0 Anesthetics, Local 0 Benzimidazoles 0 Indoles 0 Vasodilator Agents IM Adrenergic beta-Antagonists chemical synthesis Anesthetics, Local chemical synthesis Benzimidazoles Indoles chemical synthesis Vasodilator Agents chemical synthesis 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 251 253 1976 03 01 2000 12 18 0014-9772 40 10 1975 Oct Fel'dsher i akusherka Feldsher Akush [Elements of scientific work organization in ambulance feldshers' functions]. 32-4 Sorokin N N NN rus Journal Article Elementy not v rabote fel'dshera skoroi pomoshchi Russia (Federation) Feldsher Akush 16930040R 0014-9772 N Emergency Medical Services Physician Assistants Systems Analysis Transportation of Patients 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 253 252 1976 03 01 2020 02 25 0014-9772 40 10 1975 Oct Fel'dsher i akusherka Feldsher Akush [Cryptorchism]. 23-6 Volozhin S I SI rus Journal Article Kriptorkhizm Russia (Federation) Feldsher Akush 16930040R 0014-9772 N Cryptorchidism Humans Male 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 252 Neurology. 1999 Sep 22;53(5):1059-63 10496266 Arch Neurol. 2000 Jan;57(1):109-13 10634456 Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9 11464847 Neurology. 2002 Jun 11;58(11):1593-6 12058084 J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1258-61 12933930 Lancet Neurol. 2006 Feb;5(2):140-7 16426990 Muscle Nerve. 2006 Sep;34(3):359-60 16609978 Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004030 17054194 Neurology. 2008 Jan 8;70(2):144-52 18180444 Science. 2008 Mar 21;319(5870):1668-72 18309045 Amyotroph Lateral Scler. 2009 Feb;10(1):53-7 18985466 Science. 2009 Feb 27;323(5918):1205-8 19251627 Science. 2009 Feb 27;323(5918):1208-1211 19251628 Neurology. 2009 Mar 24;72(12):1087-94 19307543 Nature. 2009 Mar 26;458(7237):415-7 19325616 N Engl J Med. 1994 Mar 3;330(9):585-91 8302340 Nature. 1993 Mar 4;362(6415):59-62 8446170 Lancet. 1996 May 25;347(9013):1425-31 8676624 J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):147-51 8708642 254 1976 03 01 2019 02 06 0014-9772 40 9 1975 Sep Fel'dsher i akusherka Feldsher Akush [Participation of feldshers and midwives in the secret and partisan activities during the great patriotic war]. 3-6 Kiselev A F AF rus Historical Article Journal Article Uchastie fel'dsherov i akusherok nikolaevskoi oblasti v podpol'nom i partizanskom dvizhenii v gody velikoi otechestvennoi voiny Russia (Federation) Feldsher Akush 16930040R 0014-9772 N Q History of Nursing History, 20th Century Midwifery history Physician Assistants history USSR 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 254 255 1976 03 01 2019 12 10 0014-9772 40 9 1975 Sep Fel'dsher i akusherka Feldsher Akush [The organization of health education meetings, verbal reports, carnivals, reader's conferences]. 31-4 Shibaeva A N AN rus Congress Organizatsiia sanitarno-prosvetitel'nykh vecherov, ustnykh zhurnalov, karnavalov, chitatel'skikh konferentsii Russia (Federation) Feldsher Akush 16930040R 0014-9772 N Congresses as Topic Exhibitions as Topic Health Education Methods USSR 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 255 256 1976 03 01 2000 12 18 0014-9772 40 9 1975 Sep Fel'dsher i akusherka Feldsher Akush [Problems concerning the training of feldshers in foreign countries]. 37-41 Galakhov E V EV Zhiliaeva E P EP rus Journal Article Problemy podgotovki fel'dsherov za rubezhom Russia (Federation) Feldsher Akush 16930040R 0014-9772 N Physician Assistants education 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 256 257 1976 03 01 2017 03 22 0015-329X 61 11 1975 Nov Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova Fiziol Zh SSSR Im I M Sechenova [Mechanisms of the thermogenic action of noradrenaline during adaptation to cold]. 1709-14 In white rats both adapted and unadapted to cold, the RQ dynamics during cold exposure, noradrenaline and ganglion blocking agent administration, were studied. The adapted animals' RQ in thermoneutral conditions was shown to be a little higher than in the control rats; 0.5 mg/kg noradrenaline injections induced a clear RQ decrease in the former and did not influence the latters' RQ. Cold exposure was followed by a RQ decrease in both. Ganglion blocking agent administration decreased the RQ in the adapted animals and prevented it from falling in the control those. Noradrenaline is supposed to be the main but not the only factor activating lipolysis in the cold adapted animals. Sobolev V I VI Pevnyi S A SA rus English Abstract Journal Article O mekhanizmakh termogennogo deistviia noradrenaline pri adaptatsii k kholodu Russia (Federation) Fiziol Zh SSSR Im I M Sechenova 0427673 0015-329X 0 Ganglionic Blockers X4W3ENH1CV Norepinephrine IM Adaptation, Physiological drug effects Animals Body Temperature drug effects Cold Temperature Depression, Chemical Ganglionic Blockers pharmacology Male Norepinephrine pharmacology Oxygen Consumption drug effects Rats 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 257 258 1976 02 09 2020 02 25 0020-7292 13 1 1975 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Int J Gynaecol Obstet Response to exogenous gonadotropins in the unresponsive ovary syndrome. 23-8 Zourlas P A PA eng Journal Article United States Int J Gynaecol Obstet 0210174 0020-7292 0 17-Ketosteroids 0 Chorionic Gonadotropin 0 Estrogens 61489-71-2 Menotropins 9002-68-0 Follicle Stimulating Hormone JR3JD1Y22C Pregnanediol R 17-Ketosteroids urine Adult Amenorrhea drug therapy Body Temperature Chorionic Gonadotropin pharmacology therapeutic use Estrogens urine Female Follicle Stimulating Hormone urine Humans Menotropins pharmacology therapeutic use Ovary drug effects Pregnanediol urine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 258 10.1002/j.1879-3479.1975.tb00329.x Eur J Cancer. 2003 Dec;39(18):2622-31 14642924 Eur J Cancer. 2004 Oct;40(15):2280-6 15454254 Rheumatology (Oxford). 2007 Jan;46(1):161-8 16790451 Cancer. 2006 Oct 1;107(7 Suppl):1645-55 16906507 Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1531-44 16939973 Cancer. 2008 Nov 15;113(10):2807-15 18846564 Hematology Am Soc Hematol Educ Program. 2008;:374-80 19074113 Semin Oncol. 2010 Apr;37(2):e1-8 20494693 BMJ. 2012 Jun 01;344:e3718 22661725 Lancet. 2013 Jan 5;381(9860):73-87 23176802 J Adolesc Young Adult Oncol. 2011 Mar;1(1):49-52 26812569 259 1976 02 09 2020 02 25 0020-7292 13 1 1975 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Int J Gynaecol Obstet A comparative study of metal and plastic (Karman) cannulae for first trimester abortion by suction curettage. 33-8 Antonovski L L Ljatkova K K Sukarov L L LL Brenner W E WE Edelman D A DA Bernard R P RP eng Comparative Study Journal Article United States Int J Gynaecol Obstet 0210174 0020-7292 R Abortion, Induced methods Adult Dilatation and Curettage Female Humans Parity Pregnancy Pregnancy Trimester, First Time Factors Vacuum Curettage 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 259 10.1002/j.1879-3479.1975.tb00331.x Addiction. 2009 Apr;104(4):554-63 19335654 260 1976 02 09 2019 08 19 0020-7292 13 1 1975 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Int J Gynaecol Obstet Acute bacterial myositis following septic abortion. An unusual complication. 6-8 Chan W F WF Ong H C HC Wong W P WP eng Case Reports Journal Article United States Int J Gynaecol Obstet 0210174 0020-7292 R Abortion, Septic complications Adult Female Gangrene etiology Humans Myositis etiology microbiology Pregnancy Streptococcal Infections Streptococcus isolation & purification 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 260 10.1002/j.1879-3479.1975.tb00325.x 261 1976 02 13 2019 07 06 0300-5127 3 5 1975 Biochemical Society transactions Biochem Soc Trans The binding of substrates and inhibitors to dihydrofolate reductase. 630-1 Roberts G C GC eng Journal Article England Biochem Soc Trans 7506897 0300-5127 0 Folic Acid Antagonists 0 Ligands 0U46U6E8UK NAD 935E97BOY8 Folic Acid EC 1.5.1.3 Tetrahydrofolate Dehydrogenase IM Binding Sites Folic Acid Folic Acid Antagonists Hydrogen-Ion Concentration Kinetics Ligands NAD Protein Binding Protein Conformation Tetrahydrofolate Dehydrogenase metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 261 10.1042/bst0030630 262 1976 02 13 2020 02 25 0300-5127 3 5 1975 Biochemical Society transactions Biochem Soc Trans Euglena gracilis deoxyribonucleic acid polymerases: subcellular locations and variations during the cell cycle. 652 McLennan A G AG Keir H M HM eng Journal Article England Biochem Soc Trans 7506897 0300-5127 0 Isoenzymes EC 2.7.7.- DNA Nucleotidyltransferases I38ZP9992A Magnesium IM Animals Cell Division Chloroplasts enzymology DNA Nucleotidyltransferases metabolism Enzyme Activation drug effects Euglena gracilis enzymology Hydrogen-Ion Concentration Isoenzymes metabolism Magnesium pharmacology Subcellular Fractions enzymology Time Factors 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 262 10.1042/bst0030652 J Clin Invest. 2000 Feb;105(3):311-20 10675357 Hum Reprod. 2000 Jun;15(6):1266-74 10831553 J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8 10902790 Recent Prog Horm Res. 2001;56:295-308 11237218 Hum Reprod. 2004 Jan;19(1):41-7 14688154 Hum Reprod. 2005 Feb;20(2):373-81 15539436 Clin Endocrinol (Oxf). 2006 Aug;65(2):137-45 16886951 Endokrynol Pol. 2007 Jan-Feb;58(1):34-41 17354203 Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7 17371468 J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5 17405838 J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004 18089693 Diabetologia. 2008 Jul;51(7):1153-8 18478198 N Engl J Med. 2009 Apr 9;360(15):1509-17 19357406 N Engl J Med. 2009 Apr 9;360(15):1518-25 19357407 J Clin Endocrinol Metab. 2009 Sep;94(9):3558-66 19567518 Med Hypotheses. 2009 Dec;73(6):981-5 19692185 BJOG. 2009 Nov;116(12):1633-9 19781047 J Clin Endocrinol Metab. 2011 Feb;96(2):E304-11 21084397 Steroids. 2012 Mar 10;77(4):312-6 22172592 Steroids. 2012 Mar 10;77(4):290-4 22178788 Mol Cell Endocrinol. 2013 Jul 5;373(1-2):68-76 23084978 J Endocrinol Invest. 2013 Jul-Aug;36(7):478-84 23211631 J Clin Endocrinol Metab. 2014 Jan;99(1):E117-21 24384025 Hepat Mon. 2014 Nov 01;14(11):e23235 25598791 Lancet. 1988 Apr 16;1(8590):870-2 2895373 J Clin Endocrinol Metab. 1995 Nov;80(11):3227-32 7593430 J Clin Endocrinol Metab. 1995 Sep;80(9):2586-93 7673399 Endocr Rev. 1997 Dec;18(6):774-800 9408743 J Clin Endocrinol Metab. 1998 Nov;83(11):3984-91 9814480 263 1976 02 13 2020 02 25 0300-5127 3 5 1975 Biochemical Society transactions Biochem Soc Trans Monomer complexes of polyadenylic acid. 655-6 Jeremy R R Davies H H eng Journal Article England Biochem Soc Trans 7506897 0300-5127 0 Xanthines 24937-83-5 Poly A IM Binding Sites Hydrogen-Ion Concentration Nucleic Acid Conformation Optical Rotatory Dispersion Poly A Structure-Activity Relationship Xanthines 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 263 10.1042/bst0030655 Clin Infect Dis. 2002 Jun 1;34(11):1481-90 12015695 Chest. 2003 Nov;124(5):1789-97 14605050 N Engl J Med. 2004 Oct 28;351(18):1826-8 15509815 J Med Microbiol. 2004 Dec;53(Pt 12):1241-6 15585504 Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6 15917519 Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S293-302 16080068 J Antimicrob Chemother. 2006 Feb;57(2):367-8 16354745 J Antimicrob Chemother. 2006 Apr;57(4):589-608 16507559 Crit Care Med. 2006 Jun;34(6):1589-96 16625125 N Engl J Med. 2006 Aug 17;355(7):653-65 16914701 J Antimicrob Chemother. 2007 Dec;60(6):1361-9 17913720 Clin Infect Dis. 2008 Apr 1;46(7):1069-77 18444827 Diagn Microbiol Infect Dis. 2008 Jul;61(3):329-38 18508226 J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii105-14 18819975 J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii41-54 18819979 J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii65-74 18819981 J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii75-85 18819982 J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii87-95 18819983 Clin Infect Dis. 2009 Jan 1;48(1):1-12 19035777 Clin Infect Dis. 2009 Jul 15;49(2):291-8 19527173 J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i29-36 19675016 Am J Respir Crit Care Med. 2010 Jan 15;181(2):150-7 19875685 J Antimicrob Chemother. 2010 Jan;65(1):79-81 19915068 J Antimicrob Chemother. 2010 Feb;65(2):369-70 20007730 J Antimicrob Chemother. 2010 Apr;65(4):721-4 20124288 Lancet Infect Dis. 2010 Jan;10(1):43-50 20129148 Antimicrob Agents Chemother. 2010 Sep;54(9):3949-52 20547786 Antimicrob Agents Chemother. 2010 Nov;54(11):4851-63 20733044 Diagn Microbiol Infect Dis. 2010 Oct;68(2):140-51 20846586 J Antimicrob Chemother. 2010 Nov;65 Suppl 3:iii25-33 20876625 Clin Infect Dis. 2011 Jan 1;52(1):31-40 21148517 Antimicrob Agents Chemother. 2011 Mar;55(3):1162-72 21173186 J Antimicrob Chemother. 2011 May;66(5):1070-8 21393160 Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94 21555763 Nat Chem Biol. 2011 Jul;7(7):415-23 21685879 Lancet Infect Dis. 2011 Nov;11(11):834-44 21784708 J Antimicrob Chemother. 2011 Nov;66(11):2628-31 21810837 Emerg Infect Dis. 2011 Oct;17(10):1791-8 22000347 Clin Infect Dis. 2012 Jan 15;54(2):167-74 22057701 J Antimicrob Chemother. 2012 Feb;67(2):269-89 22086858 Clin Infect Dis. 2012 Jan 15;54(2):268-74 22198992 Int J Antimicrob Agents. 2012 Apr;39(4):295-9 22341298 Antimicrob Agents Chemother. 1981 Jul;20(1):38-46 6974539 Rev Infect Dis. 1980 Jan-Feb;2(1):129-39 6994200 Antimicrob Agents Chemother. 1998 Dec;42(12):3086-91 9835495 264 1976 02 13 2020 02 25 0300-5127 3 5 1975 Biochemical Society transactions Biochem Soc Trans 5-Carbamoylmethyluridine: a new minor nucleoside of transfer ribonucleic acid. 656-9 Dunn D B DB Trigg M M MM eng Journal Article England Biochem Soc Trans 7506897 0300-5127 9014-25-9 RNA, Transfer WHI7HQ7H85 Uridine IM Hydrogen-Ion Concentration Plants analysis RNA, Transfer analysis Saccharomyces cerevisiae analysis Species Specificity Spectrophotometry, Ultraviolet Triticum analysis Uridine analogs & derivatives analysis 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 264 10.1042/bst0030656 Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E155-60 10893335 Neth J Med. 2001 Mar;58(3):150-4 11246115 Diabet Med. 2006 Jul;23 Suppl 3:22-4 16805880 Lancet. 1995 Aug 12;346(8972):413-7 7623573 J Am Osteopath Assoc. 1996 Oct;96(10):603-4 8936928 265 1976 02 13 2019 07 06 0300-5127 3 5 1975 Biochemical Society transactions Biochem Soc Trans The protective effects of cephaloridine on rat kidney lysosomes in vitro. 736-8 Fry M M Ngaha E O EO Plummer D T DT eng Journal Article England Biochem Soc Trans 7506897 0300-5127 EC 1.4.1.2 Glutamate Dehydrogenase EC 1.4.3.3 D-Amino-Acid Oxidase EC 3.1.3.2 Acid Phosphatase EC 3.1.3.9 Glucose-6-Phosphatase EC 3.1.6.1 Arylsulfatases LVZ1VC61HB Cephaloridine IM Acid Phosphatase analysis Animals Arylsulfatases analysis Cephaloridine pharmacology D-Amino-Acid Oxidase analysis Glucose-6-Phosphatase analysis Glutamate Dehydrogenase analysis Kidney enzymology Lysosomes drug effects enzymology ultrastructure Male Microscopy, Fluorescence Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 265 10.1042/bst0030736 266 1976 02 09 2020 02 25 0029-0629 20 4 1975 Oct Nihon Funin Gakkai zasshi Nihon Funin Gakkai Zasshi [In vitro studies on human ovarian contractility (author's transl)]. 38-43 Okamura H H Okazaki T T Nakajima A A jpn Comparative Study English Abstract Journal Article Japan Nihon Funin Gakkai Zasshi 7505712 0029-0629 0 Adrenergic beta-Agonists 0 Prostaglandins 0 Prostaglandins E 0 Prostaglandins F 0TTZ664R7Z Phenoxybenzamine N9YNS0M02X Acetylcholine R15UI3245N Isoxsuprine X4W3ENH1CV Norepinephrine R Acetylcholine pharmacology Adrenergic beta-Agonists pharmacology Corpus Luteum drug effects Electric Stimulation Female Humans In Vitro Techniques Isoxsuprine pharmacology Muscle Contraction drug effects Muscle, Smooth drug effects Norepinephrine pharmacology Ovarian Follicle drug effects Ovary drug effects physiology Phenoxybenzamine pharmacology Prostaglandins pharmacology Prostaglandins E pharmacology Prostaglandins F pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 266 Clin Infect Dis. 2001 May 1;32(9):1249-72 11303260 Arch Intern Med. 2002 Jan 14;162(1):25-32 11784216 Intern Med J. 2002 May-Jun;32(5-6):224-32 12036220 Ann Intern Med. 1976 May;84(5):558-60 1275357 J Clin Pathol. 2003 Jul;56(7):558 12835308 Clin Infect Dis. 1992 Jan;14(1):75-82 1571466 J Antimicrob Chemother. 2009 May;63(5):849-61 19282331 Clin Infect Dis. 1993 Apr;16(4):567-73 8513067 Clin Infect Dis. 1997 Apr;24(4):584-602 9145732 267 1976 02 09 2020 02 25 0029-0629 20 4 1975 Oct Nihon Funin Gakkai zasshi Nihon Funin Gakkai Zasshi [Studies on the energy for sperm motility (author's transl)]. 6-13 Imamura K K jpn English Abstract Journal Article Japan Nihon Funin Gakkai Zasshi 7505712 0029-0629 8L70Q75FXE Adenosine Triphosphate EC 3.6.1.- Adenosine Triphosphatases R Adenosine Triphosphatases metabolism Adenosine Triphosphate metabolism Humans Hydrogen-Ion Concentration Male Oxygen Consumption Sperm Motility Spermatozoa metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 267 Circulation. 2003 Jul 1;107(25):3176-83 12821558 N Engl J Med. 2006 Mar 2;354(9):934-41 16510747 Circulation. 2008 Dec 9;118(24):2498-505 19029470 Circ Arrhythm Electrophysiol. 2009 Aug;2(4):349-61 19808490 Circ Arrhythm Electrophysiol. 2010 Feb;3(1):32-8 19995881 JAMA. 2010 Jan 27;303(4):333-40 20103757 Heart Rhythm. 2011 Sep;8(9):1444-51 21457789 Heart. 2012 Jan;98(1):48-53 21930724 Heart Rhythm. 2012 Apr;9(4):632-696.e21 22386883 N Engl J Med. 2012 Oct 25;367(17):1587-95 23094720 J Am Coll Cardiol. 2013 Apr 23;61(16):1713-23 23500312 Eur Heart J. 2014 Feb;35(8):501-7 24135832 JAMA. 2014 Feb 19;311(7):692-700 24549549 Circ Arrhythm Electrophysiol. 2014 Apr;7(2):267-73 24610740 J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76 24685669 Heart Rhythm. 2014 Nov;11(11):1862-9 24960268 Eur Heart J. 2014 Sep 21;35(36):2454-9 25053659 J Am Coll Cardiol. 2014 Aug 26;64(8):823-31 25145528 N Engl J Med. 1998 Sep 3;339(10):659-66 9725923 268 1976 02 09 2019 08 13 0303-7207 3 4 1975 Oct Molecular and cellular endocrinology Mol Cell Endocrinol Properties of urophysial proteins (urophysins) from the white sucker, Catostomus commersoni. 297-307 Moore G G Burford G G Lederis K K eng Journal Article Ireland Mol Cell Endocrinol 7500844 0303-7207 0 Carrier Proteins IM Animals Carrier Proteins analysis isolation & purification Dialysis Electrophoresis, Polyacrylamide Gel Fishes Hydrogen-Ion Concentration Isoelectric Focusing Neurosecretory Systems analysis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 268 0303-7207(75)90011-8 10.1016/0303-7207(75)90011-8 269 1976 02 20 2020 02 25 0012-1606 45 2 1975 Aug Developmental biology Dev Biol Glutamine synthetase in newborn mice homozygous for lethal albino alleles. 369-71 Gluecksohn-Waelsch S S Schiffman M B MB eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Dev Biol 0372762 0012-1606 0 Proteins EC 6.3.1.2 Glutamate-Ammonia Ligase IM Albinism genetics Alleles Animals Brain enzymology Eye enzymology Female Genes, Lethal Glutamate-Ammonia Ligase analysis Heterozygote Homozygote Liver enzymology Male Mice Myocardium enzymology Proteins analysis 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 269 0012-1606(75)90075-5 10.1016/0012-1606(75)90075-5 Clin Sci (Lond). 2001 Apr;100(4):363-9 11256973 Gut. 2002 Dec;51(6):876-80 12427793 Obstet Gynecol. 2004 May;103(5 Pt 1):981-91 15121574 Int J Gynaecol Obstet. 2004 Jun;85(3):240-4 15145258 Gastrointest Endosc. 2005 Mar;61(3):357-62 15758903 Hepatology. 2005 Dec;42(6):1399-405 16317669 Liver Transpl. 2006 Jul;12(7):1138-43 16799943 BJOG. 2007 Jan;114(1):99-103 17081185 Am J Surg. 2006 Dec;192(6):762-6 17161090 Am J Gastroenterol. 2007 Sep;102(9):1947-54 17573787 Dis Colon Rectum. 2007 Aug;50(8):1128-38 17588223 Gastrointest Endosc. 2009 Mar;69(3 Pt 1):453-61 19136111 Obstet Gynecol. 2009 Feb;113(2 Pt 2):508-10 19155937 World J Gastroenterol. 2009 May 7;15(17):2049-66 19418576 J Hepatol. 2009 Jul;51(1):47-54 19443069 N Engl J Med. 2009 Oct 1;361(14):1376-85 19797284 Hum Reprod. 2010 Feb;25(2):528-34 19939833 J Clin Gastroenterol. 2011 Oct;45(9):828-33 20962668 Am J Transplant. 2010 Nov;10(11):2520-6 20977643 J Crohns Colitis. 2010 Nov;4(5):493-510 21122553 BJOG. 2011 Mar;118 Suppl 1:1-203 21356004 Nat Rev Gastroenterol Hepatol. 2011 Oct 04;8(11):610-34 21970872 BMJ. 2012 Jun 13;344:e3799 22695903 Gastroenterology. 2012 Dec;143(6):1492-501 22892336 Hepatology. 1994 Feb;19(2):339-45 8294091 Am J Gastroenterol. 1996 Feb;91(2):348-54 8607505 270 1976 02 19 2018 11 13 0016-6731 80 4 1975 Aug Genetics Genetics Chromosomal basis of the merozygosity in a partially deploid mutant of Pneumococcus. 667-78 A sulfonamide-resistant mutant of pneumococcus, sulr-c, displays a genetic instability, regularly segregating to wild type. DNA extracts of derivatives of the strain possess transforming activities for both the mutant and wild-type alleles, establishing that the strain is a partial diploid. The linkage of sulr-c to strr-61, a stable chromosomal marker, was established, thus defining a chromosomal locus for sulr-c. DNA isolated from sulr-c cells transforms two mutant recipient strains at the same low efficiency as it does a wild-type recipient, although the mutant property of these strains makes them capable of integrating classical "low-efficiency" donor markers equally as efficiently as "high efficiency" markers. Hence sulr-c must have a different basis for its low efficiency than do classical low efficiency point mutations. We suggest that the DNA in the region of the sulr-c mutation has a structural abnormality which leads both to its frequent segregation during growth and its difficulty in efficiently mediating genetic transformation. Ledbetter M L ML Hotchkiss R D RD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Genetics 0374636 0016-6731 0 Sulfonamides IM Chromosome Mapping Chromosomes, Bacterial Crosses, Genetic DNA Replication Diploidy Drug Resistance, Microbial Genetic Linkage Haploidy Mutation Streptococcus pneumoniae drug effects Sulfonamides pharmacology Transformation, Genetic 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 270 PMC1213367 J Mol Biol. 1971 Jun 14;58(2):595-610 4933418 Virology. 1965 Nov;27(3):329-39 5321952 Nature. 1957 Jun 29;179(4574):1322-5 13451613 J Gen Physiol. 1959 Mar 20;42(4):737-48 13631200 Cold Spring Harb Symp Quant Biol. 1958;23:85-97 13635545 Genetics. 1963 Feb;48:157-69 13954911 J Mol Biol. 1964 Aug;9:308-22 14202268 J Bacteriol. 1965 May;89:1314-21 14293004 Proc Natl Acad Sci U S A. 1954 Feb;40(2):55-60 16589434 Genetics. 1965 Mar;51(3):455-75 17248248 Proc Natl Acad Sci U S A. 1973 Dec;70(12):3541-5 4148702 Genetics. 1966 Jan;53(1):207-35 4379022 Genetics. 1967 Sep;57(1):125-53 4383874 J Bacteriol. 1969 Jun;98(3):1073-9 4389232 271 1976 02 19 2018 11 13 0016-6731 80 4 1975 Aug Genetics Genetics Recombination as a requirement for segregation of a partially diploid mutant of Pneumococcus. 679-94 Conditions are described in which the pneumococcal mutant strain sulr-c, resistant to the drug sulfanilamide, gives rise to sensitive segregants resistant to nitrobenzoic acid at a frequency constant with time. This segregant frequency is markedly enhanced upon exposure of the cells to doses of ultraviolet light or mitomycin C that permit survival of 50% to 90% of the cells. Treatment with acridine orange diminishes the segregant frequency. From the known influences of these three agents on genetic recombination, we propose that a recombination event is necessary in the generation of segregants.--During a period of incubation following treatment with ultraviolet light or mitomycin C, cell division resumes and the original segregant frequency is restored. Thus potential segregants are either unable to replicate in the absence of selection, or they are under-represented among the cells dividing soon after treatment.--If the sulr-c mutation is introduced into a mutant pneumococcal strain lacking an ATP-dependent exonuclease activity and deficient in recombination with transforming DNA, segregant frequencies are unaffected. This fact may indicate limits upon the type of recombination event responsible for segregation. Ledbetter M L ML Hotchkiss R D RD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Genetics 0374636 0016-6731 0 Acridines 0 Mitomycins 0 Nitrobenzoates 0 Salicylates 0 Sulfonamides IM Acridines pharmacology Cell Division Diploidy Drug Resistance, Microbial Meiosis drug effects radiation effects Mitomycins pharmacology Mutation Nitrobenzoates pharmacology R Factors Radiation Genetics Recombination, Genetic Salicylates pharmacology Streptococcus pneumoniae drug effects Sulfonamides pharmacology Time Factors Ultraviolet Rays 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 271 PMC1213368 J Bacteriol. 1973 Feb;113(2):718-23 4144144 Nature. 1952 Jun 14;169(4311):1017-8 14947866 J Cell Comp Physiol. 1961 Dec;58(3)Pt 2:135-44 14007731 J Gen Microbiol. 1963 Feb;30:289-97 13954545 Genetics. 1967 Apr;55(4):699-707 5341209 Biochim Biophys Acta. 1970 Nov 12;224(1):42-54 4395244 J Gen Microbiol. 1969 Apr;56(1):1-14 4891926 J Mol Biol. 1969 Feb 14;39(3):563-81 4901859 Mutat Res. 1967 Mar-Apr;4(2):93-110 5340977 J Gen Physiol. 1959 Mar 20;42(4):737-48 13631200 272 1976 02 27 2020 02 25 0017-4955 43 11 1975 Nov Gruzlica i choroby pluc; tuberculosis et pneumonologia Gruzlica [Extrabronchial effects of Bronchodilat in patients with asthma and chronic asthmatic bronchitis]. 995-1000 Rozniecki J J Grabski W W pol Comparative Study Journal Article Ocena bronchospasmolitycznego i pozaoskrzelowego dzialania brondilatu u chorych na astme oskrzelowa lub przewlekle astmatyczne zapalenie oskrzeli Poland Gruzlica 0167652 0017-4955 0 Anesthetics, Local 0 Drug Combinations 0 Histamine H1 Antagonists 0 Phenethylamines 0 Propylamines 27Y3KJK423 Aminophylline 76986-90-8 bronchodilat IM Adolescent Adult Aminophylline pharmacology therapeutic use Anesthetics, Local pharmacology therapeutic use Asthma drug therapy Bronchi drug effects Bronchitis drug therapy Chronic Disease Drug Combinations Heart drug effects Histamine H1 Antagonists pharmacology therapeutic use Humans Middle Aged Phenethylamines pharmacology therapeutic use Propylamines pharmacology therapeutic use 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 272 N Engl J Med. 2002 Dec 5;347(23):1825-33 12466506 N Engl J Med. 2002 Dec 5;347(23):1834-40 12466507 Control Clin Trials. 2003 Dec;24(6 Suppl):269S-276S 14643073 J Am Coll Cardiol. 2006 May 16;47(10):1997-2004 16697316 N Engl J Med. 2008 Jun 19;358(25):2667-77 18565859 Eur J Heart Fail. 2009 Jul;11(7):676-83 19553398 Pacing Clin Electrophysiol. 2009 Aug;32(8):987-94 19659616 Eur J Heart Fail. 2012 Aug;14(8):803-69 22828712 World J Cardiol. 2013 Jul 26;5(7):215-27 23888191 Heart Rhythm. 2014 Mar;11(3):344-51 24374320 Circ Arrhythm Electrophysiol. 2014 Feb;7(1):31-8 24382410 Heart Fail Rev. 2014 May;19(3):305-13 24445936 Eur J Heart Fail. 2014 Jan;16(1):103-11 24453099 Clin Epidemiol. 2014 Jun 16;6:213-20 24966695 Lancet. 2014 Dec 20;384(9961):2235-43 25193873 Eur Heart J. 2014 Aug 1;35(29):1908-9 25229080 Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1011-8 25262686 JAMA. 2014 Nov 19;312(19):1988-98 25399274 Hosp Pract (1995). 2014 Oct;42(4):153-62 25502139 Stroke. 2015 Mar;46(3):667-72 25628308 Eur Heart J. 2015 Jul 21;36(28):1831-8 25939649 Drugs. 2015 Dec;75(18):2155-61 26578027 Arch Intern Med. 1987 Sep;147(9):1561-4 3632164 J Am Coll Cardiol. 1998 Sep;32(3):695-703 9741514 Eur Heart J. 1998 Dec;19 Suppl P:P9-16 9886707 273 1976 02 27 2019 05 01 0017-5749 16 11 1975 Nov Gut Gut Involvement of the small intestine in systemic mast cell disease. 918-24 A patient is reported with mast cell infiltration of the small intestine in the absence of the skin involvement characteristic of mast cell disease. She also had subtotal villous atrophy responsive to a gluten-free diet. Criteria for diagnosing mast cell disease of the small intestine are proposed. The literature of small intestinal mast cell disease is reviewed and the relationship to coeliac disease is discussed. Scott B B BB Hardy G J GJ Losowsky M S MS eng Case Reports Journal Article England Gut 2985108R 0017-5749 0 Histamine H1 Antagonists AIM IM Adult Celiac Disease complications diet therapy pathology Female Histamine H1 Antagonists therapeutic use Humans Intestinal Mucosa pathology Intestine, Small pathology Jejunum pathology Malabsorption Syndromes complications Middle Aged Urticaria Pigmentosa diagnosis drug therapy pathology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 273 PMC1413129 10.1136/gut.16.11.918 Gastroenterology. 1961 Jan;40:120-6 13700282 Arch Dermatol. 1960 Feb;81:198-202 13794652 Q J Med. 1959 Oct;28:459-70 13852143 Gastroenterology. 1963 Apr;44:448-55 13938969 Gastroenterology. 1963 Oct;45:535-49 14070428 Isr Med J. 1963 May-Jun;22:156-75 14077936 Ann Intern Med. 1963 Dec;59:887-906 14082741 Gastroenterology. 1964 Feb;46:99-108 14121058 N Engl J Med. 1964 Sep 10;271:533-5 14172469 Arch Dis Child. 1959 Jun;34:205-9 14415245 Lancet. 1974 Oct 26;2(7887):1011 4138357 Lancet. 1975 Jan 18;1(7899):136-4 46052 Gut. 1973 Jan;14(1):1-12 4692249 Gut. 1973 Aug;14(8):627-30 4743492 J Clin Invest. 1972 Jun;51(6):1602-5 5024049 Gastroenterology. 1965 Dec;49(6):676-97 5321229 Gut. 1970 Mar;11(3):212-6 5423899 Am J Med. 1970 Mar;48(3):382-9 5435650 Am J Roentgenol Radium Ther Nucl Med. 1968 Jun;103(2):405-12 5656235 Science. 1966 Nov 25;154(3752):1017-9 5919749 Gut. 1967 Feb;8(1):64-8 6034728 274 1976 02 19 2019 05 01 0017-5749 16 9 1975 Sep Gut Gut Gastric pH and microflora of normal and diarrhoeic infants. 719-26 The microflora and pH of gastric contents were determined in breast-fed and in bottle-fed normal infants, in well nourished infants with acute diarrhoea and in infants with chronic diarrhoea and protein-calorie malnutrition. The last group of infants was reevaluated after recovery from diarrhoea and protein-calorie malnutrition. A bactericidal pH effect below 2-5 was observed. Bottle-fed controls had low pH values and low bacterial concentrations, whereas infants with chronic diarrhoea and protein-calorie malnutrition had high pH values and bacterial overgrowth, essentially of Gram-negative bacilli. After recovery, the only remaining alteration was the frequent isolation of yeast-like fungi in low concentrations. Infants with acute diarrhoea, except for the isolation more frequently of yeast-like fungi, presented no alterations; this seems to indicate that pH alterations and Gram-negative bacilli overgrowth occurred during the evolution of the disease to a chronic state. Breast-fed normal infants had hydrogen-ion concentrations similar to those of the chronic diarrhoea group, but without Gram-negative bacilli overgrowth, suggesting that other factors, besides pH, regulate bacterial growth in the gastric contents of these groups of infants. Maffei H V HV Nóbrega F J FJ eng Comparative Study Journal Article England Gut 2985108R 0017-5749 AIM IM Acute Disease Bacteria isolation & purification Breast Feeding Candida albicans isolation & purification Chronic Disease Diarrhea, Infantile microbiology Enterobacteriaceae isolation & purification Gastric Juice metabolism Humans Hydrogen-Ion Concentration Infant Pharynx microbiology Protein-Energy Malnutrition microbiology Pseudomonas isolation & purification Staphylococcus isolation & purification Stomach microbiology Streptococcus isolation & purification 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 274 PMC1413111 10.1136/gut.16.9.719 Acta Paediatr. 1955 Jul;44(4):348-54 13292244 J Bacteriol. 1957 Apr;73(4):590-1 13428699 Gastroenterology. 1958 Apr;34(4):625-35 13524561 Clin Sci. 1960 Feb;19:147-63 13807647 Nature. 1964 Oct 3;204:76-7 14240122 Arch Dis Child. 1965 Feb;40:77-9 14259277 Gastroenterology. 1960 Jul;39:1-11 14440828 Arch Dis Child. 1962 Aug;37:387-91 14470855 J Clin Pathol. 1962 Nov;15(6):563-5 16810991 Proc Soc Exp Biol Med. 1966 Aug-Sep;122(4):1098-100 4162235 Pediatrics. 1967 Feb;39(2):202-13 4163495 Br Med J. 1972 Jan 8;1(5792):69-75 4550126 Gut. 1972 Apr;13(4):251-6 4556018 Gut. 1972 Jun;13(6):441-9 4557306 Gut. 1972 Jun;13(6):450-8 4557307 Acta Paediatr Scand. 1972 Sep;61(5):587-90 4559695 Aust N Z J Med. 1972 Aug;2(3):215-9 4564048 Br Med J. 1972 Dec 2;4(5839):515-8 4566015 Arch Dis Child. 1974 Apr;49(4):270-7 4598080 Acta Paediatr Scand. 1974 May;63(3):418-22 4599283 J Clin Invest. 1973 Mar;52(3):645-57 4685087 Gastroenterology. 1969 Jan;56(1):71-9 4885396 J Trop Pediatr (1967). 1969 Dec;15(4):159-62 4907279 N Engl J Med. 1970 Jun 18;282(25):1402-5 4910837 Br J Surg. 1970 Nov;57(11):854 4921419 Am J Clin Nutr. 1971 Jan;24(1):144-59 4923462 Br Med J. 1971 Aug 7;3(5770):338-43 4934188 Gut. 1972 Mar;13(3):182-8 5024722 Pediatrics. 1972 Feb;49(2):233-42 5059529 Can Med Assoc J. 1971 Aug 21;105(4):380-6 5128711 Arch Argent Pediatr. 1971 Dec;69(10):377-81 5157696 J Infect Dis. 1970 Jan;121(1):46-7 5410781 Am J Clin Nutr. 1970 Dec;23(12):1595-601 5481893 Ann Paediatr Fenn. 1968;14(4):115-8 5731356 Am J Dig Dis. 1969 Jan;14(1):1-8 5762810 Am J Dis Child. 1969 Feb;117(2):142-6 5763825 Helv Paediatr Acta. 1969 Jun;24(3):278-92 5800161 Scand J Gastroenterol. 1967;2(3):209-13 6050715 275 1976 02 21 2020 02 25 0440-0607 16 1975 Hamatologie und Bluttransfusion Hamatol Bluttransfus [Allogenic bone marrow transplantation in men]. 306-29 Dicker K A KA Löwenberg B B Schaefer U W UW van Bekkum D W DW ger Journal Article Allogene knochenmarktransplantation beim menschen Germany Hamatol Bluttransfus 7804332 0440-0607 0 HLA Antigens IM Age Factors Anemia, Aplastic surgery Animals Bone Marrow Cells Bone Marrow Transplantation Cell Survival Graft vs Host Reaction HLA Antigens Hematopoietic Stem Cell Transplantation Humans Mice Radiation Injuries surgery Tissue Donors Transplantation, Homologous 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 275 BMJ. 2000 Sep 9;321(7261):605-7 10977838 JAMA. 2000 Nov 15;284(19):2476-82 11074777 Qual Health Care. 2001 Sep;10 Suppl 1:i34-8 11533436 BMJ. 2002 Oct 26;325(7370):929 12399341 JAMA. 2003 May 14;289(18):2387-92 12746362 BMJ. 2005 Mar 19;330(7492):611-2 15774965 Chest. 2005 Jun;127(6):2188-96 15947336 Palliat Med. 2009 Mar;23(2):126-31 18974174 276 1976 02 21 2004 11 17 0440-0607 16 1975 Hamatologie und Bluttransfusion Hamatol Bluttransfus [Bone marrow transplantation in patients with aplastic anemia]. 330-51 Dooren L J LJ de Koning J J Kamphuis R P RP Uittenbogaart C H CH Brubakk A M AM Vossen J M JM ger Journal Article Knochenmarktransplantation bei patienten mit aplastischer anämie Germany Hamatol Bluttransfus 7804332 0440-0607 0 HLA Antigens IM Adolescent Adult Anemia, Aplastic surgery Bone Marrow Cells Bone Marrow Transplantation Child Child, Preschool Female Graft vs Host Reaction HLA Antigens Humans Male Middle Aged Tissue Donors Transplantation, Homologous 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 276 277 1976 02 09 2020 02 25 0015-5616 17 3 1975 Folia medica Cracoviensia Folia Med Cracov [Analysis of clinical phenomena and changes in physico-chemical properties of the blood in mentally ill children]. 313-28 Bichonski R R pol English Abstract Journal Article Analiza zjawisk klinicznych oraz zmian wlasciwosci fizykochemicznych krwi u dzieci psychicznie chorych Poland Folia Med Cracov 0374617 0015-5616 IM Adolescent Age Factors Blood Viscosity Child Child, Preschool Humans Hydrogen-Ion Concentration Mental Disorders blood Surface Tension 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 277 Lancet. 2003 Jan 4;361(9351):13-20 12517460 Circulation. 2004 Mar 16;109(10):1223-5 15007008 N Engl J Med. 2005 Mar 24;352(12):1179-89 15758000 N Engl J Med. 2008 Feb 7;358(6):557-67 18256391 Lancet. 2008 Jun 7;371(9628):1915-20 18539223 Am Heart J. 1991 Apr;121(4 Pt 1):1042-9 1901190 Circulation. 2009 Mar 10;119(9):1211-9 19237658 Lancet. 2009 Feb 28;373(9665):723-31 19249633 N Engl J Med. 2009 Sep 10;361(11):1045-57 19717846 Lancet. 2010 Oct 9;376(9748):1233-43 20817281 Lancet. 2011 Apr 23;377(9775):1409-20 21470671 Lancet. 2011 Jun 25;377(9784):2193-204 21665265 Eur Heart J. 2012 Oct;33(20):2569-619 22922416 N Engl J Med. 2013 Apr 11;368(15):1379-87 23473396 J Am Coll Cardiol. 2013 Apr 16;61(15):1601-6 23500251 Heart. 2013 Jun;99(11):774-8 23514976 Circ Cardiovasc Interv. 2013 Aug;6(4):378-90 23922145 N Engl J Med. 2013 Sep 19;369(12):1115-23 23991625 JACC Cardiovasc Imaging. 2013 Oct;6(10):1124-1126 24135329 N Engl J Med. 2014 Jan 16;370(3):283 24428477 J Am Coll Cardiol. 2014 May 27;63(20):2088-2098 24583294 Eur Heart J. 2014 Sep 21;35(36):2460-7 24849104 Lancet. 2014 Nov 22;384(9957):1849-1858 25002178 N Engl J Med. 2014 Sep 18;371(12):1111-20 25176395 JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):178-188 25240548 N Engl J Med. 2014 Dec 11;371(24):2339 25494279 J Am Coll Cardiol. 2015 Mar 17;65(10):963-72 25766941 JAMA. 2015 Apr 7;313(13):1336-46 25775052 J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102 25790880 Lancet. 2015 Jun 20;385(9986):2465-76 25791214 Circ Cardiovasc Interv. 2015 Apr;8(4):null 25873730 BMJ. 2015 Apr 16;350:h1618 25883067 Eur Heart J. 2015 Sep 14;36(35):2364-72 26129947 Eur Heart J. 2016 Jan 14;37(3):267-315 26320110 N Engl J Med. 2015 Sep 10;373(11):997-1009 26324049 Lancet. 2016 Jan 9;387(10014):127-35 26474811 EuroIntervention. 2017 Aug 4;13(5):e531-e539 28506940 Eur J Heart Fail. 2017 Nov;19(11):1545-1550 28948706 Circulation. 1977 Nov;56(5):786-94 912839 278 1976 03 01 2020 02 25 0015-5691 71 5 1975 Jul Nihon yakurigaku zasshi. Folia pharmacologica Japonica Nihon Yakurigaku Zasshi [Biphasic (ulcer-forming and ulcer-preventing) effect of adrenaline in rats]. 405-14 Adrenaline-induced gastric ulceration was studied in rats. Adrenaline in high doses caused gastric ulcer, which was completely blocked by pretreatment with alpha-blockers (phenoxybenzamine, dibenamine), but not by pretreatment with propranolol or atropine, nor by vagotomy, hypophysectomy or adrenalectomy. After successive administration of adrenaline, once daily for 7 days, however, no gastric ulcer was observed. Recovery from the ulcerogenic action of adrenaline was seen after 4 weeks withdrawal. Pretreatment with a small dose of adrenaline inhibited the ulcerogenic action of a high dose of adrenaline. Pretreatment with reserpine, pyrogallol or iproniazid inhibited the action of adrenaline. It is concluded that adrenaline has a biphasic effect on gastric ulceration, the ulcerogenic action is due to its alpha-action and antiulcerogenic effect is due to development of tachyphylaxis. Dozaki T T Imai K K Mizukami S S jpn English Abstract Journal Article Japan Nihon Yakurigaku Zasshi 0420550 0015-5691 0 Adrenergic alpha-Antagonists 0 Adrenergic beta-Antagonists 0 Catecholamines 0 Histamine H1 Antagonists 01Y4A2QXY0 Pyrogallol 7C0697DR9I Atropine 8B1QWR724A Reserpine D892HFI3XA Iproniazid YKH834O4BH Epinephrine IM Adrenalectomy Adrenergic alpha-Antagonists pharmacology Adrenergic beta-Antagonists pharmacology Animals Atropine pharmacology Catecholamines pharmacology Dose-Response Relationship, Drug Epinephrine administration & dosage antagonists & inhibitors pharmacology Histamine H1 Antagonists pharmacology Hypophysectomy Iproniazid pharmacology Male Pyrogallol pharmacology Rats Reserpine pharmacology Stomach Ulcer chemically induced prevention & control Vagotomy 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 278 Diabetologia. 2002 Mar;45(3):427-35 11914749 Lancet. 2003 Oct 18;362(9392):1275-81 14575972 Curr Opin Lipidol. 2009 Apr;20(2):106-11 19280766 Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S15-21 20115926 Diabetologia. 2010 Dec;53(12):2504-8 20499044 Diabetes Care. 2010 Sep;33(9):1919-24 20724646 PLoS Genet. 2010 Dec 23;6(12):e1001256 21203500 Expert Rev Mol Diagn. 2011 Apr;11(3):313-20 21463240 J Clin Endocrinol Metab. 2011 Aug;96(8):E1346-51 21677039 Diabetes Care. 2011 Aug;34(8):1860-2 21700917 Diabetologia. 2011 Nov;54(11):2801-10 21814873 Diabetes Care. 2012 Jan;35 Suppl 1:S64-71 22187472 Diabetes Care. 2012 Jun;35(6):1206-12 22432108 Diabetes. 2013 Apr;62(4):1329-37 23274891 Diabet Med. 1998 Jan;15(1):11-4 9472858 279 1976 03 01 2020 02 25 0015-5691 71 5 1975 Jul Nihon yakurigaku zasshi. Folia pharmacologica Japonica Nihon Yakurigaku Zasshi [Comparison of drug effects on the isolated rat colon and duodenum]. 415-26 Adrenaline and isoproterenol elicited nearly maximal relaxation of the colon even in small doses, whereas increase in the doses caused greater relaxation in the duodenum. In the colon, these drugs prevented, to a great extent the contraction induced by acetylcholine (ACh) and serotonin but in the duodenum were totally ineffective. Dibenamine and propranolol reduced adrenaline- and isoproterenol-induced relaxation in the duodenum, though propranolol decreased the relaxation caused by isoproterenol. Atropine prevented ACh-induced contraction in both the colon and duodenum in the same way. After 2-bromolysergic acid diethylamide, duodenal contraction caused by ACh or serotonin decreased by over 70%; however, the contraction of the colon was not significantly inhibited. Methysergide had similar effects, but to a lesser degree. In calcium-free bathing fluid without addition of Na2EDTA, ACh and prostaglandin E1 elicited contraction in the colon, but not in the duodenum. Koshiba H H jpn Comparative Study English Abstract Journal Article Japan Nihon Yakurigaku Zasshi 0420550 0015-5691 0 Prostaglandins E 333DO1RDJY Serotonin 43EXU2S56H Dibenzylchlorethamine 7C0697DR9I Atropine 8NA5SWF92O Lysergic Acid Diethylamide 9G34HU7RV0 Edetic Acid 9Y8NXQ24VQ Propranolol AYI8EX34EU Creatinine L628TT009W Isoproterenol N9YNS0M02X Acetylcholine XZA9HY6Z98 Methysergide YKH834O4BH Epinephrine IM Acetylcholine pharmacology Animals Atropine pharmacology Colon drug effects Creatinine pharmacology Dibenzylchlorethamine pharmacology Duodenum drug effects Edetic Acid pharmacology Epinephrine pharmacology Female In Vitro Techniques Isoproterenol pharmacology Lysergic Acid Diethylamide pharmacology Male Methysergide pharmacology Propranolol pharmacology Prostaglandins E pharmacology Rats Serotonin pharmacology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 279 Am J Kidney Dis. 2003 Oct;42(4):677-84 14520617 Nephron Clin Pract. 2003;95(2):c40-6 14610329 Am J Kidney Dis. 2003 Dec;42(6):1239-47 14655196 Nephrol Dial Transplant. 2004 Mar;19(3):686-91 14767027 Nephrol Dial Transplant. 2004 Jun;19(6):1357-60 15004252 Nephrol Dial Transplant. 2004 Dec;19(12):3137-9 15575002 Kidney Int. 2006 Jan;69(2):375-82 16408129 Palliat Med. 2006 Sep;20(6):631-6 17060257 Am J Kidney Dis. 2007 Jan;49(1):27-36 17185143 Nephrol Dial Transplant. 2007 Jul;22(7):1955-62 17412702 J Palliat Med. 2007 Dec;10(6):1266-76 18095805 Am J Kidney Dis. 2009 Feb;53(2):218-28 18950914 280 1976 03 01 2013 11 21 0015-5691 71 5 1975 Jul Nihon yakurigaku zasshi. Folia pharmacologica Japonica Nihon Yakurigaku Zasshi [Monoamine oxidase (XXXVI). Characteristics of benzylamine oxidase in the dog serum]. 457-62 Enzymic properties of monoamine oxidase (MAO) in dog serum were studied and the following results were obtained. Some of enzymic properties of MAO in dog serum differed from that of mitochondrial MAO. When dog serum was fractionated by ammonium sulfate, proteins were concentrated in two fractions, such as 25 approximately 33% and 67 approximately 80% of saturated ammonium sulfate fraction, while MAO activity was concentrated in 40 approximately 50% of saturated ammonium sulfate fraction. The reaction rate of MAO in dog serum was found to be proportional to enzyme concentration. The optimum pH of MAO in dog serum was 7.0 which differed from that of MAO in rabbit serum (pH 8.0). Tris-HCl buffer strongly inhibited MAO activity in dog serum. When benzylamine was used as substrate, the highest activity was obtained compared with the other substrate used. The activities with butylamine, amylamine, beta-phenylethylamine and tyramine showed about 30% while tryptamine and serotonin showed 3 approximately 10% compared to that with benzymlamine as substrate. The value of pI50 of catron was about 3 X 10(-6) M and that of harmaline was about 3 X 10(-5) M, but pargyline did not inhibit MAO activity in dog serum at the concentration of 1 X 10(-4) M. Fukushima T T jpn English Abstract Journal Article Japan Nihon Yakurigaku Zasshi 0420550 0015-5691 0 Blood Proteins EC 1.4.3.- Benzylamine Oxidase EC 1.4.3.4 Monoamine Oxidase SU46BAM238 Ammonium Sulfate IM Ammonium Sulfate Animals Benzylamine Oxidase blood Blood Proteins analysis Dogs Hydrogen-Ion Concentration Monoamine Oxidase blood 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 280 281 1976 02 20 2011 07 27 0015-5691 71 6 1975 Sep Nihon yakurigaku zasshi. Folia pharmacologica Japonica Nihon Yakurigaku Zasshi [Combined use of bucolome and pyrazolone derivatives (1). Pharmacological activities and blood concentration]. 609-29 A combination of two or more drugs may exert a drug-drug interaction, in which case the effect can be potentiated or antagonized. Such synergistic effects are well known in the case of pyrabital (barbital + aminopyrine) or irgapyrine (phenylbutazone + aminopyrine). Bucolome (BCP), a non-steroidal anti-inflammatory agent, has the chemical structure of a barbiturate and also resembles the formula of pheylbutazone. Thus the influence of BCP combination on the pharmacological activities of various pyrazolone derivatives was examined. BCP potentiated the analgesic and antipyretic effects of 4-aminoantipyrine (4A), methylaminoantipyrine (MA), aminopyrine (AM) and isopropylaminoantipyrine (IPA), which were substituted by the alkylamino group at 4-position of the pyrazolone ring. This potentiation occurred when the dose of BCP exceeded that of the pyrazolones, and was especially marked when combination ratio of BCP exceeded that of the pyrazolones, and was especially marked when combination ratio of BCP and pyrazolone was 2:1 mola. The analgesic effects of antipyrine (AN), isopropylantipyrine (IP) and aminopropylone (AP), which were substituted by alkyl group or aminoacylamino group at 4-position, were not potentiated by BCP in any combination ratio. Most pyrazolones showed additive acute toxicity in their combination with BCP, but acute toxicities of 4A and AM, which were potentiated in analgesic effects, were decreased and antagonized when combined with BCP. The plasma concentration of AM was increased and prolonged by BCP, while that of IP remained much the same. These results suggest that the pharmacological activities are associated with certain molecular interactions between BCP and pyrazolones, which are substituted by the alkylamino group at 4-position of the pyrazolone ring. Nozaki M M jpn English Abstract Journal Article Japan Nihon Yakurigaku Zasshi 0420550 0015-5691 0 Analgesics 0 Barbiturates 0 Drug Combinations 0 Pyrazoles IM Analgesics pharmacology Animals Barbiturates blood pharmacology toxicity Body Temperature drug effects Drug Combinations Drug Interactions Male Mice Pyrazoles blood pharmacology toxicity Rabbits 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 281 282 1976 02 20 2020 02 25 0015-5691 71 6 1975 Sep Nihon yakurigaku zasshi. Folia pharmacologica Japonica Nihon Yakurigaku Zasshi [Combined use of bucolome and pyrazolone derivatives (II). Complex formation due to interaction between bucolome and pyrazolones]. 631-9 We have already reported that bucolome (BCP), a non-steroidal anti-inflammatory agent, potentiates significantly the analgesic and antipyretic effects of pyrazolones which are substituted by alkylamino group at 4-position of the pyrazolone ring. Physical and quantum chemistry were applied to the mechanism of this synergistic action. The solubility of BCP was markedly increased in proportion to elevation of aminopyrine (AM) concentration, but not by a combination with isopropylantipyrine (IP). The binding of BCP to bovine serum albumin was slightly inhibited by AM, but not by IP. The mixture of AM and BCP in aqueous media generated optical absorption in the ultraviolet differential spectrum, due to the charge transfer interaction. The results of the infrared or NMR spectrum demonstrated the formation of a hydrogen binding in non-aqueous media between BCP and AM. From the calculation of the charge on an atom, the energy of the highest occupied molecular orbital and the frontier electron density, BCP is considered to be a good electron acceptor. The beta-units of Mho of pyrazolones were found to correlate with the potentiation coefficient of analgesic activity in combination drugs. These results suggest that the complex formation between BCP and pyrazolones is an important factor for the synergism of action and is due to the charge transfer interaction and the hydrogen binding of both molecules. Nozaki M M jpn English Abstract Journal Article Japan Nihon Yakurigaku Zasshi 0420550 0015-5691 0 Barbiturates 0 Drug Combinations 0 Pyrazoles 0 Serum Albumin IM Barbiturates blood pharmacology Chemical Phenomena Chemistry Drug Combinations Drug Interactions Protein Binding drug effects Pyrazoles pharmacology Serum Albumin metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 282 J R Coll Physicians Lond. 1999 Jan-Feb;33(1):39-45 10192069 J Med Ethics. 2001 Oct;27(5):310-6; discussion 317-23 11579186 Lancet Oncol. 2003 May;4(5):312-8 12732169 J Med Ethics. 2006 Jun;32(6):311-5 16731726 Intensive Care Med. 2007 Feb;33(2):237-45 17019558 Palliat Med. 2007 Mar;21(2):77-80 17344254 Palliat Med. 2007 Mar;21(2):81-6 17344255 Palliat Med. 2007 Sep;21(6):507-17 17846091 Anaesthesia. 2007 Dec;62(12):1207-16 17991255 Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006273 18425944 Clin Med (Lond). 2008 Apr;8(2):182-5 18478868 Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006274 18843710 Palliat Med. 2009 Apr;23(3):198-204 19318459 283 1976 02 09 2019 08 27 0015-5632 20 5 1975 Folia microbiologica Folia Microbiol (Praha) Fructose 1,6-bisphosphate aldolase activity of Rhizobium species. 412-7 FDP aldolase was found to be present in the cell-free extracts of Rhizobium leguminosarum, Rhizobium phaseoli, Rhizobium trifolii, Rhizobium meliloti, Rhizobium lupini, Rhizobium japonicum and Rhizobium species from Arachis hypogaea and Sesbania cannabina. The enzyme in 3 representative species has optimal activity at pH 8.4 in 0.2M veronal buffer. The enzyme activity was completely lost by treatment at 60 degrees C for 15 min. The Km values were in the range from 2.38 to 4.55 X 10(-6)M FDP. Metal chelating agents inhibited enzyme activity, but monovalent or bivalent metal ions failed to stimulate the activity. Bivalent metal ions in general were rather inhibitory. Siddiqui K A KA Banerjee A K AK eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Chelating Agents 0 Metals EC 4.1.2.13 Fructose-Bisphosphate Aldolase K848JZ4886 Cysteine IM Cell-Free System Chelating Agents pharmacology Cysteine pharmacology Fructose-Bisphosphate Aldolase metabolism Hot Temperature Hydrogen-Ion Concentration Metals pharmacology Rhizobium enzymology Species Specificity 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 283 10.1007/BF02877044 J Bacteriol. 1970 Mar;101(3):698-704 5438044 Can J Microbiol. 1957 Oct;3(6):879-84 13472513 Nature. 1955 Mar 26;175(4456):551-2 14370165 J Biol Chem. 1961 Dec;236:3185-92 14491940 J Biol Chem. 1949 Feb;177(2):859-72 18110462 J Bacteriol. 1970 Feb;101(2):541-50 4984076 Biochem J. 1956 May;63(1):94-105 13315254 J Bacteriol. 1969 Mar;97(3):1184-91 5776525 J Bacteriol. 1962 Oct;84:694-700 13981195 Plant Physiol. 1966 Oct;41(8):1330-6 16656404 Fed Proc. 1964 Nov-Dec;23:1248-57 14236133 284 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) Prevention of cell agglutination and competence in a genetically transformable strain of Pneumococcus by D-glucosamine and D-galactosamine. 443-51 In the presence of amino sugars D-glucosamine and D-galactosamine no spontaneous competence could be observed in the highly transformable R6bd strain of Pneumococcus or it was decreased by several orders of magnitude. The highest inhibition of competence was detected when the amino sugar at a concentration 5 mg/ml of the medium was added not only to the transformation but also to the pretransformation medium. After a 150 min growth in the transformation medium in the presence of the amino sugar a 3--4-fold greater number of cells (as a viable count) could be detected as compared with the control without the amino sugar. It was found microscopically that the amino sugar prevents natural agglutination, which normally occurs in the competent culture. The role of specific amino sugar determinants for binding of the competence factor on the cell surface and the resulting inhibitory effect of these sugars on the development of competence are discussed. Kohoutová M M eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Amino Sugars 0 DNA, Bacterial 7535-00-4 Galactosamine N08U5BOQ1K Glucosamine PHA4727WTP Mannose IM Agglutination drug effects Amino Sugars pharmacology DNA, Bacterial Depression, Chemical Galactosamine pharmacology Glucosamine pharmacology Mannose Stereoisomerism Streptococcus pneumoniae drug effects immunology Transformation, Genetic drug effects 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 284 10.1007/BF02891702 J Bacteriol. 1971 Nov;108(2):668-79 5001867 Nature. 1974 Feb 1;247(5439):277-9 4150438 Folia Microbiol (Praha). 1975;20(3):212-8 237807 J Biol Chem. 1963 Jun;238:1928-34 13931034 Folia Microbiol (Praha). 1973;18(6):499-505 4149534 J Bacteriol. 1974 Dec;120(3):1478-80 4154936 Biochim Biophys Acta. 1955 Dec;18(4):467-81 13304028 J Bacteriol. 1972 Feb;109(2):652-8 4621684 J Bacteriol. 1972 Apr;110(1):273-80 5018023 J Biol Chem. 1967 Feb 10;242(3):463-70 4381522 Can J Microbiol. 1970 May;16(5):345-50 5463244 J Bacteriol. 1966 Mar;91(3):1050-61 4379672 Science. 1972 Sep 15;177(4053):949-59 5055944 J Gen Microbiol. 1965 Feb;38:211-9 14287199 Folia Microbiol (Praha). 1973;18(6):506-13 4775441 J Bacteriol. 1971 Mar;105(3):1213-5 4396142 Proc Natl Acad Sci U S A. 1954 Feb;40(2):49-55 16589433 285 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) Effect of some aldoses on growth of Saccharomyces cerevisiae inhibited with molybdenum. 467-9 The inhibitory effect of molybdenum ions on growth of yeasts at pH 5.5 was found to be decreased by aldoses in the following order: D-talose greater than L-mannose greater than L-ribose greater than D-lyxose greater than L-galactose greater than L-arabinose greater than L-glucose greater than L-xylose. Increased concentrations of molybdenum brought about morphological changes of yeast cells. Cells grown under these conditions were smaller, had thicker walls and formed clusters. Zemek J J Bílik V V Zákutná L L eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Carbohydrates 681HV46001 Ribose 81AH48963U Molybdenum A1TA934AKO Xylose B40ROO395Z Arabinose IY9XDZ35W2 Glucose PHA4727WTP Mannose X2RN3Q8DNE Galactose IM Arabinose pharmacology Carbohydrates pharmacology Cell Wall ultrastructure Galactose pharmacology Glucose pharmacology Hydrogen-Ion Concentration Mannose pharmacology Molybdenum pharmacology Ribose pharmacology Saccharomyces cerevisiae drug effects growth & development ultrastructure Stereoisomerism Xylose pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 285 10.1007/BF02891705 286 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) Transport properties of membrane vesicles from Acholeplasma laidlawii. II. Kinetic characteristics and specificity of glucose transport system. 480-7 The glucose transport system of membrane vesicles isolated from Acholeplasma laidlawii is saturable, with a Km of 21.2 mum and V of 0.68 nmol min-1 (mg protein)-1. The process is pH-dependent and a break occurs in the Arrhenius plot at 15 degrees C. Exogenous substrates did not stimulate glucose transport probably due to their inability to penetrate into membrane vesicles. 3-O-Methylglucose and 6-deoxyglucose competitively inhibited glucose transport. Maltose inhibited transport of glucose noncompetitively. These sugars also elicited glucose efflux from preloaded membrane vesicles. Panchenko L F LF Fedotov N S NS Tarshis M A MA eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Methylglucosides 69-79-4 Maltose 9G2MP84A8W Deoxyglucose IY9XDZ35W2 Glucose IM Acholeplasma laidlawii metabolism Biological Transport, Active Cell Membrane metabolism Deoxyglucose metabolism Glucose metabolism Hydrogen-Ion Concentration Kinetics Maltose metabolism Methylglucosides metabolism Subcellular Fractions Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 286 10.1007/BF02891707 Biochim Biophys Acta. 1969 Jul 15;183(2):295-303 5792242 J Bacteriol. 1974 Feb;117(2):888-99 4590489 J Bacteriol. 1972 Aug;111(2):454-8 5053467 Biochem Biophys Res Commun. 1972 May 26;47(4):838-45 4337324 J Bacteriol. 1969 Feb;97(2):787-92 5773029 Folia Microbiol (Praha). 1975;20(6):470-9 127739 Biochim Biophys Acta. 1973 Oct 25;323(3):429-40 4271263 J Bacteriol. 1973 Jan;113(1):212-7 4688137 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Eur J Biochem. 1973 Dec 3;40(1):171-5 4772677 Proc Natl Acad Sci U S A. 1973 Dec;70(12):3376-81 4587250 287 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) Transport of 4-deoxy- and 6-deoxy-D-glucose in baker's yeast. 496-503 Tritium-labelled 4-deoxy-D-glucose (4-dglc) and 6-deoxy-D-glucose (6-dgcl) were prepared by catalytic hydrogenolysis of the corresponding deoxyiodo derivatives with gaseous tritium. The two sugars are transported into Saccharomyces cerevisiae by both the constitutive glucose and the inducible galactose carrier. Uranyl ions are powerful inhibitors. The pH optimum in uninduced cells lies at 5.5 for both sugars, the apparent activation energies (between 15 and 35 degrees C) are 25.1 kJ/mol and 16.5 kJ/mol, respectively. The steady-state intracellular concentration of both sugars is less than the extracellular one (no uphill transport). Neither of them is a substrate of yeast hexokinase. 4-Deoxy-D-glucose undergoes a dinitrophenol-sensitive conversion to an unknown metabolite which is not phosphorylated and may represent one of its oxidation products. Kotyk A A Michaljanicová D D Veres K K Soukupová V V eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Deoxy Sugars 0 Dinitrophenols 30237-26-4 Fructose 4OC371KSTK Uranium 9G2MP84A8W Deoxyglucose EC 2.7.1.1 Hexokinase IY9XDZ35W2 Glucose ZRH8M27S79 Iodoacetamide IM Deoxy Sugars metabolism Deoxyglucose chemical synthesis metabolism Dinitrophenols pharmacology Electron Transport Fructose metabolism Glucose metabolism Hexokinase metabolism Hydrogen-Ion Concentration Iodoacetamide pharmacology Saccharomyces cerevisiae enzymology metabolism Temperature Uranium pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 287 10.1007/BF02891709 J Theor Biol. 1972 Apr;35(1):113-8 5044826 Folia Microbiol (Praha). 1968;13(3):212-20 5672582 Eur J Biochem. 1968 Aug;5(3):321-9 5680352 Folia Microbiol (Praha). 1971;16(6):432-44 4947177 Folia Microbiol (Praha). 1968;13(1):12-9 5642682 Folia Microbiol (Praha). 1967;12(2):121-31 6047678 J Bacteriol. 1968 Feb;95(2):603-11 5640385 288 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) Gluconic acid production by Penicillium puberulum. 504-8 Twenty-five Penicillium species isolated from Egyptian soil were examined for their ability to produce gluconic acid in surface culture. Of the eight species capable of producing gluconic acid, Penicillium puberulum gave the maximum yield (91% gluconic acid from glucose after 7 days of fermentation with 3% CaCO3). Peptone was the best nitrogen source for acid fermentation and glucose was superior to sucrose. Addition of low concentrations of KH2PO4 and MgSO4 - 7 H2O stimulated acid production. An initial pH of 6.1 was most favourable for acid accumulation and addition of CaCO3 was necessary for maximum acid production. Elnaghy M A MA Megalla S E SE eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Gluconates 0 Peptones 0 Phosphates 57-50-1 Sucrose 7487-88-9 Magnesium Sulfate H0G9379FGK Calcium Carbonate IY9XDZ35W2 Glucose IM Calcium Carbonate metabolism Egypt Fermentation Gluconates biosynthesis Glucose metabolism Hydrogen-Ion Concentration Magnesium Sulfate pharmacology Penicillium metabolism Peptones metabolism Phosphates pharmacology Soil Microbiology Species Specificity Sucrose metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 288 10.1007/BF02891710 Folia Microbiol (Praha). 1963 Jul;8:203-14 13936632 Can J Microbiol. 1955 Jun;1(6):470-2 14390024 Appl Microbiol. 1965 Sep;13(5):713-9 5325935 289 1976 02 09 2019 08 27 0015-5632 20 6 1975 Folia microbiologica Folia Microbiol (Praha) A simple method of isolation and purification of cultures of wood-rotting fungi. 519-20 A simple method of isolation and purification of cultures of higher fungi, mainly wood-rotting fungi, without special requirements for the presence of nitrogencontaining nutrients is described. Parts of fruiting bodies, spores or infected wood is inoculated on Petri dishes with an agar medium of the following composition: 1.0 g KH2PO4, 0.2 g MgSO4 - 7 H2O, 0.1 g caSO4, 0.01 g Fe2(SO4)3, 10.0 g glucose, tap water to 1 litre; 20.0 g agar. This medium does not suit most of the contaminants but fungal hyphae overgrow the whole surface of the dish so that a purified culture can be obtained from parts distant from the inoculation site. Ginterová A A Janotková O O eng Journal Article United States Folia Microbiol (Praha) 0376757 0015-5632 0 Culture Media 9002-18-0 Agar N762921K75 Nitrogen IM Agar Culture Media Fungi isolation & purification metabolism Hydrogen-Ion Concentration Nitrogen metabolism Wood 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 289 10.1007/BF02891714 Folia Microbiol (Praha). 1966;11(2):146-54 5916361 290 1976 03 01 2020 02 25 0015-6264 13 5 1975 Oct Food and cosmetics toxicology Food Cosmet Toxicol The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat. 517-20 Isomaa B B Sjöblom G G eng Journal Article England Food Cosmet Toxicol 0374623 0015-6264 0 Cetrimonium Compounds 0 Palmitates 0 Palmitic Acids 0 Quaternary Ammonium Compounds IM Animal Feed Animals Cetrimonium Compounds pharmacology Diet Gastric Juice metabolism Gastric Mucosa drug effects metabolism Hydrogen-Ion Concentration Intestinal Absorption drug effects Male Palmitates metabolism Palmitic Acids metabolism Quaternary Ammonium Compounds pharmacology Rats Stimulation, Chemical 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 290 10.1016/0015-6264(75)90005-x Curr Opin Neurol. 2003 Jun;16(3):283-8 12858063 Nurs Older People. 2004 Mar;16(1):22-6 15045859 N Engl J Med. 2004 Dec 9;351(24):2509-18 15590953 Mult Scler. 2005 Jun;11(3):322-7 15957515 J Palliat Care. 2006 Autumn;22(3):158-65 17058754 J Pain Symptom Manage. 2006 Nov;32(5):462-9 17085272 Neurology. 2007 Aug 7;69(6):611-2 17679683 Mov Disord. 2007 Dec;22(16):2314-24 18098298 Clin Med (Lond). 2008 Apr;8(2):186-91 18478869 Neurology. 2009 Mar 10;72(10):886-92 19092112 Age Ageing. 2009 Sep;38(5):617-9 19628680 291 1976 02 27 2020 02 25 0015-8178 93 34 1975 Dec 04 Fortschritte der Medizin Fortschr Med [Language of the other]. 1708-11 von Ferber L L ger Congress Die Sprache des Anderen Germany Fortschr Med 2984763R 0015-8178 IM Congresses as Topic Disabled Persons Female Germany, West Humans Language Language Development Male Mother-Child Relations Neurotic Disorders complications Psychotic Disorders complications Schizophrenic Language Speech Disorders etiology Verbal Behavior 1975 12 4 1975 12 4 0 1 1975 12 4 0 0 ppublish 291 N Engl J Med. 2000 May 25;342(21):1581-9 10824078 N Engl J Med. 2003 Oct 9;349(15):1465-9 14534340 Am J Med. 2006 Jan;119(1):71.e1-8 16431193 J Am Soc Nephrol. 2007 Feb;18(2):606-12 17229917 J Pediatr. 2007 May;150(5):467-73 17452217 Ann Clin Biochem. 2007 Sep;44(Pt 5):417-31 17761027 Semin Nephrol. 2009 May;29(3):271-81 19523574 Semin Nephrol. 2009 May;29(3):282-99 19523575 Am J Med. 2009 Sep;122(9):857-65 19699382 Neurosurg Clin N Am. 2010 Apr;21(2):339-52 20380974 Am J Med. 2010 Jul;123(7):652-7 20609688 Am J Kidney Dis. 2010 Oct;56(4):774-9 20709440 J Biol Chem. 2011 Mar 25;286(12):10864-75 21135109 Clin J Am Soc Nephrol. 2011 May;6(5):960-5 21441132 Kidney Int. 2011 Sep;80(6):594-600 21451459 292 1976 03 01 2020 02 25 0367-6102 50 2 1975 Mar [Hokkaido igaku zasshi] The Hokkaido journal of medical science Hokkaido Igaku Zasshi [Studies on low volume priming heart lung bypass (author's transl)]. 137-67 This report concerns the feasibility of low volume priming extracorporeal circulation. Through this study, the bubble oxygenator with Zuhdi's heat exchange was used. Moderate hypothermia with surface cooling and hemodilution perfusion with 5 per cent D/W was evaluated in 32 mongrel dogs and 16 clinical open heart cases. The results obtained here were as follow: 1) Body temperature reduction by surface cooling before bypass provided more even cooling than did core cooling by low flow partial bypass alone. 2) In regard to cardiac loading on returning the whole perfusate of the circuit to patient, approximately 20 ml/kg of 5 per cent D/W was feasible as a priming solution. 3) To reduce the blood visicosity, hemodilution technique with 5 per cent D/W was superior, and hemodilution effect during postoperative periods was temporaly. 4) The excess lactate volume postulated by Huckabee was a available index to evaluate metabolic acidosis during the extracorporeal circulation. 5) With aid of surface cooling, the acid-base balance during perfusion was kept to lesser extent than that of core cooling only. 6) This study indicated that the low priming perfusion in conjunction with surface cooling hypothermia was a reliable technique for the open heart operation and may be applied in more prolonged perfusion. Kawamura M M jpn English Abstract Journal Article Review Japan Hokkaido Igaku Zasshi 17410290R 0367-6102 0 Electrolytes 0 Lactates IM Acid-Base Equilibrium Adolescent Adult Animals Blood Cell Count Blood Viscosity Blood Volume Body Temperature Child Child, Preschool Dogs Electrolytes blood Extracorporeal Circulation methods Female Heart-Lung Machine Hematocrit Humans Hydrogen-Ion Concentration Hypothermia, Induced methods Lactates blood Male Perfusion 117 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 292 Ann Trop Med Parasitol. 2001 Mar;95(2):215-7 11299128 Neurology. 2001 May 22;56(10):1313-8 11376180 Neurology. 2002 Oct 22;59(8):1281-3 12391369 Neurol Res. 2008 Feb;30(1):74 17711619 J Neurol Sci. 2013 Nov 15;334(1-2):183-5 24029237 Ceylon Med J. 1986 Sep;31(3):147-50 3555874 J Assoc Physicians India. 1980 May-Jun;28(5-6):152-6 7216988 J Neurol. 1994 Jun;241(7):456-9 7931448 Lancet. 1996 Oct 5;348(9032):917-21 8843810 293 1976 03 01 2016 11 23 0367-6102 50 2 1975 Mar [Hokkaido igaku zasshi] The Hokkaido journal of medical science Hokkaido Igaku Zasshi [Studies on extracorporeal circulation with large volume hemodilution using lactate ringer's solution and low molecular weight dextran: alterations of acid-base balance associated with intentional hemodilution (author's transl)]. 169-96 Twenty mongrel dogs, weighing between 7.5 and 13.0 kg were used to investigate the percentage limits permissible for hemodilution using a double-helical reservoir heart-lung machine which has a 1,100 ml of priming volume. In both 40 and 50 per cent groups of intentional hemodilution by 30 minute extracorporeal circulation, remarkable anemia was inevitable and recovery was extremely slow, especially in the 50 per cent dilution group. In both 40 and 50 per cent groups of intentional hemodilutions by 30 minute extracorporeal circulation, metabolic acidosis was observed. In 50 per cent group of intentional hemodilution, no improvement of metabolic acidosis was observed even after perfusion. When sodium bicarbonate was administered to 40 per cent hemodilution group, minimum alterations of acid-base balance and of serum electrolytes were observed during and after extracorporeal perfusion. When sodium bicarbonate was administered to 50 per cent hemodilution group, metabolic acidosis was more evident than in 40 per cent hemodilution group accompanied with an increase in serum sodium concentration and a decrease in serum chloride concentration. These data qualify the use of 40 per cent intentional hemodilution using Lactate Ringer's solution or low molecular weight dextran for 30 minute extracorporeal circulation when sodium bicarbonate is administered in adequate amounts. Yamada T T jpn Journal Article Review Japan Hokkaido Igaku Zasshi 17410290R 0367-6102 0 Bicarbonates 0 Dextrans 0 Electrolytes 0 Hemoglobins 0 Isotonic Solutions 0 Lactates 0 Plasma Substitutes S88TT14065 Oxygen IM Acid-Base Equilibrium drug effects Acidosis etiology Anemia etiology Animals Bicarbonates blood Blood Volume Dextrans pharmacology Dogs Electrolytes blood Extracorporeal Circulation methods Hematocrit Hemoglobins analysis Hydrogen-Ion Concentration Isotonic Solutions Lactates blood pharmacology Oxygen blood Plasma Substitutes 113 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 293 294 1976 03 01 2020 02 25 0367-6102 50 3 1975 May [Hokkaido igaku zasshi] The Hokkaido journal of medical science Hokkaido Igaku Zasshi [Malignant rheumatoid arthritis]. 278-80 Nakahara M M jpn Journal Article Japan Hokkaido Igaku Zasshi 17410290R 0367-6102 IM Adult Arthritis, Rheumatoid complications diagnosis Female Humans Male Middle Aged Pericarditis complications Polyarteritis Nodosa complications Polyneuropathies complications 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 294 Diabet Med. 2002 Sep;19(9):795 12207822 Diabetes. 1952 Jan-Feb;1(1):37-40 14906130 Pituitary. 2003;6(4):181-8 15237929 Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):217-23 20375886 Endocrinol Metab Clin North Am. 1989 Mar;18(1):145-54 2537192 Br Med J. 1965 Sep 25;2(5464):727-31 4283893 Br Med J. 1970 Jun 20;2(5711):709 5429657 295 1976 02 09 2019 09 02 0018-4888 356 7 1975 Jul Hoppe-Seyler's Zeitschrift fur physiologische Chemie Hoppe Seylers Z Physiol Chem Purification and characterization of phosphodiesterase from Crotalus venom. 1085-96 A procedure for the purification of phosphodiesterase from Crotalus venom on DEAE-cellulose at alkaline pH is described. The enzyme gives a single band in polyacrylamide gels and is free of contaminating nucleolytic enzymes. The molecular weight is about 115000. Concentration in an Amicon ultrafiltrator gave a highly concentrated active enzyme. Phosphodiesterase is relatively stable and can be stored at 4 degrees C in the presence of Mg2 and serum albumin for years. For the detection of contaminating endonuclease, an assay was used in which tRNA was the substrate and possible internal breaks were detected in polyacrylamide gel after denaturation. With bis(p-nitrophenyl) phosphate as substrate, 15mM Mg2 was necessary for optimal activity. The reaction remained linear for at least 15 min at 22 degrees C. At 45 degrees C, the liberation of p-nitrophenol was highest within 25 min of incubation. At 75 degrees C, inactivation of the enzyme occurred after 4 min. Philipps G R GR eng Journal Article Germany Hoppe Seylers Z Physiol Chem 2985060R 0018-4888 0 Snake Venoms 9014-25-9 RNA, Transfer EC 3.1.- Endonucleases EC 3.1.4.- Phosphoric Diester Hydrolases I38ZP9992A Magnesium IM Animals Chromatography, DEAE-Cellulose Electrophoresis, Polyacrylamide Gel Endonucleases Hydrogen-Ion Concentration Magnesium pharmacology Methods Molecular Weight Phosphoric Diester Hydrolases isolation & purification metabolism RNA, Transfer metabolism Snake Venoms analysis metabolism Temperature Ultrafiltration 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 295 10.1515/bchm2.1975.356.2.1085 296 1976 02 09 2020 02 25 0018-4888 356 7 1975 Jul Hoppe-Seyler's Zeitschrift fur physiologische Chemie Hoppe Seylers Z Physiol Chem Limited hydrolysis of tRNA by phosphodiesterase. 1097-104 Digestion of tRNA by electrophoretically pure phosphodiesterase is limited to a short sequence of nucleotides at the 3'-terminus. On the average, four percent of all nucleotides can be released from tRNA. The optimum Mg2 concentration is 10mM and the optimum pH 9.2. The mode of action is a random attack by the enzyme on the substrate. The terminal AMP is completely removed at 15 degrees C after short incubation; about 400 mol of AMP were removed per min by 1 mol of enzyme. The following CMP residues are released much more slowly; at 15 degrees C incompletely, and at 37 degrees C more or less completely in 1 h. In about 50% of the tRNA molecules, the fourth nucleotide could be removed in very long incubations or with very high enzyme concentrations. Philipps G R GR Chiemprasert T T eng Journal Article Germany Hoppe Seylers Z Physiol Chem 2985060R 0018-4888 415SHH325A Adenosine Monophosphate 9014-25-9 RNA, Transfer EC 2.7.7.- Nucleotidyltransferases EC 3.1.4.- Phosphoric Diester Hydrolases F469818O25 Cytidine Monophosphate I38ZP9992A Magnesium IM Adenosine Monophosphate metabolism Base Sequence Cytidine Monophosphate metabolism Escherichia coli enzymology Hydrogen-Ion Concentration Hydrolysis Magnesium pharmacology Nucleotidyltransferases metabolism Phosphoric Diester Hydrolases metabolism RNA, Transfer metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 296 10.1515/bchm2.1975.356.2.1097 Am J Surg Pathol. 1999 Nov;23(11):1414-7 10555011 Br J Clin Pharmacol. 2003 Sep;56(3):284-91 12919176 J Clin Gastroenterol. 2004 Sep;38(8):686-91 15319653 Gastroenterol Clin Biol. 2004 Apr;28 Spec No 3:C62-72 15366676 Clin Gastroenterol Hepatol. 2005 Jan;3(1):55-9 15645405 Arch Surg. 2005 Dec;140(12):1162-6 16365236 Clin Gastroenterol Hepatol. 2007 Sep;5(9):1040-5 17625980 Am J Clin Pathol. 2008 Oct;130(4):518-25 18794043 J Clin Pathol. 1988 May;41(5):516-26 3384981 Pharmacol Ther. 1994 Apr-May;62(1-2):145-57 7991640 297 1976 02 09 2020 02 25 0018-4888 356 7 1975 Jul Hoppe-Seyler's Zeitschrift fur physiologische Chemie Hoppe Seylers Z Physiol Chem Ecdysone Oxidase, an enzyme from the blowfly Calliphora erythrocephala (Meigen). 1131-8 In the blowfly, the formation of 3-dehydroecdysone from the insect molting hormone ecdysone is catalyzed by an enzyme which carries hydrogen from ecdysone and ecdysterone to oxygen. The enzyme is therefore called "ecdysone oxidase". Two methods are described for the detection of ecdysone oxidase activity, one using a radiolabelled substrate which is separated from the product by thin-layer chromatography after the reaction, and the other using dichloroindophenol, which is discoloured by the redox reaction. The ecdysone oxidase is purified by a factor of 2200 from prepupae of Calliphora erythrocephala using salt precipitation and ion exchange chromatography. The ecdysone oxidase has a Km value for ecdysone of 42muM. The pH optimum is 6.5. The temperature optimum lies at 45 degrees C. The ecdysone oxidase has a molecular weight of 240000. Koolman J J Karlson P P eng Journal Article Germany Hoppe Seylers Z Physiol Chem 2985060R 0018-4888 3604-87-3 Ecdysone 5289-74-7 Ecdysterone C35QN2Z58B 2,6-Dichloroindophenol EC 1.- Oxidoreductases IM 2,6-Dichloroindophenol Animals Chromatography, Ion Exchange Chromatography, Thin Layer Diptera enzymology Ecdysone metabolism Ecdysterone metabolism Hydrogen-Ion Concentration Kinetics Molecular Weight Oxidation-Reduction Oxidoreductases isolation & purification metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 297 10.1515/bchm2.1975.356.2.1131 Circulation. 2014 Apr 8;129(14):1540-1 24709869 Br Heart J. 1986 Dec;56(6):531-4 3801244 298 1976 03 01 2019 08 16 0022-1597 26 10 1975 Oct Hospital & community psychiatry Hosp Community Psychiatry Using a hospital for desensitization of an outpatient's illness-related fears. 675-7 An outpatient with phobias related to enclosed places, hospitals, doctors, and cancer was treated by systematic desensitization; the facilities of a general hospital were used for part of the process. Steps in treatment included securing a complete psychiatric and social history, teaching the patient relaxation therapy techniques, and establishing a hierarchy of anxiety-provoking stimuli specifically related to the patient's fears. After desensitization the patient was able to enter the hospital for tests for a physical ailment and showed a general decrease in her fears. Powers P S PS Powers H P HP eng Case Reports Journal Article United States Hosp Community Psychiatry 0040250 0022-1597 IM Adult Behavior Therapy Depression therapy Desensitization, Psychologic Female Hospitals, General Humans Phobic Disorders therapy Relaxation Therapy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 298 10.1176/ps.26.10.675 299 1976 02 27 2019 09 18 0018-9294 23 1 1976 Jan IEEE transactions on bio-medical engineering IEEE Trans Biomed Eng Analog computer for base excess and HCO3-from pH and PCO2 electrodes. 77-81 Severinghaus J W JW eng Journal Article United States IEEE Trans Biomed Eng 0012737 0018-9294 0 Bicarbonates 142M471B3J Carbon Dioxide IM Acid-Base Equilibrium Bicarbonates blood Carbon Dioxide blood Computers, Analog Electrodes Extracellular Space analysis Humans Hydrogen-Ion Concentration Partial Pressure 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 299 10.1109/tbme.1976.324622 300 1976 02 09 2019 02 06 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Alcohol-related problems in a general hospital emergency room. 509-10 Amdur M A MA eng Comparative Study Journal Article United States IMJ Ill Med J 7703940 IM Alcoholic Intoxication epidemiology Alcoholism epidemiology Emergency Service, Hospital Female Hospitals, General Humans Illinois Male 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 300 301 1976 02 09 2014 05 30 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Analysis of fatal blunt trauma presenting at an areawide trauma center. 511-5 Bartley V H VH eng Comparative Study Journal Article United States IMJ Ill Med J 7703940 IM Accidents, Traffic Adolescent Adult Aged Child, Preschool Emergency Medical Services Female Humans Illinois Male Middle Aged Trauma Centers Wounds, Nonpenetrating mortality 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 301 302 1976 02 09 2020 02 25 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Surgical grand rounds: Ruptured abdominal aortic aneurysm. 516-8 Beal J M JM eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Aged Aorta, Abdominal surgery Aortic Aneurysm surgery Humans Male Rupture, Spontaneous 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 302 Clin Infect Dis. 2008 Feb 1;46(3):327-60 18177225 Clin Med (Lond). 2015 Oct;15(5):492-4 26430194 303 1976 02 09 2014 05 30 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J The psychological reactions of children to burn traumata: a review. 519-24 contd Breslin P W PW eng Journal Article Review United States IMJ Ill Med J 7703940 IM Adolescent Affective Symptoms etiology Anxiety etiology Body Image Burns complications etiology Child Child, Preschool Defense Mechanisms Female Hospitalization Humans Infant Male Patient Isolators Psychotic Disorders etiology Socioeconomic Factors 0 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 303 304 1976 02 09 2019 02 06 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J EKG of the month. 525, 533 Tobin J R JR Jr Nemickas R R Scanlon P J PJ Moran J F JF Johnson S S Gunnar R M RM eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Arrhythmias, Cardiac diagnosis Electrocardiography Female Humans Middle Aged 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 304 305 1976 02 09 2019 02 06 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Relative severity of hemolysis in the subtypes of ABO incompatible hemolytic disease. 526-7, 530 Seungdamrong S S Yasunaga S S eng Comparative Study Journal Article United States IMJ Ill Med J 7703940 0 ABO Blood-Group System IM ABO Blood-Group System Erythroblastosis, Fetal blood Female Hemolysis Humans Infant, Newborn Pregnancy 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 305 306 1976 02 09 2014 05 30 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J The demise of the Hopewellian moundbuilders: a plausible conjecture. 528-30 Johnson H A HA eng Historical Article Journal Article United States IMJ Ill Med J 7703940 IM Q Asia Disease Outbreaks history Europe History, 15th Century History, 16th Century History, 17th Century History, 18th Century History, 19th Century History, 20th Century History, Ancient History, Medieval Humans North America Ohio Plague history 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 306 307 1976 02 09 2014 05 30 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Digitalis as treatment for pulmonary comsumption, 1799. 531 Greenwood R D RD eng Biography Historical Article Journal Article United States IMJ Ill Med J 7703940 0 Digitalis Glycosides IM Q Digitalis Glycosides therapeutic use England History, 18th Century Humans Tuberculosis, Pulmonary drug therapy history Drake N N 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 307 308 1976 02 09 2020 02 25 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Aqueductal stenosis and Parinaud's syndrome. 532-3 Azar-Kia B B Palacios E E Churchill R R eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Brain Diseases complications Cerebral Aqueduct Humans Male Middle Aged Ophthalmoplegia etiology Reflex, Pupillary Syndrome 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 308 J Hosp Med. 2006 May;1(3):191-9 17219493 Qual Saf Health Care. 2010 Oct;19(5):e14 20430932 BMJ. 2010 Aug 13;341:c4078 20709715 Clin Med (Lond). 2010 Oct;10(5):445-9 21117374 309 1976 02 09 2020 02 25 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Time, money and the housestaff officer. 534, 557 Hughey M M eng Journal Article United States IMJ Ill Med J 7703940 IM Collective Bargaining Hospital Administration Internship and Residency United States 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 309 Clin Chem. 2004 Nov;50(11):1968-9 15502078 BMJ. 2007 Mar 31;334(7595):693-5 17395950 MedGenMed. 2006 Oct 11;8(4):9 17415291 Clin Med (Lond). 2007 Aug;7(4):357-61 17882852 South Med J. 2009 Feb;102(2):167-70 19139717 Crit Rev Clin Lab Sci. 2011 May-Jun;48(3):143-53 21875312 310 1976 02 09 2020 02 25 148 5 1975 Nov IMJ. Illinois medical journal IMJ Ill Med J Mitral valve prolapse in sarcoid heart disease. 551-5 Shenkoya K A KA Walsh W F WF Falicov R E RE Resnekov L L eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Adult Humans Male Mitral Valve Insufficiency etiology Sarcoidosis complications 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 310 Gut. 2000 Oct;47(4):533-8 10986214 Intensive Care Med. 2001 Apr;27(4):706-10 11398697 Fam Pract. 2003 Jun;20(3):231-6 12738689 Crit Care. 2003 Dec;7(6):R129-32 14624686 Arch Intern Med. 2005 Jul 11;165(13):1493-9 16009864 Ann Intern Med. 2006 Oct 3;145(7):488-96 17015866 CJEM. 2001 Oct;3(4):271-6 17610769 Am J Med. 2008 May;121(5 Suppl):S2-23 18440350 BMJ. 2009 Nov 19;339:b4489 19926688 Med Educ. 2010 Jan;44(1):94-100 20078760 311 1976 02 09 2019 02 06 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Jaundice after enflurane anesthesia. 593-4 Tsang H S HS eng Case Reports Journal Article United States IMJ Ill Med J 7703940 0 Methyl Ethers 91I69L5AY5 Enflurane IM Adult Anesthesia, Inhalation Enflurane adverse effects Female Humans Jaundice chemically induced Methyl Ethers adverse effects 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 311 312 1976 02 09 2020 02 25 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J The psychological reactions of children to burn traumata: a review. Part II. 595-7, 602 Breslin P W PW eng Journal Article United States IMJ Ill Med J 7703940 IM Adaptation, Psychological Burns Child Child, Hospitalized Humans Mental Disorders genetics Parents Stress, Psychological 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 312 Am J Health Syst Pharm. 1999 Jan 1;56(1):57-62 10048880 JAMA. 1999 Jul 21;282(3):267-70 10422996 Am J Health Syst Pharm. 2002 Nov 1;59(21):2089-92 12434722 Rep Med Guidel Outcomes Res. 2002 Dec 13;13(24):9-10, 12 12747368 Arch Intern Med. 2003 Sep 22;163(17):2014-8 14504113 Qual Saf Health Care. 2005 Jun;14(3):207-11 15933319 J Am Pharm Assoc (2003). 2006 Sep-Oct;46(5):618-20 17036650 Pharm World Sci. 2007 Jun;29(3):213-20 17310304 Am J Health Syst Pharm. 2007 Jul 15;64(14):1541-6 17617506 BMJ. 1990 Apr 14;300(6730):986-90 2344509 JAMA. 1995 Jul 5;274(1):29-34 7791255 Am J Health Syst Pharm. 1997 Feb 15;54(4):397-405 9043562 313 1976 02 09 2016 11 23 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Azygos venous connection of anomalous inferior vena cava. 599-602 Agarwala B B Agarwala R R Baffes T T eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Azygos Vein abnormalities Child Female Heart Defects, Congenital diagnostic imaging Humans Infant, Newborn Male Radiography Vena Cava, Inferior abnormalities 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 313 314 1976 02 09 2019 02 06 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Second primary lung tumors. 603-5 Beal J M JM eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Aged Carcinoma, Small Cell diagnosis Carcinoma, Squamous Cell diagnosis Female Humans Lung Neoplasms diagnosis surgery Neoplasms, Multiple Primary diagnosis Prognosis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 314 316 1976 02 09 2017 03 22 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J An improved gastrostomy technique. 610-1 Field R E RE Romanus R J RJ eng Journal Article United States IMJ Ill Med J 7703940 IM Gastrostomy methods Humans 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 316 315 1976 02 09 2020 02 25 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Penetrating injuries of the thorax: certain aspects of treatment. 606-9 Khedroo L G LG eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Adult Female Humans Male Thoracic Injuries surgery Wounds, Penetrating surgery 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 315 Anaesth Intensive Care. 2002 Apr;30(2):230-3 12002936 J Laryngol Otol. 2002 Oct;116(10):854-8 12437846 Thyroid. 2008 May;18(5):567-9 18397159 J Emerg Med. 2012 Jul;43(1):41-3 19545965 Hered Cancer Clin Pract. 2008 Feb 15;6(1):15-21 19706203 317 1976 02 09 2020 02 25 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Basal cell epithelioma in smallpox vaccination scar-fifty years later. 612-3 Kulwin M H MH eng Case Reports Journal Article United States IMJ Ill Med J 7703940 0 Smallpox Vaccine IM Aged Carcinoma, Basal Cell Cicatrix Humans Male Skin Neoplasms Smallpox Vaccine Vaccination 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 317 J R Soc Med. 2001 Jul;94(7):322-30 11418700 Acad Med. 2002 Oct;77(10):981-92 12377672 Acad Med. 2003 Aug;78(8):775-80 12915363 Ann Intern Med. 2005 Jan 18;142(2):115-20 15657159 Arch Intern Med. 2005 Jul 11;165(13):1493-9 16009864 Clin Med (Lond). 2006 Mar-Apr;6(2):157-62 16688973 Ann Intern Med. 2006 Oct 17;145(8):629-30 17043345 Qual Saf Health Care. 2007 Feb;16(1):40-4 17301203 N Engl J Med. 2007 Mar 1;356(9):889-90 17329694 N Engl J Med. 1991 Feb 7;324(6):377-84 1824793 JAMA. 2009 Mar 11;301(10):1060-2 19278949 Arch Intern Med. 2009 Nov 9;169(20):1881-7 19901140 N Engl J Med. 2010 Apr 8;362(14):1304-11 20375407 Arch Intern Med. 2010 Jun 28;170(12):1015-21 20585065 Arch Intern Med. 2010 Jun 28;170(12):1021-2 20585066 N Engl J Med. 2010 Nov 11;363(20):1928-37 21067384 318 1976 02 09 2019 02 06 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J The adolescent who has lost a significant other. 614-5 Bauer W W eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Acting Out Adolescent Child Reactive Disorders etiology Female Grief Humans Male Stress, Psychological 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 318 320 1976 02 09 2019 02 06 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J A small community blood bank frozen blood program. Twelve month report. 633-6 Crowley R D RD eng Journal Article United States IMJ Ill Med J 7703940 IM Blood Banks Blood Preservation Freezing Hospitals, Community 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 320 319 1976 02 09 2020 02 25 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J EKG of the month. 616, 618 Tobin J R JR Jr Nemickas R R Scanlon P J PJ Moran J F JF Johnson S S Gunnar R M RM eng Case Reports Journal Article United States IMJ Ill Med J 7703940 IM Arrhythmia, Sinus diagnosis Electrocardiography Heart Block diagnosis Humans Male Middle Aged 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 319 Thorax. 2006 Dec;61(12):1043-7 17040932 Thorax. 2008 Oct;63 Suppl 6:vi1-68 18838559 Chest. 2011 May;139(5):1018-1024 20947648 BMJ. 2010 Oct 18;341:c5462 20959284 Thorax. 2011 Jan;66(1):43-8 21075776 Clin Med (Lond). 2012 Feb;12(1):79-81 22372231 Postgrad Med J. 2012 Dec;88(1046):684-9 22977283 BMJ. 2012 Oct 18;345:e6856 23078806 321 1976 02 09 2019 02 06 148 6 1975 Dec IMJ. Illinois medical journal IMJ Ill Med J Utilization and referral patterns in the acute illness department of a multispecialty clinic. 640-4 Jones F F Kruger C C eng Journal Article United States IMJ Ill Med J 7703940 IM Acute Disease Community Health Services standards statistics & numerical data Humans Illinois Referral and Consultation Utilization Review 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 321 322 1976 02 20 2020 02 25 0019-4832 27 3 1975 Jul Indian heart journal Indian Heart J Cardiovascular effects of beta-receptor stimulants in healthy volunteers. 206-12 Shah S J SJ Anand M P MP Billimoria A R AR Goyal B K BK eng Clinical Trial Comparative Study Journal Article India Indian Heart J 0374675 0019-4832 0 Adrenergic beta-Agonists 53QOG569E0 Metaproterenol L628TT009W Isoproterenol QF8SVZ843E Albuterol IM Adrenergic beta-Agonists pharmacology Adult Albuterol pharmacology Blood Pressure drug effects Clinical Trials as Topic Female Heart Rate drug effects Humans Isoproterenol pharmacology Male Metaproterenol pharmacology Middle Aged 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 322 Med Teach. 2009 May;31(5):403-8 19142797 Aust Health Rev. 2009 Feb;33(1):57-61 19203334 PLoS One. 2009 Sep 23;4(9):e7103 19774078 BMJ. 2009 Oct 13;339:b3949 19826175 BMJ. 2009 Oct 13;339:b3974 19826176 Postgrad Med J. 2009 Nov;85(1009):582-9 19892893 J Trauma. 2010 Jan;68(1):19-22 20065752 BMC Med Educ. 2010 Jun 23;10:48 20573253 Arch Intern Med. 1989 Apr;149(4):765-8 2495778 Med Care. 1993 Jan;31(1):73-83 8417272 323 1976 02 09 2019 09 18 0019-2791 12 3 1975 Mar Immunochemistry Immunochemistry Isoelectric distribution of specifically purified rabbit antibody against 4-azo-naphthalene-1-sulfonate. 199-204 Yoo T J TJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England Immunochemistry 0010301 0019-2791 0 Anilino Naphthalenesulfonates 0 Antibodies 0 Azo Compounds 0 Naphthalenesulfonates IM Anilino Naphthalenesulfonates Animals Antibodies isolation & purification Azo Compounds Binding Sites, Antibody Chromatography, Ion Exchange Hydrogen-Ion Concentration Isoelectric Focusing Kinetics Naphthalenesulfonates immunology Protein Binding Rabbits Spectrometry, Fluorescence 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 323 0019-2791(75)90232-3 10.1016/0019-2791(75)90232-3 324 1976 02 09 2020 02 25 0019-2791 12 4 1975 Apr Immunochemistry Immunochemistry Studies of hyperimmune restricted and partially restricted anti-pneumococcal polysaccharide antibodies from allotype-defined pedigreed rabbits--IV. Amino-terminal light chain sequence analyses of restricted homozygous b4 rabbit anti-SIII and SVIII antibodies from partially inbred rabbits. 263-72 Freedman M M Hofmann T T Rhee S S Yeger H H Slaughter M M Milandre J J eng Comparative Study Journal Article England Immunochemistry 0010301 0019-2791 0 Antibodies 0 Immunoglobulin Heavy Chains 0 Immunoglobulin Light Chains 0 Peptide Fragments 0 Polysaccharides, Bacterial IM Amino Acid Sequence Animals Antibodies analysis Homozygote Immunoglobulin Heavy Chains analysis Immunoglobulin Light Chains analysis Peptide Fragments analysis Polysaccharides, Bacterial immunology Rabbits immunology Streptococcus pneumoniae immunology 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 324 0019-2791(75)90174-3 10.1016/0019-2791(75)90174-3 Clin Nutr. 2008 Feb;27(1):5-15 18061312 325 1976 02 20 2018 11 13 0019-2805 29 6 1975 Dec Immunology Immunology Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo. 953-65 The kinetics and cellular characteristics of immunosuppression in (CBA-p X C57/Bl)F1 mice during graft-versus-host (GVH) reaction induced with spleen cells from either parental strain have been investigated. Effects on PFC responses to thymus-dependent (chicken red blood cells) and independent (levan) antigens have been compared. The unresponsive state which developed in GVH mice was expressed to comparable extent by their spleen cells following transfer to irradiated recipients. Furthermore, GVH spleen cells suppressed normal spleen cells in a mixed transfer system, but this effect was lost completely by day 21 whereas the original donors (or their cells) were still totally refractory after 80 days. This active suppressor effect was found to be mediated by T cells of perental origin based on cell fractionation analysis and selective deletion of donor or host cells by alloimmune attack. The delayed transfer of GVH cells to irradiated repopulated recipients challenged with antigen, indicated that suppressor T cells exert an anti-mitotic influence on antigen-stimulated B-cell proliferation. Supplementation of macrophage-depleted, anti-theta-treated GVH spleen cells with purified normal T cells demonstrated that B cells in GVH mice are normally reactive even when active suppression by T cells is no longer demonstrable. The likelihood that this later phase of immunosuppression is attributable to another mechanism is discussed. Shand F L FL eng Journal Article England Immunology 0374672 0019-2805 0 Antigens 0 Transfer Factor IM Animals Antibody-Producing Cells Antigens B-Lymphocytes immunology Female Graft vs Host Reaction Hemolytic Plaque Technique Immunity radiation effects Immunization, Passive Immunosuppression Kinetics Macrophages immunology Male Mice Mice, Inbred C57BL Mice, Inbred CBA Radiation Effects Skin Transplantation Spleen immunology T-Lymphocytes immunology Transfer Factor Transplantation, Homologous 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 325 PMC1446034 Transplant Bull. 1959 Apr;6(2):433-5 13647637 Nature. 1962 Sep 8;195:1024-5 13894383 Transplantation. 1963 Jan;1:2-14 13959034 Cell Immunol. 1975 Mar;16(1):106-14 163703 J Exp Med. 1971 Feb 1;133(2):169-86 4109111 Cell Immunol. 1973 May;7(2):268-74 4145118 J Immunol. 1973 Jul;111(1):72-84 4145923 Cancer Res. 1973 Sep;33(9):2068-77 4146854 Transplantation. 1973 Sep;16(3):211-6 4147031 Nature. 1973 Nov 30;246(5431):306-7 4148524 Cell Immunol. 1974 Jul;13(1):164-8 4155999 Cell Immunol. 1974 Mar 30;11(1-3):419-26 4156194 Immunology. 1972 Apr;22(4):537-47 4401408 Clin Exp Immunol. 1972 Nov;12(3):365-75 4404919 Immunology. 1972 Dec;23(6):829-42 4405409 Immunology. 1972 Apr;22(4):549-56 4552638 Immunology. 1973 Apr;24(4):759-70 4574801 Scand J Immunol. 1972;1(1):75-87 4627539 Nature. 1971 Dec 24;234(5330):454-6 4944187 J Exp Med. 1967 Sep 1;126(3):443-54 6034750 Transplantation. 1967 Sep 5;5(5):1304-22 6056943 326 1976 02 09 2005 11 17 0019-5189 13 2 1975 Mar Indian journal of experimental biology Indian J Exp Biol Schiff-type dyes in the cytochemical staining of DNA. 142-6 Dutt M K MK eng Journal Article India Indian J Exp Biol 0233411 0019-5189 0 Amines 0 Coloring Agents 0 Schiff Bases 9007-49-2 DNA IM Amines Animals Coloring Agents DNA analysis Histocytochemistry Hydrogen-Ion Concentration Rats Schiff Bases 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 326 327 1976 02 09 2015 11 19 0019-5189 13 2 1975 Mar Indian journal of experimental biology Indian J Exp Biol Response of alanine, tyrosine & leucine aminotransferases to dietary pyridoxine & protein in rat tissues. 149-52 Lalitha K K Radhakrishnamurty R R eng Journal Article Research Support, U.S. Gov't, P.H.S. India Indian J Exp Biol 0233411 0019-5189 EC 2.6.1.- Transaminases EC 2.6.1.2 Alanine Transaminase EC 2.6.1.5 Tyrosine Transaminase KV2JZ1BI6Z Pyridoxine IM Alanine Transaminase metabolism Animals Diet Liver enzymology Male Myocardium enzymology Protein Deficiency enzymology Pyridoxine pharmacology Rats Transaminases metabolism Tyrosine Transaminase metabolism 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 327 328 1976 02 09 2019 02 06 0019-5189 13 2 1975 Mar Indian journal of experimental biology Indian J Exp Biol A modified minimal medium for aspergillus nidulans. 218-20 Prasad N V NV Sandhu R S RS eng Journal Article India Indian J Exp Biol 0233411 0019-5189 0 Culture Media 0 Nitrates 0 Phosphates 0 Quaternary Ammonium Compounds IM Aspergillus nidulans enzymology growth & development Culture Media Hydrogen-Ion Concentration Nitrates Phosphates Quaternary Ammonium Compounds 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 328 329 1976 02 09 2020 07 24 0019-9567 12 4 1975 Oct Infection and immunity Infect Immun Pneumococcal type-associated variability in alternate complement pathway activation. 772-8 Opsonization of Streptococcus pneumoniae may be mediated by the alternate complement pathway. To study the importance of this interaction to human disease, complement consumption by pneumococci of various serotypes was measured in humwn serum chelated with ethyleneglycoltraacetic acid, a substance that blocks the classic but not the alternate complement pathwway. Serotype I, in contrast to all other types studied, lacked ability to consume complement in this system. The ability for serotypes III, IV, and VIII to activate the alternate pathway could be eliminated by prior serum absorption at O C with they type in question, a condition that would remove antibody but not complement. Types VII, XII, XIV, and XXV readily activated the alternate pathway in unabsorbed and absorbed sera. Differences could not be related to properties of the capsules. It was concluded that types I, III, IV, and VIII lack intrinsic ability to activate and thus be opsonized by the alternate complement pathway, although types III, IV, and VIII can do so in concert with specific antibody. The fact that these same types are especially prominent in human disease suggests that the ability to evade opsonization by the alternate complement pathway in pre-antibody phases of infection may be a virulence factor in pneumococci. Fine D P DP eng Journal Article United States Infect Immun 0246127 0019-9567 0 Antigen-Antibody Complex 0 Complement C3 526U7A2651 Egtazic Acid 9007-36-7 Complement System Proteins 9010-72-4 Zymosan 9G34HU7RV0 Edetic Acid IM Antigen-Antibody Complex Complement C3 metabolism Complement System Proteins metabolism Edetic Acid pharmacology Egtazic Acid pharmacology Humans Serotyping Streptococcus pneumoniae immunology Zymosan pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 329 PMC415355 10.1128/IAI.12.4.772-778.1975 Yale J Biol Med. 1958 Feb;30(4):257-91 13531168 Ann Intern Med. 1964 May;60:759-76 14156606 Immunochemistry. 1966 Mar;3(2):111-35 5960883 J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s 4105810 J Pediatr. 1973 May;82(5):747-53 4144636 J Immunol. 1974 May;112(5):1635-42 4150446 Arch Intern Med. 1974 Sep;134(3):505-10 4152800 Infect Immun. 1974 Aug;10(2):402-4 4152919 Proc Soc Exp Biol Med. 1974 Apr;145(4):1431-3 4208047 Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(3):333-6 4394495 J Immunol. 1972 Jun;108(6):1681-9 4402312 J Immunol. 1972 Sep;109(3):477-86 4403402 Immunology. 1974 Jun;26(6):1251-6 4604857 J Immunol. 1972 Jul;109(1):26-31 4624675 J Immunol. 1972 Oct;109(4):807-9 4627510 J Exp Med. 1971 Jul 1;134(1):176-87 4997584 Annu Rev Microbiol. 1971;25:309-32 5005029 J Exp Med. 1970 Nov;132(5):941-50 5470510 J Immunol. 1971 Jan;106(1):51-5 5543727 330 1976 02 09 2020 07 24 0019-9567 12 4 1975 Oct Infection and immunity Infect Immun Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. 833-40 Mycobacterial growth inhibitory factor (MycoIF), found in supernatant fluids of mouse spleen cell cultures that have been stimulated in vitro with homologous antigen, inhibited the intracellular multiplication of virulent tubercle bacilli within normal mouse peritoneal macrophages in vitro. Antigenically stimulated H37Ra-immunized mouse spleen cells required 72 h of incubation to produce supernatant fluids that would cause intracellular inhibition. Supernatant fluids from 48-h mouse spleen cell cultures were not able to produce intracellular inhibition. Investigation of the culture conditions showed that at lease 1.0% human serum was required in the tissue culture medium for the production of MycoIF by spleen cells from immunized mice. MycoIF activity was noted only in supernatant fluids from spleen cell cultures incubated with antigen for 72 h. MycoIF was nondialyzable and unaffected by freezing, lyophilization, or incubation at 60 C for 30 min. However, MycoIF was inactivated after incubation at 80 C for 30 min. MycoIF was unaffected by low hydrogen ion concentrations (pH 7 to 12), but exposure to higher hydrogen ion concentrations (pH 6, pH 5) significantly decrease MycoIF activity, and exposure to pH 4 to 2 abolished all activity. Supernatant fluids diluted 1:32 were still able to produce significant intracellular inhibition of growth of virulent tubercle bacilli. Cahall D L DL Youmans G P GP eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Infect Immun 0246127 0019-9567 0 Antigens, Bacterial 0 Lymphokines IM Animals Antigens, Bacterial administration & dosage Dialysis Freeze Drying Freezing Hydrogen-Ion Concentration Lymphokines antagonists & inhibitors physiology Macrophages microbiology Male Mice Mice, Inbred C57BL Mycobacterium tuberculosis growth & development immunology Spleen immunology Temperature Time Factors Vaccination 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 330 PMC415364 10.1128/IAI.12.4.833-840.1975 Infect Immun. 1973 Mar;7(3):409-15 4197391 J Immunol. 1973 Nov;111(5):1459-69 4270393 J Infect Dis. 1969 Jan;119(1):11-8 4885249 Am Rev Respir Dis. 1971 May;103(5):607-11 4996267 Proc Soc Exp Biol Med. 1972 Jul;140(3):750-4 5039373 J Exp Med. 1970 Jun 1;131(6):1049-78 5419268 J Natl Cancer Inst. 1964 Jan;32:19-35 14114967 Infect Immun. 1970 Jan;1(1):30-40 16557690 Infect Immun. 1970 Jun;1(6):600-3 16557782 Infect Immun. 1971 Apr;3(4):553-8 16558016 J Reticuloendothel Soc. 1973 Mar;13(3):263-74 4196702 331 1976 02 09 2020 07 24 0019-9567 12 4 1975 Oct Infection and immunity Infect Immun Effect of pneumococci on blood clotting, platelets, and polymorphonuclear leukocytes. 910-8 Infections due to Streptococcus pneumoniae and products from the organism have been associated with alterations in blood clotting and function of platelets. Pneumococci and pneumococcal polysaccharide shortened the clotting times of whole blood, platelet-rich plasma (PRP), and platelet-poor plasma (PPP) in vitro. Clotting times of PPP and PRP from C6-deficient animals were likewise decreased. The bacteria had no effect on the one-stage prothrombin time or the partial thromboplastin time when the organisms were used as activating agents. Platelets aggregated in the presence of pneumococci, but aggregation was prevented by the addition of cyclic adenosine 3', 5'-monophosphate (cAMP). Furthermore, cAMP corrected the shortened clotting time of PRP in the presence of pneumococci. The clumping and release of polymorphonuclear coagulant that was induced by pneumococci was not prevented by cAMP. Thus, pneumococci exert several dose-dependent thromboplastic effects: (i) release of platelet thromboplastic substances; (ii) a direct thromboplastic effect; and (iii) release of polymorphonuclear coagulant. Guckian J C JC eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Infect Immun 0246127 0019-9567 0 Polysaccharides IM Animals Blood Coagulation Blood Coagulation Tests Blood Platelets Neutrophils Platelet Aggregation Pneumococcal Infections blood Polysaccharides pharmacology Rabbits Streptococcus pneumoniae 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 331 PMC415373 10.1128/IAI.12.4.910-918.1975 J Exp Med. 1968 Nov 1;128(5):1049-57 4176223 J Clin Invest. 1971 Jan;50(1):131-41 4322665 J Clin Invest. 1971 Apr;50(4):920-9 4323128 J Clin Invest. 1972 Feb;51(2):307-13 4333021 J Clin Invest. 1972 Mar;51(3):615-24 4334720 J Lab Clin Med. 1973 May;81(5):778-86 4698662 Med J Aust. 1969 Jun 14;1(24):1213-9 4894854 J Exp Med. 1971 Dec 1;134(6):1601-7 5166613 Arch Pathol. 1970 Feb;89(2):154-9 5410983 Ann Intern Med. 1970 Mar;72(3):389-93 5415422 Arch Intern Med. 1970 May;125(5):876-8 5424498 JAMA. 1970 Jan 19;211(3):467-71 5466920 JAMA. 1970 May 25;212(8):1373-4 5467531 Acta Med Scand. 1970 Oct;188(4):293-9 5488669 Exp Mol Pathol. 1969 Jun;10(3):295-311 5788629 Tex Rep Biol Med. 1966 Spring;24(1):125-40 5962232 J Clin Invest. 1967 Apr;46(4):668-79 6021213 J Exp Med. 1960 Dec 1;112:983-1004 13694490 Am J Clin Pathol. 1961 Sep;36:212-9 13738153 J Exp Med. 1961 Dec 1;114:857-74 13885652 J Exp Med. 1962 Nov 1;116:619-33 13954979 Am J Pathol. 1963 Nov;43:775-95 14075014 Ann Intern Med. 1962 Apr;56:627-32 14490551 J Appl Physiol. 1950 Dec;3(6):365-77 14794596 Infect Immun. 1970 Jan;1(1):8-14 16557699 J Bacteriol. 1946 Oct;52(4):439-48 16561197 Arch Pathol. 1968 Feb;85(2):149-61 4169545 332 1976 02 20 2020 07 24 0019-9567 12 5 1975 Nov Infection and immunity Infect Immun Some properties of a D-alanine carboxypeptidase in envelope fractions of Neisseria gonorrhoeae. 1065-9 Envelope preparations of Neisseria gonorrhoeae strain GC1 (a stable, piliated strain of intermediate colony morphology) and type T1 possess a D-alanine carboxypeptidase which releases the terminal alanine residue from the uridine 5'-diphosphate-N-acetyl muramylpentapeptide substrate (isolated from Bacillus cereus T). The D-alanine carboxypeptidase of the GC1 envelopes has a broad pH optimum between pH 8.0 to 10.0. When the molarity of the tris(hydroxymethyl)aminomethane buffer was varied, the activity showed an optimum over the range 0.2 to 0.4 M. Activity was higher (135% of control level) when 20 to 80 mM Mg2+ was present. The Km for the enzyme was 0.25 mM. The D-alanine carboxypeptidase was inhibited by several beta-lactam antibiotics and the 50% inhibitory levels were 10(-8) M penicillin G, 10(-8) M ampicillin, 10(-5) M cloxacillin, and 5 x 10(-7) M methicillin. Davis R H RH Salton M R MR eng Journal Article United States Infect Immun 0246127 0019-9567 EC 3.4.- Carboxypeptidases EC 3.4.17.8 Muramoylpentapeptide Carboxypeptidase Q42T66VG0C Penicillin G IM Carboxypeptidases analysis antagonists & inhibitors Cell Membrane analysis Hydrogen-Ion Concentration Kinetics Muramoylpentapeptide Carboxypeptidase analysis Neisseria gonorrhoeae enzymology Penicillin G pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 332 PMC415398 10.1128/IAI.12.5.1065-1069.1975 Antimicrob Agents Chemother. 1974 Jul;6(1):22-8 15828166 Ann N Y Acad Sci. 1974 May 10;235(0):236-68 4528051 Prog Nucleic Acid Res Mol Biol. 1973;13:191-248 4633732 Proc Natl Acad Sci U S A. 1966 Mar;55(3):656-63 5329013 Biochim Biophys Acta. 1951 Jul;7(2):177-97 14858403 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Biol Chem. 1973 Oct 10;248(19):6759-66 4200864 J Infect Dis. 1973 Sep;128(3):321-30 4269625 Proc Natl Acad Sci U S A. 1972 Mar;69(3):662-6 4501580 Ann N Y Acad Sci. 1974 May 10;235(0):569-86 4604884 Bacteriol Rev. 1974 Sep;38(3):291-335 4608953 Obstet Gynecol. 1972 Feb;39(2):274-85 4621637 J Bacteriol. 1968 Jun;95(6):2010-3 4970219 J Infect Dis. 1970 Nov;122(5):459-61 4990947 J Bacteriol. 1971 Oct;108(1):20-9 5001198 Arch Biochem Biophys. 1966 Sep 26;116(1):487-515 5961853 Infect Immun. 1975 Jun;11(6):1332-41 806526 Antimicrob Agents Chemother. 1975 Jun;7(6):788-92 808158 333 1976 02 20 2020 07 24 0019-9567 12 5 1975 Nov Infection and immunity Infect Immun Phenomenon of hot-cold hemolysis: chelator-induced lysis of sphingomyelinase-treated erythrocytes. 1104-11 Staphylococcus aureus produces a phospholipase C specific for sphingomyelin (beta-hemolysin). Erythrocytes with approximately 50% sphingomyelin in their membranes, e.g., from sheep, have been shown to have up to 60% of this phospholipid hydrolyzed by this enzyme at 37 C in isotonic buffered saline without hemolysis. Cooling of sphingomyelinase C-treated erythrocytes to 4 C causes complete lysis of the cells, a phenomenon known as hot-cold hemolysis. The addition of ethylenediaminetetraacetate (EDTA) to sheep erythrocytes preincubated with sphingomyelinase C was found to induce rapid hemolysis at 37 C. The treated cells became susceptible to chelator-induced hemolysis and to hot-cold hemolysis simultaneously, and the degree of lysis of both mechanisms increased equally with prolonged preincubation with sphingomyelinase C. Erythrocytes of species not readily susceptible to hot-cold hemolysis were equally insusceptible to chelator-induced lysis. Chelators of the EDTA series were the most effective, whereas chelators more specific for Ca2+, Zn2+, Fe2+, Cu2+, and Mg2+ were without effect. The rate of chelator-induced lysis was dependent on the preincubation period with beta-hemolysin and on the concentration of chelator added. The optimal concentration of EDTA was found to equal the amount of exogenously added Mg2+, a cation necessary for sphingomyelinase C activity. Hypotonicity increased the rate of chelator-induced hemolysis, whereas increasing the osmotic pressure to twice isotonic completely inhibited chelator-induced lysis. The data suggest that exogenously added and/or membrane-bound divalent cations are important for the stability of sphingomyelin-depleted membranes. The phenomenon of hot-cold hemolysis may be a consequence of the temperature dependence of divalent ion stabilization. Smyth C J CJ Möllby R R Wadström T T eng Journal Article United States Infect Immun 0246127 0019-9567 0 Chelating Agents 0 Hemolysin Proteins 0 Phenanthrolines 551W113ZEP 2,2'-Dipyridyl 7A314HQM0I Pentetic Acid 9G34HU7RV0 Edetic Acid EC 3.1.4.- Phosphoric Diester Hydrolases EC 3.1.4.12 Sphingomyelin Phosphodiesterase IM 2,2'-Dipyridyl pharmacology Animals Chelating Agents pharmacology Edetic Acid pharmacology Erythrocytes drug effects Hemolysin Proteins analysis isolation & purification Hemolysis drug effects Humans Osmolar Concentration Pentetic Acid pharmacology Phenanthrolines pharmacology Phosphoric Diester Hydrolases pharmacology Rabbits Sheep Spectrophotometry Sphingomyelin Phosphodiesterase pharmacology Temperature Time Factors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 333 PMC415404 10.1128/IAI.12.5.1104-1111.1975 Chem Pharm Bull (Tokyo). 1973 Jun;21(6):1364-8 4732296 Biochim Biophys Acta. 1973 Apr 25;307(1):74-82 4736381 Chem Pharm Bull (Tokyo). 1974 Feb;22(2):368-74 4845545 Biochim Biophys Acta. 1974 Feb 26;339(1):116-25 4855063 Biochemistry. 1968 Oct;7(10):3682-700 4878704 J Physiol. 1968 Dec;199(2):367-81 4972779 Biochim Biophys Acta. 1972 Feb 11;255(2):696-702 5057940 Experientia. 1972 May 15;28(5):565-6 5064814 J Nucl Med. 1966 Dec;7(12):917-27 5958071 J Gen Microbiol. 1966 Aug;44(2):233-40 5969501 Can J Microbiol. 1967 Apr;13(4):369-76 6034410 Aust J Exp Biol Med Sci. 1954 Jun;32(3):347-52 13208475 J Theor Biol. 1964 Sep;7:360-73 14212282 J Clin Invest. 1965 Mar;44:379-89 14271298 Can J Microbiol. 1965 Jun;11:463-71 14346121 Biochem J. 1950 Sep;47(3):270-9 14800880 Infect Immun. 1971 May;3(5):648-52 16558031 Biochem J. 1941 Nov;35(10-11):1257-69 16747411 Nouv Rev Fr Hematol. 1972 Nov-Dec;12(6):799-813 4268789 Biochim Biophys Acta. 1971 Jul 21;242(1):308-20 4330626 Toxicon. 1973 Feb;11(2):139-47 4351816 Biochim Biophys Acta. 1973 Oct 11;323(2):178-93 4356540 FEBS Lett. 1974 Apr 1;40(2):331-4 4369039 Ann N Y Acad Sci. 1974 Jul 31;236(0):292-306 4371058 J Hyg Epidemiol Microbiol Immunol. 1974;18(3):259-70 4371133 Toxicon. 1974 May;12(3):279-85 4376283 Contrib Microbiol Immunol. 1973;1:298-313 4616788 Ann N Y Acad Sci. 1972 Jun 20;195:75-85 4624660 J Membr Biol. 1972;8(1):1-26 4628383 Toxicon. 1972 Aug;10(5):501-9 4672314 Chem Pharm Bull (Tokyo). 1973 Jan;21(1):171-5 4711510 334 1976 02 20 2020 07 24 0019-9567 12 5 1975 Nov Infection and immunity Infect Immun Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice. 1222-3 Resistance to pneumococcal infection was tested in T-lymphocyte-deficient, nude (nu/nu) mice. Pneumococcal serum opsonizing activity, in vivo phagocytosis of the pneumococcus, and the mean lethal dose for the pneumococcus were all found to be the same in nude mice as in control (+/+) mice. T-lymphocytes do not appear to play a significant role in the host's defense against the pneumococcus. Winkelstein J A JA Swift A J AJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Infect Immun 0246127 0019-9567 0 Opsonin Proteins IM Animals Immunity, Cellular Lethal Dose 50 Mice Mice, Nude Opsonin Proteins analysis Phagocytosis Pneumococcal Infections immunology Streptococcus pneumoniae immunology pathogenicity T-Lymphocytes immunology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 334 PMC415421 10.1128/IAI.12.5.1222-1223.1975 Immunology. 1971 Feb;20(2):247-52 4100989 J Immunol. 1970 Dec;105(6):1581-3 4394909 J Exp Med. 1975 Apr 1;141(4):821-39 1092791 N Engl J Med. 1968 Dec 12;279(24):1295-301 4177112 J Exp Med. 1969 Dec 1;130(6):1209-27 4390899 J Exp Med. 1969 Dec 1;130(6):1229-41 4390900 Nature. 1973 Dec 7;246(5432):350-1 4586319 Nature. 1968 Jan 27;217(5126):370-1 5639157 335 1976 03 01 2018 12 03 0019-9605 17 9 1975 Sep L' Infirmiere canadienne Infirm Can [The women don't know how to talk in Mexico]. 28-9 Wagner M V MV fre Congress A Mexico, les femmes n'ont pas su se parler Canada Infirm Can 0042116 0019-9605 N Child Congresses as Topic Culture Female Human Rights Humans International Cooperation Mexico Prejudice Women 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 335 336 1976 02 09 2019 08 16 0020-5915 49 6 1975 International archives of allergy and applied immunology Int Arch Allergy Appl Immunol In vitro antagonism of the mediators of allergy by a benzopyrano-benzopyran carboxylic acid PR-D-92-EA. 789-95 PR-D-92-EA was tested on isolated guinea pig ileum and rat stomach strips for activity against mediators probably released after allergen antibody union. It antagonized the response produced by histamine, bradykinin, serotonin, prostaglandin E2, prostaglandin F2ALPHA and slow-reacting substance of anaphylaxis (SRS-A). The concentrations which blocked 50% of the response were 150, 145, 92, 70, 47, and 32 mug/ml, respectively. This compound may be useful in the treatment of allergic conditions. Possanza G J GJ Bauen A A Stewart P B PB eng Journal Article Switzerland Int Arch Allergy Appl Immunol 0404561 0020-5915 0 Anti-Inflammatory Agents 0 Benzopyrans 0 Carboxylic Acids 0 Histamine H1 Antagonists 0 Prostaglandins E 0 Prostaglandins F 0 SRS-A 0 Serotonin Antagonists S8TIM42R2W Bradykinin IM Animals Anti-Inflammatory Agents pharmacology Benzopyrans pharmacology Bradykinin antagonists & inhibitors Carboxylic Acids pharmacology Dose-Response Relationship, Drug Guinea Pigs Haplorhini Histamine H1 Antagonists Ileum immunology In Vitro Techniques Lung immunology Muscle Contraction drug effects Prostaglandins E antagonists & inhibitors Prostaglandins F antagonists & inhibitors Rats SRS-A antagonists & inhibitors Serotonin Antagonists Stomach immunology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 336 10.1159/000231463 337 1976 03 01 2019 07 08 0020-7136 16 6 1975 Dec 15 International journal of cancer Int J Cancer Tyrosine aminotransferase induction in normal and tumor-bearing chickens. 897-904 Tyrosine aminotransferase (TAT) induction by glucagon and dexamethasone in the liver of tumor-bearing chickens was studied and compared with induction in healthy animals. The transplantable tumor was caused by inoculation of cells from a cell line induced by MC29 avian leukosis virus. TAT was hardly detectable in tumor tissue of control and dexamethasone-treated chickens, but it was induced by glucagon to levels which were significant although very low when compared to those in host liver or the liver of non-tumor-bearing controls after glucagon treatment. Dexamethasone failed to induce TAT in host liver at 8 A.M. while it significantly indiced TAT in the normal liver at the same time of the day. Similar failure of TAT induction was not detectable when glucagon was used instead of dexamethasone. Furthermore, it was found that diurnal variations in basal and dexamethasone or glucagon-induced TAT levels are considerably mitigated in host liver as compared to those observed in the liver of healthy animals. The possible reasons for these findings are discussed. Horváth I I Arányi P P Náray A A Földes I I Gyuris A A eng Comparative Study Journal Article United States Int J Cancer 0042124 0020-7136 7S5I7G3JQL Dexamethasone 9007-92-5 Glucagon EC 2.6.1.5 Tyrosine Transaminase IM Animals Avian Leukosis Virus Cell Line Chickens Circadian Rhythm Dexamethasone pharmacology Enzyme Induction Glucagon pharmacology Liver enzymology Neoplasm Transplantation Neoplasms, Experimental enzymology etiology Transplantation, Homologous Tyrosine Transaminase biosynthesis 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 337 10.1002/ijc.2910160603 338 1976 03 01 2019 09 02 0020-773X 10 6 1975 The International journal of the addictions Int J Addict A behavior modification training program for staff working with drug addicts. 1073-101 This paper described a Behavior Modification Training Program, emphasizing self-control, for staff working with drug addicts. The program, which is primarily geared toward the training of paraprofessionals, takes place in ten 1-1/2 hour sessions and includes an overview of behavior modification as well as instruction in techniques of relaxation, desensitization, self-image improvement, behavior analysis, behavior control, assertive training, rational thinking, and how to set up and run similar behavior modification training programs for staff and patients. Since this training began at the New Jersey Neuropsychiatric Institute in November 1971, a total of 898 staff members, mostly paraprofessionals working with addicts, alcoholics, mentally ill patients, and inmates, including 53 from our own institution, 576 persons from other facilities in New Jersey, and 269 from facilities in other states, have been trained, while 2,021 patients have been trained in similar programs. Most of this training has been accomplished by paraprofessionals. Preliminary evaluation data have been promising and the response of participants enthusiastic. Cheek F E FE Tomarchio T T Burtle V V Moss H H McConnell D D eng Journal Article United States Int J Addict 0123640 0020-773X UC6VBE7V1Z Methadone IM Allied Health Personnel education Behavior Therapy education Costs and Cost Analysis Curriculum Desensitization, Psychologic education Evaluation Studies as Topic Female Humans Male Methadone therapeutic use New Jersey Professional-Patient Relations Psychological Tests Relaxation Therapy education Self Concept Substance-Related Disorders rehabilitation Teaching Teaching Materials Time Factors 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 338 10.3109/10826087509028362 339 1976 03 01 2019 09 02 0367-8377 7 6 1975 International journal of peptide and protein research Int J Pept Protein Res A kinetic study of the hydrolysis of N-acetyl dehydroalanine methyl ester. 461-6 Hydrolysis rates of N-acetyl dehydroalanine methyl ester (methyl 2-acetamidoacrylate) and related model compounds were measured in aqueous, organic and mixed aqueous media. Adding dimethylsulfoxide (DMSO) to water, retarded hydrolysis of the ester by a factor of 2 to 500, depending on the pH of the medium and concentration of DMSO. Ethanol also slowed hydrolysis, but the effect was not so pronounced. Related studies show that the acetamido group C-N bond of sodium 2-acetamido-acrylate is hydrolyzed only about 1/130 as fast as the ester group C-O bond. Aqueous dimethyl sulfoxide should by a useful medium for synthesis of peptide, amino acid and protein derivatives of N-acetyl dehydroalanine methyl ester. Snow J T JT Finley J W JW Friedman M M eng Journal Article Denmark Int J Pept Protein Res 0330420 0367-8377 0 Acrylates 3K9958V90M Ethanol OF5P57N2ZX Alanine YOW8V9698H Dimethyl Sulfoxide IM Acrylates Alanine analogs & derivatives Chemical Phenomena Chemistry, Physical Dimethyl Sulfoxide Ethanol Hydrogen-Ion Concentration Hydrolysis Kinetics Structure-Activity Relationship Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 339 10.1111/j.1399-3011.1975.tb02466.x 340 1976 03 01 2020 02 25 0020-8167 15 2 1975 Summer International ophthalmology clinics Int Ophthalmol Clin The ophthalmologist's office: planning and practice. Patient traffic flow and use of paramedical personnel. 133-9 In order for the ophthalmologist to achieve the greatest earning power and personal satisfaction, he or she must devise traffic flow techniques that efficiently allow for maximum utilization of all examining areas and paramedical personnel in the office without dehumanizing patients. By delegating as much responsibility as possible to staff, the ophthalmologist will have the opportunity of performing his or her specialized skills to the fullest extent, and therefore will achieve optimal personal gratification. This emotional reward indemnifies the future of private practice, because it can exist only in the presence of a close patient-physician relationship, which is the cornerstone of the private practice of ophthalmology. Byron H M HM eng Journal Article United States Int Ophthalmol Clin 0374731 0020-8167 IM Ophthalmic Assistants Patients Physician Assistants Practice Management, Medical United States 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 340 10.1097/00004397-197501520-00017 Biol Psychiatry. 2000 Apr 15;47(8):699-706 10773176 N Engl J Med. 2001 May 24;344(21):1594-602 11372012 J Am Med Assoc. 1955 Dec 24;159(17):1602-6 13271123 Am J Cardiol. 1960 Apr;5:483-6 13816818 Psychosom Med. 2005 Mar-Apr;67(2):301-13 15784798 Brain. 2008 Apr;131(Pt 4):902-17 17932100 J Pediatr. 2008 Apr;152(4):527-33, 533.e1 18346509 Eur Neuropsychopharmacol. 2008 Jul;18(7):473-85 18495442 Ann N Y Acad Sci. 2009 Mar;1156:198-210 19338509 J Physiol. 2009 Aug 1;587(Pt 15):3869-83 19546163 Philos Ethics Humanit Med. 2009 Dec 03;4:16 19958542 Br J Rheumatol. 1986 Feb;25(1):77-81 2417648 Pain. 1989 Jul;38(1):109-16 2780058 Peptides. 1980 Winter;1(4):387-90 6272242 Clin Pharmacol Ther. 1993 Nov;54(5):578-83 8222500 CMAJ. 1993 Jun 15;148(12):2187-8 8324694 BMJ. 1996 Dec 21-28;313(7072):1624-6 8991013 341 1976 02 19 2017 02 14 0020-7640 21 2 1975 Summer The International journal of social psychiatry Int J Soc Psychiatry Behaviour therapy and personality change. 111-6 Kraft T T eng Case Reports Journal Article England Int J Soc Psychiatry 0374726 0020-7640 IM Adult Anxiety therapy Behavior Therapy Desensitization, Psychologic Female Humans Personality Phobic Disorders therapy 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 341 10.1177/002076407502100205 342 1976 02 09 2019 02 06 0021-0005 13 3 1975 Nov Investigative urology Invest Urol Computer evaluation of the effect of urecholine on the spontaneous activity of smooth muscle from the urinary bladder of the rabbit. 189-95 The spontaneous activity exhibited in vitro by smooth muscle strips from the urinary bladder of the rabbit under the influence of Urecholine in concentrations from 0.3 to 30 muM has been characterized in terms of three parameters: mean tension, frequency of contraction, and contractile deviation, all obtained by computer an alysis. While mean tension and frequency monotonically increased with concentration, the contractile deviation rose to a peak in the vicinity of 3.0 to 6.0 muM and thereafter decreased. At concentrations less than 10 muM the contractile patterns were almost periodic, while at 10 and 30 muM, the patterns became highly erratic. Histologic examination of a limited number of tissues showed longitudinally oriented muscle bundles with multiple anastomosing. Keyser G F GF Boyarsky S S Labay P P eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Invest Urol 0374747 0021-0005 0 Bethanechol Compounds 0 Quaternary Ammonium Compounds IM Animals Bethanechol Compounds pharmacology Computers In Vitro Techniques Male Muscle Contraction drug effects Muscle, Smooth analysis drug effects Quaternary Ammonium Compounds pharmacology Rabbits Urinary Bladder anatomy & histology drug effects 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 342 343 1976 02 19 2018 02 14 0300-5526 5 3-4 1975 Intervirology Intervirology Characteristics of the non-occluded form of a nuclear polyhedrosis virus. 109-21 Non-occluded virions of a nuclear polyhedrosis virus of the alfalfa looper, Autographa californica, found in the medium of cell cultures of infected fall armyworm, Spodopter frugiperda, and in the hemolymph of infected S. frugiperda larvae were partially characterized by biological, chemical and physical methods. Also, the rate of appearance of the virions was studied in cell culture and the host insect to determine maximum virion production. Virions obtained from both sources were heat-sensitive, acid-labile and inactivated by several organic solvents. The non-occluded virions found in the insect cell culture fluid and in the hemolymph were identical, and both were enveloped nucleocapsids. Visualization of the fragilely enveloped nucleocapsid was accomplished only after fixation with glutaraldehyde. Differences between the non-occluded and occluded virions of nuclear polyhedrosis viruses are discussed. Dougherty E M EM Vaughn J L JL Reichelderfer C F CF eng Journal Article Switzerland Intervirology 0364265 0300-5526 0 Acids 0 Ethyl Ethers 0 Phenols 3K9958V90M Ethanol 7V31YC746X Chloroform IM Acids pharmacology Animals Cell Line Chloroform pharmacology Drug Resistance, Microbial Ethanol pharmacology Ethyl Ethers pharmacology Hemolymph microbiology Hot Temperature Hydrogen-Ion Concentration Insect Viruses drug effects growth & development ultrastructure Insecta microbiology Larva microbiology Phenols pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 343 10.1159/000149889 344 1976 02 19 2020 02 25 0300-5526 5 3-4 1975 Intervirology Intervirology Degradation of myxovirus virion RNA by periodate. 150-61 Extensively degraded RNA was isolated from virions of influenza virus which had been oxidized with sodium m-periodate. Similarly, although to a lesser extent, RNA isolated from periodate-treated ribonucleoprotein of influenza virus was also degraded. In contrast, influenza virus RNA, if first freed from other virion components, was not degraded by periodate oxidation. Tannock G A GA Griffith I P IP eng Journal Article Switzerland Intervirology 0364265 0300-5526 0 Phenols 0 RNA, Viral 0 Viral Proteins 10450-60-9 Periodic Acid IM Hydrogen-Ion Concentration Newcastle disease virus metabolism Orthomyxoviridae metabolism Oxidation-Reduction Periodic Acid pharmacology Phenols RNA, Viral metabolism Tobacco Mosaic Virus metabolism Viral Proteins metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 344 10.1159/000149892 Chest. 2001 Nov;120(5):1514-9 11713128 Singapore Med J. 2003 Jan;44(1):8-11 12762557 Trop Doct. 2003 Jul;33(3):154-6 12870601 Clin Pharmacokinet. 2003;42(9):819-50 12882588 Diabetes Care. 2004 May;27(5):1047-53 15111519 J Indian Med Assoc. 2005 Jun;103(6):318, 320, 322 passim 16225157 Southeast Asian J Trop Med Public Health. 2005;36 Suppl 4:213-20 16438212 Int J Tuberc Lung Dis. 2006 Jan;10(1):74-9 16466041 Epidemiol Infect. 2007 Apr;135(3):483-91 16863600 Clin Infect Dis. 2006 Oct 1;43(7):848-54 16941365 BMC Public Health. 2007 Sep 06;7:234 17822539 Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):97-103 17962984 Indian J Med Res. 2007 Nov;126(5):452-8 18160750 PLoS Med. 2008 Jun 10;5(6):e124 18547138 Epidemiol Infect. 2009 Feb;137(2):203-10 18559125 PLoS Med. 2008 Jul 15;5(7):e152 18630984 Scand J Infect Dis. 2008;40(11-12):888-93 18728934 Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):325-30 18830725 Rev Saude Publica. 2008 Oct;42(5):805-12 18833381 Am J Trop Med Hyg. 2009 Apr;80(4):634-9 19346391 Diabetes Care. 2009 Jul;32(7):1327-34 19502545 Tubercle. 1990 Dec;71(4):271-6 2267680 Am Rev Respir Dis. 1982 Jan;125(1):23-7 7039435 Am J Public Health. 1997 Apr;87(4):574-9 9146434 345 1976 02 19 2018 02 14 0300-5526 5 3-4 1975 Intervirology Intervirology Failure of rubella virus to replicate in mosquitos. 216-9 Rubella virus failed to replicate in mosquitoes (Aedes albopictus and Culex fatigans) following parenteral inoculation. The virus demonstrated in mosquitoes tested immediately after inoculation but was not detected in insects sampled 7, 14 and 21 days postinoculation. This experiment provides further evidence that rubella is not an arbovirus, but does not invalidate its classification as a togavirus. Tesh R B RB Rosen L L eng Journal Article Switzerland Intervirology 0364265 0300-5526 IM Aedes microbiology Animals Arboviruses classification Culex microbiology Culicidae microbiology Rubella virus classification growth & development Virus Replication 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 345 10.1159/000149898 346 1976 02 19 2016 12 03 0021-2180 11 10 1975 Oct Israel journal of medical sciences Isr J Med Sci Treatment of severe hypertension with minoxidil. 991-8 Minoxidil in daily doses of 6 to 40 mg was administered to 11 patients with severe hypertension. Two patients died of causes unrelated to the drug and one patient withdrew from the study. Blood pressure was controlled in the remaining eight subjects, who received the drug for periods ranging from 5 to 40 months. In three patients minoxidil could subsequently be replaced by conventional antihypertensive therapy. Adverse effects of minoxidil included fluid retention (as assessed by edema and plasma volume studies), nonspecific ECG changes, hypertrichosis and conjunctival redness. Concomitant administration of diuretic and beta-adrenergic blocking agents resulted in excellent tolerance of the treatment and high patient compliance. Traub Y M YM Redmond D P DP Rosenfeld J B JB McDonald R H RH Jr Shapiro A P AP eng Journal Article Research Support, U.S. Gov't, P.H.S. Israel Isr J Med Sci 0013105 0021-2180 0 Adrenergic beta-Antagonists 0 Diuretics 0 Pyrimidines 5965120SH1 Minoxidil IM Adrenergic beta-Antagonists therapeutic use Adult Aged Blood Chemical Analysis Blood Pressure Determination Chemical Phenomena Chemistry Diuretics therapeutic use Female Humans Hypertension drug therapy Male Middle Aged Minoxidil adverse effects therapeutic use Pyrimidines therapeutic use 1975 10 1 2001 3 28 10 1 1975 10 1 0 0 ppublish 346 347 1976 02 19 2019 02 06 0017-9078 29 5 1975 Nov Health physics Health Phys The influence of injection route and pH value on the activity ratio of yttrium-90 to strontium-90 in the rat skeleton after 90Sr incorporation. 788-9 Stevenson A F AF eng Journal Article United States Health Phys 2985093R 0017-9078 0 Strontium Radioisotopes 0 Yttrium Radioisotopes IM Animals Bone and Bones analysis Female Hydrogen-Ion Concentration Injections, Intramuscular Injections, Intraperitoneal Injections, Intravenous Injections, Subcutaneous Male Rats Strontium Radioisotopes administration & dosage analysis Yttrium Radioisotopes administration & dosage analysis 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 347 350 1976 02 09 2018 12 03 0017-6192 23 8 1975 Aug HNO HNO [Parotid secretion and its pharmacologically induced variants (author's transl)]. 229-32 The secretion of alpha-amylase and electrolytes by the parotid gland is now well understood and similarities exist in this respect between man and animals. Many modern drugs influence parotid secretion and morphology, and these are discussed. Chilla R R Arold R R ger Journal Article Review Uber Skretionsmechanismen der Ohrspeicheldrüse und deren medikamentöse Beeinflussung Germany HNO 2985099R 0017-6192 0 Adrenergic beta-Antagonists 0 Antihypertensive Agents 0 Dinitrophenols 0 Receptors, Adrenergic 0 Sympathomimetics 3G6A5W338E Caffeine 6M3C89ZY6R Nicotine C137DTR5RG Theophylline E0399OZS9N Cyclic AMP EC 3.2.1.- Amylases IM Adrenergic beta-Antagonists pharmacology Amylases metabolism Animals Antihypertensive Agents adverse effects Caffeine pharmacology Cyclic AMP biosynthesis Dinitrophenols metabolism Humans Nicotine pharmacology Oxidative Phosphorylation Parotid Gland drug effects metabolism Receptors, Adrenergic Sialadenitis prevention & control Sympathomimetics pharmacology Theophylline pharmacology 64 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 350 351 1976 02 09 2019 05 09 0021-8812 41 5 1975 Nov Journal of animal science J Anim Sci Analyses of rumen fluid from "sudden death", lactic acidotic and healthy cattle fed high concentrate ration. 1249-55 Wilson J R JR Bartley E E EE Anthony H D HD Brent B E BE Sapienza D A DA Chapman T E TE Dayton A D AD Milleret R J RJ Frey R A RA Meyer R M RM eng Comparative Study Journal Article United States J Anim Sci 8003002 0021-8812 0 Fatty Acids, Volatile 0 Lactates 820484N8I3 Histamine IM Acidosis etiology metabolism veterinary Animal Feed adverse effects Animals Cattle Cattle Diseases etiology metabolism mortality Death, Sudden veterinary Fatty Acids, Volatile metabolism Female Histamine metabolism Hydrogen-Ion Concentration Lactates metabolism Male Rumen metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 351 10.2527/jas1975.4151249x 348 1976 02 09 2020 02 25 0147-9563 4 4 1975 Jul-Aug Heart & lung : the journal of critical care Heart Lung Medical approach to the hypotensive patient and the patient in shock. 577-87 Jahre J A JA Grace W J WJ Greenbaum D M DM Sarg M J MJ Jr eng Journal Article United States Heart Lung 0330057 0147-9563 0 Adrenergic alpha-Antagonists 0 Anti-Bacterial Agents 0 Autonomic Agents 0 Plasma Substitutes 0 Steroids 3OWL53L36A Mannitol IM Adrenergic alpha-Antagonists therapeutic use Anti-Bacterial Agents therapeutic use Assisted Circulation methods Autonomic Agents therapeutic use Central Venous Pressure Electrocardiography Humans Hypotension therapy Infusions, Parenteral Mannitol therapeutic use Plasma Substitutes therapeutic use Shock drug therapy physiopathology therapy Shock, Cardiogenic therapy Shock, Septic therapy Steroids therapeutic use 1975 7 1 2001 3 28 10 1 1975 7 1 0 0 ppublish 348 Resuscitation. 2004 Feb;60(2):205-12 15036739 Resuscitation. 2004 Dec;63(3):233-49 15582757 Resuscitation. 2005 Jun;65(3):265-77 15919562 Resuscitation. 2007 Mar;72(3):394-403 17161519 Resuscitation. 1997 Apr;34(2):151-83 9141159 349 1976 02 13 2010 11 18 0147-9563 4 6 1975 Nov-Dec Heart & lung : the journal of critical care Heart Lung Acute renal failure. 873-8 Acute renal failure is a life-threatening situation for which satisfactory treatment is currently available. Death is usually related to concomitant infection rather than uremia. Prompt recognition and treatment of underlying factors that predispose to renal insufficiency can frequently prevent the development of intrinsic acute renal failure. Freedman P P Smith E C EC eng Journal Article United States Heart Lung 0330057 0147-9563 IM Acute Kidney Injury etiology metabolism therapy Adolescent Adult Aged Child Humans Hydrogen-Ion Concentration Kidney physiopathology Middle Aged 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 349 352 1976 02 09 2019 05 09 0021-8812 41 5 1975 Nov Journal of animal science J Anim Sci Mitochondrial traits of muscle from stress-susceptible pigs. 1314-7 Campion D R DR Olson J C JC Topel D G DG Christian L L LL Kuhlers D L DL eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Anim Sci 8003002 0021-8812 61D2G4IYVH Adenosine Diphosphate IM Adenosine Diphosphate metabolism Animals Hydrogen-Ion Concentration Mitochondria, Muscle metabolism Oxygen Consumption Stress, Physiological metabolism veterinary Swine Swine Diseases metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 352 10.2527/jas1975.4151314x 353 1976 02 09 2020 02 25 0021-8987 39 4 1975 Oct Journal of applied physiology J Appl Physiol Local control of pulmonary resistance and lung compliance in the canine lung. 580-9 Local control of pulmonary resistance and lung compliance was studied in the in situ left lower lobe of the canine lung. Recirculation of blood through the lobe while the Pco2 of the ventilatory gas was varied resulted in an increase in resistance and a decrease in compliance only when the pulmonary venous pH was greater than 7.42. Alternating sodium bicarbonate and lactic acid infusion while alveolar Pco2 was maintained below 5 mmHg demonstrated the dependence of the hypocapnic response on the acid-base status of the blood perfusing the respiratory airways. The increase in resistance and decrease in compliance observed at a pulmonary venous pH of 7.64 was comparable to that observed after lobar pulmonary artery occlusion. Varying degrees of hypoxia did not significantly affect bronchomotor tone, nor was the bronchoconstriction following lobar pulmonary artery occlusion affected by the hypoxia. Vagal stimulation superimposed on a stepwise increase in pulmonary venous pH from 7.32 to 7.62 resulted in an increase in resistance which paralleled the increase in resistance when pulmonary venous pH alone was increased. Compliance was not significantly affected by vagal stimulation at any level of pulmonary venous pH. Coon R L RL Rattenborg C C CC Kampine J P JP eng Journal Article United States J Appl Physiol 0376576 0021-8987 0 Bicarbonates 0 Lactates 142M471B3J Carbon Dioxide IM Airway Resistance Animals Bicarbonates pharmacology Bronchi physiology Carbon Dioxide blood Constriction Dogs Hydrogen-Ion Concentration Lactates pharmacology Lung Compliance Muscle, Smooth physiology Pulmonary Circulation Vagus Nerve physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 353 10.1152/jappl.1975.39.4.580 J Clin Microbiol. 2000 Mar;38(3):1203-8 10699023 Science. 2005 Jan 14;307(5707):223-7 15591164 Lancet. 2006 Sep 16;368(9540):1012-21 16980117 N Engl J Med. 2006 Oct 12;355(15):1539-50 17035648 Lancet. 2006 Nov 4;368(9547):1575-80 17084757 Chest. 2008 Jul;134(1):187-92 18628223 Antimicrob Agents Chemother. 2009 Mar;53(3):849-62 19075046 Lancet. 2009 Apr 4;373(9670):1183-9 19345831 J Immunol. 2009 May 1;182(9):5865-72 19380835 Lancet. 2010 May 29;375(9729):1920-37 20488517 Lancet Infect Dis. 2010 Oct;10(10):688-98 20813587 N Engl J Med. 2010 Sep 9;363(11):1005-15 20825313 Sci Transl Med. 2011 Feb 23;3(71):71ps6 21346167 354 1976 02 09 2017 03 22 0004-5756 58 6 1975 Nov Journal - Association of Official Analytical Chemists J Assoc Off Anal Chem Analysis of pesticides by chemical derivatization. I. a new procedure for the formation of 2-chloroethyl esters of ten herbicidal acids. 1294-1301 A new esterification procedure was developed to form 2-chloroethyl esters for 10 common herbicidal acids, using dicyclohexyl carbodiimide and 2-chloroethanol. This reagent was found to be more desirable than the commonly used boron trichloride/2-chloroethanol reagent. Maximum esterification was given for picloram at a lower reaction temperature with a shorter reaction time. Also, maximum esterification of dicamba and 2,3,6-TBA was achieved. The boron trichloride/2-chlorethanol gave poor or little esterification with these 2 acids under the various conditions investigated. The effect of solvents on esterification with the 2 reagents was also explored. Chau A S AS Terry K K eng Journal Article United States J Assoc Off Anal Chem 7505559 0004-5756 0 Esters 0 Herbicides 0 Indicators and Reagents 0 Solvents 0 Water Pollutants, Chemical IM Chemical Phenomena Chemistry Esters analysis Herbicides analysis Hydrogen-Ion Concentration Indicators and Reagents Solvents Temperature Water Pollutants, Chemical analysis 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 354 355 1976 02 21 2013 11 21 0004-5772 23 8 1975 Aug The Journal of the Association of Physicians of India J Assoc Physicians India Irreversible drug induced parkinsonism (two case reports). 529-30 Sahoo R N RN Mitra G C GC Mohanty P C PC eng Case Reports Journal Article India J Assoc Physicians India 7505585 0004-5772 0 Phenothiazines 214IZI85K3 Trifluoperazine YHP6YLT61T Prochlorperazine IM Adult Humans Male Middle Aged Parkinson Disease, Secondary chemically induced Phenothiazines adverse effects Prochlorperazine adverse effects Trifluoperazine adverse effects 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 355 356 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Inactivation of citrate lyase from Rhodopseudomonas gelatinosa by a specific deacetylase and inhibition of this inactivation by L-(+1-glutamate. 1052-61 A previously unrecognized enzyme, citrate lyase deacetylase, has been purified about 140-fold from cell extracts of Rhodopseudomonas gelatinosa. It catalyzed the conversion of enzymatically active acetyl-S-citrate lyase into the inactive HS-form and acetate. The enzyme exhibited an optimal rate of inactivation at pH 8.1. Because of the instability of acetyl-S-citrate lyase at acidic and alkaline pH values, all assays were carried out at pH 7.2, where the spontaneous hydrolysis of the acetyl-S-citrate lyase was negligible and deacetylase showed 70% of the activity at pH 8.1. The apparent Km value for citrate lyase was 10(-7) M at pH 7.2 and 30 C. The activity of the deacetylase was restricted to the citrate lyase from R. gelatinosa. The corresponding lyases from Enterobacter aerogenes (formerly Klebsiella aerogenes) and Streptococcus diacetilactis were not deacetylated; likewise, thioesters such as acetyl-S coenzyme A, acetoacetyl-S coenzyme A, and N-acetyl-S-acetyl-cysteamine were also not hydrolyzed. Citrate lyase deacetylase was present in very small amounts in cells of R. gelatinosa grown with acetate or succinate; it was induced by citrate along with the citrate lyase. L-(+)-Glutamate strongly inhibited the deacetylase. Fifty percent inhibition was obtained at a concentration of 1.4 X 10(-4) L-(+)-glutamate. D-(-)-Glutamate, alpha-ketoglutarate, L-alpha-hydroxyglutarate, L-(-)-proline, and other metabolites were less effective. Giffhorn F F Gottschalk G G eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Acetates 0 Citrates 0 Glutamates 0 Malates 0 Succinates EC 3.1.1.6 Acetylesterase EC 3.1.2.- Thiolester Hydrolases EC 3.1.2.- citrate (pro-3S)-lyase deacetylase EC 4.1.3.- Oxo-Acid-Lyases IM Acetates metabolism Acetylesterase metabolism Citrates metabolism Enzyme Induction Enzyme Repression Glutamates pharmacology Hydrogen-Ion Concentration Malates metabolism Oxo-Acid-Lyases metabolism Rhodopseudomonas enzymology metabolism Stereoisomerism Succinates metabolism Thiolester Hydrolases 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 356 PMC236005 10.1128/JB.124.3.1052-1061.1975 J Bacteriol. 1975 Dec;124(3):1046-51 1194229 J Biol Chem. 1971 Nov;246(21):6511-21 4257200 Eur J Biochem. 1968 Apr 3;4(2):190-2 4871903 Anal Biochem. 1966 Dec;17(3):369-76 5965976 Arch Microbiol. 1975;102(2):111-6 1115558 Arch Biochem Biophys. 1959 May;82(1):70-7 13650640 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Arch Microbiol. 1974;100(4):307-28 4141604 Proc Natl Acad Sci U S A. 1974 May;71(5):1987-91 4365579 Biochem Biophys Res Commun. 1974 Aug 19;59(4):1211-8 4414837 Eur J Biochem. 1973 Aug 17;37(2):295-304 4745732 J Gen Microbiol. 1970 Dec;64(2):171-85 4995906 Hoppe Seylers Z Physiol Chem. 1971 Sep;352(9):1195-205 5096065 Arch Biochem Biophys. 1971 Nov;147(1):262-9 5114933 357 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Novel type of murein transglycosylase in Escherichia coli. 1067-76 The purification and properties of a novel type of murein transglycosylase from Escherichia coli are described. The purified enzyme appears as a single band on sodium dodecyl sulfate-polyacrylamide gels and has an apparent molecular weight of approximately 65,000 as estimated by gel filtration and gel electrophoresis. It degrades pure murein sacculi from E. coli almost completely into low-molecular-weight products. The two prominent muropeptide fragments in the digest are the disaccharide-tripeptide N-acetylglucosamine-N-acetylmuramic acid-L-alanine-D-iso-glutamic acid-meso-diaminopimelic acid and the corresponding disaccharide-tetrapeptide N-acetylglucosamine-N-acetylmuramic acid-L-alanine-D-iso-glutamic acid-meso-diaminopimelic acid-D-alanine. The unique feature of these compounds is that the disaccharide has no reducing end group and that the muramic acid residue possesses an internal 1 leads to 6 anhydro linkage. The new lytic enzyme is designated as a murein: murein transglycosylase. Its possible role in the rearrangement of murein during cell growth and division is discussed. Höltje J V JV Mirelman D D Sharon N N Schwarz U U eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Hydroxyapatites 0 Peptidoglycan EC 2.- Transferases EC 2.4.- Glycosyltransferases EC 2.4.99.- murein transglycosylase I38ZP9992A Magnesium SU46BAM238 Ammonium Sulfate IM Ammonium Sulfate Cell-Free System Chemical Precipitation Chromatography Chromatography, DEAE-Cellulose Escherichia coli enzymology Glycosyltransferases Hydrogen-Ion Concentration Hydroxyapatites Magnesium pharmacology Molecular Weight Peptide Biosynthesis Peptidoglycan metabolism Transferases isolation & purification metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 357 PMC236007 10.1128/JB.124.3.1067-1076.1975 Z Naturforsch B. 1963 Dec;18:1060-2 14117578 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Eur J Biochem. 1970 Apr;13(2):336-46 4245367 Bacteriol Rev. 1972 Dec;36(4):407-77 4568761 J Biol Chem. 1956 Jan;218(1):97-106 13278318 Biochim Biophys Acta. 1961 Jan 1;46:68-80 13738039 Z Naturforsch B. 1963 Nov;18:950-6 14101871 Adv Enzymol Relat Areas Mol Biol. 1964;26:193-232 14150645 J Biol Chem. 1964 Jul;239:PC2398-9 14209975 J Biol Chem. 1960 Jan;235:1-5 14445588 J Biol Chem. 1949 Nov;181(1):149-51 15390401 Biochem J. 1964 May;91(2):222-33 4158310 Eur J Biochem. 1974 Jan 3;41(1):203-8 4205935 Anal Biochem. 1973 Sep;55(1):72-84 4356653 FEBS Lett. 1974 Apr 1;40(2):261-4 4368528 Nature. 1972 Feb 25;235(5339):426-9 4553687 J Mol Biol. 1973 Jun 25;78(1):185-95 4581291 Ann N Y Acad Sci. 1974 May 10;235(0):294-9 4604883 J Mol Biol. 1969 May 14;41(3):419-29 4896021 Biochemistry. 1969 Jan;8(1):213-22 5777325 J Biol Chem. 1969 Aug 25;244(16):4406-12 5806584 358 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Formation and cleavage of 2-keto-3-deoxygluconate by 2-keto-3-deoxygluconate aldolase of Aspergillus niger. 1128-31 2-Keto-3-deoxygluconate aldolase of Aspergillus niger, an enzyme that has not been reported previously, was purified 468-fold. Maximal activity was obtained at pH 8.0 and 50 C. The enzyme exhibited relative stereochemical specificity with respect to glyceraldehyde. The Km values for 2-keto-3-deoxygluconate, glyceraldehyde, and pyruvate were 10, 13.3, and 3.0 mM, respectively. The effects of some compounds and inhibitors on enzyme activity were examined. Stability of the enzyme under different conditions was investigated. The equilibrium constant was about 0.33 X 10(-3) M. Allam A M AM Hassan M M MM Elzainy T A TA eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Cyanides 0 Gluconates 0 Iodoacetates 0 Metals 0 Sulfhydryl Compounds 9G34HU7RV0 Edetic Acid EC 4.1.2.- 2-keto-3-deoxygluconate aldolase EC 4.1.2.- Aldehyde-Lyases FXS1BY2PGL Mercury IM Aldehyde-Lyases isolation & purification metabolism Aspergillus enzymology Aspergillus niger enzymology metabolism Cyanides pharmacology Drug Stability Edetic Acid pharmacology Enzyme Induction Gluconates biosynthesis Hydrogen-Ion Concentration Iodoacetates pharmacology Mercury pharmacology Metals pharmacology Sulfhydryl Compounds pharmacology Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 358 PMC236016 10.1128/JB.124.3.1128-1131.1975 J Biol Chem. 1964 Oct;239:3511-4 14245410 J Biol Chem. 1964 Oct;239:3515-8 14245411 J Bacteriol. 1973 Apr;114(1):457-9 4698214 J Biol Chem. 1972 Apr 10;247(7):2238-41 5016652 Arch Mikrobiol. 1969;69(2):160-70 5383859 359 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Chemotaxis of a motile Streptococcus toward sugars and amino acids. 1142-7 A motile Streptococcus was isolated and its chemotactic behavior toward sugars and amino acids was studied. Motility was optimal in the presence of an exogenous energy source and a nonionic detergent, e.g., Tween 80 or Brij-36. Both glucose and pyruvate could serve as energy source. Chemotaxis toward leucine was optimal at pH 7 to 8.5 and a temperature between 30 and 37 C. The Streptococcus showed a chemotactic response toward a variety of sugars. All commonly occurring L-amino acids, except alanine, asparagine, aspartate, glutamate, arginine, and lysine, were attractants. From concentration response curves the thresholds, peak concentrations, and optimal responses were determined. van der Drift C C Duiverman J J Bexkens H H Krijnen A A eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Amino Acids 0 Carbohydrates 0 Pyruvates 0 Surface-Active Agents GMW67QNF9C Leucine IY9XDZ35W2 Glucose IM Amino Acids pharmacology Carbohydrates pharmacology Chemotaxis drug effects Glucose metabolism Hydrogen-Ion Concentration Leucine pharmacology Pyruvates metabolism Streptococcus cytology metabolism Surface-Active Agents pharmacology Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 359 PMC236019 10.1128/JB.124.3.1142-1147.1975 Acta Pathol Microbiol Scand. 1957;41(5):403-10 13497684 J Bacteriol. 1960 Nov;80:714-8 13758910 Can J Microbiol. 1959 Aug;5:351-4 14403832 Arch Mikrobiol. 1974 Mar 4;96(2):83-92 4209482 J Gen Microbiol. 1967 Oct;49(1):67-80 4294246 J Bacteriol. 1974 Feb;117(2):517-26 4359648 Anal Biochem. 1972 Mar;46(1):164-72 4552878 Biochem Biophys Res Commun. 1972 Sep 26;48(6):1348-53 4562155 J Bacteriol. 1972 Oct;112(1):315-26 4562400 J Bacteriol. 1973 Sep;115(3):824-47 4580570 J Bacteriol. 1974 May;118(2):560-76 4597449 Proc Natl Acad Sci U S A. 1974 Apr;71(4):1239-43 4598295 J Gen Microbiol. 1973 Jan;74(1):77-91 4632978 Science. 1969 Dec 26;166(3913):1588-97 4902679 J Gen Microbiol. 1967 Feb;46(2):175-84 4961758 360 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Phospholipase D activity of gram-negative bacteria. 1148-52 A phospholipase hydrolyzing cardiolipin to phosphatidic acid and phosphatidyl glycerol was characterized in gram-negative bacteria but was absent in preparations of gram-positive bacteria, Saccharomyces cerevisiae, and rat liver mitochondria. In cell-free extracts of Escherichia coli, Salmonella typhimurium, Proteus vulgaris, and Pseudomonase aeruginosa, this cardiolipin-hydrolyzing enzyme had similar pH and Mg2+ requirements and displayed a specificity which excluded phosphatidyl glycerol and phosphatidyl ethanolamine as substrates. Cole R R Proulx P P eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Cardiolipins 0 Phosphatidic Acids 0 Phosphatidylglycerols EC 3.1.- Phospholipases I38ZP9992A Magnesium IM Animals Bacillus cereus enzymology Bacillus subtilis enzymology Cardiolipins metabolism Cell-Free System Escherichia coli enzymology Gram-Negative Aerobic Bacteria enzymology Gram-Negative Anaerobic Bacteria enzymology Hydrogen-Ion Concentration Hydrolysis Magnesium pharmacology Mitochondria, Liver enzymology Phosphatidic Acids biosynthesis Phosphatidylglycerols biosynthesis Phospholipases metabolism Proteus vulgaris enzymology Pseudomonas aeruginosa enzymology Rats Saccharomyces cerevisiae enzymology Salmonella typhimurium enzymology Species Specificity Staphylococcus aureus enzymology 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 360 PMC236020 10.1128/JB.124.3.1148-1152.1975 J Bacteriol. 1971 Dec;108(3):1065-71 5139531 Adv Lipid Res. 1964;2:91-125 5334818 Biochim Biophys Acta. 1975 Mar 24;380(3):414-20 1095058 J Biol Chem. 1959 Mar;234(3):466-8 13641241 Can J Biochem Physiol. 1959 Aug;37(8):911-7 13671378 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Biochim Biophys Acta. 1974 Mar 28;337(3):325-32 4208971 Biochem J. 1969 Mar;112(1):91-108 4304512 J Gen Microbiol. 1970 Feb;60(2):251-7 4321178 J Bacteriol. 1970 Nov;104(2):712-8 4321331 Biochim Biophys Acta. 1972 Feb 14;265(1):25-60 4552305 Biochim Biophys Acta. 1972 Apr 18;260(4):558-70 4554951 J Lipid Res. 1967 Sep;8(5):447-55 4860577 J Bacteriol. 1968 Jun;95(6):2054-61 4876126 Biochim Biophys Acta. 1969;187(2):214-20 4898381 Bull Soc Chim Biol (Paris). 1968 Dec;50(9):1455-71 4974369 C R Acad Sci Hebd Seances Acad Sci D. 1970 Feb 9;270(6):882-5 4984958 J Bacteriol. 1971 Sep;107(3):790-7 4999416 J Bacteriol. 1972 Feb;109(2):820-6 5058454 361 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Pyridine nucleotide-linked oxidation of methanol in methanol-assimilating yeasts. 1165-7 An alcohol dehydrogenase linked to nicotinamide adenine dinucleotide and requiring glutathione has been isolated and partially purified from two methanol-assimilating yeasts. It differs from previously described methanol-oxidizing enzymes in pH optima, electron acceptor specificity, substrate specificity, inhibition pattern, and stability. Mehta R J RJ eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Chloromercuribenzoates 0 Metals 0U46U6E8UK NAD EC 1.1.- Alcohol Oxidoreductases GAN16C9B8O Glutathione Y4S76JWI15 Methanol ZRH8M27S79 Iodoacetamide IM Alcohol Oxidoreductases isolation & purification metabolism Ascomycota metabolism Candida enzymology metabolism Cell-Free System Chloromercuribenzoates pharmacology Drug Stability Glutathione metabolism Hydrogen-Ion Concentration Iodoacetamide pharmacology Metals pharmacology Methanol metabolism NAD metabolism Oxidation-Reduction Pichia enzymology metabolism Species Specificity 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 361 PMC236023 10.1128/JB.124.3.1165-1167.1975 Experientia. 1975 Apr 15;31(4):407-8 164367 Biochem J. 1964 Nov;93(2):281-90 4284499 Eur J Biochem. 1973 Jul 2;36(1):250-6 4354620 Antonie Van Leeuwenhoek. 1973;39(2):303-12 4541604 Biochem J. 1965 Sep;96(3):808-12 5862419 362 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Expression of the hut operons of Salmonella typhimurium in Klebsiella aerogenes and in Escherichia coli. 1263-8 The normal hut (histidine utilization) operons, as well as those with mutations affecting the regulation of their expression, of Salmonella typhimurium were introduced on an F' episome into cells of S. typhimurium and Klebsiella aerogenes whose chromosomal hut genes had been deleted and into cells of Escherichia coli, whose chromosome does not carry hut genes. The episomal hut operons respond in a manner very similar to induction and catabolite repression in all three organisms. The small differences found reflect both different abilities to take up inducers from the medium and different degrees of catabolite repression exerted by glucose. Parada J L JL Magasanik B B eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Propionates 4QD397987E Histidine 816-90-0 Formiminoglutamic Acid E0399OZS9N Cyclic AMP EC 3.- Hydrolases EC 3.5.- Amidohydrolases EC 4.2.1.49 Urocanate Hydratase EC 4.3.1.3 Histidine Ammonia-Lyase IY9XDZ35W2 Glucose IM Amidohydrolases biosynthesis Cell-Free System Cyclic AMP pharmacology Enterobacter enzymology metabolism Enterobacteriaceae metabolism Enzyme Induction Enzyme Repression Escherichia coli enzymology metabolism Formiminoglutamic Acid Genes Glucose pharmacology Histidine metabolism Histidine Ammonia-Lyase biosynthesis Hydrolases biosynthesis Operon Plasmids Propionates Salmonella typhimurium enzymology metabolism Species Specificity Urocanate Hydratase biosynthesis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 362 PMC236036 10.1128/JB.124.3.1263-1268.1975 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Bacteriol. 1975 Jun;122(3):1025-31 238937 J Biol Chem. 1969 Nov 10;244(21):5828-35 4310825 J Biol Chem. 1971 Oct 25;246(20):6288-96 4331387 Proc Natl Acad Sci U S A. 1973 Mar;70(3):808-12 4577136 J Biol Chem. 1969 Oct 10;244(19):5392-402 4899018 J Biol Chem. 1971 May 25;246(10):3320-9 4930059 J Biol Chem. 1971 May 25;246(10):3330-41 4930060 Proc Natl Acad Sci U S A. 1971 Jul;68(7):1493-7 4934521 J Biol Chem. 1970 Jul 25;245(14):3536-44 4990470 J Biol Chem. 1970 Jul 25;245(14):3545-8 4990471 363 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Regulation of the hut operons of Salmonella typhimurium and Klebsiella aerogenes by the heterologous hut repressors. 1269-72 In merodiploid strains of Klebsiella aerogenes with chromosomal hut genes of K. aerogenes and episomal hut genes of Salmonella typhimurium, the repressor of either species can regulate the hut operons of the other species. The repression exerted by the homologous repressor on the left-hand hut operon is, in both organisms, stronger than that exerted by the heterologous repressor. Gerson S L SL Magasanik B B eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 4QD397987E Histidine 816-90-0 Formiminoglutamic Acid EC 3.- Hydrolases EC 4.2.1.49 Urocanate Hydratase EC 4.3.1.3 Histidine Ammonia-Lyase IM Cell-Free System Chromosomes, Bacterial Enterobacter enzymology metabolism Enterobacteriaceae metabolism Enzyme Repression Formiminoglutamic Acid Genes, Regulator Histidine metabolism Histidine Ammonia-Lyase metabolism Hydrolases metabolism Mutation Operon Plasmids Salmonella typhimurium enzymology metabolism Urocanate Hydratase metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 363 PMC236037 10.1128/JB.124.3.1269-1272.1975 J Bacteriol. 1975 Feb;121(2):583-93 234417 J Bacteriol. 1975 Jun;122(3):1025-31 238937 J Bacteriol. 1975 Dec;124(3):1263-8 362 J Biol Chem. 1971 Oct 25;246(20):6288-96 4331387 J Biol Chem. 1969 Oct 10;244(19):5392-402 4899018 J Biol Chem. 1971 May 25;246(10):3320-9 4930059 Proc Natl Acad Sci U S A. 1971 Jul;68(7):1493-7 4934521 364 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Transport of molybdate by Clostridium pasteurianum. 1295-1301 The transport of 99MoO42- into dinitrogen-fixing cells of Clostridium pasteurianum was investigated. Transport of molybdate in this organism is energy dependent; sucrose is required in the minimal media, and the system is inhibited by the glycolysis inhibitors, NaF, iodoacetic acid, and arsenate. The cells accumulate molybdate against a concentration gradient, and the uptake shows a marked dependence on temperature (optimum 37 C) and pH (optimum 6.0). The rate of molybdate uptake with increasing molybdate concentrations shows saturation kinetics with an apparent Km and Vmax of 4.8 X 10(-5) M and 55 nmol/g of dry cells per min, respectively. Inhibition studies with the anions SO42-, S2O32-, WO42-, and VO32- show that SO42- and WO42- competitively inhibit MoO42- uptake (apparent Ki [SO42-] is 3.0 X 10(-5) M; apparent Ki [WO42-] is 2.4 X 10(-5), whereas S2O32- and VO32- have no inhibitory effect. Exchange experiments with MoO42- show that only a small percentage of the 99MoO42- taken up by the cells is exchangeable. Exchange experiments with WO42- and SO42- indicate that once inside the cells WO42- and SO42- cannot substitute for MoO42-. Elliott B B BB Mortenson L E LE eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Arsenates 0 Iodoacetates 0 Pyruvates 0 Sulfates 0 Thiosulfates 00J9J9XKDE Vanadium 57-50-1 Sucrose 81AH48963U Molybdenum Q80VPU408O Fluorides V9306CXO6G Tungsten IM Anaerobiosis Arsenates pharmacology Biological Transport, Active Clostridium metabolism Fluorides pharmacology Hydrogen-Ion Concentration Iodoacetates pharmacology Kinetics Molybdenum metabolism Pyruvates metabolism Sucrose metabolism Sulfates pharmacology Temperature Thiosulfates pharmacology Tungsten pharmacology Vanadium pharmacology 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 364 PMC236041 10.1128/JB.124.3.1295-1301.1975 Proc Natl Acad Sci U S A. 1966 Sep;56(3):979-86 5230193 Proc Natl Acad Sci U S A. 1970 Jul;66(3):1016-23 4393266 Biochem Biophys Res Commun. 1971 Aug 6;44(3):702-10 4107835 FEBS Lett. 1973 Feb 1;29(3):219-221 11946917 Biochem J. 1972 Jul;128(3):655-75 4344006 J Bacteriol. 1972 Apr;110(1):103-9 5018019 Dokl Akad Nauk SSSR. 1974;217(1):228-31 4152421 J Bacteriol. 1974 Jun;118(3):986-9 4598014 J Bacteriol. 1975 Sep;123(3):978-84 1158853 J Biol Chem. 1974 Aug 25;249(16):5046-55 4368926 Biochim Biophys Acta. 1970 Jan 6;196(1):95-106 5412251 Biochim Biophys Acta. 1967 Aug 29;141(3):516-22 6049514 Arch Biochem Biophys. 1957 Aug;70(2):585-90 13459414 365 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol 3-Deoxy-D-arabino-heptulosonic acid 7-phosphate synthase mutants of Salmonella typhimurium. 1312-20 The first committed step of aromatic amino acid biosynthesis in Salmonella typhimurium was shown to be catalyzed by three isoenzymes of 3-deoxy-D-arabino-heptulosonic acid 7-phosphate (DAHP) synthase. Mutations in each of the genes specifying the isoenzymes were isolated and mapped. aroG, the structural gene for the phenylalanine-inhibitable isoenzyme, was linked to gal, and aroH, the structural gene for the tryptophan-inhibitable isoenzyme, was linked to aroE. aroF, the structural gene for the tyrosine-inhibitable isoenzyme, was linked to pheA and tyrA, which specify the phenylalanine- and tyrosine-specific branch-point enzymes, respectively. The phenylalanine-inhibitable isoenzyme was the predominant DAHP synthase in wild-type cells, and only the tryosine-inhibitable isoenzyme was completely repressed, as well as inhibited, by low levels of its allosteric effector. The DAHP synthase isoenzymes were separated by chromatography on diethylaminoethyl-cellulose with a phosphate gradient which contained enolpyruvate phosphate to protect the otherwise unstable phenylalanine-inhibitable isoenzyme. No cross-inhibition of either the tyrosine- or phenylalanine-inhibitable isoenzyme was observed at inhibitor concentrations up to 1 mM. The tryptophan-inhibitable isoenzyme was partially purified from extracts of a strain lacking the other two isoenzymes and shown to be inhibited about 30% by 1 mM tryptophan. A preliminary study of interference by tryptophan in the periodate-thiobarbiturate assay for DAHP suggested a combined effect of tryptophan and erythrose 4-phosphate, or an aldehydic compound resulting from degradation of erythrose 4-phosphate by periodate. DeLeo A B AB Sprinson D B DB eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Isoenzymes 0 Sugar Phosphates 0 Tetroses 42HK56048U Tyrosine 47E5O17Y3R Phenylalanine 50NP6JJ975 Glyoxal 8DUH1N11BX Tryptophan EC 2.5.1.54 3-Deoxy-7-Phosphoheptulonate Synthase EC 4.1.2.- Aldehyde-Lyases IM 3-Deoxy-7-Phosphoheptulonate Synthase biosynthesis isolation & purification metabolism Aldehyde-Lyases biosynthesis Cell-Free System Chromatography, DEAE-Cellulose Chromosome Mapping Genes Glyoxal pharmacology Isoenzymes biosynthesis isolation & purification metabolism Mutation Phenylalanine metabolism Salmonella typhimurium enzymology metabolism Sugar Phosphates pharmacology Tetroses Tryptophan metabolism pharmacology Tyrosine metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 365 PMC236043 10.1128/JB.124.3.1312-1320.1975 J Biol Chem. 1956 Jan;218(1):97-106 13278318 J Biol Chem. 1962 Nov;237:3566-70 13989507 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Biol Chem. 1951 Dec;193(2):481-95 14907737 J Bacteriol. 1973 Sep;115(3):1094-102 4147003 J Bacteriol. 1974 Nov;120(2):590-7 4218228 Hoppe Seylers Z Physiol Chem. 1970 Mar;351(3):373-6 4316056 Biochim Biophys Acta. 1965 Jun 22;99(3):561-3 4378825 J Bacteriol. 1971 Jul;107(1):8-15 4397929 Bacteriol Rev. 1972 Dec;36(4):558-86 4568764 J Biol Chem. 1973 Apr 10;248(7):2344-53 4572729 J Biol Chem. 1967 Nov 25;242(22):5323-8 4863746 Genetics. 1968 Sep;60(1):31-48 4884590 Bacteriol Rev. 1968 Dec;32(4 Pt 2):465-92 4884716 J Bacteriol. 1969 Mar;97(3):1234-41 4887504 Biochim Biophys Acta. 1969 May 27;178(3):588-98 4891421 Biochem Biophys Res Commun. 1969 May 8;35(3):389-95 4892346 J Bacteriol. 1971 Sep;107(3):798-805 4937786 J Bacteriol. 1971 Dec;108(3):1174-80 4945189 Biochim Biophys Acta. 1971 Sep 22;242(3):630-6 5003719 J Bacteriol. 1967 Jan;93(1):237-44 5335890 Biochem Biophys Res Commun. 1967 Jan 23;26(2):187-92 5339942 Hoppe Seylers Z Physiol Chem. 1970 Dec;351(12):1465-74 5497438 366 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Membrane location of a deoxyribonuclease implicated in the genetic transformation of Diplococcus pneumoniae. 1321-9 The cellular localization of enzymes in Diplococcus pneumoniae was examined by fractionation of spheroplasts. A deoxyribonuclease implicated in the entry of deoxyribonucleic acid (DNA) into the cell during genetic transformation was located in the cell membrane. This enzyme, the major endonuclease of the cell (endonuclease I), which is necessary for the conversion of donor DNA to single strands inside the cell and oligonucleotides outside, thus could act at the cell surface. Another enzyme, the cell wall lysin (autolysin), was also found in the membrane fraction. Other enzymes, including amylomaltase, two exonucleases, and adenosine triphosphate-dependent deoxyribonuclease, and a restriction type endonuclease, were located in the cytosol within the cell. None of the enzymes examined were predominantly periplasmic in location. Spheroplasts were obtained spontaneously on incubation of pneumococcal cells in concentrated sugar solutions. The autolytic enzyme appears to be involved in this process. Cells that were physiologically competent to take up DNA formed osmotically sensitive spheroplasts two to three times faster than cells that were not in the competent state. Although some genetically incompetent mutants also formed spheroplasts more slowly, other such mutants formed them at the faster rate. Lacks S S Neuberger M M eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Bacteriol 2985120R 0021-9193 0 DNA, Bacterial EC 2.4.1.- Glucosyltransferases EC 3.1.- Deoxyribonucleases EC 3.1.- Endonucleases EC 3.1.- Exonucleases IM Cell Fractionation Cell Membrane enzymology Cytosol enzymology DNA, Bacterial metabolism Deoxyribonucleases isolation & purification metabolism Endonucleases isolation & purification metabolism Exonucleases isolation & purification Glucosyltransferases isolation & purification Spheroplasts Streptococcus pneumoniae analysis enzymology Subcellular Fractions analysis enzymology Transformation, Genetic 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 366 PMC236044 10.1128/JB.124.3.1321-1329.1975 J Bacteriol. 1974 Sep;119(3):784-94 4212100 Genetics. 1966 Jan;53(1):207-35 4379022 Proc Natl Acad Sci U S A. 1966 Jan;55(1):58-66 4380138 J Biol Chem. 1967 Jul 10;242(13):3108-20 4381878 Genetics. 1968 Dec;60(4):685-706 4389668 J Biol Chem. 1970 Jan 25;245(2):287-98 4391619 J Bacteriol. 1970 Feb;101(2):373-83 4391801 J Bacteriol. 1970 Mar;101(3):860-71 4392399 Biochim Biophys Acta. 1970 Nov 12;224(1):29-41 4395243 J Bacteriol. 1965 Nov;90(5):1355-64 4954555 Biochem Biophys Res Commun. 1965 Sep 8;20(5):555-9 4955462 Anal Biochem. 1970 Feb;33(2):238-43 5439481 J Bacteriol. 1975 Apr;122(1):25-33 804469 Biochim Biophys Acta. 1960 Dec 4;45:155-63 13758095 J Biol Chem. 1963 Jun;238:1928-34 13931034 J Mol Biol. 1962 Jul;5:119-31 14461406 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Bacteriol. 1975 Jan;121(1):344-53 234940 J Biol Chem. 1975 Jun 10;250(11):4060-66 236309 J Bacteriol. 1975 Jul;123(1):222-32 237879 J Bacteriol. 1974 May;118(2):735-46 4133354 J Bacteriol. 1973 Apr;114(1):152-63 4144589 Biochim Biophys Acta. 1973 Apr 11;299(4):545-56 4145314 J Bacteriol. 1974 Feb;117(2):796-804 4149515 Proc Natl Acad Sci U S A. 1974 Jun;71(6):2305-9 4152205 J Bacteriol. 1973 Oct;116(1):154-62 4200840 367 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Regulation of dihydrodipicolinate synthase during growth and sporulation of Bacillus cereus. 1344-50 A four- to sixfold increase in specific activity of dihydrodipicolinic acid synthase was observed during sporulation of Bacillus cereus. The enzyme from cells harvested before and after the increase in specific activity appeared to be very similar as judged by pH optima, heat denaturation kinetics, apparent Michaelis constants, chromatography on diethylaminoethyl-cellulose and Sephadex G-200, and polyacrylamide gel electrophoresis. Studies with various combinations of amino acids and one of the enzyme substrates, pyruvate, failed to give evidence for control of the enzyme by activation, inhibition, repression, induction, or stabilization. Omission of calcium from the sporulation medium had no significant effect on the specific activity pattern of the enzyme as a function of age of culture. Hoganson D A DA Stahly D P DP eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Amino Acids 0 Picolinic Acids 0 Pyruvates EC 4.2.1.- Hydro-Lyases K3Z4F929H6 Lysine SY7Q814VUP Calcium IM Amino Acids metabolism Bacillus cereus enzymology Bacillus subtilis growth & development metabolism Calcium metabolism Cell-Free System Hot Temperature Hydro-Lyases metabolism Hydrogen-Ion Concentration Lysine metabolism Picolinic Acids Pyruvates metabolism Spores, Bacterial enzymology growth & development metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 367 PMC236046 10.1128/JB.124.3.1344-1350.1975 Appl Microbiol. 1968 Oct;16(10):1605 5684208 J Bacteriol. 1975 Dec;124(3):1628-9 811651 J Bacteriol. 1953 Feb;65(2):160-6 13034709 J Bacteriol. 1954 Mar;67(3):295-302 13142994 Science. 1958 Jan 3;127(3288):26-7 13495474 Can J Microbiol. 1960 Apr;6:213-24 13801176 Biochim Biophys Acta. 1963 Jan 8;67:16-30 13941895 Ann N Y Acad Sci. 1964 Dec 28;121:404-27 14240539 J Biol Chem. 1955 Mar;213(1):39-50 14353904 J Bacteriol. 1975 Mar;121(3):970-4 163819 Biochem J. 1964 May;91(2):222-33 4158310 J Biochem. 1974 Sep;76(3):611-21 4215809 Clin Chem. 1966 May;12(5):299-307 4287484 Biochem Biophys Res Commun. 1967 Feb 21;26(4):454-60 4382288 Biochem J. 1972 Feb;126(3):503-13 4627586 Biochim Biophys Acta. 1969 Nov 4;191(2):439-51 4901235 J Biol Chem. 1966 Oct 10;241(19):4563-4 4958818 J Bacteriol. 1968 Dec;96(6):2099-109 4972917 J Bacteriol. 1970 Jan;101(1):118-26 4983642 J Bacteriol. 1971 May;106(2):551-60 4995650 J Biol Chem. 1965 Dec;240(12):4710-6 5321309 368 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol D-Lactate dehydrogenase of Peptostreptococcus elsdenii. 1454-61 D-Lactate dehydrogenase has been purified to near homogeneity from Peptostreptococcus elsdenii. As isolated, the enzyme contains flavine adenine dinucleotide and a tightly bound metal cofactor. Inactivation by ortho-phenanthroline occurs in two steps and is partially blocked by D-lactate. Reactivation by divalent metal ions occurs, with divalent zinc being the most effective. When ferricyanide is used as the electron acceptor, D-lactate has an apparent K0.5 of 3.3 M0.46; its binding is negatively cooperative with a Hill coefficient of 0.46. Replacement of ferricyanide by the other components of the electron transport system yields hyperbolic kinetics with an apparent Km for D-lactate of 26 mM. The apparent Km for ferricyanide is 2.2 X 10(-4) M. Phosphate and pyrophosphate compounds stimulate the D-lactate:ferricyanide activity. These properties suggest that interaction of this enzyme with other electron transport proteins in the chain may enhance D-lactate binding and, hence, the rate of electron transport. Brockman H L HL Wood W A WA eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Ferricyanides 0 Flavoproteins 0 Hydroxybutyrates 0 Lactates 0 Metals 0 Phenanthrolines 0 Phosphates EC 1.1.1.27 L-Lactate Dehydrogenase J41CSQ7QDS Zinc IM Cell-Free System Electron Transport Enzyme Activation Ferricyanides metabolism Flavoproteins metabolism Hydrogen-Ion Concentration Hydroxybutyrates metabolism L-Lactate Dehydrogenase isolation & purification metabolism Lactates metabolism Metals pharmacology Oxidation-Reduction Peptostreptococcus enzymology Phenanthrolines pharmacology Phosphates pharmacology Stereoisomerism Zinc pharmacology 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 368 PMC236060 10.1128/JB.124.3.1454-1461.1975 J Bacteriol. 1956 Nov;72(5):681-9 13376515 Appl Microbiol. 1959 Jan;7(1):16-22 13617940 J Biol Chem. 1964 May;239:1466-73 14189880 Ann N Y Acad Sci. 1964 Dec 28;121:404-27 14240539 Biochem J. 1960 Apr;75:57-65 14423361 J Bacteriol. 1975 Dec;124(3):1447-53 172488 Proc Natl Acad Sci U S A. 1969 Apr;62(4):1121-8 5256410 Biochemistry. 1966 Jan;5(1):365-85 5938952 369 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Purification, new assay, and properties of coenzyme A transferase from Peptostreptococcus elsdenii. 1462-74 Coenzyme A (CoA) transferase from Peptostreptococcus elsdenii has been purified and crystallized, and some of its properties have been established. The work was facilitated by a newly developed coupled and continuous spectrophotometric assay in which the disappearance of added acrylate could be followed at 245 nm. The rate-limiting conversion of acetyl- and beta-hydroxypropionyl CoA to acrylyl CoA by CoA transferase was followed by the non-rate-limiting conversion to beta-hydroxypropionyl CoA by excess crotonase. Thus, a small priming quantity of acetyl CoA served to generate acrylyl CoA, which, by hydration, generated beta-hydroxypropionyl CoA. This product then served to generate more acrylyl CoA in cyclic fashion. The net result was the CoA transferase-limited conversion of acrylate to beta-hydroxypropionate. The purified transferase has a molecular weight of 125,000 and is composed of two subunits of 63,000 each, as determined by disc gel electrophoresis. Short-chain-length monocarboxylic acids are substrates, whereas dicarboxylic or beta-ketocarboxylic acids are not. The reaction kinetics are typical of a ping-pong bi bi mechanism composed of two half reactions linked by a covalent enzyme intermediate. Incubation of the transferase with acetyl CoA in the absence of a fatty acid acceptor yielded a stable intermediate which, by absorption spectrophotometry, radioactivity measurements, reduction with borohydride, reactivity with hydroxylamine, and catalytic activity, was identified as an enzyme-CoA compound. Kinetic constants for CoA transferase are: final specific activity, 110 U/mg of protein corresponding to 1.38 X 10(4) mumol of acrylate activated per mumol of transferase; Km for acrylate, 1.2 X 10(-3) M; Km for acetyl CoA (beta-hydroxypropionyl CoA), 2.4 X 10(-5) M. Tung K K KK Wood W A WA eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Acrylates 0 Amino Acids 0 Carboxylic Acids 0 Crotonates 0 Propionates 72-89-9 Acetyl Coenzyme A EC 2.- Transferases EC 3.- Hydrolases SAA04E81UX Coenzyme A IM Acetyl Coenzyme A metabolism Acrylates metabolism Amino Acids analysis Carboxylic Acids pharmacology Cell-Free System Coenzyme A Crotonates Crystallization Hydrogen-Ion Concentration Hydrolases metabolism Kinetics Molecular Weight Peptostreptococcus enzymology Propionates biosynthesis Transferases analysis isolation & purification metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 369 PMC236061 10.1128/JB.124.3.1462-1474.1975 Ann N Y Acad Sci. 1964 Dec 28;121:404-27 14240539 Biochim Biophys Acta. 1965 Feb 15;97:202-13 14292829 Anal Biochem. 1967 Jul;20(1):150-4 4166536 J Biol Chem. 1968 May 25;243(10):2500-6 4297649 J Biol Chem. 1971 Apr 10;246(7):2069-74 5555561 Arch Biochem Biophys. 1968 Jul;126(1):155-64 5671059 Anal Biochem. 1968 Nov;26(2):295-8 5758045 J Biol Chem. 1969 Feb 10;244(3):1079-81 5769180 Biochemistry. 1969 Feb;8(2):633-40 5793714 J Biol Chem. 1969 Aug 25;244(16):4406-12 5806584 J Biol Chem. 1967 Jan 25;242(2):339-40 6016620 Biochemistry. 1967 Jul;6(7):1948-54 6049437 J Biol Chem. 1953 Jul;203(1):501-12 13069532 Biochem J. 1955 Aug;60(4):683-92 13249967 J Biol Chem. 1956 Feb;218(2):985-1002 13295248 J Biol Chem. 1956 Jul;221(1):15-31 13345795 Biochem J. 1959 Feb;71(2):364-73 13628579 J Biol Chem. 1959 Jul;234(7):1666-71 13672942 J Biol Chem. 1959 Sep;234:2272-80 13840645 J Biol Chem. 1960 Feb;235:346-50 13840646 J Bacteriol. 1964 Jan;87:171-87 14102852 Ann N Y Acad Sci. 1964 Dec 28;121:373-81 14240536 370 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Isolation and purification of Flavobacterium alpha-1,3-glucanase-hydrolyzing, insoluble, sticky glucan of Streptococcus mutans. 1489-501 Studies were made on the physical and chemical properties of polysaccharides synthesized by cell-free extracts of Streptococcus mutans, Streptococcus sanguis, and Streptococcus sp. and their susceptibilities to dextranases. Among the polysaccharides examined, insoluble glucans were rather resistant to available dextranase preparations, and the insoluble, sticky glucan produced by S. mutans OMZ 176, which could be important in formation of dental plaques, was the most resistant. By enrichment culture of soil specimens, using OMZ 176 glucans as the sole carbon source, an organism was isolated that produced colonies surrounded by a clear lytic zone on opaque agar plates containing the OMZ 176 glucan. The organism was identified as a strain of Flavobacterium and named the Ek-14 bacterium. EK-14 bacterium was grown in Trypticase soy broth, and an enzyme capable of hydrolyzing the OMZ 176 glucan was concentrated from the culture supernatant and purified by negative adsorption on a diethylaminoethyl-cellulose (DE-32) column and gradient elution chromatography with a carboxymethyl-cellulose (CM-32) column. The enzyme was a basic protein with an isoelectric point of pH 8.5 and molecular weight of 65,000. Its optimum pH was 6.3 and its optimal temperature was 42 C. The purified enzyme released 11% of the total glucose residues of the OMZ 176 glucan as reducing sugars and solubilized about half of the substrate glucan. The products were found to be isomaltose, nigerose, and nigerotriose, with some oligosaccharides. The purified enzyme split the alpha-1,3-glucan endolytically and was inactive toward glucans containing alpha-1,6, alpha-1,4, beta-1,3, beta-1,4, and/or beta-1,6 bonds as the main linkages. Ebisu S S Kato K K Kotani S S Misaki A A eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Metals 0 Polysaccharides 0 Polysaccharides, Bacterial EC 3.2.1.- Glycoside Hydrolases IM Cell-Free System Dental Plaque metabolism Flavobacterium enzymology Glycoside Hydrolases isolation & purification metabolism Hydrogen-Ion Concentration Hydrolysis Metals pharmacology Molecular Weight Polysaccharides Polysaccharides, Bacterial biosynthesis metabolism Soil Microbiology Solubility Streptococcus metabolism Streptococcus mutans metabolism Streptococcus sanguis metabolism Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 370 PMC236064 10.1128/JB.124.3.1489-1501.1975 Biochim Biophys Acta. 1968 May;158(2):313-5 5654602 J Biol Chem. 1969 Aug 25;244(16):4406-12 5806584 Helv Odontol Acta. 1967 Oct;11(2):131-52 6056776 J Biochem. 1964 Feb;55:205-8 14135466 J Bacteriol. 1965 May;89:1217-24 14292989 Nature. 1950 Sep 9;166(4219):444-5 14775715 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Biol Chem. 1949 Nov;181(1):149-51 15390401 Infect Immun. 1974 Nov;10(5):1135-45 16558101 J Biochem. 1975 Nov;78(5):879-87 1213996 Microbios. 1973 Sep-Oct;8(30):143-50 4359607 Carbohydr Res. 1972 Dec;25(2):443-51 4369741 Carbohydr Res. 1974 Dec;38:374-81 4447949 J Dent Res. 1972 Mar-Apr;51(2):394-402 4501478 Caries Res. 1972;6(2):132-47 4502280 J Dent Res. 1973 Jul-Aug;52(4):658-67 4515843 Infect Immun. 1973 Oct;8(4):555-62 4582634 Infect Immun. 1974 Jul;10(1):189-96 4601768 Biochim Biophys Acta. 1972 Feb 28;258(2):541-7 4622000 Acta Chem Scand. 1972;26(6):2223-30 4635690 Infect Immun. 1974 Jul;10(1):197-203 4842127 Arch Oral Biol. 1967 Jan;12(1):11-23 4960207 Odontol Revy. 1970;21(2):143-52 4992207 Odontol Revy. 1967;18(4):373-86 5234965 Arch Oral Biol. 1968 Oct;13(10):1249-62 5250250 Int Dent J. 1970 Dec;20(4):657-78 5276615 J Biol Chem. 1969 Oct 25;244(20):5460-70 5388595 Helv Odontol Acta. 1970 Nov;14:Suppl 5:89+ 5486279 371 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Production, purification, and characterization of an extracellular chitosanase from Streptomyces. 1574-85 The synthesis by Streptomyces sp. no. 6 of an extracellular chitosanase was induced by glucosamine. The enzyme was purified to homogeneity by Sephadex G-100, carboxymethyl-cellulose, and diethylaminoethyl-cellulose chromatography. The purified enzyme hydrolyzed chitosan (the beta-1,4-linked polymer of glucosamine) but not chitin nor carboxymethyl-cellulose. The only products of the hydrolysis detectable by paper chromatography were di- and triglucosamine. Sephadex G-100 chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated that the molecular weight of the enzyme was between 29,000 and 26,000. Acid hydrolysates of the enzyme contained no cysteic acid or glucosamine or other carbohydrate. At 25 C, maximum activity was obtained between pH 4.5 and 6.5. The enzymatic hydrolysis of chitosan occurred over a wide range of temperatures and was maximal at 60 C. The rate of the reaction was inhibited by concentrations of soluble chitosan higher than 0.5 g/liter. The apparent Km calculated from a Lineweaver-Burke plot was 0.688 g/liter at pH 5.5. The enzyme prevented spore germination and caused a significant decrease in the turbidity of germinated spore suspensions of the Mucor strains tested. Such a decrease was the result of a partial lysis of the cell wall. Price J S JS Storck R R eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Bacteriol 2985120R 0021-9193 0 Amino Sugars 0 Polysaccharides, Bacterial EC 3.2.1.- Glycoside Hydrolases EC 3.2.1.132 chitosanase N08U5BOQ1K Glucosamine IM Amino Sugars metabolism Cell Wall metabolism Cell-Free System Enzyme Induction Glucosamine metabolism Glycoside Hydrolases biosynthesis isolation & purification metabolism Hydrogen-Ion Concentration Hydrolysis Molecular Weight Mucor metabolism Polysaccharides, Bacterial metabolism Spores, Fungal metabolism Streptomyces enzymology metabolism Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 371 PMC236072 10.1128/JB.124.3.1574-1585.1975 Biochim Biophys Acta. 1962 Mar 26;58:102-19 13865457 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Bacteriol. 1974 Nov;120(2):844-53 4218236 Annu Rev Microbiol. 1968;22:87-108 4879523 Biochim Biophys Acta. 1954 Jan;13(1):1-9 13140276 J Bacteriol. 1955 Dec;70(6):641-8 13271308 J Biol Chem. 1959 Dec;234:3263-8 13835291 Methods Biochem Anal. 1955;2:313-58 14393572 Biochim Biophys Acta. 1960 Feb 26;38:212-8 14418725 Nature. 1950 Sep 9;166(4219):444-5 14775715 Arch Biochem. 1950 Jan;25(1):191-200 15401229 Biochem J. 1946;40(5-6):628-32 16748065 Anal Biochem. 1969 Jul;30(1):148-52 4183001 J Bacteriol. 1966 Oct;92(4):1236-44 4288798 Mol Gen Genet. 1974;135(3):273-6 4456224 Nat New Biol. 1973 Sep 19;245(142):78-80 4580792 Antonie Van Leeuwenhoek. 1968;34(2):173-82 5301324 J Biol Chem. 1969 Aug 25;244(16):4406-12 5806584 Biochem J. 1965 Sep;96(3):595-606 5862401 372 1976 02 20 2020 07 24 0021-9193 124 3 1975 Dec Journal of bacteriology J Bacteriol Simple and sensitive procedure for screening yeast mutants that lyse at nonpermissive temperatures. 1604-6 After mutagenesis, surviving yeast cells are grown on plates at 25 C and later exposed to 37 C. The plates are then overlaid with a soft agar containing p-nitrophenylphosphate at pH 9.7. Lysed cells liberate alkaline phosphatase which gives rise to a yellow color on and around colonies. Cabib E E Duran A A eng Journal Article United States J Bacteriol 2985120R 0021-9193 0 Mutagens 0 Nitrophenols 0 Organophosphorus Compounds 9002-18-0 Agar 9H154DI0UP Ethyl Methanesulfonate EC 3.1.3.1 Alkaline Phosphatase IM Agar Alkaline Phosphatase metabolism Ethyl Methanesulfonate Hydrogen-Ion Concentration Mutagens Mutation Nitrophenols Organophosphorus Compounds Saccharomyces cerevisiae enzymology growth & development isolation & purification Temperature 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 372 PMC236077 10.1128/JB.124.3.1604-1606.1975 Biochim Biophys Acta. 1960 Jan 29;37:482-90 13835748 Biochim Biophys Acta. 1963 Feb 12;67:324-6 13932174 Genet Res. 1965 Feb;6:13-26 14301537 Biochem Biophys Res Commun. 1965 Oct 26;21(2):182-6 4159772 373 1976 02 21 2013 11 21 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem A nucleoside triphosphate-dependent deoxyribonuclease from Bacillus laterosporus. Purification and characterization of the enzyme. 105-14 A deoxyribonuclease, which requires nucleoside triphosphate for reaction, has been purified about 150-fold from extracts of Bacillus laterosporus. Potassium phosphate and ethylene glycol stabilize the purified enzyme. The enzyme degrades double-stranded DNA about 100 times faster than heat-denatured DNA in the presence of nucleoside triphosphate. Double-stranded DNA is not degraded to any measurable extent in the absence of ATP, but the enzyme exhibits activity toward denatured DNA in the absence of nucleoside triphosphate, and this activity seems to be an intrinsic property of this enzyme protein. The optimum pH is 8.5 and the maximum activity is obtained in the copresence of Mg2+ (8.0 X 10(-3)M) and Mn2+ (7.0 X 10(-5)M). ATP and dATP are most effective and nucleoside di- or monophosphates are ineffective. ATP is converted to ADP and inorganic phosphate during the reaction and the ratio of the amount of ATP cleaved to that of hydrolyzed phosphodiester bonds of DNA is about 3:1. An inhibitor of the enzyme was observed in bacterial extracts prepared by sonic disruption; the inhibitory substance is produced in the bacteria in the later stages of cell growth. Preliminary results show that the inhibitor emerged near the void volume of a Sephadex G-200 column, and was relatively heat-stable, RNase-resistant, and DNase-sensitive. Anai M M Mihara T T Yamanaka M M Shibata T T Takagi Y Y eng Journal Article England J Biochem 0376600 0021-924X 0 DNA, Bacterial 0 Deoxyribonucleotides 0 Ribonucleotides 42Z2K6ZL8P Manganese 8L70Q75FXE Adenosine Triphosphate EC 3.1.- Deoxyribonucleases I38ZP9992A Magnesium IM Adenosine Triphosphate metabolism Bacillus enzymology DNA, Bacterial metabolism Deoxyribonucleases isolation & purification metabolism Deoxyribonucleotides pharmacology Hot Temperature Hydrogen-Ion Concentration Magnesium pharmacology Manganese pharmacology Ribonucleotides pharmacology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 373 374 1976 02 21 2019 02 06 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Rapid radioimmunoassay for guanosine 3',5'-cyclic monophosphate using tritiated ligand. 131-7 A radioimmunoassay procedure for guanosine 3',5'-cyclic monophosphate (CGMP) is described. The procedure is based on competitive binding between [3H]CGMP and non-radioactive CGMP, with separation of bound and unbound CGMP by Millipore filtration. The binding reaction showed very high specificity to CGMP, had a broad pH optimum, and reached equilibrium within a short time. A simple procedure for the pruification of assay samples using Dowex AG 50W-X2 resin is also described. CGMP contents in urine samples were assayed without purification. Injection of glucagon into healthy human volunteers resulted in a small but significant reduction in urinary CGMP level, whereas CAMP excretion increased dramatically. Fujimoto M M Mihara S S Okabayashi T T Sugase T T Tarui S S eng Journal Article England J Biochem 0376600 0021-924X 0 Salts 10028-17-8 Tritium 86-01-1 Guanosine Triphosphate 9007-92-5 Glucagon E0399OZS9N Cyclic AMP EC 3.1.4.- Phosphoric Diester Hydrolases H2D2X058MU Cyclic GMP IM Animals Binding, Competitive drug effects Cyclic AMP urine Cyclic GMP analysis metabolism urine Glucagon pharmacology Guanosine Triphosphate analysis Humans Hydrogen-Ion Concentration Male Micropore Filters Phosphoric Diester Hydrolases pharmacology Radioimmunoassay methods Rats Salts pharmacology Tritium 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 374 375 1976 02 21 2017 03 22 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem The effect of tryptophan administration on fatty acid synthesis in the livers of rats under various nutritional conditions. 139-47 1. Tryptophan was administered to rats under various nutritional conditions: fasted for 24 hr, fasted and refed with glucose or corn-oil, fasted and administered glycerol intramuscularly, and nonfasted. 2. The changes in the contents of glycolytic intermediates in the livers indicated that the phosphoenolpyruvate carboxykinase [EC 4.1.1.32] reaction is inhibited by tryptophan administration in all groups of rats. The inversely related changes in the contents of malate and phosphoenolpyruvate were associated with the accumulation of quinolinate in the livers. The content of quinolinate which exhibited the half-maximal effect on the contents of both metabolites was 0.1-0.2 mumole per g liver. 3. The rate of incorporation of 3H from 3H2O into the total hepatic fatty acids was increased about 2-fold by the administration of this amino acid to the fasted rats. The enhancement of the rate was closely related to the increase in the citrate content. The hyperlipogenesis was also related to the decrease of acetyl-CoA and the increase of malonyl-CoA. The content of long-chain acyl-CoA was not affected. These effects of tryptophan administration on the hepatic fatty acid metabolism were found in all groups of rats. The liver content of glycerol 3-phosphate was decreased by tryptophan administration was markedly increased by glycerol injection. The injection of glycerol into the control and the tryptophan-treated rats produced a marked increase of glycerol 3-phosphate but did not affect the rate of fatty acid synthesis in the livers of either group. 4. It may be concluded that, in the livers of rats under various nutritional conditions, the short-term control of fatty acid synthesis by tryptophan administration is most likely due to the activation of acetyl-coenzyme A carboxylase [EC 6.4.1.2] by citrate. Miyazawa S S Sakurai T T Shindo Y Y Imura M M Hashimoto T T eng Journal Article England J Biochem 0376600 0021-924X 0 Citrates 0 Fatty Acids 0 Fructosephosphates 0 Glycerophosphates 0 Ketone Bodies 0 Lactates 0 Malates 0 Malonates 0 Quinolinic Acids 72-89-9 Acetyl Coenzyme A 8DUH1N11BX Tryptophan EC 4.1.1.32 Phosphoenolpyruvate Carboxykinase (GTP) EC 6.4.1.2 Acetyl-CoA Carboxylase PDC6A3C0OX Glycerol IM Acetyl Coenzyme A metabolism Acetyl-CoA Carboxylase metabolism Animals Carbohydrate Metabolism Citrates metabolism Enzyme Activation drug effects Fasting Fatty Acids biosynthesis Fructosephosphates metabolism Gluconeogenesis drug effects Glycerol pharmacology Glycerophosphates metabolism Ketone Bodies metabolism Lactates metabolism Liver enzymology metabolism Malates metabolism Male Malonates metabolism Phosphoenolpyruvate Carboxykinase (GTP) metabolism Quinolinic Acids metabolism Rats Tryptophan administration & dosage pharmacology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 375 376 1976 02 21 2020 02 25 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Electrophoretic investigations of the acid conformational change of alpha-lactalbumin. 205-11 In order to clarify how the electrophoretic behavior reflects the conformational transition of globular proteins, moving boundary electrophoresis was applied to analysis of the acid conformational change of alpha-lactalbumin. The appearance of only a single electrophoretic boundary in the transition region of the protein suggests a very rapid transition with a half-time estimated to be smaller than 7 min on the basis of the theory of isomerizing systems in electrophoresis. The transition is clearly reflected in the dependence of the mobility on the protein net charge, which shows a sigmoidal curve closely similar to that obtained by a Linderstrøm-Lang pH-tritration plot for the carboxyl groups of alpha-lactalbumin. It was also concluded from the transition curves that the acidfication does not result in complete unfolding, but that a compact structure is maintained in the acidic region with an apparently expanded form as compared to the native state of the protein. All results obtained by electrophoresis were also supported by the results of pH-jump studies, analytical gel chromatography, and CD measurements. Kuwajima K K Nitta K K Sugai S S eng 090441 Wellcome Trust United Kingdom Journal Article England J Biochem 0376600 0021-924X 0 Myoglobin 9013-90-5 Lactalbumin IM Circular Dichroism Electrophoresis Hydrogen-Ion Concentration Lactalbumin Myoglobin Protein Conformation Time Factors 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 376 Nature. 1999 Nov 25;402(6760 Suppl):B12-7 10586890 J Allergy Clin Immunol. 1999 Dec;104(6):1139-46 10588993 Clin Exp Allergy. 2003 Sep;33(9):1183-9 12956752 Respir Med. 2004 Oct;98 Suppl B:S4-8 15481282 Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001187 15495009 Allergy. 2005 Mar;60(3):309-16 15679715 Allergy. 2006 Oct;61(10):1235 16942576 Allergy. 2007 Aug;62(8):943-8 17620073 J Allergy Clin Immunol. 2007 Dec;120(6):1466-8 17936891 Thorax. 2008 May;63 Suppl 4:iv1-121 18463203 Ther Clin Risk Manag. 2008 Dec;4(6):1255-60 19337432 Cochrane Database Syst Rev. 2010 Aug 04;(8):CD001186 20687065 Cochrane Database Syst Rev. 2010 Dec 08;(12):CD002893 21154351 J Clin Invest. 1997 Mar 1;99(5):879-87 9062345 J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):558-62 9802362 377 1976 02 21 2017 03 22 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Studies on cathepsins of rat liver lysosomes. II. Comparative studies on multiple forms of cathepsin A. 31-9 The multiple forms of cathepsin A (AI, AII, and AIII) purified from the lysosome fraction of rat liver by Sephadex G-200 and DEAE-Sephadex chromatographies were studied comparatively. Forms AI, AII and AIII were stable between pH 3.0 and 5.5, and had pH optima for CBZ-Glu-Phe at 5.6, 5.8, and 5.9, respectively. These activities were rapidly lost on heating above 60 degrees. Their isoelectric points were at 4.7, 4.8, and 4.9, and the Michaelis constants for CBZ-Glu-Phe were calculated as 10, 6.6, and 4.2 X 10(-4)M, respectively. Activity was inhibited by Ag+, Au3+, Hg2+, iodine, and p-chloromercuribenzoate (PCMB). Diisopropyl fluorophosphate (DFP), phenylmethanesulfonyl fluoride (PMSF), toluenesuffonyl fluoride (TSF), and sodium dodecyl sulfate (SDS) were inhibitory at a concentration of 10(-3)M. Soybean trypsin inhibitor, pepstatin, leupeptins, and antipain were not inhibitory, while chymostatin caused slight inhibition. No distinct difference was observed in the effects of these compounds on the multiple forms of cathepsin A despite differences in the molecular weights of these forms (100,000, 200,000, and 420,000, respectively). In immuno-diffusion analysis, cathepsin AI, AII, and AIII which had been treated with EDTA, dithiothreitol, PCMB, and a high concentration of NaCl, gave the same precipitin patterns as the untreated enzymes, but treatment with 6 M urea caused a slight alteration of the pattern. After SDS-treatment (50 mM or more), the precipitin lines of these multiple forms fused and gave a single, identical line. This suggests that the different forms of the cathepsin A are all composed of subunits which are immunologically identical or closely related, and that the subunits are mainly bound by hydrophobic forces. This conclusion is supported by results obtained by poliacrylamide gel electrophoresis in the presence of SDS. Matsuda K K Misaka E E eng Comparative Study Journal Article England J Biochem 0376600 0021-924X 0 Chloromercuribenzoates 0 Isoenzymes 0 Metals 0 Sulfhydryl Reagents 0 Trypsin Inhibitors 12UHW9R67N Isoflurophate 368GB5141J Sodium Dodecyl Sulfate EC 3.4.- Cathepsins IM Animals Cathepsins analysis antagonists & inhibitors metabolism Chloromercuribenzoates pharmacology Hot Temperature Hydrogen-Ion Concentration Isoelectric Point Isoenzymes analysis Isoflurophate pharmacology Liver cytology enzymology Lysosomes enzymology Metals pharmacology Molecular Weight Rats Sodium Dodecyl Sulfate pharmacology Sulfhydryl Reagents pharmacology Trypsin Inhibitors pharmacology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 377 378 1976 02 21 2013 11 21 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Recombination of ciliary dynein of Tetrahymena with the outer fibers. 41-9 Recombination of ciliary dyneins of Tetrahymena pyriformis with the outer fibers was investigated using turbidimetry, co-sedimentation analysis and electron microscopy. As reported by Gibbons, 30S dynein could recombine with the outer fibers, while 14S dynein did to so a lesser extent. At acidic pH, however, most of the 14S dynein was also rebound to the outer fibers. When an excess of crude dynein fraction was added to the outer fiber fraction at pH 8.2, electron microscopic observations showed that the outer doublet microtubules were decorated not only with arms but also with other electron-dense materials. On the other hand, when crude dynein fraction was mixed with the outer fibers in an appropriate quantity, only arms were reconstituted at the regular positions of A-subfibers. ATP had an inhibitory effect on the recombination of dynein with the outer fibers. Shimizu T T eng Journal Article England J Biochem 0376600 0021-924X 8L70Q75FXE Adenosine Triphosphate EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium IM Adenosine Triphosphatases metabolism Adenosine Triphosphate pharmacology Cilia enzymology metabolism ultrastructure Flagella enzymology metabolism ultrastructure Hydrogen-Ion Concentration Magnesium pharmacology Microtubules enzymology metabolism ultrastructure Nephelometry and Turbidimetry Tetrahymena enzymology metabolism ultrastructure 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 378 379 1976 02 21 2019 12 10 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Affinity labeling of D-amino acid oxidase with an acetylenic substrate. 57-63 The acetylenic substrate, D-2-amino-4-pentynoic acid (D-propargylglycine), was oxidatively deaminated by hog kidney D-amino acid oxidase[EC 1.4.3.3], with accompanying inactivation of the enzyme. The flavin which was extracted by hot methanol from the inactivated enzyme was identical with authentic FAD by thin-layer chromatography and circular dichroism. The excitation spectrum of emission at 520 nm of the released flavin was very similar to the absorption spectrum of oxidized FAD. The released flavin was reduced by potassium borohydride. The apoenzyme prepared after propargylglycine treatment did not show restored D-amino acid oxidase activity on adding exogenous FAD. The absorption spectrum of this inactivated apoenzyme showed absorption peaks at 279 and 317 nm, and a shoulder at about 290 nm. These results strongly indicate that the inactivation reaction is a dynamic affinity labeling with D-propargylglycine which produces irreversible inactivation of the enzyme by a covalent modification of an amino acid residue at the active site. Horiike K K Nishina Y Y Miyake Y Y Yamano T T eng Journal Article England J Biochem 0376600 0021-924X 0 Affinity Labels 0 Alkynes 0 Amino Acids 146-14-5 Flavin-Adenine Dinucleotide 64165-64-6 propargylglycine EC 1.11.1.6 Catalase EC 1.4.3.3 D-Amino-Acid Oxidase TE7660XO1C Glycine IM Affinity Labels Alkynes metabolism Amino Acids metabolism Animals Catalase metabolism Circular Dichroism D-Amino-Acid Oxidase metabolism Deamination Enzyme Activation Flavin-Adenine Dinucleotide metabolism Glycine analogs & derivatives Kidney enzymology Oxygen Consumption Swine 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 379 380 1976 02 21 2020 02 25 0021-924X 78 1 1975 Jul Journal of biochemistry J Biochem Studies on trypsin inhibitor in barley. I. Purification and some properties. 9-17 To clarify the properties and functions of a trypsin inhibitor from Japanese barley in comparison with the inhibitor from Pirkka barley, an inhibitor was isolated from the barley Hordeum distichum L var. emend Lamark by extraction with 1% NaCl, ammonium sulfate fractionation and repeated chromatography on DEAE-cellulose and CM-cellulose. The final purified preparation of the inhibitor was found to be homogeneous by both chromatographic and electrophoretic analysis. The inhibitor was thermostable and was stable over the broad pH range from 2 to 11. No inhibition was observed by heavy metal ions and many reagents at 10(-2) M, except that p-chloromercuribenzoate caused a 69% loss of activity. The inhibitor was subjected to isoelectric focusing at pH 7.51 and its molecular weight was calculated to be 14,200+/-900 by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. The apparent dissociation constant for the complex between the inhibitor and trypsin[EC 3.4.21.4] was 1.64 X 10(-7)M with casein as a substrate. One microgram of purified inhibitor inhibited 1.5 mug of pure trypsin in the hydrolysis of alpha-N-benzoyl-DL-arginine-p-nitroanilide. By chemical modification of arginyl residues in the inhibitor with 1,2-cyclohexanedione, the inhibitor was shown to be an arginine inhibitor. The inhibitor contained relatively many basic amino acids and few half cystines as compared with Pirkka barley trypsin inhibitor. Ogiso T T Noda T T Sako Y Y Kato Y Y Aoyama M M eng Comparative Study Journal Article England J Biochem 0376600 0021-924X 0 Amino Acids 0 Chloromercuribenzoates 0 Metals 0 Trypsin Inhibitors IM S Amino Acids analysis Chloromercuribenzoates pharmacology Hordeum analysis Hot Temperature Hydrogen-Ion Concentration Metals pharmacology Molecular Weight Plants analysis Trypsin Inhibitors analysis isolation & purification 76069167 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 380 Semin Hematol. 2002 Apr;39(2):75-81 11957188 Clin Exp Immunol. 2006 Aug;145(2):204-14 16879238 J Allergy Clin Immunol. 2009 Dec;124(6):1161-78 20004777 Clin Med (Lond). 2009 Dec;9(6):595-9 20095309 381 1976 02 09 2013 11 21 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Metabolism of dog gastric mucosa. Nucleotide levels in parietal cells. 8321-9 Adenine and pyridine nucleotide levels as well as those of phosphate, phosphocreatine, lactate, pyruvate, beta-hydroxybutyrate, acetoacetate, glucose, and glycogen were measured in histologically defined parietal and mucous cell sections of biopsies of dog gastric mucosa at rest, and in various secretory states. As a result of stimulation of secretion, there appeared to be no change in adenine nucleotide levels, or phosphocreatine, but there was a rise in inorganic phosphate and a fall in phosphorylation potential. However, there was a marked increase in NADH, but no change in NADPH with onset of acid secretion. The increase in the lactate to pyruvate ratio showed that the increased NADH level occurred in the cytoplasm and these data are discussed with reference to change in cell pH. Sarau H M HM Foley J J Moonsammy G G Wiebelhaus V D VD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Acetates 0 Adenine Nucleotides 0 Hydroxybutyrates 0 Lactates 0 Phosphates 0 Pyruvates 020IUV4N33 Phosphocreatine 0U46U6E8UK NAD 53-59-8 NADP 9005-79-2 Glycogen IY9XDZ35W2 Glucose IM Acetates metabolism Adenine Nucleotides metabolism Animals Dogs Gastric Mucosa blood supply cytology metabolism Glucose metabolism Glycogen metabolism Hydroxybutyrates metabolism Lactates metabolism NAD metabolism NADP metabolism Phosphates metabolism Phosphocreatine metabolism Pyruvates metabolism Regional Blood Flow 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 381 382 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Metal ion dependence of the binding of triiodothyronine by cytosol proteins of bullfrog tadpole tissues. 8337-43 The binding of triiodothyronine by Rana catesbeiana tadpole tail fin, tail muscle, kidney, and liver cytosol was studied using dextran-coated charcoal to separate bound and free hormone. A metal ion dependency was suggested by the fact that EDTA decreased the binding of triiodothyronine 80 to 90% in tail fin and tail muscle cytosol. Inhibition of binding in kidney or liver was less, 40 to 50%. This inhibition could be restored by adding an excess of divalent cations with an order of potency of Mn2+ greater than Ca2+ congruent to Co2+ greater than Sr2+ greater than Ba2+ greater than Mg2+. Other chelators, e.g. o-phenanthroline, 8-hydroxyquinoline, and ethylene glycol bis(beta-aminoethylether)-N,N'-tetraacetate also decreased the binding of triiodothyronine, whereas citrate, oxalate, imidazole, and glycine had no effect. The triiodothyronine binding capacity of tail fin cytosol was reduced by EDTA treatment and dialysis against buffer. Ca2+ in the 1 to 10 mM range and Mn2+ at 1 mM could restore the binding to normal levels. Higher Mn2+ increased binding 70% above normal or to Ca2+-restored levels. The triiodothyronine cytosol binding activity was nondialyzable, heat-labile. pH-dependent, pronase-digestible, but unaffected by incubation with trypsin, RNase, and DNase, suggesting that the cytosol binding sites are acidic proteins. Scatchard analysis of triiodothyronine binding by the cytosol of different tissues, revealed Kassoc of 7.1 x 10(6) M(-1), 11.6 x 10(6) M(-1), 3.6 X 10(6) M(-1), and 68.0 x 10(6) M(-1) for tail fin, tail muscle, kidney, and liver cytosol, respectively. The corresponding maximal binding capacities in picomoles per mg of crude cytosol protein in these four tissues were 10.4, 0.86, 1.3, and 0.04, respectively. Yoshizato K K Kistler A A Frieden E E eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Cations, Divalent 0 Chelating Agents 0 Proteins 0 Receptors, Cell Surface 06LU7C9H1V Triiodothyronine 9G34HU7RV0 Edetic Acid IM Animals Anura Binding Sites Cations, Divalent Chelating Agents pharmacology Cytosol drug effects metabolism Edetic Acid pharmacology Hydrogen-Ion Concentration Kidney metabolism Kinetics Liver metabolism Muscles metabolism Organ Specificity Protein Binding Proteins metabolism Rana catesbeiana Receptors, Cell Surface drug effects Triiodothyronine metabolism 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 382 383 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem The active form of cytochrome P-450 from bovine adrenocortical mitochondria. 8445-8 Cytochrome P-450 from bovine adrenocortical mitochondria exists in three forms of molecular weight: 850,000 (protein 16), of one-half (protein 8), and of one-quarter of this value (protein 4). The forms of the enzyme are named according to the number of subunits and all appear to be active in converting cholesterol to 3beta-hydroxy-5-pregnen-20-one (side chain cleavage) (Shikita, M., and Hall, P.F. (1973) J. Biol. Chem. 248, 5606). To determine whether all three forms are active at their characteristic molecular weights, the three cytochromes were each layered onto separate sucrose density gradients and centrifuged at 49,000 rpm for 60 min; the gradients contained all the factors necessary for side chain cleavage including one of the following substrates: cholesterol, 20S-hydroxycholesterol, and 20S,22R-dihydroxycholesterol. Regardless of the form of P-450 layered onto the gradient and regardless of the substrate, enzyme activity (side chain cleavage) was observed only in fractions corresponding to a sedimentation coefficient of 20 to 22 S which is that for protein 16. No activity was observed at S values corresponding to either protein 8 or protein 4. These findings indicate that the active form of cytochrome P-450 from adrenocortical mitochondria is that containing 16 subunits, i.e. the form in which the cytochrome is normally isolated from adrenal mitochondria. Forms consisting of eight and four subunits which can be prepared from protein 16 become active only by forming protein 16, at least in an aqueous medium in vitro. Takagi Y Y Shikita M M eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Macromolecular Substances 53-59-8 NADP 9035-51-2 Cytochrome P-450 Enzyme System IM Adrenal Cortex enzymology ultrastructure Adrenal Glands enzymology Animals Cattle Centrifugation, Density Gradient Cytochrome P-450 Enzyme System isolation & purification metabolism Kinetics Macromolecular Substances Mitochondria enzymology Molecular Weight NADP Temperature 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 383 384 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Effects of strong electrolyte upon the activity of Clostridium perfringens sialidase toward sialyllactose and sialoglycolipids. 8462-6 Clostridium perfringens sialidase was purified by affinity chromatography. Kinetic properties of the enzyme were examined with sialyllactose and with mixed sialoglycolipids (gangliosides) as substrates. With the latter substrate in 0.01 M Tris-acete in the absence of strong electrolyte, the pH optimum for enzymatic activity was 6.8. Addition of strong electrolyte (0.01 to 0.10 M Nac1) to the reaction medium caused an acidic shift and a broadening of the pH optimum, Enzymatic activity at pH 5.8 rose approximately 2.5-fold; a concomitant loss of activity at pH 6.8 was also observed. The alteration of enzymatic activity caused by strong electrolyte were dependent upon changes in Vmax. Km remained nearly invariant. Thus, a reversible transition of the enzyme from a relatively inactive to a highly active form occurred as a function of strong electrolyte concentration. Determination of the pK values of the active functional groups of C. perfringens sialidase revealed that the effects of strong electrolyte were exerted upon the pKa group of the enzyme. Strong electrolyte appeared to shield unfavorable electrostatic interactions between polyanionic sialoglycolipid micelles and the enzyme molecule, thus protecting the pKa group from inactivation. In comparision with the effects of strong electrolyte upon enzymatic activity toward the sialoglycolipid substrate, those observed with the monovalent substrate, sialyllacthose, were minor. Collectively, these findings indicate that ionic environment may effectively control the activity and relative substrate specificity of C. perfringens sialidase at a given pH. Furthermore, they explain the low pH optima and skewed pH profiles previously reported for enzymatic activity toward high molecular weight substrates. Barton N W NW Lipovac V V Rosenberg A A eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 451W47IQ8X Sodium Chloride EC 3.2.1.18 Neuraminidase IM Clostridium perfringens enzymology Hydrogen-Ion Concentration Kinetics Neuraminidase isolation & purification metabolism Osmolar Concentration Sodium Chloride pharmacology 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 384 385 1976 02 09 2018 04 29 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Reconstitution of ion transport and respiratory control in vesicles formed from reduced coenzyme Q-cytochrome c reductase and phospholipids. 8467-71 Reduced coenzyme Q-cytochrome c reductase from bovine heart mitochondria (complex III) was incorporated into phospholipid vesicles by the cholate dialysis procedure. Soybean phospholipids or mixtures of purified phosphatidylcholine, phosphatidylethanolamine, and cardiolipin could be used. Oxidation of reduced coenzyme Q2 by the reconstituted vesicles with cytochrome c as oxidant showed the following energy-coupling phenomena. 1. Protons were translocated outward with a coupling ratio, H+/2e, of 1.9 +/- 0.2. Measurements with mitochondria under similar conditions showed an H+/2e ratio of 1.8. Proton translocation was not seen in the presence of uncoupling agents and was in addition to the net acidification of the medium from the over-all oxidation reaction. 2. Potassium ions were taken up by the reconstituted vesicles in the presence of valinomycin in a reaction coupled to electron transfer. The coupling ratio for K+ uptake, K+/2e, was 2.0 in the vesicles and approximately 1.5 in mitochondria. 3. The rate of oxidation of reduced coenzyme Q2 by the reconstituted vesicles was stimulated up to 10-fold by uncouplers or by valinomycin plus nigericin and K+ ions. Addition of valinomycin alone in a K+ medium caused a transient stimulation of electron transfer. The results indicate that energy coupling can be observed with isolated reduced coenzyme Q-cytochrome c reductase if the enzyme complex is properly incorporated into a phospholipid vesicle. Leung K H KH Hinkle P C PC eng 090441 Wellcome Trust United Kingdom Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Cholic Acids 0 Ionophores 0 Phospholipids 1339-63-5 Ubiquinone EC 1.6.2.- Cytochrome Reductases RWP5GA015D Potassium IM Animals Biological Transport, Active Cattle Cholic Acids pharmacology Cytochrome Reductases metabolism Electron Transport Hydrogen-Ion Concentration Ionophores pharmacology Kinetics Mitochondria, Muscle drug effects metabolism Models, Biological Myocardium Oxygen Consumption drug effects Phospholipids pharmacology Potassium metabolism Ubiquinone 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 385 386 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Ion transport and respiratory control in vesicles formed from reduced nicotinamide adenine dinucleotide coenzyme Q reductase and phospholipids. 8472-6 NADH-coenzyme Q reductase from bovine heart mitochondria (complex I) was incorporated into phospholipid vesicles by the cholate dialysis procedure. Mixtures of purified phosphatidylcholine and phosphatidylethanolamine were required. Oxidation of NADH by coenzyme Q1 catalyzed by the reconstituted vesicles was coupled to proton translocation, directed inward, with an H+/2e ratio greater than 1.4. Similar experiments measuring proton translocation in submitochondrial particles gave an H+/2e ratio of 1.8. The proton translocation in both systems was not seen in the presence of uncoupling agents and was in addition to the net proton uptake from the reduction of coenzyme Q1 by NADH. Electron transfer in the reconstituted vesicles also caused the uptake of the permeant anion tetraphenylboron. The rate of electron transfer by the reconstituted vesicles was stimulated about 3-fold by uncouplers or by valinomycin plus nigericin and K+ ions. The results indicate that energy coupling can be observed with isolated NADH-coenzyme Q reductase if the enzyme complex is properly incorporated into a phospholipid vesicle. Ragan C I CI Hinkle P C PC eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Phospholipids 03L9OT429T Rotenone 1339-63-5 Ubiquinone 2001-95-8 Valinomycin 555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone EC 1.6.- NADH, NADPH Oxidoreductases EC 1.9.3.1 Electron Transport Complex IV RRU6GY95IS Nigericin IM Animals Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology Cattle Electron Transport Electron Transport Complex IV metabolism Hydrogen-Ion Concentration Kinetics Mitochondria, Muscle metabolism Myocardium NADH, NADPH Oxidoreductases metabolism Nigericin pharmacology Oxygen Consumption drug effects Phospholipids pharmacology Rotenone pharmacology Ubiquinone Valinomycin pharmacology 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 386 387 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem sn-Glycerol-3-phosphate acyltransferase activity in particulate preparations from anaerobic, light-grown cells of Rhodopseudomonas spheroides. Involvement of acyl thiolester derivatives of acyl carrier protein in the synthesis of complex lipids. 8530-5 Crude particulate preparations obtained from anaerobic, light-grown cells of Rhodopseudomonas spheroides have been shown to possess a significant level of sn-glycerol-3-phosphate acyltransferase (EC 2.3.1.15) activity. In contrast to the enzyme from Escherichia coli, the R. spheroides glycerophosphate acyltransferase has a high specificity for acyl thiolester derivatives of acyl carrier protein (ACP) as acyl donors for the reaction. Only limited , nonlinear glycerophosphate incorporation into lipid occurs when acyl coenzyme A (CoA) derivatives are employed as acyl substrate. With oleyl-ACP as substrate, maximal enzyme activity was observed at 40 degrees, over a broad pH range (6.0 to 8.5) and did not require a divalent metal cation. The presence of dithiothreitol stimulated enzyme-activity 15 to 20%. When oleyl-ACP or palmityl-ACP was employed as sole acyl group donor, the major products recoverable from the reaction mixtures were lysophosphatidic acid, phosphatidic acid, and monoglyceride. Althouh oleyl-ACP and palmityl-ACP gave comparable maximal velocities in the initial acylation of glycerophosphate, the formation of phosphatidic acid occurred preferentially with the unsaturated acyl-ACP derivative. Lueking D R DR Goldfine H H eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Bacteriochlorophylls 0 Glycerophosphates EC 2.3.- Acyltransferases IM Acyltransferases isolation & purification metabolism Anaerobiosis Bacteriochlorophylls Glycerophosphates Hydrogen-Ion Concentration Kinetics Light Rhodobacter sphaeroides enzymology Temperature 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 387 388 1976 02 09 2013 11 21 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Studies on thyroid hormone-binding proteins. I. The subunit structure of human thyroxine-binding globulin and its interaction with ligands. 8543-53 Thyroxine-binding globulin was isolated from human plasma by ammonium sulfate fractionation, chromatographic separations on diethylaminoethyl-Sephadex, gel chromatography, and two different electrophoretic procedures. The highly purified was homogeneous when subjected to polyacrylamide gel electrophoresis, ultracentrifugation analyses, and immunochemical determinations. The weight average molecular weight as determined by sedimentation equilibrium ultracentrifugations was 54,000 and by sedimentation diffusion data 55,000. Amino acid analyses indicated a minimum of 110 amino acid residues per molecule. By determination of the minimum in the curve for the fraction of maximum deviation from the amino acid analyses it was found that the minimum molecular weight for the polypeptide was 12,200. Carbohydrate analyses demonstrated the presence f equimolar amounts of amnnose, galactose, and glucosamine, and the carbohydrate portion constituted 7.5% of the total weight. The amino acid analyses suggested that thyroxine-binding globulin is composed of 4 subunits. Molecular weight determinations by gel chromatography in 6 M guanidine hydrochloride indicated the presence of three species of globulin with apparent molecular weights 52,000, 25,000, and 13,500, respectively. Prolonged storage in guanidine hydrochloride promoted a more than 60% yield of the monomeric species. Moreover, a half-molecule of thyroxine-binding globulin was isolated and shown to consist of two polypeptide chains of similar molecular weight... Nilsson S F SF Peterson P A PA eng Journal Article United States J Biol Chem 2985121R 0021-9258 0 Amino Acids 0 Carbohydrates 0 Ligands 0 Serum Globulins 0 Thyroxine-Binding Proteins 06LU7C9H1V Triiodothyronine Q51BO43MG4 Thyroxine IM Amino Acids analysis Binding Sites Carbohydrates analysis Humans Hydrogen-Ion Concentration Immunodiffusion Kinetics Ligands Mathematics Molecular Weight Protein Binding Serum Globulins analysis isolation & purification Thyroxine Thyroxine-Binding Proteins analysis isolation & purification Triiodothyronine 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 388 389 1976 02 09 2019 02 06 0021-9258 250 21 1975 Nov 10 The Journal of biological chemistry J Biol Chem Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity. 8569-75 Heterogeneities of the two ovalbumin glycopeptides, (Man)5(GlcNAc)2Asn and (Man)6(GlcNAc)2Asn, were revealed by borate paper electrophoresis of oligosaccharide alcohols obtained from the glycopeptides by endo-beta-N-acetylglucosaminidase H digestion and NaB3H4 reduction. The structures of the major components of the oligosaccharides were determined by the combination of methylation analysis, acetolysis, and alpha-mannosidase digestion. Based on the results, the whole structures of the major components of (Man)5(GlcNAc)2Asn and (Man)6(GlcNAc)2Asn were elucidated as Manalpha1 leads to 6[Manalpha1 leads to 3]-Manalpha1 leads to 6[Manalpha1 leads to 3[Manbeta1 leads to 4GlcNAcbeta1 leads to 4GlcNAc leads to Asn and Manalpha1 leads to 6[Manalpha1 leads to 3]Manalpha1 leads to 6[Manalpha1 leads to 2Manalpha1 leads to 3]Manbeta1 leads to 4GlcNAcbeta1 leads to GlcNAc leads to Asn, respectively. Since endo-beta-N-acetylglucosamini dase D hydrolyzes (Man)5(GlcNAc)2Asn but not (Man)6(GlcNAc)2Asn, the presence of the unsubstituted alpha-mannosyl residue linked at the C-3 position of the terminal mannose of Manbeta1 leads to 4GlcNAcbeta1 leads to 4 GlcNAcAsn core must be essential for the action of the enzyme. Tai T T Yamashita K K Ogata-Arakawa M M Koide N N Muramatsu T T Iwashita S S Inoue Y Y Kobata A A eng Journal Article United States J Biol Chem 2985121R 0021-9258 0 Glycopeptides 7006-34-0 Asparagine 9006-59-1 Ovalbumin EC 3.2.1.- Hexosaminidases EC 3.2.1.52 Acetylglucosaminidase PHA4727WTP Mannose V956696549 Acetylglucosamine IM Acetylglucosamine analysis Acetylglucosaminidase metabolism Animals Asparagine analysis Chickens Gas Chromatography-Mass Spectrometry Glycopeptides analysis Hexosaminidases metabolism Kinetics Mannose analysis Milk analysis Ovalbumin analysis Streptococcus pneumoniae enzymology Streptomyces griseus enzymology 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 389 390 1976 02 09 2020 02 25 0021-9258 250 22 1975 Nov 25 The Journal of biological chemistry J Biol Chem Use of 5-deazaFAD to study hydrogen transfer in the D-amino acid oxidase reaction. 8728-34 The apoprotein of hog kidney D-amino acid oxidase was reconstituted with 5-deazaflavin adenine dinucleotide (5-deazaFAD) to yield a protein which contains 1.5 mol of 5-deazaFAD/mol of enzyme. The deazaFAD-containing enzyme forms complexes with benzoate, 2-amino benzoate, and 4-aminobenzoate which are both qualitatively and quantitatively similar to those observed with native enzyme. The complex with 2-aminobenzoate exhibits a new long wavelength absorption band characteristic of a flavin charge-transfer complex. The reconstituted enzyme exhibits no activity when assayed by D-alanine oxidation. However, the bound chromophore can be reduced by alanine, phenylalanine, proline, methionine, and valine, but not by glutamate or aspartate, indicating the deazaFAD enzyme retains the substrate specificity of the native enzyme. Reduction of the enzyme by D-alanine exhibits a 1.6-fold deuterium isotope effect. Reoxidation of the reduced enzyme occurred in the presence of pyruvate plus ammonia, but not with pyruvate alone or ammonia alone. beta-Phenylpyruvate and alpha-ketobutyrate, but not alpha-ketoglutarate could replace pyruvate. Reduced enzyme isolated following reaction with [alpha-3H]alanine was found to contain 0.5 mol of tritium/mol of deazaFADH2. After denaturation of the tritium-labeled enzyme, the radioactivity was identified as deazaFADH2. Reaction of the reduced tritium-labeled enzyme with pyruvate plus ammonia prior to denaturation yields [alpha-3H]alanine and unlabeled deazaFAD. These results suggest that reduction and reoxidation of enzyme-bound deazaFAD involves the stereo-specific transfer of alpha-hydrogen from substrate to deazaFAD. Hersh L B LB Jorns M S MS eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Aminobenzoates 0 Apoenzymes 0 Benzoates 146-14-5 Flavin-Adenine Dinucleotide EC 1.4.3.3 D-Amino-Acid Oxidase IM Aminobenzoates Animals Apoenzymes Benzoates Binding Sites D-Amino-Acid Oxidase metabolism Flavin-Adenine Dinucleotide analogs & derivatives Kidney enzymology Protein Binding Protein Conformation Spectrometry, Fluorescence Spectrophotometry Spectrophotometry, Ultraviolet Structure-Activity Relationship Swine 1975 11 25 1975 11 25 0 1 1975 11 25 0 0 ppublish 390 Arch Intern Med. 2001 Jan 8;161(1):15-21 11146694 J Allergy Clin Immunol. 2001 Nov;108(5):861-6 11692116 Curr Opin Allergy Clin Immunol. 2003 Aug;3(4):305-11 12865776 BMJ. 2003 Dec 6;327(7427):1332-5 14656845 Am Fam Physician. 2004 Mar 1;69(5):1123-8 15023012 J Allergy Clin Immunol. 2006 Feb;117(2):391-7 16461139 Mayo Clin Proc. 2006 Jul;81(7):958-72 16835976 CMAJ. 2006 Oct 24;175(9):1065-70 17060655 Am J Hum Genet. 2006 Dec;79(6):1098-104 17186468 J Dermatol Sci. 2007 Aug;47(2):109-17 17507204 Allergy. 2007 Aug;62(8):830-7 17620060 Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):337-41 17620826 J Allergy Clin Immunol. 2008 Mar;121(3):632-638.e2 18207562 J R Soc Med. 2008 Mar;101(3):139-43 18344471 Resuscitation. 2008 May;77(2):157-69 18358585 Allergy. 2009 Feb;64(2):204-12 19178399 Allergy. 2010 Oct;65(10):1205-11 20584003 J Allergy Clin Immunol. 2010 Sep;126(3):477-80.e1-42 20692689 Clin Exp Allergy. 1996 Dec;26(12):1364-70 9027436 391 1976 02 09 2013 11 21 0021-9258 250 23 1975 Dec 10 The Journal of biological chemistry J Biol Chem The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. 8990-6 NSILA-s (nonsuppressible insulin-like activity, soluble in acid ethanol) is a serum peptide that has insulin-like and growth-promoting activities. We have demonstrated previously that liver plasma membranes possess separate receptors for NSILA-s and insulin and have characterized the insulin receptor in detail. In the present study we have characterized the properties and specificity of the NSILA-s receptor and compared them to those of the insulin receptor in the same tissue. Both 125I-NSILA-s and 125I-insulin bind rapidly and reversibly to their receptors in liver membranes; maximal NSILA-s binding occurs at 20 degrees while maximal insulin binding is seen at 1-4 degrees. The pH optimum for NSILA-s binding is broad (6.0 to 8.0), in contrast to the very sharp pH optimum (7.5 to 8.0) for insulin binding. Both receptors exhibit a high degree of specificity. With the insulin receptor, NSILA-s and insulin analogues compete for binding in proportion to their insulin-like potency: insulin greater than proinsulin greater than NSILA-s. With the NSILA-s receptor, NSILA-s is most potent and the order is reversed: NSILA-s greater than proinsulin greater than insulin. Furthermore, six preparations of NSILA-s which varied 70-fold in biological activity competed for 125I-NSILA-s binding in order of their potencies. NSILA-s which had been inactivated biologically by reduction and aminoethylation and growth hormone were less than 1/100,000 as potent as the most purified NSILA-s preparation. Purified preparations of fibroblast growth factor, epidermal growth factor, nerve growth factor, and somatomedins B and C were less than 1% as effective as NSILA-s in competing for the 125I-NSILA-s suggesting that these factors act through other receptors. In contrast, somatomedin A was 10% as active as NSILA-s and multiplication-stimulating activity was fully as active as NSILA-s in competing for the NSILA-s receptor. Analysis of the data suggests that there are approximately 50 times more insulin receptors than NSILA-s receptors per liver cell, while the apparent affinity of NSILA-s receptors is somewhat higher than that of the insulin receptor. Megyesi K K Kahn C R CR Roth J J Neville D M DM Jr Nissley S P SP Humbel R E RE Froesch E R ER eng Journal Article United States J Biol Chem 2985121R 0021-9258 0 Blood Proteins 0 Insulin 0 Receptors, Cell Surface 3K9958V90M Ethanol IM Animals Binding Sites Blood Proteins metabolism Cell Membrane metabolism Ethanol Hydrogen-Ion Concentration Insulin immunology metabolism Kinetics Liver metabolism Lymphocytes metabolism Protein Binding Rats Receptors, Cell Surface Solubility 1975 12 10 2001 3 28 10 1 1975 12 10 0 0 ppublish 391 392 1976 02 09 2013 11 21 0021-9258 250 23 1975 Dec 10 The Journal of biological chemistry J Biol Chem Decarboxylation of oxalacetate to pyruvate by purified avian liver phosphoenolpyruvate carboxykinase. 9099-105 Phosphoenolpyruvate carboxykinase, which has been isolated from chicken liver mitochondria in essentially homogenous form, carries out the irreversible decarboxylation of oxalacetate to pyruvate in the presence of catalytic amounts of GDP or IDP, as well as the reversible decarboxylation of oxalacetate to phosphoenolpyruvate in the presence of substrate amounts of GTP or ITP. The pyruvate- and phosphoenolpyruvate-forming reactions are similar in their nucleoside specificity and appear to be carried out by the same protein. However, the two activities vary markedly in their response to added metal ions and sulfhydryl reagents. Phosphoenolpyruvate formation is completely dependent on the presence of a divalent metal ion, with Mn2+ the most effective species. This reaction is also stimulated by sulfhydryl reagents such as 2-mercaptoethanol. In contrast, the pyruvate-forming reaction is strongly inhibited by divalent metal ions, including Mn2+, and also by moderate concentrations of sulfhydryl reagents. These observations and the demonstration that pyruvate kinase-like activity is very low or absent make it unlikely that pyruvate formation proceeds via phosphoenolpyruvate as an intermediate. Although the pyruvate-forming reaction is inhibited by added metal ions, the reaction is also inhibited by metal-chelating agents such as 8-hydroxyquinoline and o-phenanthroline, suggesting that the reaction is dependent on the presence of a metal ion. It has not been possible, however, to demonstrate that the enzyme is a metalloprotein. Noce P S PS Utter M F MF eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Oxaloacetates 0 Phenanthrolines 0 Pyruvates 0 Quinolines 0 Ribonucleotides 42Z2K6ZL8P Manganese 551W113ZEP 2,2'-Dipyridyl 60-24-2 Mercaptoethanol EC 4.1.1.32 Phosphoenolpyruvate Carboxykinase (GTP) I38ZP9992A Magnesium SY7Q814VUP Calcium IM 2,2'-Dipyridyl pharmacology Animals Calcium pharmacology Chickens Enzyme Activation drug effects Kinetics Liver enzymology Magnesium pharmacology Manganese pharmacology Mercaptoethanol pharmacology Oxaloacetates metabolism Phenanthrolines pharmacology Phosphoenolpyruvate Carboxykinase (GTP) isolation & purification metabolism Pyruvates metabolism Quinolines pharmacology Ribonucleotides 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 392 393 1976 02 09 2019 02 06 0021-9258 250 24 1975 Dec 25 The Journal of biological chemistry J Biol Chem Hemoglobin Deer Lodge (beta 2 His replaced by Arg). Consequences of altering the 2,3-diphosphoglycerate binding site. 9250-5 Hemoglobin Deer Lodge is an abnormal human hemoglobin with arginine substituted for histidine at the beta 2 position. X-ray crystallography of normal human hemoglobin has shown that the beta 2 residue is normally part of the binding site for 2,3-diphosphoglycerate. The substitution of arginine for histidine at beta 2 affects both the kinetics and equilibria of ligand binding. When stripped of anions, Hb Deer Lodge has an increased oxygen affinity and a decreased degree of cooperativity relative to Hb A. The alkaline Bohr effect is slightly increased and there are marked increases in oxygen affinity below pH 6 and above pH 8. In the presence of 2,3-diphosphoglycerate the cooperativity in increases to nromal and the pH dependence of oxygen binding is reduced. This contrasts with the enhanced Bohr effect seen for Hb A in the presence of organic phosphates. Due to enhanced anion binding at high pH, Hb Deer Lodge has a slightly lower oxygen affinity than Hb A at pH 9 in the presence of 2,3-diphosphoglycerate or inositol hexaphosphate. Kinetic studies at neutral pH in the absence of organic phosphates revealed biphasicity in the rate of oxygen dissociation from Hb Deer Lodge, while approximately linear time courses were observed for Hb A. The fast phase of the oxygen dissociation kinetics shows great pH sensitivity, and organic phosphates increase the rate and percentage of the fast phase without greatly affecting the slow phase. The two phases are not resolvable at high pH. CO combination kinetics are much like those of Hb A except that "fast" and "slow" phases were apparent at wavelengths near the deoxy-CO isobestic point. We suggest that functional differences between the alpha and beta chains are enhanced in Hb Deer Lodge. After flash photolysis of the CO derivative, the percentage of quickly reacting material was slightly greater for Hb Deer Lodge than for Hb A. This may imply a somewhat greater tendency to dissociate into high affinity subunits. The substitution of arginine for histidine at beta 2 thus results in a macromolecule whose ligand-binding properties are significantly altered, the primary differences being expressed at high pH where Hb Deer Lodge binds anions more strongly than Hb A. The properties of Hb Deer Lodge are compared to those of other hemoglobin variants with substitutions at residues involved in binding of 2,3-diphosphoglycerate. Bonaventura J J Bonaventura C C Sullivan B B Godette G G eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Diphosphoglyceric Acids 0 Hemoglobins 0 Hemoglobins, Abnormal 7IGF0S7R8I Phytic Acid S88TT14065 Oxygen IM Binding Sites Diphosphoglyceric Acids blood Hemoglobins Hemoglobins, Abnormal Heterozygote Humans Hydrogen-Ion Concentration Kinetics Manitoba Models, Molecular Oxygen blood Phytic Acid blood Protein Binding Protein Conformation 1975 12 25 1975 12 25 0 1 1975 12 25 0 0 ppublish 393 394 1976 02 09 2019 02 06 0021-9258 250 24 1975 Dec 25 The Journal of biological chemistry J Biol Chem Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. 9342-7 We describe a method for measuring the release of fatty acids from endogenous substrates of human platelet homogenates and membranes. The method depends on the availability of lipids whose fatty acids are odd-chained and therefore suitable as internal reference compounds that, at the time of lipid extraction, can be added to an incubation to permit subsequent quantification of the content of free fatty acids or fatty acids esterified to specific lipids. We found four types of lipolytic activities in human platelets. In homogenates at pH 4.0 a triglyceride lipase operated as shown by the synchrony of triglyceride degradation and release of glycerol and those fatty acids that are the predominant constituents of triglycerides. However, enough arachidonic acid was released at this pH level to suggest some phospholipid breakdown, since triglycerides hold relatively small amounts of this acid. With membranous preparations, in the alkaline pH range there were two peaks of fatty acid release with accompanying degradation of phospholipids. At pH 8.5, where release of the saturated acids, palmitic and stearic, predominated, their sum was 3.5 times that of arachidonic acid. At pH 9.5 the release of palmitic and stearic acids was only slightly below their peak values; however, the release of arachidonic acid nearly equaled the sum of the saturated acids. Linoleic acid was not released in representative amounts by those reactions that released arachidonic acid, despite the overwhelming propensity of both to be esterified at the 2-position of phospholipids. Pertinently, the choline phospholipids are linoleic-rich and the non-choline phospholipids linoleic-poor, while both have a generous endowment of arachidonic acid. With this in mind, we raise the possibility that the phospholipase A2 of human platelets is an endoenzyme because of its tendency to act on those phospholipids that are thought to comprise the inner layer of the cell membrane. Derksen A A Cohen P P eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Cholesterol Esters 0 Fatty Acids, Nonesterified 0 Phospholipids 0 Triglycerides 9G34HU7RV0 Edetic Acid SY7Q814VUP Calcium IM Blood Platelets analysis metabolism Calcium pharmacology Cell Membrane analysis drug effects metabolism Cholesterol Esters blood Edetic Acid pharmacology Fatty Acids, Nonesterified blood Humans Hydrogen-Ion Concentration Kinetics Phospholipids blood Triglycerides blood 1975 12 25 1975 12 25 0 1 1975 12 25 0 0 ppublish 394 395 1976 02 09 2019 02 06 0021-9258 250 24 1975 Dec 25 The Journal of biological chemistry J Biol Chem Oxidation of NADPH by submitochondrial particles from beef heart in complete absence of transhydrogenase activity from NADPH to NAD. 9397-403 Treatment of submitochondrial particles (ETP) with trypsin at 0 degrees destroyed NADPH leads to NAD (or 3-acetylpyridine adenine dinucleotide, AcPyAD) transhydrogenase activity. NADH oxidase activity was unaffected; NADPH oxidase and NADH leads to AcPyAD transhydrogenase activities were diminished by less than 10%. When ETP was incubated with trypsin at 30 degrees, NADPH leads to NAD transhydrogenase activity was rapidly lost, NADPH oxidase activity was slowly destroyed, but NADH oxidase activity remained intact. The reduction pattern by NADPH, NADPH + NAD, and NADH of chromophores absorbing at 475 minus 510 nm (flavin and iron-sulfur centers) in complex I (NADH-ubiquinone reductase) or ETP treated with trypsin at 0 degrees also indicated specific destruction of transhydrogenase activity. The sensitivity of the NADPH leads to NAD transhydrogenase reaction to trypsin suggested the involvement of susceptible arginyl residues in the enzyme. Arginyl residues are considered to be positively charged binding sites for anionic substrates and ligands in many enzymes. Treatment of ETP with the specific arginine-binding reagent, butanedione, inhibited transhydrogenation from NADPH leads to NAD (or AcPyAD). It had no effect on NADH oxidation, and inhibited NADPH oxidation and NADH leads to AcPyAD transhydrogenation by only 10 to 15% even after 30 to 60 min incubation of ETP with butanedione. The inhibition of NADPH leads to NAD transhydrogenation was diminished considerably when butanedione was added to ETP in the presence of NAD or NADP. When both NAD and NADP were present, the butanedione effect was completely abolished, thus suggesting the possible presence of arginyl residues at the nucleotide binding site of the NADPH leads to NAD transhydrogenase enzyme. Under conditions that transhydrogenation from NADPH to NAD was completely inhibited by trypsin or butanedione, NADPH oxidation rate was larger than or equal to 220 nmol min-1 mg-1 ETP protein at pH 6.0 and 30 degrees. The above results establish that in the respiratory chain of beef-heart mitochondria NADH oxidation, NADPH oxidation, and NADPH leads to NAD transhydrogenation are independent reactions. Djavadi-Ohaniance L L Hatefi H H eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Butanones 0 Palmitic Acids 0U46U6E8UK NAD 53-59-8 NADP EC 1.6.- NADH, NADPH Oxidoreductases EC 3.4.21.4 Trypsin SAA04E81UX Coenzyme A IM Animals Butanones pharmacology Cattle Coenzyme A pharmacology Kinetics Mitochondria, Muscle drug effects metabolism Myocardium NAD metabolism NADH, NADPH Oxidoreductases antagonists & inhibitors NADP metabolism Palmitic Acids pharmacology Trypsin 1975 12 25 1975 12 25 0 1 1975 12 25 0 0 ppublish 395 396 1976 03 01 2020 02 25 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Protein inhibitor of acid deoxyribonucleases. Improved purification procedure and properties. 116-23 A method is described for the extensive purification of acid deoxyribonuclease (acid DNase) and its specific inhibitor from beef liver, the existence of which had been only supported by indirect evidence. By the use of insolubilized acid deoxyribonuclease, eight other proteins interacting with the enzyme have been detected. One of them (molecular weight, 59,000) was identified as responsible for phosphodiesterase activity which is often a contaminant of DNase preparations. Acid DNase (free of phosphodiesterase) and its inhibitor have been obtained as homogeneous proteins, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The molecular weight of acid DNase and its inhibitor are, respectively, 26,500 and 21,500; those of other proteins range from 17,000 to 112,000. The properties of beef liver acid DNase are similar to those described for the enzymes extracted from other sources. The same alteration of DNase kinetics by this inhibitor, as that previously demonstrated with an impure protein has been confirmed; the sigmoidal shape observed at pH 5 for the plot of initial rate versus substrate concentration progressively disappears with increasing pH. We have also demonstrated that RNA, which inhibits the acid DNase through a competitive binding to the catalytic site, is able, like the substrate, to reverse the binding of inhibitor to the enzyme. Lesca P P eng Journal Article United States J Biol Chem 2985121R 0021-9258 0 Enzyme Inhibitors 0 Hydroxymercuribenzoates 0 Iodoacetates 0 Phosphodiesterase Inhibitors EC 3.1.- Deoxyribonucleases IM Animals Cattle Deoxyribonucleases antagonists & inhibitors isolation & purification Drug Stability Enzyme Inhibitors isolation & purification Helix, Snails enzymology Hydrogen-Ion Concentration Hydroxymercuribenzoates pharmacology Iodoacetates pharmacology Kinetics Liver enzymology Phosphodiesterase Inhibitors 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 396 Cell. 1999 Apr 2;97(1):133-44 10199409 Nat Genet. 1999 Jun;22(2):175-7 10369261 Nat Genet. 1999 Jun;22(2):178-81 10369262 Nat Genet. 2001 Nov;29(3):301-5 11687797 Am J Hum Genet. 2002 Jun;70(6):1498-506 11992256 Am J Hum Genet. 2002 Jul;71(1):198-203 12032915 PLoS Med. 2006 Aug;3(8):e297 16942393 Rheumatology (Oxford). 2007 Oct;46(10):1597-600 17804452 Ann Rheum Dis. 2008 Nov;67(11):1589-95 18086728 Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1614-9 18230725 Joint Bone Spine. 2008 May;75(3):263-6 18378180 Arthritis Rheum. 2008 May;58(5):1516-20 18438813 Isr Med Assoc J. 2008 May;10(5):358-60 18605359 Arthritis Rheum. 2008 Aug;58(8):2443-52 18668535 Arthritis Rheum. 2009 Feb;60(2):619-25 19180495 Nat Rev Rheumatol. 2009 May;5(5):249-56 19412191 N Engl J Med. 2009 Jun 4;360(23):2416-25 19494217 N Engl J Med. 2009 Jun 4;360(23):2426-37 19494218 Curr Opin Rheumatol. 2010 Sep;22(5):567-78 20671522 Nat Rev Rheumatol. 2011 Feb;7(2):105-12 21060333 Nat Genet. 1997 Sep;17(1):25-31 9288094 Cell. 1997 Aug 22;90(4):797-807 9288758 397 1976 03 01 2019 02 06 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Nucleotide-metabolizing enzymes in Chlamydomonas flagella. 182-92 Nucleotides have at least two functions in eukaryotic cilia and flagella. ATP, originating in the cells, is utilized for motility by energy-transducing protein(s) called dynein, and the binding of guanine nucleotides to tubulin, and probably certain transformations of the bound nucleotides, are prerequisites for the assembly of microtubules. Besides dynein, which can be solubulized from Chlamydomonas flagella as a heterogeneous, Mg2+ or Ca2+-activated ATPase, we have purified and characterized five other flagellar enzymes involved in nucleotide transformations. A homogeneous, low molecular weight, Ca2+-specific adenosine triphosphatase was isolated, which was inhibited by Mg2+ and was not specific for ATP. This enzyme was not formed by treating purified dynein with proteases. It was absent from extracts of Tetrahymena cilia. Its function might be an auxiliary energy transducer, or in steering or tactic responses. Two species of adenylate kinase were isolated, one of which was much elevated in regenerating flagella; the latter was also present in cell bodies. A large part of flagellar nucleoside diphosphokinase activity could not be solubilized. Two soluble enzyme species were identified, one of which was also present in cell bodies. Since these enzymes are of interest because they might function in microtubule assembly, we studied the extent to which brain nucleoside diphosphokinase co-polymerizes with tubulin purified by repeated cycles of polymerization. Arginine kinase was not detected in Chlamydomonas flagellar extracts. Watanabe T T Flavin M M eng Journal Article United States J Biol Chem 2985121R 0021-9258 0 Nucleotides EC 2.7.- Phosphotransferases EC 2.7.4.3 Adenylate Kinase EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium SY7Q814VUP Calcium IM Adenosine Triphosphatases metabolism Adenylate Kinase metabolism Animals Calcium pharmacology Chlamydomonas enzymology Cilia enzymology Enzyme Activation drug effects Flagella enzymology Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Nucleotides metabolism Phosphotransferases metabolism Species Specificity Tetrahymena enzymology 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 397 398 1976 03 01 2013 11 21 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem In vitro biosynthesis of sialosylgalactosylceramide (G7) by mouse brain microsomes. 198-203 A sialytransferase activity which catalyzes the synthesis of sialosylgalactosylceramide (G7) from added galactocerebroside and CMP-N-acetylneuraminic acid has been demonstrated in mouse brain microsomes. The enzyme reaction shows a pH optimum of 6.3 and requires detergents. Both Mn2+ and Ca2+ inhibited the reaction, whereas Mg2+ had no effect. The apparent Km for galactocerebroside leading to G7 was estimated to be 8.7 X 10(-4) M. The same microsomal preparation also synthesized hematoside when ceramide lactoside was the glycolipid acceptor. The apparent Km for ceramide lactoside was about one-tenth that for galactocerebroside. When the preparations were partially inactivated by heat the synthesis of G7 and of hematoside was reduced at approximately the same rate. Liver appeared to have the highest activity for G7 synthesis (as well as of hematoside), followed by brain. The synthesis of B7 by mouse brain microsomes in vitro demonstrates a new pathway for brain ganglioside synthesis. Yu R K RK Lee S H SH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Cerebrosides 0 Detergents 0 Gangliosides 0 Sialic Acids X2RN3Q8DNE Galactose IM Animals Brain metabolism Cerebrosides biosynthesis Detergents pharmacology Galactose metabolism Gangliosides biosynthesis metabolism Humans Hydrogen-Ion Concentration Kinetics Male Mice Microsomes drug effects metabolism Middle Aged Sialic Acids metabolism Subcellular Fractions metabolism 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 398 399 1976 03 01 2006 11 15 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Proteolytic enzymes of the K-1 strain of Streptomyces griseus obtained from a commercial preparation (Pronase). Purification and characterization of the carboxypeptidase. 204-8 We described earlier the facilitated purifications of the trypsin and aminopeptidase components present in Pronase (Vosbeck, K. D., Chow, K. -F., and Awad, W. M., Jr. (1973) J. Biol. Chem. 248, 6029-6034). A partially resolved protein mixture left over after one of the steps in that procedure was passed through a Sephadex G-75 column. By this means, a component with carboxypeptidase activity was separated from associated serine endopeptidases. Further purification of this exopeptidase to apparent homogeneity was acheived by refiltration through the same Sephadex column and by CM-cellulose chromatography. A single protein band was observed after acrylamide gel electrophoresis; analysis by sedimentation equilibrium using the meniscus depletion method gave a molecular weight of 30,300. This enzyme demonstrates activity against Nalpha-benzyloxycarbonylglycyl-L-leucine and hippuryl-D,L-phenyllactate; no activity was found against Nalpha-acetyl-L-tyrosine ethyl ester, Nalpha-benzoyl-D,L-arginine-p-nitroanilide, or L-leuckne-p-nitroanilide. The maximum activity lies between pH values of 7 and 8; the enzyme is stable between pH values of 6 and 10. At room temperature 1,10-phenanthroline inactivates the enzyme completely whereas EDTA has no effect. Of the many cations tested, only Co2+, Ni2+, or Zn2+ restores activity to the 1,10-phenanthroline-treated enzyme; Co2+ provided 3 times the native activity. The metal in the native protein was found to be zinc. These findings are similar to those recorded with bovine pancreatic carboxypeptidase A, and suggest the possibility that the present enzyme may ge genetically related to the mammalian protein, as in previously noted examples of homology of three Pronase endopeptidases to pancreatic serine enzymes. Seber J F JF Toomey T P TP Powell J T JT Brew K K Awad W M WM Jr eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Amino Acids EC 3.4.- Carboxypeptidases EC 3.4.24.- Pronase IM Amino Acids analysis Carboxypeptidases isolation & purification metabolism Hydrogen-Ion Concentration Kinetics Pronase analysis Streptomyces griseus enzymology 1976 1 10 2001 3 28 10 1 1976 1 10 0 0 ppublish 399 400 1976 03 01 2019 02 06 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Trypsin-sensitive photosynthetic activities in chloroplast membranes from Chlamydomonas reinhardi, y-1. 247-52 Location of electron transport chain components in chloroplast membranes of chlamydomonas reinhardi, y-1 was investigated by use of proteolytic digestion with soluble or insolubilized trypsin. Digestion of intact membrane vesicles with soluble trypsin inactivates the water-splitting system, the 3-(3,4-dichlorophenyl)-1,1-dimethylurea inhibition site of Photosystem II, the electron transport between the two photosystems as well as the ferredoxin NADP reductase. Reduction of NADP with artificial electron donors for Photosystem I could be restored, however, by addition of purified reductase to trypsin-digested membranes. Electron transfer activities of Photosystems I and II reaction centers were resistant to trypsin digestion either from outside or from within the thylakoids when active trypsin was trapped inside the membrane vesicles by sonication and digestion carried out in the presence of trypsin inhibitor added from outside. In the latter case, the water-splitting system was also found to be resistant to digestion. Polyacrylamide-bound insolubilized trypsin inactivated only the ferredoxin NADP reductase. Photosynthetically active membranes obtained at different stages of development showed a basically similar behavior toward trypsin. Regitz G G Ohad I I eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Biol Chem 2985121R 0021-9258 53-59-8 NADP 9007-73-2 Ferritins EC 3.4.21.4 Trypsin IM Cell Membrane drug effects metabolism Chlamydomonas metabolism Chloroplasts drug effects metabolism ultrastructure Ferritins metabolism Kinetics Membranes ultrastructure Microscopy, Electron NADP metabolism Permeability Photophosphorylation drug effects Photosynthesis drug effects Trypsin pharmacology 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 400 401 1976 03 01 2013 11 21 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem A complex of cardiac cytochrome c1 and cytochrome c. 29-36 The interactions of cytochrome c1 and cytochrome c from bovine cardiac mitochondria were investigated. Cytochrome c1 and cytochrome c formed a 1:1 molecular complex in aqueous solutions of low ionic strength. The complex was stable to Sephadex G-75 chromatography. The formation and stability of the complex were independent of the oxidation state of the cytochrome components as far as those reactions studied were concerned. The complex was dissociated in solutions of ionic strength higher than 0.07 or pH exceeding 10 and only partially dissociated in 8 M urea. No complexation occurred when cytochrome c was acetylated on 64% of its lysine residues or photooxidized on its 2 methionine residues. Complexes with molecular ratios of less than 1:1 (i.e. more cytochrome c) were obtained when polymerized cytochrome c, or cytochrome c with all lysine residues guanidinated, or a "1-65 heme peptide" from cyanogen bromide cleavage of cytochrome c was used. These results were interpreted to imply that the complex was predominantly maintained by ionic interactions probably involving some of the lysine residues of cytochrome c but with major stabilization dependent on the native conformations of both cytochromes. The reduced complex was autooxidizable with biphasic kinetics with first order rate constants of 6 X 10(-5) and 5 X U0(-5) s-1 but did not react with carbon monoxide. The complex reacted with cyanide and was reduced by ascorbate at about 32% and 40% respectively, of the rates of reaction with cytochrome c alone. The complex was less photoreducible than cytochrome c1 alone. The complex exhibited remarkably different circular dichroic behavior from that of the summation of cytochrome c1 plus cytochrome c. We concluded that when cytochromes c1 and c interacted they underwent dramatic conformational changes resulting in weakening of their heme crevices. All results available would indicate that in the complex cytochrome c1 was bound at the entrance to the heme crevice of cytochrome c on the methionine-80 side of the heme crevice. Chiang Y L YL Kaminsky L S LS King T E TE eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Cyanides 0 Cytochrome c Group 0 Guanidines 0 Macromolecular Substances 8W8T17847W Urea 9035-42-1 Cytochromes c1 IM Animals Binding Sites Cattle Circular Dichroism Cyanides Cytochrome c Group analogs & derivatives metabolism Cytochromes c1 metabolism Guanidines Horses Hydrogen-Ion Concentration Kinetics Macromolecular Substances Mitochondria, Muscle enzymology Myocardium enzymology Protein Binding Protein Conformation Spectrophotometry Spectrophotometry, Ultraviolet Urea 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 401 402 1976 03 01 2020 02 25 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Leucine aminopeptidase (bovine lens). Effect of pH on the relative binding of Zn2+ and Mg2+ to and on activation of the enzyme. 53-60 Incubation of leucine aminopeptidase (bovine lens) (EC 3.4.1.1) with various concentrations of Mg2+ at various pH values in 1 M KCl and 0.155 M trimethylamine-HCl at 37 degrees confirms that Mg2+ competes with Zn2+ for binding only 1 site per 54,000-dalton subunit. The ratio of the apparent association constants (1KZn:1KMg = 1KZn/Mg) at this site (site 1) was estimated to be 20,720 at pH 8.16, 10,570 at pH 8.44, 3,590 at pH 8.78, and 660 AT PH 9.14. The decrease in values of 1KZn/Mg with increasing pH in the activation of leucine aminopeptidase by Mg2+ is attributed to the lowering of the free Zn2+ concentration relative to that of free Mg2+ caused by the formation of ZnOH+ and Zn(OH)2 complexes with increasing OH- concentration. When corrections are made for the binding of Zn2+ by OH- ions, the pH-independent ratio of association constants (1KZn:1KMg = 1KZn/Mg) for the relative binding of Zn2+ and Mg2+ at site 1 of leucine aminopeptidase in 29,800. From the effect of pH on the relative binding constant, a value (beta2) for the product of the two stepwise association constants for the formation of Zn(OH)2 from Zn2+ and OH- (Zn2+ + OH- in equilibrium ZnOH+; ZnOH+ + OH- in equilibrium Zn(OH)2) was estimated to be 4.42 X 10(10) M-2 at 37 degrees. Values of Km at pH 7.5 AND 30 degrees with L-leucine p-nitroanilide as substrate in the presence of 0.01 M NaHCO3 are 4.13 and 2.01 mM for the zinc-zinc and magnesium-zinc enzymes, respectively. Values for Vmax are 0.2 and 2.49 mumol/min/mg, respectively. Thompson G A GA Carpenter F H FH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 EC 3.4.11.1 Leucyl Aminopeptidase I38ZP9992A Magnesium J41CSQ7QDS Zinc IM Animals Binding Sites Cattle Enzyme Activation drug effects Hydrogen-Ion Concentration Kinetics Lens, Crystalline enzymology Leucyl Aminopeptidase metabolism Magnesium pharmacology Mathematics Protein Binding Zinc pharmacology 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 402 J Emerg Med. 2000 Jul;19(1):35-41 10863116 AJNR Am J Neuroradiol. 2000 Aug;21(7):1280-92 10954281 Curr Opin Cardiol. 2000 Sep;15(5):316-21 11128183 N Engl J Med. 2001 Mar 22;344(12):898-906 11259724 AJNR Am J Neuroradiol. 2005 Oct;26(9):2328-35 16219841 J Vasc Surg. 2005 Nov;42(5):854-60; discussion 860 16275436 J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1021-4 16820416 AJR Am J Roentgenol. 2007 Feb;188(2):593-602 17242273 AJNR Am J Neuroradiol. 2008 Oct;29(9):1753-60 18635617 J Emerg Med. 2011 Jul;41(1):43-6 18790590 Neuroimaging Clin N Am. 2009 May;19(2):257-70, Table of Contents 19442909 Neurology. 2009 Oct 13;73(15):1242-3 19822875 Stroke. 1996 Jul;27(7):1226-30 8685933 403 1976 03 01 2013 11 21 0021-9258 251 1 1976 Jan 10 The Journal of biological chemistry J Biol Chem Biochemical studies of tast sensation. Binding of L-[3H]alanine to a sedimentable fraction from catfish barbel epithelium. 88-97 Large numbers of taste buds are distributed over the body surface of the channel catfish ictalurus punctatus, with the barbels having an especially high density. L-Alanine, as well as certain other amino acids, are taste stimuli in this animal. Epithelial tissue obtained by gentle scraping of the barbel surface was fractionated by differential centrifugation. A sedimentable fraction (P2) was prepared that was enriched in L[OH]alanine binding activity, the plasma membrane marker enzyme 5'-nucleotidase, and the mitochondrial marker succinate cytochrome c reductase, but not the microsomal marker NADH cytochrome c redu.ctase. Binding of L-[OH]alanine was measured using a Millipore filter method in which correction for non-specific binding was also determined. Time, temperature, and pH for measuring binding activity were established. At the optimal pH of 7.8, the KD for L-alanine is 4.8 X 10(-6) M. The first order dissociation rate constant at 6 degrees is 3.8 X 10(-4) s-1 and at 24 degrees it is 12.1 X 10(-4) s-1. The second order rate constant for association is between 10(2) and 10(3) M-1 S-1. Reversibility of the binding interaction was also demonstrates by the rapid displacement of bound L-[3H]alanine by a large excess of unlabeled L-alanine. That the binding does not represent incorporation into protein was confirmed by the lack of effect of puromycin. The amounts bound of several other chemostimulatory amino acids werealso determined. Krueger J M JM Cagan R H RH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Biol Chem 2985121R 0021-9258 0 Receptors, Drug 4A6ZS6Q2CL Puromycin OF5P57N2ZX Alanine IM Alanine metabolism Animals Binding Sites Binding, Competitive Cyprinidae physiology Epithelium metabolism Freezing Hydrogen-Ion Concentration Kinetics Protein Binding Puromycin pharmacology Receptors, Drug drug effects Skin metabolism Taste Buds metabolism 1976 1 10 1976 1 10 0 1 1976 1 10 0 0 ppublish 403 404 1976 02 09 2020 02 25 0021-9509 16 5 1975 Sep-Oct The Journal of cardiovascular surgery J Cardiovasc Surg (Torino) Arterialization of the coronary veins in diffuse coronary arteriosclerosis. 520-5 Since the coronary veins and capillaries are not involved with arteriosclerotic disease the authors performed experimental, and afterwards, clinical total and selective coronary vein arterialization. Acute myocardial ischaemia created for instance by ligation of the anterior descending branch, was treated by an internal mammary artery to regional coronary vein anastomosis. In 21 patients the selective arterialization of the "Vena cordis magna" or of "Vena cordis media", and total arterialization of the coronary sinus was performed. The clinical improvement and follow-up studies seem to be promising in the treatment of patients with advanced diffuse heavy coronary arteriosclerosis. In acute myocardial ischaemia with coronarographically localized coronary occlusion, the aim of regional vein arterialization is to minimize the area of infarction. Moll J W JW Dziatkowiak A J AJ Edelman M M Iljin W W Ratajczyk-Pakalska E E Stengert K K eng Journal Article Italy J Cardiovasc Surg (Torino) 0066127 0021-9509 IM Adult Aged Coronary Disease surgery Coronary Vessels surgery Female Follow-Up Studies Humans Male Methods Middle Aged Myocardial Revascularization Veins surgery 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 404 J Asthma. 2003;40(5):515-22 14529101 Am J Respir Crit Care Med. 2004 Nov 1;170(9):960-6 15184207 Clin Ther. 2006 Mar;28(3):319-31 16750447 Prim Care Respir J. 2007 Jun;16(3):149-54 17530144 J Clin Endocrinol Metab. 2010 Nov;95(11):4855-63 20719838 405 1976 02 13 2019 02 06 0021-9509 16 6 1975 Nov-Dec The Journal of cardiovascular surgery J Cardiovasc Surg (Torino) Preparations of internal mammary arteries for coronary bypass with intraluminal papaverine. 632-3 Mills N L NL Ochsner J L JL eng Journal Article Italy J Cardiovasc Surg (Torino) 0066127 0021-9509 DAA13NKG2Q Papaverine IM Blood Flow Velocity Dilatation Humans Injections, Intra-Arterial Internal Mammary-Coronary Artery Anastomosis methods Myocardial Revascularization methods Papaverine administration & dosage 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 405 406 1976 02 13 2019 05 08 0021-9525 67 2PT.1 1975 Nov The Journal of cell biology J Cell Biol Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. 281-309 Peroxisome proliferation has been induced with 2-methyl-2-(p-[1,2,3,4-tetrahydro-1-naphthyl]-phenoxy)-propionic acid (Su-13437). DNA, protein, cytochrome oxidase, glucose-6-phosphatase, and acid phosphatase concentrations remain almost constant. Peroxisomal enzyme activities change to approximately 165%, 50%, 30%, and 0% of the controls for catalase, urate oxidase, L-alpha-hydroxy acid oxidase, and D-amino acid oxidase, respectively. For catalase the change results from a decrease in particle-bound activity and a fivefold increase in soluble activity. The average diameter of peroxisome sections is 0.58 +/- 0.15 mum in controls and 0.73 +/- 0.25 mum after treatment. Therefore, the measured peroxisomal enzymes are highly diluted in proliferated particles. After tissue fractionation, approximately one-half of the normal peroxisomes and all proliferated peroxisomes show matric extraction with ghost formation, but no change in size. In homogenates submitted to mechanical stress, proliferated peroxisomes do not reveal increased fragility; unexpectedly, Su-13437 stabilizes lysosomes. Our results suggest that matrix extraction and increased soluble enzyme activities result from transmembrane passage of peroxisomal proteins. The changes in concentration of peroxisomal oxidases and soluble catalase after Su-13437 allow the calculation of their half-lives. These are the same as those found for total catalase, in normal and treated rats, after allyl isopropyl acetamide: about 1.3 days, a result compatible with peroxisome degradation by autophagy. A sequential increase in liver RNA concentration, [14C]leucine incorporation into DOC-soluble proteins and into immunoprecipitable catalase, and an increase in liver size and peroxisomal volume per gram liver, characterize the trophic effect of the drug used. In males, Su-13437 is more active than CPIB, another peroxisome proliferation-inducing drug; in females, only Su-13437 is active. Leighton F F Coloma L L Koenig C C eng Journal Article United States J Cell Biol 0375356 0021-9525 0 Antigens 0 Hydroxy Acids 0 Propionates 093W78U96W Nafenopin EC 1.- Oxidoreductases EC 1.11.1.6 Catalase EC 1.4.3.3 D-Amino-Acid Oxidase EC 1.7.3.3 Urate Oxidase EC 3.1.3.2 Acid Phosphatase GMW67QNF9C Leucine HPN91K7FU3 Clofibrate IM Acid Phosphatase analysis Animals Antigens Catalase analysis immunology Cell Fractionation Clofibrate pharmacology D-Amino-Acid Oxidase analysis metabolism Female Histocytochemistry Hydroxy Acids Leucine metabolism Liver drug effects ultrastructure Male Microbodies drug effects metabolism ultrastructure Nafenopin pharmacology Organoids drug effects Oxidoreductases analysis Propionates pharmacology Protein Biosynthesis Rats Urate Oxidase analysis metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 406 PMC2109608 10.1083/jcb.67.2.281 Biochimie. 1973;55(11):1491-4 4151476 J Histochem Cytochem. 1969 Oct;17(10):675-80 4194356 J Cell Biol. 1974 May;61(2):344-58 4208071 J Cell Biol. 1967 Dec;35(3):631-48 4294244 J Cell Biol. 1968 May;37(2):482-513 4297786 J Cell Biol. 1971 Jan;48(1):61-78 4322718 J Membr Biol. 1972 Dec 29;10(3):345-56 4356143 FEBS Lett. 1973 Oct 15;36(2):163-8 4356785 Mol Pharmacol. 1965 Sep;1(2):149-56 4378655 Biochem J. 1964 Jul;92(1):179-84 4378796 J Cell Biol. 1965 Jul;26(1):219-43 4379260 Biochemistry. 1966 Jan;5(1):203-12 4380071 J Biol Chem. 1968 Oct 25;243(20):5385-95 4387403 J Cell Biol. 1969 May;41(2):521-35 4389026 Annu Rev Biochem. 1970;39:929-76 4394639 J Biol Chem. 1973 May 25;248(10):3426-32 4702872 Exp Parasitol. 1973 Aug;34(1):44-55 4722484 J Cell Biol. 1973 Aug;58(2):379-89 4729505 Eur J Biochem. 1973 Sep 3;37(3):553-62 4777253 J Cell Biol. 1973 Nov;59(2 Pt 1):507-24 4805011 J Biochem. 1965 Dec;58(6):530-7 4956394 J Cell Biol. 1967 Oct;35(1):127-52 4964831 Fed Proc. 1971 May-Jun;30(3):835-40 4996475 Toxicol Appl Pharmacol. 1972 Sep;23(1):42-53 5071041 Biochem Biophys Res Commun. 1972 Sep 26;48(6):1371-7 5077823 J Biol Chem. 1971 Nov;246(21):6587-91 5132672 Arch Biochem Biophys. 1971 May;144(1):204-8 5165697 Ann N Y Acad Sci. 1969 Dec 19;168(2):342-7 5270942 Ann N Y Acad Sci. 1969 Dec 19;168(2):369-81 5270945 Physiol Rev. 1966 Apr;46(2):323-57 5325972 Biochim Biophys Acta. 1969 Nov 4;191(2):488-90 5357727 J Atheroscler Res. 1969 Sep-Oct;10(2):235-46 5381845 Clin Pharmacol Ther. 1970 Jan-Feb;11(1):97-105 5410898 Biochim Biophys Acta. 1970 Jul 27;214(1):230-2 5488944 Atherosclerosis. 1970 Sep-Oct;12(2):185-92 5493088 J Biol Chem. 1971 Apr 25;246(8):2574-83 5553411 Experientia. 1968 May 15;24(5):418-9 5674960 J Cell Biol. 1969 Mar;40(3):734-46 5765763 J Cell Biol. 1969 May;41(2):536-46 5783872 Experientia. 1969;25(7):699-700 5801782 Nature. 1965 Nov 27;208(5013):856-8 5870099 J Cell Biol. 1966 Aug;30(2):442-50 5968981 J Cell Biol. 1967 Aug;34(2):597-615 6035648 Biochem J. 1955 Aug;60(4):604-17 13249955 Biochem J. 1956 Feb;62(2):315-23 13293190 J Biophys Biochem Cytol. 1959 Aug;6(1):113-4 13673056 J Biol Chem. 1962 Nov;237:3468-75 13986151 J Biol Chem. 1963 Dec;238:3945-51 14086728 J Cell Biol. 1965 May;25:407-8 14287192 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Plant Physiol. 1971 Nov;48(5):637-41 16657851 407 1976 03 01 2019 05 08 0021-9525 67 3 1975 Dec The Journal of cell biology J Cell Biol Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. 566-86 The ultrastructural localization of NADH oxidase, a possible enzyme in the increased oxidative activity of polymorphonuclear leukocytes (PMN) during phagocytosis, was studied. A new cytochemical technique for the localization of H2O2, a product of NADH oxidase activity, was developed. Cerous ions, in the presence of peroxide, form an electron-dense precipitate. Resting and phagocytically stimulated PMN were exposed to cerous ions at pH 7.5 to demonstrate sites of NADH-dependent, cyanide-insensitive H2O2 production. Resting PMN exhibites slight activity on the plasma membrane; phagocytizing PMN had extensive deposits of reaction product localized within the phagosome and on the plasma membrane. Peroxide involvement was demonstrated by the inhibitory effect of catalase on cerium precipitation; the surface localization of the enzyme responsible was confirmed by using nonpenetrating inhibitors of enzymatic activity. A correlative study was performed with an NADH-dependent, tetrazolium-reduction system. As with cerium, formazan deposition on the surface of the cell was NADH dependent, cyanide insensitive, and stimulated by phagocytosis. Superoxide dismutase did not inhibit tetrazolium reduction, as observed cytochemically, indicating direct enzymatic dye reduction without superoxide interposition. These findings, combined with oxygen consumption studies on resting and stimulated PMN in the presence or absence of NADH, indicate that NADH oxidase is a surface enzyme in human PMN. It is internalized during phagocytosis and retains its peroxide-generating capacity within the phagocytic vacuole. Briggs R T RT Drath D B DB Karnovsky M L ML Karnovsky M J MJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Biol 0375356 0021-9525 0 Cyanides 0 Lipopolysaccharides 0 Sulfhydryl Reagents 0U46U6E8UK NAD 1HG84L3525 Formaldehyde 298-83-9 Nitroblue Tetrazolium 30K4522N6T Cerium 53-59-8 NADP BBX060AN9V Hydrogen Peroxide EC 1.11.1.6 Catalase EC 1.6.- NADH, NADPH Oxidoreductases RWP5GA015D Potassium T3C89M417N Glutaral IM Animals Catalase pharmacology Cell Membrane enzymology Cerium metabolism Cyanides pharmacology Cytoplasmic Granules ultrastructure Formaldehyde pharmacology Glutaral pharmacology Guinea Pigs Histocytochemistry methods Humans Hydrogen Peroxide metabolism Lipopolysaccharides pharmacology NAD pharmacology NADH, NADPH Oxidoreductases metabolism NADP metabolism Neutrophils drug effects enzymology metabolism ultrastructure Nitroblue Tetrazolium metabolism Oxygen Consumption drug effects Phagocytosis drug effects Potassium Sulfhydryl Reagents pharmacology Vacuoles ultrastructure 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 407 PMC2111669 10.1083/jcb.67.3.566 J Pathol Bacteriol. 1953 Jul;66(1):135-46 13109626 J Biol Chem. 1964 Jun;239:2022-6 14213392 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Biochem Biophys Res Commun. 1973 Aug 6;53(3):830-7 4125982 J Clin Invest. 1974 Nov;54(5):1227-34 4153897 J Clin Invest. 1973 Mar;52(3):741-4 4346473 N Engl J Med. 1968 May 2;278(18):971-6 4384563 Annu Rev Med. 1971;22:39-62 4400133 Clin Sci Mol Med. 1973 Dec;45(6):817-26 4586397 J Clin Invest. 1974 May;53(5):1207-15 4596505 N Engl J Med. 1974 Jan 31;290(5):280-1 4808930 Biochim Biophys Acta. 1968 Feb 1;156(1):168-78 4868928 J Cell Biol. 1969 Jan;40(1):216-24 4881437 J Exp Med. 1967 Dec 1;126(6):1063-78 4964565 J Biol Chem. 1968 Nov 10;243(21):5753-60 4972775 J Reticuloendothel Soc. 1972 Aug;12(2):170-96 5075520 J Clin Invest. 1969 Oct;48(10):1895-904 5387730 Science. 1967 Feb 17;155(3764):835-6 6018195 Blood. 1967 May;29(5):737-46 6023547 J Cell Biol. 1967 Mar;32(3):629-47 6034482 J Clin Invest. 1967 Sep;46(9):1422-32 6036538 J Cell Biol. 1975 Jan;64(1):254-60 1109235 J Cell Biol. 1963 Jun;17:487-501 13940299 Nature. 1964 Apr 4;202:85-6 14166725 Nature. 1964 Oct 17;204:255-7 14212420 J Cell Biol. 1965 May;25:407-8 14287192 J Gen Physiol. 1965 Mar;48:617-32 14324978 Physiol Rev. 1962 Jan;42:143-68 14454025 Biochem Biophys Res Commun. 1975 Feb 17;62(4):966-71 235265 J Histochem Cytochem. 1971 Jul;19(7):405-15 4105040 J Clin Invest. 1971 Aug;50(8):1745-7 4106463 Lancet. 1974 Nov 23;2(7891):1248-52 4139481 Fed Proc. 1973 Apr;32(4):1527-33 4144970 Nat New Biol. 1973 May 23;243(125):111-2 4145342 Biochim Biophys Acta. 1969 Jun 3;183(1):65-78 4183114 Science. 1974 Mar 15;183(4129):1096-8 4204581 Arch Oral Biol. 1973 Apr;18(4):505-16 4516063 Life Sci I. 1970 Aug 1;9(15):841-9 4320212 N Engl J Med. 1974 Mar 14;290(11):593-7 4359964 J Clin Invest. 1974 Jun;53(6):1662-72 4364409 J Biol Chem. 1974 Nov 25;249(22):7111-20 4373458 Science. 1968 Dec 13;162(3859):1277-9 4387010 Biochim Biophys Acta. 1971 Apr 6;234(1):43-5 4397788 Arch Biochem Biophys. 1971 Jul;145(1):255-62 4399354 Exp Cell Res. 1972 Aug;73(2):456-62 4403379 J Clin Invest. 1974 Oct;54(4):1005-9 4430711 408 1976 03 01 2019 05 08 0021-9525 67 3 1975 Dec The Journal of cell biology J Cell Biol Defective lysosomal enzyme secretion in kidneys of Chediak-Higashi (beige) mice. 774-88 The beige mouse is an animal model for the human Chediak-Higashi syndrome, a disease characterized by giant lysosomes in most cell types. In mice, treatment with androgenic hormones causes a 20-50-fold elevation in at least one kidney lysosomal enzyme, beta-glucuronidase. Beige mice treated with androgen had significantly higher kidney beta-glucuronidase, beta-galactosidase, and N-acetyl-beta-D-glucosaminidase (hexosaminidase) levels than normal mice. Other androgen-inducible enzymes and enzyme markers for the cytosol, mitochondria, and peroxisomes were not increased in kidney of beige mice. No significant lysosomal enzyme elevation was observed in five other organs of beige mice with or without androgen treatment, nor in kidneys of beige females not treated with androgen. Histochemical staining for glucuronidase together with subcellular fractionation showed that the higher glucuronidase content of beige mouse kidney is caused by a striking accumulation of giant glucuronidase-containing lysosomes in tubule cells near the corticomedullary boundary. In normal mice lysosomal enzymes are coordinately released into the lumen of the kidney tubules and appreciable amounts of lysosomal enzymes are present in the urine. Levels of urinary lysosomal enzymes are much lower in beige mice than in normal mice. It appears that lysosomes may accumulate in beige mice because of defective exocytosis resulting either from decreased intracellular motility of lysosomes or from their improper fusion with the plasma membrane. A similar defect could account for characteristics of the Chediak-Higashi syndrome. Brandt E J EJ Elliott R W RW Swank R T RT eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Biol 0375356 0021-9525 0 Proteins 3XMK78S47O Testosterone EC 1.1.- Alcohol Oxidoreductases EC 1.3.99.1 Succinate Dehydrogenase EC 1.4.3.3 D-Amino-Acid Oxidase EC 3.2.1.- Galactosidases EC 3.2.1.- Hexosaminidases EC 3.2.1.31 Glucuronidase IM Alcohol Oxidoreductases metabolism Animals Carbohydrate Metabolism Chediak-Higashi Syndrome enzymology Cytoplasmic Granules ultrastructure D-Amino-Acid Oxidase metabolism Disease Models, Animal enzymology Enzyme Induction Female Galactosidases metabolism Glucuronidase metabolism Hexosaminidases metabolism Kidney enzymology ultrastructure Lipid Metabolism Liver enzymology Lysosomes enzymology Mice Mice, Inbred C57BL Myocardium enzymology Proteins metabolism Spleen enzymology Succinate Dehydrogenase metabolism Testosterone pharmacology 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 408 PMC2111673 10.1083/jcb.67.3.774 Nature. 1975 Feb 6;253(5491):471-3 163013 Anal Biochem. 1972 Dec;50(2):344-53 4118996 Am J Pathol. 1973 Oct;73(1):217-32 4127163 Nat New Biol. 1971 Jun 2;231(22):131-5 4326352 J Clin Invest. 1972 Mar;51(3):649-65 4400956 Am J Pathol. 1974 Dec;77(3):407-22 4432912 Proc Natl Acad Sci U S A. 1973 May;70(5):1442-6 4514314 Blood. 1974 Feb;43(2):201-6 4589319 Genetics. 1972 Nov;72(3):451-60 4643821 J Histochem Cytochem. 1973 Mar;21(3):218-28 4697831 J Mol Biol. 1973 Jul 5;77(3):371-89 4727071 Histochemie. 1973 Oct 26;37(2):169-85 4766986 J Mol Biol. 1973 Dec 5;81(2):225-43 4777306 Biochem Genet. 1974 Apr;11(4):325-35 4838000 Biochem Genet. 1974 May;11(5):367-72 4841975 Am J Pathol. 1972 May;67(2):227-36 5021101 Proc Natl Acad Sci U S A. 1967 Sep;58(3):938-45 5233850 Blood. 1967 Jun;29(6):906-15 5339467 Science. 1965 Aug 27;149(3687):981-2 5827345 J Biol Chem. 1975 Feb 10;250(3):1146-8 1112792 Endocrinology. 1953 Jun;52(6):692-7 13060280 Scand J Clin Lab Invest. 1953;5(3):218-22 13135413 Can J Biochem Physiol. 1959 Aug;37(8):911-7 13671378 J Hered. 1963 Mar-Apr;54:47-50 13943454 J Histochem Cytochem. 1964 Apr;12:293-7 14187340 J Cell Biol. 1964 Jun;21:295-308 14189907 Exp Cell Res. 1961 Nov;25:286-301 14483210 Ann N Y Acad Sci. 1951 Dec;54(4):548-57 14903798 409 1976 02 09 2020 02 25 0021-9541 86 2 Pt 1 1975 Oct Journal of cellular physiology J Cell Physiol Stimulation of 2-deoxy-d-glucose transport in control and virus-transformed cells by ethidium bromide. 269-80 Recently we demonstrated that ethidium bromide altered the plasma and subcellular membrane glycoproteins in control and virus transformed cells. It is reported here that ethidium bromide also stimulated the membrane associated process of sugar transport. The KM of the virus transformed cells and the ethidium bromide treated cells is the same as that of the control cells while the maximum velocity as compared to the control cells is significantly increased. The transport of 2-deoxyl-D-glucose was inhibited by glucose, cytochalasin B and neuraminidase but was unaffected by variations in cell density or pH of the incubation medium. Soslau G G Nass M M MM eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Physiol 0050222 0021-9541 0 Deoxy Sugars 3CHI920QS7 Cytochalasin B 9G2MP84A8W Deoxyglucose EC 3.2.1.18 Neuraminidase EN464416SI Ethidium IY9XDZ35W2 Glucose IM Avian Sarcoma Viruses Biological Transport, Active drug effects Cell Count Cell Line Cell Transformation, Neoplastic Cytochalasin B pharmacology Deoxy Sugars metabolism Deoxyglucose metabolism Ethidium pharmacology Glucose pharmacology Hydrogen-Ion Concentration Kinetics Neuraminidase pharmacology Stimulation, Chemical Temperature 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 409 10.1002/jcp.1040860211 Lancet. 2000 Sep 16;356(9234):998 11041402 Postgrad Med J. 1981 May;57(667):294-6 6117845 410 1976 02 09 2019 02 06 0021-9541 86 2 Pt 1 1975 Oct Journal of cellular physiology J Cell Physiol Effect of pharmacological agents on human keratinocyte mitosis in vitro. II. Inhibition by catecholamines. 293-9 Catecholamines produce mitotic inhibition in primary cell cultures of human keratinocytes probably via a block in the G2 part of the cell cycle. Epinephrine produced significant mitotic inhibition (49%) at a concentration as low as 4.5 X 10(-10) M, while its analog, isoproterenol, produced 47% inhibition at 1 X 10(-10) M. Norepinephrine elicited a 49% inhibitory response at 1 X 10(-8) M. One other catecholamine, dopamine, caused a 53% decrease in mitosis at 1 X 10(-6) M. Other structurally related amines to exhibit mitotic inhibition were phenylephrine, 58% at 1 X 10(-7) M; octopamine, 47% at 1 X 10(-5) M; and tyramine, 52% at 1 X 10(-4) M. Serotonin showed no mitotic inhibition at 1 X 10(-4) M. Various alpha and beta adrenergic blocking agents were added to the cell system. The alpha blocking agent, phentolamine, had no effect on mitosis. When added in conjunction with epinephrine or norepinephrine, no reduction of the catecholamine-induced mitotic inhibition was observed. The beta blocking agent, propranolol, by itself showed slight mitotic inhibition at 1 X 10(-6) M. When added along with epinephrine or noreinephrine, propranolol reduced the catecholamine-induced mitotic inhibition approximately 65%. In addition, propranolol blocked mitotic inhibition caused by phenylephrine, an alpha adrenergic agent. However, another beta blocking agent, dichloroisoproterenol, showed strong mitotic inhibition (53%) when added to the cultures at a concentration of 1 X 10(-8) M. The effect was reduced to zero in the presence of propranolol. These data suggest that while beta receptors may be involved in the catecholamine-induced mitotic inhibition of human keratinocytes in vitro, the nature of the receptor-molecule interaction may be complex. Harper R A RA Flaxman B A BA eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Physiol 0050222 0021-9541 0 Catecholamines 0 Tryptamines 14O50WS8JD Octopamine 1WS297W6MV Phenylephrine 333DO1RDJY Serotonin 9Y8NXQ24VQ Propranolol L628TT009W Isoproterenol VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine X8ZC7V0OX3 Tyramine YKH834O4BH Epinephrine Z468598HBV Phentolamine IM Catecholamines pharmacology Dopamine pharmacology Dose-Response Relationship, Drug Epinephrine pharmacology Humans Isoproterenol pharmacology Mitosis drug effects Norepinephrine pharmacology Octopamine pharmacology Phentolamine pharmacology Phenylephrine pharmacology Propranolol pharmacology Serotonin pharmacology Skin cytology Structure-Activity Relationship Tryptamines pharmacology Tyramine pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 410 10.1002/jcp.1040860213 411 1976 02 09 2019 10 27 0021-9541 86 2 PT 2 SUPPL 1 1975 Oct Journal of cellular physiology J Cell Physiol Serum-free growth of HTC cells containing glucocorticoid- and insulin-inducible tyrosine aminotransferase and cytoplasmic glucocorticoid receptors. 403-11 HTC cells have been made to grow in chemically defined medium without any macromolecular supplements whatsoever. Initial estimates of their relative amino acid requirements have been made. The cells grown in the defined medium retain many of the differentiated features which have been the focus of investigation in their serum-grown counterparts. Thus, the cells in defined medium contain cytoplasmic glucocorticoid receptors and have tyrosine aminotransferase which can be induced by glucocorticoids, serum or insulin. These cells also produce, in small amounts, an as yet undefined rat serum protein. Thompson E B EB Anderson C U CU Lippman M E ME eng Journal Article United States J Cell Physiol 0050222 0021-9541 0 Culture Media 0 Glucocorticoids 0 Growth Substances 0 Insulin 0 Receptors, Cell Surface 1CC1JFE158 Dactinomycin 7S5I7G3JQL Dexamethasone EC 2.6.1.5 Tyrosine Transaminase WI4X0X7BPJ Hydrocortisone IM Cell Survival Clone Cells enzymology Culture Media Dactinomycin pharmacology Dexamethasone pharmacology Enzyme Induction Glucocorticoids pharmacology Growth Substances biosynthesis Hydrocortisone pharmacology Insulin pharmacology Receptors, Cell Surface Tyrosine Transaminase biosynthesis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 411 10.1002/jcp.1040860412 412 1976 03 01 2020 02 25 0021-9541 86 3 Pt 1 1975 Dec Journal of cellular physiology J Cell Physiol Stimulation of lactic acid production in chick embryo fibroblasts by serum and high pH in the absence of external glucose. 453-7 Lactic acid production by chick embryo fibroblasts occurs in the absence of exogenous glucose. Fifteen to 50-fold less lactic acid is formed in the absence of glucose than in its presence. Nevertheless, serum and pH stimulation enhances this residual lactic acid production to the same relative extent as when glucose is present. The amount of lactic acid formed cannot be accounted for by the catabolism of residual glucose in the medium since its concentration is less than one-tenth that of the lactic acid eventually produced. Moreover, the residual glucose concentration remains constant or increases during the course of the experiment. To a large extent lactic acid accumulation in the absence of external glucose is dependent on the presence of amino acids in the medium, but amino acid transport is not affected by the stimulatory agents used in this study. The results suggest that treatments which stimulate cell multiplication also activate those enzymatic pathways which convert amino acids to pyruvic and thence to lactic acid. Fodge D W DW Rubin H H eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Physiol 0050222 0021-9541 0 Amino Acids 0 Culture Media 0 Lactates 30KYC7MIAI Aspartic Acid 9007-49-2 DNA GMW67QNF9C Leucine IY9XDZ35W2 Glucose IM Amino Acids pharmacology Aspartic Acid metabolism Blood Cells, Cultured Culture Media DNA biosynthesis Glucose pharmacology Hydrogen-Ion Concentration Kinetics Lactates biosynthesis Leucine metabolism Stimulation, Chemical 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 412 10.1002/jcp.1040860303 BMC Health Serv Res. 2006 Apr 03;6:43 16584544 413 1976 03 01 2020 02 25 0021-9541 86 3 Pt 1 1975 Dec Journal of cellular physiology J Cell Physiol Isolation and studies of the granules of the amebocytes of Limulus polyphemus, the horseshoe crab. 533-42 Granules were isolated from the cytoplasm of the amebocytes of Limulus polyphemus, the horseshoe crab, by disruption of cells obtained from blood which had been drawn into 2 mM propranolol. The granules subsequently were purified by centrifugation through a sucrose gradient that contained heparin. Extracts of the granules were prepared by freezing and thawing the granule preparations in distilled water. Transmission and scanning electron microscopy of the granules revealed round or ovoid particles. However, only one type of granule appeared to be present. The ultraviolet spectrum of the extract of amebocyte granules demonstrated a peak at 277 nm at pH 7.4, and a shift into two peaks of 281 nm and 290 nm at alkaline pH. Analytical ultracentrifugation revealed a pattern similar to that observed with lysates prepared from intact amebocytes. Polyacrylamide gel electrophoresis, in the presence of urea at pH 4.5, demonstrated patterns similar to those observed with amebocyte lysate. Extracts of the granules were gelled by bacterial endotoxin. The blood of the horseshoe crab contains only one type of cell, the amebocyte. Previous studies have shown that the blood coagulation mechanism of Limulus is contained entirely within amebocytes. The current studies suggest that the granules, which pack the cytoplasm of these cells, contain all of the factors required for the coagulation of blood, including the clottable protein. The intracellularly localized coagulation system is released from amebocytes when their granules rupture during cell aggregation. Mürer E H EH Levin J J Holme R R eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Cell Physiol 0050222 0021-9541 0 Proteins IM Animals Arachnida ultrastructure Blood Cells ultrastructure Cell Fractionation Cytoplasmic Granules analysis ultrastructure Hydrogen-Ion Concentration Membranes ultrastructure Proteins analysis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 413 10.1002/jcp.1040860310 J Psychiatr Ment Health Nurs. 1998 Oct;5(5):343-53 10067481 J R Coll Physicians Lond. 1992 Oct;26(4):413-22 1432885 414 1976 02 20 2019 10 27 0021-9584 52 12 1975 Dec Journal of chemical education J Chem Educ The enzyme kinetics of phospholipase A. A student experiment. 816-7 Devine J E JE Toom P M PM eng Journal Article United States J Chem Educ 2985122R 0021-9584 0 Snake Venoms EC 3.1.- Phospholipases IM Hydrogen-Ion Concentration Kinetics Phospholipases analysis Snake Venoms analysis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 414 10.1021/ed052p816 415 1976 02 21 2017 03 22 0300-922X 21 1975 Journal of the Chemical Society. Perkin transactions 1 J Chem Soc Perkin 1 Carotenoids and related compounds. Part XXXII. Synthesis of astaxanthin, phoenicoxanthin, hydroxyechinenone, and the corresponding diosphenols. 2195-2204 Cooper R D RD Davis J B JB Leftwick A P AP Price C C Weedon B C BC eng Journal Article England J Chem Soc Perkin 1 7505598 0300-922X 36-88-4 Carotenoids IM Carotenoids chemical synthesis Hydrogen-Ion Concentration Methods Oxidation-Reduction 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 415 416 1976 03 01 2019 06 29 114 2 1975 Nov 26 Journal of chromatography J Chromatogr Purification of human red cell glucose 6-phosphate dehydrogenase by affinity chromatography. 321-7 Human glucose 6-phosphate dehydrogenase associated with NADPH was efficiently bound with agarose-bound NADP, whereas the enzyme associated with NADP was poorly bound with agarose-bound NADP. After the elimination of haemoglobin from haemolyzate by treatment with DEAE-cellulose, the enzyme was converted into the NADPH-bound form and was applied on an affinity column. The enzyme was specifically eluted from the column by NADP in the elution buffer. A homogeneous enzyme preparation was obtained in high yield. Yoshida A A eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Netherlands J Chromatogr 0427043 0 Buffers 53-59-8 NADP 9012-36-6 Sepharose EC 1.1.1.49 Glucosephosphate Dehydrogenase IM Binding Sites Buffers Chromatography, Affinity Chromatography, DEAE-Cellulose Erythrocytes enzymology Glucosephosphate Dehydrogenase isolation & purification Humans NADP analysis Sepharose 1975 11 26 1975 11 26 0 1 1975 11 26 0 0 ppublish 416 10.1016/s0021-9673(01)91996-x 417 1976 03 01 2019 12 10 114 2 1975 Nov 26 Journal of chromatography J Chromatogr Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography. 351-9 A quantitative method for the simultaneous determination of propranolol and its active metabolite 4-hydroxypropranolol in human plasma is described. Plasma samples are extracted at pH 9.6 with ethyl acetate after the addition of sodium bisulphite and the internal standard oxprenolol. The extracts are derivatized with trifluoroacetic anhydride before separation on a gas chromatograph--mass spectrometer. Detection and quantitation of the trifluoroacetyl derivatives are made by single-ion monitoring. The minimum detectable concentration of propranolol is 1 ng/ml and of 4-hydroxypropranolol 5 ng/ml using 1-ml plasma samples. No interferences from normal plasma constituents or from drugs commonly prescribed together with propranolol were detected. Walle T T Morrison J J Walle K K Conradi E E eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands J Chromatogr 0427043 2449QP4SVP 4-hydroxypropranolol 9Y8NXQ24VQ Propranolol IM Chromatography, Gas Gas Chromatography-Mass Spectrometry Hydrogen-Ion Concentration Methods Propranolol analogs & derivatives blood 1975 11 26 1975 11 26 0 1 1975 11 26 0 0 ppublish 417 10.1016/s0021-9673(01)92000-x 418 1976 03 01 2019 06 29 115 1 1975 Dec 10 Journal of chromatography J Chromatogr High pressure liquid chromatography on cannabis. Identification of separated constituents. 101-6 Delta9-and-delta8-Tetrahydrocannabinol, delta9-tetrahydrocannabinolic acid, cannabidiol, cannabidolic acid, cannabinol, cannabinolic acid, cannabichromene and cannabichromenic acid were located in the liquid chromatogram of cannabis. Identifications were confirmed by gas chromatography-mass spectrometry. Smith R N RN eng Journal Article Netherlands J Chromatogr 0427043 0 Solvents 19GBJ60SN5 Cannabidiol 7J8897W37S Dronabinol IM Cannabidiol analysis Cannabis analysis Chromatography, High Pressure Liquid Dronabinol analogs & derivatives analysis Hydrogen-Ion Concentration Mass Spectrometry Solvents 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 418 10.1016/s0021-9673(00)89021-4 419 1976 03 01 2019 06 29 115 1 1975 Dec 10 Journal of chromatography J Chromatogr Amino acid analysis by ion-exchange chromatography using a lithium elution gradient. Influence of methanol concentration and sample pH. 33-40 The separation of amino acids has been achieved on a short column of Chromo-Beads C2 resin, with a lithium gradient-elution system. The analysis took 8 h. The separation of asparagine and glutamine from glutamic acid was highly dependent on the sample pH and on the methanol concentration in the first buffer of the gradient. The method has been applied to analysis of human plasma and granulocytes for amino acids. Houpert Y Y Tarallo P P Siest G G eng Journal Article Netherlands J Chromatogr 0427043 0 Amino Acids 0 Glutamates 0 Ion Exchange Resins 0RH81L854J Glutamine 7006-34-0 Asparagine 9FN79X2M3F Lithium Y4S76JWI15 Methanol IM Amino Acids blood Asparagine analysis Chromatography, Ion Exchange methods Glutamates analysis Glutamine analysis Granulocytes analysis Humans Hydrogen-Ion Concentration Ion Exchange Resins Lithium Methanol 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 419 10.1016/s0021-9673(00)89013-5 420 1976 03 01 2019 12 10 115 1 1975 Dec 10 Journal of chromatography J Chromatogr Determination of 3-(5-tetrazolyl) thioxanthone 10,10-dioxide in human plasma, urine and faeces. 93-9 A gas chromatographic method is described for assay of 3-(5-tetrazolyl) thioxanthone 10,10-dioxide (BW 59C) in human plasma, urine and faeces. After extraction into 1,2-dichloroethane from alkaline medium the compound is converted to the heptafluorobutyrate derivative which is injected into a gas chromatograph and measured using a 63Ni electron capture detector. The assay produces a linear calibration curve over the range 0-30 mug/ml when the internal standard method is used. Reproducibility is good and sensitivity down to 1 ng injected on column is possible. The method has been used to investigate the pharmacokinetic properties of BW 59C in man and has been semi-automated by the use of an autosampler and dedicated computer. Bye A A Land G G eng Journal Article Netherlands J Chromatogr 0427043 0 Tetrazoles 0 Thioxanthenes 0 Xanthones U5Q9UW0HCH doxantrazole IM Chromatography, Gas methods Feces analysis Humans Hydrogen-Ion Concentration Tetrazoles analysis blood urine Thioxanthenes analysis blood urine Xanthones 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 420 10.1016/s0021-9673(00)89020-2 421 1976 02 20 2018 11 13 0095-1137 2 5 1975 Nov Journal of clinical microbiology J Clin Microbiol Methods to improve detection of pneumococci in respiratory secretions. 453-5 Simple methods to enhance the detection of pneumococci in respiratory secretions are needed. Sheep blood agar containing 5 mug of gentamicin per ml was more often positive (89%) than either standard sheep blood agar (54%) or mouse inoculation (65%) in recovering pneumococci from 62 adult and pediatric patients. In adults, the direct quellung test on sputum smear was a rapid, sensitive method for predicting subsequent pneumococcal isolation by culture (19 of 20 patients, 95%). The quellung test and gentamicin plate show improved sensitivity over current techniques for pneumococcal detection and can be recommended for general use. Dilworth J A JA Stewart P P Gwaltney J M JM Jr Hendley J O JO Sande M A MA eng Comparative Study Journal Article United States J Clin Microbiol 7505564 0095-1137 0 Gentamicins 9002-18-0 Agar IM Adult Agar Animals Bacteriological Techniques Blood Child Child, Preschool Evaluation Studies as Topic Gentamicins Humans Pharynx microbiology Sheep Sputum microbiology Streptococcus pneumoniae growth & development isolation & purification 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 421 PMC274207 Lancet. 1953 Sep 12;265(6785):534-7 13097990 Ann Intern Med. 1964 May;60:759-76 14156606 N Engl J Med. 1973 Mar 8;288(10):510-2 4119290 Med Clin North Am. 1974 May;58(3):555-64 4132588 Am Rev Respir Dis. 1974 May;109(5):577-8 4150886 Appl Microbiol. 1973 Jun;25(6):905-7 4352009 Johns Hopkins Med J. 1967 Jan;120(1):46-8 4381206 Am Rev Respir Dis. 1968 Apr;97(4):533-45 4384558 Am J Med Sci. 1969 Jan;257(1):44-51 4387669 Am Rev Respir Dis. 1971 Jun;103(6):845-8 4397407 Infect Immun. 1972 Oct;6(4):431-7 4628896 Br Med J. 1966 Jan 22;1(5481):203-5 5901728 422 1976 03 01 2018 11 13 0021-9738 56 6 1975 Dec The Journal of clinical investigation J Clin Invest Dependence on dose of the acute effects of ethanol on liver metabolism in vivo. 1411-9 The dose dependence of the acute effects of ethanol upon liver intermediary metabolism in vivo has been demonstrated in rats. Ethanol was given i.p. in doses of 0.69, 1.7, and 3.0 g/kg in equal volumes (20 ml/kg). The liver was freeze-clamped 120 min after injection, and multiple metabolites were measured in the perchloric acid extract of the tissue. Each group showed a significantly different pattern of metabolites, redox states, and phosphorylation potentials although the rate of ethanol disappearance, at least between the two highest dose groups, was not significantly different. The mitochondrial free [NAD+]/[NADH] ratios and the cytoplasmic free [NADP+]/[NADPH] ratio were paradoxically most reduced with the lowest dose of ethanol and became progressively more oxidized with increasing dose. Once established, the differences in these ratios between the groups tended to persist with time, relatively independent of the concentration of ethanol. In a somewhat different pattern, the phosphorylation potential ([ATP]/[ADP][P1]) remained at the control level in the low-dose group but was significantly elevated in the two higher-dose groups. The results, therefore, show distinct and complicated dose-dependent patterns of intermediary metabolism that cannot be explained completely by any one hypothesis but that imply significant dose-dependent effects of ethanol upon intermediary metabolism not directly related to NADH production. Guynn R W RW Pieklik J R JR eng Journal Article United States J Clin Invest 7802877 0021-9738 0U46U6E8UK NAD 3K9958V90M Ethanol 53-59-8 NADP 8L70Q75FXE Adenosine Triphosphate AIM IM Adenosine Triphosphate metabolism Animals Dose-Response Relationship, Drug Ethanol blood pharmacology Liver drug effects metabolism Male NAD metabolism NADP metabolism Oxidation-Reduction Rats Time Factors 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 422 10.1172/JCI108222 PMC333119 Biochem J. 1973 Nov;136(3):639-47 4149946 J Biol Chem. 1974 Aug 10;249(15):4926-33 4152562 Science. 1973 Nov 16;182(4113):712-3 4201681 N Engl J Med. 1974 Jan 17;290(3):128-35 4202520 Biochem Pharmacol. 1965 Dec;14(12):1803-14 4222535 Biochem J. 1966 Jul;100(1):34-46 4290533 Biochem J. 1967 May;103(2):514-27 4291787 Adv Enzyme Regul. 1968;6:467-80 4305296 Eur J Biochem. 1970 Mar 1;13(1):111-6 4314705 J Biol Chem. 1970 May 25;245(10):2505-12 4315645 Biochem J. 1970 Apr;117(3):499-503 4315932 Biochem J. 1970 Nov;120(1):105-11 4321927 Biochem Pharmacol. 1969 Oct;18(10):2759-66 4327390 Biochem J. 1972 Feb;126(4):945-52 4342167 Biochem J. 1972 Apr;127(2):387-97 4342558 Eur J Biochem. 1973 Dec 3;40(1):275-82 4359143 J Biol Chem. 1969 Sep 25;244(18):5044-54 4390471 Biochem J. 1969 Dec;115(4):609-19 4391039 Biochem Pharmacol. 1970 Jun;19(6):2033-41 4398026 Eur J Biochem. 1972 Feb;25(3):420-30 4402915 Life Sci. 1974 Oct 1;15(7):1327-34 4549980 Life Sci II. 1972 Oct 22;11(20):983-93 4662153 J Neurochem. 1972 Nov;19(11):2679-86 4673618 Anal Biochem. 1972 Jan;45(1):277-85 5009289 Q J Stud Alcohol. 1972 Sep;33(3):751-5 5076881 Biochem J. 1970 Jul;118(4):635-44 5481498 Biochem Pharmacol. 1970 Jun;19(6):2017-22 5513971 Biochem J. 1969 Mar;112(1):117-24 5774487 J Neurochem. 1969 Feb;16(2):191-203 5795934 J Pharmacol Exp Ther. 1955 Nov;115(3):360-70 13272188 Am J Physiol. 1956 Sep;186(3):380-2 13362543 Pflugers Arch Gesamte Physiol Menschen Tiere. 1960;270:399-412 13845757 J Biol Chem. 1964 Jan;239:18-30 14114842 Biochem J. 1973 Jun;134(2):515-21 16742812 423 1976 03 01 2018 11 13 0021-9738 56 6 1975 Dec The Journal of clinical investigation J Clin Invest Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. 1571-9 The solubility of triclinic calcium pyrophosphate dihydrate (CPPD) crystals was measured under varying conditions using 45Ca-labeled crystals, expressing solubility as micromoles per liter of 45Ca in solution. In a 0.1-M Tris-HC1 buffer pH 7.4, the solubility of accurately sized CPPD crystals (37-20mum) was 60muM with maximal solubility being attained after about 8 h incubation at 37degreeC. Reduction in crystal size, decrease in pH, increase in ionic strength, Mg++, citrate, and albumin all increased solubility. The most marked effects on solubility occurred when changing the calcium concentration or by enzymatic hydrolysis of inoganic pyrophosphate to orthophosphate. It was found that decreasing the ionized calcium level below 5 mg/100 ml resulted in a progressive enhancement of solubility. The observed solubility-enhancing effects of albumin could be explained solely on its calcium-binding ability and thereby, altered ionized calcium level. Diffusible calcium in synovial fluid was only 40% of the total calcium concentration, which means most joint fluids are normally near the critical concentration of 5 mg/100 ml of ionized calcium, below which solubility is enhanced. During surgery, especially parathyroidectomy, calcium levels fall, favoring dissolution of CPPD crystals. We speculate that the slight decrease in crystal size during dissolution frees them from their cartilaginous mold, resulting in a dose-dependent inflammatory reaction as they are "shed" into the joint space. Crystal shedding may be reinforced by the modest fall in joint fluid pH accompanying the inflammatory response. Bennett R M RM Lehr J R JR McCarty D J DJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Clin Invest 7802877 0021-9738 0 Citrates 0 Diphosphates 0 Serum Albumin EC 3.6.1.- Pyrophosphatases I38ZP9992A Magnesium SY7Q814VUP Calcium AIM IM Arthritis, Rheumatoid metabolism Calcium metabolism Chondrocalcinosis metabolism Citrates Diphosphates metabolism Gout metabolism Humans Hydrogen-Ion Concentration Hydrolysis Joint Diseases enzymology metabolism Joints injuries Magnesium Osteoarthritis metabolism Pyrophosphatases metabolism Serum Albumin Solubility Synovial Fluid enzymology metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 423 10.1172/JCI108239 PMC333136 Ann Surg. 1957 Oct;146(4):530-40; discussion 540-1 13470746 Ann Rheum Dis. 1963 May;22:171-87 14017521 J Clin Invest. 1975 Jun;55(6):1373-81 166095 Lancet. 1970 Oct 31;2(7679):899-902 4097282 Lancet. 1973 Mar 3;1(7801):445-6 4120363 Arthritis Rheum. 1970 Jul-Aug;13(4):381-8 4317094 J Lab Clin Med. 1971 Aug;78(2):216-29 4327881 Arthritis Rheum. 1973 Mar-Apr;16(2):171-8 4351956 JAMA. 1973 Oct 1;226(1):42-4 4361132 J Lab Clin Med. 1974 Apr;83(4):518-31 4361744 Arthritis Rheum. 1974 May-Jun;17(3):289-96 4825648 Biochem J. 1967 Oct;105(1):155-61 4964763 Arthritis Rheum. 1971 Jul-Aug;14(4):513-26 5564923 Q J Med. 1968 Jan;37(145):171-82 5657764 JAMA. 1968 Feb 12;203(7):508-12 5694150 Nature. 1967 May 20;214(5090):842-3 6051880 425 1976 02 20 2019 08 17 0021-9940 89 5 1975 Jul Journal of comparative and physiological psychology J Comp Physiol Psychol Evidence from rats that morphine tolerance is a learned response. 498-506 It is proposed that the direct analgesic effect of morphine becomes attenuated over the course of successive administrations of the narcotic by a conditioned, compensatory, hyperalgesic response elicited by the administration procedure, the net result being analgesic tolerance. Using the "hot plate" analgesia assessment situation with rats, this conditioning view of tolerance is supported by several findings: (a) It is necessary to have reliable environmental cues predicting the systemic effects of morphine if tolerance is to be observed, (b) a hyperalgesic conditioned response may be observed in morphine-tolerant subjects when drug administration cues are followed by a placebo, and (c) merely by repeatedly presenting environmental cues previously associated with morphine (but now presented with a placebo), morphine tolerance can be extinguished. Siegel S S eng Journal Article United States J Comp Physiol Psychol 0414612 0021-9940 0 Analgesics, Opioid 0 Placebos 451W47IQ8X Sodium Chloride 76I7G6D29C Morphine IM Analgesics, Opioid pharmacology Animals Association Conditioning, Classical Cues Drug Tolerance Extinction, Psychological Male Morphine pharmacology Pain drug therapy Placebos Rats Reaction Time drug effects Sodium Chloride pharmacology Time Factors 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 425 10.1037/h0077058 426 1976 02 13 2013 11 21 0022-0302 58 11 1975 Nov Journal of dairy science J Dairy Sci Murexide for determination of free and protein-bound calcium in model systems. 1595-608 The determination with murexide of free and protein-bound calcium in model systems of known composition, ionic strength, and pH was investigated. The spectra of calcium murexide in the presence of varying amounts of calcium ions indicated that the absorption maximum fo calcium murexide complex occurs at 480 nm while that of murexide ion is at 520 nm. The absorbance at 509 nm is independent of calcium ion concentration and, therefore, could be used to measure the total dye. The spectra are pH dependent but constant in the range 6.5 to 7.0. The apparent dissociation constant of calcium murexide is dependent upon ionic environment, ionic strength, and free calcium ion concentration. The relationship between the apparent dissociation constant and free calcium concentration was established. Whole casein had no effect on the absorption spectra of calcium murexide and no affinity for calcium murexide complex or murexide ion. Beta-casein, at the concentrations employed, did not influence the dissociation fo calcium murexide. At pH 7.0, ionic strength .1, and 2 C, Beta-casein bound calcium as if there were 8.65 binding sites per molecule, each of pK 2.23, corresponding to an intrinsic association constant of 168.9 liters per mole. Sundararajan N R NR Whitney R M RM eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Dairy Sci 2985126R 0022-0302 0 Barbiturates 0 Caseins 4W6L62S876 Murexide SY7Q814VUP Calcium IM Barbiturates Binding Sites Calcium analysis Caseins Evaluation Studies as Topic Hydrogen-Ion Concentration Murexide Osmolar Concentration Protein Binding Spectrophotometry 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 426 S0022-0302(75)84757-6 10.3168/jds.S0022-0302(75)84757-6 427 1976 02 21 2019 08 17 0022-006X 43 6 1975 Dec Journal of consulting and clinical psychology J Consult Clin Psychol External validity of laboratory fear assessment: implications from two case studies. 864-6 Lick J R JR Unger T E TE eng Case Reports Journal Article United States J Consult Clin Psychol 0136553 0022-006X IM Adult Behavior Therapy Desensitization, Psychologic Fear Female Humans Middle Aged Phobic Disorders therapy Psychometrics 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 427 10.1037//0022-006x.43.6.864 424 1976 02 09 2019 08 23 0091-2700 15 11-12 1975 Nov-Dec Journal of clinical pharmacology J Clin Pharmacol Lorazepam compared with pentobarbital for nighttime sedation. 752-9 Lorazepam (0.5, 1, 2, and 4 mg) was compared with pentobarbital (60 and 180 mg) for its effect on sleep in "hospital insomnia." Subjective-response data were collected by research nurses. Lorazepam was found to be a potent nighttime sedative: 1 to 1.25 mg of lorazepam is equivalent to 100 mg sodium pentobarbital for measures of sleep quality and duration. At this dose level it is less effective than 100 mg of pentobarbital as a sleep inducer. Studies at higher doses (up to 4 mg) indicate that lorazepam has a wide therapeutic index. Brown P J PJ Forrest W H WH Jr Brown C R CR eng Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England J Clin Pharmacol 0366372 0091-2700 0 Anti-Anxiety Agents 0 Hypnotics and Sedatives I4744080IR Pentobarbital O26FZP769L Lorazepam IM Anti-Anxiety Agents pharmacology Humans Hypnotics and Sedatives Lorazepam adverse effects pharmacology Middle Aged Pentobarbital adverse effects pharmacology Sleep drug effects Time Factors 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 424 10.1002/j.1552-4604.1975.tb02339.x 428 1976 02 21 2019 08 17 0022-006X 43 6 1975 Dec Journal of consulting and clinical psychology J Consult Clin Psychol Relaxation as a factor in semantic desensitization. 925 Bechtel J E JE McNamara J R JR eng Journal Article United States J Consult Clin Psychol 0136553 0022-006X IM Behavior Therapy Desensitization, Psychologic Female Follow-Up Studies Humans Phobic Disorders therapy Relaxation Therapy Semantics 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 428 10.1037//0022-006x.43.6.925 431 1976 02 20 2019 05 09 0022-0493 68 6 1975 Dec Journal of economic entomology J Econ Entomol Atmospheric levels of propoxur aboard submarines after residual spraying. 755-60 Mulrennan J A JA Jr Lamdin J M JM Bolton H T HT Hammond C L CL eng Journal Article England J Econ Entomol 2985127R 0022-0493 0 Aerosols BFH029TL73 Propoxur IM S Aerosols Air analysis Ecological Systems, Closed Propoxur analysis Ships Submarine Medicine 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 431 10.1093/jee/68.6.755 432 1976 02 20 2019 05 09 0022-0493 68 6 1975 Dec Journal of economic entomology J Econ Entomol Activity and longevity of insect growth regulators against mosquitoes. 791-4 Mulla M S MS Darwazeh H A HA eng Journal Article England J Econ Entomol 2985127R 0022-0493 0 Carbamates 0 Juvenile Hormones 0 Phenylurea Compounds 8B830OJ2UX Methoprene IM Animals Carbamates metabolism Culicidae Juvenile Hormones metabolism Methoprene metabolism Mosquito Control Phenylurea Compounds metabolism Time Factors 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 432 10.1093/jee/68.6.791 429 1976 02 20 2017 02 14 0022-0345 54 6 1975 Nov-Dec Journal of dental research J Dent Res Effect of trace elements on dissolution of hydroxyapatite by cariogenic streptococci. 1107-14 The effect of low levels of strontium, boron, lithium, molybdenum, and fluorine, alone and in combination, on hydroxyapatite solubility, bacterial growth, and acid production in five antigenic types of Streptococcus mutans was investigated. Pour plates containing synthetic hydroxyapatite were used to compare dissolution of hydroxyapatite. The colonies of the five antigenic types of S mutans produced zones of dissolution that were measured. Acid production and growth were studied in broth culture media. The results show that low levels of strontium and fluorine can significantly reduce demineralization of synthetic hydroxyapatite by S mutans in vitro. Herbison R J RJ Handelman S L SL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Dent Res 0354343 0022-0345 0 Hydroxyapatites 0 Trace Elements 284SYP0193 Fluorine 81AH48963U Molybdenum 9FN79X2M3F Lithium N9E3X5056Q Boron YZS2RPE8LE Strontium D IM Animals Boron pharmacology Dental Caries microbiology Fluorine pharmacology Humans Hydrogen-Ion Concentration Hydroxyapatites metabolism Lithium pharmacology Molybdenum pharmacology Solubility Streptococcus metabolism Streptococcus mutans drug effects metabolism Strontium pharmacology Trace Elements pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 429 10.1177/00220345750540060201 430 1976 02 20 2018 04 29 0022-0345 54 6 1975 Nov-Dec Journal of dental research J Dent Res Conductometric titration of aqueous solutions of polyacrylic acid and its copolymers. 1238 Crisp S S Lewis B G BG Wilson A D AD eng 100406 Wellcome Trust United Kingdom Journal Article United States J Dent Res 0354343 0022-0345 0 Acrylates 0 Polymers 0 Solutions D IM Acrylates analysis Conductometry methods Hydrogen-Ion Concentration Polymers analysis Solutions 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 430 10.1177/00220345750540062801 433 1976 02 09 2019 12 10 0021-8561 23 6 1975 Nov-Dec Journal of agricultural and food chemistry J Agric Food Chem Uptake, translocation, and metabolism of tirpate in tobacco. Nicotiana tabacum. 1125-9 Hill J E JE Krieger R I RI eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Agric Food Chem 0374755 0021-8561 0 Antinematodal Agents 0 Carbamates 0 Insecticides 0 Oximes 0 Pesticide Residues 8W03WH1E76 tirpate EC 3.1.6.- Sulfatases EC 3.2.1.- Glucosidases IM Antinematodal Agents metabolism Carbamates Glucosidases metabolism Half-Life Hydrogen-Ion Concentration Insecticides metabolism Oximes metabolism Pesticide Residues analysis Plants, Toxic Sulfatases metabolism Tobacco metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 433 10.1021/jf60202a047 434 1976 02 09 2019 07 23 0021-8561 23 6 1975 Nov-Dec Journal of agricultural and food chemistry J Agric Food Chem Cannabis smoke condensate. Identification of some acids, bases, and phenols. 1129-31 Jones L A LA Foote R S RS eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Agric Food Chem 0374755 0021-8561 0 Amines 0 Benzoates 0 Fatty Acids 0 Phenols 0 Salicylates IM Amines analysis Benzoates analysis Cannabis analysis Chromatography, Gas Fatty Acids analysis Hydrogen-Ion Concentration Mass Spectrometry Phenols analysis Salicylates analysis Volatilization 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 434 10.1021/jf60202a055 437 1976 02 09 2019 07 08 0002-7863 97 25 1975 Dec 10 Journal of the American Chemical Society J Am Chem Soc Kinetics of cyanate and imidazole binding to hemin in micelles. 7319-26 Simplicio J J Schwenzer K K Maenpa F F eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Am Chem Soc 7503056 0002-7863 0 Cyanates 0 Imidazoles 0 Micelles 42VZT0U6YR Heme 743LRP9S7N Hemin IM Binding Sites Cyanates Heme analogs & derivatives Hemin Hydrogen-Ion Concentration Imidazoles Kinetics Micelles Temperature 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 437 10.1021/ja00858a019 438 1976 02 13 2016 12 03 0098-6151 74 12 1975 Aug The Journal of the American Osteopathic Association J Am Osteopath Assoc Inguinal herniography in children. 1139-45 Melnick A A Levyn M E ME Mogul H N HN Berger R R eng Case Reports Journal Article United States J Am Osteopath Assoc 7503065 0098-6151 IM Child, Preschool Cryptorchidism complications diagnostic imaging Hernia, Inguinal complications diagnostic imaging Humans Infant Male Methods Radiography 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 438 435 1976 02 09 2019 07 23 0021-8561 23 6 1975 Nov-Dec Journal of agricultural and food chemistry J Agric Food Chem Stability of myofibrillar EDTA-ATPase in rabbit psoas fiber bundles. 1163-8 Yasui T T Sumita T T Tsunogae S S eng Journal Article United States J Agric Food Chem 0374755 0021-8561 9G34HU7RV0 Edetic Acid EC 1.9.3.1 Electron Transport Complex IV EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins IM Adenosine Triphosphatases metabolism Animals Binding Sites Drug Stability Edetic Acid Electron Transport Complex IV metabolism Hydrogen-Ion Concentration Kinetics Muscles enzymology Myofibrils enzymology Myosins metabolism Preservation, Biological Protein Denaturation Rabbits Temperature 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 435 10.1021/jf60202a030 439 1976 02 13 2015 11 19 0368-2315 4 SUPPL 2 1975 Journal de gynecologie, obstetrique et biologie de la reproduction J Gynecol Obstet Biol Reprod (Paris) [Use of isotopes in the diagnosis of malignant breast tumors]. 109-16 The authors, with 67 Gallium, have obtained positive scintigraphy of the breast only in cases of carcinoma. Reliability of negative scintigraphy however is less good. Isotopic investigation of the bones is important in breast cancer and reveal early osseous metastasis. Destailleur G G Vernaillen P P Pluygers E E fre English Abstract Journal Article Utilisation des isotopes dans la mise au point des tumeurs malignes du sein France J Gynecol Obstet Biol Reprod (Paris) 0322206 0150-9918 0 Gallium Radioisotopes IM Breast Neoplasms diagnosis metabolism Evaluation Studies as Topic False Negative Reactions Female Gallium Radioisotopes Humans Hydrogen-Ion Concentration Neoplasm Metastasis Radiation Dosage Radionuclide Imaging 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 439 436 1976 02 09 2019 07 23 0021-8561 23 6 1975 Nov-Dec Journal of agricultural and food chemistry J Agric Food Chem Soluble protein concentrate from alfalfa by low-temperature acid precipitation. 1177-9 Miller R E RE de Fremery D D Bickoff E M EM Kohler G O GO eng Journal Article United States J Agric Food Chem 0374755 0021-8561 0 Dietary Proteins 0 Plant Proteins IM Cold Temperature Dietary Proteins analysis Fractional Precipitation Freeze Drying Hydrogen-Ion Concentration Medicago sativa analysis Plant Proteins analysis Solubility 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 436 10.1021/jf60202a037 440 1976 02 21 2017 02 14 0022-1554 23 12 1975 Dec The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society J Histochem Cytochem Peroxisome development in the metanephric kidney of mouse. 957-73 The relationship of enzymatic activity to organelle development and organelle number during differentiation of the metanephric kidney in the mouse was approached from several experimental directions. Biochemical analyses of marker enzymes for peroxisomes (catalase and D-amino acid oxidase), mitochondria (cytochrome oxidase) and lysosomes (acid phosphatase) were performed on kidneys at ages from 17 days prenatal to adult. These data were correlated with a morphometric analysis of populations of peroxisomes and mitochondria in differentiating cells of the proximal tubule. Postnatal development of the metanephric kidney was found to be accompanied by a rapid increase in both the specific activity of catalase and the number of peroxisomes per 100 mu2 in the proximal tubule during the first 4 weeks of postnatal growth. Elaboration of the endoplasmic reticulum (ER) was seen to parallel the increase in number of peroxisomes to which segments of ER were often in close apposition. Extensive interactions between segments of ER and peroxisomes were readily visible in 0.5-mu sections viewed in the high voltage electron microscope. In contrast to peroxisomes, neither mitochondria nor lysosomes followed a similar pattern of net organelle increase, suggesting that a defined population density of mitochondria and lysosomes may exist in the proximal tubule at birth, prior to complete development of the kidney. Goeckermann J A JA Vigil E L EL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Histochem Cytochem 9815334 0022-1554 EC 1.11.1.6 Catalase EC 1.4.3.3 D-Amino-Acid Oxidase EC 1.9.3.1 Electron Transport Complex IV EC 3.1.3.2 Acid Phosphatase IM Acid Phosphatase analysis Aging Animals Catalase analysis D-Amino-Acid Oxidase analysis Electron Transport Complex IV analysis Female Fetus Histocytochemistry Kidney embryology enzymology growth & development Kidney Tubules, Proximal enzymology ultrastructure Male Mice Microbodies enzymology ultrastructure Microscopy, Electron Mitochondria enzymology ultrastructure Organoids ultrastructure Pregnancy 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 440 10.1177/23.12.440 441 1976 02 21 2019 09 07 0022-1910 21 12 1975 Dec Journal of insect physiology J Insect Physiol Physiological basis of host susceptibility of Florida mosquitoes to Dirofilaria immitis. 1965-75 Nayar J K JK Sauerman D M DM Jr eng Journal Article England J Insect Physiol 2985080R 0022-1910 IM Animals Culicidae parasitology Dirofilaria immitis Dogs Female Filarioidea Florida 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 441 0022-1910(75)90229-2 10.1016/0022-1910(75)90229-2 442 1976 03 01 2019 05 09 0022-1899 132 6 1975 Dec The Journal of infectious diseases J Infect Dis Inhibitory effects of antihistamines and antiserotonins on the bone marrow reactions produced by Escherichia coli endotoxin in mice. 611-16 The bone marrow reactions (that is, decrease of nucleated cell counts and increase of red blood cell counts) of mouse bone were observed 1 hr after injection of endotoxin and peaked after 18 hr. These reactions were significantly inhibited when diphenhydramine, promethazine (antihistamines), chlorpromazine (antiserotonin), or cyproheptadine (antihistamine and antiserotonin) was given 30 min before endotoxin. Such bone marrow reactions were also induced with histamine or serotonin and peaked 1 hr after administration. The histamine-induced changes were inhibited by prior treatment with diphenhydramine. These reactions were also produced by injection of a small amount of both histamine and serotonin, whereas no change was found when mice were given a single injection of a larger dose of histamine or serotonin. These results indicate that histamine and serotonin released in mice at the initial stage after endotoxin synergistically trigger the bone marrow reactions, which then continue in the presence of further mediators. Antihistamines and antiserotonins are considered to hinder the whole process of reactions produced by endotoxin. Hirata M M eng Journal Article United States J Infect Dis 0413675 0022-1899 0 Endotoxins 0 Histamine H1 Antagonists 0 Serotonin Antagonists 2YHB6175DO Cyproheptadine 820484N8I3 Histamine 8GTS82S83M Diphenhydramine FF28EJQ494 Promethazine U42B7VYA4P Chlorpromazine YQE403BP4D Phenobarbital AIM IM Animals Bone Marrow Diseases chemically induced prevention & control Chlorpromazine therapeutic use Cyproheptadine therapeutic use Diphenhydramine therapeutic use Endotoxins Escherichia coli analysis Histamine Histamine H1 Antagonists therapeutic use Male Mice Phenobarbital therapeutic use Promethazine therapeutic use Serotonin Antagonists 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 442 10.1093/infdis/132.6.611 443 1976 02 13 2013 11 21 0369-4739 23 7 1975 Jul [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai Nihon Kyobu Geka Gakkai Zasshi [Experimental study of hypothermia--with special reference to changes in cerebrospinal fluid gases and lactate during perfusion cooling and circulatory arrest]. 847-65 Nasu M M jpn English Abstract Journal Article Japan Nihon Kyobu Geka Gakkai Zasshi 19130180R 0369-4739 0 Lactates 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Animals Blood Circulation Body Temperature Carbon Dioxide blood Dogs Extracorporeal Circulation Hydrogen-Ion Concentration Hypothermia cerebrospinal fluid Lactates blood cerebrospinal fluid Oxygen blood Partial Pressure 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 443 444 1976 02 09 2019 07 23 0021-5384 64 6 1975 Jun 10 Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine Nihon Naika Gakkai Zasshi [A case of allergic granulomatous angitis (author's transl)]. 565-73 Yokoyama Y Y Kono T T Aoki M M jpn MC_PC_U127592696 Medical Research Council United Kingdom MC_U127592696 Medical Research Council United Kingdom MC_PC_U127592696 MRC United Kingdom MC_U127592696 MRC United Kingdom Case Reports Journal Article Japan Nihon Naika Gakkai Zasshi 19130210R 0021-5384 IM Adult Female Granuloma pathology Humans Polyarteritis Nodosa pathology Pulmonary Eosinophilia pathology 1975 6 10 1975 6 10 0 1 1975 6 10 0 0 ppublish 444 10.2169/naika.64.565 446 1976 02 13 2013 11 21 0022-2275 16 6 1975 Nov Journal of lipid research J Lipid Res On the interactions between pancreatic lipase and colipase and the substrate, and the importance of bile salts. 411-7 The interactions between pancreatic lipase and colipase and the substrate and the effect of bile salts on these interactions have been investigated by the use of kinetic experiments and studies on the semiquantitative phase distribution of lipase and colipase activities. The results suggest that lipase binds to hydrophobic interfaces with partial irreversible inactivation. Bile salts in the range of micellar concentrations and above a pH of about 6.5 displace lipase from this binding, resulting in a reversible in activation. At pH values below about 6.5, lipase binds strongly to the substrate even in the presence of bile salt, and a low activity peak is seen around pH 5.5. This is the result of the binding of lipase to the "supersubstrate" and the activity of the catalytic site. In the presence of bile salt, colipase promotes the binding of lipase to the "supersubstrate" but not to other hydrophobic interfaces, and catalytic activity is reestablished. Kinetic data indicate that the binding between colipase and lipase in the presence of substrate is strong and occurs in an approximately stoichiometric relationship. Borgström B B eng Journal Article United States J Lipid Res 0376606 0022-2275 0 Colipases 0 Proteins 0 Triglycerides 005990WHZZ Deoxycholic Acid 1EQV5MLY3D Taurine EC 3.1.1.3 Lipase IM Animals Binding Sites Colipases metabolism Deoxycholic Acid analogs & derivatives Hydrogen-Ion Concentration Kinetics Lipase metabolism Pancreas metabolism Protein Binding Proteins metabolism Swine Taurine analogs & derivatives Triglycerides 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 446 447 1976 02 20 2019 07 09 0022-0795 66 3 1975 Sep The Journal of endocrinology J Endocrinol Effect of ionic strength and ionic composition of assay buffers on the interaction of thyroxine with plasma proteins. 319-27 When plasma proteins are diluted with buffer the ionic strength and ionic composition of that buffer affects the interactions between thyroxine (T4) and its plasma protein-binding sites. Increases in phosphate, chloride or barbiturate ion concentration from 50 to 200 mmol/l caused a significant decrease in the affinity of plasma proteins for T4, and a concurrent increase in the concentration of unbound T4. These results cannot be completely accounted for by changes in ionic strength since at the same ionic strength different anions caused quantitatively different effects on unbound T4 concentration. The degree of depression of T4 binding by the three anions studied was in the order barbiturate greater than chloride greater than phosphate. The results of a systematic study on the composition of diluent buffer systems indicated that when a 50 mM-sodium phosphate-100 mM-NaCl buffer (pH 7-4) was used as a plasma diluent, there were unlikely to be gross changes in the T4-binding properties of plasma proteins with dilution. Sutherland R L RL Brandon M R MR Simpson-Morgan M W MW eng Journal Article England J Endocrinol 0375363 0022-0795 0 Barbiturates 0 Blood Proteins 0 Buffers 0 Chlorides 0 Phosphates 0 Thyroxine-Binding Proteins Q51BO43MG4 Thyroxine IM Barbiturates pharmacology Binding Sites Blood Proteins metabolism Buffers Chlorides pharmacology Humans Hydrogen-Ion Concentration In Vitro Techniques Osmolar Concentration Phosphates pharmacology Thyroxine metabolism Thyroxine-Binding Proteins metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 447 10.1677/joe.0.0660319 445 1976 02 19 2018 12 03 0093-1748 3 10 1975 Nov-Dec The Journal of legal medicine J Leg Med (N Y) Criminal exposure of physician assistants. 32-4 Archer D W DW eng Journal Article United States J Leg Med (N Y) 0367344 0093-1748 IM Drug Prescriptions Jurisprudence Legislation, Medical Licensure, Medical Michigan Pharmaceutical Services Physician Assistants statistics & numerical data United States 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 445 448 1976 03 01 2019 02 06 0022-0949 63 2 1975 Oct The Journal of experimental biology J Exp Biol The innervation of the salivary gland of the moth, Manduca sexta: evidence that dopamine is the transmitter. 413-9 1. Using the Falck-Hillarp histochemical technique for monoamines, evidence was found for the presence of a catecholamine in the salivary gland nerves of the moth, Manduca sexta. 2. The innervation was studied with the electron microscope. Only the fluid-secreting region of the gland is innervated and the nerve endings are characteristic of monoamine-containing terminals. 3. Using a sensitive enzymatic-isotopic assay for catecholamines, it was found that whole salivary glands contain 0.33 mug/g dopamine but no noradrenaline. 4. It seems likely that dopamine mediates fluid-secretion in the salivary gland of Manduca as it does a number of other arthropods. Robertson H A HA eng Journal Article England J Exp Biol 0243705 0022-0949 0 Neurotransmitter Agents VTD58H1Z2X Dopamine IM Animals Dopamine physiology Lepidoptera physiology Moths physiology Neurotransmitter Agents physiology Salivary Glands innervation 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 448 449 1976 03 01 2008 11 21 0022-0949 63 2 1975 Oct The Journal of experimental biology J Exp Biol An electrophysiological analysis of chemoreception in the sea anemone Tealia felina. 525-36 1. Electrophysiological techniques have been employed to examine the nature of the response observed in the ectodermal slow-conduction system (SSI) when dissolved food substances contact the column of Tealia felina. The response seems to consist entirely of sensory activity which may continue for periods of many minutes, provided that the stimulatory chemicals remain contacting the column. 2. The interval between each evoked pulse gradually increases as the sensory response progresses. This does not result from fatigue in the conduction system but involves a genuine process of sensory adaptation. This may occur over a period of several minutes, which is much longer than comparable adaptation in higher animals. 3. Physiological evidence suggests that the chemoreceptors involved are dispersed throughout the column ectoderm and are absent from the pedal disc, oral disc, tentacles and pharynx. 4. The basic role of the SSI in coordinating behavioural activity in sea anemones is reviewed. It is concluded that it functions primarily as a single, diffuse-conducting unit responsible for transmitting frequency-coded sensory information from ectodermal chemoreceptors to ectodermal (and perhaps endodermal) effectors. Dawn I D ID eng Journal Article England J Exp Biol 0243705 0022-0949 IM Action Potentials Animals Chemoreceptor Cells anatomy & histology physiology Cnidaria physiology Feeding Behavior physiology Sea Anemones anatomy & histology physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 449 450 1976 02 26 2019 05 08 0022-1007 142 6 1975 Dec 01 The Journal of experimental medicine J Exp Med The selective eosinophil chemotactic activity of histamine. 1462-76 Histamine diphosphate was shown to selectively attract human eosinophils from mixed granulocyte populations when over 20% eosinophils were used in a modified Boyden chamber chemotactic assay system. This effect of histamine is abolished by incubation with diamine oxidase (histaminase) and was generated by decarboxylation of L-histidine. A linear dose dependent increase in eosinophil migration was observed between 3 X 10(-7) M and 1.25 X 10(-6) M, while higher concentrations of histamine inhibited the migration of eosinophils. The attractant activity of histamine was not inhibited by H-1 or H-2 receptor antagonists, however, the inhibition of migration observed at higher histamine concentrations was reversed by metiamine, an H-2 receptor antagonist. The effects of histamine upon eosinophil migration were demonstrable using three different assays: (a) counting cells that had traversed 5-mum pore, 12-mum thick polycarbonate filters, (b) counting cells that had migrated various distances into a 3-mum pore, 145-mum cellulose nitrate filters, or (c) measuring the number of cells that had traversed an upper polycarbonate filter and migrated into a lower cellulose nitrate filter using 15Cr-labeled cells. The ability of histamine to enhance eosinophil migration was shown to be dependent upon the presence of a concentration gradient; histamine did not cause a dose-dependent increase in random motility. Furthermore, preincubation of the eosinophils with histamine deactivate the cells to further stimulation by histamine or by C5a. It is concluded that in low doses histamine is a chemoattractant for human eosinophils, while in higher doses histamine inhibits eosinophil migration. These observations may relate to the influx and localization of eosinophils in immediate hypersensitivity reactions. Clark R A RA Gallin J I JI Kaplan A P AP eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Exp Med 2985109R 0022-1007 0 Histamine H1 Antagonists 3K7670861M Metiamide 4QD397987E Histidine 820484N8I3 Histamine EC 1.4.3.21 Amine Oxidase (Copper-Containing) HPE317O9TL Pyrilamine AIM IM Amine Oxidase (Copper-Containing) Chemotaxis drug effects Dose-Response Relationship, Drug Eosinophils drug effects Histamine pharmacology Histamine H1 Antagonists pharmacology Histidine metabolism Humans Metiamide pharmacology Pyrilamine pharmacology 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 450 PMC2190076 10.1084/jem.142.6.1462 Proc Natl Acad Sci U S A. 1975 Mar;72(3):1059-62 1093163 J Physiol. 1953 Jun 29;120(4):528-37 13070225 Nature. 1954 Oct 9;174(4432):698 13213986 J Clin Invest. 1975 Apr;55(4):856-74 164483 J Immunol. 1975 Jun;114(6):1831-7 165239 Am J Physiol. 1949 Feb;156(2):261-73 18127230 J Immunol. 1971 Sep;107(3):899-902 4105937 J Exp Med. 1971 Mar 1;133(3):602-19 4106805 J Immunol. 1972 Apr;108(4):1000-8 4112412 Clin Allergy. 1972 Dec;2(4):381-90 4118072 J Immunol. 1970 Feb;104(2):335-43 4189671 Antibiot Chemother (1971). 1974;19:233-70 4219117 Nature. 1972 Apr 21;236(5347):385-90 4401751 J Exp Med. 1972 Feb 1;135(2):376-87 4551218 J Exp Med. 1973 Feb 1;137(2):387-410 4568301 J Immunol. 1975 Jan;114(1 Pt 1):87-92 46247 J Immunol. 1973 Jan;110(1):233-40 4685404 J Cell Biol. 1974 Sep;62(3):594-609 4855032 J Immunol. 1972 Mar;108(3):857-60 5011759 J Immunol Methods. 1972 Jan;1(2):165-8 5079997 Am J Med. 1966 Nov;41(5):724-33 5332171 Int Arch Allergy Appl Immunol. 1970;37(1):98-103 5410775 451 1976 02 20 2017 11 16 0022-104X 194 1 1975 Oct The Journal of experimental zoology J Exp Zool Hemoglobins and hemocyanins: comparative aspects of structure and function. 155-74 Comparative studies of protein structure and function can be quite interesting by themselves, and even more interesting when interpreted with respect to an animal's physiology. In the case of fish hemoglobins, some success in the latter has been achieved but there are still many unsolved problems. It appears that comparative physiology and biochemistry have entered an era where results from comparative studies can shed a great deal of light on biochemical mechanisms in general. The trout hemoglobin system is an example. Distinctive hemoglobins in this system are presently being used as high resolution probes of the ligand-binding mechanism. Characterization of the multiple, structurally distinct subunits of the 60S Limulus hemocyanin molecule may similarly aid in understanding its function. Our studies suggest the possibility of using Limulus hemocyanin and other hemocyanins as structural homologs and analogs of more complex macromolecular arrays. The rapid development of molecular structural data from X-ray crystallographers combined with the vast data of comparative physiology and biochemistry makes this one of the most exciting areas in present day science. Bonaventura J J Bonaventura C C Sullivan B B eng Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review United States J Exp Zool 0375365 0022-104X 0 Hemoglobins 0 Oxyhemoglobins 9013-72-3 Hemocyanins IM Animals Binding Sites Brachyura metabolism Fishes blood Hemocyanins analysis isolation & purification Hemoglobins analysis isolation & purification Humans Hydrogen-Ion Concentration Molecular Weight Oxyhemoglobins analysis Polymorphism, Genetic Trout blood 46 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 451 10.1002/jez.1401940110 452 1976 02 20 2013 11 21 0022-104X 194 1 1975 Oct The Journal of experimental zoology J Exp Zool How do biological systems discriminate among physically similar ions? 227-39 This paper reviews the history of understanding how biological systems can discriminate so strikingly among physically similar ions, especially alkali cations. Appreciation of qualitative regularities ("permitted sequences") and quantitative regularities ("selectivity isotherms") in ion selectivity grew first from studies of ion exchangers and glass electrodes, then of biological systems such as enzymes and cell membranes, and most recently of lipid bilayers doped with model pores and carriers. Discrimination of ions depends on both electrostatic and steric forces. "Black-box" studies on intact biological membranes have in some cases yielded molecular clues to the structure of the actual biological pores and carriers. Major current problems involve the extraction of these molecules; how to do it, what to do when it is achieved, and how (and if) it is relevant to the central problems of membrane function. Further advances are expected soon from studies of rate barriers within membranes, of voltage-dependent ("excitable") conducting channels, and of increasingly complex model systems and biological membranes. Diamond J M JM eng Journal Article Research Support, U.S. Gov't, P.H.S. Review United States J Exp Zool 0375365 0022-104X 0 Ligands 0 Membranes, Artificial 2001-95-8 Valinomycin 5ACL011P69 Ouabain 9NEZ333N27 Sodium EC 3.6.1.- Adenosine Triphosphatases RWP5GA015D Potassium SY7Q814VUP Calcium IM Adenosine Triphosphatases antagonists & inhibitors metabolism Animals Biological Transport, Active Calcium metabolism Cell Membrane metabolism Cell Membrane Permeability Decapodiformes Gallbladder metabolism Hydrogen Bonding Hydrogen-Ion Concentration Ion Exchange Ligands metabolism Lipid Metabolism Membranes, Artificial Metabolism Muscles metabolism Ouabain pharmacology Potassium metabolism Sodium metabolism Valinomycin pharmacology 74 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 452 10.1002/jez.1401940116 453 1976 02 20 2013 11 21 0022-104X 194 1 1975 Oct The Journal of experimental zoology J Exp Zool Photoreceptor processes: some problems and perspectives. 89-101 Visual photoreceptors from both vertebrates and invertebrates are characterized by extensive elaboration of membrane which contains visual pigment (rhodopsin). Visual pigments in all phyla examined are chemically similar: the chromophore is 11-cis retinaldehyde attached by an aldimine linkage (Schiff base) to a membrane protein, opsin. The effect of light is to isomerize the chromophore to the all-trans configuration. Beyond these fundamental similarities, several specific areas are discussed in which variations and differences appear. (1) Light causes vertebrate visual pigments to bleach, liberating the chromophore. Most invertebrate visual pigments do not bleach in the light, but instead form a thermally stable metarhodopsin, with the chromophore in the all-trans configuration still attached to the opsin. (2) In the disk membranes of vertebrate rod and cone outer segments, the rhodopsin molecules are oriented with their chromophores nearly coplanar with the disks. Within this plane, however, both rotational and translational diffusion are possible. In the microvillar membranes of arthropod and cephalopod rhabdoms, on the other hand, the situation is less clear. There is evidence for some preferential orientation of chromophores that implies restrictions on Brownian rotation. (3) In the outer segments of vertebrate receptors, absorption of light by rhodopsin causes the plasma membrane to hyperpolarize due to a decrease in sodium conductance, possibly mediated by calcium ions. In most invertebrate photoreceptors, light causes a depolarization due to an increase in conductance, principally to sodium ions. A subsequent entry of calcium causes a partial repolarization of the membrane, due to a decrease in sodium conductance. (4) For vertebrate receptors, log threshold is directly proportional to the fraction of rhodopsin bleached (Dowling-Rushton relationship). The proportionality constant varies in different preparations from less than four to more than 30, and the physical basis for the relationship is unknown. For invertebrates, by contrast, the dependence of sensitivity on rhodopsin concentration is much less dramatic and may well depend simply on the probability of quantum catch. (5) In most species, vertebrate and invertebrate, the accumulation of photoproduct probably has no effect on membrane conductance, but several possible exceptions exist. (6) Photoregeneration of rhodopsin from metarhodopsin is likely an important mechanism of recovery in certain arthropods such as diurnal insects, but dark mechanisms of recovery also exist in all phyla. In no single case are they adequately understood. Goldsmith T H TH eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Review United States J Exp Zool 0375365 0022-104X 9009-81-8 Rhodopsin 9NEZ333N27 Sodium SY7Q814VUP Calcium IM Adaptation, Ocular Animals Arachnida Arthropods Calcium metabolism Cell Membrane ultrastructure Columbidae Crustacea Decapodiformes Diptera Humans Hydrogen-Ion Concentration Lipid Metabolism Membrane Potentials Nephropidae Photochemistry Photoreceptor Cells metabolism physiology ultrastructure Rhodopsin analysis metabolism physiology Sodium metabolism Vision, Ocular 97 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 453 10.1002/jez.1401940107 454 1976 02 19 2019 02 06 0022-104X 194 2 1975 Nov The Journal of experimental zoology J Exp Zool Hydrolysis of the hen egg vitelline membrane by cock sperm acrosin and other enzymes. 429-37 A technique utilizing Pregnant Mare's Serum Gonadotropin and Human Chorionic Gonadotropin treatment of hens (Gallus domesticus), followed by manual ovulation of the excised follicles, was developed to obtain a large number of mature ova. The intact ova were used to test whether acrosin, partially purified from the spermatozoa of the cock (Gallus domesticus), partially purified rabbit testicular acrosin and commercial preparations of several hydrolytic enzymes could dissolve the inner vitelline membrane. Enzymes were applied to pieces of filter paper placed on the ovum. Cock acrosin and endopeptidases such as trypsin, chymotrypsin, collagenase and elastase hydrolyzed the membrane whereas exopeptidases such as leucine aminopeptidase and carboxypeptidase A did not. Phospholipase A, sulfatase, hyaluronidase, beta-glucuronidase and rabbit testicular acrosin also failed to hydrolyze the membrane. Cock acrosin hydrolysis of the ovum surface was inhibited by soybean trypsin inhibitor. The surface of the ovum over the germinal disc region was hydrolyzed more quickly by cock acrosin than the surface over other regions of the ovum. Acrosin from cock sperm caused the release of trichloroacetic acid soluble material absorbing at 280 nm from sonicated preparations of inner vitelline membranes. Hydrolysis was greatest at pH 8.0 and was inhibited by soybean trypsin inhibitor. Ho J J JJ Meizel S S eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Exp Zool 0375365 0022-104X 0 Chorionic Gonadotropin 0 Gonadotropins, Equine EC 3.4.- Endopeptidases EC 3.4.21.10 Acrosin EC 3.4.21.36 Pancreatic Elastase IM Acrosin metabolism Animals Chickens metabolism physiology Chorionic Gonadotropin pharmacology Endopeptidases metabolism Female Gonadotropins, Equine pharmacology Hydrogen-Ion Concentration Hydrolysis In Vitro Techniques Male Ovulation drug effects Ovum metabolism Pancreatic Elastase metabolism Vitelline Membrane metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 454 10.1002/jez.1401940209 455 1976 02 20 2015 11 19 0371-7682 74 4 1975 Apr Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association Taiwan Yi Xue Hui Za Zhi Studies on renal tubular acidosis in collagen diseases. Part II. The response of patients with collagen diseases to an acid load. 288-301 Cheng J T JT eng Comparative Study Journal Article China (Republic : 1949- ) Taiwan Yi Xue Hui Za Zhi 0413761 0371-7682 0 Quaternary Ammonium Compounds 01Q9PC255D Ammonium Chloride IM Acidosis metabolism Adolescent Adult Ammonium Chloride Blood Chemical Analysis Collagen Diseases metabolism Female Humans Hydrogen-Ion Concentration Male Middle Aged Quaternary Ammonium Compounds urine 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 455 456 1976 02 20 2015 09 01 0371-7682 74 4 1975 Apr Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association Taiwan Yi Xue Hui Za Zhi A field survey on home environmental sanitation in two districts of Kaohsiung city, Taiwan. 302-9 Chang T T TT Chen K P KP eng Journal Article China (Republic : 1949- ) Taiwan Yi Xue Hui Za Zhi 0413761 0371-7682 059QF0KO0R Water IM Animals Culicidae Health Surveys Houseflies Rats Residential Facilities Sanitation Taiwan Toilet Facilities Water 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 456 457 1976 02 20 2015 09 01 0371-7682 74 5 1975 May Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association Taiwan Yi Xue Hui Za Zhi Inactivation of Formosan snake venoms in vitro by the crude extract of Aristolochia radix. 352-60 Tsai L H LH Liu H J HJ Yang C P CP Chang C C eng Journal Article China (Republic : 1949- ) Taiwan Yi Xue Hui Za Zhi 0413761 0371-7682 0 Plant Extracts 0 Snake Venoms IM Animals Hydrogen-Ion Concentration Medicine, Chinese Traditional Mice Plant Extracts pharmacology Snake Venoms metabolism toxicity Taiwan 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 457 458 1976 02 20 2019 02 06 0371-7682 74 7 1975 Jul Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association Taiwan Yi Xue Hui Za Zhi Takayasu's arteritis with coronary arterial occlusion and preinfarction angina. 469-75 Huang P J PJ Chu S H SH Chen C M CM eng Journal Article China (Republic : 1949- ) Taiwan Yi Xue Hui Za Zhi 0413761 0371-7682 IM Adult Angina Pectoris surgery Aortic Arch Syndromes surgery Coronary Artery Bypass Coronary Disease surgery Female Humans Takayasu Arteritis surgery 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 458 459 1976 02 13 2019 05 08 0022-1295 65 6 1975 Jun The Journal of general physiology J Gen Physiol Some effects of low pH on chloride exchange in human red blood cells. 731-49 In order to test the range of pH values over which the titratable carried model for inorganic anion exchange is valid, chloride self-exchange across human red blood cells was examined between pH 4.75 and 5.7 at 0 decrees c. It was found that chloride self-exchange flux had a minimum near pH 5 and increased again with further increase in hydrogen ion activity. The Arrhenius activation energy for chloride exchange was greatly reduced at low pH values. The chloride flux at pH 5.1 did not show the saturation kinetics reported at higher pH values but was proportional to the value of the chloride concentration squared. In addition, the extent of inhibition of chloride self-exchange flux by phloretin was reduced at low pH. Our interpretation of these findings is that the carrier-mediated flux becomes a progressively smaller fraction of the total flux at lower pH values and that a different transport mode requiring two chloride ions to form the permeant species and having a low specificity and temperature dependence becomes significant below pH5. A possible mechanism for this transport is that chloride crosses red cell membranes as dimers of HCl at these very low pH values. Gunn R B RB Wieth J O JO Tosteson D C DC eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Gen Physiol 2985110R 0022-1295 0 Chlorides S5J5OE47MK Phloretin IM Biological Transport Cell Membrane Permeability Chlorides metabolism Erythrocytes metabolism Humans Hydrogen-Ion Concentration In Vitro Techniques Kinetics Models, Biological Phloretin pharmacology Temperature 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 459 PMC2214889 10.1085/jgp.65.6.731 Pflugers Arch Gesamte Physiol Menschen Tiere. 1964 Jul 30;280:243-74 14257858 J Biol Chem. 1959 Nov;234:3022-6 14415272 J Gen Physiol. 1973 Feb;61(2):185-206 4688320 Biochim Biophys Acta. 1973 Mar 16;298(2):529-33 4719143 Naturwissenschaften. 1970 Apr;57(4):172-9 4911154 J Gen Physiol. 1972 Feb;59(2):155-66 5058472 J Physiol. 1972 Aug;224(3):583-610 5071931 Acta Physiol Scand. 1967 Sep;71(1):113-24 6056954 460 1976 02 13 2019 05 08 0022-1295 65 6 1975 Jun The Journal of general physiology J Gen Physiol Ionic properties of the acetylcholine receptor in cultured rat myotubes. 751-67 The acetylcholine reversal potential (Er) of cultured rat myotubes is -3mV. When activated, the receptor is permeable to K+ and Na+, but not to Cl- ions. Measurement of Er in Tris+-substituted, Na-free medium also indicated a permeability to Tris+ ions. Unlike adult frog muscle the magnitude of Er was insensitive to change in external Ca++ (up to 30 mM) or to changes in external pH (between 6.4 and 8.9). The equivalent circuit equation describing the electrical circuit composed of two parallel ionic batteries (EK and ENa) and their respective conductances (gK and gNa), which has been generally useful in describing the Er of adult rat and frog muscle, could also be applied to rat myotubes when Er was measured over a wide range of external Na+ concentrations. The equivalent circuit equation could not be applied to myotubes bathed in media of different external K+ concentrations. In this case, the Er was more closely described by the Goldman constant field equation. Under certain circumstances, it is known that the receptor in adult rat and frog muscle can be induced to reversibly shift from behavior described by the equivalent circuit equation to that described by the Goldman equation. Attempts to similarly manipulate the responses of cultured rat myotubes were unsussessful. These trials included a reduction in temperature (15 degress C), partial alpha-bungarotoxin blodkade, and activation of responses with the cholinergic agonist, decamethonium. Ritchie A K AK Fambrough D M DM eng Journal Article United States J Gen Physiol 2985110R 0022-1295 0 Bungarotoxins 0 Chlorides 0 Decamethonium Compounds 0 Receptors, Cholinergic 9NEZ333N27 Sodium RWP5GA015D Potassium SY7Q814VUP Calcium IM Animals Bungarotoxins pharmacology Calcium metabolism Cell Membrane Permeability Chlorides metabolism Culture Techniques Decamethonium Compounds pharmacology Electrophysiology Hydrogen-Ion Concentration Membrane Potentials Muscles embryology Potassium metabolism Rats Receptors, Cholinergic Sodium metabolism 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 460 PMC2214888 10.1085/jgp.65.6.751 J Physiol. 1959 Jun 23;147(1):178-93 13673396 J Physiol. 1962 Aug;162:393-408 13886109 J Physiol. 1961 Nov;159:111-27 14451604 Dev Biol. 1971 Sep;26(1):55-68 4255788 J Physiol. 1971 Oct;218(1):101-16 4331819 Dev Biol. 1972 Jun;28(2):407-29 4338026 Nat New Biol. 1973 Dec 19;246(155):214-6 4519606 Experientia. 1973 Feb 15;29(2):157-8 4540304 J Physiol. 1973 Nov;234(3):553-67 4543573 J Physiol. 1973 Dec;235(3):655-91 4543940 Nature. 1972 Apr 28;236(5348):453-4 4555361 J Physiol. 1973 May;230(3):707-17 4717155 J Physiol. 1973 Mar;229(3):751-66 4735059 Br J Pharmacol. 1973 Sep;49(1):138-9 4787522 Fed Proc. 1967 Nov-Dec;26(6):1613-26 4864744 J Physiol. 1972 May;223(1):173-97 5046143 J Physiol. 1972 Aug;224(3):665-99 5071933 J Cell Physiol. 1971 Oct;78(2):289-99 5167851 J Gen Physiol. 1971 Dec;58(6):599-619 5315827 Biofizika. 1969 Jul-Aug;14(4):658-62 5396306 Biofizika. 1969 May-Jun;14(3):485-94 5397717 Nature. 1968 Apr 27;218(5139):363-5 5649678 J Physiol. 1969 Oct;204(2):493-502 5824649 J Physiol. 1966 Apr;183(3):592-606 5919558 461 1976 02 19 2019 05 08 0022-1295 66 6 1975 Dec The Journal of general physiology J Gen Physiol Effect of cross-reinnervation on physiological parameters and on properties of myosin and sarcoplasmic reticulum of fast and slow muscles of the rabbit. 811-21 Cross-reinnvervation of fast (extensor digitorum longus) and slow (soleus) twitch muscles of the rabbit showed essentially complete fast to slow and slow to fast conversion, respectively, 11-12 mo after surgery with respect to a number of physiological parameters including intrinsic shortening, velocity, and isometric twitch time to peak. There was pronounced bu incomplete biochemical conversion as judged by Ca2+ uptake by sarcoplasmic reticulum, myosin ATPase, alkali lability, and light chain complement. The question of trophic substances of neural origin is discussed in light of the fact that chronic stimulation for 15 wk of a fast muscle produces complete biochemical and physiological conversion to the slow type. Sréter F A FA Luff A R AR Gergely J J eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Gen Physiol 2985110R 0022-1295 EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins SY7Q814VUP Calcium IM Adenosine Triphosphatases metabolism Animals Calcium metabolism Hydrogen-Ion Concentration Muscle Contraction Muscles innervation metabolism Myosins biosynthesis metabolism Rabbits Sarcoplasmic Reticulum metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 461 PMC2226229 10.1085/jgp.66.6.811 462 1976 02 09 2019 02 06 0022-1287 90 2 1975 Oct Journal of general microbiology J Gen Microbiol Chitin synthase in Mortierella vinacea: properties, cellular location and synthesis in growing cultures. 228-36 Chitin synthase of Mortierella vinacea was present in the "microsomal' fraction (100 000 g precipitate), the 'cell-wall' fraction (2000 g precipitate) and the 'mitochondrial' fraction (10 000 g precipitate). The properties of the 'microsomal' enzyme were investigated. The pH optimum was between 5-8 and 6-2, and the temperature optimum was between 31 and 33 degrees C. The Km for UDP N-acetyl-D-glucosamine was 1.8 mM. The enzyme was stimulated by Mg2+ and a slight stimulation was also effected by N-acetyl-D-glucosamine. Soluble chitodextrins were inhibitory. A pH-dependent, heat-stable inhibitor of chitin synthase activity was present in the soluble cytoplasm from the mycelium. The effects of aeration and glucose concentration on enzyme production in growing cultures were also investigated; maximum specific activity of chitin synthase was associated with the cessation of exponential growth. Peberdy J F JF Moore P M PM eng Journal Article England J Gen Microbiol 0375371 0022-1287 0 Enzyme Inhibitors 1398-61-4 Chitin EC 2.4.1.- Hexosyltransferases EC 2.4.1.16 Chitin Synthase I38ZP9992A Magnesium V956696549 Acetylglucosamine IM Acetylglucosamine pharmacology Cell Wall enzymology Chitin biosynthesis Chitin Synthase biosynthesis isolation & purification metabolism Cytoplasm Enzyme Inhibitors Fungi enzymology Hexosyltransferases Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Microsomes enzymology Mitochondria enzymology Mucorales enzymology Subcellular Fractions enzymology Temperature 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 462 10.1099/00221287-90-2-228 463 1976 02 09 2013 11 21 0022-1287 90 2 1975 Oct Journal of general microbiology J Gen Microbiol Protoplasts of Schizosaccharomyces pombe: an improved method for their preparation and the study of their guanine uptake. 260-4 A new method is described for the efficient conversion of Schizosaccharomyces pombe cells into protoplasts. The following parameters of guanine uptake determined in whole cells were unchanged in protoplasts: Km value, requirement for an energy source, sensitivity to competitive inhibitors, pH optimum, as well as the typical variation of the initial velocity of uptake observed during the growth phase. Housset P P Nagy M M Schwencke J J eng Comparative Study Journal Article England J Gen Microbiol 0375371 0022-1287 0 Azides 0 Culture Media 0 Hypoxanthines 0 Polysaccharides 5Z93L87A1R Guanine EC 3.2.1.- Glycoside Hydrolases JAC85A2161 Adenine Q150359I72 Azaguanine IM Adenine pharmacology Ascomycota metabolism Azaguanine pharmacology Azides pharmacology Cell Wall metabolism Culture Media Glycoside Hydrolases metabolism Growth Guanine metabolism Hydrogen-Ion Concentration Hypoxanthines pharmacology Polysaccharides Protoplasts metabolism physiology Saccharomyces growth & development Schizosaccharomyces metabolism Snails enzymology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 463 10.1099/00221287-90-2-260 464 1976 02 09 2017 03 22 0022-1287 90 2 1975 Oct Journal of general microbiology J Gen Microbiol Manganese mutagenesis in yeast. A practical application of manganese for the induction of mitochondrial antibiotic-resistant mutations. 265-70 When yeast cells were incubated for 4 to 8 h in yeast extract-peptone-glucose medium, pH 6, containing 8 mM-manganese, and then plated on selective media, there was a strong induction of antibiotic-resistant mutations. Indirect evidence suggests that practically all resistant mutants selected were of independent origin. The analysis of manganese-induced resistant mutants showed that most were extranuclear, while those tested showed recombination with known mitochondrial markers. Our results suggest that manganese can be considered as a mutagen which specifically induces mitochondrial mutations in Saccharomyces cerevisiae. Putrament A A Branowska H H Ejchart A A Prazmo W W eng Journal Article England J Gen Microbiol 0375371 0022-1287 0 Anti-Bacterial Agents 0 Mutagens 42Z2K6ZL8P Manganese IM Anti-Bacterial Agents pharmacology Cell Division Drug Resistance, Microbial Extrachromosomal Inheritance Hydrogen-Ion Concentration Manganese pharmacology Mitochondria drug effects Mutagens Mutation Recombination, Genetic Saccharomyces cerevisiae drug effects growth & development 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 464 10.1099/00221287-90-2-265 465 1976 03 01 2019 02 06 0022-1287 91 1 1975 Nov Journal of general microbiology J Gen Microbiol The properties and large-scale production of L-asparaginase from citrobacter. 1-16 An intracellular L-asparaginase with antitumour activity was purified from a strain of Citrobacter. The optimum conditions for enzyme production by fermentation on scales up to 2700 l were investigated. Highest enzyme yield was obtained in corn-steep liquor medium (9-2%, W/V) at 37 degrees C. Oxygen limitation was not necessary for high enzyme yield. A total recovery of 4-3% from nucleic-acid-free extract and a 180-fold increase in specific activity were obtained after purificaiton. The specific activity of the purified preparation was 45 i.u./mg protein. The enzyme hydrolysed D-asparagine and L-glutamine at 7 and 5%, respectively, of its activity toward L-asparagine, but L-glutaminase activity could be demonstrated only at substrate concentrations above 5 mM. The Km values for L-asparagine and D-asparagine were 2-6 X 10(-5) and 1-4 X 10(-4) respectively. The anti-lymphoma activity of the enzyme was demonstrated with Gardner lymphosarcoma and was found only slightly less potent that Crasnitin, the most active asparaginase so far tested in this system. Bascomb S S Banks G T GT Skarstedt M T MT Fleming A A Bettelheim K A KA eng Journal Article England J Gen Microbiol 0375371 0022-1287 0 Culture Media 0RH81L854J Glutamine 7006-34-0 Asparagine EC 3.5.1.1 Asparaginase EC 3.5.1.2 Glutaminase S88TT14065 Oxygen IM Animals Asparaginase biosynthesis isolation & purification therapeutic use Asparagine metabolism Citrobacter enzymology Culture Media Drug Evaluation, Preclinical Enterobacteriaceae enzymology Fermentation Glutaminase metabolism Glutamine metabolism Hydrogen-Ion Concentration Lymphoma, Non-Hodgkin drug therapy Mice Molecular Weight Neoplasms, Experimental Oxygen Stereoisomerism Temperature Zea mays 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 465 10.1099/00221287-91-1-1 466 1976 03 01 2013 11 21 0022-1287 91 1 1975 Nov Journal of general microbiology J Gen Microbiol Effect of inorganic phosphate on acridine inhibition and plasmid curing in Escherichia coli. 45-52 Some mutants and stock strains of Escherichia coli K12 were sensitive to acriflavine in the presence of inorganic phosphate but were resistant to acriflavine in its absence. They mutated spontaneously to resistance to acriflavine plus phosphate. The synergistic effect of phosphate on acriflavine sensitivity was increased at high pH values. Genetic analysis suggested that the mutations occurred in the gene acrA. Electron microscopic observation suggested that the presence of acriflavine plus phosphate affected the structure of the plasma membrane and the cytoplasm under it. This structural alteration was not caused by acriflavine alone. Acridine orange plus phosphate can more effectively eliminate the plasmid F8-gal+ than acridine orange alone. Nakamura H H Suganuma A A Greenberg J J eng Journal Article England J Gen Microbiol 0375371 0022-1287 0 Acridines 0 Phosphates 1T3A50395T Acriflavine IM Acridines pharmacology Acriflavine pharmacology Cell Membrane drug effects ultrastructure Cytoplasm drug effects ultrastructure Drug Resistance, Microbial Drug Synergism Escherichia coli drug effects ultrastructure Extrachromosomal Inheritance drug effects Genes Hydrogen-Ion Concentration Mutation Phosphates pharmacology Plasmids drug effects 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 466 10.1099/00221287-91-1-45 467 1976 03 01 2013 11 21 0022-1287 91 1 1975 Nov Journal of general microbiology J Gen Microbiol Oxidation of carbon monoxide and methane by Pseudomonas methanica. 79-91 The oxidation of carbon monoxide and methane by suspensions and ultrasonic extracts of Pseudomonas methanica was studied. A continuous assay for the oxidation of CO to CO2 was devised, using O2 and CO2 electrodes in combination. Stoicheiometries of CO-dependent CO2 formation, O2 consumption and NADH oxidation, and the partial stoicheiometries of methane-dependent NADH oxidation, suggest the involvement of a mono-oxygenase in these oxidations. Evidence is presented suggesting methane and CO oxidation are catalysed by a single enzyme system, distinct, at least in part, from the NADH oxidase present in extracts. Ethanol was able to provide the reductant necessary for CO oxidation by cell suspensions, though the metabolism of ethanol by P. methanica was found unlikely to result in substrate-level formation of NADH; the means whereby alcohol oxidation could supply reductant for the mono-oxygenase are discussed. Ferenci T T Strom T T Quayle J R JR eng Journal Article England J Gen Microbiol 0375371 0022-1287 01Q9PC255D Ammonium Chloride 0U46U6E8UK NAD 142M471B3J Carbon Dioxide 3K9958V90M Ethanol 7U1EE4V452 Carbon Monoxide EC 1.13.- Oxygenases EC 1.6.- NADH, NADPH Oxidoreductases L99N5N533T Ethane OP0UW79H66 Methane IM Ammonium Chloride pharmacology Carbon Dioxide biosynthesis Carbon Monoxide metabolism Cell-Free System Ethane pharmacology Ethanol metabolism Hydrogen-Ion Concentration Methane metabolism NAD metabolism NADH, NADPH Oxidoreductases metabolism Oxidation-Reduction Oxygen Consumption Oxygenases metabolism Pseudomonas enzymology metabolism Temperature 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 467 10.1099/00221287-91-1-79 468 1976 02 09 2019 07 24 0022-3018 161 6 1975 Dec The Journal of nervous and mental disease J Nerv Ment Dis Systematic desensitization to reduce dream-induced anxiety. 433-5 A modified version of systematic desensitization was used to reduce the anxiety and negative interpersonal consequences produced by a recurrent aversive dream resulting from events in the real world. The subject, a 16-year-old incarcerated male, was first taught a standard relaxation technique. The subject's dream was divided into 12 hierarchical imaginal scenes. Following initial relaxation, each scene was sequentially introduced and followed by the therapist's suggestion that the subject was still very relaxed. After three sessions with the therapists and several practice sessions by himself, the subject reported no further anxiety to the dream (which continued to occur) and improved relations with the institutional staff. Six months of follow-up showed no recurrence of the anxiety or the subsequent irritability which the subject had initially reported as leading to negative interpersonal relations with the staff. Cavior N N Deutsch A M AM eng Case Reports Journal Article United States J Nerv Ment Dis 0375402 0022-3018 AIM IM Adolescent Anxiety therapy Behavior Therapy Desensitization, Psychologic methods Dreams Humans Male 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 468 10.1097/00005053-197512000-00007 469 1976 02 26 2019 06 30 0022-3042 25 5 1975 Nov Journal of neurochemistry J Neurochem Cerebral aromatic aminotransferase. 579-82 Noguchi T T Nakatani M M Minatogawa Y Y Okuno E E Kido R R eng 100406 Wellcome Trust United Kingdom Journal Article England J Neurochem 2985190R 0022-3042 343-65-7 Kynurenine EC 2.6.1.- Transaminases EC 2.6.1.1 Aspartate Aminotransferases EC 2.6.1.5 Tyrosine Transaminase IM Animals Aspartate Aminotransferases Brain enzymology Catalysis Chemical Phenomena Chemistry Chromatography, Gel Electrophoresis, Disc Kynurenine Male Mitochondria enzymology Molecular Weight Rats Transaminases isolation & purification Tyrosine Transaminase 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 469 10.1111/j.1471-4159.1975.tb04371.x 470 1976 02 26 2019 06 30 0022-3042 25 5 1975 Nov Journal of neurochemistry J Neurochem Stearyl coenzyme A desaturase activities in rat brain microsomes. 607-10 Pullarkat R K RK Reha H H eng Journal Article England J Neurochem 2985190R 0022-3042 EC 1.14.19.- Fatty Acid Desaturases EC 1.14.19.1 Stearoyl-CoA Desaturase IM Age Factors Animals Brain enzymology Brain Mapping Cerebellum enzymology Fatty Acid Desaturases metabolism Medulla Oblongata enzymology Mesencephalon enzymology Microsomes enzymology Rats Rats, Inbred Strains Stearoyl-CoA Desaturase metabolism Telencephalon enzymology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 470 10.1111/j.1471-4159.1975.tb04375.x 471 1976 02 26 2019 06 30 0022-3042 25 5 1975 Nov Journal of neurochemistry J Neurochem ATPase activity of neuroblastoma cells in culture. 635-40 Ledig M M Ciesielski-Treska J J Cam Y Y Montagnon D D Mandel P P eng Comparative Study Journal Article England J Neurochem 2985190R 0022-3042 0 Insulin 005990WHZZ Deoxycholic Acid 57-50-1 Sucrose 63X7MBT2LQ Bucladesine 9NEZ333N27 Sodium EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium RWP5GA015D Potassium IM Adenosine Triphosphatases metabolism Animals Bucladesine pharmacology Cell Differentiation Cells, Cultured Clone Cells Deoxycholic Acid pharmacology Hydrogen-Ion Concentration Insulin pharmacology Magnesium Mice Neuroblastoma enzymology Potassium Sodium Sucrose pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 471 10.1111/j.1471-4159.1975.tb04380.x 472 1976 03 01 2016 11 23 0022-3085 44 1 1976 Jan Journal of neurosurgery J Neurosurg Experimental evaluation of the spasmogenicity of dopamine on the basilar artery. 45-9 Arteriograms of the basilar artery reveal that dopamine given intracisternally to dogs can generate cerebral vasospasm. This finding supports a recent hypothesis of others that dopamine may play a role in the pathogenesis of vasospasm, especially since many substances are known which fail to produce such spasm. Compared to blood or prostaglandin E2, however, the spasm induced by dopamine was delayed in onset, less in incidence, and usually less intense. Possible explanations for such experimental differences are discussed. White R P RP Hagen A A Robertson J T JT eng Comparative Study Journal Article United States J Neurosurg 0253357 0022-3085 0 Prostaglandins E VTD58H1Z2X Dopamine AIM IM Animals Basilar Artery diagnostic imaging drug effects Blood Blood Pressure drug effects Dogs Dopamine administration & dosage adverse effects Dose-Response Relationship, Drug Female Hydrogen-Ion Concentration Injections, Intraventricular Ischemic Attack, Transient chemically induced Male Prostaglandins E adverse effects Radiography Respiration drug effects Time Factors 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 472 10.3171/jns.1976.44.1.0045 473 1976 02 21 2019 10 27 0047-2603 7 2 1975 Dec Journal of neurosurgical nursing J Neurosurg Nurs The evolving role of the nurse and the neurosurgical physician's assistant in the treatment of intractable pain states. 107-15 Goloskov J W JW LeRoy P L PL eng Journal Article United States J Neurosurg Nurs 1300146 0047-2603 N Electric Stimulation methods Health Facilities Humans Inactivation, Metabolic Nurse Practitioners Pain, Intractable therapy Patient Care Team Physician Assistants 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 473 10.1097/01376517-197512000-00009 474 1976 02 21 2019 10 27 0047-2603 7 2 1975 Dec Journal of neurosurgical nursing J Neurosurg Nurs The neurosurgical nurse as a departmental assistant. 99-101 Madeja C C Plank N N Revta R R eng 100591 Wellcome Trust United Kingdom Journal Article United States J Neurosurg Nurs 1300146 0047-2603 N Hospital Departments Humans Neurosurgery Physician Assistants Specialties, Nursing 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 474 10.1097/01376517-197512000-00007 475 1976 02 09 2018 03 30 0022-3166 105 11 1975 Nov The Journal of nutrition J Nutr Fatty acid and ketone body metabolism in the rat: response to diet and exercise. 1422-32 This study was designed to measure the response of key enzymes of ketone body metabolism in heart, skeletal muscle, and liver to diet and exercise, two conditions known to influence ketone body utilization. A 3 (diet: control, high fat, or high carbohydrate) X 2 (kill condition: rested or exhausted) X 2 (training: trained or untrained) factorial design was used to estimate main experimental effects as well as identify significant interactions of the variables. Physical training (treadmill running) was associated with a doubling of the activity of skeletal muscle 3-oxoacid CoA transferase, a key enzyme in extrahepatic ketone body utilization. The activity of the rate-limiting enzyme of liver ketone body production, hydroxymethylglutaryl CoA synthetase (HMG CoA synthetase), was not greatly influenced by training or exhuastive exercise indicating that the metabolic control of the ketosis of exercise may more likely be a function of the supply of fatty acids to the liver rather than the activity of HMG CoA synthetase. Feeding a high fat diet, on the other hand, significantly increased the activity of liver HMG CoA synthetase, indicating that the ketosis of fat feeding may be of a different nature than that of exercise. The results of this study indicate that physical training is associated with biochemical adaptations in ketone body metabolism as well as fatty acid oxidation, and that trained individuals are metabolically better endowed to benefit from the ketosis of exercise than untrained individuals. Askew E W EW Dohm G L GL Huston R L RL eng Journal Article United States J Nutr 0404243 0022-3166 0 Dietary Carbohydrates 0 Dietary Fats 0 Fatty Acids 0 Keto Acids 0 Ketone Bodies 0 Proteins EC 1.9.3.1 Electron Transport Complex IV EC 2.3.1.9 Acetyl-CoA C-Acetyltransferase EC 2.3.3.10 Hydroxymethylglutaryl-CoA Synthase EC 2.8.1.- Sulfurtransferases SAA04E81UX Coenzyme A IM S Acetyl-CoA C-Acetyltransferase metabolism Animals Coenzyme A Dietary Carbohydrates administration & dosage Dietary Fats administration & dosage Electron Transport Complex IV metabolism Fatty Acids metabolism Hydroxymethylglutaryl-CoA Synthase metabolism Keto Acids Ketone Bodies metabolism Ketosis etiology Liver metabolism Male Muscles metabolism Myocardium metabolism Oxidation-Reduction Physical Exertion Proteins metabolism Rats Sulfurtransferases metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 475 10.1093/jn/105.11.1422 476 1976 02 09 2018 03 30 0022-3166 105 11 1975 Nov The Journal of nutrition J Nutr Some mechanisms of reduction of carotenoid levels in chickens infected with Eimeria acervulina or E. tenella. 1447-56 The levels of plasma carotenoids were markedly reduced in broiler cockerels infected with Eimeria acervulina or E. tenella. The mechanisms of this depigmentation differed between the two species, being primarily associated with interference of absorption of xanthophyll (carotenoids) from the intestinal lumen with E. acervulina infection and with leakage through the damaged wall of the cecum with E. tenella infection. Chicks reared on an essentially carotenoid-free diet and inoculated with E. acervulina showed no detectable levels of carotenoids in the blood 48 hours after being changed to a diet containing 30 mg of xanthophyll/kg. Conversely, uninoculated chicks and chicks inoculated with E. tenella showed significant and similar increases in plasma levels of carotenoids. Chicks reared on a diet containing xanthophyll and inoculated with E. tenella showed a more rapid decrease in plasma carotenoids than did uninoculated controls when changed to a xanthophyll-free diet. In chicks fed high xanthophyll diets containing chromic oxide, no indication of malabsorption was seen in chicks infected with E. tenella compared with uninoculated controls, whereas chicks inoculated with E. acervulina showed significantly less xanthophyll absorption. Conversely, a marked increase in the xanthophyll : Cr2O3 ratio was observed in the cecal contents of chicks inoculated with E. tenella compared with uninuoculated controls or those inoculated with E. acervulina. Studies of uninoculated chicks pair-fed with chicks inoculated with E. acervulina or E. tenella indicated that the decrease in plasma carotenoids and increases in intestinal pH are not associated with the reduced intake of feed associated with infection. The studies involving uninoculated birds with reciprocal chagnes between high and low xanthophyll diets indicated that plasma carotenoids are a more rapid and sensitive means of measuring changes in pigmentation levels than are visual skin scores carotenoid levels from the skin. Ruff M D MD Fuller H L HL eng Journal Article United States J Nutr 0404243 0022-3166 36-88-4 Carotenoids X72A60C9MT Lutein IM Animals Carotenoids metabolism Chickens metabolism Coccidiosis metabolism Diet Eimeria Hydrogen-Ion Concentration Intestines physiology Lutein administration & dosage metabolism Malabsorption Syndromes Male Skin metabolism Skin Pigmentation Species Specificity 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 476 10.1093/jn/105.11.1447 477 1976 02 19 2018 03 30 0022-3166 105 12 1975 Dec The Journal of nutrition J Nutr Metabolic studies on the development of ethanol-induced fatty liver in KK-Ay mice. 1500-8 Mechanisms involved in the development of the alcoholic fatty liver in KK-Ay mice were investigated. Incorporation studies using [14C]acetate and [3H]palmitate indicated that the half-life of hepatic triglycerides was doubled in the ethanol-ingesting mice, and utilization of the exogenous fat was significantly increases as compared with that of the control. No persistent alteration was recognized in hepatic oxidation of palmitate, as estimated by in vitro experiments using liver slices obtained from control and ethanol-drinking mice. Enzymic studies indicated that the activities of acetyl COA carboxylase, ATP citrate lyase, malic enzyme, and 6-phosphogluconate dehydrogenase were increased with ethanol drinking. The increment in hepatic triglycerides accumulated during ethanol ingestion was largely accounted for by palmitoleic, oleic, and linoleic acids. These findings demonstrated an augmentation in hepatic lipogenesis as well as an increased utilization of exogenous fats. Ethanol drinking did not cause any appreciable change in plasma triglyceride level and metabolism of adipose tissue. In summary of the present studies, accelerated lipogenesis and increased utilization of the dietary fats may be possible causal factors in the alcoholic fatty liver of KK-Ay mice. Arakawa M M Taketomi S S Furuno K K Matsuo T T Iwatsuka H H eng Journal Article United States J Nutr 0404243 0022-3166 0 Acetates 0 Fatty Acids, Unsaturated 0 Palmitates 0 Triglycerides 142M471B3J Carbon Dioxide 3K9958V90M Ethanol EC 1.1.- Alcohol Oxidoreductases EC 2.3.3.8 ATP Citrate (pro-S)-Lyase EC 2.7.- Phosphotransferases EC 3.1.3.2 Phosphoric Monoester Hydrolases EC 6.4.1.2 Acetyl-CoA Carboxylase IM ATP Citrate (pro-S)-Lyase metabolism Acetates metabolism Acetyl-CoA Carboxylase metabolism Adipose Tissue metabolism Alcohol Oxidoreductases metabolism Animals Carbon Dioxide metabolism Ethanol pharmacology Fatty Acids, Unsaturated biosynthesis Fatty Liver chemically induced metabolism Lipid Metabolism Male Mice Palmitates metabolism Phosphoric Monoester Hydrolases metabolism Phosphotransferases metabolism Triglycerides biosynthesis 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 477 10.1093/jn/105.12.1500 478 1976 02 21 2019 07 10 0022-3263 40 26 1975 Dec 26 The Journal of organic chemistry J Org Chem Different reactivities of 5-bromo-2'-deoxyuridine and 5-bromouracil in the bisulfite-mediated debromination. 3862-5 Hayatsu H H Chikuma T T Negishi K K eng Journal Article United States J Org Chem 2985193R 0022-3263 0 Sulfites 4HK400G5UO Bromouracil G34N38R2N1 Bromodeoxyuridine IM Bromodeoxyuridine analysis Bromouracil analysis Chemical Phenomena Chemistry Hydrogen-Ion Concentration Sulfites analysis 1975 12 26 1975 12 26 0 1 1975 12 26 0 0 ppublish 478 10.1021/jo00914a009 479 1976 02 19 2019 09 18 0300-5577 3 1 1975 Journal of perinatal medicine J Perinat Med Renal response to acid loading in the developing lamb fetus, intact in utero. 34-43 Response of the fetal kidney to metabolic acidosis was studied in five fetal lambs, 115-125 days gestation, in order to evaluate the renal contribution to elimination of hydrogen ion during intra-uterine development. Experiments were conducted on healthy unanesthetized fetuses, intact in utero, with catheters implanted at hysterotomy into a fetal femoral artery and vein and into the bladder via the urachus, four or more days prior to the study. A metabolic acidosis was induced by infusion of isotonic lactic acid, 15 m mole/kg, intravenously over a period of 90 minutes. Serial arterial samples were taken and urine collected in fractions before, during and for three hours following the infusion, for measurements of pH, bicarbonate, lactate and electrolytes as well as urine output. During the infusion, urine pH fell from 6.65 to 6.25 and was 6.34 three hours later (Figs. 1 to 4, Tabs. III to IV). Lactic acid infusion caused a prompt increase in urine output from a mean rate of 0.12 to a maximum of 0.28 ml/kg/min at the end of the infusion, returning to control rates three hours later. Lactate excretion increased from 0.05 to a maximum of 4.6 mumole/kg/min at the end of infusion; titratable acid increased from 0.22 to a maximum of 4 muEq/kg/min; the rates of excretion of lactate and titratable acid were still higher than control at the end of three hours. Ammonia excretion increased from 0.21 to a maximum of 0.56 muEq/kg/min three hours after the end of infusion. The acid infusion caused a small but significant fall in excretion of bicarbonate. During the 90 minutes of infusion and over the following three hours, about 800 mumole lactate was excreted while net acid excretion over the same period was no more than half that amount. The diuresis was also accompanied by a net loss of sodium and chloride, the excretion of these ions increasing more than threefold following acid infusion; excretion of potassium decreased to one-third its rate prior to the infusion. During the 90 minutes of infusion, blood pH fell from 7.36 to 7.13, base deficit rose from 3.8 to 16.4 mEq/L and lactate rose from 2.2 to 14.8 mM/L; there was also a small but significant rise in both blood PCO2 and PO2 (Figs. 1 to 2, Tabs. I to II). During the following three hours of recovery, pH rose gradually to 7.29, base deficit and lactate fell to 7.4 mEq/L and 8.7 mM/L respectively. Since renal excretion of net acid and lactate was small, the decrease in blood base deficit and lactate levels during the recovery must therefore be mainly due to equilibration in various fetal compartments as well as placental transfer. These experiments indicate that, in the lamb fetus, intact in utero, the kidney although limited by immaturity of several mechanisms, is capable of responding to an acid load and thus can make a small contribution to fetal homeostasis. The increase in excretion of net acid is accompanied by loss of sodium and chloride in the urine. Daniel S S SS Bowe E T ET Lallemand R R Yeh M N MN James L S LS eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Germany J Perinat Med 0361031 0300-5577 0 Bicarbonates 0 Lactates 0 Phosphates 7664-41-7 Ammonia IM Acid-Base Equilibrium Acidosis metabolism Ammonia metabolism Animals Bicarbonates blood Diuresis Female Fetus metabolism Gestational Age Humans Hydrogen-Ion Concentration Kidney metabolism Lactates metabolism Maternal-Fetal Exchange Phosphates metabolism Pregnancy Sheep 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 479 10.1515/jpme.1975.3.1.34 480 1976 02 19 2019 09 18 0300-5577 3 1 1975 Journal of perinatal medicine J Perinat Med Recognition and significance of maternogenic fetal acidosis during intensive monitoring of labor. 53-67 FHR monitoring and microanalysis of fetal blood are mutually complementary procedures, and optimal knowledge of the fetal state is achieved by making use of both, the former for the preliminary screening of all cases at risk and the latter for the purpose of deciding on obstetric management where pathological changes are evident in the FHR. The major difficulty in obtaining a precise value for the fetal acid-base balance lies in the occurence of "falsely abnormal" cases, i.e. cases in which the fetal pH falls during labor but the clinical condition at birth is good (APGAR greater than or equal to 7). In our own series the incidence of such cases among fetuses at risk was 11.2% (Tab. I). In the majority of these cases the fetal acidosis is thought to be a result of increased metabolic acidosis in the mother (maternogenic fetal metabolic acidosis). The importance of the maternogenic fetal acidosis during labor lies in the fact that unless it is recognised, rapid extraction of the fetus will appear necessary on clinical grounds, although it is in fact unnecessary, since this form of acidosis has no adverse effect on the fetus. Various parameters have been proposed for the differential diagnosis of the maternogenic fetal acidosis. These include the feto-maternal difference in base deficit (F/M deltaBD), the materno-fetal differences in pHqu 40 (M/F deltapHqu 40) the materno-fetal difference actual pH (M/F actual deltapH), and the materno-fetal difference in base deficit of the extra-cellular fluid (M/F deltaBDHb5). A critical analysis of these parameters has been carried out on the results of microtests performed during a 5 year period (1968-1972) at the First Clinic of Obstetrics and Gynecology of Milan University. The cases comprised 59 regarded as normal (normal course of pregnancy, spontaneous commencement of labor at term, clear amniotic fluid, regular FHR, spontaneous birth, APGAR at 90 sec between 8 and 10, weight at birth greater than 2500 g), and 335 considered to be at risk (maternal disease, presence of meconium stained amniotic fluid and/or abnormal changes in FHR). In all of these cases the FHR was recorded by cardiotokography, and the tracings were interpreted according to HON. Microsamples of blood were taken from both mother and fetus during labor and the following determinations were carried out: actual pH, pHqu 40, Hb concentration, hemoglobin oxygen saturation, base deficit Hb5 (BDHb5). The maternofetal differences were then calculated. The same determinations were carried out on samples of maternal blood and of arterial and venous cord blood taken immediately after delivery. The clinical condition of the infant was evaluated by the APGAR score at 90 seconds after birth. Roversi G D GD Canussio V V Spennacchio M M eng Journal Article Germany J Perinat Med 0361031 0300-5577 0 Hemoglobins IM Acid-Base Equilibrium Acidosis diagnosis Apgar Score Bradycardia diagnosis Electrocardiography methods Female Fetal Distress diagnosis Fetal Heart physiopathology Heart Rate Hemoglobins Humans Hydrogen-Ion Concentration Infant, Newborn Maternal-Fetal Exchange Monitoring, Physiologic Obstetric Labor Complications diagnosis Pregnancy Uterine Contraction 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 480 10.1515/jpme.1975.3.1.53 481 1976 02 19 2019 12 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Solubilization and stabilization of the cytotoxic agent coralyne. 1825-30 Kinetic studies were carried out on the ring opening of the quaternary nitrogen cation, coralynium ion (I), to yield 6'-acetylpapaverine (III), on the cyclization of III to yield I, and on a photochemical reaction undergone by I in aqueous solutions exposed to visible light. From the results, it was concluded that: (a) I and III are in facile equilibrium in aqueous solution but appreciable amounts of III do not exist in dilute solutions with pH values below 10: (b) the photochemical reaction of I in water (presumably a photohydration) can be reversed by lyophilization, by heatiing, and by increasing the pH of solutions to values greater than 12; (c) the photochemical reaction of I can be inhibited by protecting the aqueous solutions from visible light, and the rate in the presence of light can be reduced by increasing the concentration of I in the solution; and (d) although the chloride and sulfoacetate salts of I react identically and have similar solubilities in water, it is possible to prepare more concentrated and, hence, more stable solutions of the sulfoacetate salt by including sodium hydroxide in the solvent. The solubility of coralyne chloride remains about the same in dilute sodium hydroxide as in water. Cho M J MJ Repta A J AJ Cheng C C CC Zee-Cheng K Y KY Higuchi T T Pitman I H IH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Pharm Sci 2985195R 0022-3549 0 Antineoplastic Agents 0 Berberine Alkaloids 6872-73-7 coralyne IM Antineoplastic Agents Berberine Alkaloids Chemistry, Pharmaceutical Drug Stability Hydrogen-Ion Concentration Kinetics Light Photochemistry Solubility Spectrophotometry, Ultraviolet 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 481 S0022-3549(15)40508-8 10.1002/jps.2600641116 482 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Solvolysis of a substituted imidazoline, mazindol. 1833-8 Hydrolysis of mazindol to form 2-(2-aminoethyl)-3-(p-chlorophenyl)-3-hydroxyphthalimidine was followed spectro-photometrically in aqueous solutions at temperatures between 37 and 70degree, pH values up to 7.6, and an ionic strength of 0.2. The effects of acetate, formate, and phosphate buffers as well as ionic strength on the observed rate constants were investigated. An interesting nonlinear dependency of the kobs with buffer concentration was noted. The velocity constants declined with increasing hydrogen-ion concentration; the log k-pH profile and rate law are given along with other relevant data. Maulding H V HV Turi P P Grossman D D Nazareno J P JP eng Journal Article United States J Pharm Sci 2985195R 0022-3549 0 Buffers 0 Indoles C56709M5NH Mazindol IM Buffers Catalysis Hydrogen-Ion Concentration Hydrolysis Indoles Kinetics Mazindol analysis Osmolar Concentration Solubility Temperature 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 482 S0022-3549(15)40506-4 10.1002/jps.2600641118 483 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Complexation in formulation of parenteral solutions: solubilization of the cytotoxic agent hexamethylmelamine by complexation with gentisic acid species. 1850-5 The apparent solubility of hexamethylmelamine in aqueous solutions suitable for intravenous use was increased by complexation with gentisic acid. Studies were carried out in the pH 0-8 range. Unprotonated hexamethylmelamine did not form complexes with the gentisate ion, while the hexamethylmelammonium ion appeared to form several different complexes with both the gentidate ion and gentisic acid. Two different solid complexes were isolated and characterized. The solubility increases observed at pH 3.5-5.0 are described by mathematical relationships involving the stability constants of some postulated complex species. From these results, sultable formulations for use as parenteral solutions are proposed. The increase in the apparent aqueous solubility of hexamethylmelamine in such formulations may range from five- to 90-fold, depending upon the pH and total gentisateion concentrations. Kreilgård B B Higuchi T T Repta A J AJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Pharm Sci 2985195R 0022-3549 0 Gentisates 0 Quaternary Ammonium Compounds 0 Triazines Q8BIH59O7H Altretamine IM Altretamine chemical synthesis Chemistry, Pharmaceutical Drug Stability Gentisates chemical synthesis Hydrogen-Ion Concentration Osmolar Concentration Oxidation-Reduction Quaternary Ammonium Compounds Solubility Triazines 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 483 S0022-3549(15)40524-6 10.1002/jps.2600641122 484 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Inhibitory effect of dioctyl sodium sulfosuccinate on trypsin activity. 1858-62 The inhibitory effect of dioctyl sodium sulfosuccinate on the proteolytic activity of trypsin was investigate over the pH 6-8 range. The antitryptic activity was determined using two different substrates: casein and N,alpha-benzoyl-DL-arginine-p-nitroanilide hydrochloride. The mechanistic studies revealed the substrate-inhibitor interaction to be the overall major mechanism of inhibition. This interaction was shown to involve substrate depletion, probably involving some primary sites of the natural substrate casein. Some inhibition was also shown to be due to an interaction between the enzyme and the inhibitior molecules. The interactions of the inhibitor with the enzyme and the substrate were irreversible. The possible therapeutic significance of the inhibitory effect of the surfactant is discussed. Jodhka G S GS Gouda M W MW Medora R S RS Knalil S A SA eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Pharm Sci 2985195R 0022-3549 0 Caseins 0 Octanols 0 Succinates 0 Trypsin Inhibitors EC 3.4.21.4 Trypsin IM Caseins Dialysis Hydrogen-Ion Concentration Kinetics Octanols metabolism pharmacology Protein Binding Succinates metabolism pharmacology Trypsin metabolism Trypsin Inhibitors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 484 S0022-3549(15)40522-2 10.1002/jps.2600641124 485 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci In vitro adsorption of diphenoxylate hydrochloride on activated charcoal and its relationship to pharmacological effects of drug in vivo. I. 1877-9 The adsorption of diphenoxylate hydrochloride, a potent antidiarrheal agent, on activated charcoal powder was studied in vitro. Langmuir adsorption isotherms were established at pH 4 and 7, and the maximum adsorption capacity of charcoal for this drug was estimated using these values. Activated charcoal modified the bioavailability of diphenoxylate hydrochloride in vivo. The antipropulsive action of diphenoxylate in the mouse was strongly inhibited in the presence of activated charcoal. A comparative evaluation of charcoal and chromium oxide used as inert, nonabsorbable markers revealed that chromium oxide may be the marker of choic in GI transit studies in laboratory animals since it does not influence the bioavailability of diphenoxylate hydrochloride. Sanvordeker D R DR Dahani E Z EZ eng Journal Article United States J Pharm Sci 2985195R 0022-3549 0 Isonipecotic Acids 0 Oxides 0R0008Q3JB Chromium 16291-96-6 Charcoal 73312P173G Diphenoxylate IM Adsorption Animals Biological Availability Charcoal pharmacology Chromium pharmacology Diphenoxylate metabolism pharmacology Gastrointestinal Motility drug effects Hydrogen-Ion Concentration Isonipecotic Acids Male Mice Oxides pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 485 S0022-3549(15)40517-9 10.1002/jps.2600641129 486 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Binding of bile acids to cholestyramine at gastric pH conditions. 1887-9 The binding of bile salts to cholestyramine was studied under varying conditions of pH and added electrolyte. The taurine-conjugated bile salts were strongly absorbed by the anion-exchange resin at low pH and in the presence of chloride anions. Glycocholic acid binding was very weak at low pH but increased strongly with increasing pH. The presence of chloride ions strongly decreased the amount of glycocholate bound by the anion-exchange resin. Lindenbaum S S Higuchi T T eng Journal Article United States J Pharm Sci 2985195R 0022-3549 0 Bile Acids and Salts 005990WHZZ Deoxycholic Acid 11041-12-6 Cholestyramine Resin 5E090O0G3Z Taurocholic Acid G59NX3I3RT Glycocholic Acid IM Adsorption Bile Acids and Salts metabolism Cholestyramine Resin metabolism Deoxycholic Acid metabolism Glycocholic Acid metabolism Hydrogen-Ion Concentration Taurocholic Acid metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 486 S0022-3549(15)40542-8 10.1002/jps.2600641133 487 1976 02 19 2019 07 10 0022-3549 64 11 1975 Nov Journal of pharmaceutical sciences J Pharm Sci Group contribution data obtained by ion-pair extraction of prostaglandin B2 with aliphatic amines. 1894-6 Cho M J MJ Schnabel R R eng Journal Article United States J Pharm Sci 2985195R 0022-3549 0 Amines 0 Prostaglandins IM Amines Chemical Phenomena Chemistry Hydrogen-Ion Concentration Prostaglandins Solubility Structure-Activity Relationship 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 487 S0022-3549(15)40538-6 10.1002/jps.2600641137 488 1976 02 27 2013 11 21 0022-3565 195 3 1975 Dec The Journal of pharmacology and experimental therapeutics J Pharmacol Exp Ther Amodiaquin accumulation by mouse erythrocytes infected with Plasmodium berghei. 397-403 [14C]amodiaquin accumulation by washed erythrocyte preparations was characterized to permit comparisons with chloroquine accumulation. Erythrocytes infected with Plasmodium berghei CS (chloroquine-susceptible) accumulate amodiaquin by a saturable process that has an apparent dissociation constant for amodiaquin of 7.6 X 10(-8) M and is competitively inhibited by chloroquine, quinine and quinacrine, as is the process of chloroquine accumulation. Within experimental error, the K1 of 8 X 10(-7) M estimated for chloroquine is the same regardless of whether the drug being accumulated is [14C]amodiaquin or [14C]chloroquine. Likewise, the K1 for amodiaquin is the same regardless of which drug is being accumulated. In addition, glucose stimulates and hydrogen ion, cold or interruption of glycolysis inhibits amodiaquin as well as chloroquine accumulation. These findings are evidence that a single process serves to accumulate both drugs. In the absence of substrate, erythrocytes infected with P. berghei CR (chloroquine-resistant) accumulate twice as much amodiaquin as chloroquine, and they accumulate more amodiaquin than do erythrocytes infected with P. berghei CS. These differences occur because P. berghei CR infects polychromatophilic erythrocytes possessing a high-affinity, substrate-independent process of accumulation to which amodiaquin has greater access than chloroquine. In the presence of glucose, amodiaquin accumulation by erythrocytes infected with P. berghei CR, when plotted as a function of amodiaquin concentration in the medium, describes a sigmoid curve. Fitch C D CD Gonzalez Y Y Chevli R R eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Pharmacol Exp Ther 0376362 0022-3565 220236ED28 Amodiaquine IY9XDZ35W2 Glucose IM Amodiaquine blood Animals Erythrocytes metabolism parasitology Glucose pharmacology Hydrogen-Ion Concentration Malaria blood parasitology Male Mice Plasmodium berghei Stimulation, Chemical 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 488 489 1976 02 27 2017 03 22 0022-3565 195 3 1975 Dec The Journal of pharmacology and experimental therapeutics J Pharmacol Exp Ther The neurochemistry of Parkinson's disease: effect of L-dopa therapy. 453-64 Post-mortem brain material from control and Parkinson's disease patients was examined to elucidate further the neurochemistry of this disease and to determine the mechanism of action of L-dopa as a therapeutic agent. The activities of L-aromatic amino acid decarboxylase (dopa D), tyrosine hydroxylase, monoamine oxidase and catechol-O-methyl transferase were examined; in addition the tissue levels of dopa, 3-O-methyldopa, dopamine (DA) and homovanillic acid (HVA) were determined. In the non-dopa-treated Parkinsonian patients, the greatest decreases were detected for striatal DA and dopa D, with homovanillic acid and tyrosine hydroxylase levels showing a lesser change. The activities of monoamine oxidase and catechol-O-methyl transferase in the striatal nuclei were not different from the controls. The putamen was consistently the most severely affected region. Dopa and 3-O-methyldopa were detectable in all brain areas only in those patients treated with L-dopa shortly before death. The mean concentrations of DA in the striatum of these patients were 1) 9 to 15 times higher than those in non-dopa-treated patients, 2) related to the time before death of the last dose of L-dopa and 3) greater in the striatum of patients clinically classified as "good responders" as compared to "poor responders." Although L-dopa therapy increased homovanillic acid levels in all brain areas, a preferential increase was observed in the striatum. It was concluded that L-dopa's principal therapeutic effects in Parkinson's disease are consistent with its transformation to DA in the striatum. Lloyd K G KG Davidson L L Hornykiewicz O O eng Journal Article United States J Pharmacol Exp Ther 0376362 0022-3565 46627O600J Levodopa 56LH93261Y Methyldopa 63-84-3 Dihydroxyphenylalanine EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.4.3.4 Monoamine Oxidase EC 2.1.1.6 Catechol O-Methyltransferase EC 4.1.1.- Dopa Decarboxylase VTD58H1Z2X Dopamine X77S6GMS36 Homovanillic Acid IM Aged Brain enzymology metabolism Catechol O-Methyltransferase metabolism Dihydroxyphenylalanine metabolism Dopa Decarboxylase metabolism Dopamine metabolism Female Homovanillic Acid metabolism Humans Levodopa therapeutic use Male Methyldopa metabolism Middle Aged Monoamine Oxidase metabolism Parkinson Disease drug therapy enzymology metabolism Tyrosine 3-Monooxygenase metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 489 490 1976 02 27 2014 11 20 0022-3565 195 3 1975 Dec The Journal of pharmacology and experimental therapeutics J Pharmacol Exp Ther Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine. 465-79 These experiments were designed to study the mechanism of depletion of dopamine (DA) in the striatum produced by alpha-methyl-m-tyrosine (alpha-MMT). alpha-Methyl-m-tyramine (alpha-MMTA), the metabolite of alpha-MMT, appears to be the active DA-depleting agent, since the administration of a decarboxylase inhibitor before alpha-MMT markedly reduced both the formation of alpha-MMTA and the depletion of DA. After injection of alpha-MMT (100 mg/kg i.p.), the striatal concentration of homovanillic acid (HVA) rose by 41% at 1 hour. This is probably due to an increase in DA metabolism, since alpha-MMT markedly enhanced the decline of DA produced by alpha-methyl-p-tyrosine (alpha-MPT). At 2, 3 and 4 hours after alpha-MMT, the concentration of HVA and dihydroxyphenylacetic acid was below control level. The decrease in dihydroxyphenylacetic acid is due partially to a decreased formation of dihydroxyphenylacetic acid from DA. In striatal slices, both alpha-MMT and alpha-MMTA decreased the formation of 3H-H2O and the accumulation of 3H-DA from 1-3,5-3H-tyrosine. Alpha-MMT did not alter the specific activity of 3H-tyrosine or release 3H-DA from the slices, but it did inhibit the activity of tyrosine hydroxylase in striatal homogenates at low concentrations of tyrosine (10 muM). Alpha-MMTA released both newly synthesized and exogenously accumulated 3H-DA from striatal slices. At low concentrations of alpha-MMTA, the percent reduction in 3H-H2O was much greater than the percentage of 3H-DA released into the medium. However, at higher concentrations, the inhibition of 3H-H2O reached a maximum while 3H-DA release kept increasing. These results suggest that both inhibition of tyrosine hydroxylase activity and DA release from storage sites by alpha-MMTA may account for the depletion of DA produced by the injection of alpha-MMT. Uretsky N J NJ Snodgrass S R SR Lorenzo A V AV eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Pharmacol Exp Ther 0376362 0022-3565 0 Methyltyrosines 102-32-9 3,4-Dihydroxyphenylacetic Acid 11F6O06WN0 Brocresine 42HK56048U Tyrosine 762OS3ZEJU Benserazide EC 1.14.16.2 Tyrosine 3-Monooxygenase FQR280JW2N p-Hydroxyamphetamine VTD58H1Z2X Dopamine X77S6GMS36 Homovanillic Acid IM 3,4-Dihydroxyphenylacetic Acid metabolism Animals Benserazide pharmacology Brocresine pharmacology Corpus Striatum drug effects enzymology metabolism Dopamine metabolism Homovanillic Acid metabolism In Vitro Techniques Male Methyltyrosines metabolism pharmacology Rats Time Factors Tyrosine metabolism Tyrosine 3-Monooxygenase metabolism p-Hydroxyamphetamine metabolism 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 490 491 1976 02 09 2019 05 09 0022-3751 251 3 1975 Oct The Journal of physiology J Physiol Characteristics of gastric inhibition by acidification of oxyntic gland area. 699-709 1. Gastric acid responses to the test meals were measured in the Heidenhain pouch, gastric and pancreatic fistula dogs, using the intragastric titration method, and monitoring the rate at which a solution of 1-0 N-NaOH had to be added to maintain the pH of the gastric content constant at pre-selected values ranging from 5-0 to 1-0. In this way the pH profile of the gastric acid and pepsin responses to a liver extract meal kept in the Heidenhain pouch or gastric fistula as well as to exogenous stimuli such as histamine, pentagastrin or Urecholine could be determined. 2. A liver extract meal adjusted to pH 5-0 produced a potent and pressure-related stimulation of acid secretion from the Heidenhain pouch without any change in secretion from the main stomach and pancreas or in the serum concentration of immuno-assayable gastrin. 3. Graded decrease of the liver extract meal pH to below 5-0 resulted in the pH-dependent inhibition of gastric acid output, which at pH 1-0 was only about 30% of the value attained at pH 5-0. Acid secretion from the Heidenhain pouch induced by exogenous stimuli such as histamine, pentagastrin or Urecholine also showed gradual decrease when the pH of the pouch content was decreased in sequential order from 5-0 to 1-0. This pH-dependent inhibition was accompanied by an increase in pepsin secretion. 4. The pH-dependent inhibition of the Heidenhain pouch response to the liver extract meal was not altered by topical application of a local anaesthetic and atropine or by the intravenous infusion of large doses of atropine, secretin or metiamide, which were shown to cause a marked inhibition of the main stomach response to the liver meal. 5. The results indicate that there is a local and gastrin-independent inhibition mechanism of gastric acid secretion activated by an acidified meal making contact with the oxyntic gland area. Konturek S J SJ Obtulowicz W W Tasler J J eng Journal Article England J Physiol 0266262 0022-3751 0 Chlorides 1393-25-5 Secretin 3K7670861M Metiamide 7C0697DR9I Atropine 820484N8I3 Histamine 98PI200987 Lidocaine EC 3.4.23.1 Pepsin A EF0NX91490 Pentagastrin IM Animals Atropine pharmacology Chlorides pharmacology Dogs Duodenum physiology Gastric Acidity Determination Gastric Juice metabolism Gastric Mucosa metabolism Histamine pharmacology Homeostasis Hydrogen-Ion Concentration Lidocaine pharmacology Metiamide pharmacology Pentagastrin pharmacology Pepsin A metabolism Secretin pharmacology Stomach drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 491 PMC1348412 10.1113/jphysiol.1975.sp011117 J Physiol. 1975 Mar;246(1):143-57 237120 Gastroenterology. 1974 May;66(5):982-6 4151198 Gastroenterology. 1974 Oct;67(4):730-1 4412295 Am J Physiol. 1973 Sep;225(3):521-7 4542193 Am J Physiol. 1973 Dec;225(6):1411-5 4586508 Am J Dig Dis. 1974 Jun;19(6):557-64 4597820 J Clin Invest. 1973 Mar;52(3):645-57 4685087 Gastroenterology. 1971 Nov;61(5):667-74 4940613 Gastroenterology. 1970 Jan;58(1):1-14 5460746 Am J Physiol. 1971 Apr;220(4):918-21 5551147 J Appl Physiol. 1968 Aug;25(2):207-9 5666100 J Clin Invest. 1966 Jan;45(1):1-13 5901177 Gastroenterology. 1967 Feb;52(2):414-20 6020109 492 1976 03 01 2019 05 09 0022-3751 252 1 1975 Oct The Journal of physiology J Physiol The influence of pH on equilibrium effects of tetrodotoxin on myelinated nerve fibres of Rana esculenta. 159-84 1. The experiments were done on single nodes of Ranvier of Rana esculenta. The effects of tetrodotoxin and H ions were determined either by the reduction of the maximum rate of rise, VA, of action potentials evoked with threshold stimuli or in the voltage clamp by the decrease of the peak Na permeability, PNa. 2. With the tetrodotoxin sample used throughout the investigation the equilibrium dissociation constant, KT, of the toxin-receptor reaction at neutral pH was determined to be 2-8 nM. Between 1-55 and 15-5 nM tetrodotoxin the normalized value, A, of VA, was found to be related to the normalized toxin concentration cT = [TTX]/2-8 nM by the empirical equation log [(1-A)/A] = 1-22 log cT-0-573. 3. On increasing the pH (up to 8-8) the effect of tetrodotoxin diminished as revealed by an increase in A. The apparent reduction of cT (as calculated from A) suggests that the toxin is active only in its cationic forms. 4. Weakly acid tetrodotoxin solutions (7-3 less than pH less than or equal to 5-5) reduced A to a lesser degree than did neutral toxin solutions in spite of the inherent depressing effect of acid pH on A (A = 0-5 at about pH 5-5). In more acid toxin solutions A decreased again and at pH 4-6 it was about equal to the value in toxin-free solution. 5. When, after equilibrium in an acid toxin solution, the perfusate was suddenly changed to neutral Ringer solution A jumped to a higher value A' as measured 1 sec after the switch. Since the blocking effect of hydrogen ions subsided within a fraction of a second while the time constant of the toxin washout is of the order of 1 min, A' reflects the number of Na channels blocked by tetrodotoxin at acid pH. 6. In acid toxin-free solution the peak PNa as obtained in voltage clamp experiments was reduced by a voltage-dependent factor (cH + 1)-1 with CH = [H+]/KH(E) and KH(E) = 2-04 muM exp (0-34 EF/RT). Adding tetrodotoxin resulted in another reduction by a constant factor p'T. 7. Experiments employing various combinations of toxin concentration (3-1-93 nM) and pH values (7-3-5-2) confirm the decreased toxin effect at low pH. Moreover, p'T was smaller (the additional toxin effect larger) when the membrane had been kept depolarized and thus cH reduced during equilibration. This suggests that tetrodotoxin cations and H ions compete for the same blocking site. A quantitative fit, however, requires additional assumptions. Ulbricht W W Wagner H H HH eng Journal Article England J Physiol 0266262 0022-3751 4368-28-9 Tetrodotoxin 9NEZ333N27 Sodium IM Action Potentials drug effects Animals Anura Binding Sites Cell Membrane Permeability drug effects Hydrogen-Ion Concentration In Vitro Techniques Kinetics Membrane Potentials Nerve Fibers, Myelinated drug effects physiology Rana esculenta Ranvier's Nodes drug effects physiology Sodium physiology Tetrodotoxin antagonists & inhibitors pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 492 PMC1348473 10.1113/jphysiol.1975.sp011139 J Physiol. 1975 Oct;252(1):185-202 493 Pflugers Arch. 1971;326(1):76-87 5104334 J Gen Physiol. 1971 Dec;58(6):599-619 5315827 J Gen Physiol. 1969 Nov;54(5):589-606 5346530 Pflugers Arch. 1969;313(1):80-8 5389973 J Gen Physiol. 1970 Mar;55(3):309-35 5520505 J Gen Physiol. 1968 Feb;51(2):199-219 5641635 J Gen Physiol. 1968 Feb;51(2):221-36 5641636 Eur J Pharmacol. 1968 Apr;3(1):58-67 5654671 Pflugers Arch. 1969;309(2):176-92 5815327 J Pharmacol Exp Ther. 1969 Oct;169(2):224-8 5824604 J Physiol. 1965 Sep;180(1):50-66 5860225 Chem Pharm Bull (Tokyo). 1964 Nov;12(11):1357-74 5888644 Tetrahedron. 1965 Aug;21(8):2059-88 5896483 Science. 1967 Jun 23;156(3782):1625-7 6025123 J Physiol. 1958 Aug 29;143(1):76-90 13576461 Helv Physiol Pharmacol Acta. 1958;16(2):127-45 13598329 J Physiol. 1959 Oct;148:188-200 13817145 Biol Bull. 1949 Jun;96(3):233-7 18153110 Pflugers Arch. 1969;313(4):361-80 4188682 Proc Natl Acad Sci U S A. 1972 Dec;69(12):3634-7 4509325 J Gen Physiol. 1973 Jun;61(6):687-708 4541078 J Physiol. 1973 Aug;233(1):167-94 4543328 Pflugers Arch. 1974;351(3):207-29 4547507 Biochim Biophys Acta. 1972 Dec 1;290(1):248-55 4640763 J Physiol. 1972 Dec;227(1):95-126 4646588 Biochemistry. 1972 Nov 21;11(24):4565-9 4654144 J Physiol. 1973 Dec;235(3):783-804 4772409 493 1976 03 01 2019 05 09 0022-3751 252 1 1975 Oct The Journal of physiology J Physiol The influence of pH on the rate of tetrodotoxin action on myelinated nerve fibres. 185-202 1. The experiments were done on single myelinated nerve fibres of Rana esculenta. The rates of toxin effect were studied either by measuring the maximum rate of rise, VA, of repetitively evoked action potentials or by measuring Na currents during periodic impulses in the voltage clamp. 2. VA measurements showed that in alkaline solutions (pH up to 8-8) the offset rate was unchanged while the onset was slowed in quantitative agreement with an assumed decrease in the active cationic form of tetrodotoxin. 3. Both VA measurements and those in the voltage clamp revealed a decrease in T'off, the offset time constant and in increase in the onset time constant, T'on, as the pH was lowered. 4. For tetrodotoxin concentrations, [TTX], up to 400 nM and pH values down to 5-3 the simple relation T'on/T'off = p'R held, where p'T is the constant factor by which the Na permeability was reduced at equilibrium with a given [TTX]. 5. The agreement between kinetic and equilibrium results was also valid when, at constant [TTX] and pH. p'T was modified by the holding potential during equilibration. 6. No unequivocal explanation of the results can be given but some of their features resemble acid catalysis. Ulbricht W W Wagner H H HH eng Journal Article England J Physiol 0266262 0022-3751 4368-28-9 Tetrodotoxin 9NEZ333N27 Sodium IM Action Potentials Animals Anura Binding Sites Cell Membrane Permeability drug effects Hydrogen-Ion Concentration In Vitro Techniques Kinetics Nerve Fibers, Myelinated drug effects physiology Rana esculenta Ranvier's Nodes drug effects physiology Sodium physiology Tetrodotoxin pharmacology Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 493 PMC1348474 10.1113/jphysiol.1975.sp011140 J Physiol. 1909 Dec 23;39(5):361-73 16992989 Proc R Soc Lond B Biol Sci. 1966 Apr 19;164(996):488-510 4379580 Proc R Soc Lond B Biol Sci. 1968 Jun 11;170(1019):135-54 4385241 J Gen Physiol. 1973 Jun;61(6):687-708 4541078 J Physiol. 1973 Aug;233(1):167-94 4543328 Pflugers Arch. 1974;351(4):303-14 4548182 Pflugers Arch. 1971;326(1):76-87 5104334 Mol Pharmacol. 1970 Jul;6(4):357-82 5429280 J Gen Physiol. 1970 Mar;55(3):309-35 5520505 J Gen Physiol. 1968 Feb;51(2):221-36 5641636 Pflugers Arch. 1969;309(2):176-92 5815327 J Physiol. 1975 Oct;252(1):159-84 492 J Gen Physiol. 1968 Feb;51(2):199-219 5641635 494 1976 03 01 2019 05 09 0022-3751 252 1 1975 Oct The Journal of physiology J Physiol The formation of synapses in amphibian striated muscle during development. 203-39 1. A study has been made of the formation of synapses in developing reinnervated and cross-reinnervated amphibian twitch muscles which receive either a focal (iliofibularis) or a distributed (sartorius) innervation from 'en plaque' nerve terminals using histological, ultrastructural and electrophysiological techniques. 2. During the development of the tadpole through metamorphosis to the adult frog, the sartorius myofibres increased in length at about twice the rate of the iliofibularis myofibres, due to a fast rate of growth at their insertions on to the pelvic tendon. 3. The short iliofibularis and sartorius myofibres of young tadpoles (800 mum long) possessed only a single synapse and the iliofibularis myofibres did not receive any further innervation during development. However the sartorius myofibres received further transient innervation on the new muscle laid down during development at the fast growing pelvic insertion, until the distance between the original synapse formed on the myofibres and the synapse at the pelvic end of the muscle was about 12 mm. 4. During development synapses possessed either skewed, multimodal, or unimodal m.e.p.p. amplitude-frequency distributions; the intervals between m.e.p.p.s. were not distributed randomly according to a Poisson process, as m.e.p.p.s. of similar amplitudes tended to be separated by very short intervals; the unit-size e.p.p. had a similar amplitude-frequency distribution as the m.e.p.p.s. if these had a unimodal distribution. 5. Reinnervation or cross-reinnervation of the sartorius and the iliofibularis muscles in adults or at a late stage of development simply reconstituted the normal focal and distributed innervation patterns of the muscles, as found in the control muscles of the contralateral and unoperated legs. 6. These observations on synapse formation in amphibia are consistent with the hypothesis that during development the axon making the initial synaptic contact on the muscle cells induces a property over a length of muscle membrane adjacent to this site which makes it refractory to synapse formation; thus during reinnervation or cross-reinnervation of adult muscles this refractory property constrains synapse formation to these sites. Bennett M R MR Pettigrew A G AG eng Journal Article England J Physiol 0266262 0022-3751 0 Neurotransmitter Agents IM Amphibians growth & development Animals Anura Bufo marinus Electrophysiology Larva Metamorphosis, Biological Muscle Denervation Muscle Development Muscles innervation Myofibrils physiology Nerve Regeneration Neuromuscular Junction physiology Neurotransmitter Agents physiology Synapses physiology ultrastructure 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 494 PMC1348475 10.1113/jphysiol.1975.sp011141 J Physiol. 1975 May;247(2):429-46 1151780 J Physiol. 1973 Sep;233(3):481-500 4127828 J Physiol. 1973 Sep;233(3):501-17 4127829 J Physiol. 1974 Jun;239(3):571-94 4152807 J Physiol. 1972 Jan;220(1):243-56 4333829 J Physiol. 1973 Apr;230(2):331-57 4350769 J Physiol. 1973 Jul;232(1):1-21 4354768 Z Zellforsch Mikrosk Anat. 1973 Oct 26;143(4):587-96 4359269 J Physiol. 1974 Apr;238(1):93-107 4365809 Dev Biol. 1974 Sep;40(1):129-53 4370444 Proc R Soc Lond B Biol Sci. 1968 Feb 27;169(1016):289-306 4384567 Brain Res. 1974 Nov 15;80(2):335-9 4417941 Brain Res. 1974 Jan 11;65(2):303-16 4420951 Growth. 1974 SEP;38(3):389-94 4421587 J Physiol. 1974 Sep;241(2):515-45 4443927 J Physiol. 1974 Sep;241(2):547-73 4443928 J Physiol. 1974 Mar;237(2):453-63 4545184 Pflugers Arch. 1974 May 6;348(4):273-86 4546013 Pflugers Arch. 1974 May 6;348(4):287-92 4546014 J Anat. 1973 Oct;116(Pt 1):45-55 4798240 Acta Anat (Basel). 1973;85(4):580-92 4799763 J Physiol. 1974 Feb;236(3):733-42 4822582 Z Zellforsch Mikrosk Anat. 1971;121(4):593-603 5118528 J Physiol. 1960 Nov;154:190-205 13770626 J Physiol. 1962 Aug;162:393-408 13886109 Dev Biol. 1963 Dec;8:322-40 14084729 J Histochem Cytochem. 1964 Mar;12:219-21 14187330 J Physiol. 1952 May;117(1):109-28 14946732 J Bone Joint Surg Br. 1950 May;32-B(2):234-43 15422025 J Physiol. 1974 Jan;236(2):327-39 16992437 J Physiol. 1974 Jan;236(2):341-61 16992438 J Physiol. 1974 Jan;236(2):363-71 16992439 J Cell Sci. 1971 Nov;9(3):751-67 5148015 J Physiol. 1971 Oct;218(1):85-100 5316145 Acta Anat (Basel). 1969;73(4):588-602 5374555 Acta Physiol Scand Suppl. 1969;333:53-76 5387387 J Physiol. 1970 Aug;209(3):701-9 5499804 J Physiol. 1970 Mar;207(1):31-50 5503879 Arch Biol (Liege). 1967;78(1):9-60 5613322 Z Zellforsch Mikrosk Anat. 1968;88(2):278-96 5697596 Acta Anat (Basel). 1968;71(2):249-67 5730867 Acta Anat (Basel). 1969;72(1):38-49 5799961 J Physiol. 1953 Aug;121(2):289-317 13085337 J Physiol. 1954 Nov 29;126(2):293-303 13222285 J Physiol. 1957 Jul 11;137(2):267-78 13449877 495 1976 02 13 2019 09 07 0022-3921 22 4 1975 Nov The Journal of protozoology J Protozool Comparative studies of Trypanosoma vespertilionis Battaglia and Trypanosoma dionisii Bettencourt & França. 509-13 In diphasic blood agar media Trypanosoma vespertilionis developed spheroid clusters as compared to rather long, sausage-shaped (sometimes branched) clusters formed by Trypanosoma dionisii. The former species attained a greater population density (approximately 6 X 10(7) organisms/ml) than the latter (approximately 2 X 10(7) organisms/ml). Greater numbers of epimastigotes, some in active binary divisions, were observed during the logarithmic phase of growth, and morphologic changes occurred during cultivation which correlated with increased acidity and a depletion of glucose. Maximum numbers of trypomastigote forms were found during the stationary and early death phases. Most of the forms observed after 20 days were sphaeromastigotes. Glucose concentrations decreased to 0 M in T. vespertilionis and to 4.4 X 10(-5) M in T. dionisii cultures during the stationary and death phases. By the 12th day of incubation cultures of T. vespertilionis were more acid (pH 5.5) than those of T. dionisii vespertilionis and T. dionisii contained common and specific antigens. At least 2-3 common antigens were detected in extracts reacted against heterologous antisera. Specific antigens were observed as nonidentical lines formed by extracts reacted against homologous and heterologous antisera and with antisera absorbed with heterologous antigens. At least 2 specific antigens were evident in extracts of T. vespertilionis and 1 in extracts of T. dionisii. Soria C A CA Dusanic D G DG eng Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Protozool 2985197R 0022-3921 0 Antigens IY9XDZ35W2 Glucose IM Animals Antigens Chiroptera parasitology Glucose metabolism Hydrogen-Ion Concentration Trypanosoma growth & development immunology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 495 10.1111/j.1550-7408.1975.tb05220.x 496 1976 02 09 2018 11 13 0035-8797 25 159 1975 Oct The Journal of the Royal College of General Practitioners J R Coll Gen Pract The use of psychotropic drugs in general practice. A report of a year's survey. 731-44 All the psychotropic tablets prescribed by a general practitioner in one year are itemised. The patients who received them are separated into diagnostic groups and their treatment is analysed by the number of attendances, prescriptions, and duration of therapy. Hospital referrals and overdoses over a longer period are recorded. My policy in psychiatric conditions is indicated. Wilks J M JM eng Journal Article England J R Coll Gen Pract 7503107 0035-8797 0 Anti-Anxiety Agents 0 Antidepressive Agents 0 Antipsychotic Agents 0 Barbiturates 0 Psychotropic Drugs IM Adolescent Adult Anti-Anxiety Agents therapeutic use Antidepressive Agents therapeutic use Antipsychotic Agents therapeutic use Anxiety drug therapy Barbiturates therapeutic use Child Child, Preschool Depression drug therapy Family Practice Female Humans Infant Male Middle Aged Psychotic Disorders drug therapy Psychotropic Drugs therapeutic use Sleep Initiation and Maintenance Disorders drug therapy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 496 PMC2157840 Br Med J. 1973 Apr 7;2(5857):18-20 4695689 Br Med J. 1968 Dec 7;4(5631):613-7 5723365 497 1976 02 09 2019 07 09 0022-2623 18 12 1975 Dec Journal of medicinal chemistry J Med Chem N-Isopropyl derivatives of dopamine and 5,6-dihydroxy-2-aminotetralin. 1212-6 Secondary and tertiary amino homologs of the title compounds have been prepared, bearing an N-isopropyl group. In peripheral evaluation, certain members of the series exhibited beta-adrenergic agonist effects of lower activity than isoproterenol. N-Methyl-N-isopropyl-5,6-dihydroxytetralin exhibited marked properties consistent with its being an alpha agonist, and it is concluded that introduction of considerable bulk about the nitrogen of a catecholamine does not a priori destroy alpha-agonist effects. The compounds qualitatively paralleled the effects of dopamine in assays based upon direct intrastriatal administration in rats, although they were less potent than dopamine. Cannon J G JG O'Donnell J P JP Lee T T Hoppin C R CR Long J P JP Ilhan M M Costall B B Naylor R J RJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Med Chem 9716531 0022-2623 0 Adrenergic alpha-Agonists 0 Adrenergic beta-Agonists 0 Naphthalenes CKR7XL41N4 2-Naphthylamine VTD58H1Z2X Dopamine IM 2-Naphthylamine analogs & derivatives chemical synthesis pharmacology Adrenergic alpha-Agonists chemical synthesis pharmacology Adrenergic beta-Agonists chemical synthesis pharmacology Animals Blood Pressure drug effects Cats Corpus Striatum Dogs Dopamine analogs & derivatives chemical synthesis pharmacology Heart Rate drug effects Humans Injections Motor Activity drug effects Naphthalenes chemical synthesis Rats Reaction Time drug effects Stereotyped Behavior drug effects 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 497 10.1021/jm00246a008 498 1976 02 21 2019 05 09 0022-2585 12 4 1975 Oct 31 Journal of medical entomology J Med Entomol Relation between diel activity and respiration in Armigeres subalbatus (Coquillett) (Diptera: Culicidae). 479-80 Berlin O G OG Dwarakanath S K SK Pandian R S RS eng Journal Article England J Med Entomol 0375400 0022-2585 IM Animals Circadian Rhythm Culicidae physiology Feeding Behavior Female Oxygen Consumption 1975 10 31 1975 10 31 0 1 1975 10 31 0 0 ppublish 498 10.1093/jmedent/12.4.479 499 1976 02 13 2020 02 25 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ Educational programs for team delivery. Interdisciplinary education of health associates: The Johns Hopkins experience. 111-7 Peterson M L ML eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Curriculum Education, Medical Family Practice education Maryland Patient Care Team Physician Assistants education Primary Health Care United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 499 10.1097/00001888-197512000-00015 Clin Med (Lond). 2012 Dec;12(6):513-6 23342402 Clin Med (Lond). 2012 Dec;12(6):517-9 23342403 500 1976 02 13 2019 08 19 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ The regional workshops on primary care. 201-9 Nourse E S ES eng Congress United States J Med Educ 0375377 0022-2577 AIM IM Community Participation Congresses as Topic Education, Medical Evaluation Studies as Topic Financing, Organized Group Processes Organization and Administration Primary Health Care United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 500 10.1097/00001888-197512000-00028 501 1976 02 13 2020 02 25 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ Current issues in primary care education: review and commentary. 211-33 Hudson J I JI Giacalone J J JJ eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Certification Curriculum Education, Medical Faculty, Medical Fees and Charges Financing, Government Health Workforce supply & distribution Internship and Residency Nurse Practitioners statistics & numerical data Physician Assistants education Primary Health Care Students, Medical United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 501 10.1097/00001888-197512000-00029 J Nurs Manag. 2011 Apr;19(3):311-30 21507102 BMJ. 2012 Jul 26;345:e5041 22836109 BMJ. 2012 Jul 26;345:e5135 22836240 BMJ. 2012 Aug 08;345:e5310 22875955 502 1976 02 13 2019 08 19 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ New health practitioner education: problems and issues. 67-73 Sadler A M AM Jr eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Accreditation Costs and Cost Analysis Health Expenditures Interprofessional Relations Nurse Practitioners education Patient Care Team Physician Assistants education Primary Health Care Quality of Health Care United States 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 502 10.1097/00001888-197512000-00010 503 1976 02 13 2019 08 19 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ The training of new health manpower. 75-83 Lewis C E CE eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Accreditation Clinical Competence Curriculum Inservice Training Nurse Practitioners education Physician Assistants education Task Performance and Analysis United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 503 10.1097/00001888-197512000-00011 504 1976 02 13 2019 02 06 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ Two training programs. MEDEX: the education-development interface. 85-92 Lawrence D M DM eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Curriculum Education standards Education, Medical, Continuing Physician Assistants education Preceptorship Primary Health Care United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 504 505 1976 02 13 2020 02 25 0022-2577 50 12 pt 2 1975 Dec Journal of medical education J Med Educ Characteristics of physician's assistant programs. 92-6 Jewett R E RE eng Journal Article United States J Med Educ 0375377 0022-2577 AIM IM Accreditation American Medical Association Certification Clinical Competence Curriculum Physician Assistants education Preceptorship Primary Health Care United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 505 10.1097/00001888-197512000-00013 Br Homeopath J. 2000 Jan;89(1):13-6 10703905 Complement Ther Med. 2000 Jun;8(2):71-5 10859598 Br J Gen Pract. 2001 Jan;51(462):25-30 11271869 Complement Ther Med. 2001 Sep;9(3):167-72 11926430 Med J Aust. 2002 Apr 15;176(8):376-80 12041633 Neurology. 2003 May 13;60(9):1424-8 12743225 Fam Pract. 2003 Oct;20(5):575-7 14507801 Acupunct Med. 2004 Jun;22(2):72-4 15253582 Acupunct Med. 2004 Sep;22(3):137-40 15551938 Br J Clin Pharmacol. 2005 Jun;59(6):743-9 15948942 Complement Ther Clin Pract. 2005 May;11(2):130-6 15955295 Br J Clin Pharmacol. 2006 Dec;62(6):647-52; discussion 645-6 16796701 Nature. 2007 Mar 22;446(7134):373-4 17377563 Int J Epidemiol. 2007 Jun;36(3):666-76 17470488 J R Soc Med. 2007 Jul;100(7):330-8 17606755 Acupunct Med. 2008 Dec;26(4):205-13 19098691 Arch Intern Med. 1995 Dec 11-25;155(22):2405-8 7503598 Fam Pract. 1997 Aug;14(4):302-6 9283851 506 1976 02 26 2019 08 19 0022-2631 23 3-4 1975 The Journal of membrane biology J Membr Biol Phospholipases. III. Effects of ionic surfactants on the phospholipase-catalyzed hydrolysis of unsonicated egg lecithin liposomes. 293-204 Apparent values of Km and Vmax have been measured for catalysis of hydrolysis of unsonicated egg lecithin liposomes, activated through addition of 0.4 M n-hexanol, by phospholipases A2 from bee and snake venoms and by phospholipase C from Clostridium welchii as a function of the concentration of three surfactants: hexadecylamine, hexadecyltrimethylammonium bromide, and dihexadecyl phosphate. For all three enzymes, values of Km and Vmax show little or no dependence on the concentration of these ionic surfactants, demonstrating that the liposomal surface charge is not a crucial factor in determining susceptibility to phospholipase-catalyzed hydrolysis. Goldhammer A R AR Jain M K MK Cordes E H EH eng Journal Article United States J Membr Biol 0211301 0022-2631 0 Amines 0 Cetrimonium Compounds 0 Hexanols 0 Liposomes 0 Organophosphorus Compounds 0 Phosphatidylcholines 0 Surface-Active Agents EC 3.1.- Phospholipases IM Amines pharmacology Cetrimonium Compounds pharmacology Hexanols pharmacology Hydrogen-Ion Concentration Kinetics Liposomes metabolism Organophosphorus Compounds pharmacology Phosphatidylcholines metabolism Phospholipases metabolism Surface-Active Agents pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 506 10.1007/BF01870255 J Biol Chem. 1973 Jun 10;248(11):4023-34 4736081 Biochimie. 1971;53(8):841-52 4948235 J Am Oil Chem Soc. 1965 Jan;42:53-6 14228472 FEBS Lett. 1973 Mar 15;30(3):281-5 4349548 Annu Rev Biochem. 1972;41:161-78 4343454 Eur J Biochem. 1971 Jun 29;20(4):459-68 5087615 J Lipid Res. 1973 Mar;14(2):152-9 4698263 Biochemistry. 1974 May 21;13(11):2265-8 4857566 Biochim Biophys Acta. 1971 Jul 13;239(2):252-66 5165845 Prog Biophys Mol Biol. 1968;18:29-95 4894874 Chem Phys Lipids. 1971 Dec;7(4):185-206 5167549 Biochim Biophys Acta. 1972 Jul 7;270(3):364-82 5064927 J Biol Chem. 1973 Jan 25;248(2):580-7 4734331 Adv Enzymol Relat Areas Mol Biol. 1967;29:1-32 4881884 Arch Biochem Biophys. 1973 Jan;154(1):47-55 4347691 FEBS Lett. 1973 Mar 15;30(3):253-60 4349546 Biochemistry. 1972 Mar 14;11(6):1030-41 5062536 Biochemistry. 1974 May 21;13(11):2248-57 4857565 Biochim Biophys Acta. 1962 May 7;59:103-15 13864657 J Biol Chem. 1974 Apr 25;249(8):2652-7 4822508 Biochim Biophys Acta. 1968 Jun 4;159(2):285-95 5657459 Arch Biochem Biophys. 1973 Oct;158(2):485-93 4798723 J Membr Biol. 1973 Dec 31;14(2):119-34 4359548 J Membr Biol. 1973 Dec 31;14(2):101-18 4359547 507 1976 02 19 2019 08 19 0022-2631 24 2 1975 Nov 07 The Journal of membrane biology J Membr Biol Negative potential level in the outer layer of the toad skin. 161-81 The isolated skin of the toad Bufo marinus ictericus when impaled from the outer surface by glass microelectrodes filled with 3 M KCl shows a voltage profile which is a continuous function of the depth of impalement. The superficial intraepithelial potential difference measured with reference to the external solution (PDi) is negative with NaCl-Ringer's solution on both sides of the skin, displaying a minimum of -26.7+/-3.6 mV at 6+/-2 mum. Null value is obtained at 19+/-3 mum, with positive values for deeper impalements. Indications of cell impalements (abrupt voltage and resistance jumps) were frequently observed at sites deeper than 25 mum from the outer surface. Measurements of the electrical resistance between the microelectrode and the external solution, made with single- and double-barreled microelectrodes, showed great discrepancies, which may be attributed to distinct pathways of different resistances in the stratum corneum. PDi measured at a depth of 5 mum was a logarithmic function of Na2SO4 or K2SO4 concentration in the external solution, increasing in negativity with a reduction in concentration. Substitution of Na by K in the external solution had only minor effects on PDi. Acidification of the external solution from pH 9 is accompanied by a reduction in the negative value of PDi. At pH 3 PDi was positive. PDi was interpreted as a diffusion potential at the tip of the microelectrode due to KCl diffusion from the electrode into the matrix of the stratum corneum. Differences in K and Cl mobilities, responsible for the origin of PDi, were attributed to fixed charges in the matrix of the stratum corneum, with density and polarity determined by their degree of proponation, controlled by the hydrogen ion concentration of the external solution. Skin potential, short-circuit current and their relationship to PDI were discussed. Nunes M A MA Vieira F L FL eng Journal Article United States J Membr Biol 0211301 0022-2631 0 Sulfates 451W47IQ8X Sodium Chloride RWP5GA015D Potassium IM Animals Bufo marinus Electric Conductivity Electric Stimulation Epithelial Cells Epithelium physiology Hydrogen-Ion Concentration In Vitro Techniques Membrane Potentials drug effects Microelectrodes Potassium pharmacology Skin drug effects Skin Physiological Phenomena Sodium Chloride pharmacology Sulfates pharmacology 1975 11 7 1975 11 7 0 1 1975 11 7 0 0 ppublish 507 10.1007/BF01868621 Acta Physiol Scand. 1957 Jul 1;39(4):348-55 13444046 J Gen Physiol. 1972 May;59(5):503-18 4537305 J Cell Comp Physiol. 1949 Dec;34(3):383-96 15410483 Acta Physiol Scand. 1958 Jun 2;42(3-4):298-308 13544986 Int Rev Cytol. 1968;24:345-71 4880140 J Gen Physiol. 1964 Mar;47:795-808 14127612 Biochim Biophys Acta. 1965 Mar 29;94:461-71 14314353 J Gen Physiol. 1966 Jul;49(6):1161-76 5951043 Invest Ophthalmol. 1968 Aug;7(4):405-15 5663551 Pflugers Arch. 1970;316(1):64-80 5461401 J Cell Physiol. 1966 Jun;67(3):367-73 5963062 Exp Eye Res. 1970 Apr;9(2):233-40 5428818 J Gen Physiol. 1965 Mar;48:543-57 14324974 J Gen Physiol. 1964 Mar;47:749-71 14127610 Am J Physiol. 1970 Jul;219(1):178-83 5424841 Am J Physiol. 1970 Dec;219(6):1811-8 5485698 J Physiol. 1971 Mar;213(2):50P-51P 5574855 Exp Eye Res. 1964 Jun;3:132-40 14211916 Acta Physiol Scand. 1964 Aug;61:484-504 14209264 Acta Physiol Scand. 1961 Nov-Dec;53:348-65 14468075 Acta Physiol Scand. 1949 Jan 31;17(1):1-37 18129271 J Physiol. 1956 Sep 27;133(3):631-58 13368111 508 1976 03 01 2019 12 10 0022-2720 104 3 1975 Aug Journal of microscopy J Microsc The avian erythrocyte: a study of fixation for electron microscopy. 293-305 The quality of ultrastructural preservation of the avian erythrocyte achieved using various fixation techniques is evaluated. Different combinations of initial fixatives, buffers and post-fixation procedures were tested as well as variations in fixative osmolarity, pH and temperature. Of the commonly used initial fixatives (glutaraldehyde, acrolein and formaldehyde), 2% glutaraldehyde, alone in a slightly hypertonic buffer containing divalent ions, produced optimum erythrocyte preservation. The osmolarity was balanced using a non-electrolyte such as a sucrose. The addition of 12% hexylene glycol to the buffer solutions also improves erythrocyte preservation, as evidenced by the increased stability of the marginal microtubules, microfilaments and proteinaceous material. The use of Spurr low-viscosity epoxy resin enables the cells to be collected using low gravitational centrifugation. Brown J N JN eng Journal Article England J Microsc 0204522 0022-2720 0 Buffers 0 Chlorides 0 Chromatin 0 Glycols 1HG84L3525 Formaldehyde 7864XYD3JJ Acrolein I38ZP9992A Magnesium KEH0A3F75J hexylene glycol T3C89M417N Glutaral IM Acrolein Animals Buffers Cell Membrane ultrastructure Cell Nucleus ultrastructure Chickens Chlorides Chromatin ultrastructure Cytological Techniques Erythrocytes ultrastructure Formaldehyde Glutaral Glycols Hydrogen-Ion Concentration Magnesium Male Microtubules ultrastructure Mitochondria ultrastructure Osmolar Concentration Temperature 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 508 10.1111/j.1365-2818.1975.tb04028.x 509 1976 02 13 2019 07 10 0022-2836 96 4 1975 Aug 25 Journal of molecular biology J Mol Biol Gelation of sickle hemoglobin. III. Nitrosyl hemoglobin. 733-43 Briehl R W RW Salhany J M JM eng Journal Article Research Support, U.S. Gov't, P.H.S. England J Mol Biol 2985088R 0022-2836 0 Gels 0 Hemoglobin, Sickle 0 Hemoglobins 0 Hemoglobins, Abnormal 0 Nitroso Compounds IM Birefringence Gels Hemoglobin, Sickle Hemoglobins Hemoglobins, Abnormal Humans Hydrogen-Ion Concentration Microscopy, Polarization Nitroso Compounds Protein Conformation Spectrophotometry 1975 8 25 1975 8 25 0 1 1975 8 25 0 0 ppublish 509 10.1016/0022-2836(75)90149-7 510 1976 02 13 2019 07 10 0022-2836 96 4 1975 Aug 25 Journal of molecular biology J Mol Biol Interactions between cysteine residues as probes of protein conformation: the disulphide bond between Cys-14 and Cys-38 of the pancreatic trypsin inhibitor. 767-76 Creighton T E TE eng Journal Article England J Mol Biol 2985088R 0022-2836 0 Disulfides 0 Trypsin Inhibitors K848JZ4886 Cysteine T8ID5YZU6Y Dithiothreitol IM Animals Binding Sites Cysteine analysis Disulfides analysis Dithiothreitol Hydrogen-Ion Concentration Kinetics Models, Molecular Pancreas Protein Binding Thermodynamics Trypsin Inhibitors analysis 1975 8 25 1975 8 25 0 1 1975 8 25 0 0 ppublish 510 0022-2836(75)90151-5 10.1016/0022-2836(75)90151-5 511 1976 02 21 2019 07 10 0022-2836 98 3 1975 Nov 05 Journal of molecular biology J Mol Biol A study of the histidine residues of human carbonic anhydrase C using 270 MHz proton magnetic resonance. 597-614 Campbell I D ID Lindskog S S White A I AI eng Journal Article England J Mol Biol 2985088R 0022-2836 0 Cyanides 0R0008Q3JB Chromium 3G0H8C9362 Cobalt 4QD397987E Histidine EC 4.2.1.1 Carbonic Anhydrases IM Binding Sites Carbonic Anhydrases analysis metabolism Chromium Cobalt Cyanides Histidine analysis Humans Hydrogen-Ion Concentration Magnetic Resonance Spectroscopy Protein Binding Protein Conformation 1975 11 5 1975 11 5 0 1 1975 11 5 0 0 ppublish 511 S0022-2836(75)80089-1 10.1016/s0022-2836(75)80089-1 512 1976 02 26 2019 07 10 0022-2836 98 4 1975 Nov 15 Journal of molecular biology J Mol Biol The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. 693-717 Bode W W Schwager P P eng Journal Article England J Mol Biol 2985088R 0022-2836 0 Benzamidines 059QF0KO0R Water EC 3.4.21.4 Trypsin SY7Q814VUP Calcium IM Amino Acid Sequence Animals Benzamidines Binding Sites Calcium Cattle Crystallization Fourier Analysis Hydrogen-Ion Concentration Mathematics Models, Molecular Protein Binding Protein Conformation Trypsin analysis Water analysis 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 512 S0022-2836(75)80005-2 10.1016/s0022-2836(75)80005-2 513 1976 02 26 2020 02 25 0022-2836 98 4 1975 Nov 15 Journal of molecular biology J Mol Biol Electrostatic side chain complementarity in collagen fibrils. 835-9 Li S S Golub E E Katz E P EP eng Journal Article Research Support, U.S. Gov't, P.H.S. England J Mol Biol 2985088R 0022-2836 0 Macromolecular Substances 9007-34-5 Collagen SY7Q814VUP Calcium IM Animals Binding Sites Calcium analysis Cattle Collagen analysis Hydrogen-Ion Concentration Kinetics Macromolecular Substances Male Osmolar Concentration Protein Binding Skin analysis Thermodynamics 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 513 S0022-2836(75)80015-5 10.1016/s0022-2836(75)80015-5 BMJ. 2012 Jan 12;344:e341 22240275 Clin Med (Lond). 2011 Dec;11(6):601-4 22268319 BMJ. 2012 Feb 17;344:e1179 22344523 514 1976 02 20 2019 07 11 0022-5282 15 11 1975 Nov The Journal of trauma J Trauma Hemoglobin solution and the oxyhemoglobin dissociation curve. 943-50 1) A study was carried out to determine the oxyhemoglobin dissociation curve of stroma-free hemoglobin solution and factors which influence it, (pH; 2,3 DPG). 2) To simulate acute volume replacement, dilution experiments, in vitro, were performed employing both hemoglobin solution and Ringer's lactate in whole blood. 3) It was determined that stroma-free hemoglobin solution has a left-shifted oxyhemoglobin dissociation curve which responds to pH change but not to the addition of 2,3 DPG. 4) The dilutional effect of hemoglobin solution when mixed with whole blood in volumes up to 50% was to left-shift the oxyhemoglobin curve, unlike the effect of Ringer's lactate (no change). 5) This may have importance in the hemodynamic compensatory response to acute normovolemic anemia. Greenburg A G AG Elia C C Levine B B Belsha J J Peskin G W GW eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States J Trauma 0376373 0022-5282 0 Diphosphoglyceric Acids 0 Hemoglobins 0 Lactates 0 Oxyhemoglobins AIM IM Blood Preservation Diphosphoglyceric Acids pharmacology Female Hemoglobins metabolism Humans Hydrogen-Ion Concentration Lactates pharmacology Male Oxyhemoglobins metabolism Resuscitation 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 514 10.1097/00005373-197511000-00001 515 1976 02 20 2019 07 11 0022-5282 15 11 1975 Nov The Journal of trauma J Trauma Effect of antihistamine-antiserotonin and ganglionic blocking agents upon increased capillary permeability following burn trauma. 969-75 Tiny (0.2% TBS), partial thickness, non-contact radiant heat burns in guinea pigs resulted, within 3 hours, in significant edema formation and protein leakage at the site of the injury. Areas of skin distant to the burn also showed an increase in water content but no protein leakage. Pretreatment of the animals with either chlorisondamine hydrochloride or a mixture of methysergide and chlorpheniramine significantly decreased postburn edema formation and protein leakage. Liquid emulsion autoradiography revealed that leakage of protein occurs primarily in the areas of skin adjacent to the panniculus carnosus. The studies suggest that: the increase in vascular permeability that occurs as a consequence of burn injuries is humorally mediated; albumin leakage is limited to the injured tissues; and histamine, serotonin, and presumably catecholamines play significant roles in the development of this phenomenon. Carvajal H F HF Brouhard B H BH Linares H A HA eng Journal Article United States J Trauma 0376373 0022-5282 0 Drug Combinations 0 Ganglionic Blockers 0 Histamine H1 Antagonists 0 Serotonin Antagonists 0 Serum Albumin 3U6IO1965U Chlorpheniramine JD3M24F66I Chlorisondamine XZA9HY6Z98 Methysergide AIM IM Animals Body Water analysis Burns physiopathology Capillary Permeability drug effects Chlorisondamine pharmacology Chlorpheniramine pharmacology Drug Combinations Edema physiopathology Female Ganglionic Blockers pharmacology Guinea Pigs Histamine H1 Antagonists pharmacology Male Methysergide pharmacology Serotonin Antagonists Serum Albumin administration & dosage analysis Skin analysis 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 515 10.1097/00005373-197511000-00005 516 1976 03 01 2020 07 24 0022-538X 16 6 1975 Dec Journal of virology J Virol Bacteriophage T4 baseplate components. II. Binding and location of bacteriophage-induced dihydrofolate reductase. 1401-8 The location of T4D phage-induced dihydrofolate reductase (dfr) has been determined in intact and incomplete phage particles. It has been found that phage mutants inducing a temperature-sensitive dfr (dfrts) procude heat-labile phage particles. The structural dfr produced by these ts mutants was shown to assume different configurations depending on the temperature at which the phage is assembled. Morphogenesis of incomplete phage particles lacking the gene 11 protein on their baseplates was found to be inhibited by reagents binding to dfr, such as antibodies to dfr. Further, cofactor molecules for dfr, such as reduced nicotinamide adenine dinucleotide phosphate and reduced nicotinamide adenine dinucleotide, also inhibited the step in morphogenesis involving the addition of gene 11 product. On the other hand, inhibitors of dfr, such as adenosine dephosphoribose, stimulated the addition of the gene 11 protein. It has been concluded that the phage-induced dfr is a baseplate component which is partially covered by the gene 11 protein. The properties of phage particles produced after infection of the nonpermissive host with the one known T4D mutant containing a nonsense mutation in its dfr gene suggested that these progeny particles contained a partial polypeptide, which was large enough to serve as a structural element. Kozloff L M LM Crosby L K LK Lute M M Hall D H DH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Virol 0113724 0022-538X 0 Adenine Nucleotides 0 Viral Proteins 0U46U6E8UK NAD 53-59-8 NADP AN164J8Y0X Trimethoprim EC 1.5.1.3 Tetrahydrofolate Dehydrogenase IM Adenine Nucleotides pharmacology Coliphages drug effects enzymology ultrastructure DNA Viruses Drug Resistance, Microbial Escherichia coli drug effects Morphogenesis drug effects Mutation NAD pharmacology NADP pharmacology Protein Conformation Temperature Tetrahydrofolate Dehydrogenase isolation & purification Trimethoprim pharmacology Viral Proteins isolation & purification 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 516 PMC355748 10.1128/JVI.16.6.1401-1408.1975 J Mol Biol. 1969 Dec 28;46(3):493-511 5365959 J Virol. 1975 Dec;16(6):1409-19 1202242 J Virol. 1975 Dec;16(6):1391-400 1238580 Virology. 1973 Oct;55(2):380-90 4147531 J Virol. 1970 Jun;5(6):740-53 4393396 Virology. 1973 Jun;53(2):413-26 4576345 Virology. 1973 Oct;55(2):391-6 4582603 Virology. 1974 Jul;60(1):265-75 4601794 Virology. 1973 Mar;52(1):234-45 4610988 J Virol. 1970 Jun;5(6):726-39 4914098 Biochem Biophys Res Commun. 1971 Jun 4;43(5):1164-70 4936128 J Virol. 1971 Apr;7(4):531-3 4939388 J Mol Biol. 1970 Nov 14;53(3):461-74 5493282 J Virol. 1973 Jun;11(6):840-7 4145894 J Virol. 1973 Jul;12(1):74-8 4579826 Proc Natl Acad Sci U S A. 1967 Aug;58(2):584-91 4860754 517 1976 03 01 2020 07 24 0022-538X 16 6 1975 Dec Journal of virology J Virol Uukuniemi virus contains an RNA polymerase. 1420-5 An RNA-dependent RNA polymerase activity has been found associated with Uukuniemi virions. The enzyme activity is expressed only after disrupting the virions with the nonionic detergent Triton X-100 and is absolutely dependent on Mn2+, whereas Mg2+ is not required, a finding that distinguishes this polymerase from those of other enveloped minus-strand RNA viruses. Within the range pH 7.2 to 8.5 no distinct optimum was found. The optimum temperature was between 37 and 40 C. The reaction was not inhibited by actinomycin D, rifampin, or DNase, whereas RNase was completely inhibitory. The partially RNase-resistant product consisted of rather small-sized RNA, which contained sequences complementary to Uukuniemi virus RNA as shown by hybridization to the template L, M, and S RNA species of Uukuniemi virus. Ranki M M Pettersson R F RF eng Journal Article United States J Virol 0113724 0022-538X 0 RNA, Viral 3WJQ0SDW1A Polyethylene Glycols 42Z2K6ZL8P Manganese EC 2.7.7.6 DNA-Directed RNA Polymerases IM Arboviruses drug effects enzymology Cell-Free System DNA-Directed RNA Polymerases metabolism Hydrogen-Ion Concentration Manganese pharmacology Polyethylene Glycols pharmacology RNA, Viral biosynthesis Temperature Templates, Genetic 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 517 PMC355750 10.1128/JVI.16.6.1420-1425.1975 J Virol. 1975 Feb;15(2):386-92 1167604 Ann Med Exp Biol Fenn. 1964;42:109-12 14229542 Virology. 1971 Dec;46(3):721-9 4109526 Intervirology. 1973;1(4):297-316 4130034 J Virol. 1974 Mar;13(3):577-83 4132669 Nature. 1970 Jun 27;226(5252):1209-11 4316300 Nature. 1970 Jun 27;226(5252):1211-3 4316301 Proc Natl Acad Sci U S A. 1970 Jun;66(2):572-6 4317920 J Virol. 1971 Jul;8(1):66-73 4328417 Bacteriol Rev. 1971 Sep;35(3):235-41 4329869 Virology. 1972 Dec;50(3):899-901 4344945 Virology. 1973 Dec;56(2):608-19 4796549 Med Biol. 1974 Apr;52(2):98-103 4837432 Intervirology. 1974;2(4):270-2 4850836 Jpn J Med Sci Biol. 1967 Dec;20 Suppl:119-29 5301557 C R Acad Sci Hebd Seances Acad Sci D. 1975 Jan 13;280(2):213-5 808281 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Intervirology. 1973;2(3):173-80 4210363 J Virol. 1971 Mar;7(3):389-94 4323712 Virology. 1973 May;53(1):247-57 4735936 J Virol. 1975 Nov;16(5):1296-307 52726 C R Acad Sci Hebd Seances Acad Sci D. 1975 Feb 10;280(6):779-82 808354 518 1976 02 09 2019 06 21 0022-5347 114 6 1975 Dec The Journal of urology J Urol Wolffian duct cyst. 946-7 Obeid M L ML Corkery J J JJ eng Case Reports Journal Article United States J Urol 0376374 0022-5347 AIM IM Abnormalities, Multiple Cryptorchidism complications Cysts congenital embryology Humans Infant Kidney abnormalities Male Urogenital Abnormalities Vas Deferens abnormalities Wolffian Ducts 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 518 S0022-5347(17)67182-9 10.1016/s0022-5347(17)67182-9 519 1976 02 13 2019 09 11 0090-3558 11 4 1975 Oct Journal of wildlife diseases J Wildl Dis Radiographic examination of mandibular lesions in barren-ground caribou. 465-70 Dental anomalies were observed in 43 of 1,226 barren-ground caribou (Rangifer tarandus groenlandicus) taken between 1966 and 1968. In five of these 43 animals, the mandibles had deformities which radiography showed to be the result of dental abscesses in four cases and probably of a trauma in the other. The absence of actinomycotic lesions of the jaw bones of these 1,226 animals, and of more than 500 examined previously, indicates that "lumpy jaw" is rare in barren-ground caribou. The authors suggest the use of radiography to determine the nature of bone growth on skeletal remains, in the absence of soft tissues for examination for Actinomyces, either microscopically or by cultural methods. Miller F L FL Cawley A J AJ Choquette L P LP Broughton E E eng Case Reports Journal Article United States J Wildl Dis 0244160 0090-3558 IM Animals Female Male Mandibular Diseases diagnostic imaging veterinary Mandibular Injuries diagnostic imaging veterinary Periapical Abscess diagnostic imaging veterinary Radiography Reindeer 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 519 10.7589/0090-3558-11.4.465 520 1976 02 13 2020 02 25 0098-7484 234 13 1975 Dec 29 JAMA JAMA Statistical data on allied medical education. 1430-2 eng Journal Article United States JAMA 7501160 0098-7484 AIM IM Accreditation Allied Health Personnel education American Medical Association Physician Assistants education United States 1975 12 29 1975 12 29 0 1 1975 12 29 0 0 ppublish 520 Harv Bus Rev. 2005 Oct;83(10):108-18, 158 16250629 BMJ. 2010 Sep 24;341:c5064 20870696 521 1976 02 26 2016 10 17 0098-7484 235 2 1976 Jan 12 JAMA JAMA Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates. 158-63 Davidson M M Tempest B B Palmer D L DL eng Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States JAMA 7501160 0098-7484 AIM IM Acute Disease Adult Catheterization instrumentation Haemophilus influenzae isolation & purification Humans Indians, North American Informed Consent Lung microbiology Middle Aged Mycobacterium tuberculosis isolation & purification Needles Pneumonia microbiology Pneumonia, Staphylococcal microbiology Sputum microbiology Staphylococcus aureus isolation & purification Streptococcus pneumoniae isolation & purification Trachea microbiology 1976 1 12 1976 1 12 0 1 1976 1 12 0 0 ppublish 521 522 1976 03 01 2016 10 17 0098-7484 235 3 1976 Jan 19 JAMA JAMA Periarteritis nodosa in the kidney. Recovery following immunosuppressive therapy. 280-1 Tuma S S Chaimovitz C C Szylman P P Gellei B B Better O S OS eng Case Reports Journal Article United States JAMA 7501160 0098-7484 0 Immunosuppressive Agents AIM IM Acute Kidney Injury complications drug therapy therapy Adolescent Biopsy Female Humans Immunosuppressive Agents therapeutic use Kidney anatomy & histology Kidney Glomerulus pathology Nephrectomy Organ Size Peritoneal Dialysis Polyarteritis Nodosa complications pathology 1976 1 19 1976 1 19 0 1 1976 1 19 0 0 ppublish 522 523 1976 02 19 2011 07 27 0047-1852 33 7 1975 Jul 10 Nihon rinsho. Japanese journal of clinical medicine Nihon Rinsho [Contractile function of the heart. Adrenergic beta receptor blockaders and cardiac function]. 2254-63 Ito M M Kanaya S S Mashiba H H jpn Journal Article Review Japan Nihon Rinsho 0420546 0047-1852 0 Adrenergic beta-Antagonists 0 Catecholamines IM Adrenergic beta-Antagonists pharmacology therapeutic use Angina Pectoris drug therapy Arrhythmias, Cardiac drug therapy Catecholamines pharmacology Hemodynamics drug effects Humans Membrane Potentials drug effects Myocardial Contraction drug effects Stimulation, Chemical 63 1975 7 10 1975 7 10 0 1 1975 7 10 0 0 ppublish 523 524 1976 02 19 2011 07 27 0021-5082 30 3 1975 Aug Nihon eiseigaku zasshi. Japanese journal of hygiene Nihon Eiseigaku Zasshi [Studies of the effects of aircraft noise causing mental fatigue during some intellectual performance (author's transl)]. 417-29 Kunitake E E Ishinishi N N Kodama Y Y jpn English Abstract Journal Article Japan Nihon Eiseigaku Zasshi 0417457 0021-5082 IM S Adult Aircraft Female Humans Mental Fatigue etiology Mental Processes Noise adverse effects 76072728 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 524 525 1976 02 13 2019 09 18 0021-5112 28 3 1975 Jun Japanese journal of medical science & biology Jpn J Med Sci Biol Experimental diarrhea in cynomolgus monkeys by oral administration with Clostridium perfringens type A viable cells or enterotoxin. 165-77 Purified C. perfringens type A enterotoxin fed orally in an amount of 5 mg caused both vomiting and diarrhea in the monkey only when the gastric juice had been neutralized. Exposure of enterotoxin to pH 4.0 or below rapidly destroyed the activity. All three monkeys receiving sodium bicarbonate and 2.4 X 10(10) viable cells grown in DS medium developed diarrhea, and only one of them vomited once. The diarrhea lasted for 13, 18 and 19 hr. The symptoms were similar to those reported in human cases of C. perfringens food poisoning. These results have verified the general notion that C. perfringens food poisoning should be categorized as a true "intravital intoxication". The reversed passive hemagglutination test detected enterotoxin directly in most fecal samples. This method may be applicable for diagnosis of human cases of C. perfringens food poisoning. Neither enterotoxin nor anti-enterotoxin was detected in serum samples taken from any monkey up to 21 days after the challenge. We are tempted to conclude, therefore, that no significant amount of C. perfringens enterotoxin is absorbed from the intestine. Uemura T T Sakaguchi G G Ito T T Okazawa K K Sakai S S eng Journal Article Japan Jpn J Med Sci Biol 0243706 0021-5112 0 Antitoxins 0 Enterotoxins IM Administration, Oral Animals Antitoxins analysis Clostridium perfringens isolation & purification Diarrhea etiology Enterotoxins administration & dosage analysis immunology Feces analysis microbiology Gastric Juice Haplorhini Hydrogen-Ion Concentration Macaca fascicularis 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 525 10.7883/yoken1952.28.165 526 1976 02 09 2020 02 25 0047-1844 31 6 1975 Jun [Hokenfu zasshi] The Japanese journal for public health nurse Hokenfu Zasshi [Impression of the 1975 General Meeting of the Japan Nursing Association. Fulfilment and some disappointment]. 334-6 Uchibori C C jpn Congress Japan Hokenfu Zasshi 17410240R 0047-1844 N Congresses as Topic Japan Societies, Nursing 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 526 Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9385-90 10430952 FASEB J. 2000 Feb;14(2):221-30 10657979 Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13626-31 14595032 Nat Genet. 2005 Jan;37(1):41-7 15580272 JAMA. 2005 Sep 21;294(11):1343-51 16174692 Lancet. 2006 Feb 25;367(9511):668-78 16503465 JAMA. 2008 Sep 10;300(10):1165-73 18780845 J Virol. 2009 Jan;83(1):283-94 18945765 J Clin Invest. 2009 Sep;119(9):2550-63 19652365 Swiss Med Wkly. 2009 Sep 19;139(37-38):540-6 19838871 Acad Med. 2010 Apr;85(4):692-701 20186033 Acad Med. 2011 Aug;86(8):953-61 21694566 Nature. 2011 Aug 18;476(7360):361-3 21853556 N Engl J Med. 2012 Mar 8;366(10):883-892 22397650 Lancet. 2012 Mar 31;379(9822):1214-24 22421340 J R Coll Physicians Lond. 1993 Apr;27(2):147-50 8501673 527 1976 02 09 2018 12 03 0047-1844 31 6 1975 Jun [Hokenfu zasshi] The Japanese journal for public health nurse Hokenfu Zasshi [Impression of the 1975 General Meeting of the Japan Association. Heated discussion in the General Meeting and bureaucratic attitude in the Public Health Section]. 336-9 Isomi A A jpn Congress Japan Hokenfu Zasshi 17410240R 0047-1844 N Authoritarianism Congresses as Topic Japan Public Health Nursing Societies, Nursing 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 527 528 1976 02 09 2018 12 03 0047-1844 31 6 1975 Jun [Hokenfu zasshi] The Japanese journal for public health nurse Hokenfu Zasshi [Impression of the 1975 General Meeting of the Japan Nursing Association. Disappointing attitude of the Assembly toward the nursing system]. 339-41 Takano E E jpn Congress Japan Hokenfu Zasshi 17410240R 0047-1844 N Attitude Congresses as Topic Japan Nursing Societies, Nursing 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 528 529 1976 02 09 2018 12 03 0047-1844 31 6 1975 Jun [Hokenfu zasshi] The Japanese journal for public health nurse Hokenfu Zasshi [Impression on the 1975 General Meeting of the Japan Nursing Association. Need for more realistic attitude toward nursing]. 342-3 Kurusu M M jpn Congress Japan Hokenfu Zasshi 17410240R 0047-1844 N Attitude Congresses as Topic Japan Nursing Societies, Nursing 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 529 530 1976 02 09 2020 02 25 0047-1844 31 6 1975 Jun [Hokenfu zasshi] The Japanese journal for public health nurse Hokenfu Zasshi [Impression of the 1975 General Meeting of the Japan Nursing Association. Lack of positive approaches in the Public Health Section]. 343-5 Shigehisa F F jpn Congress Japan Hokenfu Zasshi 17410240R 0047-1844 N Congresses as Topic Japan Public Health Nursing Societies, Nursing 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 530 J Investig Med. 2002 Nov;50(6):412-8 12425427 BMJ. 2003 Nov 1;327(7422):1041-3 14593043 Clin Med (Lond). 2004 Mar-Apr;4(2):169-72 15139740 Acad Med. 2007 Jul;82(7):623-4 17595556 Acad Med. 2007 Jul;82(7):633-45 17595558 JAMA. 2008 Sep 10;300(10):1165-73 18780845 Acad Med. 2010 Apr;85(4):692-701 20186033 Med Teach. 2010;32(9):727-32 20795802 N Engl J Med. 1979 Dec 6;301(23):1254-9 503128 J R Coll Physicians Lond. 1993 Apr;27(2):147-50 8501673 531 1976 02 09 2020 02 25 0021-5287 66 8 1975 Aug Nihon Hinyokika Gakkai zasshi. The japanese journal of urology Nihon Hinyokika Gakkai Zasshi [A study on cryptorchidism. Report 1. Changes in plasma levels of FSH, LH and testosterone in cryptorchidism with loading of luteinizing hormone-releasing hormone (author's transl)]. 462-6 Matsuda S S jpn English Abstract Journal Article Japan Nihon Hinyokika Gakkai Zasshi 2984841R 0021-5287 33515-09-2 Gonadotropin-Releasing Hormone 3XMK78S47O Testosterone 9002-67-9 Luteinizing Hormone 9002-68-0 Follicle Stimulating Hormone IM Adolescent Adult Cryptorchidism blood Follicle Stimulating Hormone blood Gonadotropin-Releasing Hormone pharmacology Humans Luteinizing Hormone blood Male Middle Aged Testosterone blood 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 531 Clin Med (Lond). 2013 Oct;13(5):424-5 24115692 Clin Med (Lond). 2013 Dec;13(6):543-6 24298096 532 1976 02 09 2020 02 25 0047-1917 23 3 1975 Jul The Japanese journal of veterinary research Jpn J Vet Res Postnatal development of testicular capillaries and the effect of experimental cryptorchid on capillaries in rats. 109 Nakashima K K eng Journal Article Japan Jpn J Vet Res 0376567 0047-1917 IM Animals Capillaries growth & development Cryptorchidism physiopathology Male Rats Testis blood supply 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 532 Lancet. 2012 Jul 7;380(9836):37-43 22579043 533 1976 03 01 2018 12 03 0022-9415 80 7-8 1975 Aug Katilolehti Katilolehti [Federation of Salaried Employees' meeting and the stand taken by the Federation of Midwives]. 297 fin Congress TVK:n liittokokous ja kätilöliiton kannanotto Finland Katilolehti 0153272 0022-9415 N Congresses as Topic Finland Labor Unions Midwifery Societies, Nursing 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 533 534 1976 02 20 2020 02 25 0022-9040 15 8 1975 Aug Kardiologiia Kardiologiia [Effect of peripheral counterpulsation on the body of an animal with intact heart]. 110-7 The effect of lasting peripheral counterpulsation upon the haemodynamics and the main biochemical factors of the blood was studied in 14 dogs with intact hearts. In cases of significant tachycardia counterpulsation in a 1:2 regimen results in only a partial reduction of the resistance to the cardiac output. This does not always permit to prevent the formation of the phenomenon of an elevated myocardial contractility. The haemodynamic conditions are most optimal in a 1:1 regimen of counterpulsation. Slowing down of the cardiac rhythm was achieved by means of hypothermia. Kolesov A P AP Skorik V I VI Malikova T M TM Safonova E S ES Shamarina T N TN rus English Abstract Journal Article Vliianie perifericheskoi kontrpul-satsii na organizm zhivotnogo s intaktnym serdtsem Russia (Federation) Kardiologiia 0376351 0022-9040 S88TT14065 Oxygen IM Acid-Base Equilibrium Animals Cardiac Output Dogs Electrocardiography Extracorporeal Circulation Heart physiology Heart, Artificial Hemodynamics Hydrogen-Ion Concentration Oxygen blood 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 534 Mayo Clin Proc. 2009 Mar;84(3):248-54 19252112 Arch Intern Med. 2010 Dec 13;170(22):2004-10 21149758 Clin Med (Lond). 2011 Dec;11(6):532-5 22268303 BMJ. 2012 Feb 13;344:e652 22331278 BMJ. 2012 Apr 04;344:e2240 22491697 Clin Med (Lond). 2012 Aug;12(4):307-8 22930869 Clin Med (Lond). 2012 Aug;12(4):316-9 22930873 Clin Med (Lond). 2012 Aug;12(4):320-3 22930874 535 1976 02 20 2020 02 25 0022-9040 15 8 1975 Aug Kardiologiia Kardiologiia [Regulation of interrelation between pulmonary ventilation and circulation]. 127-32 In acute experiments on 92 cats anesthetized with Urethane and kept under controlled respiration the mechanism of tonic activity of the pulmonary vessels was studied in the presence of a decreased partial pressure of oxygen in the alveoli. The tonicity of the pulmonary vessels was recorded during autoperfusion of the vessels of the posterior lobe of the left lung by means of a perfusion pump. Simultaneously, the pressure in the common carotid artery was recorded and the oxygen saturation of the blood was measured. Pharmacological analysis was used for the study of the mechanism of the pressor reaction of the pulmonary vessels under hypoxic hypoxy, and it demonstrated that the pression of the pulmonary vessels that develops under alveolar hypoxy is less distinct under the effect of the ganglioblocking agent Benzo-hexonium, as well as the myotropic agents Papaverine and Chloracizine. The above reaction was significantly inhibited by the blocking agents of the D- and M-serotonin-reactive structures -- Dihydroergothamine, Morphine and Novocain, and it was completely lacking against the background of the action of Izadrine and Dimedrol -- blocking agents of serotonin- and histamine-reactive structures. It can be supposed that the D- and M-serotonin-reactive, and probably also the histamine-reactive structures participate in the regulation of the interrelationship of ventilation and pulmonary circulation. Volyntseva V A VA Kositskii G I GI Kupriianov V S VS rus Journal Article O reguliatsii vzaimosviazi ventiliatsii i krovoobrashcheniia v legkikh Russia (Federation) Kardiologiia 0376351 0022-9040 0 Ganglionic Blockers 436O5HM03C Dihydroergotamine 4Z8Y51M438 Procaine 76I7G6D29C Morphine L628TT009W Isoproterenol S88TT14065 Oxygen IM Animals Carotid Arteries physiopathology Cats Dihydroergotamine pharmacology Ganglionic Blockers pharmacology Hypoxia physiopathology Isoproterenol pharmacology Lung blood supply Morphine pharmacology Muscle, Smooth Oxygen blood Procaine pharmacology Pulmonary Alveoli physiopathology Pulmonary Circulation drug effects Respiration drug effects 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 535 Lancet. 2005 Aug 20-26;366(9486):665-75 16112304 J Clin Oncol. 2005 Dec 1;23(34):8812-8 16314641 J Clin Endocrinol Metab. 2007 Oct;92(10):3822-8 17652212 J Clin Endocrinol Metab. 2011 Mar;96(3):717-25 21190975 Eur J Endocrinol. 2012 Feb;166(2):151-8 21896620 536 1976 02 09 2019 07 25 0085-2538 8 5 1975 Nov Kidney international Kidney Int Dilution acidosis and contraction alkalosis: review of a concept. 279-83 Garella S S Chang B S BS Kahn S I SI eng Journal Article United States Kidney Int 0323470 0085-2538 0 Bicarbonates 0 Buffers 0 Hypertonic Solutions 142M471B3J Carbon Dioxide IM Acid-Base Equilibrium Acidosis metabolism Alkalosis metabolism Animals Bicarbonates metabolism Buffers Carbon Dioxide blood Dogs Extracellular Space Homeostasis Hydrogen-Ion Concentration Hypertonic Solutions Partial Pressure 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 536 S0085-2538(15)31522-2 10.1038/ki.1975.114 537 1976 02 09 2019 07 25 0085-2538 8 5 1975 Nov Kidney international Kidney Int Multiple cyclic nucleotide phosphodiesterases in rat kidney. 284-91 Using DEAE-cellulose chromatography and Agarose gel filtration we have partially purified a low Km cyclic adenosine monophosphate (AMP) phosphodiesterase from the 100,000 X g supernatant of rat kidneys. The characteristics of this enzyme included a Km of approximately 4 muM a pH optimum of around 8.0 and a requirement for magnesium. This preparation should be suitable for investigation of possible effects of hormones, drugs and cellular constituents on the cyclic AMP pathway through any direct effects on the low Km enzyme. We have also demonstrated a nonspecific, high Km cyclic nucleotide phosphodiesterase and possibly a specific cyclic guanosine monophosphate (GMP) phosphodiesterase in the soluble fraction from rat kidneys. Gulyassy P F PF Farrand J R JR Gugler H D HD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Kidney Int 0323470 0085-2538 E0399OZS9N Cyclic AMP EC 3.1.4.- Phosphoric Diester Hydrolases EC 3.1.4.17 3',5'-Cyclic-AMP Phosphodiesterases H2D2X058MU Cyclic GMP IM 3',5'-Cyclic-AMP Phosphodiesterases isolation & purification Animals Chromatography, DEAE-Cellulose Chromatography, Gel Chromatography, Ion Exchange Cyclic AMP metabolism Cyclic GMP metabolism Hydrogen-Ion Concentration Kidney enzymology Phosphoric Diester Hydrolases isolation & purification Rats 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 537 S0085-2538(15)31523-4 10.1038/ki.1975.115 538 1976 02 09 2019 07 25 0085-2538 8 5 1975 Nov Kidney international Kidney Int Effect on aging on plasma renin and aldosterone in normal man. 325-33 The influence of aging on the renin-angiotensin-aldosterone system was evaluated by comparing young (20 to 30 yr) with elderly (62 to 70 yr) healthy subjects. Despite comparable body sodium-fluid balance in the two age groups, serum renin concentration, plasma renin activity and aldosterone concentrations were lower in the elderly. The age-related decreases in circulating renin and aldosterone concentrations were slight while subjects were supine and receiving normal sodium intake; when upright and during sodium depletion, they were more pronounced. Inverse renin-blood pressure interrelations were noted during two of four study conditions involving normal sodium intake or mild sodium depletion (r = --0.44 and --0.47, respectively), but not during progressive sodium depletion. Plasma renin levels were decreased in the elderly regardless of the presence or absence of an inverse relationship with blood pressure. Aldosterone and cortisol responses to corticotropin infusion were unaltered in the elderly. It is concluded that aging may cause a decrease in circulating renin, with parallel lowering of plasma aldosterone concentrations. Weidmann P P De Myttenaere-Bursztein S S Maxwell M H MH de Lima J J eng Journal Article United States Kidney Int 0323470 0085-2538 11128-99-7 Angiotensin II 4964P6T9RB Aldosterone 9002-60-2 Adrenocorticotropic Hormone 9NEZ333N27 Sodium EC 3.4.23.15 Renin RWP5GA015D Potassium IM Adrenocorticotropic Hormone pharmacology Adult Aged Aging Aldosterone blood Angiotensin II physiology Blood Blood Pressure Female Glomerular Filtration Rate Humans Hydrogen-Ion Concentration Male Middle Aged Posture Potassium blood Renin blood physiology Sodium blood Water-Electrolyte Balance 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 538 S0085-2538(15)31528-3 10.1038/ki.1975.120 539 1976 03 01 2015 11 19 0098-6577 1975 Sep Kidney international. Supplement Kidney Int Suppl Modification of angiotensin-mediated tubulo-glomerular feedback by extracellular volume. S202-7 Thurau K K eng Journal Article United States Kidney Int Suppl 7508622 0098-6577 11128-99-7 Angiotensin II 451W47IQ8X Sodium Chloride IM Angiotensin II physiology Animals Dogs Extracellular Space Feedback Glomerular Filtration Rate Humans Hydrogen-Ion Concentration Intracellular Fluid Juxtaglomerular Apparatus physiology Kidney Tubules physiology Perfusion Pressure Renal Artery Obstruction physiopathology Sodium Chloride metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 539 540 1976 02 09 2019 07 11 0023-2173 53 10 1975 May 15 Klinische Wochenschrift Klin Wochenschr [Immune mechanisms in uremia]. 461-6 There is both clinical and experimental evidence that cellular and humoral immunity are suppressed in patients with renal insufficiency: observations in organ transplantation and in vitro stimulation of lymphocytes from uraemic patients, investigations of acute and late hypersensitivity reactions, the immune response after active immunization as well as changes of immunoglobulins and lymphatic organs in uraemia are discussed in the paper. The underlying mechanisms are complex and not yet fully understood. Lymphopenia, atrophy of the thymus gland, toxic serum factors, induction of enhancing mechanisms by certain serum fractions and metabolic defects of lymphocytes--all were shown to be involved or at least considered to be. At present, however, it is impossible to define their rank of importance and the exact place they may occupy in the genesis of this type of "natural immunosuppression". Dobbelstein H H ger English Abstract Journal Article Immunmechanismen bei Urämie Germany Klin Wochenschr 2985205R 0023-2173 0 Hepatitis B Antigens 0 Immunoglobulin G 0 Immunoglobulin M IM Animals Antibody Formation Dogs Graft vs Host Reaction Hepatitis B immunology Hepatitis B Antigens analysis Humans Immunity, Cellular Immunoglobulin G analysis Immunoglobulin M analysis Immunosuppression Kidney Transplantation Lymphocyte Transfusion Renal Dialysis Skin Transplantation Transplantation Immunology Transplantation, Homologous Uremia immunology 1975 5 15 1975 5 15 0 1 1975 5 15 0 0 ppublish 540 10.1007/BF01468631 J Clin Invest. 1955 Feb;34(2):327-82 13233354 Vitam Horm. 1964;22:591-607 14284121 N Engl J Med. 1958 Aug 14;259(7):320-3 13566472 Klin Wochenschr. 1969 Apr 1;47(7):387-8 4192245 Ann N Y Acad Sci. 1957 Mar 22;64(5):967-76 13411933 J Exp Med. 1964 May 1;119:727-42 14157027 Transplantation. 1973 Mar;15(3):298-307 4576040 J Nutr. 1968 Jun;95(2):184-90 5665622 Int Arch Allergy Appl Immunol. 1960;16:276-87 14399794 Vitam Horm. 1955;(13):1-27 13291768 Dtsch Med Wochenschr. 1974 Feb;99(8):339-42 4207113 Ann Surg. 1955 Aug;142(2):145-63 13239049 Am J Clin Nutr. 1971 Feb;24(2):265-71 5545853 Lancet. 1973 Mar 10;1(7802):506-8 4119947 J Urol. 1972 Aug;108(2):312-3 5047427 Br J Surg. 1962 Mar;49:558-68 13875081 Klin Wochenschr. 1973 May 15;51(10):494-505 4126830 Wien Klin Wochenschr. 1971 Dec 10;83(49):893-4 5131385 N Engl J Med. 1969 Sep 11;281(11):571-8 4186067 N Engl J Med. 1973 Apr 5;288(14):695-9 4631743 Acta Med Scand. 1971 Jan-Feb;189(1-2):113-8 4941339 Klin Wochenschr. 1974 May 1;52(9):437-43 4409847 Lancet. 1964 Mar 14;1(7333):581-4 14104485 Proc Soc Exp Biol Med. 1946 May;62:88 20987579 Dtsch Med Wochenschr. 1970 Feb 6;95(6):253-6 5417676 Kidney Int. 1974 Mar;5(3):233-9 4362246 Transplantation. 1974 Jan 1;17(1):111-4 4588149 Dtsch Med Wochenschr. 1969 Jan 3;94(1):17-20 passim 4177792 J Allergy. 1964 May-Jun;35:242-51 14160432 Clin Exp Immunol. 1973 Jul;14(3):365-70 4725396 J Clin Invest. 1964 Oct;43:1881-91 14236212 Clin Exp Immunol. 1969 Jul;5(1):75-82 5789563 Lancet. 1966 Mar 26;1(7439):682-5 4159600 Br J Exp Pathol. 1973 Apr;54(2):183-91 4573425 Surgery. 1960 Feb;47:340-5 14420701 J Med Microbiol. 1971 Aug;4(3):337-42 5116254 Br J Exp Pathol. 1973 Aug;54(4):380-7 4726091 541 1976 02 13 2019 07 11 0023-2173 53 12 1975 Jun 15 Klinische Wochenschrift Klin Wochenschr Improvement of renin determination in human plasma using a commonly available renin standard in a radioimmunological method. 559-69 A new method for the measurement of renin in human plasma is described. The method is based on the introduction of the internationally available renin standard of the Medical Research Council (MRC) London, as a calibration system. Thus, some principal disadvantages of methods expressing results in renin reaction velocity (angiotensin generation rate) only are avoided. Both renins, unknown and standard, react with a sheep substrate preparation and are handled identically throughout the whole procedure including the angiotensin I radioimmunoassay (RIA). The plasma renin concentration (PRC) is given in 10(-6) MRC-renin units (muM/ml). the renin standard is free of angiotensin, angiotensinases, and angiotensinogen; it is stable on storage. Identical enzyme kinetics are shown for both renins. An interference between endogenous and exogenous substrate could be avoided. The potentially harmful influences of proteins from the enzyme incubation mixture of the RIA dose response curve are shown. The use of an angiotensin I calibration system could be omitted. Using a standard renin dilution from 250-0.9 muU/ml also the full biological range is covered. When giving an unrestricted diet the preliminary normal values of PRC are 21.9 +/- 12.6 muU/ml in recumbent and 40.1 +/- 19.8 muU/ml in upright position (n = 16,x +/- s, age 20-35 years). Earlier findings of age-dependency of PRC were confirmed. Hummerich W W Krause D K DK eng Journal Article Germany Klin Wochenschr 2985205R 0023-2173 11002-13-4 Angiotensinogen EC 3.4.23.15 Renin IM Adult Angiotensinogen Humans Hydrogen-Ion Concentration Methods Preservation, Biological Radioimmunoassay Renin blood standards 1975 6 15 1975 6 15 0 1 1975 6 15 0 0 ppublish 541 10.1007/BF01468900 Recent Prog Horm Res. 1965;21:119-77 14321056 J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55 4311082 Z Kreislaufforsch. 1969 Sep;58(9):996-1001 5375050 Lancet. 1969 Feb 1;1(7588):213-8 4178586 Clin Sci. 1973 Jul;45(1):51-64 4124171 Klin Wochenschr. 1972 Jul 15;50(14):702-5 4341942 Pflugers Arch. 1969;310(2):137-49 4310422 Biochim Biophys Acta. 1970 Dec 22;221(3):536-48 5499438 J Steroid Biochem. 1972 Apr;3(3):349-56 4343482 Scand J Clin Lab Invest Suppl. 1973;132:3-86 4358365 Lab Invest. 1966 Nov;15(11):1802-13 4288919 Endocrinology. 1972 Feb;90(2):422-30 4109649 J Nucl Biol Med. 1972 Jan-Mar;16(1):24-31 4347867 Lancet. 1968 Mar 30;1(7544):657-61 4170648 Klin Wochenschr. 1972 Sep 1;50(17):833-40 4342523 Klin Wochenschr. 1972 Mar 15;50(6):327-31 4338645 J Clin Invest. 1967 Mar;46(3):418-28 6023776 J Lab Clin Med. 1971 Aug;78(2):309-15 4327882 Dtsch Med Wochenschr. 1970 Jun 26;95(26):1404-7 4316329 Can J Physiol Pharmacol. 1970 Jun;48(6):350-8 4194495 Circ Res. 1967 Apr;20(4):391-402 6025403 Klin Wochenschr. 1971 Aug 1;49(15):870-6 4327894 J Lab Clin Med. 1971 Jun;77(6):1025-38 4327019 Acta Endocrinol Suppl (Copenh). 1973;173:160 4542088 Am J Clin Pathol. 1971 May;55(5):513-22 4326232 Nature. 1971 Aug 27;232(5313):631 4328549 Kidney Int. 1972 Apr;1(4):240-53 4365636 Circ Res. 1971 May;28(5):Suppl 2:175-91 4327961 Biochem J. 1964 Dec;93(3):594-600 4284558 Circ Res. 1968 Nov;23(5):605-9 5688014 Nature. 1971 Apr 9;230(5293):382 4323825 Biochem J. 1964 May;91(2):346-52 4284488 Adv Intern Med. 1967;13:183-240 5334722 Clin Sci. 1973 Jan;44(1):43-54 4346187 Clin Sci Mol Med Suppl. 1973 Aug;45 Suppl 1:273s-8 4522174 Circ Res. 1966 Oct;19(4):739-49 4288199 Am J Med. 1973 Sep;55(3):303-14 4355700 Am J Physiol. 1960 Nov;199:788-92 13747214 Eur J Clin Invest. 1973 Jan;3(1):1-9 4347094 Verh Dtsch Ges Inn Med. 1972;78:1644-7 4665633 Clin Sci. 1969 Feb;36(1):67-76 4306500 542 1976 02 13 2019 07 11 0023-2173 53 12 1975 Jun 15 Klinische Wochenschrift Klin Wochenschr [Validity of pH measurements by means of micro pH combination electrodes in blood and other biological fluids (author's transl)]. 589-91 pH measurements in blood or in media containing either proteins or polypeptides and performed by means of micro pH combination electrodes type N 58 (Schott & Gen., Mainz) yield in a systematic error according to the regression line y = 1.135 chi - 0.842, in the range between pH 5.3 and 8.3. This deviation from the real pH value is independent of the protein concentration and amounts to 0.1-0.2 pH units in the physiological range. The error does not occur if the pH measurements are performed in media which are free of proteins and polypeptides, respectively. If the electrolyte solution within the reference electrode is replaced (NaCl solution instead of KCl solution) the error is distinctly reduced. For this reason, this deviation should be caused by the variation of the diffusion potential across the platinum junctions. Hutten H H Vaupel P P ger English Abstract Journal Article Validität der pH-Messung mit der Mikro-pH-Einstabmesskette in blut und anderen biologischen Flüssigkeiten Germany Klin Wochenschr 2985205R 0023-2173 0 Peptides 0 Proteins IM Diagnostic Errors Electrodes Hydrogen-Ion Concentration Peptides analysis Proteins analysis 1975 6 15 1975 6 15 0 1 1975 6 15 0 0 ppublish 542 10.1007/BF01468906 543 1976 02 13 2019 07 11 0023-2173 53 17 1975 Sep 01 Klinische Wochenschrift Klin Wochenschr [Glutathione (author's transl)]. 789-802 Glutathione plays an important role in biology and medicine. Most cells of plants and animals contain high concentrations of reduced glutathione and a much smaller amount of oxidised glutathione. GSH is important for several metabolic functions of live cells, e.g. the protection of oxidative stress by peroxides, mediation of enzyme reactions, regulation of metabolic events, transport of amino acids across cell membranes via the gamma-glutamyl cycle, elimination of foreign compounds by GSH-conjugation, release of neurotransmitter substances. Irreversible perturbations of the glutathione metabolism may be the reason for severe clinical symptoms of hemolytic anemia or, perhaps, of central nervous disease. Benöhr H C HC Waller H D HD ger English Abstract Journal Article Glutathion Germany Klin Wochenschr 2985205R 0023-2173 0 Hexosephosphates 0 Neurotransmitter Agents EC 2.3.2.2 gamma-Glutamyltransferase EC 2.5.1.18 Glutathione Transferase EC 4.4.1.5 Lactoylglutathione Lyase GAN16C9B8O Glutathione IM Anemia, Hemolytic metabolism Animals Cell Membrane metabolism Erythrocytes analysis Glucosephosphate Dehydrogenase Deficiency metabolism Glutathione biosynthesis Glutathione Transferase metabolism Heinz Bodies Hemoglobinopathies metabolism Hexosephosphates metabolism Humans Lactoylglutathione Lyase metabolism Neurotransmitter Agents metabolism Oxidation-Reduction Reaction Time gamma-Glutamyltransferase metabolism 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 543 10.1007/BF01466750 Biochem J. 1970 Sep;119(3):353-7 5500299 Biochem J. 1959 Feb;71(2):275-80 13628565 Biochem J. 1932;26(3):785-90 16744886 Proc Natl Acad Sci U S A. 1970 Nov;67(3):1248-55 5274454 Biochem Genet. 1969 Apr;3(2):137-50 5364922 J Lab Clin Med. 1962 Aug;60:302-19 14449875 J Lab Clin Med. 1957 Jan;49(1):84-95 13385579 Nature. 1960 Mar 26;185:931 14436100 J Lab Clin Med. 1963 May;61:882-8 13967893 Blood. 1968 Feb;31(2):131-50 5643703 Klin Wochenschr. 1971 Jun 15;49(12):669-83 4932493 Experientia. 1970;26(7):760-1 5431144 Vox Sang. 1961 May;6:370-3 13731008 Humangenetik. 1970;9(3):250-2 5451689 Ann Hum Genet. 1967 May;30(4):339-53 5619935 Pharmacol Rev. 1969 Mar;21(1):73-103 4887725 Adv Enzymol Relat Subj Biochem. 1951;11:201-66 24540592 J Clin Invest. 1961 Jun;40:981-8 13694895 Blood. 1967 Apr;29(4):481-93 6023063 Biochem Biophys Res Commun. 1974 Jul 10;59(1):347-51 4842301 Biochem J. 1969 Oct;114(4):833-7 5387975 J Clin Invest. 1971 Aug;50(8):1637-43 5097571 Biochem J. 1955 Jul;60(3):409-24 13239574 Nature. 1958 May 3;181(4618):1256 13541446 Klin Wochenschr. 1969 Jan 1;47(1):25-30 5381435 Biochem J. 1968 Dec;110(3):37P 5701661 Ann Hum Genet. 1973 Oct;37(2):151-5 4768554 J Biol Chem. 1959 Aug;234(8):2123-8 13673024 J Biol Chem. 1951 Jun;190(2):685-96 14841219 Boll Soc Ital Biol Sper. 1958 Apr 15;34(7):327-9 13536107 J Lab Clin Med. 1971 Oct;78(4):533-45 5114050 Klin Wochenschr. 1970 Jan 15;48(2):79-85 5521216 Presse Med. 1970 Jan 24;78(4):171-4 5418590 Klin Wochenschr. 1973 Dec 15;51(24):1177-84 4789325 J Mol Biol. 1970 Sep 28;52(3):483-90 5492291 Biochem J. 1959 Apr;71(4):690-6 13651118 Biochim Biophys Acta. 1970 Sep 22;215(3):456-60 5507367 Biochem Biophys Res Commun. 1969 Nov 6;37(4):593-6 5353890 Anal Biochem. 1966 May;15(2):205-10 5961059 Biochem J. 1959 Apr;71(4):680-90 13651117 Nature. 1961 Aug 19;191:767-8 13682109 J Biol Chem. 1957 Nov;229(1):189-97 13491573 J Invest Dermatol. 1967 Feb;48(2):149-52 6020678 Biochim Biophys Acta. 1969 Oct 7;192(1):23-8 5347970 Arch Biochem Biophys. 1959 Mar;81(1):119-23 13637972 J Clin Invest. 1962 Jul;41:1514-23 14450645 Nat New Biol. 1971 Sep 22;233(38):121-3 4328800 Adv Enzymol Relat Areas Mol Biol. 1969;32:173-219 4892500 Semin Hematol. 1970 Jul;7(3):341-54 5425759 J Clin Invest. 1959 Sep;38:1659-61 14436102 Nouv Rev Fr Hematol. 1966 May-Jun;6(3):452-7 4225373 Biochemistry. 1967 Jun;6(6):1722-34 6035915 Blood. 1963 May;21:573-85 13967896 Proc Natl Acad Sci U S A. 1967 Mar;57(3):835-40 16591538 Biochim Biophys Acta. 1971 Dec 21;252(3):489-505 4332837 Bull Johns Hopkins Hosp. 1958 Apr;102(4):169-75 13523280 J Biol Chem. 1961 Feb;236:PC5 13756115 Klin Wochenschr. 1970 Dec 1;48(23):1400-6 5521262 J Biol Chem. 1956 Jan;218(1):261-7 13278333 J Biol Chem. 1969 Jan 10;244(1):9-16 5773294 Klin Wochenschr. 1957 Oct 15;35(20):1022-7 13515125 Proc Natl Acad Sci U S A. 1974 Apr;71(4):1026-9 4151516 Biochim Biophys Acta. 1971 Jan 1;228(1):245-51 5546565 Proc Natl Acad Sci U S A. 1960 Jul;46(7):938-44 16590696 Proc Natl Acad Sci U S A. 1962 Oct 15;48:1868-76 14014720 Science. 1973 Apr 6;180(4081):33-9 4144403 Biochem J. 1932;26(3):817-28 16744891 N Engl J Med. 1970 Dec 3;283(23):1253-7 5476481 Biochemistry. 1963 Nov-Dec;2:1420-8 14093920 Semin Hematol. 1970 Jul;7(3):249-58 4913044 J Clin Invest. 1959 Dec;38:2234-7 14436097 Science. 1956 Sep 14;124(3220):484-5 13360274 Biochem Pharmacol. 1968 Feb;17 (2):177-86 5647044 Biochem J. 1974 May;139(2):289-95 4447610 Arch Biochem Biophys. 1954 Jan;48(1):38-42 13125568 Lancet. 1964 Apr 25;1(7339):895-9 14124079 Biochem J. 1962 Oct;85(1):104-9 16748962 Anal Biochem. 1968 Oct 24;25(1):70-6 5750729 Nat New Biol. 1971 Sep 22;233(38):120-1 4328799 Blood. 1975 Jan;45(1):49-54 803110 J Biol Chem. 1965 Jan;240:338-47 14253434 Nature. 1970 May 23;226(5247):759-60 5443254 Arch Biochem Biophys. 1959 May;82(1):70-7 13650640 Blood. 1967 Mar;29(3):313-9 6019951 J Lab Clin Med. 1965 Jan;65:81-7 14260699 J Clin Invest. 1968 Dec;47(12):2664-77 5725279 Methods Biochem Anal. 1955;2:259-78 14393570 World Health Organ Tech Rep Ser. 1967;366:1-53 4963040 J Clin Invest. 1961 Mar;40:454-75 13682509 Biochem J. 1952 Apr;51(1):25-35 14944528 Nature. 1967 Jul 15;215(5098):285-6 6059514 Klin Wochenschr. 1964 Oct 1;42:948-54 14323807 J Biol Chem. 1955 Jun;214(2):639-46 14381401 J Clin Invest. 1962 Apr;41:779-92 14450644 Proc Natl Acad Sci U S A. 1972 Nov;69(11):3292-6 4343962 Arch Biochem Biophys. 1957 Aug;70(2):311-26 13459388 Biochim Biophys Acta. 1969 Jul 8;185(1):63-9 5796112 N Engl J Med. 1972 Nov 23;287(21):1062-6 4673006 Anal Biochem. 1969 Mar;27(3):502-22 4388022 J Biol Chem. 1953 Jul;203(1):47-54 13069485 J Biol Chem. 1963 Dec;238:3928-33 14086726 N Engl J Med. 1972 Mar 16;286(11):557-61 5058793 Biochem Biophys Res Commun. 1968 Apr 19;31(2):145-50 5656060 Biochim Biophys Acta. 1972 Jul 31;272(4):623-37 5050922 Biochemistry. 1971 Feb 2;10(3):372-80 5543962 J Biol Chem. 1955 Apr;213(2):813-24 14367342 J Bacteriol. 1970 Mar;101(3):1092-3 4908779 Nature. 1969 Oct 11;224(5215):181-2 4390492 Nature. 1962 Feb 10;193:602-3 13897099 J Clin Invest. 1958 Aug;37(8):1176-84 13563647 Verh Dtsch Ges Inn Med. 1973;79:461-3 4790261 Proc Natl Acad Sci U S A. 1974 Feb;71(2):293-7 4150022 J Lab Clin Med. 1961 Aug;58:225-33 13752331 Proc Natl Acad Sci U S A. 1974 Jun;71(6):2505-9 4152248 J Biol Chem. 1955 Apr;213(2):769-76 14367337 J Biol Chem. 1966 Sep 25;241(18):4243-50 4380814 J Clin Invest. 1969 Oct;48(10):1957-66 5822598 J Biol Chem. 1951 Feb;188(2):717-22 14824159 J Biol Chem. 1956 Oct;222(2):581-5 13367027 Klin Wochenschr. 1967 Aug 15;45(16):827-32 5592450 J Lab Clin Med. 1954 Aug;44(2):177-84 13184225 J Biol Chem. 1974 Dec 10;249(23):7593-602 4154944 Med Klin. 1963 Dec 27;58:2111-20 14119605 Nature. 1961 Oct 28;192:338-40 13899212 J Biol Chem. 1952 Oct;198(2):721-9 12999789 Bull Soc Chim Biol (Paris). 1962;44:301-8 14487093 Nature. 1969 Oct 11;224(5215):117-20 5343512 Isr J Med Sci. 1968 Jul-Aug;4(4):852-7 5707783 544 1976 02 20 2020 02 25 0038-3139 71 11 1975 Nov Journal of the South Carolina Medical Association (1975) J S C Med Assoc MEDEX South Carolina: a progress report. 337-8 Buhmeyer K J KJ Hutson A R AR Jr eng Journal Article United States J S C Med Assoc 7503045 0038-3139 IM Delivery of Health Care Humans Physician Assistants education South Carolina Workforce 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 544 N Engl J Med. 2000 Mar 30;342(13):913-20 10738049 J Am Coll Cardiol. 2000 Jul;36(1):139-46 10898425 Am J Cardiol. 2000 Nov 1;86(9):950-3 11053705 J Am Coll Cardiol. 2001 Feb;37(2):542-7 11216976 JAMA. 2001 May 9;285(18):2370-5 11343485 JAMA. 2001 Jun 13;285(22):2864-70 11401607 N Engl J Med. 2002 Dec 5;347(23):1825-33 12466506 N Engl J Med. 2002 Dec 5;347(23):1834-40 12466507 Int J Cardiol. 2003 Feb;87(2-3):121-8 12559528 Arch Intern Med. 2003 Jul 14;163(13):1580-6 12860581 Clin Cardiol. 2004 Jan;27(1):40-6 14743856 Circulation. 2004 Mar 30;109(12):1509-13 15007003 Circulation. 2004 Jul 20;110(3):247-52 15226218 J Am Coll Cardiol. 2004 Dec 21;44(12):2355-61 15607398 J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9 15936615 Arch Intern Med. 2006 Apr 10;166(7):719-28 16606807 Lancet. 2006 Jun 10;367(9526):1903-12 16765759 Circulation. 2006 Jul 11;114(2):119-25 16818816 Am Heart J. 2006 Aug;152(2):217-22 16875900 Europace. 2006 Sep;8(9):651-745 16987906 Eur Heart J. 2007 Jun;28(11):1351-7 17329409 Ann Intern Med. 2007 Jun 19;146(12):857-67 17577005 Am J Med. 2007 Aug;120(8):700-5 17679129 Lancet. 2007 Aug 11;370(9586):493-503 17693178 Circulation. 2007 Oct 9;116(15):1647-52 17804441 Am J Ther. 2008 Jan-Feb;15(1):36-43 18223352 Circulation. 2008 Mar 25;117(12):1518-25 18332267 Eur Heart J. 2008 Apr;29(7):915-22 18334476 N Engl J Med. 2008 Jun 19;358(25):2667-77 18565859 N Engl J Med. 2008 Jun 19;358(25):2678-87 18565860 Stroke. 2009 Jan;40(1):235-40 18757287 Circulation. 2008 Nov 11;118(20):2029-37 18955670 N Engl J Med. 1991 Mar 21;324(12):781-8 1900101 Stroke. 2009 Apr;40(4):1410-6 19182090 N Engl J Med. 2009 Feb 12;360(7):668-78 19213680 N Engl J Med. 2009 May 14;360(20):2066-78 19336502 J Thorac Cardiovasc Surg. 2009 Sep;138(3):678-686.e1 19698856 N Engl J Med. 2009 Sep 17;361(12):1139-51 19717844 Chest. 2010 Feb;137(2):263-72 19762550 Circ Arrhythm Electrophysiol. 2009 Dec;2(6):652-9 19948506 N Engl J Med. 2010 Apr 15;362(15):1363-73 20231232 J Cardiovasc Electrophysiol. 2010 Jun 1;21(6):597-605 20384650 J Am Coll Cardiol. 2010 May 25;55(21):2299-307 20488299 Am J Med. 2010 Jul;123(7):638-645.e4 20609686 Eur Heart J. 2010 Oct;31(19):2369-429 20802247 Am J Ther. 2011 May;18(3):241-60 20861719 J Cardiovasc Pharmacol Ther. 2010 Dec;15(4 Suppl):36S-50S 20940451 Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):624-31 20959565 Stroke. 2010 Dec;41(12):2731-8 20966417 Am J Cardiol. 2010 Nov 1;106(9):1277-83 21029824 N Engl J Med. 2010 Nov 4;363(19):1875-6 21047252 Europace. 2011 Mar;13(3):329-45 21227948 N Engl J Med. 2011 Mar 3;364(9):806-17 21309657 Europace. 2011 Mar;13(3):308-28 21345926 Europace. 2011 May;13(5):763 21398312 J Am Coll Cardiol. 2011 Jul 26;58(5):493-501 21777747 J Am Coll Cardiol. 2011 Jul 26;58(5):551; author reply 551 21777759 Thromb Haemost. 2011 Oct;106(4):739-49 21789337 Expert Rev Cardiovasc Ther. 2011 Jul;9(7):801-4 21809959 Circulation. 2011 Sep 13;124(11):1212-22 21859974 N Engl J Med. 2011 Sep 15;365(11):981-92 21870978 Circulation. 2011 Sep 6;124(10):1093-6 21900094 N Engl J Med. 1990 Jul 19;323(3):147-52 2194126 N Engl J Med. 2011 Dec 15;365(24):2268-76 22082198 Clin Ther. 2011 Nov;33(11):1668-1681.e1 22108302 Int J Cardiol. 2013 Jun 5;166(1):147-51 22108512 J Cardiovasc Electrophysiol. 2012 May;23(5):462-72 22171925 J Interv Card Electrophysiol. 2012 Jun;34(1):1-9 22205496 Circulation. 2012 Feb 7;125(5):669-76 22215856 Circulation. 2012 Jan 3;125(1):165-70; discussion 170 22215891 Arch Intern Med. 2012 Mar 12;172(5):397-402 22231617 Am J Cardiol. 2012 Apr 15;109(8):1179-86 22245414 Lancet. 2012 Jan 28;379(9813):e24; author reply e24-5 22284660 Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8 22319005 Cardiovasc Drugs Ther. 2012 Apr;26(2):167-79 22418856 Int J Cardiol. 2013 May 10;165(2):229-36 22469557 Nat Genet. 2012 Apr 29;44(6):670-5 22544366 N Engl J Med. 1990 Mar 22;322(12):863-8 2407959 Lancet. 1996 Jul 6;348(9019):7-12 8691967 Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2470-4 9825369 J Am Coll Cardiol. 1999 Feb;33(2):304-10 9973007 545 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol The effects of drinking on offspring: an historical survey of the American and British literature. 1395-420 Current research on the effects on offspring of drinking during pregnancy has revived interest in an extremely old topic. Observations made during England's Gin Epidemic (1720-1750) were followed by warnings of 19th-century medical writers that parental drinking could damage the fetus. Many concurring studies were reported in the medical literature from 1865 to 1920. Research interest declined during Prohibition, and authorities later discounted the previous work. Recently a relationship between maternal drinking and abnormal morphogenesis has been again described. Warner R H RH Rosett H L HL eng Historical Article Journal Article United States J Stud Alcohol 7503813 0096-882X 3K9958V90M Ethanol IM Q Abnormalities, Multiple etiology Alcohol Drinking Alcoholism complications genetics Animals Birth Weight drug effects Child Development drug effects Ethanol pharmacology Female Fetal Diseases etiology Fetus drug effects Guinea Pigs History, 18th Century History, 19th Century History, 20th Century Humans Infant Mortality Infant, Newborn Infant, Newborn, Diseases etiology Maternal-Fetal Exchange Obstetric Labor Complications etiology Parents Pregnancy Prospective Studies Rats Temperance history United Kingdom United States 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 545 10.15288/jsa.1975.36.1395 546 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Problems of epidemiology in alcohol problems. 1442-51 Keller M M eng Historical Article Journal Article United States J Stud Alcohol 7503813 0096-882X IM Q Alcoholism epidemiology history mortality History, 18th Century History, 19th Century History, 20th Century Humans United States 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 546 10.15288/jsa.1975.36.1442 547 1976 02 13 2020 02 25 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Prevalence of alcoholism among ward patients in a veterans administration hospital. 1458-67 Gomberg E S ES eng Journal Article United States J Stud Alcohol 7503813 0096-882X IM Adult Alcoholism epidemiology Hospitals, Veterans Humans Male Middle Aged Patients United States 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 547 10.15288/jsa.1975.36.1458 Biochem Biophys Res Commun. 2001 Jun 29;284(5):1189-93 11414709 Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10972-6 12944565 N Engl J Med. 2003 Oct 23;349(17):1614-27 14573733 J Clin Endocrinol Metab. 2005 Dec;90(12):6609-15 16174713 J Clin Endocrinol Metab. 2007 Oct;92(10):3958-66 17635940 J Clin Endocrinol Metab. 2009 Nov;94(11):4315-23 19820030 J Endocrinol. 2011 Feb;208(2):97-105 21084385 N Engl J Med. 2012 Feb 16;366(7):629-35 22335740 J Clin Invest. 2012 Oct;122(10):3791-5 23006326 548 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Extracellular volume Expansion after ethanol in dogs. 1468-79 Sargent W Q WQ Simpson J R JR Beard J D JD eng Comparative Study Journal Article United States J Stud Alcohol 7503813 0096-882X 0 Lactates 059QF0KO0R Water 3K9958V90M Ethanol 9NEZ333N27 Sodium I38ZP9992A Magnesium RWP5GA015D Potassium IM Animals Blood Volume drug effects Dogs Ethanol pharmacology Extracellular Space drug effects Infusions, Parenteral Kidney drug effects metabolism Lactates pharmacology Magnesium metabolism Male Potassium metabolism Sodium metabolism Water pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 548 10.15288/jsa.1975.36.1468 549 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Hyperexcitability in the neural substrate of emotional behavior in cats after alcohol withdrawal. Evidence of a rapid development of alcohol dependence. 1480-92 Substantial and prolonged withdrawal hyperexcitability in the neural substrate for affective defense was revealed by behavioral and electrophysiological measures in cats exposed to moderate to heavy doses of alcohol for periods ranging from 6 to 72 hours. The data are interpreted as indicating a rapid development of physical dependence on alcohol in this portion of the central nervous system. MacDonnell M F MF Brown S H SH Davy B B eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Stud Alcohol 7503813 0096-882X 3K9958V90M Ethanol IM Amygdala drug effects physiopathology Animals Behavior, Animal drug effects Cats Emotions drug effects Ethanol pharmacology Female Humans Hypothalamus physiopathology Hypothalamus, Middle drug effects physiopathology Substance Withdrawal Syndrome physiopathology Substance-Related Disorders physiopathology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 549 10.15288/jsa.1975.36.1480 550 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Interactions of age, sex and long-term alcohol intake in selectively bred strains of rats. 1493-507 The alcohol consumption by five genotypes of rats was studied in two experiments. Alcohol intake was age-dependent in rats bred for high emotional reactivity and avoidance conditionability. Differences in consumption by sex appeared to be primarily due to differences in body weight. Satinder K P KP eng Comparative Study Journal Article United States J Stud Alcohol 7503813 0096-882X IM Age Factors Alcohol Drinking Animals Body Weight Genotype Humans Male Rats Rats, Inbred Strains physiology Sex Factors Time Factors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 550 10.15288/jsa.1975.36.1493 551 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol The mediating role of emotions in alcohol use. 1508-36 Russell J A JA Mehrabian A A eng Journal Article Research Support, U.S. Gov't, P.H.S. United States J Stud Alcohol 7503813 0096-882X 3K9958V90M Ethanol IM Alcohol Drinking Arousal drug effects Dominance-Subordination Emotions Environment Ethanol pharmacology Humans Personality 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 551 10.15288/jsa.1975.36.1508 552 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Alcoholism and marriage: the argument against specialism. 1537-63 Orford J J eng Journal Article United States J Stud Alcohol 7503813 0096-882X IM Adaptation, Psychological Alcoholism rehabilitation Divorce Female Humans Interpersonal Relations Male Marriage Prognosis Psychological Theory Psychology, Social Role Self Concept Stress, Psychological 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 552 10.15288/jsa.1975.36.1537 553 1976 02 13 2020 02 25 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Symptoms of alcoholism in women: a preliminary survey of A.A. members. 1564-9 James J E JE eng Journal Article United States J Stud Alcohol 7503813 0096-882X IM Adult Aged Alcoholics Anonymous Alcoholism diagnosis Behavior Female Humans Marriage Middle Aged 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 553 10.15288/jsa.1975.36.1564 Emerg Med J. 2004 Nov;21(6):652-3 15496684 J Nurs Scholarsh. 2007;39(2):155-64 17535316 Health Aff (Millwood). 1991 Winter;10(4):254-67 1778560 Med Care Res Rev. 2010 Feb;67(1):27-37 19638641 Int J Qual Health Care. 2009 Dec;21(6):397-407 19903756 J R Soc Med. 2012 Dec;105(12):496-8 23263785 BMJ Open. 2013 Jan 03;3(1):null 23293244 554 1976 02 13 2019 12 10 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Sex-role adjustment and drinking disposition of women college students. 1570-3 Parker F B FB eng Comparative Study Journal Article United States J Stud Alcohol 7503813 0096-882X IM Adult Alcoholism etiology Family Female Gender Identity Humans Identification, Psychological Neurotic Disorders complications Students 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 554 10.15288/jsa.1975.36.1570 555 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Prearrest behavior of persons convicted of driving while intoxicated. 1573-7 Yoder R D RD eng Journal Article United States J Stud Alcohol 7503813 0096-882X IM Accidents, Traffic prevention & control Alcohol Drinking Alcoholic Intoxication Automobile Driving Criminal Psychology Female Humans Male Social Control, Formal Stress, Psychological 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 555 10.15288/jsa.1975.36.1573 556 1976 02 13 2019 08 27 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Daily alcohol consumption patterns in Boston: some findings and a partial test of the Tuesday hypothesis. 1578-83 Argeriou M M eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States J Stud Alcohol 7503813 0096-882X IM Accidents, Traffic Adolescent Adult Aged Alcohol Drinking Alcoholic Intoxication Boston Circadian Rhythm Female Homicide Humans Male Middle Aged Sex Factors Urban Population 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 556 10.15288/jsa.1975.36.1578 557 1976 02 13 2020 02 25 0096-882X 36 11 1975 Nov Journal of studies on alcohol J Stud Alcohol Treatment of alcoholic methadone-maintenance patients with disulfiram. 1584-8 Pugliese A A Martinez M M Maselli A A Zalick D H DH eng Case Reports Journal Article United States J Stud Alcohol 7503813 0096-882X TR3MLJ1UAI Disulfiram UC6VBE7V1Z Methadone IM Adult Alcoholism complications drug therapy Disulfiram therapeutic use Humans Male Methadone therapeutic use Substance-Related Disorders complications rehabilitation 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 557 10.15288/jsa.1975.36.1584 Semin Cancer Biol. 1999 Aug;9(4):245-54 10448112 Br J Surg. 2002 Jul;89(7):845-60 12081733 Cancer Res. 1976 Jul;36(7 PT 2):2669-72 1277173 Gastroenterology. 2006 Nov;131(5):1400-7 17101316 Gastroenterol Clin North Am. 2008 Mar;37(1):25-46, v 18313538 Z Gastroenterol. 2008 Aug;46(8):799-840 18759205 Ann Intern Med. 2009 Jan 6;150(1):1-8 19075198 Histopathology. 2009 Jul;55(1):63-6 19614768 Am J Gastroenterol. 2010 May;105(5):1189-95 20010923 J Natl Cancer Inst. 2010 Jan 20;102(2):89-95 20042716 Gastroenterology. 2010 Oct;139(4):1128-37 20600026 Gastroenterology. 2010 Nov;139(5):1503-10, 1510.e1-3 20643134 Hum Pathol. 2011 Jan;42(1):1-10 20869746 Clin Gastroenterol Hepatol. 2011 Jan;9(1):42-6 20888435 Ann Intern Med. 2011 Jan 4;154(1):22-30 21200035 Expert Rev Mol Diagn. 2011 Jul;11(6):605-16 21745014 Gastrointest Endosc. 2012 Mar;75(3):515-20 22018551 Gut. 2012 Oct;61(10):1439-46 22156981 Pathology. 2012 Feb;44(2):80-8 22198259 Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):411-6 22219318 Gut. 2013 Jan;62(1):83-93 22287596 Am J Gastroenterol. 2012 Aug;107(8):1213-9 22688851 Am J Gastroenterol. 2012 Sep;107(9):1315-29; quiz 1314, 1330 22710576 Clin Endosc. 2012 Mar;45(1):44-61 22741132 J Gastroenterol. 2013 Mar;48(3):287-302 23208018 558 1976 02 13 2019 07 24 0022-5193 53 1 1975 Sep Journal of theoretical biology J Theor Biol Kinetic analysis of active membrane transport systems: equations for net velocity and isotope exchange. 125-44 Cuppoletti J J Segel I H IH eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England J Theor Biol 0376342 0022-5193 0 Carrier Proteins 0 Ligands 0 Sulfates 0 Sulfur Isotopes 27YLU75U4W Phosphorus IM Biological Transport, Active Carrier Proteins Hydrogen-Ion Concentration Kinetics Ligands Models, Biological Penicillium metabolism Phosphorus metabolism Sulfates metabolism Sulfur Isotopes 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 558 0022-5193(75)90107-1 10.1016/0022-5193(75)90107-1 559 1976 02 13 2019 07 24 0022-5193 53 1 1975 Sep Journal of theoretical biology J Theor Biol Quantitative aspects of regulation of cellular cyclic AMP levels. II. Kinectics of drug action in a model cyclic AMP generating system. 31-50 Davies J I JI Williams P A PA eng Journal Article England J Theor Biol 0376342 0022-5193 0 Adrenergic beta-Antagonists 0 Catecholamines 0 Hormones 0 Ligands 0 Phosphodiesterase Inhibitors 0 Receptors, Cell Surface 0 Xanthines E0399OZS9N Cyclic AMP EC 2.7.4.3 Adenylate Kinase EC 3.1.4.- Phosphoric Diester Hydrolases IM Adenylate Kinase metabolism Adrenergic beta-Antagonists pharmacology Catecholamines pharmacology Cyclic AMP biosynthesis Dose-Response Relationship, Drug Drug Synergism Hormones Ligands Models, Biological Phosphodiesterase Inhibitors Phosphoric Diester Hydrolases metabolism Protein Binding Receptors, Cell Surface Xanthines pharmacology 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 559 0022-5193(75)90101-0 10.1016/0022-5193(75)90101-0 560 1976 02 19 2019 07 24 0022-5193 53 2 1975 Sep Journal of theoretical biology J Theor Biol A hypothesis for the pathway of the thermally-induced unfolding of bovine pancreatic ribonuclease. 403-20 Burgess A W AW Scheraga H A HA eng Journal Article Research Support, U.S. Gov't, P.H.S. England J Theor Biol 0376342 0022-5193 EC 3.1.- Ribonucleases IM Amino Acid Sequence Animals Cattle Hydrogen-Ion Concentration Models, Chemical Pancreas enzymology Protein Binding Protein Conformation Protein Denaturation Ribonucleases Temperature 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 560 S0022-5193(75)80012-9 10.1016/s0022-5193(75)80012-9 563 1976 02 19 2019 10 21 0025-696X 13 3 1975 May Medical & biological engineering Med Biol Eng Development of a miniature pH glass electrode with field-effect-transistor amplifier for biomedical applications. 450-6 Ahn B K BK Wist A O AO Liu C C CC Ko W H WH eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Med Biol Eng 0043417 0025-696X IM Acid-Base Equilibrium Amplifiers, Electronic Biochemistry instrumentation Biomedical Engineering instrumentation Electrodes Glass Hydrogen-Ion Concentration Semiconductors Surface Properties Temperature Transistors, Electronic 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 563 10.1007/BF02477118 Scand J Clin Lab Invest. 1961;13:205-11 13683157 564 1976 02 27 2019 10 21 0025-696X 13 6 1975 Nov Medical & biological engineering Med Biol Eng Development of a minature pCO2 electrode for biomedical applications. 876-82 Lai N C NC Liu C C CC Brown E G EG Neuman M R MR Ko W H WH eng Journal Article England Med Biol Eng 0043417 0025-696X 142M471B3J Carbon Dioxide IM Carbon Dioxide analysis Electrodes Hydrogen-Ion Concentration Temperature 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 564 10.1007/BF02478092 Trans Am Soc Artif Intern Organs. 1971;17:341-9 5003423 Lancet. 1960 May 14;1(7133):1035-9 13794904 Clin Chem. 1973 Aug;19(8):891-4 4720812 Arch Phys Med Rehabil. 1957 Oct;38(10):646-50 13471145 J Appl Physiol. 1958 Nov;13(3):515-20 13587443 J Appl Physiol. 1966 Jul;21(4):1377-80 5916679 Med Biol Eng. 1975 May;13(3):450-6 563 Scand J Clin Lab Invest. 1960;12:172-6 13683155 J Biol Chem. 2002 Jul 5;277(27):e16 12091502 Scand J Clin Lab Invest. 1957;9(2):122-32 13442565 Science. 1959 Apr 3;129(3353):900-1 13635034 565 1976 02 19 2020 02 25 0023-7205 72 48 1975 Nov 26 Lakartidningen Lakartidningen [Treatment of ischemic wounds in the elderly by covering with pigskin heterografts]. 4736-7 Hansson B B Mannheimer C C swe English Abstract Journal Article Behandling av ischemiska sår hos åldringar medelst täckning av heterograft från svinhud Sweden Lakartidningen 0027707 0023-7205 IM Aged Animals Foot blood supply Foot Diseases surgery Foot Injuries Gangrene surgery Humans Ischemia Male Middle Aged Skin Transplantation Sweden Swine Transplantation, Heterologous 1975 11 26 1975 11 26 0 1 1975 11 26 0 0 ppublish 565 BMJ Qual Saf. 2011 Aug;20(8):718-24 21441605 Stud Health Technol Inform. 2012;180:1191-3 22874397 562 1976 02 13 2019 08 27 0047-6374 4 3-4 1975 May-Aug Mechanisms of ageing and development Mech Ageing Dev The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. II. Cell-mediated immune activity. 241-9 The late effects of various immunosuppressive insults on cell-mediated immunity in mice were studied in an attempt to assess the role of immune surveillance in the aging process. Results were obtained using susceptibility to allogeneic tumor cell challenge, graft-versus-host reaction (GVHR), blastogenic response to PHA, a thymus derived T cell-specific plant mitogen, and cytolytic activity against allogeneic tumor cells as measures of immunologic activity. In vivo studies late in life show that resistance to allogeneic tumor cells is significantly decreased in thymectomized mice, whereas those treated with cortisone, cyclophosphamide and sublethal X-ray remain unchanged. Spleen cells from only the thymectomized and the sublethally irradiated mice show reduced activity in the GVHR. No difference is seen in the activity of bone marrow cells. Results consistent with these findings were obtained in in vitro studies. Thus spleen cells from thymectomized or sublethally irradiated mice show decreased activity is response to PHA, whereas no change is seen in spleen cells from other treated groups. Hence, surgical and physical insults are more likely to induce long-lasting immunosuppression in those immunocompetent tissues whose activity normally diminishes with advancing age. Furthermore, the degree of immunosuppression seen in this study is not of the order of magnitude that one could reasonably predict a significant decrease in mean life-span. Peterson W J WJ Perkins E H EH Goodman S A SA Hori Y Y Halsall M K MK Makinodan T T eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Ireland Mech Ageing Dev 0347227 0047-6374 8N3DW7272P Cyclophosphamide V27W9254FZ Cortisone IM Age Factors Animals Cortisone pharmacology Cyclophosphamide pharmacology Cytotoxicity Tests, Immunologic Female Graft vs Host Reaction Immunity, Cellular drug effects radiation effects Immunosuppression Longevity drug effects radiation effects Lymphocyte Activation Male Mice Mice, Inbred BALB C Mice, Inbred Strains Radiation Injuries, Experimental immunology Spleen immunology Thymectomy 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 562 0047-6374(75)90026-3 10.1016/0047-6374(75)90026-3 561 1976 02 13 2020 02 25 0047-6374 4 3-4 1975 May-Aug Mechanisms of ageing and development Mech Ageing Dev Regional study of acid hydrolases and lysosomal membrane properties in the normal human brain at various ages. 201-13 Acid hydrolases and lysosomal membrane properties were studied at various ages in the normal human brain. In CSF and four brain regions, the inferior olive, the cerebellar cortex, the caudate nucleus and the frontal cortex were thus beta-galactosidase, beta-glucosidase, alpha-mannosidase, hexosaminidase and acid phosphatase biochemically quantitated at ages varying between 2 and 89 years of age. Also the membrane latency for acid phosphatase was studied in these regions. No major regional quantitative differences were found with regard to the enzymes studied. Their kinetic properties were also defined. There appeared to exist a regional and intra-areal variation in lysosomal membrane permeability. There was, however, no age related increase in total enzyme contents. The possibility significance of these findings are discussed with reference to the aging process. Brun A A Hultberg B B eng Comparative Study Journal Article Ireland Mech Ageing Dev 0347227 0047-6374 EC 3.1.3.2 Acid Phosphatase EC 3.2.1.- Disaccharidases EC 3.2.1.- Galactosidases EC 3.2.1.- Glucosidases EC 3.2.1.- Hexosaminidases EC 3.2.1.- Mannosidases IM Acid Phosphatase metabolism Adult Age Factors Aged Brain cytology enzymology Caudate Nucleus enzymology Cerebellar Cortex enzymology Cerebrospinal Fluid enzymology Disaccharidases metabolism Female Frontal Lobe enzymology Galactosidases metabolism Glucosidases metabolism Hexosaminidases metabolism Humans Hydrogen-Ion Concentration Lysosomes metabolism Male Mannosidases metabolism Membranes metabolism Middle Aged Olivary Nucleus enzymology Permeability 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 561 0047-6374(75)90022-6 10.1016/0047-6374(75)90022-6 Ann Emerg Med. 2002 Mar;39(3):238-47 11867975 J Am Geriatr Soc. 2001 Oct;49(10):1327-34 11890491 Age Ageing. 2005 Jan;34(1):24-30 15496462 BMJ. 2011 Oct 27;343:d6553 22034146 Emerg Med J. 2013 Sep;30(9):699-700 23250895 Perspectives. 1989 Summer;13(2):10-2 2515710 Lancet. 1993 Oct 23;342(8878):1032-6 8105269 566 1976 02 09 2019 07 01 0024-3205 16 10 1975 May 15 Life sciences Life Sci Calcium activation of brain tryptophan hydroxylase. 1583-93 Knapp S S Mandell A J AJ Bullard W P WP eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Metals, Alkaline Earth EC 1.- Mixed Function Oxygenases EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.14.16.4 Tryptophan Hydroxylase EC 4.1.1.- Dopa Decarboxylase SY7Q814VUP Calcium IM Animals Calcium pharmacology Dopa Decarboxylase metabolism Dose-Response Relationship, Drug Enzyme Activation Male Mesencephalon enzymology Metals, Alkaline Earth pharmacology Mixed Function Oxygenases metabolism Rats Structure-Activity Relationship Tryptophan Hydroxylase metabolism Tyrosine 3-Monooxygenase metabolism 1975 5 15 1975 5 15 0 1 1975 5 15 0 0 ppublish 566 0024-3205(75)90076-4 10.1016/0024-3205(75)90076-4 567 1976 02 09 2019 07 01 0024-3205 16 10 1975 May 15 Life sciences Life Sci Acute and chronic effects of nicotine on synthesis and storage of catecholamines in the rat adrenal medulla. 1613-22 Slotkin T A TA Seidler F J FJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Netherlands Life Sci 0375521 0024-3205 0 Catecholamines 6M3C89ZY6R Nicotine EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.14.17.1 Dopamine beta-Hydroxylase YKH834O4BH Epinephrine IM Adrenal Medulla drug effects enzymology metabolism Animals Catecholamines metabolism Dopamine beta-Hydroxylase metabolism Epinephrine metabolism Male Nicotine pharmacology Rats Time Factors Tyrosine 3-Monooxygenase metabolism 1975 5 15 1975 5 15 0 1 1975 5 15 0 0 ppublish 567 0024-3205(75)90079-X 10.1016/0024-3205(75)90079-x 568 1976 02 27 2020 02 25 0024-3205 17 6 1975 Sep 15 Life sciences Life Sci Subcellular localization of guanylate cyclase. 837-43 Kimura H H Murad F F eng Journal Article Research Support, U.S. Gov't, P.H.S. Review Netherlands Life Sci 0375521 0024-3205 EC 4.6.1.2 Guanylate Cyclase IM Animals Cell Membrane enzymology Golgi Apparatus enzymology Guanylate Cyclase metabolism Humans Liver enzymology ultrastructure Microsomes, Liver enzymology Solubility Subcellular Fractions enzymology 43 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 568 0024-3205(75)90433-6 10.1016/0024-3205(75)90433-6 Diabetes Care. 1999 Jun;22(6):920-4 10372242 Clin Chem. 2001 Feb;47(2):153-63 11159762 Endocr J. 2006 Jun;53(3):387-91 16717395 Endocr J. 2007 Feb;54(1):139-44 17159300 Clin Endocrinol (Oxf). 2008 Oct;69(4):556-61 18248645 Diabetes Care. 2010 Feb;33(2):270-2 19846794 BMJ. 2009 Oct 28;339:b4354 19864355 Endocr J. 2010;57(2):135-40 19926921 Diabetes Care. 2009 Dec;32(12):e159; author reply e160 19940222 Diabetologia. 2011 Dec;54(12):3028-36 21947435 Proc Natl Acad Sci U S A. 1979 Sep;76(9):4258-61 291961 Diabetes. 1995 Aug;44(8):968-83 7622004 N Engl J Med. 1976 Aug 19;295(8):417-20 934240 Lancet. 1998 Sep 12;352(9131):837-53 9742976 569 1976 02 27 2019 12 10 0024-3205 17 6 1975 Sep 15 Life sciences Life Sci Further studies on the pharmacology of a false cholinergic transmitter, (2-hydroxyethyl) methyldiethylammonium (diethylcholine). 907-13 Chiou C Y CY eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Life Sci 0375521 0024-3205 0 Ganglionic Blockers 0 Parasympatholytics 13213-99-5 diethylcholine N91BDP6H0X Choline IM Animals Anura Cats Choline analogs & derivatives pharmacology Depression, Chemical Dogs Dose-Response Relationship, Drug Ganglionic Blockers pharmacology In Vitro Techniques Neuroeffector Junction drug effects Neuromuscular Junction drug effects Parasympathetic Nervous System physiology Parasympatholytics Synaptic Transmission drug effects 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 569 0024-3205(75)90442-7 10.1016/0024-3205(75)90442-7 570 1976 02 27 2019 07 01 0024-3205 17 6 1975 Sep 15 Life sciences Life Sci Catechol-O-methyltransferase from rat liver: two forms having different meta:para methylation ratios. 933-41 Marzullo G G Friedhoff A J AJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Netherlands Life Sci 0375521 0024-3205 EC 2.1.1.6 Catechol O-Methyltransferase IM Animals Catechol O-Methyltransferase isolation & purification metabolism Cytoplasm enzymology Hydrogen-Ion Concentration Liver enzymology ultrastructure Microsomes, Liver enzymology Molecular Weight Rats Solubility Structure-Activity Relationship Temperature 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 570 10.1016/0024-3205(75)90446-4 571 1976 02 27 2019 07 01 0024-3205 17 6 1975 Sep 15 Life sciences Life Sci Properties of solubilized prostaglandin synthetase from sheep vesicular glands. 951-8 Raz A A Kloog Y Y Perel E E Kenig-Wakshal R R eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Detergents 0 Prostaglandins 0 Prostaglandins E 0 Prostaglandins F EC 1.- Mixed Function Oxygenases EC 1.13.- Oxygenases EC 1.14.99.1 Prostaglandin-Endoperoxide Synthases IM Animals Cold Temperature Detergents Hydrogen-Ion Concentration Male Microsomes enzymology Mixed Function Oxygenases metabolism Oxygenases metabolism Prostaglandin-Endoperoxide Synthases isolation & purification metabolism Prostaglandins biosynthesis Prostaglandins E biosynthesis Prostaglandins F biosynthesis Seminal Vesicles enzymology ultrastructure Solubility 1975 9 15 1975 9 15 0 1 1975 9 15 0 0 ppublish 571 0024-3205(75)90448-8 10.1016/0024-3205(75)90448-8 572 1976 02 09 2020 02 25 0024-3205 17 7 1975 Oct 10 Life sciences Life Sci Adenosine as a putative transmitter in the cerebral cortex. Studies with potentiators and antagonists. 1085-94 Phillis J W JW Kostopoulos G K GK eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Adenine Nucleotides 0 Neurotransmitter Agents 0 Receptors, Drug 3G6A5W338E Caffeine B6X4SYR93B Hexobendine C137DTR5RG Theophylline DAA13NKG2Q Papaverine K72T3FS567 Adenosine IM Action Potentials drug effects Adenine Nucleotides pharmacology Adenosine analogs & derivatives antagonists & inhibitors pharmacology Animals Blood Pressure drug effects Caffeine pharmacology Cerebral Cortex drug effects Dose-Response Relationship, Drug Hexobendine pharmacology Male Neurotransmitter Agents Papaverine pharmacology Rats Receptors, Drug Structure-Activity Relationship Theophylline pharmacology 1975 10 10 1975 10 10 0 1 1975 10 10 0 0 ppublish 572 0024-3205(75)90329-X 10.1016/0024-3205(75)90329-x Gut. 2003 Dec;52 Suppl 7:vii1-vii12 14612488 Nutrition. 2005 Nov-Dec;21(11-12):1127-33 16308136 Obes Surg. 2006 May;16(5):603-6 16687029 Clin Med (Lond). 2008 Aug;8(4):364-5 18724599 Crit Care Med. 2009 Jun;37(6):1866-72 19384225 Clin Nutr. 2009 Aug;28(4):365-77 19464090 Clin Med (Lond). 2010 Feb;10(1):3 20411611 BMJ. 2010 May 07;340:c2414 20453010 Br J Hosp Med (Lond). 2010 Dec;71(12):686-90 21135765 Wound Repair Regen. 2011 May-Jun;19(3):330-6 21539650 Clin Nutr. 2012 Jun;31(3):345-50 22122869 Ann Surg. 1984 Mar;199(3):299-305 6703791 Nutrition. 1996 Oct;12(10):677-84 8936490 Gut. 1996 Dec;39(6):833-5 9038665 Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1791-7 9620907 573 1976 02 09 2020 02 25 0024-3205 17 7 1975 Oct 10 Life sciences Life Sci Kinetic characterization of rat serum dopamine-beta-hydroxylase using a simplified radioenzymatic assay. 1179-86 Henry D P DP Johnson D G DG Starman B J BJ Williams R H RH eng Journal Article Research Support, U.S. Gov't, P.H.S. Netherlands Life Sci 0375521 0024-3205 0 Fumarates 789U1901C5 Copper EC 1.14.17.1 Dopamine beta-Hydroxylase EC 2.1.1.28 Phenylethanolamine N-Methyltransferase PQ6CK8PD0R Ascorbic Acid X8ZC7V0OX3 Tyramine IM Animals Ascorbic Acid pharmacology Copper pharmacology Dopamine beta-Hydroxylase blood metabolism Enzyme Activation Fumarates pharmacology Hydrogen-Ion Concentration Kinetics Phenylethanolamine N-Methyltransferase metabolism Rats Tyramine metabolism 1975 10 10 1975 10 10 0 1 1975 10 10 0 0 ppublish 573 0024-3205(75)90341-0 10.1016/0024-3205(75)90341-0 Lancet. 2002 Feb 23;359(9307):650-6 11879860 JAMA. 2007 Sep 5;298(9):1057-9 17785653 Surgery. 2013 Feb;153(2):160-76 22884087 BMC Med Educ. 2012 Oct 19;12:98 23082941 574 1976 02 26 2019 07 01 0024-3205 17 8 1975 Oct 15 Life sciences Life Sci The serotonergic system in the brain and its possible functional connections with other aminergic systems. 1201-9 Samanin R R Garattini S S eng Journal Article Review Netherlands Life Sci 0375521 0024-3205 0 Catecholamines 0 Hydroxydopamines 0 Methyltyrosines 0 Neurotransmitter Agents 333DO1RDJY Serotonin 54-16-0 Hydroxyindoleacetic Acid VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine IM Animals Behavior, Animal drug effects Brain cytology drug effects metabolism Catecholamines antagonists & inhibitors Corpus Striatum metabolism Dopamine metabolism Hydroxydopamines pharmacology Hydroxyindoleacetic Acid metabolism Methyltyrosines pharmacology Neurotransmitter Agents metabolism Norepinephrine metabolism Serotonin metabolism pharmacology 79 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 574 0024-3205(75)90128-9 10.1016/0024-3205(75)90128-9 575 1976 02 26 2020 02 25 0024-3205 17 8 1975 Oct 15 Life sciences Life Sci Proctolin: a peptide transmitter candidate in insects. 1241-52 Brown B E BE eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Glutamates 0 Neuropeptides 0 Neurotransmitter Agents 0 Oligopeptides 0 Peptides 0 Serotonin Antagonists 4368-28-9 Tetrodotoxin 57966-42-4 proctolin 8NA5SWF92O Lysergic Acid Diethylamide X8ZC7V0OX3 Tyramine IM Animals Cockroaches physiology Dose-Response Relationship, Drug Glutamates pharmacology Lysergic Acid Diethylamide pharmacology Muscle Contraction drug effects Neuromuscular Junction drug effects Neuropeptides Neurotransmitter Agents antagonists & inhibitors metabolism pharmacology Oligopeptides Peptides pharmacology Periplaneta physiology Serotonin Antagonists Tetrodotoxin pharmacology Tyramine pharmacology 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 575 0024-3205(75)90133-2 10.1016/0024-3205(75)90133-2 N Engl J Med. 1992 Jun 11;326(24):1593-8 1584260 N Engl J Med. 2006 Jul 6;355(1):11-20 16822992 N Engl J Med. 2006 Sep 14;355(11):1114-23 16971718 JAMA. 2007 Jan 17;297(3):267-77 17227978 J Clin Oncol. 2007 Apr 1;25(10):1160-8 17401004 Lancet. 2007 Dec 15;370(9604):2020-9 18083404 N Engl J Med. 2008 Jan 3;358(1):36-46 18172173 J Clin Oncol. 2008 Apr 20;26(12):2013-9 18421054 N Engl J Med. 2008 Jul 24;359(4):378-90 18650514 Lancet Oncol. 2009 Jan;10(1):25-34 19095497 J Clin Oncol. 2009 May 1;27(13):2269-77 19307501 J Clin Oncol. 2009 Jul 1;27(19):3109-16 19451431 J Clin Oncol. 2009 Nov 20;27(33):5513-8 19858379 Gut. 2010 May;59(5):666-89 20427401 J Clin Oncol. 2010 Aug 10;28(23):3687-94 20567019 Lancet. 2010 Aug 28;376(9742):687-97 20728210 J Clin Oncol. 2010 Nov 1;28(31):4697-705 20921465 N Engl J Med. 2011 May 12;364(19):1817-25 21561347 Cancer Epidemiol. 2012 Aug;36(4):e232-42 22425027 Ann Oncol. 2012 Oct;23(10):2619-26 22431703 576 1976 02 26 2020 02 25 0024-3205 17 8 1975 Oct 15 Life sciences Life Sci Structure of the pentapeptide proctolin, a proposed neurotransmitter in insects. 1253-6 Starratt A N AN Brown B E BE eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Neurotransmitter Agents 0 Oligopeptides IM Amino Acid Sequence Animals Cockroaches analysis Muscle Contraction drug effects Neurotransmitter Agents analysis chemical synthesis pharmacology Oligopeptides analysis Periplaneta analysis 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 576 0024-3205(75)90134-4 10.1016/0024-3205(75)90134-4 Hepatology. 1999 Dec;30(6):1356-62 10573511 N Engl J Med. 2002 Apr 18;346(16):1221-31 11961152 Am J Clin Nutr. 2004 May;79(5):820-5 15113720 Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103 15508109 Clin Endocrinol (Oxf). 2005 Mar;62(3):265-81 15730407 Diabetes Care. 2005 May;28(5):1228-30 15855599 Nutr Metab Cardiovasc Dis. 2007 Sep;17(7):517-24 16928437 Hepatology. 2007 Aug;46(2):285-7 17661403 Nutr Rev. 2008 Oct;66(10 Suppl 2):S98-112 18844852 Clin Endocrinol (Oxf). 2010 Sep;73(3):330-8 20184597 Hepatol Int. 2010 Jul 25;4(3):634-40 21063488 BMC Med. 2011 Jul 12;9:85 21749681 J Obes. 2011;2011:495101 22254134 Int J Vitam Nutr Res. 2011 Sep;81(5):317-27 22419202 J Clin Endocrinol Metab. 2012 Jun;97(6):1953-61 22442263 J Hepatol. 2012 Oct;57(4):897-909 22634121 J Diabetes Complications. 2012 Sep-Oct;26(5):363-8 22770938 Eur J Clin Invest. 2012 Nov;42(11):1189-96 22958216 Am J Clin Nutr. 2013 Apr;97(4):774-81 23407306 Endocr J. 2013;60(6):743-52 23411507 Br Med J (Clin Res Ed). 1986 Jan 4;292(6512):13-5 3080046 Diabetologia. 1985 Jul;28(7):412-9 3899825 Mayo Clin Proc. 1980 Jul;55(7):434-8 7382552 577 1976 02 26 2019 07 01 0024-3205 17 8 1975 Oct 15 Life sciences Life Sci On the substrate specificity of cathepsins B1 and B2 including a new fluorogenic substrate for cathepsin B1. 1269-76 McDonald J K JK Ellis S S eng Journal Article Netherlands Life Sci 0375521 0024-3205 0 Oligopeptides EC 3.4.- Carboxypeptidases EC 3.4.- Cathepsins T8ID5YZU6Y Dithiothreitol IM Animals Carboxypeptidases metabolism Cathepsins metabolism Cattle Dithiothreitol pharmacology Enzyme Activation Hydrogen-Ion Concentration Kinetics Oligopeptides metabolism Spleen enzymology Structure-Activity Relationship 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 577 0024-3205(75)90137-X 10.1016/0024-3205(75)90137-x 580 1976 02 09 2019 08 14 0024-4201 10 11 1975 Nov Lipids Lipids Lipoxygenase isozymes of peanut. 681-5 Lipoxygenase was isolated and partially purified from peanut seed by ammonium sulfate precipitation, gel filtration, and ion exchange column chromatography. Three isozymes of lipoxygenase were identified. Two had pH optima of 6.2, and the other an optimum of 8.3. Molecular weight of each isozyme was 7.3 x 10(4), as determined by gel filtration. The alkaline optimum isozyme was not inhibited by NaCN and was inhibited by CaCl2 except at very low concentrations. The acid optimum isozymes were inhibited by NaCN and were stimulated by CaCl2 concentrations up to ca. 0.7 mM. Sanders T H TH Pattee H E HE Singleton J A JA eng Journal Article United States Lipids 0060450 0024-4201 0 Cyanides 0 Isoenzymes EC 1.13.11.12 Lipoxygenase M4I0D6VV5M Calcium Chloride IM Arachis Calcium Chloride pharmacology Cyanides pharmacology Hydrogen-Ion Concentration Isoenzymes isolation & purification metabolism Kinetics Lipoxygenase isolation & purification metabolism Molecular Weight Plants enzymology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 580 10.1007/BF02532761 Acta Chem Scand. 1947;1(6):571-6 18907700 J Agric Food Chem. 1974 Sep-Oct;22(5):802-5 4213569 Arch Biochem Biophys. 1970 Feb;136(2):413-21 5461616 J Sci Food Agric. 1973 Sep;24(9):1039-53 4202020 Biochim Biophys Acta. 1970 Jan 14;198(1):12-9 5461103 Lipids. 1974 May;9(5):302-6 4208310 Biochim Biophys Acta. 1972 Sep 19;284(1):54-62 4672511 581 1976 02 20 2003 11 14 0025-8334 20 9 1975 Sep Meditsinskaia radiologiia Med Radiol (Mosk) [Foci of lymphocyte-like cells in the bone marrow of irradiated mice]. 70-2 Shvets V N VN rus Journal Article Ochagi limfotsitopodobnykh kletok v kostnom mozge obluchennykh myshei Russia (Federation) Med Radiol (Mosk) 2984767R 0025-8334 IM Animals Bone Marrow radiation effects Bone Marrow Cells Hematopoietic Stem Cell Transplantation Lymphocytes radiation effects Mice Mice, Inbred C57BL Mice, Inbred CBA Radiation Effects 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 581 582 1976 02 09 2013 11 21 0025-7583 103 11 1975 Nov Medical times Med Times Asthma: the promise of drug therapy. 76-87 Middleton E E Jr eng Journal Article United States Med Times 0406055 0025-7583 0 Adrenal Cortex Hormones 0 Adrenergic alpha-Agonists 0 Adrenergic beta-Agonists 0 Phosphodiesterase Inhibitors 0 Prostaglandins 7C0697DR9I Atropine Q2WXR1I0PK Cromolyn Sodium IM Adrenal Cortex Hormones therapeutic use Adrenergic alpha-Agonists therapeutic use Adrenergic beta-Agonists therapeutic use Asthma drug therapy physiopathology Atropine therapeutic use Cromolyn Sodium therapeutic use Humans Phosphodiesterase Inhibitors Prostaglandins therapeutic use 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 582 579 1976 03 01 2017 11 16 0024-5461 38 5 1975 Sep-Oct Lloydia Lloydia Ecological amplitudes of herbs, spices, and medicinal plants. 404-10 Duke J A JA Hurst S J SJ eng Journal Article United States Lloydia 0376626 0024-5461 0 Narcotics 0 Soil IM Condiments Ecology Hydrogen-Ion Concentration Magnoliopsida Narcotics Plants, Medicinal Rain Soil Temperature 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 579 578 1976 03 01 2006 11 15 0024-5461 38 5 1975 Sep-Oct Lloydia Lloydia Crassin acetate, the principal antineoplastic agent in four gorgonians of the Pseudoplexaura genus. 378-82 Crassin acetate, a lactonic cembrane diterpene, has been shown to be the principal antineoplastic agent present in the marine invertebrates (gorgonians) Pseudoplexaura porosa, P. flagellosa, P. wagenaari and P. crucis. Weinheimer A J AJ Matson J A JA eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Lloydia 0376626 0024-5461 0 Antineoplastic Agents 0 Diterpenes IM Animals Antineoplastic Agents isolation & purification therapeutic use Biological Assay Carcinoma drug therapy Cnidaria analysis Diterpenes isolation & purification therapeutic use Humans Mouth Neoplasms drug therapy Species Specificity 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 578 583 1976 02 09 2020 02 25 0025-8512 26 43 1975 Oct 24 Die Medizinische Welt Med Welt [Coronary heart disease and its differential treatment]. 1980-8 Diewitz M M ger Journal Article Review Die koronare Herzkrankheit und ihre differenzierte Behandlung Germany Med Welt 0376641 0025-8512 0 Adrenergic beta-Antagonists 0 Digitalis Glycosides 0 Nitro Compounds 0 Vasodilator Agents SY7Q814VUP Calcium IM Adrenergic beta-Antagonists therapeutic use Aorta physiopathology Blood Pressure Calcium antagonists & inhibitors Coronary Disease physiopathology therapy Digitalis Glycosides therapeutic use Heart physiopathology Hematocrit Hemodynamics Humans Nitro Compounds therapeutic use Oxygen Consumption drug effects Vasodilator Agents therapeutic use 71 1975 10 24 1975 10 24 0 1 1975 10 24 0 0 ppublish 583 J Antimicrob Chemother. 2004 May;53(5):882-4 15073160 Gut. 2004 May;53(5):673-7 15082585 CMAJ. 2004 Aug 31;171(5):466-72 15337727 Euro Surveill. 2005 Jun 30;10(6):E050630.2 16783109 J Clin Microbiol. 2006 Aug;44(8):2785-91 16891493 Am J Infect Control. 2007 Mar;35(2):131-7 17327194 Trends Microbiol. 2007 Apr;15(4):172-80 17336071 Clin Infect Dis. 2007 Aug 1;45(3):302-7 17599306 Intensive Care Med. 2008 Jan;34(1):17-60 18058085 Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S32-42 18177219 FEMS Microbiol Rev. 2008 May;32(3):541-55 18397287 N Engl J Med. 2008 Oct 30;359(18):1932-40 18971494 Clin Microbiol Infect. 2009 Dec;15(12):1053-66 19929972 N Engl J Med. 2010 Jan 21;362(3):197-205 20089970 PLoS One. 2010 Jan 15;5(1):e8740 20090901 Res Microbiol. 2010 Nov;161(9):730-4 20863888 Aliment Pharmacol Ther. 2011 Feb;33(4):428-41 21198703 N Engl J Med. 2011 Feb 3;364(5):422-31 21288078 Annu Rev Microbiol. 2011;65:501-21 21682645 Cochrane Database Syst Rev. 2011 Sep 07;(9):CD004610 21901692 Aliment Pharmacol Ther. 2011 Dec;34(11-12):1269-81 21999643 J Antimicrob Chemother. 2012 Mar;67(3):742-8 22146873 PLoS One. 2012;7(1):e30258 22291926 Vaccine. 2012 Mar 16;30(13):2245-9 22306375 Aliment Pharmacol Ther. 2012 Apr;35(8):865-75 22360412 Int J Antimicrob Agents. 2012 Jul;40(1):1-8 22398198 Infect Control Hosp Epidemiol. 2012 May;33(5):470-6 22476273 Infection. 2012 Oct;40(5):479-84 22527876 Clin Infect Dis. 1994 May;18 Suppl 4:S265-72 8086574 J Clin Pathol. 1977 Jan;30(1):1-12 838865 Br Med J. 1977 May 14;1(6071):1246-8 861560 584 1976 02 20 2013 11 21 0025-8512 26 47 1975 Nov 21 Die Medizinische Welt Med Welt [The value of gamma-glutamyl transpeptidases in the diagnosis of liver diseases]. 2139-41 Thefeld W W ger Journal Article Der Wert der gamma-Glutamyl-Transpeptidase bei der Diagnostik von Leberkrankheiten Germany Med Welt 0376641 0025-8512 3K9958V90M Ethanol EC 2.3.2.2 gamma-Glutamyltransferase IM Clinical Enzyme Tests Diagnosis, Differential Ethanol pharmacology Humans Liver Diseases diagnosis enzymology gamma-Glutamyltransferase blood 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 584 586 1976 03 01 2009 10 27 0076-6356 3 1975 Membranes Membranes The action of uncouplers on lipid bilayer membranes. 215-53 Neumcke B B eng Journal Article Review United States Membranes 0340707 0076-6356 0 Anions 0 Lipids 0 Membranes, Artificial 0 Uncoupling Agents IM Adsorption Anions Binding Sites Chemical Phenomena Chemistry Diffusion Electric Conductivity Hydrogen-Ion Concentration Lipids Mathematics Membranes, Artificial Models, Biological Uncoupling Agents 71 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 586 587 1976 03 01 2013 11 21 0076-6356 3 1975 Membranes Membranes Cation permeation mechanisms and cation selectivity in "tight junctions" of gallbladder epithelium. 383-497 Moreno J H JH Diamond J M JM eng Journal Article United States Membranes 0340707 0076-6356 0 Cations, Monovalent 7664-41-7 Ammonia AD84R52XLF Thallium IM Ammonia metabolism Animals Anura Binding Sites Biological Transport, Active Cations, Monovalent Electric Conductivity Epithelial Cells Epithelium metabolism ultrastructure Freeze Fracturing Gallbladder anatomy & histology metabolism Humans Hydrogen-Ion Concentration Mathematics Microelectrodes Microscopy, Electron Models, Biological Molecular Conformation Permeability Rabbits Rana catesbeiana Thallium Urodela 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 587 585 1976 02 09 2020 02 25 0025-7680 35 4 1975 Jul-Aug Medicina Medicina (B Aires) [6 years of the International Union of Societies of Immunology. Presidential report (Brighton 1974)]. 389-94 Cinader B B spa Congress Seis años de la Unión Internacional de Sociedades de Inmunología (UISI). Informe Presidencial (Brighton, 1974) Argentina Medicina (B Aires) 0204271 0025-7680 IM Allergy and Immunology Congresses as Topic England International Agencies International Cooperation Societies, Medical 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 585 Hepatology. 1999 Jun;29(6):1690-7 10347109 J Hepatol. 2000 Apr;32(4):596-602 10782908 N Engl J Med. 2001 Jan 4;344(1):23-8 11136956 Am J Gastroenterol. 2001 Jul;96(7):1968-76 11467622 Hepatology. 2002 Mar;35(3):609-15 11870374 Cochrane Database Syst Rev. 2003;(1):CD002147 12535432 World J Gastroenterol. 2003 Mar;9(3):534-8 12632513 J Hepatol. 2003 Aug;39(2):187-92 12873814 BMJ. 2004 May 1;328(7447):1046 15054035 J Hepatol. 2005 Feb;42(2):195-201 15664244 Clin Gastroenterol Hepatol. 2005 Feb;3(2):184-91 15704053 Hepatology. 1992 Jul;16(1):138-44 1618465 Hepatology. 2006 Feb;43(2 Suppl 1):S121-31 16447289 CMAJ. 2006 May 9;174(10):1433-43 16682712 Gut. 2006 Oct;55 Suppl 6:vi1-12 16966752 Hepatology. 2006 Oct;44(4):806-12 17006916 Hepatology. 2006 Oct;44(4):844-9 17006921 Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285 17030175 Clin J Am Soc Nephrol. 2006 Sep;1(5):1066-79 17699328 Gastroenterology. 2007 Sep;133(3):818-24 17854593 Ann Intern Med. 2008 Jul 15;149(2):109-22 18626050 J Gastroenterol Hepatol. 2009 Jan;24(1):9-14 18823442 Gastroenterology. 2009 May;136(5):1651-8 19208350 Gut. 2010 Jan;59(1):98-104 19570764 N Engl J Med. 2009 Sep 24;361(13):1279-90 19776409 Eur J Gastroenterol Hepatol. 2010 Aug;22(8):905-11 20093937 N Engl J Med. 2010 Mar 25;362(12):1071-81 20335583 J Hepatol. 2010 Aug;53(2):273-82 20570385 J Hepatol. 2010 Sep;53(3):397-417 20633946 J Hepatol. 2010 Oct;53(4):762-8 20638742 Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):515-25 20703237 Cochrane Database Syst Rev. 2010 Sep 08;(9):CD002907 20824832 Aliment Pharmacol Ther. 2010 Oct;32(7):859-71 20839387 Eur J Clin Invest. 1990 Feb;20(1):111-7 2108033 Am J Kidney Dis. 2011 Dec;58(6):928-38 21962618 Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1250-7 21971378 Int J Hepatol. 2011;2011:841407 21994873 Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008716 22071855 Gut. 2012 Feb;61(2):297-310 22147550 J Hepatol. 2012 Jun;56(6):1293-8 22322237 Eur J Gastroenterol Hepatol. 2012 Jul;24(7):831-9 22522141 Eur J Clin Nutr. 2012 Oct;66(10):1116-9 22872031 J Clin Gastroenterol. 2012 Sep;46(8):709-15 22878533 Aliment Pharmacol Ther. 2012 Oct;36(7):619-26 22908905 Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005162 22972083 Am J Gastroenterol. 2013 Apr;108(4):560-7 23419385 Hepatol Res. 2014 Jan;44(1):73-82 23551935 Gastroenterology. 1989 Nov;97(5):1304-12 2676683 Hepatology. 1988 Sep-Oct;8(5):1151-7 2971015 Hepatology. 1987 Jan-Feb;7(1):122-8 3804191 Gastroenterology. 1983 May;84(5 Pt 1):961-8 6339312 Br J Nutr. 1995 Oct;74(4):557-67 7577893 J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):47-50 7620107 Ren Fail. 1995 Mar;17(2):135-46 7644764 Hepatology. 1995 Mar;21(3):674-9 7875666 Hepatology. 1994 Jan;19(1):72-9 8276370 Gastroenterology. 1996 Oct;111(4):1011-7 8831596 J Gastroenterol Hepatol. 1997 Feb;12(2):159-66 9083918 Hepatology. 1998 Aug;28(2):374-8 9695999 588 1976 02 19 2019 09 11 0091-679X 12 1975 Methods in cell biology Methods Cell Biol Growth and handling of yeasts. 1-16 Rose A H AH eng Journal Article Review United States Methods Cell Biol 0373334 0091-679X 0 Acridines 0 Anti-Bacterial Agents 0 Coloring Agents 0 Culture Media T42P99266K Methylene Blue IM Acridines Aerobiosis Anaerobiosis Anti-Bacterial Agents Candida isolation & purification Cell Survival Coloring Agents Cryptococcus neoformans isolation & purification Culture Media Filtration Freeze Drying Hydrogen-Ion Concentration Malassezia isolation & purification Methylene Blue Pichia isolation & purification Preservation, Biological Refrigeration Saccharomycopsis isolation & purification Species Specificity Specimen Handling Temperature Yeasts classification growth & development isolation & purification 45 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 588 10.1016/s0091-679x(08)60948-6 589 1976 02 19 2020 02 25 0091-679X 12 1975 Methods in cell biology Methods Cell Biol Methods for avoiding proteolytic artefacts in studies of enzymes and other proteins from yeasts. 149-84 Pringle J R JR eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review United States Methods Cell Biol 0373334 0091-679X 0 Chloromercuribenzoates 0 Pepstatins 0 Phenanthrolines 0 Protease Inhibitors 12UHW9R67N Isoflurophate 57KD15003I Phenylmethylsulfonyl Fluoride 9G34HU7RV0 Edetic Acid EC 1.1.1.37 Malate Dehydrogenase EC 2.7.1.1 Hexokinase EC 2.7.1.11 Phosphofructokinase-1 EC 3.4.- Carboxypeptidases EC 3.4.- Peptide Hydrolases EC 3.4.11.- Aminopeptidases EC 4.1.1.1 Pyruvate Decarboxylase IM Aminopeptidases metabolism Carboxypeptidases metabolism Cell Fractionation Chloromercuribenzoates pharmacology Edetic Acid pharmacology Hexokinase isolation & purification Hydrogen-Ion Concentration Isoelectric Point Isoflurophate pharmacology Malate Dehydrogenase isolation & purification Molecular Weight Pepstatins pharmacology Peptide Hydrolases analysis metabolism Phenanthrolines pharmacology Phenylmethylsulfonyl Fluoride pharmacology Phosphofructokinase-1 isolation & purification Protease Inhibitors Protein Denaturation Pyruvate Decarboxylase isolation & purification Saccharomyces cerevisiae enzymology Temperature Vacuoles 191 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 589 10.1016/s0091-679x(08)60956-5 Lancet. 2000 Oct 14;356(9238):1318-21 11073021 N Engl J Med. 2007 Apr 19;356(16):1631-40 17442905 Drugs. 2009;69(4):435-48 19323587 Ann Intern Med. 2010 Jan 19;152(2):101-13 20083829 Aliment Pharmacol Ther. 2011 Jan;33(1):64-76 21128984 Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001319 21412871 Transfusion. 2011 Sep;51(9):1940-8 21585395 Nat Rev Gastroenterol Hepatol. 2012 Jan 10;9(2):97-104 22230903 Gut. 1996 Mar;38(3):316-21 8675081 590 1976 02 19 2019 09 11 0091-679X 12 1975 Methods in cell biology Methods Cell Biol Induction of haploid glycoprotein mating factors in diploid yeasts. 185-207 Crandall M M Caulton J H JH eng Journal Article Research Support, U.S. Gov't, P.H.S. Review United States Methods Cell Biol 0373334 0091-679X 0 Culture Media 0 Glycoproteins 0 Vitamins 00J9J9XKDE Vanadium 81AH48963U Molybdenum IY9XDZ35W2 Glucose KV2JZ1BI6Z Pyridoxine SY7Q814VUP Calcium IM Agglutination Ascomycota physiology Calcium pharmacology Conjugation, Genetic Culture Media Diploidy Genes Glucose pharmacology Glycoproteins biosynthesis Haploidy Hydrogen-Ion Concentration Karyotyping Molybdenum pharmacology Pichia metabolism physiology ultrastructure Pyridoxine pharmacology Saccharomyces cerevisiae ultrastructure Spores, Fungal Vanadium pharmacology Vitamins pharmacology 25 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 590 10.1016/s0091-679x(08)60957-7 591 1976 02 19 2019 09 11 0091-679X 12 1975 Methods in cell biology Methods Cell Biol Induction, selection, and experimental uses of temperature-sensitive and other conditional mutants of yeast. 233-72 Pringle J R JR eng Journal Article Research Support, U.S. Gov't, P.H.S. Review United States Methods Cell Biol 0373334 0091-679X 0 Fungal Proteins 63231-63-0 RNA IM Cell Division Cell Survival Cold Temperature Crosses, Genetic DNA Replication Fungal Proteins biosynthesis Genes Genetic Complementation Test Genetic Techniques Hydrogen-Ion Concentration Mutation Osmolar Concentration Phenotype RNA biosynthesis Saccharomyces cytology metabolism Suppression, Genetic Temperature 161 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 591 10.1016/s0091-679x(08)60959-0 592 1976 02 13 2020 02 25 0025-729X 2 14 1975 Oct 04 The Medical journal of Australia Med J Aust Recycling doctors. 562-5 Gill P F PF eng Journal Article Australia Med J Aust 0400714 0025-729X IM Attitude of Health Personnel Australia Education, Medical Education, Medical, Continuing Education, Medical, Undergraduate Efficiency Family Practice education Financing, Government Physician Assistants Physicians supply & distribution Physicians, Women Retirement 1975 10 4 1975 10 4 0 1 1975 10 4 0 0 ppublish 592 J Neuroimmunol. 2004 Mar;148(1-2):200-5 14975602 Pract Neurol. 2009 Oct;9(5):289-91 19762889 Neurology. 1993 Feb;43(2):414-7 8437711 Neurology. 1998 Oct;51(4):1110-5 9781538 593 1976 03 01 2019 02 06 0025-8458 70 45 1975 Nov 07 Medizinische Klinik Med Klin [Pulmonary involvement in collagen diseases]. 1801-14 Siegenthaler W W Leutenegger H H Siegenethaler G G Medici T T ger Journal Article Review Lungenbeteiligung bei Kollagenkrankheiten Germany Med Klin 0376637 0025-8458 IM Adolescent Anti-Glomerular Basement Membrane Disease complications Arthritis, Rheumatoid complications Collagen Diseases complications Dermatomyositis complications Female Granulomatosis with Polyangiitis complications Humans Lung Diseases diagnostic imaging etiology Lupus Erythematosus, Systemic complications Male Middle Aged Pleural Diseases etiology Polyarteritis Nodosa complications Polymyalgia Rheumatica complications Pulmonary Fibrosis etiology Radiography Scleroderma, Systemic complications Sjogren's Syndrome complications 61 1975 11 7 2000 3 22 9 0 1975 11 7 0 0 ppublish 593 595 1976 02 20 2008 02 26 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Less medicine than we think? 10, 14, 16 Cunningham R M RM Jr eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Attitude to Health Delivery of Health Care Environmental Health Humans 1975 12 1 2001 3 28 10 1 1975 12 1 0 0 ppublish 595 594 1976 03 01 2020 02 25 0025-8458 70 45 1975 Nov 07 Medizinische Klinik Med Klin [Computer experience and further developments in the respiratory function laboratory (author's transl)]. 1815-20 Reported is on satisfactory results obtained with a small-size computer consisting of punching and scanning device, as well as plain writing machine in the respiratory function laboratory. Developed in on- as well as off-line processing by an own technical staff, a diagnostic and teaching program was established for all respiratory function routine methods with the advantages of a large number of cases examined, elimination of sources of error, considerable supply of data and information, automatic documentation and filing, plain writing, interpretation and evaluation of findings. In continuation of such works also the blood gas analysis has been included. These values as the total of disturbances of the pathophysiological acid-base status are considered and interpreted. Clinical correction is forced in this man-machine dialogue by automatic stops of the whole machinery before going on. Subsequently and in addition are computer alveolar-arterial oxygen pressure gradient, venous shunt and oxygen saturation and expressed utilizing the capacity of the small-size computer. Further developments in the respiratory function diagnostic- and teaching program for small-size computers--not too expensive in the building block principle - are intended. Schindl R R Mayer K K Aigner K K ger English Abstract Journal Article Praktische EDV-erfahrung und Weiterentwicklung im Atemfunktionslabor Germany Med Klin 0376637 0025-8458 S88TT14065 Oxygen IM Acid-Base Equilibrium Blood Gas Analysis Blood Pressure Computers Data Display Diagnosis, Computer-Assisted Diagnostic Errors Female Humans Hydrogen-Ion Concentration Male Man-Machine Systems Online Systems Oxygen blood Partial Pressure Respiratory Function Tests Respiratory Tract Diseases diagnosis 1975 11 7 2000 3 22 9 0 1975 11 7 0 0 ppublish 594 Muscle Nerve. 2000 Oct;23(10):1456-71 11003781 Nat Rev Drug Discov. 2003 May;2(5):379-90 12750741 Science. 2003 Oct 24;302(5645):643-6 14576434 Diabetes. 2005 Sep;54(9):2503-13 16123337 Trends Mol Med. 2006 Mar;12(3):122-9 16443393 Hum Mol Genet. 2006 May 15;15(10):1623-8 16595608 Curr Med Chem. 2007;14(2):199-212 17266579 J Clin Pharmacol. 2007 Apr;47(4):430-44 17389552 Nature. 2007 May 3;447(7140):87-91 17450125 J Clin Invest. 2007 Jun;117(6):1456-65 17549248 Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R96-105 17613554 Nucleic Acids Res. 2008 Feb;36(3):826-38 18084024 N Engl J Med. 2007 Dec 27;357(26):2677-86 18160687 Hum Mutat. 2009 Mar;30(3):293-9 19156838 Mol Ther. 2009 Aug;17(8):1418-26 19293776 PLoS Med. 2009 May 26;6(5):e1000083 19478831 Lancet Neurol. 2009 Oct;8(10):918-28 19713152 Nature. 2010 Jan 14;463(7278):184-90 20016488 J Child Neurol. 2010 Sep;25(9):1158-64 20519671 N Engl J Med. 2010 Oct 7;363(15):1429-37 20925545 Ann Neurol. 2010 Nov;68(5):629-38 21031578 Brief Funct Genomics. 2010 Dec;9(5-6):477-85 21062751 Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):762-7 21187385 Ann Rheum Dis. 2011 Mar;70 Suppl 1:i119-22 21339215 N Engl J Med. 2011 Apr 21;364(16):1513-22 21428760 Mol Ther. 2011 May;19(5):830-40 21468001 PLoS One. 2011 May 06;6(5):e19189 21573153 Annu Rev Genomics Hum Genet. 2011;12:217-44 21721939 Lancet. 2011 Aug 13;378(9791):595-605 21784508 Nat Rev Drug Discov. 2011 Aug 01;10(8):621-37 21804598 Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84 22006329 Drug Des Devel Ther. 2011;5:471-85 22162641 Blood. 2012 Mar 29;119(13):3038-41 22271447 Cell. 2012 Mar 16;148(6):1293-307 22424236 Methods Mol Biol. 2012;867:415-35 22454077 Curr Gene Ther. 2012 Jun;12(3):206-44 22571500 Neurosci Lett. 2012 Oct 11;527(2):90-9 22609847 Mol Ther. 2012 Aug;20(8):1501-7 22692496 Hum Mol Genet. 2012 Sep 15;21(18):4007-20 22692682 Nature. 2012 Jul 18;487(7407):330-7 22810696 J Lipid Res. 2012 Dec;53(12):2515-24 22811413 Prog Retin Eye Res. 2013 Jan;32:22-47 22995954 Trends Mol Med. 2012 Nov;18(11):667-78 23044248 Trends Mol Med. 2012 Nov;18(11):679-88 23083810 J Biomol Screen. 2013 Apr;18(4):400-6 23112083 Expert Opin Biol Ther. 2013 Feb;13(2):183-96 23253281 Hum Gene Ther. 2013 May;24(5):472-8 23578007 Nat Rev Genet. 2013 Jun;14(6):373-8 23609411 Clin Cancer Res. 2013 Aug 15;19(16):4326-34 23770823 Ann Oncol. 2013 Aug;24(8):1951-5 23878113 Genome Biol. 2013 Jul 29;14(7):R78 23895045 Hum Gene Ther. 2013 Aug;24(8):715-6 23944718 Nature. 2013 Aug 22;500(7463):415-21 23945592 Nature. 1990 Jan 11;343(6254):180-2 2404210 Genomics. 1988 Jan;2(1):90-5 3384440 Nature. 1986 Oct 16-22;323(6089):646-50 3773991 Hum Genet. 1984;67(1):6-17 6086495 Nucleic Acids Res. 1983 Apr 25;11(8):2303-12 6304647 J R Coll Physicians Lond. 1997 Jan-Feb;31(1):82-9 9044206 596 1976 02 20 2020 02 25 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) The challenge of HEW. 16b Brazda J F JF eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Abortion, Induced Female Financing, Government Humans Legislation, Medical Pregnancy Research Support as Topic United States United States Dept. of Health and Human Services 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 596 Circulation. 2005 Sep 27;112(13):2047-60 16186440 Heart Rhythm. 2008 Feb;5(2):235-40 18242546 Amyloid. 2011 Jun;18 Suppl 1:130-1 21838460 597 1976 02 20 2008 02 26 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Manpower, medicine and money. 16n-16o Isaacman T T eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Education, Medical Family Practice education Financing, Government Physicians supply & distribution Schools, Medical Training Support United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 597 598 1976 02 20 2020 02 25 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Alaska. 20-3 eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 0 Petroleum IM S Alaska Architecture Arctic Regions Communication Delivery of Health Care Humans Occupational Health Services Petroleum 76075304 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 598 J Hepatol. 2008 Nov;49(5):732-8 18667256 Drug Metabol Drug Interact. 2011;26(1):5-12 21557672 Ann Pharmacother. 1995 Jul-Aug;29(7-8):667-70 8520077 599 1976 02 20 2018 12 03 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) EDP. Alternatives: two case histories. 29-33 Hendrickson R M RM eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Chicago Computers Economics, Hospital Electronic Data Processing Equipment and Supplies, Hospital Hospital Administration Hospital Shared Services Information Systems 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 599 600 1976 02 20 2019 02 06 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Choosing a computer system. 33-6 Hodge M H MH eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Computers Cost-Benefit Analysis Evaluation Studies as Topic Hospital Administration Humans Information Systems Quality of Health Care 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 600 601 1976 02 20 2019 02 06 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Planning for HIS. 36-8 Mathews J B JB eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Computers Cost-Benefit Analysis Evaluation Studies as Topic Hospital Administration Information Systems 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 601 602 1976 02 20 2020 02 25 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Mental health reform fails. 45-8 eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Aftercare Aged Community Mental Health Services standards supply & distribution Female Financing, Government Foster Home Care Hospitalization Hospitals, Psychiatric Humans Intellectual Disability rehabilitation Male Mental Disorders rehabilitation Nursing Homes Residential Facilities standards Social Control, Formal United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 602 JAMA. 2000 Aug 16;284(7):835-42 10938172 Eur Heart J. 2000 Dec;21(24):2033-41 11102254 Circulation. 2002 Sep 24;106(13):1622-6 12270853 Arch Intern Med. 2003 Oct 27;163(19):2345-53 14581255 Eur Heart J. 2005 May;26(9):865-72 15764619 Heart. 2007 Feb;93(2):177-82 16757543 BMJ. 2006 Nov 25;333(7578):1091 17032691 Eur Heart J. 2007 May;28(9):1072-8 17437970 Arch Intern Med. 2007 May 28;167(10):1009-16 17533203 J Am Coll Cardiol. 2007 Aug 14;50(7):e1-e157 17692738 Heart. 2009 Mar;95(3):221-7 18467355 Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):580-9 18665136 Am J Med. 2009 Feb;122(2):107-8 19185082 Arch Intern Med. 2009 Feb 23;169(4):372-8 19237721 Circulation. 2009 Apr 14;119(14):1873-82 19332461 Circulation. 2009 May 5;119(17):2408-16 19364974 N Engl J Med. 2009 May 21;360(21):2165-75 19458363 J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45 20359842 Heart. 2010 Jul;96(14):1095-101 20511625 Am J Med. 2011 Jan;124(1):40-7 21187184 Eur Heart J. 2011 Aug;32(15):1854-64 21715717 Eur Heart J. 2011 Dec;32(23):2999-3054 21873419 603 1976 02 20 2019 02 06 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Evaluate job to set compensation. 52 Plachy R J RJ eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Evaluation Studies as Topic Income Occupations Personnel Management 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 603 605 1976 02 20 2019 02 06 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Choosing an understudy. 60 Hayes J L JL eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Administrative Personnel Hospital Administration 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 605 604 1976 02 20 2020 02 25 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Setting depreciation schedules. 54, 56 Holmgren J H JH eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Accounting Economics, Hospital Equipment and Supplies, Hospital Financing, Organized Purchasing, Hospital United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 604 BMJ. 2011 Mar 31;342:d1938 21454457 Stroke. 2012 Feb;43(2):422-31 22180252 N Engl J Med. 2012 Mar 15;366(11):991-9 22417252 N Engl J Med. 2012 Mar 15;366(11):1048-50 22417260 BMJ. 2012 Mar 21;344:e2226 22438388 N Engl J Med. 2012 Jun 14;366(24):2322; author reply 2323-4 22694008 Clin Med (Lond). 2012 Aug;12(4):391-2 22930890 606 1976 02 20 2019 02 06 0093-7061 4 6 1975 Dec Modern healthcare. [Short-term care ed.] Mod Healthc (Short Term Care) Denial of staff privileges upheld. 64-5 Horty J F JF eng Journal Article United States Mod Healthc (Short Term Care) 0417653 0093-7061 IM Hospital Administration Jurisprudence Medical Staff, Hospital United States 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 606 607 1976 02 19 2020 02 25 0544-6872 6 1975 Modern trends in neurology Mod Trends Neurol Chemical transmitter systems in the brain. 183-203 Shute C C CC eng Journal Article Review England Mod Trends Neurol 0075472 0544-6872 0 Neurotransmitter Agents 333DO1RDJY Serotonin 46627O600J Levodopa 56-12-2 gamma-Aminobutyric Acid N9YNS0M02X Acetylcholine VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine IM Acetylcholine physiology Brain physiology Chorea physiopathology Corpus Striatum physiology Dopamine physiology Humans Learning physiology Levodopa adverse effects Memory physiology Neural Inhibition Neural Pathways Neurotransmitter Agents physiology Norepinephrine physiology Parasympathetic Nervous System physiology Serotonin physiology Substantia Nigra physiology Sympathetic Nervous System physiology Synapses physiology Synaptic Transmission gamma-Aminobutyric Acid physiology 54 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 607 J Am Coll Cardiol. 2000 Oct;36(4):1303-9 11028487 J Am Coll Cardiol. 2004 Jan 21;43(2):241-7 14736444 Eur Heart J. 2005 Nov;26(22):2422-34 16204266 N Engl J Med. 2009 Sep 17;361(12):1139-51 19717844 Circ Arrhythm Electrophysiol. 2010 Feb;3(1):32-8 19995881 Circ Arrhythm Electrophysiol. 2010 Jun;3(3):237-42 20335557 Eur Heart J. 2010 Oct;31(19):2369-429 20802247 Heart. 2011 Nov;97(22):1847-51 21357370 J Cardiovasc Electrophysiol. 2012 Mar;23(3):239-46 21914026 Heart. 2012 Jan;98(1):48-53 21930724 Europace. 2012 Apr;14(4):528-606 22389422 Europace. 2012 Nov;14(11):1553-9 22490371 Circ J. 2012;76(10):2337-42 22785434 PLoS One. 2012;7(9):e46034 23049929 J Cardiovasc Electrophysiol. 2012 Dec;23(12):1277-85 23130890 Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93 23810130 Acta Med Scand. 1988;223(1):53-9 3348103 Circulation. 1998 Sep 8;98(10):946-52 9737513 608 1976 02 19 2013 11 21 0544-6872 6 1975 Modern trends in neurology Mod Trends Neurol Regional cerebral circulation in man and its regulation. 59-81 Lassen N A NA Skinhoj E E eng Journal Article Review England Mod Trends Neurol 0075472 0544-6872 0 Radioactive Tracers 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Acidosis physiopathology Blood Viscosity Brain metabolism Brain Neoplasms physiopathology Carbon Dioxide blood Cerebrovascular Circulation drug effects Cerebrovascular Disorders diagnosis physiopathology Coma physiopathology Epilepsy physiopathology Homeostasis Humans Hydrogen-Ion Concentration Hypertension physiopathology Injections, Intra-Arterial Injections, Intravenous Migraine Disorders physiopathology Models, Biological Oxygen blood Radioactive Tracers Regional Blood Flow Rheology methods Vasomotor System anatomy & histology 55 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 608 609 1976 02 26 2019 08 18 0300-8177 9 2 1975 Nov 14 Molecular and cellular biochemistry Mol Cell Biochem Phosphate transport in rat liver mitochondria. Kinetics, inhibitor sensitivity, energy requirements, and labeled components. 109-24 Experiments were carried out to define the kinetic parameters of the major phosphate transport processes of rat liver mitochondria, and to obtain information about the molecular properties of these systems. Coty W A WA Pedersen P L PL eng 100406 Wellcome Trust United Kingdom Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Netherlands Mol Cell Biochem 0364456 0300-8177 0 Dinitrophenols 0 Malates 0 Malonates 0 Mercuribenzoates 0 Oligomycins 0 Oxazoles 0 Phosphates 03L9OT429T Rotenone 57-50-1 Sucrose O3C74ACM9V Ethylmaleimide RRU6GY95IS Nigericin IM Animals Biological Transport, Active Dinitrophenols pharmacology Ethylmaleimide pharmacology Hydrogen-Ion Concentration Kinetics Malates metabolism Male Malonates pharmacology Membranes metabolism Mercuribenzoates pharmacology Mitochondria, Liver drug effects metabolism Mitochondrial Swelling Nigericin pharmacology Oligomycins pharmacology Oxazoles metabolism Phosphates metabolism Rats Rotenone pharmacology Sucrose metabolism 1975 11 14 1975 11 14 0 1 1975 11 14 0 0 ppublish 609 10.1007/BF01732202 Biochem J. 1973 Jul;134(3):769-74 4749276 Eur J Biochem. 1969 Oct;10(3):484-93 5348074 J Biol Chem. 1956 Nov;223(1):147-56 13376584 J Biol Chem. 1971 Sep 10;246(17):5280-6 5094670 J Clin Invest. 1959 May;38(5):720-9 13654506 FEBS Lett. 1974 Nov 15;48(2):188-91 4435218 Eur J Biochem. 1971 Jun 11;20(3):392-9 5581324 J Membr Biol. 1972 Dec;7(1):391-401 24177519 Biochim Biophys Acta. 1971 Mar 2;226(2):297-308 5575160 Proc Natl Acad Sci U S A. 1974 Apr;71(4):1520-4 4364542 Eur J Biochem. 1971 Sep 13;22(1):134-43 5099211 Biochem J. 1970 Feb;116(4):37P 5435479 Biochim Biophys Acta. 1970 Aug 4;216(1):63-70 5497191 J Biol Chem. 1972 May 25;247(10):3107-13 5027745 Biochim Biophys Acta. 1968 Jan 15;153(1):98-112 5638406 Biochem Z. 1963;338:698-713 14087335 Biochem Biophys Res Commun. 1971 Jul 2;44(1):132-8 4940369 J Bioenerg. 1972 May;3(1):5-24 4263930 Eur J Biochem. 1970 Dec;17(2):230-8 5500391 J Cell Biol. 1970 May;45(2):291-305 4254678 Eur J Biochem. 1970 Aug;15(2):263-72 4396031 Eur J Biochem. 1968 Oct 17;6(1):66-79 5725814 J Biol Chem. 1968 May 10;243(9):2337-48 5648435 J Biol Chem. 1974 Apr 25;249(8):2593-8 4822505 Biochim Biophys Acta. 1969 May;180(1):28-34 4239613 Eur J Biochem. 1972 Apr 24;26(4):587-94 5025933 Eur J Biochem. 1971 Sep 13;22(1):66-74 5099217 Br Med Bull. 1968 May;24(2):150-7 5649935 Biochem J. 1969 Mar;111(5):665-78 5783467 Biochem Biophys Res Commun. 1971 Dec 17;45(6):1533-41 5128194 FEBS Lett. 1973 Nov 1;36(3):273-6 4763307 Biochimie. 1974;56(1):161-70 4847068 J Theor Biol. 1966 Feb;10(2):301-6 5964395 Biomembranes. 1972;3:107-16 4666508 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Biol Chem. 1973 Nov 10;248(21):7427-31 4126855 J Biol Chem. 1971 Aug 25;246(16):4987-94 4255092 Biochim Biophys Acta. 1970 Jan 13;197(1):97-100 5412038 J Biol Chem. 1969 Nov 10;244(21):5981-7 4900505 J Cell Biol. 1968 Jul;38(1):158-75 5691970 J Bioenerg. 1971 Sep;1(3):287-307 4109246 610 1976 02 13 2019 08 18 0300-8177 9 3 1975 Dec 31 Molecular and cellular biochemistry Mol Cell Biochem L-tyrosine: 2-oxoglutarate aminotransferase induction by hydrocortisone in the thymus of the white rat. 131-3 Hydrocortisone hemisuccinate within 4 hours after in vivo administration produced an increase in precursor incoporation into rat thymus RNA and proteins in the whole animal. From these results, together with information obtained from measurements of the tyrosine aminotransferase activity and the action of mitomycin C administered one hour before the injection of hydrocortisone, it can be concluded that the increase in tissue level of the enzyme, consequent to hydrocortisone treatment, results from an increased rate of biosynthesis of the enzyme, which participates in the catabolic processes of proteins in glucocorticoid sensitive thymus cells. Abraham A D AD eng Journal Article Netherlands Mol Cell Biochem 0364456 0300-8177 0 Mitomycins 63231-63-0 RNA EC 2.6.1.5 Tyrosine Transaminase WI4X0X7BPJ Hydrocortisone IM Animals Enzyme Induction drug effects Hydrocortisone pharmacology Male Mitomycins pharmacology Protein Biosynthesis RNA biosynthesis Rats Thymus Gland drug effects enzymology Tyrosine Transaminase biosynthesis 1975 12 31 1975 12 31 0 1 1975 12 31 0 0 ppublish 610 10.1007/BF01751307 Br J Exp Pathol. 1951 Oct;32(5):462-9 14886511 Proc Natl Acad Sci U S A. 1963 Nov;50:912-8 14082357 Biokhimiia. 1958;23(5):656-62 13607482 Enzymol Biol Clin (Basel). 1966;7(1):1-10 5296861 Biochim Biophys Acta. 1973 Jan 24;297(1):142-54 4348320 Exp Cell Res. 1972 Oct;74(2):606-10 5080799 Arch Biochem. 1950 Feb;25(2):262-76 15404816 Biochim Biophys Acta. 1962 Apr 2;55:495-504 13892026 Perspect Biol Med. 1971 Winter;14(2):265-9 5546253 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Endocrinology. 1966 Mar;78(3):481-6 5931631 611 1976 02 19 2019 10 28 0301-4851 2 3 1975 Oct Molecular biology reports Mol Biol Rep Identification of the 30 S protein adjacent to peptidyl transferase catalytic center of Escherichia coli ribosomes. 282-8 Iodoacetylphenylalanyl-tRNAPhe was used as an affinity label to localize the ribosomal components involved in the peptidyl transferase catalytic center of Escherichia coli ribosomes. When labeling was carried out at pH 5.0, the affinity label could specifically label the ribosomal components which comprise the catalytic center. Analysis of ribosomal proteins which had reacted with the affinity label revealed that a 30 S subunit protein, S 20, was located at or near to the ribosomal binding site of the 3'-terminus of aminoacyl- or peptidyl-tRNA. Hatayama T T Yukioka M M Morisawa S S eng Journal Article Netherlands Mol Biol Rep 0403234 0301-4851 0 Iodoacetates 0 Macromolecular Substances 0 Ribosomal Proteins 47E5O17Y3R Phenylalanine 9014-25-9 RNA, Transfer EC 2.3.- Acyltransferases EC 2.3.2.12 Peptidyl Transferases IM Acyltransferases metabolism Escherichia coli analysis Hydrogen-Ion Concentration Iodoacetates Macromolecular Substances Peptidyl Transferases metabolism Phenylalanine analogs & derivatives Protein Binding Protein Conformation RNA, Transfer Ribosomal Proteins metabolism Ribosomes metabolism ultrastructure 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 611 10.1007/BF00356986 Anal Biochem. 1970 Aug;36(2):401-12 4916449 Cold Spring Harb Symp Quant Biol. 1969;34:49-61 4909519 J Mol Biol. 1974 Oct 5;88(4):797-808 4214936 Proc Natl Acad Sci U S A. 1974 Jan;71(1):230-4 4589893 J Mol Biol. 1966 Oct 28;21(1):145-71 5338993 J Mol Biol. 1974 Jun 25;86(2):411-32 4607040 Proc Natl Acad Sci U S A. 1973 May;70(5):1423-6 4576018 FEBS Lett. 1973 Dec 1;37(2):291-4 4587218 FEBS Lett. 1973 Nov 15;37(1):47-50 4585032 FEBS Lett. 1974 Sep 1;45(1):213-7 4606460 Proc Natl Acad Sci U S A. 1974 Oct;71(10):3951-5 4610566 Mol Gen Genet. 1973 Dec 31;127(4):359-68 4594008 J Mol Biol. 1974 Oct 5;88(4):809-29 4610159 Cold Spring Harb Symp Quant Biol. 1969;34:197-207 4909498 Biochem Biophys Res Commun. 1973 Nov 1;55(1):117-24 4595629 612 1976 02 09 2018 12 03 0028-4793 294 1 1976 Jan 01 The New England journal of medicine N Engl J Med Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1976. 37-42 eng Case Reports Journal Article United States N Engl J Med 0255562 0028-4793 0 Gastrins AIM IM Adult Diagnosis, Differential Diarrhea etiology Female Gastrectomy Gastric Mucosa pathology Gastrins metabolism Humans Hypercalcemia etiology Liver Neoplasms diagnosis pathology Multiple Endocrine Neoplasia diagnosis Neoplasm Metastasis Zollinger-Ellison Syndrome diagnosis pathology physiopathology surgery 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 612 10.1056/NEJM197601012940109 613 1976 02 09 2019 08 23 0028-4793 294 1 1976 Jan 01 The New England journal of medicine N Engl J Med Letter: Impact of physicians' assistants. 57-8 Gaus C R CR eng Journal Article United States N Engl J Med 0255562 0028-4793 AIM IM Economics, Medical Physician Assistants United States 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 613 10.1056/nejm197601012940134 614 1976 02 13 2020 02 25 0028-4793 294 2 1976 Jan 08 The New England journal of medicine N Engl J Med Letter: Dyskinesia associated with chronic antihistamine use. 113 eng Case Reports Journal Article United States N Engl J Med 0255562 0028-4793 0 Histamine H1 Antagonists 3U6IO1965U Chlorpheniramine VTD58H1Z2X Dopamine AIM IM Chlorpheniramine adverse effects Dopamine metabolism Histamine H1 Antagonists adverse effects Humans Male Middle Aged Movement Disorders chemically induced physiopathology Neurons drug effects Rhinitis, Allergic, Seasonal drug therapy Time Factors 1976 1 8 1976 1 8 0 1 1976 1 8 0 0 ppublish 614 10.1056/NEJM197601082940218 Eur Heart J. 2003 Nov;24(21):1965-91 14585256 Circulation. 2004 Jan 20;109(2):278-91 14707021 JAMA. 2006 Oct 4;296(13):1593-601 17018804 N Engl J Med. 2008 Jan 10;358(2):169-76 18184962 Eur Heart J. 2008 Dec;29(23):2909-45 19004841 Circulation. 2009 Aug 11;120(6):518-25 19635968 Eur Heart J. 2009 Nov;30(21):2631-71 19713422 J Am Coll Cardiol. 2010 Apr 20;55(16):1713-20 20394876 Lancet. 2012 Oct 27;380(9852):1520-9 23101719 Am J Epidemiol. 1984 Dec;120(6):888-99 6239541 Circulation. 1995 Aug 15;92(4):785-9 7641357 Br J Sports Med. 1997 Dec;31(4):269-76 9429003 615 1976 02 13 2004 11 17 0028-4793 294 2 1976 Jan 08 The New England journal of medicine N Engl J Med Letter: Grams of antipsychotics? 113-4 Baldessarini R J RJ Gelenberg A J AJ Lipinski J F JF eng Journal Article United States N Engl J Med 0255562 0028-4793 0 Antipsychotic Agents AIM IM Antipsychotic Agents administration & dosage adverse effects therapeutic use Humans Movement Disorders chemically induced 1976 1 8 1976 1 8 0 1 1976 1 8 0 0 ppublish 615 616 1976 02 19 2013 11 21 0028-4793 294 3 1976 Jan 15 The New England journal of medicine N Engl J Med The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome. 133-5 Inhibition of acid secretion by an H2-receptor antagonist (metiamide) was assessed in three patients with the Zollinger-Ellison syndrome. Metiamide (200 or 300 mg) inhibited acid secretion transiently (2 1/2 hours) by 85 to 100 per cent in all patients. Although anticholinergic drugs alone inhibited acid secretion by only 0 to 35 per cent in these patients, the combination of metiamide and anticholinergic markedly prolonged the inhibitory effect of metiamide. Total gastrectomy was refused by one patient, and was impossible in another; both were treated with metiamide and anticholinergic for five and 10 months. A third patient was treated with metiamide and anticholinergic for three weeks in preparation for total gastrectomy. Ulcer pain and diarrhea disappeared, and each gained weight. H2-receptor antagonists may be useful in the treatment of some patients with the Zollinger-Ellison syndrome. Richardson C T CT Walsh J H JH eng Case Reports Journal Article Research Support, U.S. Gov't, P.H.S. United States N Engl J Med 0255562 0028-4793 0 Histamine H1 Antagonists 0 Receptors, Drug 1306V2B0Q8 Propantheline 3K7670861M Metiamide GYV9AM2QAG Thiourea V92SO9WP2I Glycopyrrolate AIM IM Adult Drug Evaluation Drug Therapy, Combination Female Glycopyrrolate administration & dosage therapeutic use Histamine H1 Antagonists therapeutic use Humans Male Metiamide administration & dosage pharmacology therapeutic use Propantheline administration & dosage therapeutic use Receptors, Drug drug effects Thiourea analogs & derivatives Time Factors Zollinger-Ellison Syndrome drug therapy 1976 1 15 1976 1 15 0 1 1976 1 15 0 0 ppublish 616 10.1056/NEJM197601152940304 617 1976 02 13 2018 12 03 0028-4793 294 4 1976 Jan 22 The New England journal of medicine N Engl J Med Shattuck lecture--strengths and weaknesses of the committee approach. An analysis of past and present recommended dietary allowances for protein in health and disease (second of two parts). 198-203 Scrimshaw N S NS eng Congress United States N Engl J Med 0255562 0028-4793 0 Dietary Proteins N762921K75 Nitrogen AIM IM Adult Congresses as Topic Dietary Proteins Energy Metabolism Female Humans International Agencies Male Nitrogen metabolism Nutritional Physiological Phenomena Nutritional Requirements Pregnancy Research Design 1976 1 22 1976 1 22 0 1 1976 1 22 0 0 ppublish 617 10.1056/NEJM197601222940405 618 1976 03 01 2020 02 25 0028-0836 258 5532 1975 Nov 20 Nature Nature Selective release of newly synthesised and newly captured GABA from synaptosomes by potassium depolarisation. 254-6 Ryan L D LD Roskoski R R Jr eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. England Nature 0410462 0028-0836 0 Aminobutyrates 0 Neurotransmitter Agents 56-12-2 gamma-Aminobutyric Acid RWP5GA015D Potassium IM Aminobutyrates metabolism Animals Biological Transport Brain ultrastructure Male Membrane Potentials drug effects Neurotransmitter Agents metabolism Potassium pharmacology Rats Synaptosomes metabolism gamma-Aminobutyric Acid biosynthesis metabolism 1975 11 20 2001 3 28 10 1 1975 11 20 0 0 ppublish 618 10.1038/258254a0 Lancet. 2002 Jul 6;360(9326):7-22 12114036 N Engl J Med. 2004 Apr 8;350(15):1495-504 15007110 Lancet. 2004 Mar 6;363(9411):757-67 15016485 J Am Coll Cardiol. 2005 Oct 18;46(8):1411-6 16226163 Lancet. 2007 Nov 24;370(9601):1781-90 17559928 Circulation. 2008 Jan 29;117(4):e25-146 18086926 N Engl J Med. 2008 Sep 25;359(13):1357-66 18765432 N Engl J Med. 2008 Nov 20;359(21):2195-207 18997196 Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37 19287307 JAMA. 2009 Nov 11;302(18):1993-2000 19903920 Lancet. 2010 Feb 27;375(9716):735-42 20167359 Lancet. 2010 Nov 13;376(9753):1670-81 21067804 Lancet. 2010 Nov 13;376(9753):1658-69 21067805 JAMA. 2012 Mar 28;307(12):1302-9 22453571 Rev Med Suisse. 2012 Mar 7;8(331):525-6, 528-30 22471115 Lancet. 1994 Nov 19;344(8934):1383-9 7968073 619 1976 02 13 2019 06 17 0028-0836 258 5534 1975 Dec 04 Nature Nature Effect of minor tranquillisers on hippocampal theta rhythm mimicked by depletion of forebrain noradrenaline. 424-5 Gray J A JA McNaughton N N James D T DT Kelly P H PH eng Journal Article England Nature 0410462 0028-0836 0 Anti-Anxiety Agents 0 Hydroxydopamines 0 Methyltyrosines 3K9958V90M Ethanol 7J8897W37S Dronabinol GWH6IJ239E Amobarbital J7A92W69L7 Droxidopa VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine IM Action Potentials drug effects Amobarbital pharmacology Animals Anti-Anxiety Agents pharmacology Brain metabolism Dopamine metabolism Dronabinol pharmacology Droxidopa pharmacology Electroencephalography Ethanol pharmacology Hippocampus drug effects physiology Hydroxydopamines pharmacology Male Methyltyrosines pharmacology Norepinephrine deficiency physiology Rats Theta Rhythm 1975 12 4 1975 12 4 0 1 1975 12 4 0 0 ppublish 619 10.1038/258424a0 620 1976 02 13 2019 06 17 0028-0836 258 5534 1975 Dec 04 Nature Nature Direct identification and characterisation of beta-adrenergic receptors in rat brain. 437-40 Alexander R W RW Davis J N JN Lefkowitz R J RJ eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. England Nature 0410462 0028-0836 0 Neurotransmitter Agents 0 Receptors, Adrenergic 333DO1RDJY Serotonin 877K5MQ27W Alprenolol 9Y8NXQ24VQ Propranolol L628TT009W Isoproterenol VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine YKH834O4BH Epinephrine Z468598HBV Phentolamine IM Alprenolol metabolism Animals Binding Sites Binding, Competitive Brain metabolism Dopamine metabolism Epinephrine metabolism Isoproterenol metabolism Kinetics Male Neurotransmitter Agents metabolism Norepinephrine metabolism Phentolamine metabolism Propranolol metabolism Rats Receptors, Adrenergic Serotonin metabolism Structure-Activity Relationship 1975 12 4 1975 12 4 0 1 1975 12 4 0 0 ppublish 620 10.1038/258437a0 621 1976 02 13 2019 06 17 0028-0836 258 5534 1975 Dec 04 Nature Nature Prolonged activation of tyrosine hydroxylase in noradrenergic neurones of rat brain by cholinergic stimulation. 440-1 Lewander T T Joh T H TH Reis D J DJ eng Journal Article England Nature 0410462 0028-0836 5RY0UWH1JL Oxotremorine EC 1.14.16.2 Tyrosine 3-Monooxygenase X4W3ENH1CV Norepinephrine IM Animals Cerebral Ventricles enzymology Enzyme Activation drug effects Male Neurons enzymology metabolism Norepinephrine metabolism Oxotremorine pharmacology Rats Tyrosine 3-Monooxygenase metabolism 1975 12 4 1975 12 4 0 1 1975 12 4 0 0 ppublish 621 10.1038/258440a0 622 1976 02 13 2019 06 17 0028-0836 258 5534 1975 Dec 04 Nature Nature Letter: Cysteine and survival of transplanted thymoma. 458 Connors T A TA Jones M M eng Journal Article England Nature 0410462 0028-0836 K848JZ4886 Cysteine IM Cysteine therapeutic use Hydrogen-Ion Concentration Neoplasm Transplantation Thymoma drug therapy pathology 1975 12 4 1975 12 4 0 1 1975 12 4 0 0 ppublish 622 10.1038/258458a0 623 1976 02 21 2020 02 25 0028-0836 258 5535 1975 Dec 11 Nature Nature Effect of denervation and local damage on extrajunctional L-glutamate receptors in locust muscle. 530-1 Cull-Candy S G SG eng Journal Article England Nature 0410462 0028-0836 0 Glutamates 0 Neurotransmitter Agents 0 Receptors, Drug 2552-55-8 Ibotenic Acid IM Action Potentials drug effects Animals Glutamates metabolism pharmacology Grasshoppers metabolism Ibotenic Acid pharmacology Muscle Denervation Neuromuscular Junction physiology Neurotransmitter Agents metabolism Receptors, Drug 1975 12 11 1975 12 11 0 1 1975 12 11 0 0 ppublish 623 10.1038/258530a0 Br Med J. 1949 Dec 3;2(4639):1267-9 15394635 Br Med J. 1948 Oct 9;2(4579):671-3 18886657 Lancet Neurol. 2010 Jan;9(1):105-18 20083041 Am J Emerg Med. 2011 Jun;29(5):576.e1-3 21030182 Colorectal Dis. 2012 Aug;14(8):e508 22212130 Ann Rehabil Med. 2012 Apr;36(2):278-81 22639755 Clin Colon Rectal Surg. 2012 Mar;25(1):37-45 23449274 Stroke. 1994 Jan;25(1):113-6 8266357 624 1976 02 09 2019 08 23 0028-1042 62 7 1975 Jul Die Naturwissenschaften Naturwissenschaften Tentative classification of NAD(P)-linked dehydrogenases in regard to their stereochemistry of hydrogen transfer to the coenzyme. 346-8 Alizade M A MA Brendel K K eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Germany Naturwissenschaften 0400767 0028-1042 53-59-8 NADP EC 1.6.- NADH, NADPH Oxidoreductases IM Binding Sites Catalysis NADH, NADPH Oxidoreductases classification NADP metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 624 10.1007/BF00608901 J Biol Chem. 1968 Mar 25;243(6):1190-7 4296411 Biochim Biophys Acta. 1974 Mar 21;341(1):48-55 4364121 Fed Proc. 1958 Dec;17(4):1150-7 13619787 Biochem Biophys Res Commun. 1962 Nov 27;9:371-5 14023097 FEBS Lett. 1973 Jun 1;32(2):254-6 4354812 J Biol Chem. 1970 Mar 25;245(6):1311-8 4392628 Biochemistry. 1963 Sep-Oct;2:1009-14 14087351 Biochim Biophys Acta. 1974 Dec 29;370(2):354-7 4374239 Biochim Biophys Acta. 1970 Mar 18;198(3):397-406 4392298 J Biol Chem. 1968 Aug 25;243(16):4372-9 4300551 Nature. 1974 Jul 19;250(463):194-9 4368490 Biochim Biophys Acta. 1974 Oct 17;364(2):204-8 4371607 J Biol Chem. 1965 Apr;240:1820-3 14285530 J Biol Chem. 1960 Jul;235:2147-51 14406805 Biochim Biophys Acta. 1968 Jun 4;159(2):401-3 4297944 J Biol Chem. 1965 Apr;240:1824-8 14285531 Biochemistry. 1973 Aug 28;12(18):3472-8 4147215 J Biol Chem. 1968 Feb 25;243(4):848-52 4384253 Biochemistry. 1970 Mar 3;9(5):1284-6 4392156 625 1976 02 09 2019 08 23 0028-1042 62 8 1975 Aug Die Naturwissenschaften Naturwissenschaften Induction of tyrosine aminotransferase by insulin not mediated by cyclic GMP. 397 Hardeland R R Holzapfel G G eng Journal Article Germany Naturwissenschaften 0400767 0028-1042 0 Insulin 63X7MBT2LQ Bucladesine EC 2.6.1.5 Tyrosine Transaminase H2D2X058MU Cyclic GMP IM Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):633-635 31054239 Animals Bucladesine pharmacology Cyclic GMP pharmacology Enzyme Induction drug effects Insulin pharmacology Liver drug effects enzymology Male Rats Tyrosine Transaminase biosynthesis 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 625 10.1007/BF00625358 FEBS Lett. 1972 Feb 1;20(2):191-194 11946413 Naturwissenschaften. 1966 Oct;53(20):529 4295025 Proc Natl Acad Sci U S A. 1973 Aug;70(8):2443-7 4365701 J Biol Chem. 1967 Oct 10;242(19):4372-7 6065084 626 1976 02 19 2019 07 25 0028-1298 291 1 1975 Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol Histamine receptors in the vasculature of the rabbit ear. 23-9 Histamine has a dual action on the isolated perfused ear preparation of the rabbit. The amine induced a dose-dependent rise in perfusion pressure when the preparation was perfused with Krebs' solution. This pressor response was reversed to a depressor effect when meypramine was added to the perfusion fluid. This depressor effect of the amine was also dose-related. Metiamide competitively inhibited the depressor effect of histamine. Prior treatment of the ear vessels with metiamide alone caused an increase in histamine-induced perfusion pressure. From these results it was concluded that the predominant pressor effect of histamine on the vascular bed of the rabbit ear is mediated through the H1-receptors and the depressor effect of the amine through histamine H2-receptors. Ercan Z S ZS Türker R K RK eng Journal Article Germany Naunyn Schmiedebergs Arch Pharmacol 0326264 0028-1298 0 Histamine H1 Antagonists 0 Receptors, Drug 0 Vasoconstrictor Agents 0 Vasodilator Agents 11128-99-7 Angiotensin II 3K7670861M Metiamide 820484N8I3 Histamine HPE317O9TL Pyrilamine N9YNS0M02X Acetylcholine X4W3ENH1CV Norepinephrine IM Acetylcholine pharmacology Angiotensin II pharmacology Animals Arteries drug effects Ear blood supply Histamine pharmacology Histamine H1 Antagonists pharmacology In Vitro Techniques Metiamide pharmacology Muscle Contraction drug effects Norepinephrine pharmacology Pyrilamine pharmacology Rabbits Receptors, Drug Vasoconstrictor Agents Vasodilator Agents Vasomotor System drug effects 1975 11 3 1975 11 3 0 1 1975 11 3 0 0 ppublish 626 10.1007/BF00510818 Arch Int Pharmacodyn Ther. 1974 May;209(1):144-9 4153520 J Pharm Pharmacol. 1972 Jan;24(1):40-6 4401315 Nature. 1972 Apr 21;236(5347):385-90 4401751 Agents Actions. 1973 Oct;3(3):133-7 4150324 Pharmacology. 1973;9(5):306-11 4146994 Aust J Exp Biol Med Sci. 1965 Oct;43(5):639-56 4284821 Br J Pharmacol Chemother. 1947 Sep;2(3):189-206 20258355 Br J Pharmacol. 1972 Jun;45(2):311-21 4403103 Br J Pharmacol. 1968 Nov;34(3):499-507 4302377 Br J Pharmacol. 1973 Oct;49(2):368-9 4152253 Eur J Pharmacol. 1974 Jul;27(2):259-62 4850326 Aust J Exp Biol Med Sci. 1974 Jun;52(Pt 3):577-82 4153827 627 1976 02 19 2019 07 25 0028-1298 291 1 1975 Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. 55-78 The rabbit pulmonary artery contains postsynaptic alpha-adrenoceptors which meidate smooth muscle contraction; its noradrenergic nerves contain presynaptic alpha-adrenoceptors which mediate inhibition of the release of the transmitter evoked by nerve impulses. Dose-response curves for the pre- and postsynaptic effects of eight alpha-receptor agonists were determined on superfused strips of the artery in the presence of cocaine, corticosterone and propranolo. 1. According to the concentrations which caused 20% of the maximal contraction (EC20 post), the postsynaptic rank order of potency was: adrenaline greater than noradrenaline greater than oxymetazoline greater than naphazoline greater than phenylephrine greater than tramazoline greater than alpha-methylnoradrenaline greater than methoxamine. The pA2 values of phentolamine againstoxymethazoline, phenylephrine, alpha-methylnoradrenaline and methoxamine were 7.43, 7.48, 7.59 and 7.69, respectively. 2. For the investigation of presynaptic effects, the arteries were preincubated with 3H-noradrenaline. All agonists inhibited the overflow of tritium evoked by transmural sympathetic nerve stimulation. According to the concentrations which reduced the stimulation-induced overflow by 20% (EC20 pre), the rank order of potency was: adrenaline greater than oxymetazoline greater than tramazoline greater than alpha-methylnoradrenaline greater than noradrenaline greater than naphazoline greater than phenylephrine greater than methoxamine. 10(-5) M phentolamine shifted the presynaptic dose-response curves for moradrenaline and oxymethazoline to the right. 3. The ratio EC20 pre/EC20 post was calculated for each agonist as an index of its relative post- and presynaptic potency. According to the ratios, the agonists were arbitrarily classified into three groups. Group 1 (ratio about 30: preferentially postsynaptic agonists) comprised methoxamine and phenylephrine; group 2 (ratio near 1; similar pre- and postsynaptic potencies) comprised noradrenaline, adrenaline and naphazoline; group 3 (ratio below 0.2; preferentially presynaptic agonists) comprised oxymetazoline, alpha-methylnoradrenaline and tramazoline (as well as clonidine). 4. Preferentially presynaptic and preferentially postsynaptic agonists had opposite effects on the basoconstrictor response to nerve stimulation. Methoxamine and phenylephrine either did not change or enhanced, but never reduced, the response. In contrast, oxymetazoline, alpha-methylnoradrenaline and tramazoline at low concentrations selectively inhibited the response to stimulation at low frequency (0.25-2Hz). 5. It is concluded that alpha-adrenoceptor agonists vary widely in their relative pre- and postsynaptic potencies, possibly because of structural differences between pre- and postsynaptic alpha-receptors. Pre- and postsynaptic components contribute to their overll postsynaptic effec in actively transmitting synapses. The preferential activation of presynaptic alpha-receptors results in alpha-adrenergic inhibition of synaptic transmission. Starke K K Endo T T Taube H D HD eng Comparative Study Journal Article Germany Naunyn Schmiedebergs Arch Pharmacol 0326264 0028-1298 0 Adrenergic alpha-Agonists 0 Receptors, Adrenergic MN3L5RMN02 Clonidine X4W3ENH1CV Norepinephrine IM Adrenergic alpha-Agonists pharmacology Animals Clonidine pharmacology Dose-Response Relationship, Drug Electric Stimulation Muscle Contraction drug effects Neural Inhibition Norepinephrine metabolism Pulmonary Artery drug effects Rabbits Receptors, Adrenergic drug effects Synapses drug effects Vasomotor System drug effects 1975 11 3 1975 11 3 0 1 1975 11 3 0 0 ppublish 627 10.1007/BF00510821 Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):18-45 4403611 Br J Pharmacol. 1971 Oct;43(2):359-69 4333804 Eur J Pharmacol. 1974 Nov;29(1):182-6 4435040 Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;258(1):48-58 4233006 Br J Pharmacol. 1975 Apr;53(4):513-6 1148494 Br J Pharmacol. 1973 Dec;49(4):706-8 4788042 Nature. 1975 Apr 3;254(5499):440-1 235100 Neuropharmacology. 1973 Apr;12(4):339-47 4145054 J Pharm Pharmacol. 1974 Aug;26(8):644-6 4155734 Naunyn Schmiedebergs Arch Pharmacol. 1973;280(1):79-91 4150044 J Pharmacol Exp Ther. 1965 Dec;150(3):370-4 5852871 Naturwissenschaften. 1971 Aug;58(8):420 5110406 J Pharmacol Exp Ther. 1970 Feb;171(2):256-64 5272380 J Pharm Pharmacol. 1972 Feb;24(2):161-4 4401975 J Physiol. 1974 Mar;237(3):505-19 4363457 Br J Pharmacol. 1973 Apr;47(4):850-2 4723805 Naunyn Schmiedebergs Arch Pharmacol. 1975;287 Suppl:R5 167306 Arch Int Pharmacodyn Ther. 1965 Jun;155(2):432-49 5841192 Br J Pharmacol. 1971 Sep;43(1):97-106 5136468 J Pharmacol Exp Ther. 1970 Mar;172(1):62-8 4313675 Arzneimittelforschung. 1969 Sep;19(9):1574-9 4310201 J Pharmacol Exp Ther. 1973 Dec;187(3):529-38 4770398 Eur J Pharmacol. 1973 Oct;24(1):101-4 4756162 Biochem Pharmacol. 1974 Jul 1;23(13):1793-800 4617579 Naunyn Schmiedebergs Arch Pharmacol. 1974;285(2):133-50 4155791 628 1976 03 01 2019 12 10 0028-1298 291 2 1975 Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol Investigation into some imidazoline compounds, with respect to peripheral alpha-adrenoceptor stimulation and depression of cardiovascular centers. 175-91 Peripheral alpha-adrenoceptor stimulation was tested by means of hypertensive effects of the drugs following i.v. injection in spinal rats. Naphazoline (NP), oxymetazoline (OM), St 91-2-(2,6-diethylphenylimino)-2-imidazolidine--and St 1697--2-(2-ethyl, 6-methylphenylimino)-2-imidazolidine--were 3 to 5 times more potent in tthis respect thatn clonidine (CLON) whereas St 363--2-(2,4-dichlorophenylimino)-2-imidazolidine--and xylazine (XY) exerted only approx. 1/20 the effect of that of clonidine. Sympathoinhibitory activity after i.v. injection was tested by the bradycardiac effect in vagotomized rats; St 1697, St 363 and XY were active, approx. 1/10-1/30 of CLON, whereas NP, OM and St 91 were inactive. However, following intracisternal (i.ci.) injection of cardiovascular depression, typical for clonidine: (1) in dogs with blocked beta-adrenoceptors, the drugs facilitated the vagally meditated cardiodepressor reflex in response to baroreceptor stimulation by i.v. injection of angiotensin; (2) in dogs treated with atropine and in (3) vagotomized cats (only NP, OM and St 363) a long lasting decrease in heart rate was observed. Some of the experiments were complicated by increases in blood pressure, due to the "leakage" of small amounts of the highly vasopressor active drugs, from the cisternal spaces into the peripheral circulation. The majority of results indicated, that the central cardiovascular depressor effects of the tested drugs depend on their alpha-adrenoreceptor stimulating potency and on their ability to penetrate from cerebrospinal fluid or from the blood to cardiovascular centers. Relationships between the ability for penetration and the lipoid affinity are discussed. Kobinger W W Pichler L L eng Comparative Study Journal Article Germany Naunyn Schmiedebergs Arch Pharmacol 0326264 0028-1298 0 Adrenergic alpha-Agonists 0 Imidazoles 0 Imidazolidines 0 Receptors, Adrenergic 2KFG9TP5V8 Xylazine 4751-48-8 ST 91 59772-30-4 St 1697 7C0697DR9I Atropine 8VLN5B44ZY Oxymetazoline H231GF11BV Naphazoline MN3L5RMN02 Clonidine IM Adrenergic alpha-Agonists Animals Atropine pharmacology Blood Pressure drug effects Brain drug effects Cats Clonidine pharmacology Dogs Female Heart Rate drug effects Imidazoles pharmacology Imidazolidines Male Naphazoline pharmacology Oxymetazoline pharmacology Pressoreceptors drug effects Rats Receptors, Adrenergic drug effects Reflex drug effects Vagotomy Vagus Nerve physiology Vasomotor System drug effects Xylazine pharmacology 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 628 10.1007/BF00500048 Eur J Pharmacol. 1973 Sep;23(3):311-6 4746747 Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;258(1):48-58 4233006 Arzneimittelforschung. 1967 Mar;17(3):292-300 5631221 Arch Int Pharmacodyn Ther. 1971 Apr;190(2):229-40 5575577 Arzneimittelforschung. 1975 May;25(5):786-93 1242325 Eur J Pharmacol. 1971 Jan;13(2):208-17 4395917 Naunyn Schmiedebergs Arch Pharmacol. 1975;286(4):371-7 238138 Eur J Pharmacol. 1971 Sep;16(1):120-2 4333655 Life Sci. 1974 Sep 1;15(5):887-99 4157274 Arch Int Pharmacodyn Ther. 1965 Jun;155(2):432-49 5841192 Eur J Pharmacol. 1971;14(1):98-100 4396661 Arzneimittelforschung. 1966 Aug;16(8):1038-50 6014885 Eur J Pharmacol. 1972 Aug;19(2):210-7 4403674 Eur J Pharmacol. 1972 Aug;19(2):203-9 4403673 Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;256(2):257-80 4233002 629 1976 03 01 2019 07 25 0028-1298 291 2 1975 Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol. 193-200 Gamma-hydroxybutyric acid (GHBA) in doses that increased the striatal dopamine (DA) content of rat brain failed to increase the affinity of striatal tyrosine hydroxylase (TH) for its pterdine cofactor or to change the sensitivity of the enzyme to the inhibition by DA. Haloperidol (1 mg/kg) decreased the apparent Km of striatal TH for the pteridine cofactor. However, when GHBA was injected before haloperidol it prevented the decrease in the apparent Kn of TH, in a dose related manner. In vitro GHBA (10(-4) M) neither changed the stimulation of the striatal adenylyl cyclase by DA nor its inhibition by haloperidol. These results suggest that in striatal dopaminergic terminals the Kn of TH for the pteridine cofactor is regulated by an molecuular mechanism which requires that the impulse flow in the DA neurons is unimpaired. Zivkovic B B Guidotti A A Costa E E eng Journal Article Germany Naunyn Schmiedebergs Arch Pharmacol 0326264 0028-1298 0 Hydroxybutyrates 0 Pteridines EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 2.7.- Protein Kinases EC 4.6.1.1 Adenylyl Cyclases J6292F8L3D Haloperidol VTD58H1Z2X Dopamine IM Adenylyl Cyclases metabolism Animals Corpus Striatum drug effects enzymology Dopamine metabolism pharmacology Haloperidol pharmacology Hydroxybutyrates pharmacology Kinetics Male Protein Kinases metabolism Pteridines metabolism Rats Sensory Receptor Cells drug effects Synaptic Transmission drug effects Tyrosine 3-Monooxygenase metabolism 1975 11 21 1975 11 21 0 1 1975 11 21 0 0 ppublish 629 10.1007/BF00500049 Brain Res. 1974 Oct 25;79(3):505-9 4153770 J Pharmacol Exp Ther. 1975 Jul;194(1):37-46 239221 Anal Biochem. 1971 Oct;43(2):588-600 4400965 J Pharmacol Exp Ther. 1975 Aug;194(2):311-8 239224 Proc Natl Acad Sci U S A. 1972 Aug;69(8):2145-9 4403305 Experientia. 1972 Mar 15;28(3):300-2 4554667 Naunyn Schmiedebergs Arch Pharmacol. 1973;279(1):89-92 4356204 J Biol Chem. 1972 May 25;247(10):3114-22 4402144 Brain Res. 1975 Jul 18;92(3):516-21 240486 J Biol Chem. 1975 Mar 10;250(5):1946-8 234470 J Pharmacol Exp Ther. 1973 Jun;185(3):560-71 4576427 Naunyn Schmiedebergs Arch Pharmacol. 1973;278(4):347-61 4269968 Nat New Biol. 1973 Sep 26;245(143):123-5 4518113 J Pharmacol Exp Ther. 1971 Mar;176(3):701-10 5111456 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Br J Pharmacol. 1973 Feb;47(2):408-14 4146575 J Pharm Pharmacol. 1975 May;27(5):359-60 239138 J Neurochem. 1968 May;15(5):377-81 5300743 Naunyn Schmiedebergs Arch Pharmacol. 1972;272(1):1-15 4257469 630 1976 02 13 2020 02 25 0028-2685 22 4 1975 Neoplasma Neoplasma Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients. 435-9 Inhibiting activity of blood serum was determined from the decrease of N-acetyl-hexosamine end groups of hyaluronic acid products released by testicular hyaluronidase. Maximum inhibition was observed within the region of pH from 6.5 to 6.8. Correlation between the serum concentration and its inhibiting effect on hyaluronidase was found within the range of the final dilution of serum (in the reaction mixture) from 9 to 45 X. Blood sera of cancer patients showed statistically significant increase of hyaluronidase inhibitor as compared with that of health people. Kolárová M M eng Journal Article Slovakia Neoplasma 0377266 0028-2685 EC 3.2.1.35 Hyaluronoglucosaminidase IM Female Humans Hyaluronoglucosaminidase antagonists & inhibitors blood Hydrogen-Ion Concentration Leukemia, Lymphoid enzymology Male Neoplasms enzymology Pregnancy Prostatic Neoplasms enzymology Testicular Neoplasms enzymology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 630 Crit Care. 2006;10(5):166 17020597 Bioethics. 2012 Jan;26(1):32-48 20459428 Lancet. 2011 Jan 22;377(9762):271 21256368 Curr Opin Organ Transplant. 2013 Apr;18(2):140-7 23334256 631 1976 02 27 2020 02 25 1660-8151 15 6 1975 Nephron Nephron Influence of peritoneal dialysis on factors affecting oxygen transport. 438-43 To determine the effect of changing concentrations of uremic metabolites on factors affecting oxygen transport, without the effects of extracorporeal blood pumping, we studied five patients before, during and after peritoneal dialysis. Significant decreases in serum urea, creatinine and phosphate and increase in serum bicarbonate were not associated with changes in P50, a reflection of hemoglobin-oxygen affinity. High erythrocyte 2,3-DPG concentrations decreased only slightly. Arterial pO2 increased slightly as negative fluid balance was achieved. The slight changes in oxygen transport parameters with dialysis suggest an interplay of compensatory factors and do not warrant modifying dialysis to limit the correction on acidosis or hyperphosphatemia. Effects on hemoglobin and pO2 resulting from fluid loss can be the dominant influence of peritoneal dialysis on tissue oxygenation. Hirszel P P Maher J F JF Tempel G E GE Mengel C E CE eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Switzerland Nephron 0331777 1660-8151 0 Diphosphoglyceric Acids AYI8EX34EU Creatinine S88TT14065 Oxygen IM Creatinine blood Diphosphoglyceric Acids blood Erythrocytes metabolism Humans Hydrogen-Ion Concentration Kidney Failure, Chronic therapy Oxygen blood Peritoneal Dialysis 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 631 10.1159/000180527 Clin Med (Lond). 2011 Dec;11(6):524-8 22268301 632 1976 02 13 2020 02 25 1660-8151 16 1 1976 Nephron Nephron Some effects of ammonium salts on renal histology and function in the dog. 42-9 NH4Cl was infused into the left renal artery of anesthetized dogs at 50-125 mum/kg/min for up to 110 min. Renal blood flow declined early then increased to supra-control levels during infusion. Kidneys perfused at 125 mum/kg/min for 90 min showed patchy to confluent mixtures of cortical necrosis and tubular necrosis. Experimental kidneys invariably showed lower urine osmolality than contralateral controls 48 h after perfusion. Kidneys with necrosis showed depressed creatinine clearance as well. Renal artery infusion of NH4 acetate or intravenous infusion of NaHCO3 during arterial infusion of NH4Cl prevented significant acidosis and caused minimal histological changes, but depression of urine osmolality was not prevented. It is concluded that renal ammonium concentrations up to 40 mum/liter for 90 min does not cause tubular necrosis but does impair urine concentration. Severe tissue damage followed renal exposure to high ammonium concentrations in the presence of metabolic or renal acidosis. Orvell B D BD Wesson L G LG eng Journal Article Research Support, U.S. Gov't, P.H.S. Switzerland Nephron 0331777 1660-8151 0 Bicarbonates 0 Electrolytes 01Q9PC255D Ammonium Chloride 7664-41-7 Ammonia 9NEZ333N27 Sodium AYI8EX34EU Creatinine IM Ammonia blood Ammonium Chloride pharmacology Animals Bicarbonates blood Creatinine urine Dogs Electrolytes blood Female Hydrogen-Ion Concentration Kidney blood supply drug effects pathology Kidney Concentrating Ability Kidney Diseases chemically induced pathology Necrosis pathology Osmolar Concentration Regional Blood Flow Sodium urine Thrombosis chemically induced pathology 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 632 10.1159/000180581 Clin Microbiol Infect. 2004 Aug;10(8):749-52 15301678 J Bras Pneumol. 2010 Jul-Aug;36(4):475-84 20835595 633 1976 02 13 2020 02 25 1660-8151 16 1 1976 Nephron Nephron Papillary necrosis associated with calyceal arteritis. 57-63 The renal papilla has a double blood supply - from both the vasa recta and the calyceal arteries. The importance of the latter supply is not established. A case of polyarteritis associated with papillary necrosis is reported, in which the calyceal vessels, supplying the area, show acute necrotizing arteritis and occlusion. The pathophysiological and clinical implications are discussed. Heaton J M JM Bourke E E eng Case Reports Journal Article Switzerland Nephron 0331777 1660-8151 WK2XYI10QM Ibuprofen IM Drug Hypersensitivity complications etiology Female Humans Ibuprofen adverse effects Kidney pathology Kidney Calices blood supply Kidney Papillary Necrosis complications pathology Kidney Pelvis Middle Aged Polyarteritis Nodosa chemically induced complications pathology 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 633 10.1159/000180583 Lancet Infect Dis. 2006 May;6(5):273-9 16631547 634 1976 02 09 2018 02 15 1660-8151 16 2 1976 Nephron Nephron Fasting uric acid and phosphate in urine and plasma of renal calcium-stone formers. 116-25 Clearance experiments in calcium-stone patients (n = 60) and controls (n = 60) demonstrated significantly higher urinary uric acid (UA) in younger (less 40 years) stone patients than controls (median: 480 vs. 351 mug/min) but not in older (greater than 40 years) patients. Serum UA and urinary oxypurines were comparable in health and stone disease. Conversely urinary phosphate was significantly lower in younger patients than matched controls (males: 224 vs. 304 mug) and presumably is responsible for the more alkaline pH. It is suggested that calcium-stone formation in humans is represented by two different populations. Schwille P P Samberger N N Wach B B eng Journal Article Switzerland Nephron 0331777 1660-8151 0 Phosphates 268B43MJ25 Uric Acid SY7Q814VUP Calcium IM Adult Calcium Fasting Female Humans Hydrogen-Ion Concentration Kidney Calculi metabolism urine Male Middle Aged Phosphates metabolism Uric Acid metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 634 10.1159/000180592 635 1976 03 01 2018 02 15 1660-8151 16 3 1976 Nephron Nephron Effects of varying dialysate calcium concentrations on the plasma calcium fractions in patients on dialysis. 181-7 The plasma-ionized calcium levels decreased during haemodialysis when a dialysate calcium concentration of 5 mg/100 ml was used. When dialysis was performed with a bath calcium concentration of 7.5 mg/100 ml, there was a significant increase in the plasm-ionized calcium levels in the post-dialysis period. These results are discussed in relation of the optimal dialysate calcium concentrations and development of dialytic bone disease. Raman A A Chong Y K YK Sreenevasan G A GA eng Journal Article Switzerland Nephron 0331777 1660-8151 0 Blood Proteins 0 Ions 0 Phosphates 0 Serum Albumin 0 Solutions SY7Q814VUP Calcium IM Blood Proteins analysis Calcium blood pharmacology Dose-Response Relationship, Drug Female Humans Hydrogen-Ion Concentration Ions Male Phosphates blood Protein Binding Renal Dialysis Serum Albumin analysis Solutions 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 635 10.1159/000180600 637 1976 02 26 2019 07 26 0028-3908 14 10 1975 Oct Neuropharmacology Neuropharmacology A study of the central effects of sympathomimetic drugs: EEG and behavioural investigations on clonidine and naphazoline. 707-14 Florio V V Bianchi L L Lonogo V G VG eng Journal Article England Neuropharmacology 0236217 0028-3908 0 Adrenergic alpha-Antagonists 0 Imidazoles 0 Methyltyrosines 8B1QWR724A Reserpine CK833KGX7E Amphetamine H231GF11BV Naphazoline MN3L5RMN02 Clonidine IM Adrenergic alpha-Antagonists pharmacology Amphetamine pharmacology Animals Behavior, Animal drug effects Cats Clonidine pharmacology Cortical Synchronization Electrodes, Implanted Electroencephalography Imidazoles pharmacology Male Methyltyrosines pharmacology Naphazoline pharmacology Rabbits Rats Reserpine pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 637 10.1016/0028-3908(75)90095-7 638 1976 02 26 2019 07 26 0028-3908 14 10 1975 Oct Neuropharmacology Neuropharmacology Influence of desmethylimipramine on some neurochemical alterations during experimental hypothyroidism. 747-53 Rastogi R B RB Singhal R L RL Hrdina P D PD eng Journal Article England Neuropharmacology 0236217 0028-3908 333DO1RDJY Serotonin 554Z48XN5E Methimazole EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.14.16.4 Tryptophan Hydroxylase N9YNS0M02X Acetylcholine TG537D343B Desipramine VTD58H1Z2X Dopamine X4W3ENH1CV Norepinephrine IM Acetylcholine metabolism Animals Brain enzymology Brain Chemistry drug effects Desipramine pharmacology Dopamine metabolism Female Hypothyroidism chemically induced metabolism Methimazole pharmacology Norepinephrine metabolism Pregnancy Rats Serotonin metabolism Tryptophan Hydroxylase metabolism Tyrosine 3-Monooxygenase metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 638 10.1016/0028-3908(75)90100-8 639 1976 02 26 2019 07 26 0028-3908 14 10 1975 Oct Neuropharmacology Neuropharmacology Further studies on the ganglionic and smooth muscle stimulating effect of potassium on the peristaltic reflex of the guinea-pig isolated ileum. 769-77 Beleslin D B DB Samardzic R R eng Journal Article England Neuropharmacology 0236217 0028-3908 0 Ganglionic Blockers 0 Ganglionic Stimulants 333DO1RDJY Serotonin 7C0697DR9I Atropine I38ZP9992A Magnesium RWP5GA015D Potassium SY7Q814VUP Calcium X4W3ENH1CV Norepinephrine YKH834O4BH Epinephrine IM Animals Atropine pharmacology Calcium pharmacology Epinephrine pharmacology Ganglionic Blockers pharmacology Ganglionic Stimulants pharmacology Gastrointestinal Motility drug effects Guinea Pigs Ileum drug effects In Vitro Techniques Magnesium pharmacology Muscle, Smooth drug effects Norepinephrine pharmacology Peristalsis drug effects Potassium pharmacology Pressure Reflex drug effects Serotonin pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 639 10.1016/0028-3908(75)90103-3 636 1976 03 01 2015 02 16 0028-3843 9 6 1975 Nov-Dec Neurologia i neurochirurgia polska Neurol Neurochir Pol [Pharmacological treatment of arterial hypertension]. 745-51 Sznajderman M M pol Journal Article Leczenie farmakologiczne nadcisnienia tetniczego Poland Neurol Neurochir Pol 0101265 0028-3843 0 Adrenergic beta-Antagonists 0 Antihypertensive Agents 0 Diuretics 0 Vasodilator Agents 8B1QWR724A Reserpine RWP5GA015D Potassium ZTI6C33Q2Q Guanethidine IM Adrenergic beta-Antagonists therapeutic use Antihypertensive Agents therapeutic use Blood Pressure Diuretics therapeutic use Drug Interactions Drug Therapy, Combination Guanethidine therapeutic use Humans Hypertension drug therapy Potassium blood Reserpine therapeutic use Vasodilator Agents therapeutic use 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 636 640 1976 02 21 2017 12 06 0026-4075 140 12 1975 Dec Military medicine Mil Med Lymphocyte physiology and function. 846-52 Caldwell C W CW Burningham R A RA eng Journal Article Review England Mil Med 2984771R 0026-4075 0 Immunoglobulins 0 Lymphotoxin-alpha 0 Macrophage Migration-Inhibitory Factors 0 Transfer Factor IM Animals Antibody Formation Autoimmune Diseases immunology Graft vs Host Reaction Humans Immunity Immunity, Cellular Immunoglobulins biosynthesis Leukemia immunology Lymphatic Diseases immunology Lymphocytes metabolism physiology Lymphoma immunology Lymphotoxin-alpha biosynthesis Macrophage Migration-Inhibitory Factors biosynthesis Mice Neoplasms immunology Transfer Factor biosynthesis 16 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 640 641 1976 02 09 2019 08 18 0360-4039 6 1 1976 Jan Nursing Nursing If you like variety, become an orthopedic surgeon's assistant. 92, 94, 96 Donahoo C A CA eng Journal Article United States Nursing 7600137 0360-4039 N Orthopedics Physician Assistants Specialties, Nursing 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 641 10.1097/00152193-197601000-00022 642 1976 03 01 2018 12 03 0029-7917 27 11 1975 Nov Occupational health; a journal for occupational health nurses Occup Health (Lond) 'War games' against cancer. 484 Brooks P P eng Congress England Occup Health (Lond) 0021263 0029-7917 N Congresses as Topic Humans Neoplasms chemically induced Occupational Diseases chemically induced 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 642 643 1976 02 27 2017 03 22 0030-9338 10 2 1975 Padiatrie und Padologie Padiatr Padol [Borderline between antiepileptic and psychopharmacological drugs (author's transl)]. 131-9 From the chemical and pharmalogical point of view it is impossible to separate strictly between antiepileptic and psychopharmalogical drugs. Inspite of that and several clinical overlappings it is possible and helpful finding differences between the two groups of drugs. Basing on the indication we try to demonstrate the use of these drug-groups. 1. Antiepileptic drugs in behaviour disorders. A. In spite of various publications we recommend carefullness and restriction. B. Only in case of behaviour disorders due to epileptic origin antiepileptic therapy is indicated. 2. Psychopharmalogical drugs in epilepsies A. The frequency of seizures may be reduced B. Psychical disorders connected with seizures may be influnced. Groh C C Rosenmayr F W FW ger English Abstract Journal Article Antiepileptika-Psychopharmaka Uberschneidungen und Grenzen Austria Padiatr Padol 0022370 0030-9338 0 Anticonvulsants 0 Antipsychotic Agents 0 Barbiturates 0 Phenothiazines 0 Thioxanthenes 0 Tranquilizing Agents 13AFD7670Q Primidone 1806D8D52K Amitriptyline 33CM23913M Carbamazepine 5SEH9X1D1D Ethosuximide OGG85SX4E4 Imipramine T2Q0RYM725 Nialamide IM Amitriptyline therapeutic use Anticonvulsants therapeutic use Antipsychotic Agents therapeutic use Barbiturates therapeutic use Carbamazepine therapeutic use Child Child Behavior Disorders drug therapy Drug Therapy, Combination Ethosuximide therapeutic use Humans Imipramine therapeutic use Nialamide therapeutic use Phenothiazines Primidone therapeutic use Thioxanthenes therapeutic use Tranquilizing Agents therapeutic use 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 643 644 1976 02 27 2009 11 11 0030-9338 10 2 1975 Padiatrie und Padologie Padiatr Padol [Intoxication due to analeptics in 8 newborn infants]. 209-12 Müller W D WD Haidvogl M M Rosegger H H Fritsch G G ger Journal Article Intoxikation mit Analeptica bei 8 Neugeborenen Austria Padiatr Padol 0022370 0030-9338 0 Central Nervous System Stimulants IM Asphyxia Neonatorum drug therapy Central Nervous System Stimulants poisoning therapeutic use Humans Hypothermia chemically induced Infant, Newborn Infant, Newborn, Diseases chemically induced Resuscitation 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 644 645 1976 03 01 2019 08 18 0031-1820 71 3 1975 Dec Parasitology Parasitology Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei. 393-417 Soluble glycoproteins have been purified from a series of clones of Trypanosoma brucei 427. Each clone yielded a characteristic predominant glycoprotein which induced clone-specific immunity to trypanosome infection in mice. These glycoproteins were shown by specific labelling and enzyme digestion of cells to be the major components of the trypanosome surface coat. Each glycoprotein consisted of a single polypeptide chain having an apparent molecular weight of 65 000 (as measured by SDS-polyacrylamide gel electrophoresis) and containing around 600 amino acid and 20 monosaccharide residues. Preliminary structural studies indicated large changes in amino acid sequence dispersed over a considerable length of the polypeptide chain. Proteolytic activity was demonstrated in semi-purified trypanosome extracts, providing one reason for the heterogeneity sometimes observed in surface glycoprotein antigen preparations. Cross G A GA eng Journal Article England Parasitology 0401121 0031-1820 0 Antigens 0 Glycoproteins 0 Phosphates 0 Sulfones 0 Uracil Nucleotides 4289-98-9 N-Formylmethionine EC 3.4.21.4 Trypsin EC 3.4.24.- Pronase IM Animals Antigens isolation & purification Clone Cells Glycoproteins immunology isolation & purification Hydrogen-Ion Concentration Isotope Labeling Methods Mice Molecular Weight N-Formylmethionine Phosphates Pronase pharmacology Rats Sulfones Trypanosoma brucei brucei drug effects immunology ultrastructure Trypanosomiasis parasitology Trypsin pharmacology Uracil Nucleotides 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 645 10.1017/s003118200004717x 646 1976 02 13 2019 09 02 0031-3025 7 3 1975 Jul Pathology Pathology The determination of gamma-glutamyl transpeptidase by reaction rate assay at 37 degrees C. 237-43 The determination of gamma-glutamyl transpeptidase by a reaction rate assay using optimal reaction conditions at 37 degrees is described. Specific conditions and instrument settings are described for the LKB Reaction Rate Analyser but the actual assay conditions are applicable to any similar reaction rate system. The precision of the method has been evaluated and a reference range for normal male (less than 45 U/l) and female (less than 30 U/l) subjects determined. Farrance I I Krauja V W VW Dennis P M PM eng Journal Article England Pathology 0175411 0031-3025 0 Anilides 0 Buffers 0 Propylene Glycols 023C2WHX2V Tromethamine 10525P22U0 Glycylglycine 9005-49-6 Heparin EC 2.3.2.2 gamma-Glutamyltransferase IM Anilides Buffers Female Glycylglycine Hemolysis Heparin Humans Hydrogen-Ion Concentration Kinetics Male Propylene Glycols Sex Factors Spectrophotometry methods Temperature Tromethamine gamma-Glutamyltransferase blood 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 646 10.3109/00313027509094413 648 1976 03 01 2019 09 11 0031-3998 9 9 1975 Sep Pediatric research Pediatr Res The influence of cortisol on the enzymes of fatty acid synthesis in developing mammalian lung and brain. 752-5 Administration of cortisol to fetal rabbits resulted in a 42% inhibition of pulmonary de novo fatty acid synthesis from acetyl coenzyme A (CoA) (P = less than 0.025). This was associated with inhibition of acetyl-CoA carboxylase (EC. 6.4.1.2.) activity (P = less than 0.01) and a tendency towards decreased activity of fatty acid synthetase. There was no effect on pulmonary microsomal fatty acid elongation activity. Light and electron microscopic examination of the apex of the right lung of control and cortisol-treated animals revealed changes consistent with accelerated lung maturation in the treated animals. The in vitro activities of acetyl-CoA carboxylase and fatty acid synthetase were similar in rabbit lung and thus acetyl-CoA carboxylase activity does not appear to be rate limiting for de novo fatty acid synthesis in lung. No significant change in the activity of enzymes associated with de novo fatty acid synthesis of microsomal fatty acid elongation was found in fetal brain after cortisol exposure. However, in a parallel study on fatty acid synthesis in fetal liver, cortisol administration resulted in a 30% increase in fatty acid synthetase activity (P less than 0.025). The finding of cortisol-induced inhibition of de novo fatty acid synthesis in fetal rabbit lung may be related to the known inhibitory effect of cortisol on lung growth in the fetus. Gross I I Rooney S A SA Warshaw J B JB eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Pediatr Res 0100714 0031-3998 0 Fatty Acids 72-89-9 Acetyl Coenzyme A EC 2.3.1.85 Fatty Acid Synthases EC 6.- Ligases EC 6.4.1.2 Acetyl-CoA Carboxylase SAA04E81UX Coenzyme A WI4X0X7BPJ Hydrocortisone IM Acetyl Coenzyme A antagonists & inhibitors Acetyl-CoA Carboxylase antagonists & inhibitors Animals Body Weight drug effects Brain growth & development Coenzyme A analogs & derivatives Fatty Acid Synthases antagonists & inhibitors Fatty Acids biosynthesis Fetus analysis Growth drug effects Hydrocortisone pharmacology Ligases antagonists & inhibitors Liver growth & development Lung growth & development ultrastructure Microsomes analysis Microsomes, Liver analysis Rabbits 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 648 10.1203/00006450-197509000-00014 649 1976 02 21 2006 11 15 0031-3939 50 12 1975 Dec Pediatria polska Pediatr Pol [Tooth and alveolar process trauma in children]. 1469-73 Kurek J J Parczynska D D pol English Abstract Journal Article Urazy zebów i wyrostka zebodolowego u dzieci Poland Pediatr Pol 2985039R 0031-3939 IM Adolescent Age Factors Alveolar Process injuries Child Child, Preschool Female Humans Male Orthodontics, Corrective Tooth Injuries Tooth Replantation Wounds and Injuries therapy 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 649 650 1976 02 27 2019 09 11 0031-5982 18 3 1975 Spring Perspectives in biology and medicine Perspect Biol Med The golden era of immunology at the Rockefeller Institute. 419-26 Goebel W F WF eng Biography Historical Article Journal Article United States Perspect Biol Med 0401132 0031-5982 0 Blood Group Antigens 0 Polysaccharides IM Q Academies and Institutes history Allergy and Immunology history Blood Group Antigens History, 20th Century New York City Pneumonia history immunology Polysaccharides immunology Streptococcus pneumoniae immunology Landsteiner K K Avery O T OT 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 650 10.1353/pbm.1975.0034 647 1976 02 27 2006 10 26 0031-4048 6 1975 Nov-Dec Pediatriia akusherstvo i ginekologiia Pediatr Akus Ginekol [Activity of some digestive enzymes in the urine and feces in infants with acute gastro-intestinal diseases]. 10-11 Skvarko S I SI Bomk H S HS Rudova A I AI ukr Journal Article Aktyvnist' deiakykh travnykh fermentiv sechi i kalu u ditei rann'oho viku, khvorykh na hostri zhlunkovo-kyshkovi zakhvoriuvannia Ukraine Pediatr Akus Ginekol 2985041R 0031-4048 EC 3.1.1.3 Lipase EC 3.2.1.- Amylases IM Acute Disease Amylases metabolism urine Feces enzymology Gastrointestinal Diseases enzymology Humans Hydrogen-Ion Concentration Infant Infant, Newborn Lipase metabolism urine 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 647 651 1976 03 01 2019 07 26 0031-6768 356 1 1975 Apr 09 Pflugers Archiv : European journal of physiology Pflugers Arch The relation between myosin adenosinetriphosphatase activity and inactivation of myosin under alkaline conditions of heart muscles in mammals of different size. 87-92 ATPase activity of myosin in the heart muscle of the mouse, rat, guinea-pig, rabbit and pig was studied at neutral pH and under mild alkaline conditions. At neutral pH the ATPase activity of myosin is inversely related to body size of the animal species. The decrease of ATPase activity of myosin after alkaline preincubation depends on the degree of ATPase activity of intact myosin, i.e. myosin from the heart of the mouse exhibits high ATPase activity ae same relationship was found, when comparing myosin of new-born and adult heart muscle. It is concluded that the rate of alkaline inactivation of heart myosin is directly related to the degree of ATPase activity of intact myosin in all animals. Syrový I I eng Journal Article Germany Pflugers Arch 0154720 0031-6768 EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins SY7Q814VUP Calcium IM Adenosine Triphosphatases metabolism Animals Animals, Newborn Calcium pharmacology Forelimb Guinea Pigs Hydrogen-Ion Concentration Mice Muscles metabolism Myocardium metabolism Myosins metabolism Rabbits Rats Swine 1975 4 9 1975 4 9 0 1 1975 4 9 0 0 ppublish 651 10.1007/BF00583523 Physiol Rev. 1972 Jan;52(1):129-97 4256989 Physiol Bohemoslov. 1976;25(4):295-300 135984 Br Med Bull. 1956 Sep;12(3):165-6 13364293 Arch Biochem Biophys. 1965 Jan;109 :185-91 14281944 J Gen Physiol. 1967 Jul;50(6):Suppl:197-218 4227924 Physiol Bohemoslov. 1975;24(4):325-34 125884 J Biol Chem. 1967 Dec 10;242(23):5623-9 12325381 J Biol Chem. 1966 Dec 25;241(24):5772-6 4224728 Biochem J. 1942 Feb;36(1-2):121-39 16747475 J Biol Chem. 1970 Jan 25;245(2):219-24 4243949 Circ Res. 1966 Sep;19(3):611-21 4224334 652 1976 03 01 2019 07 26 0031-6768 358 2 1975 Jul 21 Pflugers Archiv : European journal of physiology Pflugers Arch Carbon dioxide response curves during hypothermia. 125-33 The responsiveness of the medullary chemoreceptors, measured by the ventilatory response to hypercapnia given in an hyperoxic gas mixture in intact anesthetized dogs has been evaluated during normothermia and at two levels of hypothermia. The response was studied in: 1) 20 dogs during normothermia, 2) 10 of these dogs at a blood temperature of 32-33 degrees C, and 3) in the other 10 dogs during deeper hypothermia (28-29 degrees C). The ventilatory response to CO2 decreased while blood temperature was lowered until the response became absent during deep hypothermia. For normothermia and both levels of hypothermia a similar oxygen drive of ventilation was found which was equivalent to approximately one fourth of the spontaneous ventilation. It is suggested, that in the deeply hypothermic animal the normal respiratory drive is apparently of peripheral (arterial) chemoreceptor origin and when this drive is nullified or significantly decreased, gentle shivering could be responsible for stimulating the respiratory center. Ruiz A V AV eng Journal Article Germany Pflugers Arch 0154720 0031-6768 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Animals Blood Blood Pressure Carbon Dioxide blood pharmacology Dogs Heart Rate Hydrogen-Ion Concentration Hypercapnia physiopathology Hypothermia physiopathology Oxygen blood pharmacology Respiration drug effects Respiratory Function Tests 1975 7 21 1975 7 21 0 1 1975 7 21 0 0 ppublish 652 10.1007/BF00583923 Pflugers Arch. 1973;338(4):335-46 4734846 Arch Int Pharmacodyn Ther. 1965 Apr;154(2):421-6 5838347 Pflugers Arch. 1975 Dec 19;361(1):75-8 1709 J Physiol. 1955 Feb 28;127(2):380-9 14354679 J Physiol. 1964 Aug;172:332-41 14199365 J Appl Physiol. 1966 Mar;21(2):447-53 5934447 Pflugers Arch. 1969;308(4):333-56 5813979 J Physiol. 1964 Dec;175:242-53 14241166 Arch Int Pharmacodyn Ther. 1965 Oct;157(2):253-71 5868732 J Physiol (Paris). 1957 Jan-Mar;49(1):115-20 13449758 Pflugers Arch Gesamte Physiol Menschen Tiere. 1958;266(4):373-93 13600984 Pflugers Arch Gesamte Physiol Menschen Tiere. 1958;266(4):341-56 13600982 J Appl Physiol. 1969 Aug;27(2):186-90 5796305 Pflugers Arch Gesamte Physiol Menschen Tiere. 1955;261(3):211-8 13266504 Pflugers Arch Gesamte Physiol Menschen Tiere. 1958;266(4):394-407 13600985 J Biol Chem. 1947 Jan;167(1):235-50 20281644 Respir Physiol. 1969 Aug;7(2):188-202 5823832 J Appl Physiol. 1966 May;21(3):1108-16 5912737 Anesth Analg. 1962 Jul-Aug;41:435-41 14455931 Surgery. 1973 Apr;73(4):561-71 4690103 Respir Physiol. 1973 Apr;17 (3):302-14 4702981 Respir Physiol. 1972 Apr;14(3):296-306 5024175 Arch Int Physiol Biochim. 1961 Mar;69:161-76 13776055 J Appl Physiol. 1960 May;15:397-401 14441163 Respir Physiol. 1972 Jul;15(3):277-301 5050469 Annu Rev Physiol. 1957;19:83-120 13412052 653 1976 02 21 2018 12 03 0301-1518 4 33 1975 Oct 11 La Nouvelle presse medicale Nouv Presse Med [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors]. 2377-81 Metiamide an histamine H2-receptors antagonist has been used to treat a case of Zollinger-Ellison syndrome characterized by a long standing diarrhea, an important gastric hypersecretion and a moderatly elevated plasma gastrin but without digestive ulceration. At the dose of 600 mg per day, Metiamide induced a complete suppression of acid secretion, an effect which lasted for 15 days after stopping the drug. Accordingly and since the only finding at time of laparotomy was a small lymph node enlarged with endocrine metastatic tissue, the stomach was left intact and Metiamide pursued. During the first 4 months of chronic administration of Metiamide, acid secretion was maintained at levels below 25 p.cent of initial values. Ulteriorly however, although dosages of Metiamide were increased, acid hypersecretion resumed and a duodenal ulcer developed. Total gastrectomy was then performed 11 months after the beginning of Metiamide. In spite of the failure of Metiamide treatment, the long term follow up of this case of Zollinger-Ellison Syndrome, allowed us to get theoretical and practical informations. Bonfils S S Bernier J J JJ Mignon M M Hautefeuille P P Corbic M M Marteau J J fre Case Reports Journal Article Syndrome de Zollinger-Ellison traité médicalement par un inhibiteur des récepteurs H2 à l'histamine. France Nouv Presse Med 0312552 0301-1518 0 Delayed-Action Preparations 0 Gastrins 0 Histamine H1 Antagonists 0 Receptors, Drug 1393-25-5 Secretin 3K7670861M Metiamide GYV9AM2QAG Thiourea IM Adult Delayed-Action Preparations Duodenal Ulcer surgery Gastrectomy Gastric Juice metabolism Gastric Mucosa drug effects Gastrins blood Histamine H1 Antagonists therapeutic use Humans Male Metiamide administration & dosage therapeutic use Middle Aged Receptors, Drug drug effects Secretin pharmacology Secretory Rate drug effects Thiourea analogs & derivatives Zollinger-Ellison Syndrome drug therapy 1975 10 11 1975 10 11 0 1 1975 10 11 0 0 ppublish 653 654 1976 02 21 2013 11 21 0301-1518 4 34 1975 Oct 15 La Nouvelle presse medicale Nouv Presse Med [Relationship between serum antibiotic concentration and inhibiting potency of the serum. Application to ampicillin and amoxicillin]. 2441-4 Acar J F JF Guibert J J fre Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Relations entre concentration sérique d'antibiotique et pouvoir inhibiteur du sérum Application à l'ampicilline et à l'amoxicilline France Nouv Presse Med 0312552 0301-1518 7C782967RD Ampicillin 804826J2HU Amoxicillin IM Amoxicillin administration & dosage blood pharmacology Ampicillin blood pharmacology Dose-Response Relationship, Drug Enterococcus faecalis drug effects Humans Salmonella typhimurium drug effects Streptococcus pneumoniae drug effects Streptococcus pyogenes drug effects 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 654 655 1976 03 01 2011 08 16 0301-1518 4 38 1975 Nov 08 La Nouvelle presse medicale Nouv Presse Med Letter: Gamma glutamyltranspeptidase (gamma GT) after myocardial infarction. 2733-4 Levy G G Zailah J J fre Journal Article Gamma-glutamyltranspeptidase (gamma GT) après infarctus du myocarde France Nouv Presse Med 0312552 0301-1518 EC 2.3.2.2 gamma-Glutamyltransferase IM Humans Myocardial Infarction diagnosis enzymology Time Factors gamma-Glutamyltransferase blood 1975 11 8 1975 11 8 0 1 1975 11 8 0 0 ppublish 655 656 1976 02 13 2008 11 21 0301-1518 4 39 1975 Nov 15 La Nouvelle presse medicale Nouv Presse Med [Exercise test in the asthmatic patient. Study of 75 patients]. 2789-92 Frequency of exercise-induced asthma has been studied in 75 unselected asthmatic patients (adults and children) by measuring the forced expiratory volume at one second (FEV1) and the vital capacity (VC) before and after a treadmill exercise, continued until heart rate was at least equal to 80 p.cent-85 p.cent of maximum heart rate. In 19 subjects (25 p.cent), a more than 20 p.cent decrease from control value of FEV1 was recorded ten minutes after exercise ended. Exercise-induced bronchial obstruction was relieved by a beta adrenergic bronchodilator aerosol inhalation. In the group of 19 subjects having exercise-induced asthma, a significant positive correlation was found between pre-exercise FEV1 values and post-exercise FEV1 decreases. In the whole group of 75 subjects exercise-induced asthma was related to the severity of asthma and not to other clinical or physical characteristics of the subjects. From the data of other authors it appears that frequency of exercise-induced asthma is variable. The reasons of those differences are discussed. Orehek J J Saraga E E Gayrard P P Grimaud C C Charpin J J fre English Abstract Journal Article Epreuve d'effort chez l'asthmatique. Etude de 75 patients France Nouv Presse Med 0312552 0301-1518 0 Adrenergic beta-Agonists 0 Bronchodilator Agents IM Injury. 2006 Jan;37(1):85-6; author reply 86-7 16384557 Adolescent Adrenergic beta-Agonists therapeutic use Adult Airway Obstruction drug therapy etiology Asthma physiopathology Bronchodilator Agents therapeutic use Child Female Forced Expiratory Volume Humans Male Maximal Expiratory Flow Rate Middle Aged Physical Exertion Vital Capacity 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 656 657 1976 02 13 2013 11 21 0301-1518 4 39 1975 Nov 15 La Nouvelle presse medicale Nouv Presse Med [Anaphylactic accidents due to glaphenine. 5 cases]. 2797-8 The authors report 5 cases of shock type anaphylactic reactions after the ingestion of glafenine. Up to the present, acute tubulo-interstitial nephritis had chiefly been reported. The existence of allergy to this medication remains to be proved by the wider application of allergological studies. Barral C C Faivre M M fre Case Reports English Abstract Journal Article Accidents anaphylactiques imputés à la glafénine. Cinq cas France Nouv Presse Med 0312552 0301-1518 0 ortho-Aminobenzoates 46HL4I09AH Glafenine IM Adult Anaphylaxis chemically induced Chemical Phenomena Chemistry Drug Hypersensitivity diagnosis Edema chemically induced Female Glafenine adverse effects therapeutic use Humans Male Pain drug therapy Time Factors ortho-Aminobenzoates adverse effects 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 657 658 1976 02 13 2013 11 21 0301-1518 4 39 1975 Nov 15 La Nouvelle presse medicale Nouv Presse Med [Letter: An undesirable effect of beta-stimulating agents? Outbreak of an acute psychiatric symptomatology in mental patients]. 2808-9 Feline A A Quetin A M AM fre Case Reports Journal Article Effet indésirable de dérivés bêta-stimulants? Emergence d'une symptomatologie psychiatrique alguë chez des malades mentaux France Nouv Presse Med 0312552 0301-1518 0 Adrenergic beta-Agonists 0 Phenethylamines QF8SVZ843E Albuterol R15UI3245N Isoxsuprine IM Acute Disease Adrenergic beta-Agonists adverse effects therapeutic use Adult Albuterol adverse effects Depression chemically induced Female Hallucinations chemically induced Humans Isoxsuprine adverse effects Mental Disorders complications Obstetric Labor, Premature drug therapy Phenethylamines adverse effects Pregnancy Pregnancy Complications 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 658 659 1976 02 09 2017 03 06 54 5 1975 Nov Polskie Archiwum Medycyny Wewnetrznej Pol Arch Med Wewn [Effect of sex hormones preparations on some indices of liver function under experimental conditions]. 455-61 Teresiak T T Patkowski J J pol English Abstract Journal Article Wplyw preparatorów hormonów plciowych na niektóre wskazniki czynnosci watroby w warunkach doswiadczalnych Poland Pol Arch Med Wewn 0401225 3XMK78S47O Testosterone 4TI98Z838E Estradiol EC 2.3.2.2 gamma-Glutamyltransferase EC 2.6.1.- Transaminases EC 3.1.3.1 Alkaline Phosphatase EC 4.1.2.13 Fructose-Bisphosphate Aldolase EC 5.3.1.9 Glucose-6-Phosphate Isomerase IM Alkaline Phosphatase blood Animals Estradiol pharmacology Fructose-Bisphosphate Aldolase blood Glucose-6-Phosphate Isomerase blood Liver drug effects enzymology Rabbits Testosterone pharmacology Transaminases blood gamma-Glutamyltransferase blood 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 659 660 1976 02 09 2008 06 20 0032-3756 30 47 1975 Nov 24 Polski tygodnik lekarski (Warsaw, Poland : 1960) Pol Tyg Lek [Diagnostic value of A1AT, alpha-amylase and GGTP activity in urine in chronic glomerulonephritis]. 1945-8 Gielniewska-Kabzowa J J pol English Abstract Journal Article Ocena wartosci diagnostycznej aktywnosci A1AT, alfa amylazy i GGTP w moczu w przewleklym zapaleniu klebków nerkowych Poland Pol Tyg Lek 9705468 0032-3756 EC 2.3.2.2 gamma-Glutamyltransferase EC 2.6.1.2 Alanine Transaminase EC 3.2.1.- Amylases IM Alanine Transaminase urine Amylases urine Chronic Disease Clinical Enzyme Tests Glomerulonephritis diagnosis urine Humans gamma-Glutamyltransferase urine 1975 11 24 1975 11 24 0 1 1975 11 24 0 0 ppublish 660 661 1976 03 01 2007 11 15 0032-6518 215 1288 1975 Oct The Practitioner Practitioner Management of myocardial infarction. 415-22 Henderson A H AH eng Journal Article England Practitioner 0404245 0032-6518 0 Adrenergic beta-Antagonists 0 Anticoagulants IM Adrenergic beta-Antagonists therapeutic use Anticoagulants therapeutic use Arrhythmias, Cardiac prevention & control Coronary Care Units Heart Failure drug therapy Home Care Services Humans Mobile Health Units Myocardial Infarction complications drug therapy rehabilitation therapy Resuscitation 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 661 662 1976 03 01 2017 03 22 0032-6518 215 1288 1975 Oct The Practitioner Practitioner The treatment of intractable pain. 461-7 Lipton S S eng Journal Article England Practitioner 0404245 0032-6518 0 Analgesics 0 Analgesics, Opioid 0 Hormones 0 Tranquilizing Agents 33CM23913M Carbamazepine 3K9958V90M Ethanol IM Acupuncture Therapy Analgesics therapeutic use Analgesics, Opioid therapeutic use Carbamazepine therapeutic use Cordotomy Electric Stimulation Therapy Ethanol administration & dosage Hormones therapeutic use Hot Temperature Humans Injections Neoplasms complications drug therapy radiotherapy Nerve Block Pain, Intractable drug therapy therapy Pituitary Gland Tranquilizing Agents therapeutic use Trigeminal Neuralgia drug therapy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 662 663 1976 03 01 2013 11 21 0032-6518 215 1288 1975 Oct The Practitioner Practitioner Anxiolytic drugs. 468-73 Lader M M eng Journal Article England Practitioner 0404245 0032-6518 0 Adrenergic beta-Antagonists 0 Anthracenes 0 Anti-Anxiety Agents 0 Antidepressive Agents, Tricyclic 0 Antipsychotic Agents 0 Barbiturates 12794-10-4 Benzodiazepines 9I7LNY769Q Meprobamate IM Adrenergic beta-Antagonists therapeutic use Anthracenes therapeutic use Anti-Anxiety Agents therapeutic use Antidepressive Agents, Tricyclic therapeutic use Antipsychotic Agents therapeutic use Anxiety drug therapy Barbiturates adverse effects pharmacology therapeutic use Benzodiazepines adverse effects pharmacology therapeutic use Depression drug therapy Humans Meprobamate adverse effects therapeutic use 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 663 664 1976 03 01 2013 11 21 0032-6518 215 1289 1975 Nov The Practitioner Practitioner 'Meningitis by the score'. 641-3 Macrae J J eng Case Reports Journal Article England Practitioner 0404245 0032-6518 66974FR9Q1 Chloramphenicol RIT82F58GK Penicillin G Benzathine IM Adult Chloramphenicol therapeutic use Focal Infection drug therapy Haemophilus influenzae isolation & purification Headache etiology Humans Male Meningitis, Meningococcal cerebrospinal fluid complications drug therapy Obesity Penicillin G Benzathine administration & dosage therapeutic use Recurrence Streptococcus pneumoniae isolation & purification 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 664 665 1976 03 01 2013 11 21 0032-6518 215 1289 1975 Nov The Practitioner Practitioner Intranasal betamethasone valerate in seasonal rhinitis. 665-8 A double-blind study comparing betamethasone valerate and placebo aerosols was carried out in 40 patients with a history of seasonal allergic rhinitis and positive skin tests to grass pollens. Analysis of the symptoms recorded on a daily record card for a period of one month indicated that the mean monthly symptom-score was lower for all symptoms in the group on active therapy and that this reached statistical significance for the symptom of sneezing. Significantly more antihistamine tablets were used by the placebo group as compared with the active group (p less than 0-05). The patients' assessment of their treatment was in favour of betamethasone valerate (p less than 0-05). No clinically significant side-effects were associated with the treatment, which was well tolerated. Coffman D A DA Jenkins M M eng Clinical Trial Journal Article Randomized Controlled Trial England Practitioner 0404245 0032-6518 0 Histamine H1 Antagonists 0 Placebos 9842X06Q6M Betamethasone 9IFA5XM7R2 Betamethasone Valerate IM Administration, Intranasal Adolescent Adult Aged Betamethasone analogs & derivatives Betamethasone Valerate administration & dosage therapeutic use Child Clinical Trials as Topic Desensitization, Immunologic Female Headache drug therapy Histamine H1 Antagonists administration & dosage Humans Male Middle Aged Placebos Rhinitis, Allergic, Seasonal drug therapy Seasons Sneezing drug effects Tears drug effects 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 665 666 1976 02 19 2008 02 21 0071-2736 11 1975 Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association Proc Eur Dial Transplant Assoc Urinary acidification in renal allografts. 277-83 Urinary acid excretion was measured in 35 human renal allograft recipients during the first few days after the onset of diuresis and two months after transplantation. In 16 out of 17 rejection episodes an early significant decrease of renal total net H+ excretion was observed. This urinary acidification impairment preceded the serum creatinine increase. Only few patients showed variations in blood pH and C1-. The acidification defect may be due to the ischaemic changes of rejection. Early impairment of urinary acidification supports a clinical diagnosis of rejection. Graziani G G de Vecchi A A Ponticelli C C eng Journal Article England Proc Eur Dial Transplant Assoc 0355210 0071-2736 0 Bicarbonates 0 Quaternary Ammonium Compounds IM Bicarbonates urine Graft Rejection Humans Hydrogen-Ion Concentration Kidney Transplantation Quaternary Ammonium Compounds urine Transplantation, Homologous Urine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 666 667 1976 02 19 2013 11 21 0071-2736 11 1975 Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association Proc Eur Dial Transplant Assoc A simple test for early detection of severe renal homograft rejection. 326-32 Adding urine to a standard buffered fibrinogen solution and then coagulating it with thrombin gives reproducible coagulation times with normal urines. Coagulation of fibrinogen by thrombin is prolonged in acid solutions with a pH below six. Urines of high acidity lower the buffer pH of the fibrinogen solution below a value of six thus rendering the system uncoagulable or significantly prolonging the coagulation time. With this test system we found that out of 16 severe homograft rejections 15 were accompanied by a high acid excretion in six-hour urine specimens. Ten of these acid episodes became apparent 12 to 48 hr before clinical symptoms and before elevation of the serum creatinine could be detected. Oppolzer R R Leithner C C Wolf A A Pinggera W W Stummvoll H H eng Journal Article England Proc Eur Dial Transplant Assoc 0355210 0071-2736 0 Fibrin Fibrinogen Degradation Products 0 Phosphates AYI8EX34EU Creatinine IM Creatinine blood Fibrin Fibrinogen Degradation Products urine Graft Rejection Humans Hydrogen-Ion Concentration Kidney Transplantation Phosphates urine Transplantation, Homologous Urine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 667 668 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Catalysis by acetylcholinesterase: evidence that the rate-limiting step for acylation with certain substrates precedes general acid-base catalysis. 3834-8 Inferences about the catalytic mechanism of acetylcholinesterase (acetylcholine hydrolase, EC 3.1.1.7) are frequently made on the basis of a presumed analogy with chymotrypsin, EC 3.4.21.1. Although both enzymes are serine hydrolases, several differences in the steady-state kinetic properties of the two have been observed. In this report particular attention is focused on the second-order reaction constant, kcat/Kapp. While the reported pH dependence and deuterium oxide isotope effect associated with this parameter for chymotrypsin are generally consistent with simple models involving rate-limiting general acid-base catalysis, this study finds a more complicated situation with acetylcholinesterase. The apparent pKa of kcat/Kapp for acetylcholinesterase varies between 5.5 and 6.3 for neutral substrates and involves nonlinear inhibition by [H+]. Deuterium oxide isotope effects for kcat/Kapp range from 1.1 for acetylcholine to 1.9 for p-nitrophenyl acetate. The bimolecular reaction rate appears rate-limiting for acetylcholine at low concentrations, while a rate-limiting induced-fit step is proposed to account for apparent pKa values and low deuterium oxide isotope effects associated with low concentrations of phenyl acetate and isoamyl acetate. Rosenberry T L TL eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Phenylacetates EC 3.1.1.7 Acetylcholinesterase N9YNS0M02X Acetylcholine IM Acetylcholine Acetylcholinesterase metabolism Animals Binding Sites Electric Organ enzymology Electrophorus Hydrogen-Ion Concentration Kinetics Mathematics Phenylacetates Protein Binding Structure-Activity Relationship 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 668 PMC433090 10.1073/pnas.72.10.3834 Cold Spring Harb Symp Quant Biol. 1972;36:1-11 4563861 Ann N Y Acad Sci. 1974 Feb 18;227:438-45 4597310 Biochemistry. 1973 Jul 17;12(15):2946-50 4719129 Biochemistry. 1973 Nov 6;12(23):4713-8 4773852 Biochemistry. 1974 Mar 26;13(7):1416-26 4819756 Biochemistry. 1974 Jul 16;13(15):3068-79 4841055 Nature. 1969 Jan 25;221(5178):337-40 5764436 Biochemistry. 1966 Jun;5(6):1988-97 5963443 Biochemistry. 1967 Apr;6(4):1183-90 6032463 Biochem J. 1967 Oct;105(1):171-9 6070126 Biochem J. 1958 Mar;68(3):493-9 13522650 J Biol Chem. 1965 May;240:1986-96 14299619 Proc Natl Acad Sci U S A. 1974 May;71(5):1643-7 4525454 Biochemistry. 1973 May 22;12(11):2035-41 4735878 Biochemistry. 1972 Nov 7;11(23):4308-21 5079901 Biochim Biophys Acta. 1954 Mar;13(3):347-53 13140346 Biochem J. 1956 Aug;63(4):656-61 13355866 Biochem J. 1956 Aug;63(4):684-90 13355871 Arch Biochem Biophys. 1958 Oct;77(2):286-96 13583993 Biochemistry. 1962 Sep;1:883-93 14018421 Nature. 1965 Jan 23;205:388-9 14243419 J Biol Chem. 1950 Oct;186(2):781-90 14794673 Proc Natl Acad Sci U S A. 1958 Feb;44(2):98-104 16590179 Cold Spring Harb Symp Quant Biol. 1972;36:63-70 4508173 669 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Light-dependent absorption and selective scattering changes at 518 nm in chloroplast thylakoid membranes. 3858-62 The light-induced absorbance change at 518 nm of isolated chloroplasts consists of a rapid phase, and a slow phase which is complete in about 20 sec. The slow component of the 518 nm absorbance change correlates with the light-induced change in 90 degrees light scattering at 518 nm. Both show a similar time course, similar pH dependence with a maximum at pH 6.0, and similar sensitivity to inhibitors and to treatment of the chloroplasts with a low concentration of glutaraldehyde. Their light minus dark difference spectra are similar with maxima at about 520 nm. It is concluded that they are manifestations of the same phenomenon, and the slow absorbance increase at 518 nm is due to enhanced scattering. It is proposed that the light-induced changes in scattering at 518 nm reflect alterations in selective dispersion, due to proton uptake and conformational changes in the chloroplast thylakoid membrane. Thorne S W SW Horvath G G Kahn A A Boardman N K NK eng Journal Article United States Proc Natl Acad Sci U S A 7505876 0027-8424 2001-95-8 Valinomycin 555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone 9I3SDS92WY Diuron RRU6GY95IS Nigericin IM Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology Cell Membrane drug effects metabolism ultrastructure Chloroplasts drug effects metabolism ultrastructure Darkness Diuron pharmacology Hydrogen-Ion Concentration Light Nigericin pharmacology Plants Scattering, Radiation Valinomycin pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 669 PMC433095 10.1073/pnas.72.10.3858 Biochim Biophys Acta. 1973 Apr 27;305(1):140-52 4146342 Biochem J. 1974 Aug;142(2):193-201 4441376 Biochim Biophys Acta. 1973 Jul 26;314(1):66-78 4741595 Biofizika. 1973 Nov-Dec;18(6):1052-7 4805514 FEBS Lett. 1974 Mar 15;40(1):229-32 4854767 Arch Biochem Biophys. 1969 Dec;135(1):97-108 4903244 Q Rev Biophys. 1971 Nov;4(4):365-477 4948246 J Bioenerg. 1970 Oct;1(4):405-12 5005955 Biochim Biophys Acta. 1972 Feb 28;256(2):396-408 5016548 Eur J Biochem. 1972 Jan 31;25(1):54-63 5023580 Biol Rev Camb Philos Soc. 1966 Aug;41(3):445-502 5329743 Int Rev Cytol. 1966;20:97-124 5337303 Biochim Biophys Acta. 1968 Feb 12;153(2):448-58 5642391 Arch Biochem Biophys. 1968 Oct;128(1):142-52 5677174 Biochem J. 1968 Oct;109(4):527-32 5683504 Biochim Biophys Acta. 1969 Jun 24;180(2):302-19 5795471 Biochem Biophys Res Commun. 1962 Oct 31;9:355-60 13940986 Biochim Biophys Acta. 1964 Jan 27;79:201-3 14117748 Biochemistry. 1964 Jun;3:817-24 14211622 Arch Biochem Biophys. 1959 Oct;84:428-41 14414452 Biochim Biophys Acta. 1961 Aug 19;51:429-41 14457538 Plant Physiol. 1959 May;34(3):193-9 16655200 Plant Physiol. 1968 May;43(5):781-7 16656840 670 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A phiX174 DNA-dependent DNA synthesis in vitro: requirement for P1 ban protein in dnaB mutant extracts of Escherichia coli. 3907-11 Ammonium sulfate fractionation of crude extracts of E. coli yields a soluble enzyme fraction (about 25-fold purification) that catalyzes the conversion of phiX174 single-stranded DNA to duplex DNA. The reaction is rifampicin-resistant, requires single-stranded DNA, Mg++, deoxynucleoside triphosphates, and ATP, and is stimulated by KCl. Such soluble enzyme fractions were prepared from E. coli strains carrying the prophage mutant P1bac, in which the viral dnaB analog (ban) protein is expressed constitutively, or P1bacban, in which the expression of ban protein is prevented. DNA-synthesizing activity of ban protein containing fractions from wild-type or dnaB(P1bac) lysogens was more temperature-resistant than that from E. coli containing only wild-type dnaB protein, whereas that from dnaB(P1bacban) lysogens of dnaB cells was extremely thermolabile. It is suggested that the temperature-resistant DNA synthesis with fractions from P1bac lysogens is mediated by the P1 ban protein. Schuster H H Mikolajczyk M M Rohrschneider J J Geschke B B eng Journal Article United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Bacterial Proteins 0 DNA, Single-Stranded 0 DNA, Viral 660YQ98I10 Potassium Chloride I38ZP9992A Magnesium VJT6J7R4TR Rifampin Y45QSO73OB Streptomycin IM Bacterial Proteins metabolism Coliphages drug effects metabolism DNA Replication drug effects DNA, Single-Stranded metabolism DNA, Viral metabolism Escherichia coli drug effects metabolism Hydrogen-Ion Concentration Kinetics Magnesium pharmacology Mutation Potassium Chloride pharmacology Rifampin pharmacology Streptomycin Temperature 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 670 PMC433105 10.1073/pnas.72.10.3907 J Mol Biol. 1975 May 25;94(3):327-40 1100839 J Mol Biol. 1975 May 25;94(3):341-66 1100840 J Bacteriol. 1964 Nov;88:1266-76 14234780 Proc Natl Acad Sci U S A. 1973 Nov;70(11):3120-4 4274130 Mol Gen Genet. 1972;114(2):173-6 4553098 Proc Natl Acad Sci U S A. 1972 Apr;69(4):965-9 4554537 J Bacteriol. 1973 Mar;113(3):1381-8 4570784 Biochem Biophys Res Commun. 1973 Aug 6;53(3):858-68 4581492 Proc Natl Acad Sci U S A. 1974 Oct;71(10):4120-4 4610569 Science. 1974 Dec 13;186(4168):987-93 4620044 J Mol Biol. 1968 Nov 14;37(3):525-8 4888152 Mol Gen Genet. 1970;106(3):274-85 4921136 Mol Gen Genet. 1971;110(3):272-88 4929819 Mol Gen Genet. 1971;113(3):273-84 4946856 J Mol Biol. 1966 Jul;18(3):429-47 5968177 671 1976 03 01 2019 12 10 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Intramolecular arsanilazotyrosine-248-Zn complex of carboxypeptidase A: a monitor of catalytic events. 3930-3 The intensely chromophoric intramolecular coordination complex formed between arsanilazotyrosine-248 and the active site zinc atom of azocarboxypeptidase A (Johansen, J. T. & Vallee, B. L. (1971) Proc. Nat. Acad. Sci. USA 68, 2532-2535) is a spectrokinetic probe of catalytic events. The interconversion of the azoTyr-248-Zn complex and its constituents is measured by stopped-flow pH and temperature-jump methods. The rate of interconversion, 64,000 sec-1, is orders of magnitude faster than that of the catalytic step itself (about 0.01-100 sec-1). Rapidly turned over peptide and ester substrates disrupt the azoTyr-248-Zn complex before hydrolysis occurs. As a consequence, formation of azoTyr-248, substrate binding, and catalysis can all be monitored while catalysis is actually in progress. The results of these dynamic studies specify a course of catalytic events, different from those postulated based on x-ray structure analysis. If azoTyr-248 is displaced, the direction is opposite to the inward movement postulated on the basis of x-ray studies and is not unique to induction by substrates, since rapid changes in pH also result in analogous spectral changes. AzoTyr-248 carboxypeptidase has all the features which are essential for mechanistic studies: (1) It is enzymatically active; (2) the spectra of the metal complex differ characteristically from those of its constituents; (3) it responds dynamically to environmental factors; and (4) the response time of the probe itself is much more rapid than is required for the measurement of the catalytic step. These combined kinetic and spectral properties of the metal complex render it a powerful spectrokinetic probe to visualize and discern microscopic details of the catalytic process. Harrison L W LW Auld D S DS Vallee B L BL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Arsenicals 0 Azo Compounds 33650-94-1 tyrosine-4-azobenzenearsonate 42HK56048U Tyrosine 7334-23-8 p-Azobenzenearsonate EC 3.4.- Carboxypeptidases J41CSQ7QDS Zinc IM Arsenicals Azo Compounds Binding Sites Carboxypeptidases Hydrogen-Ion Concentration Protein Binding Spectrophotometry Temperature Tyrosine analogs & derivatives Zinc analysis p-Azobenzenearsonate 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 671 PMC433110 10.1073/pnas.72.10.3930 Biochemistry. 1975 Feb 25;14(4):649-60 234737 Philos Trans R Soc Lond B Biol Sci. 1970 Feb 12;257(813):177-214 4399045 Biochemistry. 1974 Jul 2;13(14):2877-82 4407782 Biochemistry. 1974 Oct 8;13(21):4355-61 4472022 Proc Natl Acad Sci U S A. 1972 Oct;69(10):2850-4 4507609 Proc Natl Acad Sci U S A. 1973 Jul;70(7):2006-10 4516200 Proc Natl Acad Sci U S A. 1973 Dec;70(12):3797-801 4521205 Proc Natl Acad Sci U S A. 1974 Oct;71(10):3922-6 4530272 Cold Spring Harb Symp Quant Biol. 1972;36:517-31 4563862 Proc Natl Acad Sci U S A. 1971 Oct;68(10):2532-5 5289887 Biochemistry. 1970 Feb 3;9(3):602-9 5461217 Brookhaven Symp Biol. 1968 Jun;21(1):24-90 5719196 672 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Ubiquinone-mediated coupling of NADH dehydrogenase to active transport in membrane vesicles from Escherichia coli. 3970-4 Addition of ubiquinone-1 to E. coli ML 308-225 membrane vesicles dramatically increases coupling between NADH oxidation and active transport such that initial rates and steady-state levels of lactose and amino-acid accumulation are comparable to those observed during D-lactate oxidation. Similar but less dramatic effects are observed with the quinone and succinate or L-lactate. In the presence of NADH and ubiquinone-1, the vesicles also generate a membrane potential (interior negative) that is similar in magnitude to that observed in the presence of D-lactate. Stimulation of NADH-dependent transport by ubiquinone-1 cannot be accounted for by increased rates of oxidation of NADH, and the effect of the quinone on NADH-dependent lactose transport is not observed in vesicles depleted of NADH dehydrogenase activity. Thus, it is apparent that ubiquinone-1 shunts electrons from NADH dehydrogenase [NADH:(acceptor)oxidoreductase; EC 1.6.99.3] to the portion of the respiratory chain containing the energy-coupling site. The findings demonstrate unequivocally that inefficient coupling of NADH oxidation to active transport cannot be due to the presence of inverted vesicles. In addition, they provide further support for specific localization of the energy-coupling site. Stroobant P P Kaback H R HR eng Journal Article United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Amino Acids 0 Lactates 0 Succinates 0U46U6E8UK NAD 1339-63-5 Ubiquinone 53-59-8 NADP EC 1.6.- NADH, NADPH Oxidoreductases J2B2A4N98G Lactose IM Amino Acids metabolism Biological Transport, Active Cell Membrane drug effects enzymology Escherichia coli drug effects enzymology metabolism Kinetics Lactates metabolism Lactose metabolism NAD metabolism NADH, NADPH Oxidoreductases metabolism NADP metabolism Oxygen Consumption drug effects Succinates metabolism Ubiquinone pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 672 PMC433119 10.1073/pnas.72.10.3970 J Biol Chem. 1975 Jun 10;250(11):4291-6 1092688 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Membr Biol. 1974;15(1):15-28 4152065 Proc Natl Acad Sci U S A. 1974 Dec;71(12):4843-6 4155073 J Bacteriol. 1973 Dec;116(3):1456-65 4201775 Bacteriol Rev. 1972 Jun;36(2):172-230 4261111 J Bioenerg. 1973 Jan;4(1):63-91 4268692 Biochim Biophys Acta. 1973 Oct 25;323(3):429-40 4271263 J Biol Chem. 1974 Jul 25;249(14):4587-93 4276462 Proc Natl Acad Sci U S A. 1970 Jul;66(3):1008-15 4316677 J Biol Chem. 1971 Sep 10;246(17):5518-22 4330922 J Biol Chem. 1971 Oct 10;246(19):5857-61 4331061 J Biol Chem. 1972 Dec 25;247(24):7844-57 4344983 Proc Natl Acad Sci U S A. 1974 Dec;71(12):5042-6 4373740 Proc Natl Acad Sci U S A. 1970 Aug;66(4):1190-8 4394455 J Biol Chem. 1972 Apr 25;247(8):2408-18 4401701 J Biol Chem. 1972 Jan 10;247(1):298-304 4553437 J Biol Chem. 1972 Oct 10;247(19):6204-11 4568608 J Biol Chem. 1973 May 25;248(10):3551-65 4573982 Proc Natl Acad Sci U S A. 1973 Jun;70(6):1804-8 4578444 Biochim Biophys Acta. 1972 Aug 4;265(3):367-416 4581579 Proc Natl Acad Sci U S A. 1973 Oct;70(10):2722-6 4583021 Proc Natl Acad Sci U S A. 1973 Dec;70(12):3376-81 4587250 J Bacteriol. 1974 Feb;117(2):888-99 4590489 J Membr Biol. 1974;15(1):1-14 4600804 Proc Natl Acad Sci U S A. 1974 Dec;71(12):5032-6 4612538 Science. 1974 Dec 6;186(4167):882-92 4620043 J Biol Chem. 1972 Jan 10;247(1):291-7 4623127 J Bacteriol. 1969 Nov;100(2):573-8 5354933 J Biol Chem. 1975 Jun 10;250(11):4285-90 805139 673 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Protection of lethally irradiated mice with allogeneic fetal liver cells: influence of irradiation dose on immunologic reconstitution. 4100-4 After lethal irradiation long-lived, immunologically vigorous C3Hf mice were produced by treatment with syngeneic fetal liver cells or syngeneic newborn or adult spleen cells. Treatment of lethally irradiated mice with syngeneic or allogeneic newborn thymus cells or allogeneic newborn or adult spleen cells regularly led to fatal secondary disease or graft-versus-host reactions. Treatment of the lethally irradiated mice with fetal liver cells regularly yielded long-lived, immunologically vigorous chimeras. The introduction of the fetal liver cells into the irradiated mice appeared to be followed by development of immunological tolerance of the donor cells. The findings suggest that T-cells at an early stage of differentiation are more susceptible to tolerance induction than are T-lymphocytes at later stages of differentiation. These investigations turned up a perplexing paradox which suggests that high doses of irradiation may injure the thymic stroma, rendering it less capable of supporting certain T-cell populations in the peripheral lymphoid tissue. Alternatively, the higher and not the lower dose of irradiation may have eliminated a host cell not readily derived from fetal liver precursors which represents an important helper cell in certain cell-mediated immune functions, e.g., graft-versus-host reactions, but which is not important in others, e.g., allograft rejections. The higher dose of lethal irradiation did not permit development or maintenance of a population of spleen cells that could initiate graft-versus-host reactions but did permit the development of a population of donor cells capable of achieving vigorous allograft rejection. These observations contribute to understanding of some of the persisting immunodeficiencies that are observed in man after fatal irradiation and bone marrow transplantation. These results should suggest better approaches to more effective cellular engineering for correction of immunodeficiency diseases and for treatment of immunodeficiency diseases and of leukemias and malignancies of man. Tulunay O O Good R A RA Yunis E J EJ eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 IM Animals Female Fetus Graft vs Host Reaction Hematopoietic Stem Cells radiation effects Humans Immune Tolerance Infant, Newborn Liver immunology Liver Transplantation Male Mice Mice, Inbred Strains immunology Radiation Dosage Radiation Effects Skin Transplantation Species Specificity Thymus Gland radiation effects Time Factors Transplantation, Homologous 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 673 PMC433146 10.1073/pnas.72.10.4100 Int J Radiat Biol. 1961 Mar;3:173-81 13688794 Proc Soc Exp Biol Med. 1956 Aug-Sep;92(4):688-93 13370496 J Natl Cancer Inst. 1957 Jul;19(1):123-30 13502711 Nature. 1958 Feb 15;181(4607):488 13517181 J Natl Cancer Inst. 1958 Mar;20(3):617-24 13539612 J Natl Cancer Inst. 1958 Mar;20(3):625-32 13539613 J Exp Zool. 1961 Mar;146:113-29 13869203 Ann N Y Acad Sci. 1962 Oct 24;99:374-85 13969359 Science. 1963 Nov 1;142(3592):584 14074829 Proc Soc Exp Biol Med. 1963 Oct;114:242-4 14076897 Nature. 1963 Aug 31;199:873-4 14079896 J Exp Med. 1965 Apr 1;121:607-32 14276780 Proc Natl Acad Sci U S A. 1958 Jun;44(6):560-5 16590239 Proc Natl Acad Sci U S A. 1974 Jun;71(6):2544-8 4152206 Transplant Proc. 1969 Mar;1(1):25-30 4400066 Physiol Rev. 1967 Jul;47(3):437-520 4864541 J Exp Med. 1970 Sep 1;132(3):583-600 4943928 J Exp Med. 1970 Sep 1;132(3):601-12 4943929 J Exp Med. 1972 Mar 1;135(3):711-7 5061980 Br J Exp Pathol. 1965 Aug;46(4):376-83 5317963 Clin Exp Immunol. 1966 Jan;1(1):61-76 5330737 J Natl Cancer Inst. 1968 Dec;41(6):1431-52 5728344 Science. 1969 Apr 18;164(3877):316-8 5813352 Proc Soc Exp Biol Med. 1959 Feb;100(2):395-9 13634151 674 1976 03 01 2019 05 01 0027-8424 72 10 1975 Oct Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Mechanism of action of penicillin: triggering of the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis. 4162-6 During penicillin treatment of an autolysin defective mutant pneumococcus we have observed three novel phenomena: (i) Growth of the mutant cultures is inhibited by the same concentrations of penicillin that induce lysis in the wild type. (ii) Mutant bacteria treated with the minimum growth inhibitory concentration of penicillin will lyse upon the addition of wild-type autolysin to the growth medium. Chloramphenicol and other inhibitors of protein synthesis protect the cells against lysis by exogenous enzyme. Sensitivity of the cells to exogenous autolysin requires treatment with penicillin or other inhibitors of cell wall synthesis (e.g., D-cycloserine or fosfonomycin) since exogenous autolysin alone has no effect on bacterial growth. (iii) Treatment with penicillin (or other inhibitors of cell wall synthesis) causes the escape into the medium of a choline-containing macromolecule that has properties suggesting that it contains pneumococcal lipoteichoic acid (Forssman antigen). Each one of these three phenomena (growth inhibition, sensitization to exogenous autolysin, and leakage of lipoteichoic acid) shows the same dose response as that of the penicillin-induced lysis of wild-type pneumococci. On the basis of these findings we propose a new hypothesis for the mechanism of penicillin-induced lysis of bacteria. It is suggested that inhibition of cell wall synthesis by any means triggers bacterial autolytic enzymes by destabilizing the endogenous complex of an autolysin inhibitor (lipoteichoic acid) and autolytic enzyme. Escape of lipoteichoic acid-like material to the growth medium is a consequence of this labilization. Chloramphenicol protects bacteria against penicillin-induced lysis by interfering with the activity of the autolytic enzyme, rather than by depleting the concentration of the enzyme at the cell surface. Tomasz A A Waks S S eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Penicillins 0 Teichoic Acids 005990WHZZ Deoxycholic Acid 66974FR9Q1 Chloramphenicol IM Autolysis Cell Wall drug effects physiology Chloramphenicol pharmacology Deoxycholic Acid pharmacology Enzyme Activation drug effects Penicillins pharmacology Streptococcus pneumoniae drug effects enzymology Teichoic Acids pharmacology Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 674 PMC433160 10.1073/pnas.72.10.4162 J Bacteriol. 1957 Jul;74(1):48-59 13462959 AMA Arch Intern Med. 1951 Mar;87(3):349-59 14810260 Proc Natl Acad Sci U S A. 1975 May;72(5):1690-4 239401 J Biol Chem. 1973 Sep 25;248(18):6394-7 4147161 Ann N Y Acad Sci. 1974 May 10;235(0):439-47 4153141 J Biol Chem. 1974 Nov 10;249(21):7032-4 4153792 J Biol Chem. 1970 Jan 25;245(2):287-98 4391619 J Bacteriol. 1970 Feb;101(2):373-83 4391801 J Bacteriol. 1970 Mar;101(3):860-71 4392399 Nature. 1970 Jul 11;227(5254):138-40 4393335 Proc Natl Acad Sci U S A. 1971 Nov;68(11):2627-30 4399413 Ann N Y Acad Sci. 1974 May 10;235(0):161-97 4604949 J Biol Chem. 1974 May 10;249(9):2684-9 4828314 Proc Natl Acad Sci U S A. 1965 Aug;54(2):587-94 5218655 675 1976 02 19 2019 05 01 0027-8424 72 11 1975 Nov Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Identification of NADPH-thioredoxin reductase system in Euglena gracillis. 4233-7 Euglena gracilis contains a protein system which can utilize the reducing power of NADPH in the ribonucleotide reductase-catalyzed reduction of CTP. The proteins required for this reaction are a flavoprotien with a molecular weight of approximately 185,000 which is functionally similar to thioredoxin reductase (NADPH), EC 1.6.4.5, and another protein (Protein I) whose function in the reaction is unknown. This new protein does not appear to contain a prosthetic group and has a molecular weight of approximately 240,000. In addition, the ribonucleotide reductase active in the Euglena NADPH-thioredoxin reductase system is more complex than the protein reported in a previous publication [(1974) j. Biol. Chem. 249, 4428-4434]. The enzyme preparation described in this report contains four different types of polypeptide chains which may complex to form the active enzyme. Munavalli S S Parker D V DV Hamilton F D FD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Cytosine Nucleotides 53-59-8 NADP EC 1.17.4.- Ribonucleotide Reductases EC 1.6.- NADH, NADPH Oxidoreductases EC 1.8.1.9 Thioredoxin-Disulfide Reductase IM Cytosine Nucleotides metabolism Euglena gracilis enzymology Molecular Weight NADH, NADPH Oxidoreductases metabolism NADP metabolism Protein Conformation Ribonucleotide Reductases isolation & purification metabolism Thioredoxin-Disulfide Reductase isolation & purification metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 675 PMC388694 10.1073/pnas.72.11.4233 J Biol Chem. 1962 Nov;237:3513-9 13973714 Ann N Y Acad Sci. 1964 Dec 28;121:404-27 14240539 J Biol Chem. 1964 Oct;239:3436-44 14245400 J Biol Chem. 1964 Oct;239:3445-52 14245401 J Biol Chem. 1964 Oct;239:3453-6 14245402 Biochem Biophys Res Commun. 1965 Feb 3;18:409-14 14300757 Eur J Biochem. 1973 Jun;35(2):346-9 4146223 Eur J Biochem. 1974 Jul 15;46(2):271-8 4152788 J Biol Chem. 1974 Jul 25;249(14):4428-34 4210502 Biochem Biophys Res Commun. 1966 Oct 5;25(1):109-15 4382007 J Biol Chem. 1973 Feb 25;248(4):1219-23 4405641 J Biol Chem. 1972 Dec 25;247(24):8058-62 4565672 Biochim Biophys Acta. 1972 Sep 14;277(3):466-70 4627085 J Biol Chem. 1972 May 25;247(10):3336-40 5027756 Eur J Biochem. 1972 Mar 15;26(1):119-24 5065076 Biochemistry. 1965 Jun;4(6):1054-62 5320387 J Biol Chem. 1970 May 10;245(9):2363-70 5442277 J Biol Chem. 1969 May 25;244(10):2716-25 5769998 J Biol Chem. 1969 Aug 25;244(16):4406-12 5806584 676 1976 02 19 2019 05 01 0027-8424 72 11 1975 Nov Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Purification of folate binding factor in normal umbilical cord serum. 4261-4 Human umbilical cord serum was found to contain both free folate and folate complexed to a high-molecular weight factor. The complexed folate was bound to a very high affinity binder and was present in concentrations equivalent to as much as 60 ng of 5-methyltetrahydrofolic acid per ml of serum. Acidification of the serum caused disassociation of the folate-binder complex. Released folates were separated from binder by Sephadex gel filtration, zonal centrifugation through sucrose gradients, or adsorption onto activated charcoal. The separated binding factor, either saturated or unsaturated with folate, had a molecular weight of about 40,000 on Sephadex G-200 chromatography. Binding of [3H]pteroylglutamic acid was rapid and, as in the original endogenous folate-binder complex, was essentially irreversible at neutral pH. The affinity and specificity of the binder were examined by competition experiments using [3H]pteroylglutamic acid and nonradioactive folate derivatives. Oxidized folates were bound in preference to reduced derivatives, but only three to four times more unlabeled 5-methyltetrahydrofolic acid than pteroylglutamic acid was required to produce an equal level of competition. The strong affinity for 5-methyltetrahydrofolic acid, the main serum folate, suggests that the binder could be part of the mechanism by which the fetus concentrates maternally supplied folate for its growth and development. Kamen B A BA Caston J D JD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Carrier Proteins 0 Tetrahydrofolates 935E97BOY8 Folic Acid IM Binding Sites Carrier Proteins blood isolation & purification metabolism Female Fetal Blood analysis Folic Acid blood metabolism Humans Hydrogen-Ion Concentration Pregnancy Tetrahydrofolates metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 676 PMC388700 10.1073/pnas.72.11.4261 J Lab Clin Med. 1972 Aug;80(2):302-12 5044785 Acta Haematol. 1971;45(2):106-11 4996564 Biochim Biophys Acta. 1969;193(2):456-67 5389249 J Biol Chem. 1975 Mar 25;250(6):2203-5 234960 Biochem Biophys Res Commun. 1974 Sep 9;60(1):81-7 4213566 Biochemistry. 1972 Apr 25;11(9):1696-703 5028112 J Lab Clin Med. 1974 Jan;83(1):164-74 4202673 Acta Haematol. 1972;48(3):145-50 4628204 FEBS Lett. 1972 Feb 15;20(3):302-306 11946443 FEBS Lett. 1973 Sep 1;35(1):76-8 4796178 J Clin Invest. 1961 Sep;40:1684-95 13790219 Biochem J. 1971 Aug;124(1):1-12 4399520 J Biol Chem. 1951 Nov;193(1):265-75 14907713 J Lab Clin Med. 1974 Feb;83(2):207-14 4855756 Arch Biochem Biophys. 1973 Mar;155(1):213-20 4736505 Proc Soc Exp Biol Med. 1970 Feb;133(2):428-32 5263683 677 1976 02 19 2019 05 01 0027-8424 72 11 1975 Nov Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Intramolecular arsanilazotyrosine-248-Zn complex of carboxypeptidase A: a monitor of multiple conformational states in solution. 4356-60 The red azoTyr-248-Zn complex of arnilazocarboxypeptidase, previously used to demonstrate differences in conformation of the enzyme in crystals and in solution, has now provided means to detect multiple conformations of the enzyme in solution by stopped-flow pH and temperature jump experiments. These studies identify two distinct processes. Er + H+ in equilibrium Ey (I), is the extremely rapid, Kfast about 10(5) sec-1, pH dependent dissociation of the metal complex. Ey in equilibrium Ey' (II), is much slower, Kslow about 5 sec-1, pH independent interconversion of two distinct populations of protein molecules, Ey and Ey', in which the yellow azo-Tyr-248 is different conformations. These two conformations can be differentiated readily by stopped-flow pH-jump experiments, since I is three to four orders of magnitude faster than II. Mathematical expressions derived from this mechanism accurately predict all observations over the pH range from 6.0 to 8.5. In a previous stopped-flow pH-jump experiment, Lipcomb and coworkers [Quiocho, F. A., McMurray, C. H. & Lipcomb, W. H. (1972), Proc. Nat. Acad. Sci. USA 69, 2850-2854] recognized only a single process with a rate constant of about 6 sec-1, but not the major, very rapid rate observed here. The failure to detect this fast process led to the postulation of a number of explanations intended to account for the detection of only a single, slow rate. The present observations show that the premise for those conjectures is not valid. The azoprobe reveals the existence of rapidly interconvertible substructures of carboxypeptidase A, and the results support the view that in solution, enzymes can adopt multiple, readily interconvertible and related conformations which could then either facilitate or impede catalysis. In crystals, rearrangement of molecular structure could be severely impaired or restricted, and crystallization might single out either active or inactive conformations. In the latter case, such crystals would have greatly reduced activities and markedly altered catalytic behavior, as is observed for carboxypeptidase A. In combination with detailed kinetic analysis of crystals, conformational analysis in solution should be a valuable guide to discern enzyme mechanisms and select crystals for x-ray structure analysis. Harrison L W LW Auld D S DS Vallee B L BL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Proc Natl Acad Sci U S A 7505876 0027-8424 0 Azo Compounds 0 Solutions EC 3.4.- Carboxypeptidases J41CSQ7QDS Zinc IM Azo Compounds Carboxypeptidases Hydrogen-Ion Concentration Kinetics Models, Biological Protein Conformation Solutions Spectrum Analysis Structure-Activity Relationship Temperature Zinc 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 677 PMC388720 10.1073/pnas.72.11.4356 Biochemistry. 1975 Feb 25;14(4):649-60 234737 Philos Trans R Soc Lond B Biol Sci. 1970 Feb 12;257(813):177-214 4399045 Biochemistry. 1974 Jul 2;13(14):2877-82 4407782 Proc Natl Acad Sci U S A. 1972 Oct;69(10):2850-4 4507609 Proc Natl Acad Sci U S A. 1973 Jul;70(7):2006-10 4516200 Proc Natl Acad Sci U S A. 1973 Dec;70(12):3797-801 4521205 Proc Natl Acad Sci U S A. 1974 Oct;71(10):3922-6 4530272 Cold Spring Harb Symp Quant Biol. 1972;36:517-31 4563862 Biochem Biophys Res Commun. 1974 Mar 25;57(2):447-51 4829403 Proc Natl Acad Sci U S A. 1971 Oct;68(10):2532-5 5289887 Biochemistry. 1968 Dec;7(12):4242-7 5700651 Brookhaven Symp Biol. 1968 Jun;21(1):24-90 5719196 Proc Natl Acad Sci U S A. 1975 Oct;72(10):3930-3 671 678 1976 02 19 2019 05 01 0027-8424 72 11 1975 Nov Proceedings of the National Academy of Sciences of the United States of America Proc Natl Acad Sci U S A Presence of norepinephrine and related enzymes in isolated brain microvessels. 4622-5 Norepinephrine and the enzymes involved in its synthesis and degradation were found to be associated with isolated brain microvessels. The significance of these results are discussed with respect to adrenergic innervation of the cerebral microvessels and thereby neural regulation of the cerebral microcirculation. Lai F M FM Udenfriend S S Spector S S eng Journal Article United States Proc Natl Acad Sci U S A 7505876 0027-8424 EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.14.17.1 Dopamine beta-Hydroxylase EC 1.4.3.4 Monoamine Oxidase EC 4.1.1.- Dopa Decarboxylase X4W3ENH1CV Norepinephrine IM Animals Brain blood supply Capillaries analysis enzymology Cerebral Arteries analysis enzymology Cerebrovascular Circulation Dopa Decarboxylase analysis Dopamine beta-Hydroxylase analysis Male Microcirculation Monoamine Oxidase analysis Norepinephrine analysis Rats Tyrosine 3-Monooxygenase analysis Veins analysis enzymology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 678 PMC388775 10.1073/pnas.72.11.4622 Circ Res. 1975 May;36(5):647-53 1122574 Life Sci. 1975 Feb 15;16(4):475-86 1123954 Anal Biochem. 1964 Sep;9:122-6 14246117 J Biol Chem. 1951 Nov;193(1):265-75 14907713 Mol Pharmacol. 1970 Jan;6(1):85-94 4125725 Blood Vessels. 1974;11(1-2):2-31 4141271 J Anat. 1973 May;115(Pt 1):53-63 4199501 J Neurosurg. 1974 Apr;40(4):433-41 4360691 Brain Res. 1971 Mar 19;27(1):33-42 4396591 Biochem Pharmacol. 1974 Sep 1;23(17):2437-46 4429570 Science. 1974 Sep 13;185(4155):953-5 4469673 Proc Natl Acad Sci U S A. 1972 Sep;69(9):2722-6 4560699 Pharmacol Rev. 1972 Jun;24(2):311-30 4564604 Biochem Med. 1974 Aug;10(4):320-8 4604037 Neurology. 1974 Mar;24(3):282-6 4855955 Arch Biochem Biophys. 1970 Nov;141(1):356-67 4991409 Stroke. 1970 Sep-Oct;1(5):356-62 5001804 Circ Res. 1972 Aug;31(2):248-56 5049740 J Neurochem. 1971 Sep;18(9):1673-82 5571107 J Anat. 1965 Oct;99(Pt 4):815-28 5867170 Pharmacol Rev. 1966 Mar;18(1):369-85 5904153 J Neurochem. 1967 May;14(5):547-50 6025622 679 1976 02 26 2018 11 13 0035-9157 68 4 1975 Apr Proceedings of the Royal Society of Medicine Proc R Soc Med Control of breathing in disease. 237-8 Semple S J SJ eng Journal Article England Proc R Soc Med 7505890 0035-9157 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Acid-Base Imbalance physiopathology Brain Chemistry Carbon Dioxide blood Cerebrospinal Fluid Chronic Disease Extracellular Space Humans Hydrogen-Ion Concentration Oxygen blood Oxygen Inhalation Therapy Partial Pressure Respiration Respiratory Insufficiency blood cerebrospinal fluid Respiratory Tract Diseases physiopathology 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 679 PMC1863820 Clin Sci (Lond). 1954 Aug;13(3):321-32 13190680 Br Med J. 1964 Nov 7;2(5418):1159-66 14190484 N Engl J Med. 1973 Dec 20;289(25):1346-51 4356636 Am Rev Respir Dis. 1973 Aug;108(2):232-40 4720689 Br Med J. 1970 May 23;1(5707):452-5 5420208 J Appl Physiol. 1969 Jul;27(1):67-76 5786972 680 1976 02 26 2018 11 13 0035-9157 68 4 1975 Apr Proceedings of the Royal Society of Medicine Proc R Soc Med Recent studies on transport of respiratory gases by the red blood cell. 266-7 Bauer C C eng Journal Article England Proc R Soc Med 7505890 0035-9157 0 Carbamates 0 Diphosphoglyceric Acids 0 Hemoglobins 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM S Altitude Blood Carbamates metabolism Carbon Dioxide blood Diphosphoglyceric Acids blood Erythrocytes metabolism Hemoglobins metabolism physiology Humans Hydrogen-Ion Concentration Muscles metabolism Oxygen blood Physical Exertion Respiration 76078588 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 680 PMC1863794 Nature. 1972 May 19;237(5351):146-9 4555506 J Physiol. 1972 Dec;227(2):457-71 4647257 Adv Exp Med Biol. 1972;28:349-60 5085177 Pflugers Arch. 1971;326(4):341-56 5105995 Proc Natl Acad Sci U S A. 1968 Nov;61(3):1102-6 5246545 Nature. 1970 Nov 21;228(5273):726-39 5528785 Scand J Clin Lab Invest. 1971 Jun;27(4):361-6 5556605 J Clin Invest. 1968 Dec;47(12):2652-6 5725278 Nature. 1969 Jun 28;222(5200):1243-6 5789658 Biochem Biophys Res Commun. 1967 Jan 23;26(2):162-7 6030262 Arch Biochem Biophys. 1967 Jul;121(1):96-102 6035074 Life Sci. 1969 Oct 15;8(20):1041-6 5355417 Nature. 1969 Jun 28;222(5200):1240-3 5789657 681 1976 03 01 2018 12 03 0035-9157 68 8 1975 Aug Proceedings of the Royal Society of Medicine Proc R Soc Med Disorders of micturition in bacterial prostatitis. 508-11 Measurements of urinary flow rate were performed in 16 patients with established prostatitis before and after a course of antimicrobial therapy. Before treatment the maximum flow rates were poor with abnormal flow curves and significant improvement in voiding characteristics were observed with treatment (P less than 0.01). A preliminary electrophysiological (EMG) study of sphincter activity suggested that the obstruction to the flow of urine was at least in part due to failure of the external sphincter to relax during micturition. Although the total number of cases in this series was small the study showed that prostatitis was associated with a disorder of micturition which correlated with the other clinical features of the disease and could be objectively evaluated. Eradication of infection restored normal conditions in the lower urinary tract. Buck A C AC eng Case Reports Journal Article England Proc R Soc Med 7505890 0035-9157 IM Adolescent Adult Bacteriuria complications Electromyography Escherichia coli isolation & purification Humans Hydrogen-Ion Concentration Male Middle Aged Prostate metabolism Prostatitis complications physiopathology Proteus isolation & purification Urethra physiopathology Urination Disorders complications physiopathology Urine 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 681 PMC1863860 Calif Med. 1961 Aug;95:100-3 13751870 Br J Urol. 1965 Feb;37:25-33 14269343 Br J Urol. 1973 Dec;45(6):631-45 4130099 J Urol. 1973 Feb;109(2):268-72 4568312 Annu Rev Med. 1973;24:83-8 4581911 Br J Urol. 1974 Oct;46(5):537-42 4609006 Br J Urol. 1971 Feb;43(1):69-82 5102137 Br J Urol. 1969 Apr;41(2):211-7 5814020 Clin Pediatr (Phila). 1966 Jun;5(6):377-84 5937865 Acta Chir Scand. 1958;115(3):227-41 13582501 Br Med J. 1969 Jun 7;2(5657):598-601 4183826 Br J Urol. 1973 Jun;45(3):289-98 4736519 Proc R Soc Med. 1975 Aug;68(8):511-3 682 682 1976 03 01 2018 12 03 0035-9157 68 8 1975 Aug Proceedings of the Royal Society of Medicine Proc R Soc Med Change in pH of expressed prostatic secretion during the course of prostatitis. 511-3 White M A MA eng Journal Article England Proc R Soc Med 7505890 0035-9157 0 Anti-Bacterial Agents IM Anti-Bacterial Agents therapeutic use Body Fluids analysis Humans Hydrogen-Ion Concentration Leukocyte Count Male Prostate metabolism Prostatitis drug therapy physiopathology Time Factors 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 682 PMC1863829 Dtsch Med Wochenschr. 1964 Dec 11;89:2366-9 14225038 Br J Urol. 1974 Oct;46(5):537-42 4609006 683 1976 02 13 2018 11 13 0035-9157 68 9 1975 Sep Proceedings of the Royal Society of Medicine Proc R Soc Med Bone marrow transplants. 577-8 Anderson I M IM eng Journal Article England Proc R Soc Med 7505890 0035-9157 0 Immunoglobulin A 0 Immunoglobulin G 0 Immunoglobulin M YL5FZ2Y5U1 Methotrexate IM Agammaglobulinemia therapy Bone Marrow Cells Bone Marrow Transplantation Female Graft vs Host Reaction Humans Immunoglobulin A Immunoglobulin G Immunoglobulin M Immunologic Deficiency Syndromes therapy Infant Infant, Newborn Male Methotrexate therapeutic use Transplantation, Homologous 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 683 PMC1864005 Br Med J. 1972 Apr 29;2(5808):265-9 4553813 684 1976 02 09 2013 11 21 0031-6865 50 10 1975 Pharmaceutica acta Helvetiae Pharm Acta Helv [Picolylamides of the nicethamide type. 6. Structure-activity relationships of analeptics of the nicethamide type]. 298-303 Sattler H J HJ Schmitz H H Schunack W W ger English Abstract Journal Article Picolylamide vom Nicethamid-Typ. 6. Mitteilung (1). Struktur-Wirkungs-Beziehungen bei Analeptica vom Typ des Nicethamids Switzerland Pharm Acta Helv 0401134 0031-6865 0 Central Nervous System Stimulants 368IVD6M32 Nikethamide IM Central Nervous System Stimulants chemical synthesis pharmacology Nikethamide analogs & derivatives chemical synthesis Structure-Activity Relationship 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 684 685 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Biotransformation and pharmacokinetics of beta-receptor blockaders]. 625-33 Pfeifer S S Zimmer C C ger Journal Article Review Biotransformation und Pharmakokinetik von beta-Rezeptorenblockern Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Ethanolamines 0 Propanolamines 519MXN9YZR Oxprenolol 67P356D8GH Acebutolol 877K5MQ27W Alprenolol 9Y8NXQ24VQ Propranolol A6D97U294I Sotalol BJ4HF6IU1D Pindolol G6317AOI7K Levobunolol L628TT009W Isoproterenol SUG9176GRW Practolol IM Acebutolol metabolism Adrenergic beta-Antagonists metabolism Alprenolol metabolism Animals Biotransformation Ethanolamines metabolism Humans Isoproterenol metabolism Kinetics Levobunolol metabolism Oxprenolol metabolism Pindolol metabolism Practolol metabolism Propanolamines metabolism Propranolol metabolism Sotalol metabolism 108 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 685 686 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Synthesis of new beta 1-receptor blockaders]. 633-7 Eckardt R R Carstens E E Fiedler W W ger Journal Article Versuche zur Synthese neuer beta 1-Rezeptorenblocker Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Phenyl Ethers 0 Propanolamines SUG9176GRW Practolol IM Adrenergic beta-Antagonists chemical synthesis Methods Phenyl Ethers chemical synthesis Practolol analogs & derivatives Propanolamines chemical synthesis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 686 687 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action]. 638-42 Femmer K K ger Comparative Study Journal Article Struktur-Wirkungs-Beziehungen bei Phenoxyalkanolaminderivaten mit selektiver beta 1-Rezeptorenblockade Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Anti-Arrhythmia Agents 0 Phenyl Ethers 0 Propanolamines 9Y8NXQ24VQ Propranolol SUG9176GRW Practolol IM Adrenergic beta-Antagonists pharmacology Animals Anti-Arrhythmia Agents Cats Female Guinea Pigs Heart Rate drug effects Hemodynamics drug effects Injections, Intravenous Lethal Dose 50 Male Phenyl Ethers pharmacology Practolol pharmacology Propanolamines pharmacology Propranolol pharmacology Rats Structure-Activity Relationship 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 687 688 1976 02 20 2019 12 10 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)]. 642-51 Femmer K K Bartsch R R Leonhardt U U von Littrow C C Riedel H H ger Comparative Study Journal Article Zur Pharmakologie von (+/-)-1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115) Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines 3S82268BKG talinolol 8W8T17847W Urea 9Y8NXQ24VQ Propranolol SUG9176GRW Practolol IM Adrenergic beta-Antagonists pharmacology Animals Blood Pressure drug effects Bronchi drug effects Cats Dogs Dose-Response Relationship, Drug Female Guinea Pigs Heart Rate drug effects Injections, Intraperitoneal Injections, Intravenous Lethal Dose 50 Male Mice Myocardial Contraction drug effects Practolol pharmacology Propanolamines pharmacology Propranolol pharmacology Rats Time Factors Urea analogs & derivatives Uterine Contraction drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 688 689 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation]. 652-5 Modersohn D D Femmer K K ger Journal Article Untersuchungen über die Beeinflussung der Koronardurchblutung durch Talinolol (Cordanum, 02-115) Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines L628TT009W Isoproterenol IM Adrenergic beta-Antagonists pharmacology Animals Blood Pressure drug effects Coronary Circulation drug effects Depression, Chemical Dogs Dose-Response Relationship, Drug Female Heart Rate drug effects Isoproterenol antagonists & inhibitors Male Myocardial Contraction drug effects Propanolamines pharmacology Stimulation, Chemical Swine 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 689 690 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum]. 656-8 Leonhardt U U Nürnberger H H Femmer K K ger Comparative Study Journal Article Wirkung von 1-[4-Cyclohexylureidophenoxyl-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115), Practolol und Propranolol auf den Lipidgehalt des Serums der Ratte Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Fatty Acids, Nonesterified 0 Lipids 0 Phospholipids 0 Propanolamines 97C5T2UQ7J Cholesterol 9Y8NXQ24VQ Propranolol L628TT009W Isoproterenol SUG9176GRW Practolol IM Adrenergic beta-Antagonists pharmacology Animals Cholesterol blood Fatty Acids, Nonesterified blood Injections, Intraperitoneal Isoproterenol antagonists & inhibitors Lipids blood Male Phospholipids blood Practolol pharmacology Propanolamines pharmacology Propranolol pharmacology Rats 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 690 691 1976 02 20 2007 01 29 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle]. 659-68 Bartsch R R Merbt E M EM Riedel H H ger Journal Article Chronische Toxizitätsprfung von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115) an Ratte und Beagle-Hund Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Blood Glucose 0 Propanolamines EC 2.6.1.1 Aspartate Aminotransferases EC 2.6.1.2 Alanine Transaminase EC 3.1.3.1 Alkaline Phosphatase IM Adrenergic beta-Antagonists administration & dosage toxicity Alanine Transaminase blood Alkaline Phosphatase blood Animals Aspartate Aminotransferases blood Blood Cell Count Blood Glucose metabolism Body Weight drug effects Dogs Dose-Response Relationship, Drug Endocrine Glands drug effects Female Heart drug effects Hemoglobinometry Lung drug effects Male Propanolamines administration & dosage toxicity Rats Spleen drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 691 692 1976 02 20 2017 03 22 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Teratological study of talinolol (Cordanum, 02-115)]. 669-1 Wendler D D Schmidt W W ger Journal Article Talinolol (Cordanum, 02-115) im teratologischen Versuch Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines 0 Teratogens IM Abnormalities, Drug-Induced etiology Adrenergic beta-Antagonists toxicity Animals Eye Abnormalities Face abnormalities Female Fetal Death chemically induced Fetal Resorption chemically induced Fetus drug effects Pregnancy Propanolamines toxicity Rats Ribs abnormalities Teratogens 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 692 693 1976 02 20 2007 01 29 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Quantitative colorimetric determination of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert butylaminopropane (talinolol Cordanum, 02-115) in body fluids]. 673 Nürnberger H H ger Journal Article Quantitative kolorimetrische Bestimmung von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115) in Körperflüssigkeiten Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines IM Adrenergic beta-Antagonists analysis Animals Body Fluids analysis Colorimetry methods Hydrolysis Propanolamines analysis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 693 694 1976 02 20 2017 03 22 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs]. 673-5 Femmer K K Klemm W W Nürnberger H H ger Journal Article Untersuchungen zur Pharmakokinetik von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115). 1. Mitteilung: Blutspiegelverläufe beim Hund Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines IM Administration, Oral Adrenergic beta-Antagonists administration & dosage blood Animals Dogs Half-Life Injections, Intravenous Kinetics Propanolamines administration & dosage blood 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 694 695 1976 02 20 2007 01 29 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat]. 675-7 Klemm W W Wenzel A A ger Journal Article Untersuchungen zur Pharmakokinetik von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115) Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines IM Administration, Oral Adrenergic beta-Antagonists administration & dosage metabolism Animals Feces analysis Female Half-Life Injections, Intravenous Kinetics Male Propanolamines administration & dosage metabolism Rats 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 695 696 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man]. 678-81 Wolf P P Feller K K Femmer K K ger Journal Article Hämodynamische Wirkungen der neuen beta-Rezeptoren blockierenden Substanz Talinolol (Cordanum, 02-115) am Menschen Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines L628TT009W Isoproterenol IM Administration, Oral Adrenergic beta-Antagonists pharmacology Adult Blood Pressure drug effects Cardiac Output drug effects Dose-Response Relationship, Drug Heart Rate drug effects Hemodynamics drug effects Humans Injections, Intravenous Isoproterenol antagonists & inhibitors Middle Aged Propanolamines pharmacology Pulse drug effects Time Factors Vascular Resistance drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 696 697 1976 02 20 2013 11 21 0031-7144 30 10 1975 Oct Die Pharmazie Pharmazie [Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases]. 681-3 Kandt D D Hackenberger F F ger Clinical Trial Journal Article Klinisch-pharmakologische Untersuchungen zur bronchokonstriktorischen Nebenwirkung des beta 1-Rezeptorenblockers Talinolol (Cordanum, 02-115) bei Asthmatikern und Patienten mit chronischen obstruktiven Lungenerkrankungen Germany Pharmazie 9800766 0031-7144 0 Adrenergic beta-Antagonists 0 Propanolamines SUG9176GRW Practolol IM Administration, Oral Adrenergic beta-Antagonists administration & dosage adverse effects Adult Asthma physiopathology Bronchi drug effects Chronic Disease Clinical Trials as Topic Dose-Response Relationship, Drug Female Forced Expiratory Volume Heart Rate drug effects Humans Injections, Intravenous Lung Diseases, Obstructive physiopathology Male Practolol adverse effects Propanolamines administration & dosage adverse effects Vital Capacity drug effects 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 697 698 1976 02 26 2013 11 21 0031-9325 7 5 1975 Physiological chemistry and physics Physiol Chem Phys Nonenzymatic reactivation of des-acetyl citrate lyase by acetyl adenylate. First example of enzyme activation by chemotrophic modification. 409-14 The experimental conditions of nonenzymatic reactivation of des-acetyl citrate lyase from K. aerogenes were studied. It was found that at pH 8.5 0.2 MM acetyl AMP causes a fast reactivation of the enzyme. The pH dependence of activity and the Km for citrate are very similar for both native and reactivated enzyme. Camici G G Manao G G Ramponi G G eng Journal Article United States Physiol Chem Phys 0202364 0031-9325 415SHH325A Adenosine Monophosphate EC 2.3.3.8 ATP Citrate (pro-S)-Lyase EC 4.1.3.- Oxo-Acid-Lyases IM ATP Citrate (pro-S)-Lyase metabolism Adenosine Monophosphate analogs & derivatives pharmacology Enzyme Activation drug effects Hydrogen-Ion Concentration Kinetics Klebsiella enzymology Oxo-Acid-Lyases metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 698 699 1976 03 01 2017 11 16 1011-6206 12 1 1975 Physiologie (Bucarest) Physiologie Relationship between bovine serum albumin structure and its chemical equilibria with hydrogen and 5-hydroxytryptamine ions. 77-80 From the analysis of titration curves with hydrogen and 5-HT ions, it was found that the electrostatic interaction parameter of protein macroion and the number sites of 5-HT fixing were smaller over an acid and base pH range as compared to their values at neutral pH. Our data were interpreted by the conformational changes which can be induced when BSA is exposed to denaturation by acid and alkali pH. Petec G G Vîlcu R R Uluitu M M Petec M M eng Journal Article Romania Physiologie 7510964 1011-6206 27432CM55Q Serum Albumin, Bovine 333DO1RDJY Serotonin 7YNJ3PO35Z Hydrogen IM Animals Cattle Hydrogen Hydrogen-Ion Concentration Protein Conformation Serotonin Serum Albumin, Bovine 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 699 700 1976 02 20 2015 04 23 1011-6206 12 3 1975 Physiologie (Bucarest) Physiologie [Circadian variations of the activity and induction of tyrosine aminotransferase after x-irradiation]. 229-31 Stefan M M Boerescu J J Gheorghe N N fre Journal Article Variations circadiennes de l'activité et de l'induction de l'aminotransférase de la tyrosine après l'irradiation aux rayons X Romania Physiologie 7510964 1011-6206 EC 2.6.1.5 Tyrosine Transaminase AIM IM Animals Circadian Rhythm Enzyme Induction Liver enzymology Male Mice Radiation Effects Tyrosine Transaminase radiation effects 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 700 701 1976 02 13 2013 11 21 0369-9463 24 6 1975 Physiologia Bohemoslovaca Physiol Bohemoslov Some psysicochemical properties of mitochondrial and cell sap alanine aminotransferase from the rat CNS. 543-9 The authors describe different properties of brain mitochondrial and cell sap alanine aminotransferase. They showed that the mitochondrial enzyme was inhibited by maleate, chlorides, acetate and phosphate with a high ionic strength (over 1.8), that its pH optimum lay between 7.5 and 8.5, that it was thermolabile at over 40 degrees C and that it was salted out from solutions with ammonium sulphate at 0.6--0.8 saturation. The activity of the cell sap enzyme was inhibited by phosphate at an ionic strength of only 0.12, less markedly by maleate and not at all by chlorides and acetate; its pH optimum was about 8, it was thermostable up to 60 degrees C and was precipitated from ammonium sulphate solution at between 0.35 and 0.6 saturation. The authors conclude from their results that two different alanine aminotransferase enzymes are present in the CNS. Ruscák M M Orlický J J eng Journal Article Czech Republic Physiol Bohemoslov 0175317 0369-9463 0 Chlorides 0 Phosphates EC 2.6.1.2 Alanine Transaminase SU46BAM238 Ammonium Sulfate IM Alanine Transaminase antagonists & inhibitors metabolism Ammonium Sulfate pharmacology Animals Brain enzymology Chlorides pharmacology Hydrogen-Ion Concentration Mitochondria drug effects enzymology Phosphates pharmacology Rats Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 701 702 1976 02 19 2006 11 15 0033-2739 27 5 1975 May Psychiatrie, Neurologie, und medizinische Psychologie Psychiatr Neurol Med Psychol (Leipz) [Postvacccinal encephalomyelitis after protective antirabic innoculation, combined with polioencephalomyelitis (lyssa?)]. 312-9 By means of two cases of postvaccinal encephalomyelitis following antirabies vaccination has been demonstrated the meaning of these complications. In one of these cases has been presumed a simultaneous illness of quiet rabies. The difficulty of an aetiological diagnostic by the morphological effigy of the encephalomyelitids has been referred. An improvement of the dispensaire-system and of the diagnostic of complications following antirabies vaccination is postulated. Franke M M Wünscher W W Glatz W W ger Case Reports English Abstract Journal Article Postvakzinale Enzephalomyelitis nach Tollwutschutzimpfung kombiniert mit Polioenzephalomyelitis (Lyssa?) Germany Psychiatr Neurol Med Psychol (Leipz) 0376467 0033-2739 0 Rabies Vaccines IM Adult Bites and Stings complications Cerebral Cortex pathology Encephalomyelitis, Acute Disseminated complications diagnosis pathology Humans Male Middle Aged Poliomyelitis complications pathology Rabies Vaccines adverse effects 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 702 704 1976 02 26 2008 11 21 0033-2941 37 3 Pt 1 1975 Dec Psychological reports Psychol Rep Drug addiction: I. A theoretical framework for behavior therapy. 947-58 Copemann C D CD eng Journal Article Review United States Psychol Rep 0376475 0033-2941 0 Psychotropic Drugs 0 Receptors, Drug IM Animals Aversive Therapy Behavior Therapy Cognition Conditioning, Classical Conditioning, Operant Desensitization, Psychologic Haplorhini Humans Internal-External Control Personality Psychotropic Drugs pharmacology Rats Receptors, Drug drug effects Recurrence Relaxation Therapy Substance Withdrawal Syndrome etiology Substance-Related Disorders etiology therapy 38 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 704 10.2466/pr0.1975.37.3.947 705 1976 02 26 2008 11 21 0033-2941 37 3 Pt 1 1975 Dec Psychological reports Psychol Rep Components of desensitization in modification of fear among genuinely fearful subjects. 959-69 McGlynn F D FD McClaren H A HA eng Journal Article United States Psychol Rep 0376475 0033-2941 IM Behavior Therapy Desensitization, Psychologic Female Humans Imagination Phobic Disorders therapy Relaxation Therapy Tape Recording 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 705 10.2466/pr0.1975.37.3.959 703 1976 02 13 2013 11 21 0033-2674 9 6 1975 Nov-Dec Psychiatria polska Psychiatr Pol [Course and results of treatment with 3 activating neuroleptics]. 613-20 Welbel L L Nurowska K K pol Comparative Study English Abstract Journal Article Przebieg i wyniki leczenia trzema neuroleptykami aktywizujacymi Poland Psychiatr Pol 0103314 0033-2674 0 Piperazines 0 Tranquilizing Agents 7318FJ13YJ Thiothixene FA0UYH6QUO Flupenthixol IM Adult Aged Female Flupenthixol therapeutic use Humans Male Middle Aged Piperazines therapeutic use Schizophrenia drug therapy Thiothixene therapeutic use Tranquilizing Agents therapeutic use 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 703 706 1976 02 09 2020 01 08 44 1 1975 Oct 14 Psychopharmacologia Psychopharmacologia The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. 105-10 Thirteen out of 18 young out-patients with simple schizophrenia under neuroleptic treatment completed a double-blind cross-over trial with Madopar [L-Dopa + benserazid (a peripheral decarboxylase inhibitor)] and placebo. Nine patients were given 900 mg L-Dopa + 225 mg benserazid daily, 1 patient received 600 mg L-Dopa + 150 mg benserazid, and 3 patients, 300 mg L-Dopa + 75 mg benserazid. In these doses, L-Dopa was effective against emotional withdrawal, blunted affect, tendency to isolation and apathy, without inducing or aggravating productive, accessory symptoms. The activity score, according to the specific activity-withdrawal scale, was significantly increased (P less than 0.05), whereas the total BPRS score (Brief Psychiatric Rating Scale) was slightly, but significantly reduced (P less than 0.05). In cases where L-Dopa had to be limited to 600 and 300 mg daily, a tendency to anxiety, distortion of thinking, and a sense of unreality were observed, depending on the dose of L-Dopa. In no case were gastrointestinal, cardiovascular or neurological side-effects observed. Gerlach J J Lühdorf K K eng Clinical Trial Controlled Clinical Trial Journal Article Germany Psychopharmacologia 7609417 0 Antipsychotic Agents 0 Drug Combinations 0 Hydrazines 0 Placebos 46627O600J Levodopa 762OS3ZEJU Benserazide IM Adult Affect drug effects Antipsychotic Agents therapeutic use Anxiety drug therapy Basal Ganglia Diseases chemically induced Benserazide therapeutic use Brief Psychiatric Rating Scale Clinical Trials as Topic Drug Combinations Emotions drug effects Humans Hydrazines therapeutic use Levodopa adverse effects therapeutic use Placebos Psychiatric Status Rating Scales Schizophrenia drug therapy Schizophrenic Psychology Social Behavior drug effects 1975 10 14 1975 10 14 0 1 1975 10 14 0 0 ppublish 706 10.1007/BF00421193 J Pharmacol Exp Ther. 1973 Oct;187(1):15-26 4746324 Psychopharmacologia. 1973;29(4):289-98 4707021 Psychopharmacologia. 1970;18(4):357-65 5491473 JAMA. 1971 Dec 27;218(13):1903-8 5171066 Psychopharmacologia. 1973 Jul 4;31(1):1-12 4578719 Acta Psychiatr Scand Suppl. 1974;249:65-77 4608707 Brain Res. 1974 Sep 13;77(3):521-5 4854165 Curr Ther Res Clin Exp. 1970 Aug;12(8):528-31 4988841 Acta Psychiatr Belg. 1974 Sep;74(5):473-84 4471027 Adv Neurol. 1974;5:347-365 4155234 JAMA. 1971 Dec 27;218(13):1915-20 5000569 Arch Gen Psychiatry. 1973 Aug;29(2):177-89 4147475 Acta Psychiatr Scand. 1966;42(3):264-71 5335155 J Ment Sci. 1957 Jan;103(430):197-9 13416856 Dis Nerv Syst. 1972 Nov;33(11):711-9 4266033 Presse Med. 1959 Jan 24;67(4):123-6 13633822 Isr Ann Psychiatr Relat Discip. 1971 Dec;9(3):252-64 5291459 Psychopharmacologia. 1972;27(4):319-26 4648617 707 1976 02 09 2020 01 08 44 2 1975 Oct 31 Psychopharmacologia Psychopharmacologia The specificity of binding of the narcotic agonist etorphine in synaptic membranes of rat brain in vivo. 125-9 When 3H-etorphine was administered to rats in a pharmacologically effective dose (0.75 mug/kg intracisternally), the labeled drug was concentrated in synaptic membrane fractions isolated from the brains of rats killed 10 min after etorphine injection. Pretreatment of the animals with the narcotic antagonists naloxone, diprenorphine or l-cyclorphan, blocked the pharmacological responses to etorphine and reduced 3H-etorphine binding in the membrane fractions. The differences between 3H-etorphine bound in synaptic membranes of rats treated with d-cyclorphan (inactive isomer) and l-cyclorphan (active antagonist) were in the same range as the reductions in etorphine binding in antagonist-treated rats, indicating that stereospecific and pharmacologically-specific binding sites in synaptic membranes in vivo were of the same magnitude: about 0.04 pmol/g brain. Mulé S J SJ Casella G G Clouet D H DH eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Germany Psychopharmacologia 7609417 0 Morphinans 0 Receptors, Neurotransmitter 1F0L5N25ZZ Diprenorphine 36B82AMQ7N Naloxone 42M2Y6NU9O Etorphine IM Animals Brain cytology metabolism Diprenorphine pharmacology Etorphine antagonists & inhibitors metabolism Male Morphinans metabolism pharmacology Naloxone pharmacology Rats Receptors, Neurotransmitter Stereoisomerism Synaptic Membranes metabolism 1975 10 31 1975 10 31 0 1 1975 10 31 0 0 ppublish 707 10.1007/BF00420998 Science. 1973 Mar 9;179(4077):1011-4 4687585 J Pharmacol Exp Ther. 1975 Mar;192(3):531-7 235639 Res Commun Chem Pathol Pharmacol. 1974 Sep;9(1):55-77 4140562 Proc Natl Acad Sci U S A. 1971 Aug;68(8):1742-7 5288759 Proc Natl Acad Sci U S A. 1973 Aug;70(8):2243-7 4525427 Life Sci. 1966 Apr;5(7):577-82 4225348 Brain Res. 1974 Apr 12;70(1):184-8 4362597 J Neurochem. 1967 Feb;14(2):215-25 4289877 Biochem Pharmacol. 1973 Jun 1;22(11):1283-93 4727782 J Pharmacol Exp Ther. 1953 Mar;107(3):385-93 13035677 Proc Natl Acad Sci U S A. 1973 Jul;70(7):1947-9 4516196 Acta Pharmacol Toxicol (Copenh). 1973;32(3):317-20 4801733 Science. 1973 Dec 28;182(4119):1359-61 4128222 Life Sci. 1973 Dec 1;13(11):1543-56 4768981 J Biol Chem. 1951 Nov;193(1):265-75 14907713 708 1976 02 09 2020 01 08 44 2 1975 Oct 31 Psychopharmacologia Psychopharmacologia The cholinergic system and nociception in the primate: interactions with morphine. 131-7 In Experiment 1 the shock titration task was used to evaluate the antinoceptive properties of 5 different classes of cholinergic compounds in the rhesus monkey. Only scopolamine and high doses of physostigmine were effective in elevating the shock threshold. The apparent antinociceptive effect of physostigmine, however, was difficult to separate from its nonspecific behavioral depressant effect and was probably not related to an increase in cholinergic tone. Experiment 2 examined the interaction of morphine with arecoline, scopolamine and physostigmine. Only scopolamine (0.05 and 0.1 mg/kg) and high doses of physostigmine (0.1 mg/kg) interacted with morphine in the shock titration paradigm. The multiplicative interaction of morphine with scopolamine was confirmed in Experiment 3 over a wider range of doses. It was concluded that morphine and the cholinergic compounds produce antinociceptive effects through different mechanisms of the pain system. Pert A A eng Journal Article Germany Psychopharmacologia 7609417 0 Cholinesterase Inhibitors 0 Ganglionic Blockers 0 Ganglionic Stimulants 0 Parasympatholytics 0 Parasympathomimetics 4ALN5933BH Arecoline 76I7G6D29C Morphine 9U1VM840SP Physostigmine DL48G20X8X Scopolamine IM Analgesia Animals Arecoline pharmacology Cholinesterase Inhibitors pharmacology Drug Synergism Electroshock Ganglionic Blockers pharmacology Ganglionic Stimulants pharmacology Haplorhini Macaca mulatta Morphine pharmacology Pain Parasympathetic Nervous System physiology Parasympatholytics pharmacology Parasympathomimetics pharmacology Physostigmine pharmacology Scopolamine pharmacology Sensory Receptor Cells drug effects 1975 10 31 1975 10 31 0 1 1975 10 31 0 0 ppublish 708 10.1007/BF00420999 J Physiol. 1965 Apr;177:411-9 14321488 Arch Int Pharmacodyn Ther. 1971 Feb;189(2):384-7 5548780 Br J Pharmacol. 1970 Sep;40(1):92-101 5487027 Int J Neuropharmacol. 1965 Nov;4(6):309-16 4379936 J Pharmacol Exp Ther. 1972 Oct;183(1):31-40 4673086 Ann N Y Acad Sci. 1957 Mar 14;66(3):496-507 13425238 Pharmacol Biochem Behav. 1973 Jul-Aug;1(4):427-31 4777579 J Pharmacol Exp Ther. 1969 Sep;169(1):17-22 4389919 Br J Pharmacol. 1971 Dec;43(4):706-14 4261560 Int J Neuropharmacol. 1969 Sep;8(5):413-25 5344487 Acta Physiol Pharmacol Neerl. 1954;3(2):164-72 13180354 Pharmacol Biochem Behav. 1973 Jul-Aug;1(4):433-44 4204777 Br J Pharmacol. 1971 Sep;43(1):53-66 5136464 Int J Neuropharmacol. 1968 Jul;7(4):325-35 5752933 Brain Res. 1974 Nov 8;80(1):135-40 4424093 Fed Proc. 1970 Jan-Feb;29(1):28-31 4391649 J Pharmacol Exp Ther. 1951 Feb;101(2):132-43 14814606 709 1976 02 09 2020 01 08 44 2 1975 Oct 31 Psychopharmacologia Psychopharmacologia Effects of thienodiazepine derivatives on human sleep as compared to those of benzodiazepine derivatives. 165-71 The effects of new thienodiazepine derivatives, such as clotiazepam and Y-7131, on normal human sleep were investigated on 5 subjects and compared to those of benzodiazepine derivatives, such as diazepam and nitrazepam. REM sleep was significantly decreased only with 2 mg of Y-7131 and rebound elevation of REM sleep did not follow in recovery 1 and 2 nights. By using partial differential REM deprivation which was designed by us, there was also no rebound elevation of REM sleep noted in recovery 2 nights following 2 mg of Y-7131 medication. REM sleep was not suppressed with 15 mg of clotiazepam, 6 mg of diazepam and 10 mg of nitrazepam when compared to the baseline night. With regard to NREM sleep, stage 2 was significantly increased with 15 mg of clotiazepam and 10 mg of nitrazepam, but stage SWS was significantly decreased with 10 mg of nitrazepam. Nakazawa Y Y Kotorii M M Oshima M M Horikawa S S Tachibana H H eng Clinical Trial Comparative Study Journal Article Germany Psychopharmacologia 7609417 0 Anti-Anxiety Agents 0 Azepines 0 Thiophenes 0 Tranquilizing Agents 9CLV70W7HS Nitrazepam A76XI0HL37 etizolam Q3JTX2Q7TU Diazepam IM Adult Anti-Anxiety Agents pharmacology Azepines pharmacology Clinical Trials as Topic Diazepam pharmacology Humans Male Nitrazepam pharmacology Sleep drug effects Sleep Deprivation Sleep, REM drug effects Thiophenes pharmacology Tranquilizing Agents pharmacology 1975 10 31 1975 10 31 0 1 1975 10 31 0 0 ppublish 709 10.1007/BF00421005 Annu Rev Pharmacol. 1973;13:243-52 4351673 J Nerv Ment Dis. 1968 Feb;146(2):165-73 5652833 Nature. 1969 Aug 30;223(5209):893-7 4308512 Biol Psychiatry. 1969 Jul;1(3):243-58 4311771 Electroencephalogr Clin Neurophysiol. 1969 Dec;27(6):574-80 4188781 J Nerv Ment Dis. 1975 Jul;161(1):18-25 168312 Res Publ Assoc Res Nerv Ment Dis. 1967;45:86-126 4384265 Int Psychiatry Clin. 1970;7(2):308-28 4316513 Br Med J. 1970 May 9;2(5705):318-22 4317051 Prog Brain Res. 1965;18:160-9 14329034 Arzneimittelforschung. 1972 Nov;22(11):1905-14 4633588 Adv Pharmacol Chemother. 1971;9:1-91 4403280 Br Med J. 1965 Nov 6;2(5470):1093-5 20790751 Electroencephalogr Clin Neurophysiol. 1967 Sep;23(3):288 4167956 Folia Psychiatr Neurol Jpn. 1973;27(3):223-30 4356561 Psychopharmacologia. 1973;33(2):185-202 4590754 Prog Brain Res. 1965;18:175-7 14329036 Electroencephalogr Clin Neurophysiol. 1970 Feb;28(2):211-2 4189543 Br J Psychiatry. 1969 Dec;115(529):1403-10 4311607 Psychiatry Clin Neurosci. 2001 Jun;55(3):305-10 11422885 Br J Psychiatry. 1972 Jun;120(559):663-72 4339630 710 1976 02 09 2020 01 08 44 2 1975 Oct 31 Psychopharmacologia Psychopharmacologia Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man. 205-8 Forty paid healthy male students participated in two subacute experiments of 6 weeks each. In the first trial 20 of them received bromazepam, thioridazine, and placebo double blind cross over for 2 weeks each, and in the second trial the active agents administered to the other 20 participants were chlorpromazine and sulpiride. The tests used were paired associate learning with nonsense syllables and digit memory span. Before testing the subjects took either an alcoholic or a nonalcoholic bitter drink. As in the previous study from this laboratory, alcohol was found to impair learning capacity. Of the drugs used only bromazepam impaired learning significantly, and the combined effect of alcohol and bromazepam on learning capacity was very deleterious. The adrenolytic effect of drugs did not correlate with their effect on learning. Caution is necessary when prescribing bromazepam for active outpatients at least in doses used in this study. Liljequist R R Linnoila M M Mattila M J MJ Saario I I Seppälä T T eng Clinical Trial Controlled Clinical Trial Journal Article Germany Psychopharmacologia 7609417 0 Anti-Anxiety Agents 0 Psychotropic Drugs 0 Receptors, Drug 3K9958V90M Ethanol 7MNE9M8287 Sulpiride N3D6TG58NI Thioridazine U42B7VYA4P Chlorpromazine X015L14V0O Bromazepam IM Adult Animals Anti-Anxiety Agents pharmacology Bromazepam blood pharmacology Chlorpromazine pharmacology Clinical Trials as Topic Drug Synergism Ethanol pharmacology Humans Male Memory, Short-Term drug effects Paired-Associate Learning drug effects Psychotropic Drugs blood Rabbits Receptors, Drug Sulpiride pharmacology Thioridazine pharmacology 1975 10 31 1975 10 31 0 1 1975 10 31 0 0 ppublish 710 10.1007/BF00421011 Int Rev Neurobiol. 1965;8:77-138 4954552 Eur J Clin Pharmacol. 1973 Aug;6(2):107-12 4588850 Pharmacol Biochem Behav. 1973 May-Jun;1(3):295-300 4775859 Science. 1963 Apr 19;140(3564):318-9 13980668 Annu Rev Psychol. 1972;23:73-104 4335280 J Oral Surg. 1974 Sep;32(9):651-64 4528957 Can Med Assoc J. 1969 Jun 28;100(24):1115-25 5786004 Eur J Pharmacol. 1974 Sep;28(1):178-88 4430320 Experientia. 1969 Jan 15;25(1):103-4 5766556 Psychopharmacologia. 1974;39(2):181-6 4449926 Clin Pharmacol Ther. 1973 Nov-Dec;14(6):978-86 4584156 Br J Anaesth. 1970 Aug;42(8):690-7 5485133 Clin Pharmacol Ther. 1975 May;17(5):515-22 1092511 712 1976 02 09 2013 11 21 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Molecular mechanisms in the receptor-mediated regulation of tyrosine hydroxylase. 11-2 Lovenberg W W Bruckwick E A EA eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Catecholamines 0 Receptors, Drug E0399OZS9N Cyclic AMP EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 2.7.- Protein Kinases IM Animals Catecholamines biosynthesis Cyclic AMP metabolism Protein Kinases metabolism Rats Receptors, Drug drug effects Tyrosine 3-Monooxygenase metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 712 713 1976 02 09 2013 11 21 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Plasma/blood level monitoring techniques in psychiatry. 18-20 Cooper T B TB Simpson G M GM eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Phenothiazines 0 Psychotropic Drugs 9FN79X2M3F Lithium IM Enzyme Induction drug effects Humans Lithium blood Methods Phenothiazines blood Psychiatry Psychotropic Drugs blood 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 713 714 1976 02 09 2017 03 22 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Short or long hospitalization for psychiatric disorders? 35-7 Glick I D ID Hargreaves W A WA Drues J J Showstack J A JA eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Antipsychotic Agents 0 Phenothiazines IM Antipsychotic Agents therapeutic use Hospitalization Humans Length of Stay Mental Disorders therapy Phenothiazines Psychiatric Status Rating Scales Psychotherapy Schizophrenia drug therapy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 714 711 1976 03 01 2019 08 27 0033-3174 37 6 1975 Nov-Dec Psychosomatic medicine Psychosom Med Effects of chronic exposure to stressors on avoidance-escape behavior and on brain norepinephrine. 522-34 A single exposure to a severe stressor (either cold swim or inescapable shock) impairs subsequent performance in a shuttle avoidance-escape task (1), a deficit attributed to reduction in brain noradrenergic activity produced by these stressors. In the present paper, two experiments are described which examine how repeated exposure to such stressors affects (a) shuttle avoidance-escape performance (Experiment 1), and (b) aspects of brain norepinephrine metabolism (Experiment 2). Experiment 1 showed that, whereas subjects receiving the single exposure to cold swim or shock showed a large avoidance-escape deficit, subjects that received repeated exposure to these stressors for 14 days performed similarly to the control group that received no stressor. Experiment 2 showed that, whereas subjects that received one session of the inescapable shock stressor showed a lower level of norepinephrine in hypothalamus and cortex than did subjects that received no shock, subjects that received repeated exposure to inescapable shock or cold swim showed neurochemical "habituation." Subjects that received repeated shock showed elevated tyrosine hydroxylase activity and no depletion of norepinephrine level, and both repeated shock and cold swim caused a decrease in uptake of 3H-norepinephrine by slices of cortex in vitro. Thus, it is concluded that the behavioral and neurochemical changes that were observed after the stressful conditions studied are consistent with the hypothesis that changes in avoidance-escape responding following exposure to these stressful events are due to changes in brain noradrenergic activity. Weiss J M JM Glazer H I HI Pohorecky L A LA Brick J J Miller N E NE eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. United States Psychosom Med 0376505 0033-3174 EC 1.14.16.2 Tyrosine 3-Monooxygenase X4W3ENH1CV Norepinephrine IM Animals Avoidance Learning physiology Brain enzymology metabolism Cerebral Cortex metabolism Cold Temperature Electroshock Escape Reaction physiology Humans Hypothalamus metabolism Male Norepinephrine metabolism Rats Reaction Time physiology Stress, Psychological physiology Swimming Time Factors Tyrosine 3-Monooxygenase metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 711 10.1097/00006842-197511000-00006 715 1976 02 09 2013 11 21 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Long-acting phenothiazine and social therapy in the community treatment of acute schizophrenics. 37-8 Goldstein M J MJ Rodnick E H EH Evans J R JR May P R PR eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Antipsychotic Agents S79426A41Z Fluphenazine IM Acute Disease Antipsychotic Agents therapeutic use Community Mental Health Services Family Therapy Fluphenazine therapeutic use Humans Patient Acceptance of Health Care Psychiatric Status Rating Scales Schizophrenia drug therapy therapy 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 715 716 1976 02 09 2009 11 11 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull CNS stimulants and anabolic substances in geropsychiatric therapy. 51 Lehmann H E HE Ban T A TA eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Anabolic Agents 0 Central Nervous System Stimulants IM Aged Anabolic Agents therapeutic use Central Nervous System Stimulants therapeutic use Dementia drug therapy Humans 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 716 717 1976 02 09 2013 11 21 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Gerovital-H3--a review of the literature. 51-3 Jarvik L F LF Milne J F JF eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Anesthetics, Local 0 Anticholesteremic Agents 0 Monoamine Oxidase Inhibitors 4Z8Y51M438 Procaine IM Aged Aging drug effects Anesthetics, Local pharmacology Anticholesteremic Agents pharmacology Dementia drug therapy Depression drug therapy Humans Hydrogen-Ion Concentration Monoamine Oxidase Inhibitors pharmacology Procaine adverse effects metabolism pharmacology therapeutic use 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 717 718 1976 02 09 2019 12 10 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Behavior analysis of the effects and mechanisms of action of benzodiazepines. 53-5 Cook L L Sepinwall J J eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Anti-Anxiety Agents 0 Neurotransmitter Agents 12794-10-4 Benzodiazepines IM Animals Anti-Anxiety Agents pharmacology Avoidance Learning drug effects Behavior, Animal drug effects Benzodiazepines Conflict, Psychological Neurotransmitter Agents physiology Rats 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 718 719 1976 02 09 2014 11 20 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. 55-6 Fuxe K K Agnati L L Bolme P P eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Aminobutyrates 0 Anti-Anxiety Agents 0 Catecholamines 12794-10-4 Benzodiazepines 56-12-2 gamma-Aminobutyric Acid IM Aminobutyrates physiology Animals Anti-Anxiety Agents pharmacology Benzodiazepines Catecholamines metabolism physiology Depression, Chemical In Vitro Techniques Neurons drug effects physiology Rats gamma-Aminobutyric Acid physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 719 720 1976 02 09 2014 11 20 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Possible involvement of GABA in the central actions of benzodiazepines. 58-9 Haefely W W Kulcsár A A Möhler H H eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Aminobutyrates 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines 14I68GI3OQ Aminooxyacetic Acid 56-12-2 gamma-Aminobutyric Acid IM Aminobutyrates physiology Aminooxyacetic Acid pharmacology Animals Anti-Anxiety Agents pharmacology Benzodiazepines Cats In Vitro Techniques Mice Neurons drug effects physiology gamma-Aminobutyric Acid physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 720 721 1976 02 09 2014 11 20 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Involvement of GABA in the action of benzodiazepine--studies on rat cerebellum. 59-60 Costa E E Guidotti A A Mao C C CC eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Aminobutyrates 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines 56-12-2 gamma-Aminobutyric Acid H2D2X058MU Cyclic GMP IM Aminobutyrates physiology Animals Anti-Anxiety Agents pharmacology Benzodiazepines Cerebellum drug effects Cyclic GMP physiology In Vitro Techniques Rats gamma-Aminobutyric Acid physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 721 722 1976 02 09 2009 11 11 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull On characterizing psychosis in multi-ethnic settings. 63-4 Katz M M MM Sanborn K O KO eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 IM Ethnopsychology Hawaii Humans Hydrogen-Ion Concentration ethnology Japan ethnology Psychotic Disorders diagnosis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 722 723 1976 02 09 2014 11 20 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Dopamine neurons: role of impulse flow and presynaptic receptors in the regulation of tyrosine hydroxylase. 8 Roth R H RH Walters J R JR Murrin L C LC Morgenroth V H VH 3rd eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Receptors, Drug EC 1.14.16.2 Tyrosine 3-Monooxygenase VTD58H1Z2X Dopamine IM Animals Corpus Striatum enzymology Dopamine physiology Electric Stimulation Enzyme Activation In Vitro Techniques Neurons physiology Receptors, Drug Tyrosine 3-Monooxygenase metabolism 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 723 724 1976 02 09 2014 11 20 0048-5764 11 4 1975 Oct Psychopharmacology bulletin Psychopharmacol Bull Evidence for drug actions on both pre- and postsynaptic catecholamine receptors in the CNS. 8-10 Bunney B S BS Aghajanian G K GK eng Journal Article United States Psychopharmacol Bull 0101123 0048-5764 0 Antipsychotic Agents 0 Catecholamines 0 Receptors, Drug VTD58H1Z2X Dopamine IM Animals Antipsychotic Agents pharmacology Catecholamines physiology Central Nervous System drug effects Dopamine physiology In Vitro Techniques Receptors, Drug drug effects Synapses physiology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 724 725 1976 03 01 2018 02 17 0033-3190 26 2 1975 Psychotherapy and psychosomatics Psychother Psychosom Evaluation of combined pharmacological and psychotherapeutic treatment in patients with functional abdominal disorders. 86-92 78 patients suffering from various functional abdominal complaints have been trated in a 2 x 2 double-blind design: (a) psychotherapy with Ro 5-3350 (TH/Ro); (b) psychotherapy with placebo (TH/P); (c) Ro 5-3350 without psychotherapy (NIH/Ro); (d) placebo without psychotherapy (NTH/P). Results show that a considerable amount of improvement cannot be ascribed to the two critical factors or the interaction of both, but are due to unspecific influences in the course of treatment. Some of the results concerning the combination of TH and the psychotropic drug pose interesting questions for further research and bare implications for double-blind trials of psychotropic drugs. The results suggest that possibly properties of any psychotropic drug have to be related to a doctor-patient relationship within which the personal problems of the patient are dealt with. In order to evaluate such properties, special methodological precautions have to be taken. These will be briefly discussed. Schonecke O W OW Schüffel W W eng Clinical Trial Controlled Clinical Trial Journal Article Switzerland Psychother Psychosom 0024046 0033-3190 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines IM Anti-Anxiety Agents therapeutic use Benzodiazepines Clinical Trials as Topic Gastrointestinal Diseases drug therapy therapy Humans Personality Inventory Physician-Patient Relations Psychophysiologic Disorders drug therapy therapy Psychotherapy, Brief 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 725 10.1159/000286915 726 1976 03 01 2019 10 27 0033-5835 8 3 1975 Jul Quarterly reviews of biophysics Q Rev Biophys Allosteric interpretation of haemoglobin properties. 325-420 Shulman R G RG Hopfield J J JJ Ogawa S S eng Journal Article Review England Q Rev Biophys 0144032 0033-5835 0 Diphosphoglyceric Acids 0 Hemoglobins 0 Hemoglobins, Abnormal 0 Ligands 0 Organophosphorus Compounds 0 Protons 0 Spin Labels 42VZT0U6YR Heme 7U1EE4V452 Carbon Monoxide K848JZ4886 Cysteine S88TT14065 Oxygen IM Allosteric Site Binding Sites Carbon Monoxide Chemical Phenomena Chemistry, Organic Chemistry, Physical Cysteine Diphosphoglyceric Acids Heme Hemoglobins physiology Hemoglobins, Abnormal Hydrogen-Ion Concentration Kinetics Ligands Magnetic Resonance Spectroscopy Models, Chemical Organic Chemistry Phenomena Organophosphorus Compounds Oxygen Protein Conformation Protons Spin Labels Structure-Activity Relationship 127 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 726 10.1017/s0033583500001840 727 1976 02 27 2014 11 20 0033-7587 64 3 1975 Dec Radiation research Radiat Res Effects of x-irradiation on cell division, oxygen consumption, and growth medium pH of an insect cell line cultured in vitro. 524-32 Koval T M TM Myser W C WC Hink W F WF eng Journal Article United States Radiat Res 0401245 0033-7587 0 Culture Media IM S Animals Cell Division radiation effects Cell Line Cells, Cultured metabolism radiation effects Culture Media Hydrogen-Ion Concentration In Vitro Techniques Lepidoptera radiation effects Moths radiation effects Oxygen Consumption radiation effects Radiation Effects X-Rays 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 727 728 1976 02 27 2013 11 21 0033-7587 64 3 1975 Dec Radiation research Radiat Res Letter: The reactions of hydrogens atoms in aqueous solutions: effect of pH on reactions with cysteine and penicillamine. 662-6 Wu J T JT Kuntz R R RR eng Journal Article United States Radiat Res 0401245 0033-7587 0 Radiation-Protective Agents 0 Radiation-Sensitizing Agents 0 Solutions 059QF0KO0R Water 7YNJ3PO35Z Hydrogen GNN1DV99GX Penicillamine K848JZ4886 Cysteine IM S Cysteine Hydrogen Hydrogen-Ion Concentration Penicillamine Radiation-Protective Agents Radiation-Sensitizing Agents Solutions Water 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 728 729 1976 02 09 2013 11 21 0079-6123 42 1975 Progress in brain research Prog Brain Res Behavioral effects of hypothalamic releasing hormones in animals and men. 1-9 Prange A J AJ Jr Wilson I C IC Breese G R GR Lipton M A MA eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Review Netherlands Prog Brain Res 0376441 0079-6123 33515-09-2 Gonadotropin-Releasing Hormone 42HK56048U Tyrosine 51110-01-1 Somatostatin 534-82-7 Methoxyhydroxyphenylglycol 5Y5F15120W Thyrotropin-Releasing Hormone 9083-38-9 MSH Release-Inhibiting Hormone I4744080IR Pentobarbital X4W3ENH1CV Norepinephrine IM Animals Behavior drug effects Brain drug effects metabolism Child Depression drug therapy Female Gonadotropin-Releasing Hormone pharmacology Humans Hyperkinesis drug therapy MSH Release-Inhibiting Hormone pharmacology Methoxyhydroxyphenylglycol metabolism Mice Motor Activity drug effects Norepinephrine metabolism Pentobarbital antagonists & inhibitors Rats Schizophrenia drug therapy Somatostatin pharmacology Temperature Thyrotropin-Releasing Hormone pharmacology therapeutic use Tyrosine metabolism 49 1975 1 1 2001 3 28 10 1 1975 1 1 0 0 ppublish 729 S0079-6123(08)63636-5 10.1016/S0079-6123(08)63636-5 730 1976 02 09 2013 11 21 0079-6123 42 1975 Progress in brain research Prog Brain Res Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies. 11-23 Plotnikoff N P NP eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 0 Neurotransmitter Agents 5Y5F15120W Thyrotropin-Releasing Hormone 63-84-3 Dihydroxyphenylalanine 9083-38-9 MSH Release-Inhibiting Hormone 9MV14S8G3E Pargyline OGG85SX4E4 Imipramine X77S6GMS36 Homovanillic Acid IM Animals Behavior, Animal drug effects Brain drug effects metabolism Dihydroxyphenylalanine pharmacology Drug Synergism Female Homovanillic Acid metabolism Imipramine pharmacology MSH Release-Inhibiting Hormone pharmacology Male Mice Neurotransmitter Agents metabolism Pargyline pharmacology Rats Thyrotropin-Releasing Hormone pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 730 S0079-6123(08)63637-7 10.1016/S0079-6123(08)63637-7 731 1976 02 09 2019 09 02 0079-6123 42 1975 Progress in brain research Prog Brain Res Some effects of ACTH4-10 on performance during a continuous reaction task. 209-10 Gaillard A W AW Sanders A F AF eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 0 Peptide Fragments 9002-60-2 Adrenocorticotropic Hormone IM Adrenocorticotropic Hormone pharmacology Humans Mental Fatigue Peptide Fragments pharmacology Reaction Time drug effects 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 731 10.1016/s0079-6123(08)63663-8 732 1976 02 09 2015 11 19 0079-6123 42 1975 Progress in brain research Prog Brain Res The renin-angiotensin system and drinking behavior. 215-33 Fitzsimons J T JT eng Journal Article Review Netherlands Prog Brain Res 0376441 0079-6123 0 Adrenergic alpha-Antagonists 0 Catecholamines 0 Saline Solution, Hypertonic 059QF0KO0R Water 11128-99-7 Angiotensin II 8Y164V895Y Carbachol EC 3.4.23.15 Renin IM Adrenergic alpha-Antagonists pharmacology Angiotensin II administration & dosage pharmacology Animals Carbachol pharmacology Catecholamines physiology Cats Columbidae Dogs Drinking Behavior drug effects Extracellular Space physiology Goats Haplorhini Iguanas Injections, Intraventricular Rabbits Rats Renin pharmacology physiology Saline Solution, Hypertonic pharmacology Thirst physiology Water 55 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 732 S0079-6123(08)63666-3 10.1016/S0079-6123(08)63666-3 733 1976 02 09 2013 11 21 0079-6123 42 1975 Progress in brain research Prog Brain Res Neurotransmitters and temperature regulation. 251-61 Lomax P P Green M D MD eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 0 Neurotransmitter Agents 820484N8I3 Histamine IM Animals Body Temperature Regulation drug effects Cerebral Ventricles physiology Histamine pharmacology Hypothalamus physiology Neurotransmitter Agents pharmacology Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 733 S0079-6123(08)63668-7 10.1016/S0079-6123(08)63668-7 734 1976 02 09 2017 03 22 0079-6123 42 1975 Progress in brain research Prog Brain Res Neuroendocrine effects of perinatal androgenization in the male ferret. 343-55 Baum M J MJ Schretlen P P eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 3XMK78S47O Testosterone IM Animals Animals, Newborn Body Weight Circadian Rhythm Cryptorchidism chemically induced Female Ferrets Gestational Age Hypothalamus physiology Male Penis drug effects Pregnancy Sexual Behavior, Animal drug effects Testis analysis drug effects Testosterone blood pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 734 S0079-6123(08)63691-2 10.1016/S0079-6123(08)63691-2 735 1976 02 09 2019 09 02 0079-6123 42 1975 Progress in brain research Prog Brain Res Delta-9-tetrahydrocannabinol action and neuronal membrane-bound enzymes. 375 Ghosh J J JJ Poddar M K MK Nag D D Biswas B B eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 7J8897W37S Dronabinol EC 3.1.1.7 Acetylcholinesterase EC 3.6.1.- Adenosine Triphosphatases EC 6.3.1.2 Glutamate-Ammonia Ligase IM Acetylcholinesterase metabolism Adenosine Triphosphatases metabolism Animals Brain drug effects enzymology Cannabis pharmacology Dronabinol pharmacology Glutamate-Ammonia Ligase metabolism Microsomes enzymology Rats Synaptosomes enzymology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 735 10.1016/s0079-6123(08)63702-4 736 1976 02 09 2019 09 02 0079-6123 42 1975 Progress in brain research Prog Brain Res Modification of in vitro neurotransmitter release from rat brain slices by hypophyseotropic factors. 67-8 Mulder A H AH Smelik P G PG eng Journal Article Netherlands Prog Brain Res 0376441 0079-6123 0 Neurotransmitter Agents 5Y5F15120W Thyrotropin-Releasing Hormone 9083-38-9 MSH Release-Inhibiting Hormone IM Animals Corpus Striatum drug effects metabolism Hypophysectomy Hypothalamus drug effects metabolism MSH Release-Inhibiting Hormone pharmacology Neurotransmitter Agents metabolism Rats Thyrotropin-Releasing Hormone pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 736 S0079-6123(08)63643-2 10.1016/s0079-6123(08)63643-2 738 1976 02 09 2019 10 27 0079-6107 29 3 1975 Progress in biophysics and molecular biology Prog Biophys Mol Biol Structure and function of haemoglobin. 225-320 Baldwin J M JM eng Journal Article Review England Prog Biophys Mol Biol 0401233 0079-6107 0 Diphosphoglyceric Acids 0 Hemoglobins 0 Hemoglobins, Abnormal 0 Ligands 0 Oxyhemoglobins 42VZT0U6YR Heme 7IGF0S7R8I Phytic Acid 9008-37-1 Methemoglobin S88TT14065 Oxygen IM Allosteric Regulation Allosteric Site Animals Binding Sites Diphosphoglyceric Acids blood Heme analysis Hemoglobins physiology Hemoglobins, Abnormal Humans Hydrogen-Ion Concentration Kinetics Ligands Mathematics Methemoglobin Osmolar Concentration Oxygen blood Oxyhemoglobins Phytic Acid blood Protein Binding Protein Conformation Thermodynamics 264 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 738 10.1016/0079-6107(76)90024-9 739 1976 02 27 2013 11 21 0039-9450 20 12 1975 Oct Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme Tanpakushitsu Kakusan Koso [The role of Mg and Ca ions in muscle contraction (author's transl)]. 1095-110 Watanabe S S jpn Journal Article Review Japan Tanpakushitsu Kakusan Koso 0413762 0039-9450 8L70Q75FXE Adenosine Triphosphate 9013-26-7 Actomyosin EC 3.6.1.- Adenosine Triphosphatases EC 3.6.4.1 Myosins I38ZP9992A Magnesium SY7Q814VUP Calcium IM Actomyosin metabolism Adenosine Triphosphatases metabolism Adenosine Triphosphate metabolism Animals Calcium physiology Cattle Chemical Phenomena Chemistry Hydrogen-Ion Concentration Magnesium physiology Muscle Contraction Muscles enzymology Myosins metabolism Rabbits 53 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 739 737 1976 03 01 2019 09 18 0033-0620 18 4 1976 Jan-Feb Progress in cardiovascular diseases Prog Cardiovasc Dis Techniques for the study of the biochemical basis of drug action. 309-21 Lefkowitz R J RJ Limbird L E LE eng Journal Article Review United States Prog Cardiovasc Dis 0376442 0033-0620 0 Catecholamines 0 Receptors, Adrenergic 0 Receptors, Cell Surface 0 Receptors, Cholinergic 0 Receptors, Drug E0399OZS9N Cyclic AMP EC 2.7.- Protein Kinases EC 3.6.1.- Adenosine Triphosphatases EC 4.6.1.1 Adenylyl Cyclases EC 4.6.1.2 Guanylate Cyclase H2D2X058MU Cyclic GMP AIM IM Adenosine Triphosphatases physiology Adenylyl Cyclases physiology Animals Binding Sites Catecholamines pharmacology Cell Fractionation Cell Membrane Cyclic AMP physiology Cyclic GMP physiology Enzyme Activation Enzyme Repression Guanylate Cyclase physiology Heart drug effects Humans Protein Kinases physiology Receptors, Adrenergic Receptors, Cell Surface Receptors, Cholinergic Receptors, Drug Subcellular Fractions 84 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 737 0033-0620(76)90024-4 10.1016/0033-0620(76)90024-4 741 1976 02 27 2013 11 21 0363-5872 6 1975 Recent advances in studies on cardiac structure and metabolism Recent Adv Stud Cardiac Struct Metab Role of cardiovascular and ionic changes in pathogenesis and prevention of isoprenaline-induced cardiac necrosis. 135-42 Blood pressure, heart rate, oxygen uptake, and blood values of PO2, PCO2, and pH were studied in unanesthetized rats for 8 hours. After a cardiotoxic dose of 20 mg/kg isoprenaline, s.c., blood pressure fell from 117 to 72 mm Hg, heart rate accelerated from 326 to 497 beats/minute, and cardiac work diminished by about 15%. Metabolic rate increased by about 80%, blood values of PO2 rose, and those of PCO2 fell somewhat, whereas blood pH dropped from 7.48 to 7.38, indicating metabolic acidosis. Propranolol (40 mg/kg, i.p.) and verapamil (50 mg/kg, i.p.), both of which almost completely prevented isoprenaline-induced cardiac necroses, inhibited the chronotropic and calorigenic actions of isoprenaline by about 50%. While propranolol inhibited the depressor effect of isoprenaline completely, verapamil enhanced it: blood pressure fell to 46 mm Hg. Isoprenaline-induced fall of blood pH was not prevented by either propranolol or verapamil. Decrease of blood pH and cardionecrotisation were enhanced when isoprenaline was given together with 4.8 g/kg ethanol, p.o. In conclusion, hemodynamic actions of isoprenaline, especially hypotension, seem to be nonessential for the production of cardiac necroses. Strong acidification can aggravate the cardiotoxicity of isoprenaline. Strubelt O O Siegers C P CP eng Journal Article United States Recent Adv Stud Cardiac Struct Metab 0325677 0363-5872 142M471B3J Carbon Dioxide 9Y8NXQ24VQ Propranolol CJ0O37KU29 Verapamil L628TT009W Isoproterenol S88TT14065 Oxygen IM Animals Blood Pressure drug effects Carbon Dioxide blood Cardiomyopathies chemically induced pathology physiopathology prevention & control Heart Rate drug effects Hydrogen-Ion Concentration Isoproterenol antagonists & inhibitors pharmacology Male Myocardium metabolism Necrosis Oxygen blood Oxygen Consumption drug effects Propranolol therapeutic use Rats Verapamil therapeutic use 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 741 742 1976 02 27 2013 11 21 0363-5872 6 1975 Recent advances in studies on cardiac structure and metabolism Recent Adv Stud Cardiac Struct Metab Alterations in norepinephrine pattern in the damaged myocardium in the rat. 159-65 In the albino rat, the evolvement of myocardial necrosis induced by a single injection of ISO was accompanied by a fall in total NE. Pretreatment with propranolol and pargyline protected against ISO-induced necrosis and myocardial hypertrophy, but did not influence the ISO-induced depletion of NE stores. The depletion of NE stores is not due to impairment in synthesis or increased intraneuronal metabolism of NE since, in ISO-treated rats, neither cardiac tyrosine hydroxylase activity nor MAO activity was altered. The decrease in endogenous NE is not due to a defect in the storage of NE. The ability of myocardium to take up and store NE returned to normal within 48 hours, whereas endogenous levels returned to normal within 5 days, even in the presence of demonstrable necrosis. Thus, there is lack of correlation between chemical and morphological changes, since catecholamine depletion occurred in the absence of morphologically demonstrable tissue injury, and the function of the adrenergic neuron returns to normal in the presence of demonstrable necrosis. Bhagat B B Sullivan J M JM Dhalla N S NS eng Journal Article United States Recent Adv Stud Cardiac Struct Metab 0325677 0363-5872 9MV14S8G3E Pargyline 9Y8NXQ24VQ Propranolol EC 1.14.16.2 Tyrosine 3-Monooxygenase EC 1.4.3.4 Monoamine Oxidase L628TT009W Isoproterenol X4W3ENH1CV Norepinephrine IM Animals Cardiomegaly chemically induced Cardiomyopathies chemically induced metabolism pathology Isoproterenol pharmacology Male Monoamine Oxidase metabolism Myocardium enzymology metabolism Necrosis Norepinephrine metabolism Pargyline pharmacology Propranolol pharmacology Rats Tyrosine 3-Monooxygenase metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 742 740 1976 02 09 2018 12 03 0035-1040 61 5 1975 Jul-Aug Revue de chirurgie orthopedique et reparatrice de l'appareil moteur Rev Chir Orthop Reparatrice Appar Mot [Giant cell tumors. Conclusions]. 447-50 d'Aubigné R M RM fre Congress Les tumeurs à cellules géantes. Conclusions. France Rev Chir Orthop Reparatrice Appar Mot 1272427 0035-1040 IM Bone Neoplasms Congresses as Topic France Giant Cell Tumors Humans 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 740 743 1976 02 27 2017 03 22 0363-5872 6 1975 Recent advances in studies on cardiac structure and metabolism Recent Adv Stud Cardiac Struct Metab Prevention of myocardial Ca overload and necrotization by Mg and K salts or acidosis. 33-42 The crucial point in the pathogenesis of isoproterenol-induced myocardial necrotization is an abundant intracellular Ca accumulation leading to high energy phosphate exhaustion. Accordingly, in the early stage of the isoproterenol-induced necrotization process, the onset of ATP and creatine phosphate breakdown strictly parallels the acute Ca gain. In this type of necrosis, the Mg losses from the myocardium appear as a concomitant phenomenon. The hearts can be protected against the deleterious Ca overload and necrotization by increasing the plasma concentration of Mg, K, or H ions in order to counterbalance Ca according to the ration (see article). On the other hand, if Mg, K, or H ion concentrations are too low, isoproterenol-induced Ca uptake and myocardial lesions are potentiated. Janke J J Fleckenstein A A Hein B B Leder O O Sigel H H eng Journal Article United States Recent Adv Stud Cardiac Struct Metab 0325677 0363-5872 020IUV4N33 Phosphocreatine 8L70Q75FXE Adenosine Triphosphate I38ZP9992A Magnesium L628TT009W Isoproterenol RWP5GA015D Potassium SY7Q814VUP Calcium IM Adenosine Triphosphate metabolism Animals Calcium antagonists & inhibitors metabolism Cardiomyopathies chemically induced metabolism prevention & control Dose-Response Relationship, Drug Hydrogen-Ion Concentration Isoproterenol antagonists & inhibitors Magnesium pharmacology therapeutic use Myocardium metabolism Necrosis Phosphocreatine metabolism Potassium pharmacology therapeutic use Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 743 744 1976 02 09 2019 10 27 0079-9963 31 1975 Recent progress in hormone research Recent Prog Horm Res Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man. 95-139 Roth J J Kahn C R CR Lesniak M A MA Gorden P P De Meyts P P Megyesi K K Neville D M DM Jr Gavin J R JR 3rd Soll A H AH Freychet P P Goldfine I D ID Bar R S RS Archer J A JA eng Journal Article Review United States Recent Prog Horm Res 0404471 0079-9963 0 Insulin 0 Receptors, Cell Surface 9002-72-6 Growth Hormone IM Animals Binding Sites Body Weight Cell Line Cell Membrane metabolism Diabetes Mellitus metabolism Growth Hormone metabolism Humans Hydrogen-Ion Concentration Insulin metabolism Insulin Resistance Kinetics Liver metabolism Lymphocytes metabolism Mice Mice, Obese Molecular Weight Obesity metabolism Protein Binding Receptors, Cell Surface 84 1975 1 1 2001 3 28 10 1 1975 1 1 0 0 ppublish 744 10.1016/b978-0-12-571131-9.50007-4 745 1976 02 09 2006 11 15 0034-5164 12 2 1975 Oct Research communications in chemical pathology and pharmacology Res Commun Chem Pathol Pharmacol Explanation of the stimulation of microsomal N-demethylation reactions by soluble supernatant fraction. 339-54 Addition of the cell soluble supernatant fraction to an assay medium containing NADPH generating system, mixed function oxidase substrate and microsomes, resulted in a stimulation of drug metabolism ranging from 12-75%. This stimulation was observed only when the supply of DADPH generating system (isocitric dehydrogenase or glucose 6 phosphate dehydrogenase) was insufficient, leading to a NADPH oxidation rate which was greater than the rate of reduction of NADP+ during the oxidation of a drug. Hence, under our assay conditions, the soluble supernate (SS) is only providing sufficient NADPH generator, and possibly relieving inhibition by the generated NADP+. Finally, microsomal lipid peroxidation measurements under these same conditions indicate negligible to no peroxidation activity in the absence of SS. Cinti D L DL eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Res Commun Chem Pathol Pharmacol 0244734 0034-5164 53-59-8 NADP EC 1.5.3.- Aminopyrine N-Demethylase EC 1.5.3.- Ethylmorphine-N-Demethylase IM Aminopyrine N-Demethylase metabolism Animals Dealkylation Ethylmorphine-N-Demethylase metabolism Female Male Microsomes, Liver enzymology metabolism NADP metabolism Rats Stimulation, Chemical Subcellular Fractions physiology Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 745 746 1976 02 19 2013 11 21 0034-5164 12 3 1975 Nov Research communications in chemical pathology and pharmacology Res Commun Chem Pathol Pharmacol An attempt to correlated analgesia to changes in brain neuromediators in rats. 449-63 The analgesic activity of delta9THC, morphine and sodium salicylate was studied concomitantly with changes in brain stem levels of 5HT, 5HIAA, DA and NA. The results show that a correlation exists between analgesia and changes in the serotonergic system of the brain stem. Furthermore morphine sulfate was found to increase the DA concentration of the brain stem while delta9THC increased NA levels. We conclude that serotonergic system may be of major importance in analgesia while simultaneous changes in this system and/or the DA and NA systems may lead to a more pronounced analgesic activity. Gascon A L AL Bensemana D D eng Journal Article United States Res Commun Chem Pathol Pharmacol 0244734 0034-5164 0 Analgesics 0 Neurotransmitter Agents 333DO1RDJY Serotonin 54-16-0 Hydroxyindoleacetic Acid 76I7G6D29C Morphine 7J8897W37S Dronabinol VTD58H1Z2X Dopamine WIQ1H85SYP Sodium Salicylate X4W3ENH1CV Norepinephrine IM Analgesia Analgesics pharmacology Animals Brain Stem drug effects metabolism Dopamine metabolism Dronabinol pharmacology Hydroxyindoleacetic Acid metabolism Male Morphine pharmacology Neurotransmitter Agents metabolism Norepinephrine metabolism Rats Reaction Time drug effects Serotonin metabolism Sodium Salicylate pharmacology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 746 747 1976 02 19 2013 11 21 0034-5164 12 3 1975 Nov Research communications in chemical pathology and pharmacology Res Commun Chem Pathol Pharmacol Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces. 571-81 A simple and convenient colorimetric method is described for the quantitative determination of 5-aminosalicylic acid (5-ASA) and N-acetyl-5-ASA in urine and feces after oral administration of salicylazosulfa-pyridine (SASP), the drug of choice in the treatment of ulcerative colitis. N-acetyl-5-ASA is extracted directly from the acidified biological specimen, deacetylated, and the liberated 5-ASA subjected to a modified Bratton-Marshall reaction. The 5-ASA present in the specimen must be acetylated with acetic anhydride prior to extraction. The violet colored product of the Bratton-Marshall reaction has a lambdamax of 560 nm and conforms to Beer's law over the concentration range of 0-70 umg/ml. Average recoveries (+/- S.D., N = 6) OF 5-ASA added to rat and human urine and rat fecal homogenates were 91.6 +/- 4.9%, 102 +/- 6.0%, and 71.0 +/- 4.8%, respectively. Interference by SASP and its sulfapyridine metabolities is negligible. As demonstrated, the colorimetric method is of sufficient sensitivity for application in most metabolic and pharmacokinetic studies conducted with SASP in laboratory animals and man. Pieniaszek H J HJ Jr BatesTR eng Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. United States Res Commun Chem Pathol Pharmacol 0244734 0034-5164 0 Aminosalicylic Acids 3XC8GUZ6CB Sulfasalazine IM Acetylation Aminosalicylic Acids analysis urine Animals Colorimetry Feces analysis Humans Male Methods Rats Spectrometry, Fluorescence Sulfasalazine metabolism Time Factors 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 747 748 1976 03 01 2019 09 11 0300-9130 166 2 1975 Dec 11 Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie Res Exp Med (Berl) [Pressures, blood gases, pH, lactate and pyruvate concentrations in the portal venous blood in patients after laparotomy during the first 9 days (author's transl)]. 131-45 In 24 patients (16 women, 8 men, mean age 60 years), who underwent abdominal operations and who had a uncomplicated postoperative course, a teflon-tube was inserted into the portal vein at the end of laparotomy and remained there for maximal 9 days. The mean values of the portal venous pressure as well as of the portal-central venous pressure gradient are unchanged during the period of all 9 days and are between 7,4 and 7,9 mmHg, between 5,6 and 6,9 mmHg respectively. The arterio-portal venous 0(2)-content difference shows in the mean no fluctuations and is about 2 Vol.%. On the first postoperative day the lactic and pyruvic acid concentrations in the artery and portal vein are moderately, but significantly elevated and decrease to normal values until day 7. - 9. Eisele R R Dissmann W W Nasseri M M Thimme W W ger English Abstract Journal Article Drücke, Blutgase, pH, Lactat und Pyruvat im Pfortaderblut bei bauchoperierten Patienten während der ersten 9 Tage Germany Res Exp Med (Berl) 0324736 0300-9130 0 Lactates 0 Pyruvates S88TT14065 Oxygen IM Adult Aged Central Venous Pressure Digestive System Surgical Procedures Female Gastrectomy Hematocrit Humans Hydrogen-Ion Concentration Lactates blood Liver Circulation Male Middle Aged Oxygen blood Partial Pressure Portal System Pyruvates blood Time Factors Venous Pressure 1975 12 11 1975 12 11 0 1 1975 12 11 0 0 ppublish 748 10.1007/BF01851180 749 1976 02 09 2019 09 07 0300-9572 4 2 1975 Resuscitation Resuscitation Biochemical and biophysical changes in guinea pigs after acute head injury. 77-86 Animal experiments were set up mainly to derive additional diagnostic data from the study of biochemical changes after acute head injury. In standardized experiments guinea pigs were subjected in groups of 20 to three identical head injuries, each of either 1.0 J or 1.5 J intensity. The trauma was likely to result in a concussion or contusion syndrome similar to that found in man; 40 animals served as controls. During the 60 min after injury observation and measurement of body functions did not reveal signs of a shock-like condition or hypoxaemia in the traumatized animals compared with control animals. Superficial anaesthesia probably did not influence the findings. Temperature and respiration were altered significantly in all the animals receiving head injuries. Blood gas analysis showed a decrease of standard bicarbonate only after the 1.5 J injury but even though hypoxaemia was not present 2,3-diphosphoglycerate values and P50 increased, compared with the control animals. The fall of plasma lipid concentrations reported probably had to be seen as a sympathomimetic effect of the minor (1.0 J) trauma. Of special significance was the increased activity of malate dehydrogenase and aldolase, found only in the blood of severely traumatized animals, as this could serve as an early diagnostic aid for evaluating head injuries. Hausdoerfer J J Heller W W Schinkmann L L eng Journal Article Ireland Resuscitation 0332173 0300-9572 0 Blood Glucose 0 Diphosphoglyceric Acids 0 Ketone Bodies 0 Lactates 0 Lipids 0 Phosphates 0 Pyruvates 142M471B3J Carbon Dioxide EC 1.1.1.37 Malate Dehydrogenase EC 2.6.1.1 Aspartate Aminotransferases EC 2.6.1.2 Alanine Transaminase EC 2.7.3.2 Creatine Kinase EC 3.1.1.8 Cholinesterases EC 4.1.2.13 Fructose-Bisphosphate Aldolase S88TT14065 Oxygen IM Alanine Transaminase blood Animals Aspartate Aminotransferases blood Blood Glucose analysis Body Temperature Brain physiopathology Carbon Dioxide blood Cholinesterases blood Craniocerebral Trauma enzymology metabolism physiopathology Creatine Kinase blood Diphosphoglyceric Acids blood Female Fructose-Bisphosphate Aldolase blood Guinea Pigs Heart Rate Hydrogen-Ion Concentration Ketone Bodies blood Lactates blood Lipids blood Malate Dehydrogenase blood Male Oxygen blood Phosphates blood Pyruvates blood Respiration Shock, Traumatic 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 749 0300-9572(75)90069-6 10.1016/0300-9572(75)90069-6 750 1976 02 09 2019 09 07 0300-9572 4 2 1975 Resuscitation Resuscitation Total brain ischaemia in dogs: cerebral physiological and metabolic changes after 15 minutes of circulatory arrest. 97-113 Cross-clamping of the ascending aorta in dogs for 15 min produced severe neurological deficit, observed for up to 20 h. Immediately after restoration of the circulation, the intracranial pressure in the cisterna magna increased transiently to a mean peak of 22.8 Torr (SD +/- 1.7) because of a compensatory increase in systemic arterial pressure, without a fall in cerebral perfusion pressure. The intracranial pressure returned to control values 15-30 min after ischaemia and showed no secondary rise during the 8 h of observation. The electroencephalogram became isoelectric 34 +/- 6.5 s (mean +/-SD) after circulatory occlusion, and was abnormal when it reappeared 5 h 36 min (SD +/- 2 h 4 min) after the circulation was restored. The electrical impedance of the brain increased immediately after ischaemia and returned rapidly towards pre-ischaemic values during re-perfusion. The cerebral water had not increased measurably 4 h after ischaemia. After ischaemia, the lactate concentration in the cerebrospinal fluid increased to 4.7 mequiv./1(SEM +/-0.1) and the pH decreased to 7.17 (SEM +/-0.02); both returned to control values after 3.5 h. The cerebral glucose uptake was decreased 35 min after ischaemia, cerebral oxygen uptake remained unchanged but cerebral blood flow decreased (P less than 0.05 at 90 min). Immediately after cardiac arrest, recovery was impaired more by the presence of focal abnormal brain perfusion than by intracranial hypertension. Lind B B Snyder J J Safar P P eng Journal Article Ireland Resuscitation 0332173 0300-9572 0 Lactates IY9XDZ35W2 Glucose IM Animals Body Water analysis Brain metabolism physiopathology Cerebrovascular Circulation Dogs Electric Conductivity Glucose metabolism Hydrogen-Ion Concentration Hypoxia, Brain metabolism physiopathology Intracranial Pressure Lactates cerebrospinal fluid Oxygen Consumption 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 750 0300-9572(75)90071-4 10.1016/0300-9572(75)90071-4 751 1976 02 13 2019 08 23 0034-5687 24 1 1975 Jun Respiration physiology Respir Physiol Oxygen and carbon dioxide dissociation of duck blood. 1-13 Oxygen and CO2 dissociation of duck blood was studied in blood samples equilibrated with known gas mixtures at the bird's body temperature (41 degrees C) and analyzed in the Van Slyke manometric apparatus and in pH electrodes. At various pH values between 7.38 and 7.55 the Hill plots yielded straight and parallel lines over a wide range of O2 saturation, the Hill coefficient being 2.9. Half saturation pressure P50 at pH = 7.50 was 36 torr. The Bohr effect factor was -0.53. Buffering properties were analyzed by equilibrating blood samples with gas mixtures of different PCO2 at 41 degrees C. The buffer value for whole blood in the range of 3-7% CO2 was 19.3 mMol-L-1-pH-1, the buffer value for true plasma 22.9 mMol-L-1-pH-1. The CO2 dissociation curve constructed using the buffer values had a slope of 0.17 mMol-L-1-torr-1 in the PCO2 range from 40 to 50 torr. The CO2 content of oxygenated blood at PCO2 = 40 torr was 21.7 mMol-L-1. The Haldane effect factor at PCO2 = 35 torr equalled 0.30 mMol of combined CO2 per mMol HbO2. With the values of PO2, PCO2 and pH measured in arterial blood of undisturbed and unrestrained, resting ducks effective dissociation curves for both O2 and CO2 were constructed assuming a metabolic R.Q. of 0.8. These curves are expected to resemble closely the actual in vitro dissociation curves of resting ducks. Scheipers G G Kawashiro T T Scheid P P eng Journal Article Netherlands Respir Physiol 0047142 0034-5687 0 Buffers 0 Hemoglobins 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Animals Buffers Carbon Dioxide blood Ducks physiology Hemoglobins metabolism Hydrogen-Ion Concentration Oxygen blood 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 751 10.1016/0034-5687(75)90117-6 752 1976 02 13 2019 08 23 0034-5687 24 1 1975 Jun Respiration physiology Respir Physiol First apparent dissociation constant of carbonic acid, pK'1, of plasma and erythrocytes. 51-68 The first apparent dissociation constant of carbonic acid, pK'1, of plasma and red cells was determined on venous blood of ten healthy, adult, male, human subjects. pH and PCO2 of plasma and red cells were analyzed electrometrically and a micromanometric method was used for the determination of total carbon dioxide content. Erythrocyte carbamino hemoglobin levels were estimated and used for the correction of erythrocyte pK'1. Each blood sample was subjected to the following regimen before centrifugation, 1) As drawn from the antecubital vein, 2) Oxygenated with a 5% CO2, O2 balance gas mixture, and 3) Reduced with a 5% CO2, N2 balance gas mixture. pK'1 of plasma and red cells are presented: (see article). The consistently larger values for red cell pK'1 than the respective plasma data may be attributed to the greater amount of carbamino hemoglobin concentration present in the erythrocytes. A simplified method for the calculation of erythrocyte bicarbonate concentration using the experimentally determined red cell pK'1 value has been formulated. The method involves the use of a regression equation relating plasma and red cell pH, the equivalence of plasma and red cell PCO2, along with the experimentally determined red cell pK'1. Messier A A AA eng Journal Article Netherlands Respir Physiol 0047142 0034-5687 0 Carbonates 463-79-6 Carbonic Acid S88TT14065 Oxygen IM Adolescent Carbonates blood Carbonic Acid blood Erythrocytes metabolism Humans Hydrogen-Ion Concentration Male Mathematics Oxygen blood Partial Pressure Plasma metabolism Tonometry, Ocular 1975 6 1 1975 6 1 0 1 1975 6 1 0 0 ppublish 752 10.1016/0034-5687(75)90121-8 753 1976 03 01 2019 08 23 0034-5687 25 2 1975 Nov Respiration physiology Respir Physiol The effects of changes in pH and PCO2 in blood and water on breathing in rainbow trout, Salmo gairdneri. 235-45 The effect of sustained hypercapnia on the acid-base balance and gill ventilation in rainbow trout, Salmo gairdneri, was studied. The response to an increase in PICO2 from 0.3 to 5.2 mm Hg was a five-fold increase in gill ventilation volume and a slight increase in breathing frequency. There was a concomitant rise in PACO2 and an immediate fall in pHa. If PICO2 was maintained at 5.2 mm Hg for several days, ventilation volume gradually returned to the initial, prehypercapnic level within three days. Arterial pH also returned to the initial level within 2-3 days. These results are consistent with the hypothesis that under these conditions fish regulate pH via HCO3/C1 exchange across the gills rather than by changes in ventilation and subsequent adjustment of PACO2. A reduction in environmental pH causes a reduction in pHa but only a slow gradual increase in VG. Injections of HC1 or NaHCO3 into the blood have opposite effects on pHa but both cause a marked increase in VG. It is concluded that a rise in PACO2 results in a rise in VG and that changes in pH in blood or water have little direct effect on VG in rainbow trout. Possible location for receptors involved in this reflex response are discussed. Janssen R G RG Randall D J DJ eng Journal Article Netherlands Respir Physiol 0047142 0034-5687 0 Bicarbonates 059QF0KO0R Water 142M471B3J Carbon Dioxide QTT17582CB Hydrochloric Acid IM Animals Bicarbonates blood pharmacology Blood Carbon Dioxide analysis blood Female Hydrochloric Acid pharmacology Hydrogen-Ion Concentration Male Respiration Salmonidae physiology Trout blood physiology Water analysis 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 753 10.1016/0034-5687(75)90099-7 754 1976 02 19 2013 11 21 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Acute toxic dilatation of the colon in hemorrhagic rectocolitis]. 101-9 Stanescu L L Dejica D D rum English Abstract Journal Article Dilatatia acuta toxica a colonului în rectocolita hemoragica Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Sulfonamides 3XC8GUZ6CB Sulfasalazine 9002-60-2 Adrenocorticotropic Hormone MRK240IY2L Azathioprine WI4X0X7BPJ Hydrocortisone IM Adolescent Adrenocorticotropic Hormone therapeutic use Adult Azathioprine therapeutic use Colitis, Ulcerative Female Humans Hydrocortisone therapeutic use Male Megacolon, Toxic drug therapy Middle Aged Sulfasalazine therapeutic use Sulfonamides therapeutic use 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 754 755 1976 02 19 2006 11 15 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Pulmonary function in chronic bronchitis and emphysema. VI. Pulmonary mixing]. 111-20 Teculescu D D Racoveanu C C Manicatide M M rum English Abstract Journal Article Functia pulmonara în bronsita cronica si emfizem. VI. Mixica pulmonara Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Adult Bronchitis physiopathology Chronic Disease Humans Male Pulmonary Emphysema physiopathology Respiration Respiratory Function Tests Respiratory Insufficiency etiology 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 755 756 1976 02 19 2016 11 23 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Hypoxemia and hypercapnia in the development of chronic cor pulmonale]. 121-7 Olinic N N Zagreanu I I Opincaru A A Stanica rum Journal Article Hipoxemia si hipercapnia în evolutia cordului pulmonar cronic Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM S Chronic Disease Humans Hypercapnia etiology Hypoxia etiology Lung Diseases, Obstructive complications Pulmonary Heart Disease complications etiology Respiratory Insufficiency complications Silicosis complications 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 756 758 1976 02 19 2006 11 15 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Diabetic lactic acidosis]. 135-9 Ionescu-Tîrgoviste C C Mincu I I rum Case Reports English Abstract Journal Article Acidoza lactica diabetica Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Lactates IM Adolescent Adult Diabetic Coma diagnosis Diabetic Ketoacidosis diagnosis mortality Diagnosis, Differential Female Humans Lactates blood 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 758 759 1976 02 19 2008 11 21 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Myeloid metaplasia with myelosclerosis in the course of a syndrome of splenogenic portal hypertension with a background of splenic tuberculosis]. 141-8 Hossu T T Vîlcu A A rum Case Reports English Abstract Journal Article Metaplazie mieloida cu mieloscleroza constituita în cadrul unui sindrom de hipertensiune portala splenogena pe fondul unei tuberculoze splenice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Esophageal and Gastric Varices complications Female Gastrointestinal Hemorrhage etiology Humans Hypertension, Portal complications Middle Aged Primary Myelofibrosis complications Tuberculosis, Splenic complications 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 759 760 1976 02 19 2006 11 15 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Left atrial calcification. Report of a case]. 149-54 Cîmpeanu A A Pompilian P P Gutiu I I Carp C C rum Case Reports English Abstract Journal Article Calcificarea atriului stîng. Prezentare de caz Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Atrial Fibrillation etiology Calcinosis Heart Atria Humans Male Middle Aged Mitral Valve Stenosis complications Pulmonary Embolism etiology Rheumatic Heart Disease complications 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 760 757 1976 02 19 2006 11 15 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Post-traumatic hemorrhagic subacute constrictive pericarditis]. 129-33 Streian C C Atanasescu I I Gavrilescu M M rum English Abstract Journal Article Pericardita constrictiva subacuta hemoragica posttraumatica Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Diagnosis, Differential Diagnostic Errors Humans Male Middle Aged Myocardial Infarction diagnosis Pericarditis, Constrictive diagnosis etiology Thoracic Injuries complications 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 757 761 1976 02 19 2018 12 03 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Current studies in the clinical physiology of gastric secretion]. 83-92 Banciu T T rum Journal Article Review Actualitati în fiziologia clinica a secretiei gastrice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Gastrins EC 3.4.23.1 Pepsin A SY7Q814VUP Calcium IM Animals Calcium blood Gastric Juice analysis enzymology metabolism Gastric Mucosa metabolism physiology Gastrins metabolism Humans Pepsin A metabolism Peptic Ulcer physiopathology Pylorus metabolism Secretory Rate Stomach Diseases physiopathology Vagus Nerve physiology 70 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 761 762 1976 02 19 2013 11 21 1220-0905 27 2 1975 Mar-Apr Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Duodenal dyskinesia (duodenal stasis) and modifiers of digestive tract behavior (atropine, insulin, metoclopramide)]. 93-100 Berinde L L Dancau G G Schneider F F Prodan P P Biroasiu G G Gavrilescu M M Sgavîrdia C C Banciu T T rum English Abstract Journal Article Dischinezia duodenala (staza duodenala) si modificatorii de comportament ai tubului digestiv (atropina, insulina, metoclopramida) Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Insulin 7C0697DR9I Atropine L4YEB44I46 Metoclopramide IM Atropine therapeutic use Duodenal Diseases drug therapy Gastrointestinal Motility drug effects Humans Insulin therapeutic use Metoclopramide therapeutic use 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 762 763 1976 02 19 2006 11 15 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Problems in the treatment of the operated stomach]. 163-70 Fodor O O Popescu S S rum English Abstract Journal Article Probleme de tratament al stomacului operat Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Anemia, Hypochromic therapy Anemia, Megaloblastic therapy Celiac Disease therapy Humans Osteomalacia therapy Osteoporosis therapy Postgastrectomy Syndromes prevention & control therapy Recurrence 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 763 764 1976 02 19 2006 11 15 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of biliary tract diseases]. 171-4 Dumitrascu D D rum English Abstract Journal Article Tratamentul afectiunilor cailor biliare Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Anti-Bacterial Agents 0 Cholagogues and Choleretics 0 Parasympatholytics IM Anti-Bacterial Agents therapeutic use Biliary Tract Diseases surgery therapy Cholagogues and Choleretics therapeutic use Cholelithiasis surgery therapy Cholestasis surgery Drainage Humans Parasympatholytics therapeutic use 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 764 765 1976 02 19 2013 11 21 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Medico-surgical tactics in the treatment of gastro-duodenal ulcer]. 175-82 Nicolaescu T T Alexiu O O rum English Abstract Journal Article Tactica tratamentului medico-chirurgical în ulcerul gastro-duodenal Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Antacids 0 Hypnotics and Sedatives 0 Parasympatholytics 7C0697DR9I Atropine IM Antacids therapeutic use Atropine therapeutic use Humans Hypnotics and Sedatives therapeutic use Parasympatholytics therapeutic use Peptic Ulcer surgery therapy Vagotomy 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 765 766 1976 02 19 2006 11 15 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of chronic pancreatitis]. 183-8 Buligescu L L rum English Abstract Journal Article Tratamentul pancreatitelor cronice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Analgesics 0 Pancreatic Extracts 0 Parasympatholytics IM Analgesics therapeutic use Celiac Disease drug therapy Chronic Disease Diabetes Mellitus therapy Humans Pancreatectomy Pancreatic Extracts therapeutic use Pancreatitis etiology surgery therapy Parasympatholytics therapeutic use Splanchnic Nerves surgery 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 766 767 1976 02 19 2013 11 21 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of ulcerative colitis]. 189-200 Spîrchez T T rum English Abstract Journal Article Tratamentul colitei ulceroase Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Aminosalicylic Acids 3XC8GUZ6CB Sulfasalazine 9002-60-2 Adrenocorticotropic Hormone MRK240IY2L Azathioprine VB0R961HZT Prednisone Y5V2N1KE8U Sulfapyridine IM Adolescent Adrenocorticotropic Hormone therapeutic use Adult Aged Aminosalicylic Acids therapeutic use Azathioprine therapeutic use Child Colectomy Colitis, Ulcerative diet therapy surgery therapy Female Humans Ileostomy Male Middle Aged Prednisone therapeutic use Sulfapyridine therapeutic use Sulfasalazine therapeutic use 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 767 768 1976 02 19 2013 11 21 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of chronic hepatitis]. 201-8 Fodor O O rum English Abstract Journal Article Tratamentul hepatitelor cronice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 30KYC7MIAI Aspartic Acid 61H4T033E5 Orotic Acid GNN1DV99GX Penicillamine MRK240IY2L Azathioprine RWP5GA015D Potassium VB0R961HZT Prednisone IM Aspartic Acid therapeutic use Azathioprine therapeutic use Hepatitis complications surgery therapy Humans Orotic Acid therapeutic use Penicillamine therapeutic use Potassium therapeutic use Prednisone therapeutic use Splenectomy 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 768 770 1976 02 19 2012 11 15 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders]. 219-25 Schwartz M M Fodor O O rum English Abstract Journal Article Posibilitati si riscuri terapeutice în cirozele hepatice cu tulburari ale metabolismului hidroelectrolitic Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Diuretics 0 Glucocorticoids 0 Mineralocorticoid Receptor Antagonists IM Ascites drug therapy etiology Diuretics adverse effects therapeutic use Glucocorticoids adverse effects therapeutic use Humans Liver Cirrhosis complications drug therapy Mineralocorticoid Receptor Antagonists Water-Electrolyte Imbalance etiology 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 770 769 1976 02 19 2016 12 03 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Prospective study of the evolutive modalities of active chronic hepatitis with or without corticotherapy]. 209-18 Banciu T T Berinde L L Prodan P P Dancau G G Reichrath S S Ocica I I Tudose I I rum English Abstract Journal Article Studiu prospectiv privind modalitatile evolutive ale hepatitei cronice active supusa sau nu corticoterapiei Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 9002-60-2 Adrenocorticotropic Hormone VB0R961HZT Prednisone IM Adrenocorticotropic Hormone therapeutic use Adult Female Hepatitis drug therapy pathology Humans Liver pathology Male Middle Aged Prednisone therapeutic use Prospective Studies 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 769 772 1976 02 19 2006 11 15 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of chronic constipation (constipation disease)]. 237-40 Berinde L L rum English Abstract Journal Article Tratamentul constipatiei cronice (constipatia boala) Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Constipation diet therapy drug therapy therapy Humans Physical Therapy Modalities 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 772 773 1976 02 19 2004 11 17 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Articular lubrication under normal and pathological conditions: therapeutic consequences]. 243-8 Bolosiu H D HD Dutu A A Gligore V V rum Journal Article Lubrifierea articulara în conditii normale si patologice: consecinte terapeutice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Dimethylpolysiloxanes 0 Polyethylenes IM Cartilage, Articular physiology Dimethylpolysiloxanes therapeutic use Humans Joint Diseases physiopathology surgery therapy Joint Prosthesis Joints physiology Lubrication Polyethylenes Synovial Fluid physiology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 773 771 1976 02 19 2018 12 03 1220-0905 27 3 1975 May-Jun Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Treatment of the malabsorption syndrome]. 227-36 Gheorghescu B B rum Journal Article Tratamentul sindromului de malasimilatie Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Anti-Bacterial Agents 0 Parasympatholytics 0 Sulfonamides 0 Vitamins 11041-12-6 Cholestyramine Resin 12001-76-2 Vitamin B Complex 5UTX5635HP Oxyquinoline IM Anti-Bacterial Agents therapeutic use Cholestyramine Resin therapeutic use Enzyme Therapy Malabsorption Syndromes diet therapy drug therapy therapy Oxyquinoline therapeutic use Parasympatholytics therapeutic use Sulfonamides therapeutic use Vitamin B Complex therapeutic use Vitamins therapeutic use Water-Electrolyte Balance 1975 5 1 1975 5 1 0 1 1975 5 1 0 0 ppublish 771 774 1976 02 19 2007 11 15 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Premise for the pathogenetic definition of toxinfectious and endotoxic shock states]. 249-57 Busila V T VT Dragomirescu N N rum English Abstract Journal Article Premise pentru delimitarea patogenetica a starilor de soc toxiinfectios si endotoxinic Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Lactates 0 Phosphates 0 Proteins IM Animals Hemodynamics Lactates metabolism Oxygen Consumption Phosphates metabolism Proteins metabolism Rabbits Shock, Septic etiology metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 774 775 1976 02 19 2007 11 15 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Clinical and prognostic studies of 41 patients with left anterior hemiblock in the onset of acute myocardial infarct]. 259-64 Manu P P Karassi A A Chirculescu N N Rotaru M M rum English Abstract Journal Article Implicatii clinice si prognostice la 41 de bolnavi cu hemibloc anterior stîng la debutul infarctului miocardic acut Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Adult Aged Female Heart Block etiology mortality Heart Failure etiology Humans Male Middle Aged Myocardial Infarction complications mortality Prognosis Shock, Cardiogenic etiology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 775 776 1976 02 19 2006 11 15 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Detection of rheumatoid factors with the "rheumatoid rosette" immunocytoadherence test]. 265-72 Suteanu S S Rîndasu G G Danila E E Ionescu-Pirvu V V Moanga M M Alexandru G G rum English Abstract Journal Article Decelarea factorilor reumatoizi prin reactia de imunocitoaderenta "rozeta reumatoida" Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 9009-79-4 Rheumatoid Factor IM Adult Arthritis, Rheumatoid diagnosis immunology Diagnosis, Differential False Positive Reactions Female Humans Immune Adherence Reaction Middle Aged Rheumatoid Factor analysis 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 776 777 1976 02 19 2013 11 21 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Prolonged treatment with prednisone and azathioprine in chronic hepatitis with immunological disorders]. 273-7 Runcan V V Oproiu A A State I I Vladareanu S S rum English Abstract Journal Article Tratament prelungit cu prednison si azatioprina în hepatite cronice cu perturbari imunologice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Anabolic Agents 0 Dietary Proteins MRK240IY2L Azathioprine VB0R961HZT Prednisone IM Adolescent Adult Anabolic Agents therapeutic use Azathioprine therapeutic use Dietary Proteins therapeutic use Female Hepatitis drug therapy immunology Humans Immune System Diseases etiology Lymphocyte Activation Male Middle Aged Prednisone therapeutic use 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 777 778 1976 02 19 2013 11 21 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Use of bethanidine sulfate in the treatment of arterial hypertension]. 279-89 Cristodorescu R R rum English Abstract Journal Article Utilizarea sulfatului de bethanidina în tratamentul hipertensiunii arteriale Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 0 Guanidines W8S3YM7AUU Bethanidine IM Adolescent Adult Aged Bethanidine adverse effects therapeutic use Drug Evaluation Female Guanidines therapeutic use Humans Hypertension drug therapy Male Middle Aged 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 778 779 1976 02 19 2013 11 21 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Value of cycloserine (Tebemicin) in the treatment of acute attacks of chronic pyelonephritis]. 291-9 Fica V V Matrescu F F Manole G G rum Comparative Study Journal Article Contributii la studiul valorii cicloserinei (tebemicin) în tratamentul puseurilor acute de pielonefrita cronica Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 3B91HWA56M Nalidixic Acid 927AH8112L Nitrofurantoin 95IK5KI84Z Cycloserine IM Acute Disease Cycloserine administration & dosage adverse effects therapeutic use Drug Evaluation Humans Nalidixic Acid therapeutic use Nitrofurantoin therapeutic use Pyelonephritis drug therapy 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 779 783 1976 03 01 2019 09 11 0029-845X 83 6 1975 Nov Scandinavian journal of dental research Scand J Dent Res The effect of pH upon fluoride uptake in intact enamel. 339-44 The relationship between pH and fluoride uptake in intact enamel of permanent premolars was investigated by using: (1) a sodium fluoride dentifrice, (2) a potassium fluoride + manganese chloride dentifrice, and (3) a sodium fluoride solution of the same fluoride concentration. The first part of this paper deals with the in vitro uptake of fluoride from dentifrice slurries and from sodium fluoride solutions of different pH ranging from 7.1 to 4.5. This investigation showed that there was no significant difference between the agents but that the effect of the pH was significant. The uptake of fluoride in the form of fluorapatite was more than five times larger at the lower pH level. The second part of the paper deals with the rate of fluoride uptake (increase in fluoride content) from dentifrices in the same pH range. It was shown that the three agents gave the same initial rate of fluoride uptake (about 50 parts/10(6)/min) at pH 6 and that the rate of fluoride uptake in the outer layer of the enamel was proportional to the hydrogen ion activity. Friberger P P eng Comparative Study Journal Article Denmark Scand J Dent Res 0270023 0029-845X 0 Dentifrices 0 Fluorides, Topical D IM Child Dental Enamel metabolism Dental Enamel Permeability Dentifrices Fluorides, Topical metabolism Humans Hydrogen-Ion Concentration Time Factors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 783 10.1111/j.1600-0722.1975.tb00447.x 781 1976 02 19 2006 11 15 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Lesional asymmetry and hepatocellular and enterocytic evolutive asynchronism under the influence of some exogenous factors]. 309-16 Barbarino F F Fodor O O rum English Abstract Journal Article Asimetrii lezionale si asincronisme evolutive hepatocelulare si enterocitare sub influenta unor factori exogeni Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Duodenal Diseases pathology Duodenum pathology Humans Intestinal Mucosa pathology Liver pathology Liver Diseases pathology 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 781 784 1976 03 01 2019 09 11 0029-845X 83 6 1975 Nov Scandinavian journal of dental research Scand J Dent Res Determination of inorganic pyrophosphatase in rat odontoblast layer by a radiochemical method. 365-9 The enzyme inorganic pyrophosphatase (PPiase, EC 3.6.1.1) from the odontoblastic layer of rat incisors has been studied by means of a radiochemical micromethod. The enzyme was incubated with 32P-pyrophosphate in tris-HCl buffer at 37 degrees C. The reaction was linear with time for at least 45 min, and the pH optimum was found to be 8.8, independent of the amount of pyrophosphate present. Heating the enzyme at 56 degrees C inhibited the enzyme activity rapidly, Mg2+ ions activated the enzyme by 15% at an ion concentration of 4 mM, while higher concentrations were inhibitory. Ca2+ ions and PO43-ions inhibited the enzyme at all concentrations. F- ions did not affect the PPiase at concentrations below 8 mM, whereas higher concentrations had an inhibiting effect. Urea was found to inhibit the enzyme at concentrations above 1.5 M, while EDTA was a strong inhibitor at very low concentrations. The characteristics of PPiase agree well with the properties of the enzyme nonspecific alkaline phosphatase (EC 3.1.3.1.) studied earlier. Granström G G Linde A A eng Journal Article Denmark Scand J Dent Res 0270023 0029-845X EC 3.6.1.- Pyrophosphatases D IM Animals Hydrogen-Ion Concentration Incisor enzymology Male Odontoblasts enzymology Pyrophosphatases metabolism Rats Time Factors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 784 10.1111/j.1600-0722.1975.tb00450.x 785 1976 03 01 2019 09 11 0029-845X 83 6 1975 Nov Scandinavian journal of dental research Scand J Dent Res Assessment of denture plaque pH in subjects with and without denture stomatitis. 370-4 To evaluate the "resting" pH and induced pH changes in denture plaque, soft deposits were collected from the fitting surface of the denture, pooled and suspended in water. Plaque pH was determined with microelectrode equipment before and after mouth rinsing with a sucrose solution. A characteristic level in the "resting" pH of denture plaque was found in most of 12 subjects tested. pH values below the baseline level were recorded for more than 2 h after a rinse. The pH depressions were more pronounced in maxillary than in mandibular plaque. Further, the pH minima tended to be lower in subjects with denture stomatitis than in controls. No clear relationship could be established between the "resting" pH and the concentration of Candida hyphae in denture smears or palatal inflammation. Olsen I I Birkeland J M JM eng Journal Article Denmark Scand J Dent Res 0270023 0029-845X D IM Aged Dental Plaque metabolism Humans Hydrogen-Ion Concentration Mandibular Diseases metabolism Maxillary Diseases metabolism Stomatitis metabolism Stomatitis, Denture metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 785 10.1111/j.1600-0722.1975.tb00451.x 782 1976 02 09 2013 11 21 0377-497X 20 1 1975 Jan-Mar Revista de medicina interna, neurologie, psihiatrie, neurochirurgie, dermato-venerologie. Neurologie, psihiatrie, neurochirurgie Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir [Some therapeutic aspects of obsessive-phobic neuroses]. 17-21 Sirbu A A Hotico T T Secareanu A A rum English Abstract Journal Article Unele aspecte terapeutice ale nevrozei obsesivo-fobice Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir 7503901 0377-497X 0 Phenothiazines 0 Psychotropic Drugs 0 Tranquilizing Agents OGG85SX4E4 Imipramine IM Humans Imipramine therapeutic use Obsessive-Compulsive Disorder therapy Phenothiazines therapeutic use Phobic Disorders therapy Psychotherapy Psychotropic Drugs therapeutic use Tranquilizing Agents therapeutic use 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 782 780 1976 02 19 2004 11 17 1220-0905 27 4 1975 Jul-Aug Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna [Adenocarcinoma of the 2d portion of the duodenum]. 301-8 Demetrescu O O Vereanu L L Jocu I I Gheorghiu I I rum Journal Article Adenocarcinom al celei de a doua portiuni a duodenului Romania Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna 7501915 1220-0905 IM Adenocarcinoma pathology surgery Duodenal Neoplasms pathology surgery Duodenum pathology Female Humans Middle Aged 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 780 786 1976 03 01 2019 09 11 0029-845X 83 6 1975 Nov Scandinavian journal of dental research Scand J Dent Res Bioluminescence assay of enzymes obtained from buccal epithelium by superficial scraping. 375-81 A method is presented for the simultaneous assay of buccal enzymes by measuring reduced nicotinamide adenine dinucleotide and adenosine triphosphate with the aid of the bioluminescence of luciferase extracts. The activity of glucose-6-phosphate dehydrogenase (G6PDH) was shown earlier to be increased in homogeneous leukoplakias of the oral mucosa. Since smoking has been implicated as an etiologic factor of leukoplakia, G6PDH was measured in the normal buccal epithelium of cigarette smokers. No difference was found in the activity of G6PDH between smokers and nonsmokers when related to the activity of pyruvate kinase, which is known to be invariable in healthy and leukoplakic oral mucosa. A new compact kinetic luminescence analyzer is briefly described. Hammar H H Wettermark G G Wladimiroff W W eng Journal Article Denmark Scand J Dent Res 0270023 0029-845X 0U46U6E8UK NAD 53-59-8 NADP 8L70Q75FXE Adenosine Triphosphate EC 1.1.1.49 Glucosephosphate Dehydrogenase EC 2.7.1.40 Pyruvate Kinase D IM Adenosine Triphosphate analysis Adult Biological Assay Cheek Epithelium enzymology Glucosephosphate Dehydrogenase analysis Humans Middle Aged Mouth Mucosa enzymology NAD analysis NADP analysis Pyruvate Kinase analysis Smoking 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 786 10.1111/j.1600-0722.1975.tb00452.x 787 1976 03 01 2018 12 03 0085-5928 35 1975 Scandinavian journal of gastroenterology. Supplement Scand J Gastroenterol Suppl Gastroduodenal emptying and motility. 1-87 eng Congress England Scand J Gastroenterol Suppl 0437034 0085-5928 IM Animals Congresses as Topic Duodenum physiology Gastrointestinal Motility Humans 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 787 788 1976 03 01 2008 02 13 0085-5928 35 1975 Scandinavian journal of gastroenterology. Supplement Scand J Gastroenterol Suppl Identification of the gastroduodenal junction by potential difference measurements. 83-7 Andersson S S Nylander B B eng Journal Article England Scand J Gastroenterol Suppl 0437034 0085-5928 IM Animals Dogs Gastrointestinal Motility Humans Hydrogen-Ion Concentration Potentiometry Pressure Pylorus physiology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 788 789 1976 02 19 2019 09 07 0036-553X 15 4 1975 Nov Scandinavian journal of haematology Scand J Haematol Allogeneic marrow transplantation for the treatment of leukaemia. A review. 287-305 22 HL-A antigen and mixed leukocyte culture-matched sibling bone marrow transplants were attempted in patients with acute leukaemia (at the National Cancer Institute) to define the toxicities of four different immunosuppressive regimens, the complications associated with warrow engraftment and antileukaemic effect. 73% (16/22) were engrafted as indicated by a change to donor red blood cells (RBC) type, leukocyte, immunoglobulin allotype or by the speed of morrow repopulation and the occurrence of the Graft Versus Host Disease (GVHD). 12 of 16 (75%) successful engrafted patients developed GVHD. The current published results of clinical bone marrow transplantation from major centers has been reviewed and will be discussed in relationship to current clinical complications associated with bone marrow transplantation. Alvegård T A TA Herzig G P GP Graw R G RG Jr eng Case Reports Journal Article Denmark Scand J Haematol 0404507 0036-553X 0 HLA Antigens 0 Immunoglobulins IM Adolescent Bone Marrow Cells Bone Marrow Transplantation Evaluation Studies as Topic Female Graft vs Host Reaction HLA Antigens Histocompatibility Testing Humans Immunoglobulins Immunosuppression Leukemia therapy Leukemia, Lymphoid immunology therapy Leukemia, Monocytic, Acute immunology therapy Leukemia, Myeloid, Acute immunology therapy Lymphocyte Culture Test, Mixed Male Transplantation, Homologous 1975 11 1 2001 3 28 10 1 1975 11 1 0 0 ppublish 789 10.1111/j.1600-0609.1975.tb01084.x 790 1976 03 01 2017 03 22 0300-8665 43 1975 Schriftenreihe des Vereins fur Wasser-, Boden- und Lufthygiene Schriftenr Ver Wasser Boden Lufthyg [Interpretation of various chemical parameters in the pollution of coastal waters]. 31-8 Jentsch F F ger Journal Article Interpretation einiger chemischer Parameter für die Belastung von Küstengewässern Germany Schriftenr Ver Wasser Boden Lufthyg 7507514 0300-8665 0 Nitrates 0 Nitrites 0 Phosphates 0 Quaternary Ammonium Compounds IM Germany, West Humans Hydrogen-Ion Concentration Nitrates analysis Nitrites analysis Phosphates analysis Quaternary Ammonium Compounds analysis Seawater analysis Water Pollution, Chemical analysis 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 790 791 1976 03 01 2018 12 03 0048-9549 13 8 1975 Aug 15 Schwestern Revue Schwest Rev [Uncertain position in the therapeutic team. Symposium for nurses on "Parenteral and Tube Feeding" and members' congress of the German Nurses' Association in Düsseldorf]. 38 Valerius T T ger Congress Unklare Stellung im therapeutischen Team. Symposion für Krankenschwestern/Krankenpfleger über "Parenterale und Sondenernährung" und Mitgliederversammlung der DGF in Düsseldorf Germany Schwest Rev 0045677 0048-9549 N Congresses as Topic Enteral Nutrition Germany, West Nursing Parenteral Nutrition Patient Care Team 1975 8 15 1975 8 15 0 1 1975 8 15 0 0 ppublish 791 792 1976 03 01 2019 07 02 0038-4348 68 12 1975 Dec Southern medical journal South Med J Current status of treatment of pneumonia. 1507-11 Proper treatment of pneumonia is dependent upon a correct diagnosis. Pneumonia may be due to infectious agents, allergic phenomena, or chemical causes. Treatment regimens are outlined for the various types of pneumonia--pneumococcal, staphylococcal, fungal, and pneumonia due to gram-negative and anaerobic gram-negative bacilli, to Blastomyces dermatitidis, and to the parasite Pneumocystis carinii. In discussing current concepts of treatment, several well-known methods are emphasized, as well as newer developments, knowledge of which is essential for optimal treatment of pneumonia. Sabath L D LD eng Journal Article United States South Med J 0404522 0038-4348 0 Anti-Bacterial Agents 0 Antifungal Agents 7C782967RD Ampicillin Q42T66VG0C Penicillin G AIM IM Ampicillin therapeutic use Anti-Bacterial Agents therapeutic use Antifungal Agents therapeutic use Bacteroides Infections drug therapy Haemophilus influenzae isolation & purification Humans Mycobacterium Infections drug therapy Mycoses drug therapy Nocardia Infections drug therapy Penicillin G therapeutic use Pneumonia diagnosis drug therapy etiology Pneumonia, Staphylococcal drug therapy Pneumonia, Viral drug therapy Staphylococcus aureus isolation & purification Streptococcus pneumoniae isolation & purification 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 792 10.1097/00007611-197512000-00012 793 1976 02 09 2004 11 17 0038-5077 8 1975 Aug Sovetskaia meditsina Sov Med [Physical work capacity of patients with bronchial asthma after treatment with bronchodilator agent, berotek]. 141-2 Eremina S S SS Solomonova L N LN rus Journal Article Fizicheskaia rabotosposobnost' bol'nykh bronkhial'noi astmoi pri lechenii praparatom berotek Russia (Federation) Sov Med 0404525 0038-5077 0 Adrenergic beta-Agonists 0 Bronchodilator Agents IM Adrenergic beta-Agonists therapeutic use Adult Aged Asthma drug therapy rehabilitation Bronchodilator Agents therapeutic use Disability Evaluation Female Humans Male Middle Aged Work Capacity Evaluation 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 793 794 1976 02 09 2014 11 20 0038-5077 8 1975 Aug Sovetskaia meditsina Sov Med [Complications of sombrevin anesthesia in minor gynecological surgery]. 147-8 Tomilets V A VA Ado V A VA Topolianskii V D VD Kolosov M M MM Podkolzin A A AA rus Journal Article Oslozhneniia vo vremia narkoza sombrevinom pri malykh ginekologicheskikh operatsiiakh Russia (Federation) Sov Med 0404525 0038-5077 0 Glucocorticoids 0 Histamine H1 Antagonists AO82L471NS Propanidid IM Adult Anesthesia, Intravenous Drug Hypersensitivity drug therapy Female Genital Diseases, Female surgery Glucocorticoids therapeutic use Histamine H1 Antagonists therapeutic use Humans Middle Aged Minor Surgical Procedures Propanidid adverse effects 1975 8 1 1975 8 1 0 1 1975 8 1 0 0 ppublish 794 795 1976 02 09 2014 09 12 0256-9574 49 46 1975 Nov 01 South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde S Afr Med J 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia. 1923-6 A member of a family which was known to be susceptible to malignant hyperpyrexia, who was identified as a carrier by the presence of an elevated serum creatine-phosphokinase, has been investigated further. Muscle was examined biochemically, and the study included the sarcoplasmic ATPase-activity, actinomycin, Mg2+ ATPase activity, ATP, phosphocreatine and glucose-6-phosphate. In addition, the calcium uptake by the sarcoplasmic reticulum was studied. The histochemical analysis of the muscle revealed the presence of a new fibre type characterised by a dense rim of ATPase activity, which gives the impression of a 'picture-frame'. Ultramicroscopic study revealed changes in the mitochondria and areas of myofibrillar disruption with swelling of the sarcoplasmic reticulum. Isaacs H H Heffron J J JJ Badenhorst M M eng Journal Article South Africa S Afr Med J 0404520 EC 3.6.1.- Adenosine Triphosphatases SY7Q814VUP Calcium UQT9G45D1P Halothane IM Adenosine Triphosphatases analysis Adult Calcium metabolism Halothane pharmacology Heterozygote Histocytochemistry Humans Hydrogen-Ion Concentration Male Malignant Hyperthermia enzymology pathology physiopathology Microscopy, Electron Mitochondria Muscle Contraction drug effects Muscles enzymology pathology Sarcoplasmic Reticulum metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 795 796 1976 02 19 2018 12 03 0256-9574 49 49 1975 Nov 15 South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde S Afr Med J The GP dilemma. Recommendations and synopsis of a student conference. 2059-60 The proceedings of a conference organised by students are reported. The present standing of the general practitioner and his need in different societies are equated and the obvious deficiencies are considered. Such themes as maldistribution, service and education are discussed. Resolutions derived from the conference are reported in full. Sprenger K J KJ Chouler C A CA eng Congress South Africa S Afr Med J 0404520 IM Congresses as Topic Delivery of Health Care Education, Medical Family Practice Physicians statistics & numerical data Primary Health Care Race Relations South Africa Students, Medical 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 796 797 1976 03 01 2018 12 03 0036-3278 50 19 1975 Oct 07 Sairaanhoitaja. Sjukskoterskan Sairaanhoitaja [Report from the National Representatives of the Scandinavian Nurses' Federation's meeting in Iceland]. 16-20 Valkonen I I fin Congress Pohjoismaiden sairaanhoitajat koolla Islannissa Finland Sairaanhoitaja 0105422 0036-3278 N Congresses as Topic International Cooperation Scandinavian and Nordic Countries Societies, Nursing 1975 10 7 1975 10 7 0 1 1975 10 7 0 0 ppublish 797 798 1976 03 01 2018 12 03 0036-3278 50 23-24 1975 Dec 09 Sairaanhoitaja. Sjukskoterskan Sairaanhoitaja [Association's meeting after half a year]. 15-7, 22-4 Juselius G G fin swe Congress Finland Sairaanhoitaja 0105422 0036-3278 N Congresses as Topic Economics, Nursing Finland Societies, Nursing 1975 12 9 1975 12 9 0 1 1975 12 9 0 0 ppublish 798 799 1976 02 09 2018 12 03 0039-5870 6 10 1975 Oct Supervisor nurse Superv Nurse A clinical conference for inactive nurses. 51-3 Niles A M AM Lutze R S RS eng Congress United States Superv Nurse 0270745 0039-5870 N Congresses as Topic Education, Nursing, Continuing Unemployment Wisconsin 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 799 800 1976 02 19 2009 11 11 0039-6087 142 1 1976 Jan Surgery, gynecology & obstetrics Surg Gynecol Obstet Gastric emptying of liquids after different vagotomies and pyloroplasty. 41-8 Gastric emptying of five liquid meals which differ in their physicochemical properties have been measured in control dogs and dogs that have received a Heinecke-Mikulicz pyloroplasty alone, proximal gastric vagotomy without drainage, selective gastric vagotomy and pyloroplasty and truncal vagotomy and pyloroplasty. The first two phases of emptying have been computed by the method of least squares to obtain a logarithmic-linear pattern and are expressed as relative rates: The initial post-ingestion process is characterized by beta or the average relative rate of emptying in the first ten minutes, the basic or exponential rate as beta and the change in rate from the initial to basic pattern as deltabeta. Each measure of gastric emptying was statistically analyzed to determine specific differences in rates between the operations studied. We confirmed the earlier claims that pyloroplasty alone does not change the emptying rate of liquid meals. Each measure or phase of emptying varies consistently across the operations from meal to meal tested. Initial emptying after all three vagotomies is significantly faster than control with progressive rate increases as proximal gastric vagotomy is compared with selective gastric vagotomy with pyloroplasty and with truncal vagotomy with pyloroplasty, probably indicative of gastric fundal loss of accommodation to volume distention after denervation. The basic exponential pattern of emptying is not lost after any of the operations studied. The basic rate after proximal gastric vagotomy and selective gastric vagotomy with pyloroplasty is nearly identical, slightly delayed from the control rate and significantly slower than the more rapid rate after truncal vagotomy with pyloroplasty. Possible explanations for these are discussed and imply a particular importance of the hepatic and celiac vagal fibers, sectioned only with truncal vagotomy, in the regulation of gastric emptying of liquids. Gleysteen J J JJ Burdeshaw J A JA Hallenbeck G A GA eng Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Surg Gynecol Obstet 0101370 0039-6087 AIM IM Animals Dogs Gastrectomy Gastrointestinal Motility Hydrogen-Ion Concentration Pylorus surgery Time Factors Vagotomy 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 800 801 1976 02 19 2018 12 03 0039-6087 142 1 1976 Jan Surgery, gynecology & obstetrics Surg Gynecol Obstet Pancreatic enzyme response with an elemental diet. 71-4 Elemental diets can maintain or slightly improve the nutritional status without a major stimulatory effect on the pancreas. Six dogs were maintained with a regular chow diet, switched to an elemental diet and, subsequently, returned to a chow diet. Cannulation of the pancreatic duct through a duodenal cutaneous fistula revealed the enzyme response to be decreased in a dog maintained with an elemental diet, with no or only a slight weight gain. Return to a regular diet resulted in a return of pancreatic enzyme response. Neviackas J A JA Kerstein M D MD eng Journal Article United States Surg Gynecol Obstet 0101370 0039-6087 0 Amino Acids 0 Dietary Carbohydrates 0 Dietary Proteins 9002-08-8 Trypsinogen EC 3.1.1.3 Lipase EC 3.2.1.- Amylases AIM IM Amino Acids Amylases metabolism Animals Diet Dietary Carbohydrates Dietary Proteins Dogs Evaluation Studies as Topic Female Hydrogen-Ion Concentration Lipase metabolism Male Osmolar Concentration Pancreatic Juice enzymology Secretory Rate Trypsinogen metabolism 1976 1 1 1976 1 1 0 1 1976 1 1 0 0 ppublish 801 802 1976 02 27 2008 11 21 0106-8350 75 36 1975 Sep 10 Sygeplejersken Sygeplejersken [Nurses' drug information: therapeutic action group: benzodiazepine derivatives. 1]. 15 Lumholtz I B IB dan Journal Article Sygeplejerskens laegemiddel information; terapeutisk hovedgruppe: benzodiazpinederivater. 1 Denmark Sygeplejersken 0421366 0106-8350 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines N Anti-Anxiety Agents Benzodiazepines 1975 9 10 1975 9 10 0 1 1975 9 10 0 0 ppublish 802 803 1976 02 27 2008 11 21 0106-8350 75 38 1975 Sep 24 Sygeplejersken Sygeplejersken [Nurses' drug information: therapeutic action group: benzodiazepine derivatives. 2]. 15 Lumholtz I B IB dan Journal Article Sygeplejerskens laegemiddel information; terapeutisk hovedgruppe: benzodiazepinderivater. 2 Denmark Sygeplejersken 0421366 0106-8350 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines N Anti-Anxiety Agents therapeutic use Benzodiazepines Humans 1975 9 24 1975 9 24 0 1 1975 9 24 0 0 ppublish 803 804 1976 02 27 2008 11 21 0106-8350 75 40 1975 Oct 08 Sygeplejersken Sygeplejersken [Nurses' drug information; therapeutic action group: benzodiazepines. 3]. 12 Lumholtz I B IB dan Journal Article Sygeplejerskens laegemiddel information; terapeutisk hivedgruppe: benzodiazepiner. 3 Denmark Sygeplejersken 0421366 0106-8350 0 Anti-Anxiety Agents 12794-10-4 Benzodiazepines N Anti-Anxiety Agents pharmacology Benzodiazepines 1975 10 8 1975 10 8 0 1 1975 10 8 0 0 ppublish 804 805 1976 02 27 2018 12 03 0106-8350 75 49 1975 Dec 10 Sygeplejersken Sygeplejersken [Health and nursing care's working environment should be critically examined. Contribution to the discussion about working environment as an introduction to the congress]. 17 dan Congress Sundheds- og sygeplejerskers arbejdsmiljø skal belyses: bidrag til debat om arbejdsmiljøet som oplaeg til kongressen Denmark Sygeplejersken 0421366 0106-8350 N Congresses as Topic Denmark Employment Environment Health Occupations 1975 12 10 1975 12 10 0 1 1975 12 10 0 0 ppublish 805 806 1976 02 27 2016 11 23 0340-5338 34 2 1975 Nov 15 Thrombosis et diathesis haemorrhagica Thromb Diath Haemorrh Molecular biology of human plasminogen. I. Physiochemical properties and microheterogeneity. 396-402 Collen D D de Maeyer L L eng Journal Article Review Germany Thromb Diath Haemorrh 7608420 0340-5338 0 Amino Acids 0 Glutamates 0 Isoenzymes 0 Sialic Acids 9001-91-6 Plasminogen K3Z4F929H6 Lysine IM Amino Acid Sequence Amino Acids analysis Chemical Phenomena Chemistry, Physical Drug Stability Electrophoresis, Polyacrylamide Gel Enzyme Activation Glutamates Humans Hydrogen-Ion Concentration Isoelectric Point Isoenzymes Kinetics Lysine Molecular Weight Plasminogen analysis isolation & purification Protein Conformation drug effects Sialic Acids analysis Solubility 36 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 806 807 1976 02 27 2013 11 21 0340-5338 34 2 1975 Nov 15 Thrombosis et diathesis haemorrhagica Thromb Diath Haemorrh Gastric fibrinolysis. 409-18 Gastric juice from 15 normals, 20 patients with gastric ulcer and 14 patients with erosive haemorrhagic gastroduodenitis was investigated in respect of its activity on unheated and heated fibrin plates and its content of FDP and plasminogen or plasmin with immunochemical methods. Gastric juice from normals showed no activity on unheated and heated fibrin plates, and no FDP or plasminogen could be demonstrated. In the patients with gastric ulcer the gastric juice showed little or no fibrinolytic activity on fibrin plates except in 2, who had regurgitation of duodenal juice and neutral pH of the juice. These patients had equally high activity on heated as on unheated plates and no plasmin could be demonstrated. It was shown that this activity was not due to fibrinolysis, but to non-specific proteolytic activity (probably trypsin). The patients with erosive haemorrhage gastroduodenitis exhibited quite a different picture. The gastric juice from these patients showed extremely high activity on fibrin plates, the activity was higher on unheated than on heated plates. The activity was inhibited in vitro by addition of EACA and in vivo after administration of AMCA. The occurence of plasmic could be demonstrated directly immunologically in the gastric juice. By comparsion of plasmin and trypsin in various assays it could further be improved that the gastric juice in these cases contained plasminogen activator and plasmin. The patients with erosive haemorrhagic gastroduodenitis showed no increase in fibrinolysis in the blood, but low values for plasminogen and alpha2-M, and the serum contained FDP. These findings in the blood and gastric juice were interpreted as signs of local fibrinolysis in the stomach and duodenum. There is reason to assume that this gastric fibrinolysis contributes substantially to the bleeding tendency. The effect of administration of AMCA on fibrinolytic activity and the haemorrhage lends support to the assumption of such a mechanism. Nilsson I M IM Bergentz S E SE Hedner U U Kullenberg K K eng Journal Article Germany Thromb Diath Haemorrh 7608420 0340-5338 0 Aminocaproates 0 Fibrin Fibrinogen Degradation Products 6T84R30KC1 Tranexamic Acid 9001-91-6 Plasminogen EC 3.4.21.- Plasminogen Activators EC 3.4.21.4 Trypsin EC 3.4.21.7 Fibrinolysin IM Aged Aminocaproates Blood Coagulation Female Fibrin Fibrinogen Degradation Products analysis Fibrinolysin analysis Fibrinolysis Gastric Juice analysis Gastric Mucosa physiopathology Gastroenteritis blood physiopathology Gastrointestinal Hemorrhage blood physiopathology Humans Hydrogen-Ion Concentration Male Middle Aged Plasminogen analysis Plasminogen Activators analysis Stomach Ulcer physiopathology Tranexamic Acid Trypsin analysis 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 807 808 1976 02 27 2014 11 20 0340-5338 34 2 1975 Nov 15 Thrombosis et diathesis haemorrhagica Thromb Diath Haemorrh Proceedings: Effects of pH on arachidonic acid induced platelet aggregation. 560 Gerrard J M JM White J G JG Krivit W W eng Journal Article Germany Thromb Diath Haemorrh 7608420 0340-5338 0 Arachidonic Acids 0 Prostaglandins IM Arachidonic Acids pharmacology Blood Blood Platelets metabolism Humans Hydrogen-Ion Concentration In Vitro Techniques Platelet Aggregation drug effects Prostaglandins biosynthesis 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 808 809 1976 02 27 2009 11 19 0340-5338 34 2 1975 Nov 15 Thrombosis et diathesis haemorrhagica Thromb Diath Haemorrh Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH. 581-2 Coller B S BS Gralnick H R HR eng Journal Article Germany Thromb Diath Haemorrh 7608420 0340-5338 1404-55-3 Ristocetin IM Blood Humans Hydrogen-Ion Concentration Platelet Aggregation drug effects Ristocetin pharmacology Time Factors von Willebrand Diseases diagnosis 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 809 810 1976 02 27 2014 11 20 0340-5338 34 2 1975 Nov 15 Thrombosis et diathesis haemorrhagica Thromb Diath Haemorrh Proceedings: Hemophilia: modified by a post-exercise plasminogen activator. 612 Hampton J W JW Weidenbach A A Skye G E GE Rubenstein C C Taylor F B FB eng Journal Article Germany Thromb Diath Haemorrh 7608420 0340-5338 EC 3.4.21.- Plasminogen Activators IM Female Hemophilia A blood genetics Humans Hydrogen-Ion Concentration In Vitro Techniques Male Physical Exertion Plasma Plasminogen Activators blood 1975 11 15 1975 11 15 0 1 1975 11 15 0 0 ppublish 810 811 1976 02 13 2019 07 27 0049-3848 7 4 1975 Oct Thrombosis research Thromb Res Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system. 543-54 Saba H I HI Herion J C JC Walker R I RI Roberts H R HR eng Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. United States Thromb Res 0326377 0049-3848 0 Aminocaproates 0 Fibrin Fibrinogen Degradation Products 0 Protease Inhibitors 0 Proteins 0 Trypsin Inhibitors 9001-31-4 Fibrin 9001-32-5 Fibrinogen 9001-91-6 Plasminogen EC 3.4.- Peptide Hydrolases EC 3.4.21.- Plasminogen Activators IM Aminocaproates pharmacology Animals Blood Coagulation drug effects Fibrin Fibrin Fibrinogen Degradation Products analysis Fibrinogen Fibrinolysis Hydrogen-Ion Concentration Leukocytes analysis Lysosomes analysis Peptide Hydrolases isolation & purification metabolism Plasminogen pharmacology Plasminogen Activators isolation & purification pharmacology Protease Inhibitors Proteins pharmacology Rabbits Trypsin Inhibitors pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 811 10.1016/0049-3848(75)90101-2 812 1976 02 26 2019 07 27 0049-3848 7 6 1975 Dec Thrombosis research Thromb Res Prothrombin profragment-1 optical rotatory dispersion and circular dichroism. 839-46 Gabriel D A DA Schaefer D J DJ Roberts H R HR Aronson D L DL Koehler K A KA eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Thromb Res 0326377 0049-3848 0 Peptide Fragments 9001-26-7 Prothrombin SY7Q814VUP Calcium IM Calcium Circular Dichroism Humans Hydrogen-Ion Concentration Optical Rotatory Dispersion Peptide Fragments Prothrombin 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 812 10.1016/0049-3848(75)90087-0 813 1976 03 01 2018 12 03 0037-6027 42 22 1975 Dec 18 Tidskrift for Sveriges sjukskoterskor Tidskr Sver Sjukskot [Students' action adopted at convention]. 23-4 Monvall E E swe Congress Elevernas agerande togs upp i riksdagen Sweden Tidskr Sver Sjukskot 7708470 0037-6027 N Congresses as Topic Education, Nursing Educational Measurement Sweden 1975 12 18 1975 12 18 0 1 1975 12 18 0 0 ppublish 813 814 1976 02 20 2016 11 23 0040-7453 100 20 1975 Oct 15 Tijdschrift voor diergeneeskunde Tijdschr Diergeneeskd Acid-base parameters in the dehydrated camel. 1105-8 The effect of prolonged (10 days) dehydration on acid-base parameters of camel blood was examined. The pH and PCO2 levels rose significantly in the course of dehydration. This state was comparable with compensated non-respiratory alkalosis found in other animals. The plasma sodium, and magnesium levels rose significantly also. The plasma oxygen and calcium levels declined significantly. There were no significant changes in potassium and phosphate levels. It is concluded that the changes found in acid-base status following dehydration are further evidence of water preservation mechanisms in the dehydrated camel. Yagil R R Etzion Z Z Berlyne G M GM eng Journal Article Netherlands Tijdschr Diergeneeskd 0031550 0040-7453 0 Phosphates 142M471B3J Carbon Dioxide 9NEZ333N27 Sodium I38ZP9992A Magnesium RWP5GA015D Potassium S88TT14065 Oxygen SY7Q814VUP Calcium IM Acid-Base Equilibrium Animals Calcium blood Camelus blood Carbon Dioxide blood Dehydration blood physiopathology veterinary Female Hydrogen-Ion Concentration Magnesium blood Oxygen blood Phosphates blood Potassium blood Sodium blood 1975 10 15 1975 10 15 0 1 1975 10 15 0 0 ppublish 814 815 1976 03 01 2006 11 15 0040-6384 23 5 1975 Oct Thoraxchirurgie, vaskulare Chirurgie Thoraxchir Vask Chir [Clinical experiences with untreated homologous vein grafts in reconstruction of arteries (author's transl)]. 468-71 50 transplantations of homologous vein grafts in reconstruction of arteries are reported on. Vein grafts were either transplanted immediately or used after deep freezing. This procedure has proved to be effective in the replacement of arteries during our observation period of four years. Results of homologous vein transplants are similar to those of autologous transplants. Schulze-Bergmann G G Fernandez C C ger English Abstract Journal Article Erfahrungen mit der unpräparierten homologen Vene bei der Rekonstruktion erkrankter und verletzter Arterien Germany Thoraxchir Vask Chir 7706134 0040-6384 IM Arterial Occlusive Diseases surgery Arteries injuries surgery Female Femoral Artery surgery Follow-Up Studies Freezing Graft vs Host Reaction Humans Prognosis Transplantation, Autologous Transplantation, Homologous Veins pathology transplantation Wound Healing 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 815 10.1055/s-0028-1097009 816 1976 03 01 2014 07 22 28 23 1975 Nov 18 Tijdschrift voor ziekenverpleging Tijdschr Ziekenverpl [Bacteria as cause of dental caries]. 1094-7 de Stoppelaar J D JD dut Journal Article Bacteriën als oorzaak van tandbederf Netherlands Tijdschr Ziekenverpl 7505126 N Dental Caries etiology Dental Plaque Humans Hydrogen-Ion Concentration Mouth microbiology Oral Hygiene 1975 11 18 1975 11 18 0 1 1975 11 18 0 0 ppublish 816 817 1976 02 13 2004 11 17 0303-6286 3 1 1975 Tierarztliche Praxis Tierarztl Prax [Current interpretation of the testicular maldescention problem]. 123-7 Holschneider A M AM ger Journal Article Uber die heutige Auffassung zum Maldescensus-testis-Problem Germany Tierarztl Prax 7501042 0303-6286 IM Cryptorchidism diagnosis physiopathology therapy Humans Infertility, Male prevention & control Male Prognosis 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 817 818 1976 02 13 2003 11 14 0303-6286 3 1 1975 Tierarztliche Praxis Tierarztl Prax [Maldescensus testis in the dog]. 129-30 Arbeiter K K ger Journal Article Zum Maldescensus testis beim Hund Germany Tierarztl Prax 7501042 0303-6286 0 Gonadotropins IM Animals Cryptorchidism drug therapy veterinary Dog Diseases diagnosis drug therapy Dogs Gonadotropins therapeutic use Male 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 818 819 1976 02 09 2019 07 27 0041-008X 34 1 1975 Oct Toxicology and applied pharmacology Toxicol Appl Pharmacol Experimental methanol toxicity in the primate: analysis of metabolic acidosis. 49-61 Clay K L KL Murphy R C RC Watkins W D WD eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Toxicol Appl Pharmacol 0416575 0041-008X 0 Bicarbonates 0 Formates 142M471B3J Carbon Dioxide Y4S76JWI15 Methanol IM Acidosis blood chemically induced Animals Bicarbonates blood Carbon Dioxide blood Chromatography, Gas Female Formates blood Haplorhini Hydrogen-Ion Concentration Macaca Macaca mulatta Male Methanol toxicity Rats Time Factors 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 819 10.1016/0041-008x(75)90174-x 820 1976 02 19 2019 07 27 0039-2499 6 6 1975 Nov-Dec Stroke Stroke The effect of a simulated subarachnoid hemorrhage on cerebral blood flow in the monkey. 664-72 The hydrogen clearance method was used to measure local and total cerebral blood flow (CBF) in the rhesus monkey before and for five hours after a simulated subarachnoid hemorrhage (SAH). CBF remained stable after SAH unless SAH was associated with a fall in cerebral perfusion pressure. In addition, cerebrovascular resistance did not increase after SAH. These results suggest that vasoactive agents in fresh whole blood, and the arterial spasm they produce when added to cerebrospinal fluid (CSF), play only a limited role in the pathogenesis of ischemic encephalopathy that follows an SAH. Martins A N AN Doyle T F TF Newby N N Kobrine A I AI Ramirez A A eng Journal Article United States Stroke 0235266 0039-2499 142M471B3J Carbon Dioxide S88TT14065 Oxygen IM Animals Carbon Dioxide blood Cerebrovascular Circulation Disease Models, Animal Female Haplorhini Hydrogen-Ion Concentration Intracranial Pressure Macaca mulatta Male Models, Neurological Oxygen blood Partial Pressure Regional Blood Flow Subarachnoid Hemorrhage physiopathology 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 820 10.1161/01.str.6.6.664 824 1976 02 20 2006 11 15 0041-1345 7 4 1975 Dec Transplantation proceedings Transplant Proc Marrow grafts between canine littermates showing one-way nonstimulation in mixed leukocyte culture. 459-60 Storb R R Weiden P L PL Schroeder M L ML Graham T C TC eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Transplant Proc 0243532 0041-1345 0 Histocompatibility Antigens IM Animals Bone Marrow Cells Bone Marrow Transplantation Dogs Graft Rejection Graft vs Host Reaction Histocompatibility Antigens Lymphocyte Culture Test, Mixed Transplantation, Homologous 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 824 821 1976 02 19 2019 07 27 0039-2499 6 6 1975 Nov-Dec Stroke Stroke Effects of oxygen saturation and pCO2 on brain uptake of glucose analogues in rabbits. 691-6 The effect of oxygen saturation and PCO2 on brain uptake of glucose analogues was studied in rabbits. Using a modified Oldendorf technique, 14C-labeled glucose analogues with a 3H2O reference standard were introduced into the cerebral circulation via the common carotid artery, and the radioactivity of the ipsilateral cerebral cortex was counted and expressed in terms of a brain uptake index (BUI). Severe hypoxia (oxygen saturation less than or equal to 18%) resulted in approximately a 40% decrease in the BUI of 2-deoxy-D-glucose and a 45% decrease in the BUI of 3-0-methyl-D-glucose. Severe hypercapnia (PCO2 = 100 mm Hg) caused a 45% decrease in the BUI of both of these glucose analogues. Hypercapnia superimposed on severe hypoxia had no additional effect. Hypocapnia (PCO2 = 15 mm Hg) increased the BUI of 3-0-methyl-D-glucose by 35% of the control value, and this increase was extremely sensitive to competitive inhibition. When BUI values were plotted against pH rather than PCO2 for the same experiments, there was a good correlation with the calculated linear regression. These results are compared with previous findings on pathologically induced changes in brain uptake of glucose analogues, and the possible role of blood flow is considered in detail. Berson F G FG Spatz M M Klatzo I I eng Journal Article United States Stroke 0235266 0039-2499 142M471B3J Carbon Dioxide IY9XDZ35W2 Glucose S88TT14065 Oxygen IM S Animals Blood Pressure Blood-Brain Barrier Carbon Dioxide blood Cerebral Cortex metabolism Female Glucose analogs & derivatives metabolism Hydrogen-Ion Concentration Hypercapnia metabolism Hypoxia metabolism Male Oxygen blood Oxygen Consumption Rabbits 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 821 10.1161/01.str.6.6.691 825 1976 02 20 2003 11 14 0041-1345 7 4 1975 Dec Transplantation proceedings Transplant Proc Engraftment of allogeneic dog bone marrow. 465-8 Resistance to allogeneic bone-marrow grafts (AR) was found to occur in many species, including the dog. The i.v. administration of silica particles suppressed AR in vivo in this species. Genetic studies provide suggestive evidence for the existence of a previously unrecognized system or systems in the canine major histocompatibility complex controlling AR. Vriesendorp H M HM Zurcher C C van Bekkum D W DW eng Journal Article United States Transplant Proc 0243532 0041-1345 0 Antilymphocyte Serum 0 Carcinoembryonic Antigen 0 Histocompatibility Antigens 7631-86-9 Silicon Dioxide EC 3.5.1.1 Asparaginase IM Animals Antilymphocyte Serum pharmacology Asparaginase pharmacology Blood Cell Count Blood Platelets Bone Marrow pathology Bone Marrow Cells Bone Marrow Transplantation Carcinoembryonic Antigen analysis Dogs Graft vs Host Reaction Histocompatibility Antigens Immunosuppression Karyotyping Leukocyte Count Lymph Nodes pathology Lymphocyte Culture Test, Mixed Reticulocytes Silicon Dioxide pharmacology Spleen pathology Transplantation, Homologous 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 825 822 1976 02 19 2019 07 27 0039-2499 6 6 1975 Nov-Dec Stroke Stroke Lactate and pyruvate concentrations, and acid-base balance of cerebrospinal fluid in experimentally induced intracerebral and subarachnoid hemorrhage in dogs. 715-9 The effect of blood injected into either subarachnoid space or subcortical brain tissue upon lactate and pyruvate concentrations as well as acid-base balance of cerebrospinal fluid (CSF) was studied in the anesthetized dog. CSF lactate and lactate/pyruvate ratio (L/P ratio) increased progressively following the intracranial injection of blood and reached the maximum level at six hours after injection. These changes were significantly greater in animals with intracerebral hematoma than in those with subarachnoid hemorrhage (SAH). An increase in CSF lactate and L/P ratio in hemorrhagic CSF seems to be caused by two different factors. Shed blood cells per se produce lactate and pyruvate, and blood in the subarachnoid space and intracerebral hematomas cause secondary changes in brain tissue metabolism by a probable reduction of cerebral blood flow. Therefore, an increase in CSF lactate with a concomitant rise in CSF L/P ratio is a useful indicator for brain tissue hypoxia, even when CSF is hemorrhagic. The association of an increase in CSF lactate to a disproportionate decrease in CSF HCO-3 was also observed in these animals. Sugi T T Fujishima M M Omae T T eng Journal Article United States Stroke 0235266 0039-2499 0 Bicarbonates 0 Lactates 0 Pyruvates IM Acid-Base Imbalance Animals Bicarbonates cerebrospinal fluid Cerebral Hemorrhage cerebrospinal fluid metabolism Disease Models, Animal Dogs Glycolysis Hydrogen-Ion Concentration Lactates cerebrospinal fluid Pyruvates cerebrospinal fluid Subarachnoid Hemorrhage cerebrospinal fluid metabolism Time Factors 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 822 10.1161/01.str.6.6.715 823 1976 02 19 2019 07 27 0041-1132 15 5 1975 Sep-Oct Transfusion Transfusion A study of variables affecting the quality of platelets stored at "room temperature". 414-21 The effect of variables associated with the donor and with methods of collecting, processing, and storing platelets on the quality of platelets kept at ambient temperature was studied. Changes in structural integrity of platelets, decrease in pH, loss of aggregability, and kinetics in vivo of platelets tagged with 51Cr were used as indicators of the tolerance of platelets to storage. A platelet concentration of less than 2.5 x 10(6) per cu mm, a temperature of storage less than 24 C, and continuous, gentle, agitation were found to be essential for satisfactory preservation of platelet integrity, function, and post-transfusion survival. Platelets from female donors tolerated storage less well than did platelets from male donors, possibly because the lower hematocrit of blood collection from females resulted in greater initial acidity of the concentrate. A number of other variables analyzed appear to be of little or no consequence for successful platelet storage. Kunicki T J TJ Tuccelli M M Becker G A GA Aster R H RH eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Transfusion 0417360 0041-1132 IM Blood Banks Blood Platelets cytology physiology Blood Preservation Cell Survival Female Humans Hydrogen-Ion Concentration Male Platelet Aggregation Sex Factors Temperature Time Factors 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 823 10.1046/j.1537-2995.1975.15576082215.x 826 1976 02 20 2006 11 15 0041-1345 7 4 1975 Dec Transplantation proceedings Transplant Proc Induction of tolerance to third-party donor organs in canine radiation chimeras. 471-4 Rapaport F T FT Bachvaroff R J RJ Watanabe K K Cannon F D FD Ayvazian J H JH Blumenstock D D Ferrebee J W JW eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Transplant Proc 0243532 0041-1345 0 Histocompatibility Antigens IM Animals Bone Marrow Cells Bone Marrow Transplantation Dogs Female Genotype Graft vs Host Reaction Histocompatibility Antigens Immune Tolerance Kidney Transplantation Male Radiation Chimera Transplantation, Homologous 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 826 827 1976 02 09 2019 10 27 0082-7134 18 1975 UCLA forum in medical sciences UCLA Forum Med Sci Dopamine-containing neurons of the substantia nigra and their terminals in the neostriatum. 227-64 Tne ultrastructural and fluorescence histochemical characteristics of the mature rabbit substantia nigra and neostriatum have been reviewed as a frame of reference for the developmental study. Biochemical investigations were reported on neostriatal dopamine concentrations and the relative uptake and accumulation of 3H-dopamine by this tissue from fetal to adult stages, to provide quantitative data for correlation with the fluorexcence information. The development of the neurons of the substantia nigra and their axons which project to the neostriatum has been presented from their appearance at day 14 of gestation to their maturation in early postnatal life. The initial bipolar neuroblasts, which develop in the midline of the caudal mesencephalon, are fluorescent as soon as they emerge from the ependymal zone. Their fluorescent axons, which form the nigroneostriatal pathway, reach the telencephalon at day 16 of gestation and ramify extensively in the putamen by day 20, but do not enter the caudate nucleus until several days later. Some of the early fluorescent axonal profiles in the putamen are extremely large. Electron microscopic study of theis stage suggests that the large fluorescent profiles may correspond to axonal growth cones or early synapses. A distinct substantia nigra, pars compacta and reticulata, can be recognized by fluorescence microscopy by day 20 of gestation. Electron microscopy reveals that the young neurons are multipolar with numerous developing dendrites, some of which exhibit early synaptic junctions. The subsequent maturaition of these cells and the neuropil is described. The fluorescent axons of the substantia nigra grow into the putamen and caudate nucleus in a nonuniform manner forming fluorescent islands throughout the neostriatum in late fetal life. Occasionally, minute beaded fluorescent axons are found. These profiles might correspond to some of the axons with varicosities "en passage" revealed by electron microscopy. In an attempt to identify further the dopamine-containing axon, the ultratructure of adult neostriatum incubated in 5-hydroxydopamine was reported. Axonal varicosities "en passage" containing a dense "tag" in the vesicles were found. Most of the tagged boutons did not exhibit synaptic contacts. The possible significance of these finding s as related to dopamine secretion are discussed. Tennyson V M VM Mytilineou C C Heikkila R R Barrett R E RE Cohen G G Côté L L Duffy P E PE Marco L L eng Journal Article Research Support, U.S. Gov't, P.H.S. United States UCLA Forum Med Sci 0067303 0082-7134 0 Biogenic Amines 0 Neurotransmitter Agents VTD58H1Z2X Dopamine IM Animals Axons metabolism Biogenic Amines metabolism Caudate Nucleus metabolism Cell Differentiation Cell Movement Corpus Striatum embryology metabolism Dopamine metabolism Histocytochemistry Microscopy, Electron Microscopy, Fluorescence Morphogenesis Neural Pathways Neurotransmitter Agents metabolism Rabbits Substantia Nigra embryology metabolism Synapses metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 827 10.1016/b978-0-12-139050-1.50021-5 828 1976 02 09 2019 10 27 0082-7134 18 1975 UCLA forum in medical sciences UCLA Forum Med Sci Discussion: Metachromatic leukodystrophy, an unusual case with a subtle cerebroside sulfatase defect. 501-6 Kihara H H eng 091038 Wellcome Trust United Kingdom Case Reports Journal Article Research Support, U.S. Gov't, P.H.S. United States UCLA Forum Med Sci 0067303 0082-7134 EC 3.1.6.- Sulfatases EC 3.1.6.1 Arylsulfatases EC 3.1.6.8 Cerebroside-Sulfatase IM Arylsulfatases metabolism Cerebroside-Sulfatase deficiency Fibroblasts enzymology Humans Leukocytes enzymology Leukodystrophy, Metachromatic enzymology Sulfatases deficiency 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 828 10.1016/b978-0-12-139050-1.50036-7 829 1976 03 01 2013 11 21 0041-610X 47 1 1975 Jan-Feb Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Separation of the hormones of the adenohypophysis of rats by use of electrophoresis in polyacrylamide gel in the presence of sodium dodecyl sulfate]. 122-5 A comparative study of rat adenohypophysis extract and its alcohol fractions was performed by two variants of the method of electrophoresis in polyacrylamide gel: at pH 9,5 and with the presence of sodium dodecyl sulphate at pH 7.2. With the presence of sodium dodecylsulphate four protein zones are found which in the order from the anode towards the cathode are identified as hemoglobin, somatotropin, lactotropin and albumin. It is shown that the somatotropin zone after the extract separation at pH 9.5 is inhomogeneous and consists of somatotropin and hemoglobin. Martynenko F P FP Sakhno T O TO ukr English Abstract Journal Article Rozdilennia hormoniv adenohipofizu shchuriv z dopomohoiu elektroforezu v poliakrylamidnomu heli za naiavnosti dodetsylsul'fatu natriiu Ukraine Ukr Biokhim Zh 0414153 0 Pituitary Hormones, Anterior 368GB5141J Sodium Dodecyl Sulfate IM Animals Electrophoresis, Polyacrylamide Gel methods Hydrogen-Ion Concentration Pituitary Hormones, Anterior analysis Rats Sodium Dodecyl Sulfate 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 829 830 1976 03 01 2013 11 21 0041-610X 47 1 1975 Jan-Feb Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Properties of NAD-glycohydrolase of the nuclei of the liver cells of rats]. 3-7 Certain properties of the rat liver cell nuclei NAD-glycohydrolase (EC 3.2.2.5) were investigated. It is established that its highest activity is at 37 degrees with activation energy equal to 9480 cal/M and with factor Q10 equal to 1.5. The enzyme pH optimum in 0.2 M tris acetate is equal to 6.5 and in 0.2 potassium phosphate - 7.5. It was shown that the enzyme manifests its strict specificity only with beta-NAD, and it hardly decomposes NADP without affecting NADH, NADPH and NMN. The apparent Km value of the enzyme with respect to NAD is established. Isonicotinic acid hydrazide, nicotinamide and to the less extent nicotinic acid inhibit the enzymatic activity of nuclei. EDTA, EGTA, p-CMB, mercaptoethanol do not cause any changes in the rat liver cells nuclei NADase activity. Pakyrbaéva L V LV Shushevich S I SI Khalmuradov A H AH Chahovets' R V RV ukr English Abstract Journal Article Vlastyvosti NAD-hlikohidrolazi iader klityn pechinky shchuriv Ukraine Ukr Biokhim Zh 0414153 0 Isonicotinic Acids 0 Nicotinic Acids 0U46U6E8UK NAD 1094-61-7 Nicotinamide Mononucleotide 25X51I8RD4 Niacinamide 526U7A2651 Egtazic Acid 53-59-8 NADP 60-24-2 Mercaptoethanol 9G34HU7RV0 Edetic Acid EC 3.2.2.- N-Glycosyl Hydrolases EC 3.2.2.5 NAD+ Nucleosidase IM Animals Cell Nucleus drug effects enzymology Edetic Acid pharmacology Egtazic Acid pharmacology Hydrogen-Ion Concentration Isonicotinic Acids pharmacology Liver drug effects enzymology Mercaptoethanol pharmacology N-Glycosyl Hydrolases metabolism NAD metabolism NAD+ Nucleosidase metabolism NADP metabolism Niacinamide pharmacology Nicotinamide Mononucleotide metabolism Nicotinic Acids pharmacology Rats Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 830 831 1976 03 01 2018 12 03 0041-610X 47 1 1975 Jan-Feb Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Some properties of "soluble" Na+ and K+-ATPase obtained from various subcellular membrane structures of the brain by use of non-ionic detergents]. 44-8 A comparative study was carried out of some properties of "soluble" Na+, K+-ATPase obtained from different subcellular membrane brain structures by means of non-ionic detergents of triton X-100 and digitonin. It is established that temperature and pH-optima of "soluble" Na+, K+-ATPase are close to these optima of the initial membrane preparations. A certain difference is observed in the dynamics of temperature and pH-dependence of Na+, K+-ATPase activity in the extracts from different subcellular structures. The stability of the preparations in storage was investigated. A conclusion is made that more stable enzyme extracts may be obtained by means of digitonin. Kravtsov O V OV Kirsenko O V OV ukr Journal Article Deiaki vlastyvosti "rozchynnoï" Na+, K+-ATFazy, oderzhanoï z riznykh subklitynnykh membrannykh struktur mozku za dopomohoiu neionnykh deterhentiv Ukraine Ukr Biokhim Zh 0414153 3WJQ0SDW1A Polyethylene Glycols 9NEZ333N27 Sodium EC 3.6.1.- Adenosine Triphosphatases KOO5CM684H Digitonin RWP5GA015D Potassium IM Adenosine Triphosphatases isolation & purification Animals Brain enzymology Cattle Cell Membrane metabolism Digitonin Drug Stability Hydrogen-Ion Concentration Methods Polyethylene Glycols Potassium Sodium Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 831 832 1976 03 01 2006 11 15 0041-610X 47 1 1975 Jan-Feb Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Properties of glutamine synthetase of the brain of rats during ontogenesis]. 65-9 When investigating activity of glutamine synthetase of the enzymatic preparations isolated from the brain of rats of 0.5, 1, 3, 12 and 24-month age, no considerable differences were found in the indices of the values Km to a-glutamate and Vmax which are respectively equal to: Km (M-10(-3))=5.5; 3.5; 3.6; 3.9; 5.5; Vmax=3.1; 4.5; 5.0; 5.2 muM were found. When adding various concentrations of a-ketoglutaric acid into the incubation medium the differences are registered in the degree and character of the age changes in brain glutamine synthetase activity in comparison with this enzyme form the liver. Hordiénko E A EA Sydorova O M OM Efremova H H HH ukr English Abstract Journal Article Vlastyvosti hlutaminsyntetazy mozku shchyriv v ontohenezi Ukraine Ukr Biokhim Zh 0414153 0 Ketoglutaric Acids EC 6.3.1.2 Glutamate-Ammonia Ligase IM Age Factors Animals Brain enzymology growth & development Glutamate-Ammonia Ligase metabolism Ketoglutaric Acids Liver enzymology Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 832 833 1976 03 01 2016 12 03 0041-610X 47 1 1975 Jan-Feb Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Properties of NAD-pyrophosphorylase of the nuclei of liver cells of chickens]. 8-11 Certain characteristics of chicken liver cells nuclei NAD-pyrophosphorylase (NMN-adenylytranspherase, EC 2.7.7.1) were investigated. It was established that NAD-pyrophosphorylase activity optimum pH is within interval of 7.0-7.5; temperature optimum - 38-39 degrees C; factor Q10 is equal to 2. Enzyme activation energy, inactivation energy and enthalpy were calculated; apparent Km values of NAD-pyrophosphorylase with respect to NMN and ATP are equal to 1.62-10(-7) M and 2.61-10(-7) M, respectively. Fomenko H I HI Shuhevych S I SI Khalmuradov A H AH ukr English Abstract Journal Article Vlastyvosti NAD-pirofosforylazi iader klityn pechinky kurchat Ukraine Ukr Biokhim Zh 0414153 1094-61-7 Nicotinamide Mononucleotide 8L70Q75FXE Adenosine Triphosphate EC 2.7.7.- Nucleotidyltransferases IM Adenosine Triphosphate Animals Cell Nucleus enzymology Chickens Hydrogen-Ion Concentration Liver enzymology Nicotinamide Mononucleotide Nucleotidyltransferases metabolism Temperature 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 833 834 1976 03 01 2020 12 09 0041-610X 47 5 1975 Sep-Oct Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Biosynthesis of flavins and its regulation in the yeast Pichia guilliermondii]. 649-60 The nature of riboflavin precursors was studied in the yeast Pichia guilliermondii. By means of mutants with blocked GMP-synthetase the purine precursors of riboflavin were shown to belong to guanylic compounds. Accumulation of 2,4,5-triamino-6-oxypyrimidine, 2,5-diamino-6-oxy-4-ribitylaminopyrimidine, 2,6-dioxy-5-amino-4-ribitylaminopyrimidine (DOARAP) and 6,7-dimethyl-8-ribityllumasine occurs in the riboflavin-deficient mutants divided into five biochemical groups. This fact evidences for identity of riboflavin precursors in the yeast P. guilliermondii and Saccharomyces cerevisiae. Synthesis of DOARAP by the washed off cells of the mutants with the blocked lumasine synthetase is strongly inhibited by riboflavin; cycloheximide in the absence of riboflavin has no effect on this process. Consequently, flavinogenesis in P. guilliermondii is regulated according to the type of negative feedback by means of retroinhibition mechanism. A change in the content of flavins in the cells has no effect on synthesis of riboflavin synthetase; at the same time iron deficiency in the cells evokes derepression of this enzyme. Incubation of the cells rich in iron with o-phenantroline or alpha, alpha'-dipyridyl also causes derepression of riboflavin synthetase which is inhibited by cycloheximide. A deficiency of hem in the mutants which need epsilon-aminolevulinic acid does not affect the riboflavinsynthetase activity of the cells. Evidently, in P. guilliermondii a certain form of nonheminic iron might take part in regulating synthesis of riboflavin synthetase and other enzymes participating in riboflavin biosynthesis. Riboflavin overproduction is established to require formation of purines de novo. With the absence of flavinogenesis enzymes derepression a genetic disturbance in regulation of purinic nucleotides biosynthesis results in stimulation of flavinogenesis. The properties were studied for 680 time purified riboflavinkinase from cells of P. guilliermondii as well as for three phosphatases possessing the optimum of the activity at pH 3.5, 5.5 and 8.6, which ARE ABLE OF HYDROLYSING FMN. A change in the content of flavins and iron in the cells has no effect on the activity of riboflavinkinase in this species. Evidently, the mechanisms of riboflavin and flavin nucleotides biosynthesis regulation would be different in P. guilliermondii. Shavlovsky G M GM Lohvynenko E M EM Struhovshchykova L M LM Kashchenko V E VE rus Journal Article Ukraine Ukr Biokhim Zh 0414153 0 Flavins 0 Phenanthrolines 42VZT0U6YR Heme 551W113ZEP 2,2'-Dipyridyl 98600C0908 Cycloheximide E1UOL152H7 Iron EC 2.5.1.9 Riboflavin Synthase EC 2.7.- Phosphotransferases TLM2976OFR Riboflavin IM 2,2'-Dipyridyl pharmacology Ascomycota metabolism Cycloheximide pharmacology Flavins metabolism Heme pharmacology Hydrogen-Ion Concentration Iron pharmacology Kinetics Mutation Phenanthrolines pharmacology Phosphotransferases metabolism Pichia drug effects metabolism Riboflavin biosynthesis Riboflavin Synthase metabolism Saccharomyces cerevisiae metabolism Species Specificity 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 834 837 1976 02 27 2008 11 21 0041-5782 137 51 1975 Dec 15 Ugeskrift for laeger Ugeskr Laeger [Drug information. Metoprolol (Seloken, Hässle)]. 3046-7 Kampmann J P JP dan Journal Article Laegemiddelinformation. Metoprolol (seloken, Hässle) Denmark Ugeskr Laeger 0141730 0041-5782 0 Adrenergic beta-Antagonists 0 Propanolamines IM Administration, Oral Adrenergic beta-Antagonists administration & dosage adverse effects therapeutic use Angina Pectoris drug therapy Chemical Phenomena Chemistry Hypertension drug therapy Propanolamines administration & dosage adverse effects 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 837 835 1976 03 01 2013 11 21 0041-610X 47 6 1975 Nov-Dec Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [DNases and RNases of Misgurnus fossilis ovocytes]. 719-23 The pH optima were determined for DNases and RNases of the loach eggs. For DNases they are 5.6 and 7.6 and for RNases - 5.2 and 7.2. It is established that Ca++ activates, and Fe++ has not effect on the activity of acid and alkaline DNases, while Mg++, Mn++ and especially Co++, Zn++, Cd++, Cu++ have an inhibitory effect on them. The activities of RNases is stimulated by Ca++ and Fe++, and inhibited by Zn++, Co++, Cd++ and Cu++. Iones Mg++ and Mn++ do not affect these activities. Localization of the above mentioned enzymes was studied by means of differential centrifugation of egg homogenates. Acid DNase is concentrated only in postmicrosomal supernatant liquid, its activity being inhibited in the presence of the nucleomitochondrial and microsomal fractions. Acid RNase is also localized predominantly in postmicrosomal supernatant fraction. Alkaline DNase is found to a great extent in nucleomitochondrial fraction, and alkaline RNase - in postmicrosomal one. Kusen' S J SJ Oleshko P S PS ukr English Abstract Journal Article Ukraine Ukr Biokhim Zh 0414153 0 Cations, Divalent EC 3.1.- Deoxyribonucleases EC 3.1.- Ribonucleases SY7Q814VUP Calcium IM Animals Calcium pharmacology Cations, Divalent Deoxyribonucleases metabolism Enzyme Activation drug effects Female Fishes Hydrogen-Ion Concentration Kinetics Oocytes enzymology Ovum enzymology Ribonucleases metabolism 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 835 838 1976 02 19 2018 02 17 0042-1138 30 6 1975 Urologia internationalis Urol Int Characteristics of renovascular hypertension in Japan. 446-54 Hidai H H eng Comparative Study Journal Article Switzerland Urol Int 0417373 0042-1138 IM Adolescent Adult Age Factors Arteriosclerosis complications epidemiology Child Female Humans Hyperplasia complications Hypertension, Renal complications diagnosis epidemiology etiology Japan Male Middle Aged Prognosis Renal Artery Obstruction complications Takayasu Arteritis complications United States 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 838 10.1159/000280012 836 1976 03 01 2017 03 22 0041-610X 47 6 1975 Nov-Dec Ukrains'kyi biokhimichnyi zhurnal Ukr Biokhim Zh [Determination of optimal conditions for the electron-cytochemical detection of ATPase activity in isolated nuclei]. 769-75 The optimal conditions are selected for electron-cytochemical detection of the ATPase activity in nuclei of the skeletal muscles of rabbits and nuclei of Vicia faba L. meristem. It is shown that the previous fixation of nuclei in the rabbit skeletal muscle for 10 min in a mixture of the buffer solutions of 4% glutaric dialdehyde and 4% neutral formalin (1:1) causes a decrease in their ATPase activity by 78% in the medium containing Mg2+ and by 34% - in the medium containing Ca2+; in nuclei of horse bean seedlings meristem it lowers respectively by 28 and 16%. Ions of lead in a concentration of 0.4 mM evoke a decrease in the ATPase activity in the medium containing Mg2+, in nuclei of the rabbit skeletal muscles by 35% and in nuclei of horse bean meristem by 15% in the medium containing Ca2+. The vaule of the residual activity is sufficient for detection of the product of ATP enzymic hydrolysis reaction by activity is sufficient for detection of the product of ATP enzymic hydrolysis reaction by the method of electronic cytochemistry. An increase in the Pb2+ concentration higher than 2.8 mM evokes nonenzymic hydrolysis of ATP. The ATPase activity under the electron-cytochemical study is found within the range of pH 6.3-8.5. The product of reaction forms most intensively at pH 7.2-7.5 in the medium with both Mg2+ and Ca2+. Konoplytska O L OL Sytnyanska N P NP ukr English Abstract Journal Article Ukraine Ukr Biokhim Zh 0414153 2P299V784P Lead EC 3.6.1.- Adenosine Triphosphatases I38ZP9992A Magnesium SY7Q814VUP Calcium IM Adenosine Triphosphatases metabolism Animals Calcium pharmacology Cell Nucleus drug effects enzymology ultrastructure Enzyme Activation drug effects Hydrogen-Ion Concentration Kinetics Lead pharmacology Magnesium pharmacology Microscopy, Electron Muscles enzymology Plants enzymology Rabbits Species Specificity 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 836 839 1976 02 13 2013 11 21 0042-4625 114 9 1975 Sep Vestnik khirurgii imeni I. I. Grekova Vestn Khir Im I I Grek [Catecholamines, cholinergic and serotoninergic complexes as criteria of prognosis in acute cranio-cerebral trauma]. 80-2 In experiments on 30 animals and in observations over the course of acute closed craniocerebral trauma in 24 patients is was found that the course and prognosis of a posttraumatic period were dependent on the functional activity of the sympathoadrenal system and cholin- and serotoninergic processes. Based on the data obtained, it is concluded that the character of neurohumoral interrelations can serve as the prognostic criterion in craniocerebral traumas, whereas the information about these processes--in selecting the appropriate therapy. Kirillov A L AL Knirik G S GS Bazarevich G Ia GIa rus English Abstract Journal Article Katekholaminy, kholinergicheskii i serotoninergicheskii kompleksy kak kriterii prognoza pri ostroi cherepno-mozgovoi travme Russia (Federation) Vestn Khir Im I I Grek 0411377 0042-4625 0 Catecholamines 0 Neurotransmitter Agents 333DO1RDJY Serotonin EC 3.1.1.8 Cholinesterases N9YNS0M02X Acetylcholine IM Acetylcholine blood Adult Brain Injuries blood Catecholamines blood Cholinesterases blood Female Humans Male Neurotransmitter Agents blood Prognosis Serotonin blood 1975 9 1 1975 9 1 0 1 1975 9 1 0 0 ppublish 839 840 1976 02 09 2006 11 15 0042-4625 115 10 1975 Oct Vestnik khirurgii imeni I. I. Grekova Vestn Khir Im I I Grek [Incarcerated gallbladder in cholecystitis]. 32-37 Among 206 examined patients with cholecystitis and similar diseases in 112 (65%) cases, as evidenced by the authors' findings, the gallbladder proved to be non-functioning. Its escape in the biliary system was functional (indirect) or organic (absolute). The main causes of a direct organic escape of the gallbladder are as follows: destructive changes in its walls, strictures, strangulated gall stones, shrinkage or hydropsy. The reliable preoperative diagnosis of an escaped gallbladder by means of accelerated chromoduodenal catheterization, intravenous (infusion-drip) or associated (intravenous-peroral) cholecystocholangiography, correlated with the anamnesis data and clinical signs, rather speaks in favour of cholecystectomy on absolute indications. D'iachenko P K PK Serdiuk I A IA rus English Abstract Journal Article Otkliuchennyi zhelchnyi puzyr' u bol'nykh kholetsistitom Russia (Federation) Vestn Khir Im I I Grek 0411377 0042-4625 IM Acute Disease Bile analysis Cholecystitis diagnosis physiopathology Cholecystography methods Cholestasis diagnosis Chronic Disease Diagnosis, Differential Endoscopy methods Gallbladder physiopathology Humans Hydrogen-Ion Concentration Organ Size Pancreatitis diagnosis 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 840 841 1976 03 01 2016 10 26 0375-8427 20 7 1975 Jul Veterinarni medicina Vet Med (Praha) [Determination of the proteolytic activity of beef liver by means of natural substrates labed with 125 I]. 399-406 There is a description of the determination of the enzymatic activity of acid proteinases: the method is based on the use of 125J-labelled natural protein substrates. Labelled albumin 125J, globulin 125J, and insulin 125J were tested for the determination of activities. All the substrates were hydrolyzed with the enzymes of the supernatant fraction (106 000 g) of beff liver homogenate in the zone of acid pH. Optimum comditions of enzymatic reaction were tested, the dependence of reaction on the concentration of the enzyme, on time, and on temperature was determined, pH optimum was ascertained for individual substrates, and pH stability was determined. It follows from the results that the method is suitable for the determination of the enzymatic activity of proteinases of the cathepsin character. Blahovec J J Ondrus I I slo English Abstract Journal Article Stanovenie proteolytickej aktivity hovädzej pecene pomocou prirodzených substratov znackovaných 125 J Czech Republic Vet Med (Praha) 0063417 0375-8427 0 Insulin 0 Iodine Radioisotopes 0 Parathyroid Hormone 9002-60-2 Adrenocorticotropic Hormone 9002-72-6 Growth Hormone EC 3.4.- Peptide Hydrolases IM Adrenocorticotropic Hormone metabolism Animals Cattle metabolism Chromatography, Gel Growth Hormone metabolism Hydrogen-Ion Concentration Hydrolysis Insulin metabolism Iodine Radioisotopes Liver enzymology Parathyroid Hormone metabolism Peptide Hydrolases metabolism 1975 7 1 1975 7 1 0 1 1975 7 1 0 0 ppublish 841 842 1976 03 01 2003 11 14 0042-4900 97 24 1975 Dec 13 The Veterinary record Vet Rec Significance of serum pepsinogen and abomasal pH levels in a field infection of O circumcincta in lambs. 468-71 Serum pepsinogen estimations from serially bled lambs grazing on pasture from spring to autumn showed correlations with the availability of Ostertagia larvae on pasture, with faecal egg counts of O circumcincta, and with Ostertagia worm counts in similar lambs slaughtered fort-nightly from the same pasture. In the slaughtered lambs correlations were recorded between worm count, serum pepsinogen level and abomasal pH. The value of serum pepsinogen estimations as a diagnostic test is discussed with reference to these findings. Thomas R J RJ Waller P J PJ eng Journal Article England Vet Rec 0031164 0042-4900 0 Pepsinogens IM Abomasum metabolism Animals Feces parasitology Female Hydrogen-Ion Concentration Ostertagiasis metabolism parasitology veterinary Parasite Egg Count Pepsinogens blood Seasons Sheep Sheep Diseases metabolism parasitology Trichostrongyloidiasis veterinary 1975 12 13 1975 12 13 0 1 1975 12 13 0 0 ppublish 842 843 1976 02 09 2006 11 15 0324-1068 12 10 1975 Veterinarno-meditsinski nauki Vet Med Nauki [Cultivation of Trichomonas gallinarum and Trichomonas tenax on a trimed medium]. 83-7 Studied was the possibility to isolate and culture Tr. gallinarum and Tr. tenax on a medium Trimed, proposed by the authors for the isolation and cultivation of Tr. vaginalis. The growth and development of the two Trichomonas species were followed up at various temperatures -- 38 degrees, 36 degrees, and 32 degrees C, in order to establish the most appropriate temperature for continuous cultivation at longer intervals of reseeding as well as the temperature optimum for the fast deposition of great amounts of biomass. It was found that the Trimed medium is suitable for the isolation and cultivation of Tr. gallinarum and Tr. tenax. Temperatures of 38 degrees and 36 degrees contribute to the accumulation of greater amounts of biomass, while at 32 degrees C the growth of these protozoa is delayed and reseeding is to be carried out at greater intervals. Tsvetkova A A Iankov N N Dorevska K K bul English Abstract Journal Article Kultivirane na Trichomonas gallinarum i Trichomonas tenax na sreda trimed Bulgaria Vet Med Nauki 0414760 0324-1068 0 Culture Media IM Animals Culture Media Dental Caries microbiology Female Humans Hydrogen-Ion Concentration Mouth microbiology Temperature Trichomonas growth & development isolation & purification Turkeys microbiology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 843 844 1976 02 27 2019 07 14 0042-6822 68 2 1975 Dec Virology Virology Pneumococcal bacteriophages. 566-9 Tiraby J G JG Tiraby E E Fox M S MS eng Journal Article Research Support, U.S. Gov't, P.H.S. United States Virology 0110674 0042-6822 0 Viral Proteins IM Adult Bacteriophages growth & development isolation & purification ultrastructure Humans Lysogeny Pharynx microbiology Streptococcus pneumoniae Viral Proteins Virus Replication 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 844 10.1016/0042-6822(75)90300-1 845 1976 02 09 2018 12 03 0042-773X 21 11 1975 Nov Vnitrni lekarstvi Vnitr Lek [44th Internal Medicine Meeting in Boboty-Terchova--April 18, 1975 on Headache]. 1136-9 Gavalec M M cze Congress 44. Internistický den na Bobotách-Terchová dna 18. 4. 1975 na téma: bolest hlavy Czech Republic Vnitr Lek 0413602 0042-773X IM Congresses as Topic Czechoslovakia Drug-Related Side Effects and Adverse Reactions Eye Diseases complications Headache chemically induced etiology Humans Migraine Disorders complications Tooth Diseases complications 1975 11 1 1975 11 1 0 1 1975 11 1 0 0 ppublish 845 847 1976 02 13 2013 11 21 0043-5147 28 24 1975 Dec 15 Wiadomosci lekarskie (Warsaw, Poland : 1960) Wiad Lek [Gasometric studies in pneumonia in newborn infants]. 1957-62 Maszkiewicz W W Banas A A pol English Abstract Journal Article Badania gazometryczne w przebiegu zapalen pluc u noworodków Poland Wiad Lek 9705467 0043-5147 142M471B3J Carbon Dioxide IM Acid-Base Equilibrium Carbon Dioxide metabolism Female Humans Hydrogen-Ion Concentration Infant, Newborn Infant, Newborn, Diseases metabolism Male Partial Pressure Pneumonia metabolism 1975 12 15 1975 12 15 0 1 1975 12 15 0 0 ppublish 847 848 1976 02 09 2019 10 21 0044-2208 15 6 1975 Zeitschrift fur allgemeine Mikrobiologie Z Allg Mikrobiol Amylase of the thermophilic actinomycete Thermomonospora vulgaris. 393-8 alpha-Amylase of the thermophilic actinomycete Thermomonospora vulgaris was partially purified. Maximal enzyme activity was obtained at 60degreeC and pH 6.0. KM value was l.4%. The effect of some metal salts on enzyme activity was studied. Enzyme activity was inhibited by by KCN, EDTA, and iodoacetate. Inhibition by EDTA was completely nullified by CaCl2, but the inhibition by iodoacetate was not overcome by 2-mercaptoethanol. Exposure of the enzyme to pH 7.0 and 9.0 for 2 hr. did not affect the enzyme, but exposure to pH 3.0 for few minutes completely inactivated the enzyme. Exposure of the enzyme to 60degreeC resulted in an appreciable inactivation and exposure to 80degreeC completely inactivated the enzyme. Addition of CaCl2, 2-mercaptoethanol, or enzyme substrate the 60degreeC exposed enzyme. However, bovine serym albumin had a protective effect when the enzyme was exposed to 60degreeC but not to 80degreeC. The enzyme was stable in the presence of 8 M urea. Allam A M AM Hussein A M AM Ragab A M AM eng Journal Article Germany Z Allg Mikrobiol 0413631 0044-2208 0 Cyanides 0 Iodoacetates 0 Metals 0 Salts 27432CM55Q Serum Albumin, Bovine 60-24-2 Mercaptoethanol 9005-25-8 Starch 9G34HU7RV0 Edetic Acid EC 3.2.1.- Amylases M4I0D6VV5M Calcium Chloride IM Amylases metabolism Calcium Chloride pharmacology Cyanides pharmacology Edetic Acid pharmacology Hot Temperature Hydrogen-Ion Concentration Hydrolysis Iodoacetates pharmacology Mercaptoethanol pharmacology Metals pharmacology Micromonosporaceae enzymology growth & development Salts Serum Albumin, Bovine pharmacology Soil Microbiology Starch metabolism 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 848 10.1002/jobm.3630150602 846 1976 02 09 2005 11 17 2 1975 MAR-APR Voprosy neirokhirurgii Vopr Neirokhir [Certain aspects of regulation of cerebral blood flow]. 52-60 Shtok V N VN rus Journal Article Review Nekotorye aspekty reguliatsii mozgovogo krovotoka Russia (Federation) Vopr Neirokhir 0424743 0042-8817 0 Neurotransmitter Agents 0 Parasympatholytics 0 Prostaglandins IM Animals Blood Pressure Brain blood supply Cerebral Arteries physiology physiopathology Cerebrovascular Circulation drug effects Dogs Humans Hydrogen-Ion Concentration Hypertension physiopathology Hypotension physiopathology Intracranial Pressure Muscle, Smooth metabolism Neurotransmitter Agents physiology Oxygen Consumption Parasympatholytics pharmacology Prostaglandins pharmacology 161 1975 3 1 1975 3 1 0 1 1975 3 1 0 0 ppublish 846 849 1976 02 09 2019 10 21 0044-2208 15 6 1975 Zeitschrift fur allgemeine Mikrobiologie Z Allg Mikrobiol [Properties of the NADP+-dependent isocitrate dehydrogenases of Acinetobacter calcoaceticus]. 431-5 Kleber H P HP ger Journal Article Eigenschaften der NADP+-abhängigen Isocitratdehydrogenasen aus Acinetobacter calcoaceticus Germany Z Allg Mikrobiol 0413631 0044-2208 0 Glyoxylates 0 Isoenzymes 0 Ketoglutaric Acids 0 Oxaloacetates 0 Pyruvates 415SHH325A Adenosine Monophosphate 42Z2K6ZL8P Manganese 53-59-8 NADP 8L70Q75FXE Adenosine Triphosphate 8W8T17847W Urea EC 1.1.1.41 Isocitrate Dehydrogenase I38ZP9992A Magnesium IM Acinetobacter enzymology Adenosine Monophosphate pharmacology Adenosine Triphosphate pharmacology Glyoxylates pharmacology Hot Temperature Hydrogen-Ion Concentration Isocitrate Dehydrogenase metabolism Isoenzymes metabolism Ketoglutaric Acids pharmacology Magnesium pharmacology Manganese pharmacology NADP metabolism Oxaloacetates pharmacology Pyruvates pharmacology Urea pharmacology 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 849 10.1002/jobm.3630150606 851 1976 02 21 2018 12 03 0300-8673 51 29 1975 Oct 20 Zeitschrift fur Allgemeinmedizin Z Allgemeinmed [Chronic heart diseases. 6th diagnostic-therapeutic discourse of the ZFA in Freudenstadt]. 1330-1 ger Congress Chronische Herzkrankheiten. 6. Diagnostisch-Therapeutische Gespräche der ZFA in Freudenstadt Germany Z Allgemeinmed 7700691 0300-8673 IM Chronic Disease Congresses as Topic Germany, West Heart Diseases Humans 1975 10 20 1975 10 20 0 1 1975 10 20 0 0 ppublish 851 850 1976 02 09 2019 10 21 0044-2208 15 6 1975 Zeitschrift fur allgemeine Mikrobiologie Z Allg Mikrobiol [Pyridine nucleotide-independent oxidation of long chain aliphatic alcohols by an enzyme of Acinetobacter calcoaceticus]. 457-60 Tauchert H H Roy M M Schöpp W W Aurich H H ger Journal Article Phridinnucleotid-unabhängige Oxydation von längerkettigen aliphatischen Alkoholen durch ein Enzym aus Acinetobacter calcoaceticus Germany Z Allg Mikrobiol 0413631 0044-2208 0 Aldehydes 0 Cyanides 0 Hexanols 0 Hydrazones 0 Octanols 299-11-6 Methylphenazonium Methosulfate 53-59-8 NADP C35QN2Z58B 2,6-Dichloroindophenol EC 1.1.- Alcohol Oxidoreductases IM 2,6-Dichloroindophenol metabolism Acinetobacter enzymology metabolism Alcohol Oxidoreductases metabolism Aldehydes metabolism Cell-Free System Cyanides pharmacology Hexanols metabolism Hydrazones metabolism Hydrogen-Ion Concentration Methylphenazonium Methosulfate pharmacology NADP metabolism Octanols metabolism Oxidation-Reduction 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 850 10.1002/jobm.3630150609 852 1976 02 27 2018 12 03 0300-8673 51 31 1975 Nov 10 Zeitschrift fur Allgemeinmedizin Z Allgemeinmed [Virus diseases of the skin and genital organs. 6th diagnostic-therapeutic discourse of the ZFA in Freudenstadt 1975]. 1441-2 Nasemann T T ger Congress Viruskrankheiten der Haut und Genitalorgane 6. Diagnostisch-Therapeutische Gespräche der ZFA in Freudenstadt 1975 Germany Z Allgemeinmed 7700691 0300-8673 IM Adult Congresses as Topic Female Genitalia Germany, West Humans Skin Diseases, Infectious Virus Diseases 1975 11 10 1975 11 10 0 1 1975 11 10 0 0 ppublish 852 853 1976 02 09 2013 11 21 0044-2178 69 10 1975 May 15 Zeitschrift fur arztliche Fortbildung Z Arztl Fortbild (Jena) [Preparation of hyperthyreotic patients for surgery]. 531-5 Werner U U Gerschner H H ger Journal Article Die Vorbereitung hyperthyreoter Patienten auf die Operation Germany Z Arztl Fortbild (Jena) 0414004 0044-2178 0 Adrenergic beta-Antagonists 0 Thyroid Hormones 9679TC07X4 Iodine IM Adrenergic beta-Antagonists therapeutic use Adult Aged Female Humans Hyperthyroidism surgery Iodine therapeutic use Male Middle Aged Postoperative Complications prevention & control Preoperative Care Thyroid Crisis prevention & control Thyroid Hormones therapeutic use 1975 5 15 1975 5 15 0 1 1975 5 15 0 0 ppublish 853 854 1976 02 09 2004 11 17 0044-2178 69 10 1975 May 15 Zeitschrift fur arztliche Fortbildung Z Arztl Fortbild (Jena) [Incidence and clinical course of vaccination complications]. 550-4 Dietzsch H J HJ Gottlöber B B ger Journal Article Häufigkeit und klinischer Verlauf von Impfkomplikationen Germany Z Arztl Fortbild (Jena) 0414004 0044-2178 0 BCG Vaccine 0 Smallpox Vaccine IM Adolescent BCG Vaccine adverse effects Child Child, Preschool Eczema etiology Encephalomyelitis, Acute Disseminated epidemiology Exanthema etiology Germany, East Humans Smallpox Vaccine adverse effects 1975 5 15 1975 5 15 0 1 1975 5 15 0 0 ppublish 854 855 1976 03 01 2013 11 21 0044-2542 30 19 1975 Oct 01 Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete Z Gesamte Inn Med [Experimental ulcer]. 624-8 Varró V V ger English Abstract Journal Article Das experimentelle Ulkus Germany Z Gesamte Inn Med 21730470R 0044-2542 0 Quinolines 01MI4Q9DI3 Pilocarpine 3G6A5W338E Caffeine 8B1QWR724A Reserpine GN5P7K3T8S Phenylbutazone XXE1CET956 Indomethacin IM Animals Caffeine adverse effects Cats Cattle Chickens Disease Models, Animal Dogs Ducks Guinea Pigs Haplorhini Indomethacin adverse effects Mice Peptic Ulcer chemically induced etiology Phenylbutazone adverse effects Pilocarpine adverse effects Quinolines adverse effects Rabbits Rats Reserpine adverse effects Swine 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 855 856 1976 02 13 2006 11 15 0044-2542 30 7 1975 Apr 01 Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete Z Gesamte Inn Med [The effect of therapeutic gentamycin doses on the enzyme secretion in urine]. 265-8 8 patients with chronic pyelonephritis were given gentamycin intramuscularly injected in individual dosage during 8-10 days. Here the behaviour of the excretion of protein, alanine aminopeptidase alkaline phosphatase, alpha-glucosidase, gamma-glutamyl transpeptidase and lysozyme with the urine was tested. With the exception of the lysozymuria, which increased only in patients with chronic renal insufficiency, regularly a hyperenzymuria developed. Most distinctly the excretion of the alanine aminopeptidase increased. After initial decrease the excretion of total protein transiently increased after completion of the gentamycin therapy. All the deviations were reversible. From the increased excretion of enzymes may not be concluded to a nephrotoxicity of gentamycin. Burchardt U U Peters J E JE Gründig C A CA ger English Abstract Journal Article Der Einfluss therapeutischer Gentamyzindosen auf die Enzymausscheidung im Harn Germany Z Gesamte Inn Med 21730470R 0044-2542 0 Gentamicins EC 2.3.2.2 gamma-Glutamyltransferase EC 3.1.3.1 Alkaline Phosphatase EC 3.1.6.1 Arylsulfatases EC 3.2.1.- Glucosidases EC 3.2.1.17 Muramidase EC 3.2.1.31 Glucuronidase EC 3.4.11.- Aminopeptidases IM Alkaline Phosphatase urine Aminopeptidases urine Arylsulfatases urine Female Gentamicins adverse effects therapeutic use Glucosidases urine Glucuronidase urine Humans Kidney Tubules drug effects Male Muramidase urine Proteinuria diagnosis Pyelonephritis drug therapy gamma-Glutamyltransferase urine 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 856 857 1976 02 09 2015 11 19 0301-0481 50 12 1975 Jun 15 Zeitschrift fur Hautkrankheiten Z Hautkr Acetylcholinesterase in atopic skin in relation to the B blockade model of atopy. 533-4 Mier P D PD Cotton D W DW eng Journal Article Germany Z Hautkr 0367576 0301-0481 0 Adrenergic beta-Antagonists E0399OZS9N Cyclic AMP EC 3.1.1.7 Acetylcholinesterase EC 4.6.1.1 Adenylyl Cyclases N9YNS0M02X Acetylcholine IM Acetylcholine pharmacology Acetylcholinesterase analysis Adenylyl Cyclases analysis Adrenergic beta-Antagonists pharmacology Animals Cyclic AMP blood Dermatitis, Atopic enzymology Dogs Skin enzymology Sweating drug effects 1975 6 15 1975 6 15 0 1 1975 6 15 0 0 ppublish 857 858 1976 02 09 2013 11 21 0044-2933 13 10 1975 Oct Zeitschrift fur klinische Chemie und klinische Biochemie Z Klin Chem Klin Biochem [Alkaline phosphatases in human feces, intestinal mucosa and bile, and the occurrence of 5'-nucleotidase in feces (author's transl)]. 437-44 Alkaline phosphatase (EC 3.1.3.1) in extracts of human feces resembles alkaline phosphatase in extracts of duodenal mucosa, except for its electrophoretic mobility in starch gel. It is very probable that the normal feces alkaline phosphatase derives from intestinal mucosa. Gall bladder alkaline phosphatase, which is markedly different, has not been found in normal feces. Some patients with acute viral hepatitis or protozoasis excrete an alkaline phosphatase which resembles gall bladder alkaline phosphatase and has the characteristics of 5'-nucleotidase (EC 3.1.3.5). The appearance of this enzyme correlates with low total alkaline phosphatase activity of the excreta. Benic V V Fiser-Herman M M ger Comparative Study English Abstract Journal Article Uber alkalische Phosphatasen in menschlichen Faeces, Dünndarmschleimhaut und Galle und das Vorkommen von 5-Nucleotidase in Faeces Germany Z Klin Chem Klin Biochem 7607250 0044-2933 47E5O17Y3R Phenylalanine EC 3.1.3.- Nucleotidases EC 3.1.3.1 Alkaline Phosphatase IM Adult Alkaline Phosphatase analysis antagonists & inhibitors isolation & purification metabolism Bile enzymology Child Child, Preschool Cholestasis enzymology Chromatography, Gel Feces enzymology Gallbladder enzymology Giardiasis enzymology Hepatitis A enzymology Humans Hydrogen-Ion Concentration Intestinal Mucosa enzymology Intestine, Small enzymology Liver Cirrhosis enzymology Nucleotidases analysis metabolism Phenylalanine pharmacology 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 858 859 1976 02 09 2019 10 27 0044-2933 13 10 1975 Oct Zeitschrift fur klinische Chemie und klinische Biochemie Z Klin Chem Klin Biochem Simultaneous determination of 5'-nucleotidase and alkaline phosphatase activities in serum. 453-9 A simple method is described for the simultaneous determination of alkaline phosphatase (EC 3.1.3.1) and 5'-nucleotidase (EC 3.1.3.5) in serum. The method is based on the determination of inorganic phosphorus released by the action of the two enzymes on adenosine-5'-monophosphate at pH 9.5 (200 mmol/l tris-buffer) in the presence and absence of L-cysteine. This amino acid at a concentration of 2--10 mmol/l was found to be a specific inhibitor for alkaline phosphatase but with no effect on 5'-nucleotidase activity. El-Aaser A A AA El-Merzabani M M MM eng Journal Article Germany Z Klin Chem Klin Biochem 7607250 0044-2933 0 Cyanides 415SHH325A Adenosine Monophosphate 7OV03QG267 Nickel EC 3.1.3.- Nucleotidases EC 3.1.3.1 Alkaline Phosphatase K848JZ4886 Cysteine Q80VPU408O Fluorides IM Adenosine Monophosphate Alkaline Phosphatase antagonists & inhibitors blood Animals Cyanides pharmacology Cysteine pharmacology Enzyme Activation Fluorides pharmacology Humans Hydrogen-Ion Concentration Intestines enzymology Kidney enzymology Liver enzymology Methods Mice Nickel pharmacology Nucleotidases blood 1975 10 1 1975 10 1 0 1 1975 10 1 0 0 ppublish 859 10.1515/cclm.1975.13.10.453 860 1976 03 01 2019 10 27 0044-2933 13 12 1975 Dec Zeitschrift fur klinische Chemie und klinische Biochemie Z Klin Chem Klin Biochem Absorption of short and medium chain fatty acids in the jejunum of the rat. 553-62 The uptake of the shortest six fatty acids (acetic to octanoic) was studied in vitro, using everted segments of rat jejunum. The marked influence of medium-pH and fatty acid chain-length suggests that non-ionic diffusion through the lipoid membrane is quantitatively the most important way of transport, but ionic diffusion through the membrane as well as transport through hydrophilic pores also seem to play a role. Though fatt acids evidently are accumulated in the tissue-fluid, and saturation kinetics, competitive inhibition and sodium- as well as energy-dependence apparently are observed, the transport mechanism is assumed to involve solely passive diffusion, - the concept of a carrier-mediated transport for short and medium chain fatty acids seems improbable. Naupert C C Rommel K K eng Journal Article Germany Z Klin Chem Klin Biochem 7607250 0044-2933 0 Caprylates 0 Dinitrophenols 0 Fatty Acids 0 Fatty Acids, Volatile 0 Heptanoic Acids 5ACL011P69 Ouabain IM Animals Biological Transport, Active drug effects Caprylates metabolism Diffusion Dinitrophenols pharmacology Fatty Acids metabolism Fatty Acids, Volatile metabolism Heptanoic Acids metabolism Hydrogen-Ion Concentration In Vitro Techniques Intestinal Absorption drug effects Jejunum metabolism Kinetics Male Ouabain pharmacology Rats 1975 12 1 1975 12 1 0 1 1975 12 1 0 0 ppublish 860 10.1515/cclm.1975.13.12.553 861 1976 03 01 2019 10 27 0084-5353 84 3 1975 Nov 25 Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Carcinogenic N-nitro-dimethylamine from the reaction of the analgesic amidopyrine and nitrite extracted from foodstuffs. 299-10 The reaction of the analgesic amidopyrine (100 mg) with nitrite extracted from cured meats and from spinach in varying degrees of spoilage was studied. Unde physiological conditions the carcinogenic dimethylnitrosamine was formed at milligram levels at nitrite concentrations as low as 4 mg (in 175 ml extracted from 100 g boiled ham). The rate of decrease in concentration in the human stomach after ingestion of amidopyrine and of nitrite contained in boiled ham or in a broth from boiled ham was also measured. LaBar J J Sander J J eng Journal Article Germany Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1276653 0084-5353 0 Food Preservatives 0 Nitrites 0 Nitrosamines 01704YP3MO Aminopyrine M43H21IO8R Dimethylnitrosamine IM Aminopyrine metabolism Digestion Dimethylnitrosamine analysis biosynthesis Food Food Preservatives adverse effects Food-Processing Industry Gastric Juice metabolism Germany, West Humans Hydrogen-Ion Concentration Legislation, Drug Liver Neoplasms chemically induced Meat analysis Nitrites adverse effects metabolism Nitrosamines biosynthesis Vegetables analysis 1975 11 25 1975 11 25 0 1 1975 11 25 0 0 ppublish 861 10.1007/BF00312251 Nature. 1972 Sep 15;239(5368):165-7 4561965 Proc Natl Acad Sci U S A. 1973 Mar;70(3):747-9 4514987 Experientia. 1967 Jun 15;23(6):497-8 4295209 Gastroenterology. 1967 Feb;52(2):414-20 6020109 Schweiz Med Wochenschr. 1971 Mar 6;101(9):328-34 5546278 Acta Med Scand. 1970 Jan-Feb;187(1-2):109-15 5423198 J Pathol Bacteriol. 1962 Jul;84:19-31 14468246 Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1973 May 7;79(3):145-7 4270220 J Pharmacol Exp Ther. 1950 Jun;99(2):171-84 15437290 Nature. 1973 Jul 20;244(5412):176-8 4583503 Nature. 1970 Oct 10;228(5267):173-4 5460018 Science. 1972 Jul 7;177(4043):65-8 5041776 Arzneimittelforschung. 1974 Aug;24(8):1181-4 4479515 J Natl Cancer Inst. 1973 Apr;50(4):1055-6 4703770 Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;82(4):259-68 4280344 J New Drugs. 1965 Jan-Feb;5(1):57-62 14283069 Arch Hyg Bakteriol. 1967 May;151(1):22-8 5598578 Food Cosmet Toxicol. 1969 Jul;7(4):301-7 5823975 Arzneimittelforschung. 1969 Jul;19(7):1091-3 5394509 Dtsch Med Wochenschr. 1965 Oct 15;90(42):1856-63 5826947 Nat New Biol. 1972 Apr 12;236(67):177-8 4503733 Zentralbl Bakteriol Orig B. 1972 Dec;156(4):299-320 4574319 862 1976 02 27 2013 11 21 0300-5860 Suppl 2 1975 Zeitschrift fur Kardiologie Z Kardiol [Proceedings: Intracellular pH and CO2-binding curve of the myocardium in normo and hyperthermia in rats]. 131 Wand T T Saborowski F F ger Journal Article Intrazelluläres pH und CO2-Bindungskurve des Herzmuskels in Normo- und Hyperthermie bei Ratten Germany Z Kardiol 0360430 0300-5860 142M471B3J Carbon Dioxide IM Acid-Base Equilibrium Animals Carbon Dioxide metabolism Fever metabolism Heart Ventricles metabolism Hydrogen-Ion Concentration Male Myocardium metabolism Rats 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 862 863 1976 02 09 2006 11 15 0044-3069 16 5 1975 Zeitschrift fur medizinische Labortechnik Z Med Labortech [A modern quick method for the acidity determination of the gastric juice (pentagastrin test)]. 241-9 The author describes a very rapid and accurate method of determining the acidity of gastric juice which is based on recent findings. Starting from the electrometrically determined pH value and the volume of the gastric juice, the actual hydrogenion concentration may be read from a table. The laboratory work is considerably simplified by this method. Pöge A W AW ger English Abstract Journal Article Eine moderne, schnelle Methode zur Bestimmung der Azidität des Magensaftes (Pentagastrintest) Germany Z Med Labortech 0413636 0044-3069 IM Gastric Acidity Determination methods Humans Hydrogen-Ion Concentration 1975 1 1 1975 1 1 0 1 1975 1 1 0 0 ppublish 863 864 1976 02 13 2006 11 15 0044-3107 89 1 1975 Zeitschrift fur mikroskopisch-anatomische Forschung Z Mikrosk Anat Forsch Histochemical observations on the occurrence of glycolytic and pentose phosphate cycle enzymes in the hepatopancreas and their possible relation to eyestalk factor(s) in the crab Scylla serrata (Forskal). 128-42